text,title,id,project_number,terms,administration,organization,mechanism,year,award_amount,cong_dist,score
"Machine learning to identify predictive SNPs and complex interaction effects    DESCRIPTION (provided by applicant): Susceptibility to complex diseases is determined by the coordinated function of multiple genetic variants and environmental factors interacting in a composite and potentially nonlinear manner. Although the genome-wide views provided by advanced single nucleotide polymorphism (SNP) arrays present an opportunity to discover previously unrecognized genomic patterns, the ability to recognize such complex features of genetic architecture has important implications for the use of genome-wide association study to discover genetic determinants of health and disease from massive genomic data. The focus of this application is the development and validation of effective computational statistics approaches to detect complex interaction effects of multi-locus SNPs which could be useful for classification and prediction of disease or dysfunction, and provide novel insights into the pathogenesis of complex phenotypes. Based on very promising preliminary studies, the specific aims of this R21 application are carefully designed: (1) to refine and evaluate the recently developed significant conditional association (SCA) criterion and heuristic combinatorial interaction growing (HCIG) search strategy (specifically designed to discover complex interaction effects of multi-locus jointly-predictive SNPs), test and validate on real SNP based realistic simulations and compare with a panel of most relevant existing methods; and (2) to apply SCA- HCIG method to the real SNP data of NIAMS-funded FMS cohort in relationship to metabolic syndrome etc. and develop SNP marker based classification/ prediction models, assessed by the prediction power and initial biological plausibility of the implicated SNP subsets. This proposal represents a unique cross-disciplinary collaboration focusing on the development of new analytical methods to more effectively identify interacting susceptibility SNPs and environmental factors that can be used to determine individual risk to a specific disease and to estimate prognosis and response to treatment. The results could also suggest novel preventive intervetions and therapeutic targets, reduce the burden of diseases, and accelerate the realization of truly personalized medicine.           Principal Investigator/Program Director (Last, First, Middle): Wang, Yue (Joseph), Ph.D. Machine learning to identify predictive SNPs and complex interaction effects Project Narrative  Susceptibility to complex diseases is determined by the coordinated function of multiple genetic and environmental factors. The identified interacting susceptibility SNPs and risk factors can be used to determine individual risk to a specific disease and to estimate prognosis and response to treatment. The results could also suggest novel preventive intervetions and therapeutic targets, reduce the burden of diseases, and accelerate the realization of truly personalized medicine. PHS 398/2590 (Rev. 09/04, Reissued 4/2006) Page 0 Continuation Format Page",Machine learning to identify predictive SNPs and complex interaction effects,7922025,R21GM085665,"['Bioinformatics ', ' Bio-Informatics ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Address ', ' Preventive ', ' Genetic Epistasis ', ' genetic epistases ', ' gene x gene interaction ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Data Set ', ' Dataset ', ' Data ', ' Detection ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Randomized ', ' randomly assigned ', ' randomization ', ' randomisation ', ' Validation ', ' Principal Investigator ', ' Molecular ', ' Development ', ' developmental ', ' Genes ', ' analytical method ', ' base ', ' Goals ', ' improved ', ' Health ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Area ', ' Specific qualifier value ', ' Specified ', ' Biological ', ' Non-linear Models ', ' Nonlinear Models ', ' Predisposition ', ' Susceptibility ', ' prognostic ', ' insight ', ' web site ', ' website ', ' Individual ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Funding ', ' Medicine ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Collaborations ', ' Simulate ', ' Phenotype ', ' Genetic ', ' Staging ', ' outcome forecast ', ' Prognosis ', ' Diagnostic ', ' Figs - dietary ', ' Figs ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Risk ', ' Risk Factors ', ' ROC Curve ', ' ROC Analyses ', ' Sensitivity and Specificity ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Solutions ', ' programs ', ' statistics ', ' Testing ', ' Complex ', ' Pattern ', ' Drug Formulations ', ' Formulation ', ' Penetrance ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' Performance ', ' success ', ' heuristics ', ' Biological Neural Networks ', ' neural network ', ' cohort ', ' trait ', ' simulation ', ' novel ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Pathogenesis ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Molecular Genetics ', ' Modeling ', ' Neural Network Simulation ', ' neural network (computer simulation of nervous system) ', ' Perceptrons ', ' Neural Networks (Computer) ', ' Neural Network Models ', ' Connectionist Models ', ' response ', ' case control ', ' software development ', ' developing computer software ', ' develop software ', ' Genomics ', ' Classification ', ' Systematics ', ' Metabolic syndrome ', ' Genetic Determinism ', ' genetic determinant ', ' clinical phenotype ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' burden of illness ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' genetic variant ', ' predictive modeling ', ' computer based prediction ', ' cluster computing ', ' grid computing ', ' distributed computing ', ' datagrid ', ' data grid ', ' computational grid ', ' design ', ' designing ', ' Outcome ', ' innovation ', ' innovative ', ' innovate ', ' combinatorial ', ' therapeutic target ', ' genome-wide ', ' genomewide ', ' Computational algorithm ', ' ']",NIGMS,VIRGINIA POLYTECHNIC INST AND ST UNIV,R21,2010,226422,VA-09,0.06687096105337388
"Analysis of the Functional Impact of Coding region SNPs    DESCRIPTION (provided by applicant):       During the current grant period, we have developed two models of the impact of missense SNPs on protein function in vivo. Through this work, and that of others, we now have a clearer understanding of the molecular mechanisms that lead to monogenic disease. We have also developed a web resource which integrates our results with a large range of other information relevant to disease. Goals for next phase fall into three categories: (1) Exploiting the present results to address basic questions concerning the relationship between genetic variation and disease. Specifically: What is the distribution of mechanisms by which mis-sense SNPs influence protein function; how common are epistatic (non-linear) interactions between SNPs with the same protein molecule and across protein-protein interfaces; what are the characteristics of the approximately 1500 proteins involved in monogenic disease, versus all the others; which SNPs are most significant in directly and indirectly affecting particular biological processes and susceptibility to common diseases? (2) Improving and extending SNP analysis methods, both to obtain a more extensive and reliable set of deleterious mis-sense SNPs, and to include analysis of SNPs that influence disease susceptibility through other processes. New models will be developed for effects on transcription, message processing and translation. Available database information will be augmented by a combination of literature analysis and   soliciting input from appropriate members of the scientific community. (3) Maintain and enhance the web resource to increase its utility to the research community. Functionality will be extended to allow users to input their own SNPs and receive a real time analysis from both models; a user annotation interface will be developed, to capture knowledge on the role of amino acids altered mis-sense SNPs, as well as which genes are most relevant to disease, and what buffering mechanisms shield the phenotype from particular deleterious SNPs; additional information sources will be incorporated, including SNP analysis by others.    Relevance to public health: Many common human diseases, such as heart attack, Alzheimer, asthma and diabetes, are partly inherited, through specific DNA features. At present, there is no common disease for which these inheritance mechanisms are understood. This work will provide specific insight into a number of diseases, and improved understanding of the inheritance process.              ",Analysis of the Functional Impact of Coding region SNPs,7842564,R01LM007174,"['Diabetes Mellitus ', ' diabetes ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Disease susceptibility ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' DNA ', ' Deoxyribonucleic Acid ', ' Address ', ' Disease Association ', ' in vivo ', ' Ligand Binding ', ' Translation Process ', ' Characteristics ', ' Molecular ', ' Process ', ' protein function ', ' Set protein ', ' Template Activating Factor I Beta ', ' SET Translocation Inhibitor-2 of Protein Phosphatase-2A ', ' Phosphatase 2A Inhibitor I2PP2A ', ' Inhibitor of GZMA-Activated DNase ', ' IGAAD ', ' HLA-DR Associated Protein II ', ' Affect ', ' Genes ', ' base ', ' Goals ', ' Grant ', ' improved ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Phase ', ' Ensure ', ' Predisposition ', ' Susceptibility ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' insight ', ' Individual ', ' Literature ', "" Alzheimer's Disease "", ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Amino Acids ', ' aminoacid ', ' Methods ', ' Myocardial Infarction ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Biological Process ', ' Biological Function ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Molting ', ' Ecdysis ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Phenotype ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' gene product ', ' public health medicine (field) ', ' Public Health ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Rest ', ' Role ', ' social role ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' Time ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Asthma ', ' Bronchial Asthma ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Work ', ' Inherited ', ' Hereditary ', ' Source ', ' Benchmarking ', ' Best Practice Analysis ', ' mutant ', ' protein structure function ', ' Buffers ', ' Structure ', ' member ', ' Categories ', ' Catalysis ', ' Code ', ' Coding System ', ' falls ', ' Modeling ', ' Communities ', ' Population ', ' human disease ', ' ']",NLM,"UNIV OF MARYLAND, COLLEGE PARK",R01,2010,290690,MD-05,0.06308341804644682
"Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers    DESCRIPTION (provided by applicant): Epigenetic silencing involving alterations in DNA methylation and chromatin structure at promoter region CpG islands is a common mechanism of tumor suppressor gene inactivation in human cancers. However, the mechanisms underlying this event remain poorly understood. An unresolved question is why are some genes targets of aberrant methylation in human cancers while others are never affected? In preliminary work, we have shown that even in the context of an increased cellular capacity for de novo methylation, CpG islands differ in their potential for aberrant methylation. By applying DNA pattern recognition and machine learning techniques, we have developed an algorithm based on several short sequence patterns that is capable of accurately discriminating methylation-prone and methylation-resistant CpG islands. These studies indicate that the epigenetic status of a CpG island can be predicted based on DNA sequence features, and lead us to propose that one factor contributing to the non-random patterns of CpG island methylation observed in human tumors is an underlying susceptibility conferred by local sequence context. The goal of this proposal is to define the genomic signature associated with aberrant methylation. The long term objectives are (i) to identify and to functionally characterize local sequence attributes that contribute to the propensity towards, or protection from, aberrant methylation, and (ii) to develop and to test novel tumor specific classifiers capable of predicting genomic loci at risk of aberrant methylation. Specifically, we will determine whether sequence features identified in silico act in cis to promote or to prevent de novo methylation in vivo using an episomal transgene approach. In preliminary work, we have identified a relationship between methylation-prone CpG islands and genomic regions bound by the polycomb repressor complex. As a second component of the project, we will determine the role of PRC2 in methylation susceptibility. As a third component of this project we will refine our computational models by 1) determining whether CpG islands predicted to be methylation-prone are in fact targets of aberrant methylation in human cancers, 2) using this information to re-train the prediction model, and 3) developing and testing a novel lung cancer specific classifier based on large-scale CpG island methylation data from primary lung tumors. We anticipate that the information gained from these studies will allow for a better understanding of the mechanisms underlying the epigenetic silencing of tumor suppressor genes that accompanies carcinogenesis. Moreover, the ability to predict the methylation status of CpG islands genome-wide will provide an important resource for the identification of novel gene targets for further study as potential cancer biomarkers. PUBLIC HEALTH RELEVANCE: The overarching goal of this research is to better understand the mechanisms by which important growth regulatory genes are targeted for epigenetic silencing in human cancers. Although the consequences of this event are the same as a mutation, there is no molecular defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the DNA and the histone proteins it is wrapped around that render certain genes abnormally and permanently silent. We plan to use a computational approach to identify DNA features that put certain genes at risk of aberrant methylation. Because genes that are silenced by methylation are otherwise structurally sound, the potential for reactivating these genes by blocking or reversing the methylation process represents an exciting molecular target for chemotherapeutic intervention. A better understanding of the factors that contribute to aberrant methylation, including the identification of sequence features that attract or repel DNA methylation, will be an important step in achieving this long-term goal. Moreover, the ability to identify those genes at risk of epigenetic silencing will provide novel molecular targets for further study as potential biomarkers for improved cancer diagnosis and treatment planning.           Project Narrative The overarching goal of this research is to better understand the mechanisms by which important growth regulatory genes are targeted for epigenetic silencing in human cancers. Although the consequences of this event are the same as a mutation, there is no molecular defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the DNA and the histone proteins it is wrapped around that render certain genes abnormally and permanently silent. We plan to use a computational approach to identify DNA features that put certain genes at risk of aberrant methylation. Because genes that are silenced by methylation are otherwise structurally sound, the potential for reactivating these genes by blocking or reversing the methylation process represents an exciting molecular target for chemotherapeutic intervention. A better understanding of the factors that contribute to aberrant methylation, including the identification of sequence features that attract or repel DNA methylation, will be an important step in achieving this long-term goal. Moreover, the ability to identify those genes at risk of epigenetic silencing will provide novel molecular targets for further study as potential biomarkers for improved cancer diagnosis and treatment planning.",Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers,7843531,R01CA132065,"['Alu Elements ', ' Alu Repetitive Sequences ', ' Alu Family ', ' Lung Neoplasms ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Gene Targeting ', ' Methylation ', ' Protein Methylation ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Biological Process ', ' Biological Function ', ' CpG Islands ', ' CpG-Rich Islands ', ' Transgenes ', ' Play ', ' Shapes ', ' Promoter Regions (Genetics) ', ' genetic promoter element ', ' Promotor Regions (Genetics) ', ' Promotor Regions ', ' Promoter Regions ', ' cancer cell ', ' Malignant Cell ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Proteins ', ' gene product ', ' Publishing ', ' Recruitment Activity ', ' recruit ', ' Repression ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' sound ', ' Employee Strikes ', ' Strikes ', ' Testing ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' carcinogenesis ', ' Cancer Induction ', ' Tumor Suppressor Proteins ', ' tumor suppressor ', ' Gene Silencing ', ' Gene Inactivation ', ' treatment planning ', ' Primary Neoplasm ', ' Primary Tumor ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Cell Culture Techniques ', ' cell culture ', ' Generations ', ' Tumor Suppressor Genes ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Code ', ' Coding System ', ' Polycomb ', ' Mediating ', ' Promotor (Genetics) ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Modeling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' Classification ', ' Systematics ', ' cancer diagnosis ', ' Cancer cell line ', ' Resistance ', ' resistant ', ' tumor ', ' overexpression ', ' overexpress ', ' public health relevance ', ' biomarker ', ' genome-wide ', ' genomewide ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Cytosine ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' histone modification ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' DNA ', ' Deoxyribonucleic Acid ', ' DNA Modification Methylases ', ' Site-Specific DNA-methyltransferase ', ' Modification Methylases ', ' EC 2.1.1.113 ', ' Dnmt ', ' DNA-Methyltransferases ', ' DNA Modification Methyltransferases ', ' prevent ', ' preventing ', ' Defect ', ' Aberrant DNA Methylation ', ' DNA Methyltransferase ', ' Data ', ' Deletion Mutation ', ' Ectopic Expression ', ' Hypermethylation ', ' Molecular Target ', ' in vivo ', ' Chromatin Structure ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Pattern Recognition ', ' Tumor-Suppressor Gene Inactivation ', ' Molecular ', ' Process ', ' Fibrinogen ', ' Factor One ', ' Factor I ', ' Coagulation Factor One ', ' Coagulation Factor I ', ' Blood Factor One ', ' Blood Coagulation Factor One ', ' Blood Coagulation Factor I ', ' DNA Sequence ', ' Affect ', ' Gene Expression ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genome ', ' Human Genome ', ' human whole genome ', ' base ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' improved ', ' Histones ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Algorithms ', ' Site ', ' Predisposition ', ' Susceptibility ', ' Training ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' ']",NCI,EMORY UNIVERSITY,R01,2010,315601,GA-05,0.045851135864643414
"Depression susceptibility genes and networks: expression, eQTL and GWAS analysis    DESCRIPTION (provided by applicant): Major depressive disorder (MDD) is the leading cause of disability in the world (WHO). The severe, recurrent form often onsets during childhood or adolescence and becomes chronic. Heritability (35-70%) is similar to that of other common disorders for which genetic methodologies have yielded major discoveries. However, genome-wide association (GWA) studies have not yet produced significant results, and success may require much larger samples than are available. Alternative discovery strategies are urgently needed. Here, we will integrate genome-wide gene expression data from fresh blood with GWAS data to detect expression quantitative trait loci (eQTLs - SNP loci that influence gene expression) with the goal of discovering new MDD susceptibility loci using two novel analytic strategies, including a gene network analysis method that will be substantially developed in the context of this work. We will also seek to refine and confirm the results with genome-wide expression data from brain tissue. We will recruit a new, population-based sample of 500 new recurrent MDD cases and 500 depression-free controls, using a novel strategy in collaboration with a survey research company. Using RNA extracted from RNA-stabilized whole blood, genome-wide gene expression levels will be assayed with Illumina HT-12 array, and common SNP genotypes will be assayed (Illumina 660W) from DNA. (We will also assay brain tissue from two regions from 39 case and 27 control specimens for confirmatory studies.) Potential non-genetic sources of variability will be considered and statistically controlled. Two novel analytic strategies will be used to discover MDD susceptibility alleles, genes and gene regulatory networks. (1) A univariate discovery strategy will identify case-control gene expression differences; detect SNP eQTLs for the selected genes using genome-wide SNP data in controls; and test the association of these SNPs to MDD in two independent GWA datasets. The prior selection of a small number of eQTLs in a separate sample greatly improves power by reducing the burden of multiple testing in GWA analysis. (2) We will extend a novel multivariate method that uses machine learning algorithms to detect gene regulatory networks, and then apply this model to the analysis of the association of co-regulated gene modules to MDD. These algorithms (a) use a background pathway graph that integrates a wide range of high-throughput and curated bioinformatic data to predict biological relationships between genes, to bias the algorithm toward biologically plausible hypotheses; and then (b) use eQTL data to construct a set of gene regulatory modules (co-expressed genes) and infer a sparse regulatory program for each module. The method will then be applied to the GWA data, and (using a novel transfer learning method) to brain data. These studies will identify genes and gene networks underlying susceptibility to major depression.      PUBLIC HEALTH RELEVANCE: The proposed project will recruit individuals with and without histories of recurrent depression and then study both the DNA sequence and the activity levels of genes in blood cells. Using a new set of statistical methods, the study will attempt to identify genes and networks of genes that are altered in some people who suffer from depression. This information would be useful in finding new treatment or prevention strategies.              The proposed project will recruit individuals with and without histories of recurrent depression and then study both the DNA sequence and the activity levels of genes in blood cells. Using a new set of statistical methods, the study will attempt to identify genes and networks of genes that are altered in some people who suffer from depression. This information would be useful in finding new treatment or prevention strategies.","Depression susceptibility genes and networks: expression, eQTL and GWAS analysis",7941979,RC2MH089916,"['Brain ', ' Encephalon ', ' Brain Nervous System ', ' novel ', ' Prevention strategy ', ' Preventive strategy ', ' Graph ', ' Patient Self-Report ', ' Self-Report ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factor Gene ', ' Statistical Methods ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' Sampling ', ' protein protein interaction ', ' case control ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' SNP genotyping ', ' Heritability ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' public health relevance ', ' population based ', ' genome-wide ', ' genomewide ', ' non-genetic ', ' nongenetic ', ' Bioinformatics ', ' Bio-Informatics ', ' Mental Depression ', ' depression ', ' Diagnosis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Major Depressive Disorder ', ' major depression ', ' DNA ', ' Deoxyribonucleic Acid ', ' Pharmaceutical Preparations ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Data Set ', ' Dataset ', ' Data ', ' Smoking Status ', ' sex ', ' Exercise ', ' Physical Exercise ', ' Adolescence ', ' teenage ', ' adolescence (12-20) ', ' 12-20 years old ', ' DNA Sequence ', ' Prefrontal Cortex ', ' Foundations ', ' Pathway interactions ', ' pathway ', ' Gene Expression ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Age ', ' Goals ', ' early onset ', ' improved ', ' Procedures ', ' Hippocampus (Brain) ', ' hippocampal ', ' Hippocampus ', ' Cornu Ammonis ', ' Ammon Horn ', ' Recording of previous events ', ' History ', ' Algorithms ', ' Chronic ', ' Biological ', ' Alleles ', ' Allelomorphs ', ' Telephone Interviews ', ' Predisposition ', ' Susceptibility ', ' recurrent depression ', ' disability ', ' Childhood ', ' pediatric ', ' Learning ', ' Alcohol or Other Drugs use ', ' using substances ', ' substance use ', ' AOD use ', ' Individual ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Collaborations ', ' Genetic ', ' Quality Control ', ' Recruitment Activity ', ' recruit ', ' Recurrence ', ' Recurrent ', ' Research ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' Sampling Studies ', ' Specimen ', ' Research Specimen ', ' Whole Blood ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Time ', ' Psychological Transfer ', ' training transfer ', ' learning transfer ', ' Transfer (Psychology) ', ' Weight ', ' Work ', ' Severities ', ' Source ', ' brain tissue ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Cells ', ' Peripheral Blood Cell ', ' mind control ', ' brain control ', ' Quantitative Trait Loci ', ' QTL ', ' success ', ' ']",NIMH,STANFORD UNIVERSITY,RC2,2010,1501832,CA-18,0.02607575342313392
"International Case Control Study of Malignant Glioma    DESCRIPTION (provided by applicant): Glioma comprises about 40% of all primary brain tumors accounting for as many as 26,000 U.S. and European deaths annually. Inherited susceptibility plays a role with 2-fold increased risk of glioma among first-degree relatives of glioma cases. We initiated a multi-center, international linkage study: ""Genetic Epidemiology of Glioma International Consortium"" in 2007 to address the role of inherited susceptibility. Since this study does not allow us currently to address the role of genetic susceptibility in sporadic cases, we propose this case- control study to address this gap. Members of the consortium have conducted genome wide association studies (GWAS) that will be the discovery phase (phase I). While of high value for discovery, we propose to recruit 6,000 newly diagnosed glioma cases and 6,000 age-gender-ethnicity-matched controls, and collect detailed epidemiologic data and biologic samples from the 13 participating Gliogene sites. We hypothesize that novel inherited variation influencing the susceptibility to glioma can be identified by high density SNP analysis, and propose the following specific aims: SA1: Identify common genetic variants contributing to the risk of glioma. We plan to conduct phases 2 and 3 of the 3 phase approach, specifically we will: (SA1a) Validate GWAS findings from the discovery sets, and replicate the top hits (~23,000 SNPs) with lowest p- values from the two phase GWA studies in a series of 2,000 cases and 2,000 controls (phase 2, validation). Validate the top hits from the test set (aim 1a). From stage 2, genes with SNPs displaying an association at pd10-4 (including the complete haplotype tagging - approximately 100 SNPs) will then be genotyped in a further series of 4,000 cases and 4,000 controls (stage 3, validation). SNPs significant at 10-7 or better will be considered in the final analyses. (SA1b). Using an a priori hypothesis that DNA repair in inflammation contribute to glioma risk, we will selectively interrogate DNA repair and inflammation pathway genes using data for select genes derived from the high-density array. We will conduct a hypothesis driven genetic association in DNA repair and in inflammation/immune function related genes with glioma risk using functional genomic and bioinformatic tools to interrogate available databases. (SA2): Evaluate gene-gene (G-G) and gene- environmental (G-E) interactions with strong biologic relevance to identify G-G and G-E interactions for glioma risk using machine-learning tools (MDR, FITF, and CART) in these exploratory analyses. There are no existing glioma case-control studies with sufficient numbers of biological samples and common epidemiologic data to conduct a comprehensive validation and replication study, or to address the issues of tumor heterogeneity as we will in this study.      PUBLIC HEALTH RELEVANCE: Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.                             Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.",International Case Control Study of Malignant Glioma,7786942,R01CA139020,"['Series ', ' Age of Onset ', ' Infection ', ' Inflammation ', ' Ensure ', ' Predisposition ', ' Susceptibility ', ' Trust ', ' European ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Sample Size ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Mining ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Play ', ' Exposure to ', ' Staging ', ' tool ', ' Ionizing radiation ', ' Radiation-Ionizing Total ', ' Ionizing Electromagnetic Radiation ', ' Recruitment Activity ', ' recruit ', ' Risk ', ' Role ', ' social role ', ' San Francisco ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Syndrome ', ' Testing ', ' Trees ', ' Asthma ', ' Bronchial Asthma ', ' Atlases ', ' Universities ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Inherited ', ' Hereditary ', ' Malignant Glioma ', ' Malignant Neuroglial Tumor ', ' Malignant Neuroglial Neoplasm ', ' Malignant Glial Tumor ', ' Malignant Glial Neoplasm ', ' success ', ' international center ', ' cohort ', ' Manuscripts ', ' California ', ' Histopathology ', ' novel ', ' member ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Primary Brain Neoplasms ', ' Primary Brain Tumors ', ' Gender ', ' forest ', ' Modeling ', ' Sampling ', ' case control ', ' genetic epidemiology ', ' functional genomics ', ' cancer site ', ' cancer location ', ' Classification ', ' Systematics ', ' Accounting ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cancer genome ', ' genetic variant ', ' Adult Glioma ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' tumor ', ' high risk ', ' public health relevance ', ' population based ', ' epidemiologic data ', ' Cessation of life ', ' Death ', ' Bioinformatics ', ' Bio-Informatics ', ' Disease ', ' disease/disorder ', ' Disorder ', ' immune function ', ' Cellular Immune Function ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' genetic association ', ' Environment ', ' Address ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data Set ', ' Dataset ', ' Data ', ' Doctor of Medicine ', ' M.D. ', ' International ', ' Research Infrastructure ', ' Infrastructure ', ' Collection ', ' First Degree Relative ', ' Newly Diagnosed ', ' Validation ', ' Malignant neoplasm of brain ', ' Malignant Tumor of the Brain ', ' Brain Cancer ', ' Family ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genotype ', ' Glioblastoma ', ' spongioblastoma multiforme ', ' glioblastoma multiforme ', ' Grade IV Astrocytoma ', ' Grade IV Astrocytic Tumor ', ' Grade IV Astrocytic Neoplasm ', ' Glioma ', ' neuroglia tumor ', ' neuroglia neoplasm ', ' glial-derived tumor ', ' Neuroglial Tumor ', ' Neuroglial Neoplasm ', ' Glial Tumor ', ' Glial Neoplasm ', ' Glial Cell Tumors ', ' Age ', ' base ', ' density ', ' Haplotypes ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Left ', ' Site ', ' Hypersensitivity ', ' Allergy ', ' Phase ', ' Variant ', ' Variation ', ' Biological ', ' Histologic ', ' Histologically ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2010,3278944,TX-09,0.04548659119244625
"DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk    DESCRIPTION (provided by applicant): My long-term goal is to become an independent molecular epidemiologist with in-depth training in genetics and advanced statistical methods in order to be able to analyze high throughput gene variant data to explore gene-gene and gene-environment interactions in cancer susceptibility. My career development plan include didatic courses/seminars, meetings with mentors in the areas of human genetics, cancer biology and advanced statistical methods. My research proposal will focus on genetic susceptibility of bladder cancer (BC). I propose to capitalize on availability of epidemiologic and genetic marker data from an on-going case-control study, ""Markers of Genetic Susceptibility to Bladder Cancer""(R01 CA74880,PI:Xifeng. Wu). The parent study currently include over 2,500,mostly Caucasian, BC cases and controls, matched on sex, age and ethnicity. My goal is to identify novel loci that confer bladder cancer susceptibility using state-of-the-art genotyping technology and novel statistical and bioinformatics tools. The Specific Aims are: 1) To enhance my knowledge and skills in genetics and statistics to identify novel genetic loci as susceptibility markers of BC by extending the original45 potential functional SNPs to include additional 2112 tagging SNPs in genes in the DNA repair, cell cycle control and apoptotic pathways in 800 Caucasian cases and 800 Caucasian controls using the Illumina Golden Gate Assay; 2) To assess haplotypes and diplotypes as markers of susceptibility; 3) To use bioinformatics tools to assess functional significance of SNPs in the DNA repair, cell cycle control and apoptotic pathways and to correlate genotype data of DNA repair and cell cycle control with functional data derived from phenotypic assays. The secondary aim is to apply hierarchical models to refine risk assessment and to apply novel machine-learning tools to explore any gene-environment and gene-gene interactions influencing BC risk. My project complements the parent grant in that it: 1) adds tagging SNPs to potential functional SNPs addressed in the parent grant; 2) adds haplotype analyses; 3) proposes novel statistical and bioinformatics approaches. RELEVANCE: Bladder cancer is a tobacco-related cancer which is the fourth most common cancer in men in U.S. The fact that only a fraction of smokers develop bladder cancer indicating genetic susceptibility to the disease. This study will identify novel genetic markers may be useful as biomarkers to identify high-risk populations that could then be targeted for intervention programs.          ","DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk",7848344,K07CA134831,"['Correlation Studies ', ' Statistical Correlation ', ' Bioinformatics ', ' Bio-Informatics ', ' Cell Cycle Regulation ', ' Cell Cycle Control ', ' Cell Cycle Checkpoint ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Clinical Oncology ', ' DNA ', ' Deoxyribonucleic Acid ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Suspension substance ', ' suspension ', ' Environment ', ' Environmental Exposure ', ' Address ', ' Length ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Erythrocytes ', ' blood corpuscles ', ' Red blood corpuscule ', ' Red Cell ', ' Red Blood Cells ', ' Marrow erythrocyte ', ' Erythrocytic ', ' Erythrocytes Reticuloendothelial System ', ' Blood normocyte ', ' Blood erythrocyte ', ' Data ', ' Dietary Practices ', ' dietary pattern ', ' Doctor of Medicine ', ' M.D. ', ' Predictive Value ', ' Apoptotic ', ' Cancer Biology ', ' Cancer Center ', ' Carcinogen Metabolism ', ' Enrollment ', ' enroll ', ' Epidemiologist ', ' Journal of the National Cancer Institute ', ' Journal of the NCI ', ' Newly Diagnosed ', ' Nutritional ', ' Molecular ', ' sex ', ' Development ', ' developmental ', ' Journals ', ' Magazine ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genetic Markers ', ' Genotype ', ' Age ', ' base ', ' Goals ', ' Haplotypes ', ' Human Genetics ', ' Algorithms ', ' Area ', ' Clinical ', ' Variant ', ' Variation ', ' Biological ', ' Medical ', ' Molecular Epidemiology ', ' Alleles ', ' Allelomorphs ', ' Predisposition ', ' Susceptibility ', ' Training ', ' Individual ', ' Development Plans ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Medicine ', ' men ', "" men's "", ' Mentors ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mutagens ', ' genotoxic agent ', ' Genotoxins ', ' Paper ', ' Parents ', ' Phenotype ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Physicians ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Exposure to ', ' tool ', ' Smoker ', ' Publishing ', ' Recruitment Activity ', ' recruit ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Research Proposals ', ' Resources ', ' Research Resources ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' medical specialties ', ' Specialty ', ' statistics ', ' Arts ', ' Suspensions ', ' Tobacco ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Complex ', ' Tobacco smoke ', ' Clinic ', ' Occupational ', ' Penetrance ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' meetings ', ' college ', ' collegiate ', ' Bladder ', ' urinary bladder ', ' Bladder Urinary System ', ' Malignant neoplasm of urinary bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' American ', ' cancer risk ', ' carcinogenesis ', ' Cancer Induction ', ' gene environment interaction ', ' environment effect on gene ', ' gene interaction ', ' intervention program ', ' skills ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' new technology ', ' novel technologies ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Carcinogens ', ' oncogenic agent ', ' Oncogens ', ' Cancer Causing Agents ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cells ', ' Gender ', ' Statistical Methods ', ' telomere ', ' Case Study ', ' case report ', ' Risk Assessment ', ' Modeling ', ' Sampling ', ' career development ', ' case control ', ' Gene Order ', ' Gene Position ', ' Gene Arrangement ', ' Genomics ', ' Complement ', ' Complement Proteins ', ' anticancer research ', ' cancer research ', ' Outcome ', ' coping ', ' Population ', ' genotyping technology ', ' parent grant ', ' high risk ', ' biomarker ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,K07,2010,134919,TX-09,0.07071791950245906
"Multi-point and multi-locus analysis of genomic association data    DESCRIPTION (provided by applicant):       Genome-wide association studies (GWAS) provide a new and powerful approach to investigate the effect of inherited genetic variation on risks of complex diseases. With recent advances in genotyping technology, genome-wide association studies are now becoming a reality. Data from GWAS are expected in an accelerated rate. Despite tremendous efforts in developing efficient algorithms for mapping complex diseases/traits, single-locus based approaches are still the primary method for GWAS. However, it is known that usually multiple genetic factors, environmental factors as well as their interactions play an important role in the etiology of complex diseases. Novel and practical approaches to simultaneously model multiple variables and their interactions from hundreds of thousands single nucleotide polymorphisms (SNPs) are greatly needed. In this project, we propose to develop efficient algorithms and practical statistical tools to address two important problems in the context of genome- wide association studies: multi-point analysis and multi-locus analysis. For multi-point analysis, our Dynamic Hidden Chain Markov Model (DHCMM) can jointly model historical recombination and muta- tions, haplotype structures and frequencies, and associations, which is expected to be more effective than existing approaches. For multi-locus analysis, we propose to use an advanced machine learning approach to jointly screen SNPs that are predictive of diseases. Our integrated software system MAVEN will facilitate management, analysis, visualization and results sharing of GWA data using cut- ting edge technologies. The true value of GWAS is pending the development of effective computational models and tools. We anticipate that this research project will greatly accelerate the understanding of the genetic architecture of complex diseases.            Principal Investigator/Program Director: Li, Jing Title: Multi-point and multi-locus analysis of genomic association data Abstract: Genome-wide association studies (GWAS) provide a new and powerful approach to inves- tigate the effect of inherited genetic variation on risks of complex diseases. With recent advances in genotyping technology, genome-wide association studies are now becoming a reality. Data from GWAS are expected in an accelerated rate. Despite tremendous efforts in developing efficient algorithms for mapping complex diseases/traits, single-locus based approaches are still the primary method for GWAS. However, it is known that usually multiple genetic factors, environmental factors as well as their interactions play an important role in the etiology of complex diseases. Novel and practical approaches to simultaneously model multiple variables and their interactions from hundreds of thousands single nucleotide polymorphisms (SNPs) are greatly needed. In this project, we propose to develop efficient algorithms and practical statistical tools to address two important problems in the context of genome- wide association studies: multi-point analysis and multi-locus analysis. For multi-point analysis, our Dynamic Hidden Chain Markov Model (DHCMM) can jointly model historical recombination and muta- tions, haplotype structures and frequencies, and associations, which is expected to be more effective than existing approaches. For multi-locus analysis, we propose to use an advanced machine learn- ing approach to jointly screen SNPs that are predictive of diseases. Our integrated software system MAVEN will facilitate management, analysis, visualization and results sharing of GWA data using cut- ting edge technologies. The true value of GWAS is pending the development of effective computational models and tools. We anticipate that this research project will greatly accelerate the understanding of the genetic architecture of complex diseases. PHS 398 Page 1",Multi-point and multi-locus analysis of genomic association data,7897811,R01LM008991,"['Principal Investigator ', ' Grouping ', ' groupings ', ' Modification ', ' Development ', ' developmental ', ' Freedom ', ' Liberty ', ' Affect ', ' Genes ', ' Genotype ', ' Imagery ', ' Visualization ', ' base ', ' Goals ', ' improved ', ' Procedures ', ' Haplotypes ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heterogeneity ', ' Algorithms ', ' Alleles ', ' Allelomorphs ', ' Intelligence ', ' Evaluation ', ' Predisposition ', ' Susceptibility ', ' Joints ', ' Articulation ', ' Learning ', ' Trust ', ' Literature ', ' Licensing ', ' Data Storage and Retrieval ', ' data storage ', ' data retrieval ', ' Maps ', ' Markov Chains ', ' Markov Process ', ' Methods ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Internet ', ' world wide web ', ' web ', ' WWW ', ' Simulate ', ' Phenotype ', ' Genetic ', ' Play ', ' Staging ', ' tool ', ' Genetic Recombination ', ' Recombination ', ' DNA recombination (naturally occurring) ', ' DNA Recombination ', ' Risk ', ' Role ', ' social role ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Catalogs ', ' programs ', ' Technology ', ' Testing ', ' Scientist ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Weight ', ' Work ', ' Frequencies (time pattern) ', ' Frequency ', ' Inherited ', ' Hereditary ', ' Complex ', ' Dependence ', ' Techniques ', ' System ', ' LOINC Axis 4 System ', ' gene interaction ', ' trait ', ' hydroxy-aluminum polymer ', ' Al(13) ', ' Rare Diseases ', ' Rare Disorder ', ' Structure ', ' Phenocopy ', ' novel ', ' research study ', ' experimental study ', ' experimental research ', ' experiment ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Cataloging ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' genetic analysis ', ' Genetic analyses ', ' abstracting ', ' Chromosomes ', ' Modeling ', ' Sampling ', ' Uncertainty ', ' doubt ', ' case control ', ' Genomics ', ' Classification ', ' Systematics ', ' Communities ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' neglect ', ' Advanced Development ', ' markov model ', ' software systems ', ' design ', ' designing ', ' genotyping technology ', ' database of Genotypes and Phenotypes ', ' dbGaP ', ' flexibility ', ' flexible ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Data Analyses ', ' Data Analysis ', ' Database Management Systems ', ' relational database management systems ', ' Data Base Management Systems ', ' Decision Trees ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Effectiveness ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Environment ', ' Address ', ' Genetic Epistasis ', ' genetic epistases ', ' gene x gene interaction ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Data ', ' Genetic Risk ', ' ']",NLM,CASE WESTERN RESERVE UNIVERSITY,R01,2010,930276,OH-11,0.07654904500416486
"Machine Learning Prediction of Cancer Susceptibility    DESCRIPTION (provided by applicant):       Susceptibility to sporadic forms of cancer is determined by numerous genetic factors that interact in a nonlinear manner in the context of an individual's age and environmental exposure. This complex genetic architecture has important implications for the use of genome-wide association studies for identifying susceptibility genes. The assumption of a simple architecture supports a strategy of testing each single-nucleotide polymorphism (SNP) individually using traditional univariate statistics followed by a correction for multiple tests. However, a complex genetic architecture that is characteristic of most types of cancer requires analytical methods that specifically model combinations of SNPs and environmental exposures. While new and novel methods are available for modeling interactions, exhaustive testing of all combinations of SNPs is not feasible on a genome- wide scale because the number of comparisons is effectively infinite. Thus, it is critical that we develop intelligent strategies for selecting subsets of SNPs prior to combinatorial modeling. The objective of this renewal application is to continue the development of a research strategy for the detection, characterization, and interpretation of gene-gene and gene-environment interactions in genome-wide association studies of bladder cancer susceptibility. To accomplish this objective, we will continue developing and evaluating modifications and extensions to the ReliefF family of algorithms for selecting or filtering subsets of single- nucleotide polymorphisms (SNPs) for multifactor dimensionality reduction (MDR) analysis of gene-gene and gene-environment interactions (AIM 1). We will continue developing and evaluating a stochastic wrapper or search strategy for MDR analysis of interactions that utilizes ReliefF values as a heuristic (AIM 2). We will continue to make available ReliefF algorithms as part of our open-source MDR software package (AIM 3). Finally, we will apply the best ReliefF-MDR analysis strategies to the detection, characterization, and interpretation of gene-gene and gene-environment interactions in large genome-wide association studies of bladder cancer susceptibility (AIM 4). We anticipate the proposed machine learning methods will provide powerful new approaches for identifying genetic variations that are predictive of cancer susceptibility.              PROJECT NARRATIVE The technology to measure information about the human genome is advancing at a rapid pace. Despite these advance, the computational methods for analyzing the data have not kept pace. We will develop new computer algorithms and software that can be used to identify genetic biomarkers of common human diseases. We will then apply these new computational methods to identifying genetic biomarkers of bladder cancer in an epidemiological study from New Hampshire.",Machine Learning Prediction of Cancer Susceptibility,8008651,R01LM009012,"['Data Analyses ', ' Data Analysis ', ' Environmental Exposure ', ' Detection ', ' Validation ', ' Characteristics ', ' Modification ', ' Development ', ' developmental ', ' Family ', ' Genes ', ' Human Genome ', ' human whole genome ', ' Age ', ' analytical method ', ' base ', ' Goals ', ' improved ', ' Algorithms ', ' Evaluation ', ' Predisposition ', ' Susceptibility ', ' Individual ', ' Methods ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' New Hampshire ', ' Genetic ', ' Research ', ' Architecture ', ' Engineering / Architecture ', ' Computer software ', ' computer program/software ', ' Software ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' programs ', ' statistics ', ' Technology ', ' Testing ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Complex ', ' Malignant neoplasm of urinary bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' gene environment interaction ', ' environment effect on gene ', ' heuristics ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Measures ', ' Modeling ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' cancer type ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' combinatorial ', ' open source ', ' human disease ', ' population based ', ' biomarker ', ' genome-wide ', ' genomewide ', ' Computational algorithm ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' ']",NLM,DARTMOUTH COLLEGE,R01,2010,392680,NH-02,0.07505714829497181
"A National Consortium to Explore the Genotypic Basis for ESRD in Lupus    DESCRIPTION (provided by applicant): End stage renal disease (ESRD), one of the most serious and costly complications of systemic lupus erythematosus (SLE), occurs in a sub-set of patients with SLE-related renal involvement. Factors predisposing to ESRD presumably include both genetics and environmental factors, and there is unequivocal evidence that ESRD disproportionately affects lupus persons of African American descent. Data in SLE-related ESRD suggest that at least two genetic factors, -- certain allelic variants of the genes FCGR3A and MYH9, -- contribute to ESRD risk. However, two genes alone do not define the scope of genetic risk for ESRD. Therefore, building on our precedent data for genetic contributions, it is timely to undertake a genome-wide association study (GWAS) to identify the genetic risk factors for ESRD in European American (EA) and African Americans (AA) with lupus nephritis (LN/ESRD). Until now, two major barriers have precluded such a study. Technical limitations in genotyping platform and coverage have been overcome with the Illumina Human Omni- 1 Quad BeadChip. To surmount the second barrier of limited study populations, we have assembled an unprecedented team of rheumatologists, nephrologists and statistical geneticists with IRB protocols active, the clinical studies infrastructure in place and the patient collections and clinical data more than 75% in hand. Thus (1) Our first aim is to characterize the genetic susceptibility factors associated with ESRD by performing a  GWAS with 800 EA LN/ESRD and 800 AA LN/ESRD compared to lupus subjects of each ethnicity but  without nephritis and normal control subjects.  (2) We propose that [gene x gene] and [gene x environment] interactions are biologically important and may be more easily detectable using the machine learning and more modern likelihood-based approaches. Therefore, our second aim is to apply novel approaches to gene discovery and biological pathway characterization including Bayesian networks, alternative decision trees, HyperLasso, and penalized logistic regression.  (3) Finally, our third aim is to build an essential resource, consistent with NIH specimen and data sharing guidelines and supported by the institution. This resource will enable follow-up studies in fine-mapping, deep-sequencing, SNP identification, pathway analysis and methods development. Our consortium leverages current resources and investments by NIAMS, NIDDK, NIEHS, NCRR, CDCP and private foundations to create a unique opportunity to address a major health care challenge. We have a substantial head start, drawing on established networks and clinical research infrastructure, and are poised to identify genetic risk factors, leading to strategies for ESRD reduction, which would enable substantial cost savings and reduction in morbidity and mortality as it reduces ethnic disparities in health outcomes.           7. PROJECT NARRATIVE Drawing on established networks and clinical research infrastructure, this study is uniquely positioned to capitalize on a multidisciplinary team to leverage existing resources to address important questions about the underlying genetic influences on susceptibility to end stage renal disease (ESRD) in lupus. This understanding may lead to strategies for ESRD intervention, may reduce ethnic disparities in health outcome, and may enable substantial cost savings in the health care industry.  ",A National Consortium to Explore the Genotypic Basis for ESRD in Lupus,7941793,RC2AR058951,"['Decision Trees ', ' health disparity ', ' health disparities ', ' Commit ', ' Diagnosis ', ' End stage renal failure ', ' End-Stage Renal Disease ', ' End-Stage Kidney Disease ', ' ESRD ', ' Institution ', ' FCGR3A gene ', ' FCGR3A ', ' CD16A ', ' Environment ', ' Address ', ' Copy Number Polymorphism ', ' copy number variation ', ' Data ', ' National Center for Research Resources ', ' NCRR ', ' National Institute of Diabetes and Digestive and Kidney Diseases ', ' NIDDK ', ' Research Infrastructure ', ' Infrastructure ', ' Clinical Data ', ' Collection ', ' Genetic Risk ', ' Guidelines ', ' Follow-Up Studies ', ' Followup Studies ', ' Foundations ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Genes ', ' Genotype ', ' base ', ' method development ', ' Hand ', ' Health ', ' Alabama ', ' National Institute of Arthritis and Musculoskeletal and Skin Diseases ', ' NIAMS ', ' National Institute of Environmental Health Sciences ', ' NIEHS ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Biological ', ' Logistic Regressions ', ' Investments ', ' Predisposition ', ' Susceptibility ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' European ', ' Systemic Lupus Erythematosus ', ' systemic lupus erythematosis ', ' disseminated lupus erythematosus ', ' Systemic SLE - Lupus Erythematosus ', ' Systemic Lupus Erythmatosus ', ' SLE ', ' Lupus Erythematosus Disseminatus ', ' Lupus Nephritis ', ' Lupus Glomerulonephritis ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Maps ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' Persons ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Nephritis ', ' Collaborations ', ' Patients ', ' Phenotype ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Predisposing Factor ', ' Resources ', ' Research Resources ', ' Risk Factors ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Southeastern United States ', ' Southeast US ', ' Southeast U.S. ', ' Testing ', ' United States ', ' United States Centers for Medicare and Medicaid Services ', ' United States Health Care Financing Administration ', ' Health Care Financing Administration ', ' Centers for Medicare and Medicaid Services ', ' Universities ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Investigation ', ' Protocols documentation ', ' Protocol ', ' Healthcare Industry ', ' Health Care Industry ', ' American ', ' experience ', ' Performance ', ' Head Start Program ', ' Head Start ', ' Participant ', ' Population Study ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Metric ', ' Positioning Attribute ', ' Position ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' genetic risk factor ', ' inherited factor ', ' Cost Savings ', ' Health Care Costs ', ' Healthcare Costs ', ' Health Costs ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Healthcare ', ' health care ', ' Pathway Analysis ', ' Network Analysis ', ' Research Ethics Committees ', ' Sampling ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Clinical Research ', ' Clinical Study ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' computer based statistical methods ', ' Bayesian Networks ', ' Lupus ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Outcome ', ' Population ', ' multidisciplinary ', ' gene discovery ', ' discover genes ', ' rheumatologist ', ' sharing data ', ' ']",NIAMS,UNIVERSITY OF ALABAMA AT BIRMINGHAM,RC2,2010,1912603,AL-07,0.02467254761313556
"Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning    DESCRIPTION (provided by applicant):       Epistasis is the interaction between two or more genes to affect phenotype. It is now widely accepted that epistasis plays an important role in susceptibility to many common diseases. The advent of high-throughput technologies has enabled genome-wide association studies (GWAS or GWA studies). It is compelling that we be able to detect epistasis using GWAS data. However, so far GWA studies have mainly focused on the association of a single gene or loci with a disease. The crucial challenge to analyzing epistasis using GWAS data is finding a way to efficiently handle high-dimensional data sets. The only possible solution is to design efficient algorithms that allow us to find the most relevant epistasic relationships without doing an exhaustive investigation. To the Principal Investigator's knowledge, no current method can do this.       This career award will investigate this problem. The specific aims are as follows: (Aim 1) develop and evaluate efficient Bayesian network-based methods for learning candidate genes associated with diseases from GWAS sets. Such genes would provide candidates for follow-up biological studies, (Aim 2) implement the methods in a pilot GWAS system for use by researchers when conducting a GWAS, (Aim 3) develop simulated genome-wide data sets and evaluate the pilot system using these data sets, and (Aim 4) conduct GWA studies concerning breast cancer and lung cancer.       Aim 1 will be addressed by developing a succinct Bayesian network model representing epistasis, efficient algorithms which are tailored to investigating such models, integration of the algorithms into methods for learning epistasis, and using simulated datasets to test the effectiveness of the methods and compare their performance to other methods. Aim 2 will be met by implementing the methods in a pilot GWAS system. Aim 3 will be satisfied by developing synthetic data sets similar to those found in GWA studies, and using them to evaluate the system. Aim 4 will be achieved by conducting GWA studies concerning breast and lung cancer. By conducting these studies, we can (1) substantiate previous results concerning the genetic basis of these diseases; (2) possibly obtain interesting new findings pertaining to these diseases.       The main hypothesis is that the proposed method will be an advance over existing methods in that it will make it computationally feasible to learn epistatic relationships from genome-wide data and it will therefore yield better discovery performance than existing methods.              Learning gene-gene interactions from genome-wide association studies (GWAS) data is an important and challenging task in genetic epidemiology. This project will develop and evaluate a pilot GWAS system for performing this task. Advances obtained in analyzing GWAS data sets could enable us to learn the genetic basis of many diseases and thereby substantially improve the quality of personalized patient care.",Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning,7958949,K99LM010822,"['Germ-Line Mutation ', ' Hereditary Mutation ', ' Germline Mutation ', ' Link ', ' Predisposition ', ' Susceptibility ', ' Joints ', ' Articulation ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', "" Alzheimer's Disease "", ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Methods ', ' Methodology ', ' Method LOINC Axis 6 ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Simulate ', ' Phenotype ', ' Genetic ', ' Play ', ' cancer cell ', ' Malignant Cell ', ' Regression Analysis ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' Apolipoprotein E ', ' ApoE ', ' Apo-E ', ' APOE [{C0003595}] ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Solutions ', ' Knowledge ', ' BRCA1 gene ', ' brca 1 gene ', ' RNF53 ', ' Hereditary Breast Cancer 1 ', ' Early Onset Gene Breast Cancer 1 ', ' Breast Cancer Type 1 Susceptibility Gene ', ' Breast Cancer 1 Gene ', ' BRCA1 ', ' Testing ', ' Investigation ', ' Woman ', ' Work ', ' Complex ', ' Award ', ' System ', ' LOINC Axis 4 System ', ' interest ', ' meetings ', ' gene interaction ', ' Performance ', ' BRCA2 gene ', ' brca 2 gene ', ' Hereditary Breast Cancer 2 ', ' FANCD1 ', ' FANCB ', ' Early Onset Gene Breast Cancer 2 ', ' Breast Cancer Type 2 Susceptibility Gene ', ' Breast Cancer 2 Gene ', ' BRCA2 ', ' Biological Neural Networks ', ' neural network ', ' Breast ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Generations ', ' Statistical Methods ', ' forest ', ' Modeling ', ' high throughput technology ', ' genetic epidemiology ', ' Cancer-Predisposing Gene ', ' Cancer Susceptibility Gene ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genetic variant ', ' computer based statistical methods ', ' Bayesian Networks ', ' design ', ' designing ', ' combinatorial ', ' Network-based ', ' network models ', ' genome-wide analysis ', ' genome-wide ', ' genomewide ', ' Data Analyses ', ' Data Analysis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Effectiveness ', ' data mining ', ' datamining ', ' Candidate Disease Gene ', ' Candidate Gene ', ' GAB2 gene ', ' GRB2-Associated Binding Protein 2 Gene ', ' GAB2 ', ' Address ', ' Genetic Epistasis ', ' genetic epistases ', ' gene x gene interaction ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Data Set ', ' Dataset ', ' Data ', ' Genetic Programming ', ' Genetic Algorithm ', ' Principal Investigator ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Affect ', ' Patient Care ', ' Patient Care Delivery ', ' Genes ', ' base ', ' career ', ' improved ', ' Algorithms ', ' Site ', ' Biological ', ' ']",NLM,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K99,2010,90000,PA-18,0.05095688162974343
"Genome-Wide Association Analysis of Bladder Cancer    DESCRIPTION (provided by applicant):       This proposal builds on a rich resource of bladder cancer (BC) cases and controls derived from two ongoing BC studies at the University of Texas M.D. Anderson Cancer Center, and from two large independent U.S. BC studies - the New England BC Study and the New Hampshire BC Study. The goal is to identify genetic loci that predispose individuals to BC through a genome-wide scanning approach. There are five specific aims. Aim 1 is to first perform genome-wide, high-density SNP genotyping using the Illumina HumanHap550 SNP platform on 800 cases and 800 controls from M.D. Anderson, with a target of candidate SNPs of about 28,000; followed by an internal validation to narrow down candidate SNPs to about 1,536 using additional 800 pairs of cases and controls. Illumina's Custom Infinium array will be the genotyping format. In this aim, in addition to individual SNP analysis, we will also implement haplotype-based analyses and pathway aggregation analysis to identify additional genetic loci that might have been overlooked using individual SNP analysis. Aim 2 is the first external validation of the 1,536 SNPs from Aim 1 using 1,000 pairs of cases and controls from the New England BC Study. Illumina's GoldenGate assay will be the genotyping format. After this stage, the candidate SNPs will be narrowed down to about 100. Aim 3 is the second independent external validation using 750 pairs of cases and controls form the New Hampshire BC Study. In this aim, the 100 top candidate SNPs passed from Aims 1 and 2 plus additional functional SNPs in genes containing these SNPs will be genotyped. GoldenGate assay will be used for this aim. Aim 4 is to perform fine mapping studies in the flanking regions of each of the top 25 SNP loci confirmed in Aim 3 to identify causative loci. This will utilize all 6,700 cases and controls. An average of 15 additional SNPs (tagging SNPs and functional SNPs) per gene is expected. Aim 5 is to apply novel machine-learning tools to identify any gene-environment and gene-gene interactions greatly influencing risk for BC in all the 6700 subjects. These analyses will be utilized to examine SNP main effect and develop and validate algorithms that will identify individuals at highest risk for BC, given their personal exposure patterns and their genetic risk profiles. This proposal applies state of art technology to perform a multistage, genome-wide SNP analysis in three largest, well-characterized U.S. population of BC cases and controls, and incorporates complete epidemiologic data and rich and unique functional data. In addition, results from this study will be provided to the International Consortium of BC Case Control Studies for future validation. The ability to identify genetically susceptible, high-risk subgroups that would benefit from intensive screening and/or chemopreventive interventions is of immense clinical and public health benefit. PUBLIC HEALTH RELEVANCE Bladder cancer (BC) is a disease mainly caused by smoking and occupational exposure. However, only a small percentage of exposed individuals develop BC. Inherited host genetic factors may play an important role in determining an individual's susceptibility to BC. This proposal builds on three largest well-characterized U.S. populations of BC cases and controls - the M. D. Anderson BC study, the New England BC Study and the New Hampshire BC Study. A total of 6700 cases and controls will be used. The goal is to identify genetic loci that predispose individuals to BC through a non-biased, discovery- driven, genome-wide scanning approach and to incorporate complete epidemiologic data and rich and unique functional data. About 550,000 genetic variations of human genome will be initially screened in an M.D. Anderson population consisting of an equal number of BC cases and normal controls. About 28,000 top candidate variations that are potentially associated with increased BC risk will be first narrowed down and internally replicated in a second M.D. Anderson population, and then be validated in the other two independent U.S. BC populations. Finally, the causative genetic loci that predispose individuals to BC will be mapped. This study is significant because by identifying BC susceptibility loci, it will shed light into the biological mechanisms of BC etiology. Furthermore, it may facilitate identifying high-risk subgroups of individuals for BC, given their genetic makeup and environmental exposures. The ability to identify high-risk subgroups of individuals for BC will provide immense public health benefit for those high- risk people who may be subjected to close surveillance and chemoprevention.          ",Genome-Wide Association Analysis of Bladder Cancer,7799290,U01CA127615,"['Age ', ' base ', ' density ', ' Goals ', ' Haplotypes ', ' Algorithms ', ' Clinical ', ' Variant ', ' Variation ', ' Biological ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Joints ', ' Articulation ', ' Serum ', ' Blood Serum ', ' Light ', ' Photoradiation ', ' Individual ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Maps ', ' Medicine ', ' Mutagens ', ' genotoxic agent ', ' Genotoxins ', ' New England ', ' Northeastern United States ', ' New Hampshire ', ' Review Literature ', ' Chemoprevention ', ' Occupational Exposure ', ' Phenotype ', ' Genetic ', ' Physicians ', ' Plasma Cells ', ' plasmocyte ', ' Plasmacytes ', ' Blood Plasma Cell ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Staging ', ' tool ', ' public health medicine (field) ', ' Public Health ', ' Recruitment Activity ', ' recruit ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoking ', ' Architecture ', ' Engineering / Architecture ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' medical specialties ', ' Specialty ', ' Reproduction spores ', ' Spores ', ' Arts ', ' Suspensions ', ' Technology ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Adopted ', ' Frequencies (time pattern) ', ' Frequency ', ' Inherited ', ' Hereditary ', ' Complex ', ' Clinic ', ' Pattern ', ' Location ', ' Penetrance ', ' One-Step dentin bonding system ', ' One Step ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' college ', ' collegiate ', ' Bladder ', ' urinary bladder ', ' Bladder Urinary System ', ' Malignant neoplasm of urinary bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' cancer risk ', ' carcinogenesis ', ' Cancer Induction ', ' gene interaction ', ' novel ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Gender ', ' Polymorphism Analysis ', ' Polymorphism Detection ', ' Statistical Methods ', ' telomere ', ' Health Benefit ', ' Modeling ', ' Sampling ', ' case control ', ' repository ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genomics ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cost ', ' computer based statistical methods ', ' Bayesian Networks ', ' design ', ' designing ', ' Outcome ', ' Population ', ' Individual Differences ', ' aggregation pathway ', ' parent grant ', ' high risk ', ' public health relevance ', ' genome-wide ', ' genomewide ', ' epidemiologic data ', ' Computational algorithm ', ' Cytogenetics ', ' Cell Cycle Regulation ', ' Cell Cycle Control ', ' Disease ', ' disease/disorder ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' TNFRSF5 gene ', ' p50 ', ' Tumor Necrosis Factor Receptor Superfamily Member 5 Gene ', ' TNFRSF5 ', ' MGC9013 ', ' CDW40 ', ' CD40 ', ' Bp50 ', ' Suspension substance ', ' suspension ', ' Environment ', ' Environmental Exposure ', ' Length ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Case Series ', ' Data ', ' Dietary Practices ', ' dietary pattern ', ' Doctor of Medicine ', ' M.D. ', ' International ', ' Subgroup ', ' Cancer Center ', ' Cancer Etiology ', ' Cancer Cause ', ' Chemopreventive Agent ', ' anticarcinogenic ', ' Chemopreventive ', ' Genetic Risk ', ' Newly Diagnosed ', ' University of Texas M D Anderson Cancer Center ', ' University of Texas MD Anderson Cancer Center ', ' MDACC ', ' Validation ', ' Molecular ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Custom ', ' Future ', ' Genes ', ' Human Genome ', ' human whole genome ', ' Genotype ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,U01,2010,1196434,TX-09,0.07403500387646271
"Genome Wide Association Study of Head and Neck Cancer    DESCRIPTION (provided by applicant): Head and neck cancers have well-documented associations with tobacco and alcohol exposure, but the disease develops in only a small fraction of users, which implies an important role for genetic susceptibility. Therefore, head and neck cancers are an excellent model for studying genetic susceptibility to environmental carcinogens. The primary goal of this R01 application is to perform a comprehensive two-stage, high-density, genome-wide single-nucleotide polymorphism (SNP) analysis of head and neck cancer cases and corresponding frequency matched controls to identify novel genetic risk factors for head and neck cancer. This proposal builds upon a well-annotated existing DNA repository of cases and controls. One of the unique features of our study is the availability of DNA repair assay data on most of the cases and controls in this study, which will allow us to conduct genotype/phenotype analyses. We also have access to genome-wide association data from 1200 white control subjects from the same source population. In aim 1, we will perform genotyping on 1000 randomly selected head and neck cancer cases and 500 controls using a 370K Illumina Infinium HapMap HumanCNV370-Duo SNP Chip. We will perform association analyses (1000 cases and 1700 controls) in the first stage using outcome variable as case-control status as well as DNA repair capacity assay data. Our second aim is to perform second-stage analysis of the SNPs selected in stage 1 using 900 additional cases and corresponding controls from the same source and from UCLA. We will use efficient joint analysis of cases and controls from the first and second aims, for a total of 1900 cases and 2600 controls. Finally, in aim 3, we will apply novel statistical tools such as the latent variable approach with Tukey's one-degree-of-freedom test and support vector machines to identify gene-gene and gene-environment (using environmental factors such as smoking and alcohol use) interactions that contribute to the risk of head and neck cancer. We are an experienced investigative team proposing a comprehensive analysis that incorporates epidemiological, behavioral, and functional data. Identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of head and neck cancers. PUBLIC HEALTH RELEVANCE: The identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of the disease and help identify individuals at highest risk for the development of head and neck cancer on the basis of their personal exposure patterns and their genetic risk profiles.              The identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of the disease and help identify individuals at highest risk for the development of head and neck cancer on the basis of their personal exposure patterns and their genetic risk profiles.",Genome Wide Association Study of Head and Neck Cancer,7777355,R01CA131324,"['Cessation of life ', ' Death ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' Disease ', ' disease/disorder ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' CCRL2 gene ', ' HCR ', ' Chemokine (C-C Motif) Receptor-Like 2 Gene ', ' CRAM-B ', ' CRAM-A ', ' CKRX ', ' CCRL2 ', ' Environment ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Data ', ' Cancer Center ', ' Cancer Etiology ', ' Cancer Cause ', ' Cancer Patient ', ' Enrollment ', ' enroll ', ' Genetic Risk ', ' sex ', ' Development ', ' developmental ', ' Behavioral ', ' Custom ', ' Freedom ', ' Liberty ', ' Gene Frequency ', ' allelic frequency ', ' Allele Frequency ', ' Genes ', ' Genotype ', ' Age ', ' base ', ' density ', ' Goals ', ' Haplotypes ', ' Alcohol consumption ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohols ', ' Alcohol Chemical Class ', ' Area ', ' Phase ', ' Biological ', ' Histologic ', ' Histologically ', ' Reporter Genes ', ' In Vitro ', ' Squamous Cell ', ' Joints ', ' Articulation ', ' Oral cavity ', ' Mouth ', ' Cavitas Oris ', ' Buccal Cavity Head and Neck ', ' Buccal Cavity ', ' Larynx ', ' voice box ', ' Larynx Head and Neck ', ' Laryngeal ', ' Individual ', ' Trust ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' DNA Adducts ', ' Carcinogen-DNA Adducts ', ' Funding ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Study models ', ' Mutagens ', ' genotoxic agent ', ' Genotoxins ', ' Head and Neck Cancer ', ' malignant head and neck tumor ', ' Malignant Head and Neck Neoplasm ', ' Parents ', ' Patients ', ' Pharyngeal structure ', ' Throat ', ' Pharynxs ', ' Pharynx Head and Neck ', ' Pharynx ', ' Phenotype ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Population Control ', ' Exposure to ', ' Staging ', ' tool ', ' Smoker ', ' Questionnaires ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Residencies ', ' Risk ', ' Role ', ' social role ', ' Smoke ', ' Smoking ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Testing ', ' Tobacco ', ' Trees ', ' United States ', ' Caucasians ', ' Frequencies (time pattern) ', ' Frequency ', ' Inherited ', ' Hereditary ', ' Scanning ', ' Source ', ' Pattern ', ' Head and neck structure ', ' Head and Neck ', ' Benzo(a)pyrene ', ' 3,4-Benzpyrene ', ' 3,4-Benzopyrene ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' adduct ', ' cancer risk ', ' Early Diagnosis ', ' early detection ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' metropolitan ', ' Structure ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Environmental Carcinogens ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Malignant Squamous Cell Neoplasm ', ' Squamous Cell Cancers ', ' Malignant Squamous Cell Tumor ', ' Malignant Epidermoid Cell Tumor ', ' Malignant Epidermoid Cell Neoplasm ', ' Epidermoid Cell Cancer ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Cells ', ' County ', ' Gender ', ' Polymorphism Analysis ', ' Polymorphism Detection ', ' Measures ', ' genetic risk factor ', ' inherited factor ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Case Study ', ' case report ', ' Chromosome abnormality ', ' Cytogenetic Abnormalities ', ' Cytogenetic Aberrations ', ' Chromosome Anomalies ', ' Chromosome Alterations ', ' Chromosome Aberrations ', ' Chromosomal Alterations ', ' Chromosomal Abnormalities ', ' Chromosomal Aberrations ', ' Aberrant Chromosome ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Sampling ', ' case control ', ' repository ', ' Genomics ', ' Classification ', ' Systematics ', ' Clinic Visits ', ' disease phenotype ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' cancer genome ', ' Outcome ', ' Population ', ' alcohol exposure ', ' exposure to alcohol ', ' exposed to alcohol ', ' ethanol exposure ', ' ethanol exposed ', ' alcohol exposed ', ' plasmid DNA ', ' high risk ', ' public health relevance ', ' population based ', ' genome-wide ', ' genomewide ', ' Control Groups ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2010,603512,TX-09,-0.00161826834739382
"Genetic Factors in Keratoconus    DESCRIPTION (provided by applicant): The purpose of this grant is to identify susceptibility genes involved in the pathogenesis of keratoconus (KC). We will achieve our goal by: 1) refining criteria for the early detection of KC using videokeratography and wavefront Zernike variables; 2) comprehensively testing genes under newly identified linkage peaks generated through genome wide linkage scans of KC families, and performing comprehensive positional candidate gene association studies; and 3) characterizing specific genetic variants that predispose an individual to developing KC. We will study a cohort comprising: normal controls, patients with 'early' KC, KC 'suspect', and KC relatives with videokeratography and aberrometry in order to determine the best combination of variables that discriminate KC 'suspects' from normals. Study subjects will be followed longitudinally to determine which combination of variables is predictive of progression to KC, and thus define subclinical KC (Aim 1). After genome-wide linkage scan of multiplex KC families, we identified regions with significant or suggestive linkage on chromosomes 4, 5, 9, 11, 12, and 14, confirmed by subsequent fine mapping studies. To follow-up these positive linkage findings, we will conduct a comprehensive positional candidate gene association study by testing all genes in these regions with tagSNPs. Any positive association results will be tested in an independent sample for confirmation (Aim 2). Additionally, using newly identified criteria for defining subclinical markers for KC (combination of videokeratography and aberrometry), we will refine our linkage analysis on families with KC in an attempt identify new linkage peaks which may encompass new potential candidate genes for study. Genes identified by both genetic association studies and expression studies published in the literature to date will be prioritized for further study to identify specific genetic variants that contribute to the susceptibility of KC (Aim 3).  Refining criteria for early detection of KC will provide the tools to prevent many patients from under- going unnecessary surgery and developing post-lasik ectasia, a significant public health issue. It will also facilitate identification of susceptibility genes for KC, which may provide an understanding of the mechanisms contributing to corneal thinning in KC. Ultimately, this work may improve our ability to treat KC and/or prevent the development of KC.          ",Genetic Factors in Keratoconus,7780356,R01EY009052,"['Cornea ', ' corneal ', ' Corneal Diseases ', ' cornea disorder ', ' Corneal Disorder ', ' Diagnosis ', ' Pathological Dilatation ', ' Pathologic Dilatation ', ' Ectasia ', ' Discriminant Analysis ', ' Discriminant Analyses ', ' prevent ', ' preventing ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Epithelial Cells ', ' Data ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Development ', ' developmental ', ' Family ', ' Affect ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Grant ', ' improved ', ' Haplotypes ', ' Clinical ', ' Link ', ' indexing ', ' Predisposition ', ' Susceptibility ', ' Screening procedure ', ' screenings ', ' screening ', ' Keratoconus ', ' Laboratories ', ' Individual ', ' Literature ', ' Data Linkages ', ' Record Linkage Study ', ' Maps ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Patients ', ' Phenotype ', ' Genetic ', ' tool ', ' public health medicine (field) ', ' Public Health ', ' Publishing ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Unnecessary Surgery ', ' aquaporin 5 ', ' AQP5 protein ', ' Testing ', ' Time ', ' Transplantation ', ' transplant ', ' Work ', ' Complex ', ' Scanning ', ' corneal epithelium ', ' corneal epithelial ', ' Biological Markers ', ' Biologic Marker ', ' Early Diagnosis ', ' early detection ', ' success ', ' cohort ', ' Videokeratographies ', ' Videokeratography ', ' Study Subject ', ' Pathogenesis ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' genetic linkage analysis ', ' linkage analyses ', ' genetic linkage analyses ', ' family based linkage study ', ' Linkage Analysis ', ' Relative (related person) ', ' Relative ', ' Chromosome Mapping ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' forest ', ' Chromosomes, Human, Pair 4 ', ' Chromosome 4 ', ' Sampling ', ' case control ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genetic variant ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' genome-wide linkage ', ' genomewide linkage ', ' ']",NEI,CEDARS-SINAI MEDICAL CENTER,R01,2010,680924,CA-28,0.005529316466804952
"Molecular Genetics of HNPCC    DESCRIPTION (provided by applicant): The overall goal of this application is to elucidate genetic risk modifiers influencing age of onset of hereditary nonpolyposis colorectal cancer (HNPCC) using a pathway-based approach. The overall hypothesis of this proposal is that SNPs in cell cycle pathways influence the efficiency of the finely tuned mechanisms of cell cycle progression. We will continue to build and expand upon our unique clinical and specimen resource of mismatch repair gene mutation carriers in order to accomplish this goal. In aim 1, we will determine the role that genetic variants in cell cycle genes have on risk for development of early onset HNPCC. We will use the Illumina Golden Gate platform to genotype SNPs from 153 cell cycle genes. We will evaluate the main effects of SNPs in these genes using a two-phase study design in order to determine if there are differences in age-associated risk for development of HNPCC between carriers of the wild type genotype vs. those carrying one or two copies of the SNP. In aim 2, we will use novel machine learning analytic tools to determine if we can identify combinations of cell cycle SNPs that work together to influence risk for development of early onset HNPCC. Two approaches will be used to accomplish this goal. A focused candidate gene approach, and the second is an exploratory, pathways based approach. In the focused candidate approach, we have selected 12 candidate genes because they are known to interact with each other in the cell cycle pathways and there is evidence that SNPs in these genes influence risk for HNPCC or other cancers. We will determine if combinations of these SNPs work together to influence development of HNPCC at an early age. In the second approach we will investigate SNPs in all 153 of the genes, including the 12 candidate genes. We hypothesize that there are many possible combinations of cell cycle genes that work together and under the influence of SNPS, contribute to development of HNPCC at an early age. We will use Random Forests (RF) modeling to rank all of the SNPs from these genes. RF can handle large numbers of predictor variables such as SNPs and provides estimates of variable importance. We will then use CART to build age-to-onset trees using the SNPs ranked the highest from RF. The proposed studies will contribute to our long-term goal to develop a risk model for early onset HNPCC by defining the role that SNPs in cell cycle genes play in risk for HNPCC. They will also provide important information regarding novel gene-gene interactions contributing to risk for development of HNPCC at an earlier age. The National Cancer Institute in its 2006 budget proposal cited risk prediction as an area of extraordinary opportunity. Risk prediction models for cancer could provide valuable tools for identifying individuals who may benefit from preventive treatments or increased surveillance or who are good candidates to participate in clinical trials. PUBLIC HEALTH REVELANCE: The proposed studies will contribute to our long-term goal to develop a risk model for HNPCC, which may also have important implications for sporadic colorectal cancer as well as other cancer sites.             ",Molecular Genetics of HNPCC,7793567,R01CA070759,"['aurora-A kinase ', ' auroraA kinase ', ' Mismatch Repair ', ' Post-Replication Mismatch Repair ', ' Cell Cycle Checkpoint ', ' Base Excision Repairs ', ' DNA Base Excision Repair ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Candidate Disease Gene ', ' Candidate Gene ', ' STK6 gene ', ' STK6 ', ' STK15 Gene ', ' STK15 ', ' BTAK ', ' AURORA2 ', ' ARK1 ', ' CHEK2 gene ', ' RAD53 ', ' PP1425 ', ' CHK2 ', ' CHEK2 ', ' CDS1 ', ' Preventive ', ' Defect ', ' Data ', ' Mutate ', ' National Cancer Institute ', ' NCI Organization ', ' Cancer Model ', ' CancerModel ', ' Cell Cycle Progression ', ' Genetic Risk ', ' Nonhomologous DNA End Joining ', ' Non-Homologous End Joining ', ' NHEJ ', ' Ubiquitination ', ' ubiquitin conjugation ', ' ubiquination ', ' Ubiquitinoylation ', ' Ubiquitilation ', ' Validation ', ' Development ', ' developmental ', ' Colorectal Cancer ', ' Foundations ', ' Pathway interactions ', ' pathway ', ' Genes ', ' Genome ', ' Genotype ', ' Cyclin D1 ', ' cyclin D ', ' c-bcl-1 Proteins ', ' bcl1 Proto-Oncogene Proteins ', ' bcl-1 Proto-Oncogene Proteins ', ' bcl-1 Proto-Oncogene Products ', ' Proto-Oncogene Proteins c-bcl-1 ', ' PRAD1 Protein ', ' G1/S-Specific Cyclin D1 ', ' CCND1 Protein ', ' Age ', ' base ', ' Goals ', ' early onset ', ' Area ', ' Clinical ', ' Phase ', ' Age of Onset ', ' Germ-Line Mutation ', ' Hereditary Mutation ', ' Germline Mutation ', ' peripheral blood ', ' Learning ', ' Leukocytes ', ' white blood corpuscle ', ' white blood cell ', ' White Cell ', ' White Blood Cells ', ' Marrow leukocyte ', ' Leukocytes Reticuloendothelial System ', ' Blood leukocyte ', ' Individual ', ' Linkage Disequilibrium ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' cdc Genes ', ' Cell Division Cycle Genes ', ' Cell Cycle Genes ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Maintenance ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Play ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' tool ', ' public health medicine (field) ', ' Public Health ', ' Research Design ', ' study design ', ' Study Type ', ' Resources ', ' Research Resources ', ' Risk ', ' Role ', ' social role ', ' Specimen ', ' Research Specimen ', ' Smoking ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Testing ', ' Aspirin ', ' Measurin ', ' Extren ', ' Entericin ', ' Empirin ', ' Ecotrin ', ' Aspergum ', ' Acetylsalicylic Acid ', ' 2-(Acetyloxy)benzoic Acid ', ' Trees ', ' Work ', ' Complex ', ' Techniques ', ' Nucleotide Excision Repair ', ' Early Diagnosis ', ' early detection ', ' gene interaction ', ' Gene Mutation ', ' Sequence Alteration ', ' Genetic mutation ', ' Gene Alteration ', ' DNA mutation ', ' DNA Alteration ', ' Proteolysis ', ' Protein Cleavage ', ' homologous recombination ', ' Budgets ', ' novel ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Abbreviations ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Cell Cycle ', ' Cell Division Cycle ', ' Cells ', ' Gender ', ' TP53 gene ', ' p53 Genes ', ' Tumor Protein p53 Gene ', ' TRP53 ', ' TP53 ', ' P53 ', ' MDM2 gene ', ' p53-Binding Protein Gene ', ' MDM2 ', ' MDM 2 ', ' forest ', ' Molecular Genetics ', ' Mediating ', ' Modeling ', ' protein protein interaction ', ' cancer site ', ' cancer location ', ' Gene Order ', ' Gene Position ', ' Gene Arrangement ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' clinical investigation ', ' Microsatellite Instability ', ' Large Intestine Carcinoma ', ' Large Bowel Carcinoma ', ' Colorectal Carcinomas ', ' Hereditary Nonpolyposis Colorectal Neoplasms ', ' hereditary non-polyposis colorectal cancer ', ' Lynch Syndrome ', ' Hereditary Nonpolyposis Colorectal Cancer ', ' Hereditary Nonpolyposis Colon Cancer ', ' Hereditary Non-Polyposis Colon Cancer (hMSH2, hMLH1, hPMS1, hPMS2) ', ' Hereditary Non-Polyposis Colon Cancer ', ' Hereditary Defective Mismatch Repair Syndrome ', ' Hereditary Colorectal Endometrial Cancer Syndrome ', ' Familial Nonpolyposis Colon Cancer ', ' Familial Non-Polyposis Colon Cancer (hMSH2, hMLH1, hPMS1, hPMS2) ', ' genetic variant ', ' mutation carrier ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2010,567593,TX-09,0.05480863612393585
"VARIABLE SELECTION IN GENETIC EPIDEMIOLOGICAL STUDIES OF CARDIOVASCULAR DISEASES    DESCRIPTION (provided by applicant): Cardiovascular diseases (CVD) affect millions of people in US and across the world. There is strong evidence of a genetic component in cardiovascular diseases (CVD) and related traits. An emerging consensus is that both genes and environment and, perhaps more importantly, their interactions are responsible for this complex disease. As a result, many genetic epidemiological (GE) studies of CVD use a study design that tests hundreds of thousands of genetic predictors (e.g., single nucleotide polymorphism (SNP) markers) and hundreds of (related) disease phenotypes and environmental covariates. This has brought tremendous analytical challenges, particularly the high dimensionality of the data and the obscure interactions among the many variables. As a result, searching for CVD disease genes has become a task of selecting important variables from a vast number of SNPs and other predictor variables. Our real data analyses in several ongoing large scale CVD related studies motivated us to consider new methodological solutions to the variable selection problem. This application is developed upon these positive preliminary findings. Our main idea is to develop a strategy for selecting important predictors of CVD by integrating multiple sources of information via the method of statistical learning (i.e., optimizing the selection by repeated learning from examples). In this strategy, we will first develop a method for selecting significant SNPs in moderate-dimensional data (e.g., lower thousands of SNPs, in candidate genes studies) by an integrated classifier. The method will build upon existing techniques assessing information of SNPs in haplotype similarity, imputed functional potential, and gene-gene interactions. We then scale up the new method to the high-dimensional setting of genome-wide association studies (e.g., at least hundreds of thousands of SNPs), by dimension reduction that utilizes the local linkage-disequilibrium (LD) structure in SNPs and by combining latent factor analysis of correlated CVD traits and pathway-based analysis to account for gene-environment (GxE) interactions. A fast-search algorithm will also be developed based on an existing search heuristic that was successfully applied in high-dimensional data of gene expression and genomic sequence analysis. The new methods and algorithms will be coded into R programs and distributed as tool set for an association analysis pipeline. Evaluations of the new methods will be performed by intensive simulation studies and by applying to existing datasets in ongoing studies of CVD and related diseases. Results from evaluation studies, together with the ancillary databases generated by the study such as imputed functional scores of potential or known CVD SNPs will be distributed on a dedicated project website. By doing so, we believe that the utilities resulted from the proposed research will make a significant contribution to many ongoing genetic epidemiological studies of CVD and related traits.  PUBLIC HEALTH RELEVANCE: This project is aimed at timely development of computational tools for emerging large-scale genome-wide association studies of cardiovascular diseases (CVD) that affect millions of people in US and across the world. The new methods deal with the analytical challenges brought forth by the high dimensionality of the data and the obscure interactions among the many variables in these studies, and the tools will be applied to ongoing studies of CVD and related diseases. The results, together with the computer programs and ancillary databases will make a significant contribution to many ongoing and new genetic epidemiological studies of CVD and related diseases.             ",VARIABLE SELECTION IN GENETIC EPIDEMIOLOGICAL STUDIES OF CARDIOVASCULAR DISEASES,7895861,R01HL091028,"['Data Analyses ', ' Data Analysis ', ' Disease ', ' disease/disorder ', ' Disorder ', ' prevent ', ' preventing ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Environment ', ' Left Ventricular Hypertrophy ', ' Data Set ', ' Dataset ', ' Data ', ' Collection ', ' Evaluation Studies ', ' hypertensive heart disease ', ' hypertensive heart disorder ', ' hypertensive cardiomyopathy ', ' heart hypertension ', ' heart disorder hypertension ', ' heart disease hypertension ', ' cardiac hypertension ', ' Molecular ', ' Process ', ' Ventricular ', ' Development ', ' developmental ', ' Public Domains ', ' Sequence Analysis ', ' Sequence Analyses ', ' SEQ-AN ', ' Pathway interactions ', ' pathway ', ' Affect ', ' Gene Expression ', ' Genes ', ' base ', ' Goals ', ' improved ', ' Procedures ', ' Haplotypes ', ' Heart failure ', ' cardiac failure ', ' National Heart, Lung, and Blood Institute ', ' NHLBI ', ' Algorithms ', ' Left ', ' Area ', ' premature ', ' prematurity ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Variant ', ' Variation ', ' Hypertrophy ', ' Evaluation ', ' Learning ', ' web site ', ' website ', ' Individual ', ' Linkage Disequilibrium ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Methods ', ' Morbidity - disease rate ', ' Morbidity ', ' Mortality Vital Statistics ', ' Mortality ', ' Functional disorder ', ' pathophysiology ', ' Physiopathology ', ' Dysfunction ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Noise ', ' Genetic ', ' tool ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Sea ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Consensus ', ' Solutions ', ' Knowledge ', ' programs ', ' Statistical Computing ', ' Testing ', ' Investigation ', ' Weight ', ' Dimensions ', ' Complex ', ' Source ', ' Techniques ', ' Country ', ' Blood Vessels ', ' vascular ', ' American ', ' experience ', ' gene interaction ', ' Performance ', ' heuristics ', ' trait ', ' Structure ', ' simulation ', ' Disease Outcome ', ' Exclusion ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Measures ', ' Code ', ' Coding System ', ' Factor Analysis ', ' Factor Analyses ', ' Chromosomes ', ' Chronic Disease ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Modeling ', ' Genomics ', ' Accounting ', ' disease phenotype ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' computer based statistical methods ', ' Bayesian Networks ', ' computerized tools ', ' computational tools ', ' scale up ', ' public health relevance ', ' Computer Programs and Programming ', ' computer programming ', ' computer program ', ' ']",NHLBI,WASHINGTON UNIVERSITY,R01,2010,228000,MO-01,0.007858102545538431
"Genome-Wide Association Analysis of Bladder Cancer    DESCRIPTION (provided by applicant):       This proposal builds on a rich resource of bladder cancer (BC) cases and controls derived from two ongoing BC studies at the University of Texas M.D. Anderson Cancer Center, and from two large independent U.S. BC studies - the New England BC Study and the New Hampshire BC Study. The goal is to identify genetic loci that predispose individuals to BC through a genome-wide scanning approach. There are five specific aims. Aim 1 is to first perform genome-wide, high-density SNP genotyping using the Illumina HumanHap550 SNP platform on 800 cases and 800 controls from M.D. Anderson, with a target of candidate SNPs of about 28,000; followed by an internal validation to narrow down candidate SNPs to about 1,536 using additional 800 pairs of cases and controls. Illumina's Custom Infinium array will be the genotyping format. In this aim, in addition to individual SNP analysis, we will also implement haplotype-based analyses and pathway aggregation analysis to identify additional genetic loci that might have been overlooked using individual SNP analysis. Aim 2 is the first external validation of the 1,536 SNPs from Aim 1 using 1,000 pairs of cases and controls from the New England BC Study. Illumina's GoldenGate assay will be the genotyping format. After this stage, the candidate SNPs will be narrowed down to about 100. Aim 3 is the second independent external validation using 750 pairs of cases and controls form the New Hampshire BC Study. In this aim, the 100 top candidate SNPs passed from Aims 1 and 2 plus additional functional SNPs in genes containing these SNPs will be genotyped. GoldenGate assay will be used for this aim. Aim 4 is to perform fine mapping studies in the flanking regions of each of the top 25 SNP loci confirmed in Aim 3 to identify causative loci. This will utilize all 6,700 cases and controls. An average of 15 additional SNPs (tagging SNPs and functional SNPs) per gene is expected. Aim 5 is to apply novel machine-learning tools to identify any gene-environment and gene-gene interactions greatly influencing risk for BC in all the 6700 subjects. These analyses will be utilized to examine SNP main effect and develop and validate algorithms that will identify individuals at highest risk for BC, given their personal exposure patterns and their genetic risk profiles. This proposal applies state of art technology to perform a multistage, genome-wide SNP analysis in three largest, well-characterized U.S. population of BC cases and controls, and incorporates complete epidemiologic data and rich and unique functional data. In addition, results from this study will be provided to the International Consortium of BC Case Control Studies for future validation. The ability to identify genetically susceptible, high-risk subgroups that would benefit from intensive screening and/or chemopreventive interventions is of immense clinical and public health benefit. PUBLIC HEALTH RELEVANCE Bladder cancer (BC) is a disease mainly caused by smoking and occupational exposure. However, only a small percentage of exposed individuals develop BC. Inherited host genetic factors may play an important role in determining an individual's susceptibility to BC. This proposal builds on three largest well-characterized U.S. populations of BC cases and controls - the M. D. Anderson BC study, the New England BC Study and the New Hampshire BC Study. A total of 6700 cases and controls will be used. The goal is to identify genetic loci that predispose individuals to BC through a non-biased, discovery- driven, genome-wide scanning approach and to incorporate complete epidemiologic data and rich and unique functional data. About 550,000 genetic variations of human genome will be initially screened in an M.D. Anderson population consisting of an equal number of BC cases and normal controls. About 28,000 top candidate variations that are potentially associated with increased BC risk will be first narrowed down and internally replicated in a second M.D. Anderson population, and then be validated in the other two independent U.S. BC populations. Finally, the causative genetic loci that predispose individuals to BC will be mapped. This study is significant because by identifying BC susceptibility loci, it will shed light into the biological mechanisms of BC etiology. Furthermore, it may facilitate identifying high-risk subgroups of individuals for BC, given their genetic makeup and environmental exposures. The ability to identify high-risk subgroups of individuals for BC will provide immense public health benefit for those high- risk people who may be subjected to close surveillance and chemoprevention.          ",Genome-Wide Association Analysis of Bladder Cancer,8054297,U01CA127615,"['Cancer Etiology ', ' Cancer Cause ', ' Medicine ', ' carcinogenesis ', ' Cancer Induction ', ' Gender ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Environment ', ' cost ', ' Validation ', ' Screening procedure ', ' screenings ', ' screening ', ' Serum ', ' Blood Serum ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' college ', ' collegiate ', ' Genotype ', ' Genomics ', ' TNFRSF5 gene ', ' p50 ', ' Tumor Necrosis Factor Receptor Superfamily Member 5 Gene ', ' TNFRSF5 ', ' MGC9013 ', ' CDW40 ', ' CD40 ', ' Bp50 ', ' high risk ', ' Inherited ', ' Hereditary ', ' Physicians ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' tool ', ' Environmental Exposure ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Sampling ', ' International ', ' Smoking ', ' Genetic ', ' Health Benefit ', ' Maps ', ' Data ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Algorithms ', ' density ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Phenotype ', ' Frequencies (time pattern) ', ' Frequency ', ' Role ', ' social role ', ' Cancer Center ', ' Future ', ' Length ', ' case control ', ' base ', ' Staging ', ' Variant ', ' Variation ', ' Population ', ' Age ', ' Complex ', ' Recruitment Activity ', ' recruit ', ' Location ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Specimen ', ' Research Specimen ', ' Clinical ', ' Genes ', ' Clinic ', ' Light ', ' Photoradiation ', ' Architecture ', ' Engineering / Architecture ', ' Predisposition ', ' Susceptibility ', ' Modeling ', ' Molecular ', ' Joints ', ' Articulation ', ' design ', ' designing ', ' Risk ', ' Health ', ' Pattern ', ' Biological ', ' cancer risk ', ' DNA ', ' Deoxyribonucleic Acid ', ' novel ', ' Individual ', ' Outcome ', ' Technology ', ' Funding ', ' Goals ', ' Resources ', ' Research Resources ', ' Adopted ', ' Play ', ' Chemoprevention ', ' public health medicine (field) ', ' Public Health ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Dietary Practices ', ' dietary pattern ', ' Suspensions ', ' parent grant ', ' telomere ', ' Computational algorithm ', ' computer algorithm ', ' New Hampshire ', ' Case Series ', ' aggregation pathway ', ' Malignant neoplasm of urinary bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' Mutagens ', ' genotoxic agent ', ' Genotoxins ', ' Polymorphism Analysis ', ' Polymorphism Detection ', ' New England ', ' Northeastern United States ', ' One-Step dentin bonding system ', ' One Step ', ' Occupational Exposure ', ' Penetrance ', ' University of Texas M D Anderson Cancer Center ', ' University of Texas MD Anderson Cancer Center ', ' MDACC ', ' Newly Diagnosed ', ' Cytogenetics ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' genome-wide ', ' genomewide ', ' Haplotypes ', ' Individual Differences ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Doctor of Medicine ', ' M.D. ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Human Genome ', ' human whole genome ', ' Suspension substance ', ' suspension ', ' Subgroup ', ' Custom ', ' Plasma Cells ', ' plasmocyte ', ' Plasmacytes ', ' Blood Plasma Cell ', ' repository ', ' Review Literature ', ' computer based statistical methods ', ' Bayesian Networks ', ' Cell Cycle Regulation ', ' Cell Cycle Control ', ' Statistical Methods ', ' Bladder ', ' urinary bladder ', ' Bladder Urinary System ', ' epidemiologic data ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Genetic Risk ', ' Chemopreventive Agent ', ' anticarcinogenic ', ' Chemopreventive ', ' medical specialties ', ' Specialty ', ' gene interaction ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,U01,2011,669490,TX-09,0.07403500387646271
"Novel Strategies to Identify GxE Contributions to MS Pathogenesis    DESCRIPTION (provided by applicant):  Multiple sclerosis (MS) is a complex and heterogeneous inflammatory disorder of the central nervous system characterized by myelin loss, varying degrees of axonal pathology, and progressive neurological dysfunction. The combined effect of many genes, environmental exposures acting during defined periods of life, and their interactions in MS is strongly supported by our own work and others. The involvement of HLA class II genes within the major histocompatibility complex (MHC) on chromosome 6p21 is well-established. The identification of non-MHC determinants of MS susceptibility, while progressing, is far from complete. Similar to other complex diseases, genome-wide association studies (GWAS) have begun to unravel the polygenic etiology of MS. However, variants identified through several large GWAS, to date, explain only a very small proportion of MS heritability. The proposed study describes critical post-GWAS era steps to further our current understanding of MS pathogenesis. First, we will utilize next-generation DNA sequence data, high-throughput genotyping and state-of-the-art bioinformatics methods to fully characterize rare, less frequent and common variants within more than 30 MS genes established through recent GWAS and their contribution to the development of MS and disease expression (Aim 1). Next, we will also comprehensively investigate a number of important life-course exposures including prenatal, perinatal, childhood, adolescent and adult time periods, GxE interactions and risk of MS (Aim 2). Finally, we will study genome-wide DNA methylation profiles in a newly established cohort of clinically isolated syndrome (CIS)/early MS cases and matched controls to identify immune cell specific epigenetic influences on the development of MS (Aim 3). We will utilize extraordinary MS case-control resources nested within the large, population-based membership of Northern California Kaiser Permanente, as well as DNA, genetic and clinical data assembled for this project through the International Multiple Sclerosis Genetics Consortium; more than 10,000 individuals of White/European ancestry will be studied using a suite of statistical methods of analysis. Results from proposed epidemiologic studies of the most important MS genes and causal variants in the context of relevant environmental exposures will inform new functional studies, and have potential to support the development of more effective approaches for prevention, diagnosis and treatment.      PUBLIC HEALTH RELEVANCE:  The complete identification of genetic and environmental influences and how they contribute independently and jointly to the development of MS and expression of particular disease characteristics would play a major role in understanding disease etiology, and would contribute greatly to disease prevention strategies and development of targeted and more effective therapies.            The complete identification of genetic and environmental influences and how they contribute independently and jointly to the development of MS and expression of particular disease characteristics would play a major role in understanding disease etiology, and would contribute greatly to disease prevention strategies and development of targeted and more effective therapies.         ",Novel Strategies to Identify GxE Contributions to MS Pathogenesis,8207321,R01ES017080,"['disease characteristic ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Odds Ratio ', ' Trust ', ' Myelin ', ' Major Histocompatibility Complices ', ' Histocompatibility Complices ', ' Histocompatibility Complex ', ' Major Histocompatibility Complex ', ' Central Nervous System Disorders ', ' CNS disorder ', ' CNS Diseases ', ' Central Nervous System Diseases ', ' environment effect on gene ', ' gene environment interaction ', ' Clinical Data ', ' Heritability ', ' European ', ' Environmental Exposure ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' unborn ', ' prenatal ', ' Risk Estimate ', ' insular sclerosis ', ' MS (Multiple Sclerosis) ', ' Disseminated Sclerosis ', ' Multiple Sclerosis ', ' Clinical Management ', ' MHC Class II ', ' HLA Class II Genes ', ' Class II Genes ', ' MHC Class II Genes ', ' Perinatal ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' insertion/deletion ', ' insertion-deletion mutation ', ' insertion-deletion ', ' insertion/deletion mutation ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Preventive strategy ', ' Prevention strategy ', ' neurological dysfunction ', ' Neurologic Dysfunctions ', ' disease risk ', ' disorder risk ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' DNA Methylation ', ' DNA Sequence ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Modeling ', ' Data ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' developmental ', ' Development ', ' novel ', ' Sampling ', ' Phenotype ', ' Cells ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Genetic ', ' Pathology ', ' Inflammatory ', ' Work ', ' Genes ', ' Site ', ' Risk ', ' Pathogenesis ', ' Variation ', ' Variant ', ' tool ', ' Complex ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Life ', ' Population ', ' Diagnosis ', ' Survey Instrument ', ' Surveys ', ' Collaborations ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Play ', ' cohort ', ' Research Resources ', ' Resources ', ' Bio-Informatics ', ' Bioinformatics ', ' Foundations ', ' next generation ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Testing ', ' International ', ' base ', ' Immune ', ' Methods ', ' Individual ', ' Laboratories ', ' social role ', ' Role ', ' Time ', ' case control ', ' Dimensions ', ' population based ', ' Deoxyribonucleic Acid ', ' DNA ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' effective treatment ', ' effective therapy ', ' Syndrome ', ' pediatric ', ' Childhood ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Statistical Methods ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Genotype ', ' genomewide ', ' genome-wide ', ' California ', ' disease prevention ', ' disorder prevention ', ' Chromosomes ', ' Approaches to prevention ', ' Prevention approach ', ' Dataset ', ' Data Set ', ' Susceptibility ', ' Predisposition ', ' Prognosis ', ' outcome forecast ', ' Chronology ', ' 6p21 ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA BERKELEY,R01,2011,643215,CA-13,0.027715199329855025
"DEVELOPING STRATEGIES FOR JOINT GENE-ENVIRONMENT ANALYSIS    DESCRIPTION (provided by applicant): A key challenge for genetic analysis today is to account for the bulk of the phenotypic variance in complex traits that is attributable to genetic factors, but remains unexplained after multiple well-powered GWAS (Goldstein 2009; Hirschhorn 2009; Kraft and Hunter 2009). Many believe that systematically testing datasets for joint gene-environment effects (GxE) and gene-gene (GxG) effects will be essential in order to understand the genetics of complex phenotypes. However, the new era of high throughput, high-density genomic data (genotypes and sequencing) has given rise to serious computational and statistical challenges for the analysis of joint effects. The goal of this project is to develop effective strategies for the statistical analysis of joint-gene environment effects. The specific aims are to (1) identify strengths and weaknesses of multiple analytic approaches to joint GxE effects, and (2) develop new methods for coordinated meta-analysis. To accomplish Aim 1, we will systematically examine and compare traditional (e.g. regression based) and modern (e.g. partitioning, machine learning, information theoretic) analysis methods for case-control and quantitative phenotypes. The primary product will be specific guidance as to the conditions under which each method performs well. To accomplish Aim 2, we will extend recent joint-effects methods to a meta-analytic framework and develop improvements to currently used methods. For both aims, we will also analyze real data related to smoking, thereby improving our understanding of genetic and environmental contributors to smoking and addiction risk. These analyses of real data will be guided by bioinformatics-based variant prioritization. This study therefore will provide both guidance and tools needed to move the field of joint effects analysis forward. As a result, it will ultimately have a significant impact on our ability to account for the currently unexplained genetic contribution to phenotypic variance for complex traits.      PUBLIC HEALTH RELEVANCE: Many diseases that greatly impact public health (such as heart disease, diabetes, and nicotine addiction) are the result of a complex interplay between genes and environmental factors. The purpose of this grant is to improve data analysis strategies (applicable to a wide variety of diseases) for the detection of joint effects of genes and environment. We will apply these methods to analyze existing data on smokers to improve our understanding of gene-environment effects on nicotine addiction.              Many diseases that greatly impact public health (such as heart disease, diabetes, and nicotine addiction) are the result of a complex interplay between genes and environmental factors. The purpose of this grant is to improve data analysis strategies (applicable to a wide variety of diseases) for the detection of joint effects of genes and environment. We will apply these methods to analyze existing data on smokers to improve our understanding of gene-environment effects on nicotine addiction.            ",DEVELOPING STRATEGIES FOR JOINT GENE-ENVIRONMENT ANALYSIS,8217748,R21DA033827,"['allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' environment effect on gene ', ' gene environment interaction ', ' Smoke ', ' tool development ', ' Cigarette ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Education Level ', ' Educational Background ', ' genetic association ', ' base ', ' trait ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Staging ', ' Genetic ', ' Grant ', ' Simulate ', ' density ', ' Recommendation ', ' Variation ', ' Variant ', ' Bio-Informatics ', ' Bioinformatics ', ' Output ', ' Genotype ', ' Genomics ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Genetic analyses ', ' genetic analysis ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Performance ', ' Genes ', ' Sensitivity and Specificity ', ' Evaluation ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Parturition ', ' Birth ', ' pathway ', ' Pathway interactions ', ' Research ', ' Articulation ', ' Joints ', ' Data Analysis ', ' Data Analyses ', ' Age ', ' Workshop ', ' Educational workshop ', ' Phenotype ', ' addictive disorder ', ' addiction ', ' Heart ', ' Family ', ' Data ', ' Public Health ', ' public health medicine (field) ', ' tool ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Dataset ', ' Data Set ', ' Complex ', ' Smoker ', ' diabetes ', ' Diabetes Mellitus ', ' Risk ', ' Guidelines ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' case control ', ' Hand ', ' Environment ', ' nicotine addiction ', ' Nicotine Dependence ', ' Statistical Methods ', ' Sample Size ', ' Smoking ', ' Biological Function ', ' Biological Process ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' improved ', ' Detection ', ' Address ', ' Testing ', ' Photoradiation ', ' Light ', ' sex ', ' Accounting ', ' Methods ', ' Reporting ', ' Knowledge ', ' Goals ', ' disease/disorder ', ' Disorder ', ' Disease ', ' ']",NIDA,WASHINGTON UNIVERSITY,R21,2011,228000,MO-01,0.011626931925872993
"Genome Wide Association Study of Head and Neck Cancer    DESCRIPTION (provided by applicant): Head and neck cancers have well-documented associations with tobacco and alcohol exposure, but the disease develops in only a small fraction of users, which implies an important role for genetic susceptibility. Therefore, head and neck cancers are an excellent model for studying genetic susceptibility to environmental carcinogens. The primary goal of this R01 application is to perform a comprehensive two-stage, high-density, genome-wide single-nucleotide polymorphism (SNP) analysis of head and neck cancer cases and corresponding frequency matched controls to identify novel genetic risk factors for head and neck cancer. This proposal builds upon a well-annotated existing DNA repository of cases and controls. One of the unique features of our study is the availability of DNA repair assay data on most of the cases and controls in this study, which will allow us to conduct genotype/phenotype analyses. We also have access to genome-wide association data from 1200 white control subjects from the same source population. In aim 1, we will perform genotyping on 1000 randomly selected head and neck cancer cases and 500 controls using a 370K Illumina Infinium HapMap HumanCNV370-Duo SNP Chip. We will perform association analyses (1000 cases and 1700 controls) in the first stage using outcome variable as case-control status as well as DNA repair capacity assay data. Our second aim is to perform second-stage analysis of the SNPs selected in stage 1 using 900 additional cases and corresponding controls from the same source and from UCLA. We will use efficient joint analysis of cases and controls from the first and second aims, for a total of 1900 cases and 2600 controls. Finally, in aim 3, we will apply novel statistical tools such as the latent variable approach with Tukey's one-degree-of-freedom test and support vector machines to identify gene-gene and gene-environment (using environmental factors such as smoking and alcohol use) interactions that contribute to the risk of head and neck cancer. We are an experienced investigative team proposing a comprehensive analysis that incorporates epidemiological, behavioral, and functional data. Identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of head and neck cancers. PUBLIC HEALTH RELEVANCE: The identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of the disease and help identify individuals at highest risk for the development of head and neck cancer on the basis of their personal exposure patterns and their genetic risk profiles.              The identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of the disease and help identify individuals at highest risk for the development of head and neck cancer on the basis of their personal exposure patterns and their genetic risk profiles.",Genome Wide Association Study of Head and Neck Cancer,8059620,R01CA131324,"['Cancer Etiology ', ' Cancer Cause ', ' Gender ', ' Control Groups ', ' Early Diagnosis ', ' early detection ', ' Reporter Genes ', ' Inherited ', ' Hereditary ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Genotype ', ' Enrollment ', ' enroll ', ' Smoking ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Cancer Patient ', ' Alcohol consumption ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' density ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Parents ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Cancer Center ', ' Questionnaires ', ' case control ', ' Scanning ', ' population based ', ' Study models ', ' Genomics ', ' Joints ', ' Articulation ', ' high risk ', ' Staging ', ' cancer risk ', ' repository ', ' sex ', ' Behavioral ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Funding ', ' United States ', ' Sampling ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Goals ', ' Source ', ' disease phenotype ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Genes ', ' Development ', ' developmental ', ' genome-wide ', ' genomewide ', ' novel ', ' Population ', ' Role ', ' social role ', ' Individual ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case Study ', ' case report ', ' Pattern ', ' Cessation of life ', ' Death ', ' Outcome ', ' Frequencies (time pattern) ', ' Frequency ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Measures ', ' Health ', ' experience ', ' Genetic Risk ', ' Data ', ' Risk ', ' Structure ', ' Patients ', ' Biological ', ' Age ', ' DNA ', ' Deoxyribonucleic Acid ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Cells ', ' Exposure to ', ' Phenotype ', ' tool ', ' Disease ', ' disease/disorder ', ' Disorder ', ' base ', ' Area ', ' Research ', ' Testing ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' In Vitro ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Phase ', ' Environment ', ' cancer genome ', ' gene environment interaction ', ' environment effect on gene ', ' Trust ', ' Chromosome abnormality ', ' Cytogenetic Abnormalities ', ' Cytogenetic Aberrations ', ' Chromosome Anomalies ', ' Chromosome Alterations ', ' Chromosome Aberrations ', ' Chromosomal Alterations ', ' Chromosomal Abnormalities ', ' Chromosomal Aberrations ', ' Aberrant Chromosome ', ' Freedom ', ' Liberty ', ' CCRL2 gene ', ' HCR ', ' Chemokine (C-C Motif) Receptor-Like 2 Gene ', ' CRAM-B ', ' CRAM-A ', ' CKRX ', ' CCRL2 ', ' Malignant Squamous Cell Neoplasm ', ' Squamous Cell Cancers ', ' Malignant Squamous Cell Tumor ', ' Malignant Epidermoid Cell Tumor ', ' Malignant Epidermoid Cell Neoplasm ', ' Epidermoid Cell Cancer ', ' tobacco exposure ', ' adduct ', ' plasmid DNA ', ' Population Control ', ' Residencies ', ' genetic risk factor ', ' inherited factor ', ' Hispanic Americans ', ' Spanish Americans ', ' Mutagens ', ' genotoxic agent ', ' Genotoxins ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' metropolitan ', ' Clinic Visits ', ' Pharyngeal structure ', ' Throat ', ' Pharynxs ', ' Pharynx Head and Neck ', ' Polymorphism Analysis ', ' Polymorphism Detection ', ' Pharynx ', ' Head and Neck Cancer ', ' malignant head and neck tumor ', ' Malignant Head and Neck Neoplasm ', ' Squamous Cell ', ' Tobacco ', ' Classification ', ' Systematics ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' County ', ' Haplotypes ', ' Histologic ', ' Histologically ', ' Caucasians ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Alcohols ', ' Alcohol Chemical Class ', ' Head and neck structure ', ' Head and Neck ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Custom ', ' African American ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Trees ', ' Gene Frequency ', ' allelic frequency ', ' Allele Frequency ', ' alcohol exposure ', ' exposure to alcohol ', ' exposed to alcohol ', ' ethanol exposure ', ' ethanol exposed ', ' alcohol exposed ', ' Benzo(a)pyrene ', ' 3,4-Benzpyrene ', ' 3,4-Benzopyrene ', ' DNA Adducts ', ' Carcinogen-DNA Adducts ', ' Environmental Carcinogens ', ' Larynx ', ' voice box ', ' Larynx Head and Neck ', ' Laryngeal ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Smoker ', ' Oral cavity ', ' Mouth ', ' Cavitas Oris ', ' Buccal Cavity Head and Neck ', ' Buccal Cavity ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2011,594620,TX-09,-0.00161826834739382
"Genetic Factors in Keratoconus    DESCRIPTION (provided by applicant): The purpose of this grant is to identify susceptibility genes involved in the pathogenesis of keratoconus (KC). We will achieve our goal by: 1) refining criteria for the early detection of KC using videokeratography and wavefront Zernike variables; 2) comprehensively testing genes under newly identified linkage peaks generated through genome wide linkage scans of KC families, and performing comprehensive positional candidate gene association studies; and 3) characterizing specific genetic variants that predispose an individual to developing KC. We will study a cohort comprising: normal controls, patients with 'early' KC, KC 'suspect', and KC relatives with videokeratography and aberrometry in order to determine the best combination of variables that discriminate KC 'suspects' from normals. Study subjects will be followed longitudinally to determine which combination of variables is predictive of progression to KC, and thus define subclinical KC (Aim 1). After genome-wide linkage scan of multiplex KC families, we identified regions with significant or suggestive linkage on chromosomes 4, 5, 9, 11, 12, and 14, confirmed by subsequent fine mapping studies. To follow-up these positive linkage findings, we will conduct a comprehensive positional candidate gene association study by testing all genes in these regions with tagSNPs. Any positive association results will be tested in an independent sample for confirmation (Aim 2). Additionally, using newly identified criteria for defining subclinical markers for KC (combination of videokeratography and aberrometry), we will refine our linkage analysis on families with KC in an attempt identify new linkage peaks which may encompass new potential candidate genes for study. Genes identified by both genetic association studies and expression studies published in the literature to date will be prioritized for further study to identify specific genetic variants that contribute to the susceptibility of KC (Aim 3).  Refining criteria for early detection of KC will provide the tools to prevent many patients from under- going unnecessary surgery and developing post-lasik ectasia, a significant public health issue. It will also facilitate identification of susceptibility genes for KC, which may provide an understanding of the mechanisms contributing to corneal thinning in KC. Ultimately, this work may improve our ability to treat KC and/or prevent the development of KC.          ",Genetic Factors in Keratoconus,8018102,R01EY009052,"['forest ', ' genetic association ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' Discriminant Analysis ', ' Discriminant Analyses ', ' Keratoconus ', ' aquaporin 5 ', ' AQP5 protein ', ' Cornea ', ' corneal ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Unnecessary Surgery ', ' case control ', ' Chromosomes, Human, Pair 4 ', ' Chromosome 4 ', ' Early Diagnosis ', ' early detection ', ' Pathological Dilatation ', ' Pathologic Dilatation ', ' Ectasia ', ' Data Linkages ', ' Record Linkage Study ', ' Chromosome Mapping ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Haplotypes ', ' genetic variant ', ' Candidate Disease Gene ', ' Candidate Gene ', ' tool ', ' Gene Expression ', ' cohort ', ' Link ', ' Data ', ' public health medicine (field) ', ' Public Health ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Epithelial Cells ', ' Grant ', ' Study Subject ', ' Complex ', ' Patients ', ' Sampling ', ' Literature ', ' Goals ', ' success ', ' improved ', ' Genes ', ' Genetic ', ' Clinical ', ' Time ', ' Development ', ' developmental ', ' Diagnosis ', ' Laboratories ', ' Family ', ' Individual ', ' Testing ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Predisposition ', ' Susceptibility ', ' Affect ', ' Transplantation ', ' transplant ', ' indexing ', ' Screening procedure ', ' screenings ', ' screening ', ' Publishing ', ' Phenotype ', ' genome-wide linkage ', ' genomewide linkage ', ' Relative (related person) ', ' Relative ', ' Work ', ' Nature ', ' corneal epithelium ', ' corneal epithelial ', ' genetic linkage analysis ', ' linkage analyses ', ' genetic linkage analyses ', ' family based linkage study ', ' Linkage Analysis ', ' Maps ', ' Pathogenesis ', ' prevent ', ' preventing ', ' Corneal Diseases ', ' cornea disorder ', ' Corneal Disorder ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Genotype ', ' Biological Markers ', ' Biologic Marker ', ' Scanning ', ' Videokeratographies ', ' Videokeratography ', ' ']",NEI,CEDARS-SINAI MEDICAL CENTER,R01,2011,672532,CA-28,0.005529316466804952
"Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers    DESCRIPTION (provided by applicant): Epigenetic silencing involving alterations in DNA methylation and chromatin structure at promoter region CpG islands is a common mechanism of tumor suppressor gene inactivation in human cancers. However, the mechanisms underlying this event remain poorly understood. An unresolved question is why are some genes targets of aberrant methylation in human cancers while others are never affected? In preliminary work, we have shown that even in the context of an increased cellular capacity for de novo methylation, CpG islands differ in their potential for aberrant methylation. By applying DNA pattern recognition and machine learning techniques, we have developed an algorithm based on several short sequence patterns that is capable of accurately discriminating methylation-prone and methylation-resistant CpG islands. These studies indicate that the epigenetic status of a CpG island can be predicted based on DNA sequence features, and lead us to propose that one factor contributing to the non-random patterns of CpG island methylation observed in human tumors is an underlying susceptibility conferred by local sequence context. The goal of this proposal is to define the genomic signature associated with aberrant methylation. The long term objectives are (i) to identify and to functionally characterize local sequence attributes that contribute to the propensity towards, or protection from, aberrant methylation, and (ii) to develop and to test novel tumor specific classifiers capable of predicting genomic loci at risk of aberrant methylation. Specifically, we will determine whether sequence features identified in silico act in cis to promote or to prevent de novo methylation in vivo using an episomal transgene approach. In preliminary work, we have identified a relationship between methylation-prone CpG islands and genomic regions bound by the polycomb repressor complex. As a second component of the project, we will determine the role of PRC2 in methylation susceptibility. As a third component of this project we will refine our computational models by 1) determining whether CpG islands predicted to be methylation-prone are in fact targets of aberrant methylation in human cancers, 2) using this information to re-train the prediction model, and 3) developing and testing a novel lung cancer specific classifier based on large-scale CpG island methylation data from primary lung tumors. We anticipate that the information gained from these studies will allow for a better understanding of the mechanisms underlying the epigenetic silencing of tumor suppressor genes that accompanies carcinogenesis. Moreover, the ability to predict the methylation status of CpG islands genome-wide will provide an important resource for the identification of novel gene targets for further study as potential cancer biomarkers. PUBLIC HEALTH RELEVANCE: The overarching goal of this research is to better understand the mechanisms by which important growth regulatory genes are targeted for epigenetic silencing in human cancers. Although the consequences of this event are the same as a mutation, there is no molecular defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the DNA and the histone proteins it is wrapped around that render certain genes abnormally and permanently silent. We plan to use a computational approach to identify DNA features that put certain genes at risk of aberrant methylation. Because genes that are silenced by methylation are otherwise structurally sound, the potential for reactivating these genes by blocking or reversing the methylation process represents an exciting molecular target for chemotherapeutic intervention. A better understanding of the factors that contribute to aberrant methylation, including the identification of sequence features that attract or repel DNA methylation, will be an important step in achieving this long-term goal. Moreover, the ability to identify those genes at risk of epigenetic silencing will provide novel molecular targets for further study as potential biomarkers for improved cancer diagnosis and treatment planning.           Project Narrative The overarching goal of this research is to better understand the mechanisms by which important growth regulatory genes are targeted for epigenetic silencing in human cancers. Although the consequences of this event are the same as a mutation, there is no molecular defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the DNA and the histone proteins it is wrapped around that render certain genes abnormally and permanently silent. We plan to use a computational approach to identify DNA features that put certain genes at risk of aberrant methylation. Because genes that are silenced by methylation are otherwise structurally sound, the potential for reactivating these genes by blocking or reversing the methylation process represents an exciting molecular target for chemotherapeutic intervention. A better understanding of the factors that contribute to aberrant methylation, including the identification of sequence features that attract or repel DNA methylation, will be an important step in achieving this long-term goal. Moreover, the ability to identify those genes at risk of epigenetic silencing will provide novel molecular targets for further study as potential biomarkers for improved cancer diagnosis and treatment planning.",Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers,8069622,R01CA132065,"['carcinogenesis ', ' Cancer Induction ', ' DNA Methyltransferase ', ' histone modification ', ' Computer Simulation ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' DNA Methylation ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Post-Translational Protein Processing ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' cancer diagnosis ', ' sound ', ' Cancer cell line ', ' Tumor Suppressor Proteins ', ' tumor suppressor ', ' Transgenes ', ' Employee Strikes ', ' Strikes ', ' genome-wide ', ' genomewide ', ' cancer therapy ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' Repression ', ' Code ', ' Coding System ', ' cancer cell ', ' Malignant Cell ', ' DNA Sequence ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' novel ', ' Gene Silencing ', ' Gene Inactivation ', ' Primary Neoplasm ', ' Primary Tumor ', ' Algorithms ', ' Recruitment Activity ', ' recruit ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Genomics ', ' Histones ', ' Gene Expression ', ' Shapes ', ' Molecular Target ', ' Gene Targeting ', ' Modeling ', ' Biological Process ', ' Biological Function ', ' prevent ', ' preventing ', ' Cell Culture Techniques ', ' cell culture ', ' DNA ', ' Deoxyribonucleic Acid ', ' Classification ', ' Systematics ', ' Binding (Molecular Function) ', ' Molecular Interaction ', ' Binding ', ' Testing ', ' Molecular ', ' Methylation ', ' Protein Methylation ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Role ', ' social role ', ' Event ', ' Genome ', ' Research ', ' Play ', ' Genes ', ' Defect ', ' Process ', ' tumor ', ' Complex ', ' Risk ', ' biomarker ', ' Affect ', ' Goals ', ' Human Genome ', ' human whole genome ', ' base ', ' Resistance ', ' resistant ', ' Tumor-Suppressor Gene Inactivation ', ' Publishing ', ' Human ', ' Modern Man ', ' Man (Taxonomy) ', ' Site ', ' Data ', ' Training ', ' treatment planning ', ' in vivo ', ' Predisposition ', ' Susceptibility ', ' overexpression ', ' overexpress ', ' CpG Islands ', ' CpG-Rich Islands ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Resources ', ' Research Resources ', ' Work ', ' Health ', ' Generations ', ' improved ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Proteins ', ' gene product ', ' Techniques ', ' Pattern ', ' Mediating ', ' Promotor (Genetics) ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Frequencies (time pattern) ', ' Frequency ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Aberrant DNA Methylation ', ' Hypermethylation ', ' Polycomb ', ' Deletion Mutation ', ' DNA Modification Methylases ', ' Site-Specific DNA-methyltransferase ', ' Modification Methylases ', ' EC 2.1.1.113 ', ' Dnmt ', ' DNA-Methyltransferases ', ' DNA Modification Methyltransferases ', ' Alu Elements ', ' Alu Repetitive Sequences ', ' Alu Family ', ' Chromatin Structure ', ' Cytosine ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Pattern Recognition ', ' Non-Small-Cell Lung Carcinoma ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Tumor Suppressor Genes ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Lung Neoplasms ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Ectopic Expression ', ' Promoter Regions (Genetics) ', ' genetic promoter element ', ' Promotor Regions (Genetics) ', ' Promotor Regions ', ' Promoter Regions ', ' ']",NCI,EMORY UNIVERSITY,R01,2011,306133,GA-05,0.045851135864643414
"Optimizing Genetic Testing for Deafness for Clinical Diagnostics     DESCRIPTION (provided by applicant):  In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. The driving force behind this initiative is the frequency of hearing impairment. As the most common sensory impairment, it is diagnosed in 1 of every 500 newborns and 50% of octogenarians (Morton Ann N Y Acad Sci 1991). With 57 genes implicated in nonsyndromic hearing loss (NSHL), it is also an extremely heterogeneous trait and presents a tremendous challenge to diagnosis.  Current strategies for genetic testing for deafness are inadequate. For most, only a minority of genes is included, with selection criteria typically reflecting: 1) high prevalence as a cause of deafness (i.e. GJB2); 2) association with another recognizable feature (i.e. SLC26A4 and enlarged vestibular aqueduct); or 3) a recognizable audioprofile (i.e. low frequency hearing loss as seen with WFS1) (Hilgert et al Mut Res 2009).  The recent advent of powerful DNA target enrichment and sequencing technologies, however, makes it possible to provide comprehensive genetic testing for deafness that is efficient and cost-effective. We have shown that it is possible to analyze all deafness genes simultaneously on a single platform (called OtoSCOPE) (Shearer et al PNAS 2010). Related to this endeavor, we have also validated AudioGene as a phenotypic tool that uses patient audiograms to predict the genetic cause of ADNSHL (Hildebrand et al Genet Med 2008; Hildebrand et al Laryngoscope 2009).  Building on these findings, in this proposal we will complete two specific aims.  Specific Aim 1: To provide comprehensive, high-throughput, low-cost DNA sequence generation and analysis for deafness genetic testing  Goal 1: Comprehensive, high-throughput, low-cost DNA sequence analysis for genetic testing for deafness is possible at sensitivities and specificities comparable to Sanger sequencing by using targeted sequence enrichment followed by massively parallel sequencing.  Specific Aim 2: To optimize both machine learning-based audioprofiling of audiometric data and phenotypic filtering of genotypic data by expanding and improving the platform we have developed called AudioGene  Goal 2: As a phenome tool, a machine-learning software system trained on an extensive set of audiometric data can be used to predict and to eliminate specific genes or gene variants as causes of deafness based on audiometric data.  Achieving these specific aims will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history, physical examination and audiological assessment.        PUBLIC HEALTH RELEVANCE:  In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. Achieving this goal will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history and physical exam.                   In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. Achieving this goal will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history and physical exam.                ",Optimizing Genetic Testing for Deafness for Clinical Diagnostics,8224101,R01DC012049,"['software systems ', ' Funding Opportunities ', ' genetic testing ', ' Genetic screening method ', ' Hypoacusis ', ' Hypoacuses ', ' Hearing Loss ', ' hearing impairment ', ' driving force ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Diagnostic tests ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Impairment ', ' tool ', ' trait ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' response ', ' Frequency ', ' Frequencies (time pattern) ', ' Sensory ', ' High Prevalence ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Family ', ' Screening procedure ', ' Variation ', ' Variant ', ' Sampling ', ' Genes ', ' Sensitivity and Specificity ', ' Caring ', ' Deoxyribonucleic Acid ', ' DNA ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Laboratories ', ' meetings ', ' Goals ', ' Data Analysis ', ' Data Analyses ', ' Diagnostic ', ' DNA Sequence ', ' Genetic ', ' Persons ', ' Dataset ', ' Data Set ', ' Diagnosis ', ' Selection Criteria ', ' Minority ', ' Training ', ' cost ', ' History ', ' Recording of previous events ', ' Clinical ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' Bar Codes ', ' Vestibular Aqueduct ', ' Octogenarian ', ' Medical Inspection ', ' Physical Examination ', ' Laryngoscopes ', ' retinitis pigmentosa-congenital deafness syndrome ', ' dystrophia retinae-dysacousis syndrome ', ' dystrophia retinae pigmentosa-dysostosis syndrome (DRD) ', ' dystrophia retinae pigmentosa-dysostosis syndrome ', "" Usher's syndrome "", ' Usher syndrome (US) ', ' Usher Syndrome ', ' Hallgren syndrome ', ' Graefe-Usher syndrome ', ' Retinitis pigmentosa-deafness syndrome ', ' Technology ', ' Detection ', ' cost-effective ', ' cost effective ', ' Research Resources ', ' Resources ', ' improved ', ' Patients ', ' Data ', ' Life ', ' Link ', ' Generations ', ' base ', ' LOINC Axis 4 System ', ' System ', ' Genets ', ' phenome ', ' DNA Sequence Analyses ', ' DNA Sequence Analysis ', ' Persons With Hearing Impairments ', ' Hard of Hearing Persons ', ' Deaf ', ' Hearing Impaired Persons ', ' Sanger Sequencing ', ' Dideoxy Chain Termination DNA Sequencing ', ' low frequency hearing loss ', ' Low Frequency Deafness ', ' Deafness ', ' Audiometric Test ', ' Audiogram ', ' Audiometry ', ' ']",NIDCD,UNIVERSITY OF IOWA,R01,2011,608130,IA-02,0.005572505154922681
"Machine Learning Prediction of Cancer Susceptibility    DESCRIPTION (provided by applicant):       Susceptibility to sporadic forms of cancer is determined by numerous genetic factors that interact in a nonlinear manner in the context of an individual's age and environmental exposure. This complex genetic architecture has important implications for the use of genome-wide association studies for identifying susceptibility genes. The assumption of a simple architecture supports a strategy of testing each single-nucleotide polymorphism (SNP) individually using traditional univariate statistics followed by a correction for multiple tests. However, a complex genetic architecture that is characteristic of most types of cancer requires analytical methods that specifically model combinations of SNPs and environmental exposures. While new and novel methods are available for modeling interactions, exhaustive testing of all combinations of SNPs is not feasible on a genome- wide scale because the number of comparisons is effectively infinite. Thus, it is critical that we develop intelligent strategies for selecting subsets of SNPs prior to combinatorial modeling. The objective of this renewal application is to continue the development of a research strategy for the detection, characterization, and interpretation of gene-gene and gene-environment interactions in genome-wide association studies of bladder cancer susceptibility. To accomplish this objective, we will continue developing and evaluating modifications and extensions to the ReliefF family of algorithms for selecting or filtering subsets of single- nucleotide polymorphisms (SNPs) for multifactor dimensionality reduction (MDR) analysis of gene-gene and gene-environment interactions (AIM 1). We will continue developing and evaluating a stochastic wrapper or search strategy for MDR analysis of interactions that utilizes ReliefF values as a heuristic (AIM 2). We will continue to make available ReliefF algorithms as part of our open-source MDR software package (AIM 3). Finally, we will apply the best ReliefF-MDR analysis strategies to the detection, characterization, and interpretation of gene-gene and gene-environment interactions in large genome-wide association studies of bladder cancer susceptibility (AIM 4). We anticipate the proposed machine learning methods will provide powerful new approaches for identifying genetic variations that are predictive of cancer susceptibility.              PROJECT NARRATIVE The technology to measure information about the human genome is advancing at a rapid pace. Despite these advance, the computational methods for analyzing the data have not kept pace. We will develop new computer algorithms and software that can be used to identify genetic biomarkers of common human diseases. We will then apply these new computational methods to identifying genetic biomarkers of bladder cancer in an epidemiological study from New Hampshire.",Machine Learning Prediction of Cancer Susceptibility,8145181,R01LM009012,"['analytical method ', ' open source ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' genome-wide ', ' genomewide ', ' Environmental Exposure ', ' Epidemiologic Studies ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Predisposition ', ' Susceptibility ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Architecture ', ' Engineering / Architecture ', ' statistics ', ' gene environment interaction ', ' environment effect on gene ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Computing Methodologies ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computational algorithm ', ' computer algorithm ', ' Human Genome ', ' human whole genome ', ' New Hampshire ', ' cancer type ', ' combinatorial ', ' Malignant neoplasm of urinary bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' Research ', ' Family ', ' Age ', ' population based ', ' Individual ', ' base ', ' Development ', ' developmental ', ' Computer software ', ' computer program/software ', ' Software ', ' human disease ', ' Measures ', ' Modification ', ' novel ', ' Validation ', ' Goals ', ' Methods ', ' Knowledge ', ' Genetic ', ' Genes ', ' Characteristics ', ' Complex ', ' Testing ', ' programs ', ' Data Analyses ', ' Data Analysis ', ' Detection ', ' Technology ', ' Evaluation ', ' Algorithms ', ' Modeling ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' improved ', ' biomarker ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' heuristics ', ' ']",NLM,DARTMOUTH COLLEGE,R01,2011,376973,NH-02,0.07505714829497181
"Molecular Genetics of HNPCC    DESCRIPTION (provided by applicant): The overall goal of this application is to elucidate genetic risk modifiers influencing age of onset of hereditary nonpolyposis colorectal cancer (HNPCC) using a pathway-based approach. The overall hypothesis of this proposal is that SNPs in cell cycle pathways influence the efficiency of the finely tuned mechanisms of cell cycle progression. We will continue to build and expand upon our unique clinical and specimen resource of mismatch repair gene mutation carriers in order to accomplish this goal. In aim 1, we will determine the role that genetic variants in cell cycle genes have on risk for development of early onset HNPCC. We will use the Illumina Golden Gate platform to genotype SNPs from 153 cell cycle genes. We will evaluate the main effects of SNPs in these genes using a two-phase study design in order to determine if there are differences in age-associated risk for development of HNPCC between carriers of the wild type genotype vs. those carrying one or two copies of the SNP. In aim 2, we will use novel machine learning analytic tools to determine if we can identify combinations of cell cycle SNPs that work together to influence risk for development of early onset HNPCC. Two approaches will be used to accomplish this goal. A focused candidate gene approach, and the second is an exploratory, pathways based approach. In the focused candidate approach, we have selected 12 candidate genes because they are known to interact with each other in the cell cycle pathways and there is evidence that SNPs in these genes influence risk for HNPCC or other cancers. We will determine if combinations of these SNPs work together to influence development of HNPCC at an early age. In the second approach we will investigate SNPs in all 153 of the genes, including the 12 candidate genes. We hypothesize that there are many possible combinations of cell cycle genes that work together and under the influence of SNPS, contribute to development of HNPCC at an early age. We will use Random Forests (RF) modeling to rank all of the SNPs from these genes. RF can handle large numbers of predictor variables such as SNPs and provides estimates of variable importance. We will then use CART to build age-to-onset trees using the SNPs ranked the highest from RF. The proposed studies will contribute to our long-term goal to develop a risk model for early onset HNPCC by defining the role that SNPs in cell cycle genes play in risk for HNPCC. They will also provide important information regarding novel gene-gene interactions contributing to risk for development of HNPCC at an earlier age. The National Cancer Institute in its 2006 budget proposal cited risk prediction as an area of extraordinary opportunity. Risk prediction models for cancer could provide valuable tools for identifying individuals who may benefit from preventive treatments or increased surveillance or who are good candidates to participate in clinical trials. PUBLIC HEALTH REVELANCE: The proposed studies will contribute to our long-term goal to develop a risk model for HNPCC, which may also have important implications for sporadic colorectal cancer as well as other cancer sites.             ",Molecular Genetics of HNPCC,8067773,R01CA070759,"['cancer site ', ' cancer location ', ' forest ', ' aurora-A kinase ', ' auroraA kinase ', ' early onset ', ' Cancer Model ', ' CancerModel ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' Smoking ', ' Molecular Genetics ', ' Abbreviations ', ' peripheral blood ', ' Preventive ', ' Early Diagnosis ', ' early detection ', ' Phase ', ' genetic variant ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Genetic Risk ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' novel ', ' homologous recombination ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Learning ', ' Genes ', ' Specimen ', ' Research Specimen ', ' Cell Cycle ', ' Cell Division Cycle ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Research Design ', ' study design ', ' Study Type ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Validation ', ' Maintenance ', ' Resources ', ' Research Resources ', ' Mutate ', ' Risk ', ' protein protein interaction ', ' Foundations ', ' Clinical ', ' Cells ', ' Gender ', ' Individual ', ' tool ', ' Role ', ' social role ', ' base ', ' Modeling ', ' Area ', ' Techniques ', ' Age ', ' Clinical Trials ', ' clinical investigation ', ' Colorectal Cancer ', ' Genome ', ' Work ', ' Defect ', ' Pathway interactions ', ' pathway ', ' Complex ', ' Testing ', ' Play ', ' Genotype ', ' Health ', ' MDM2 gene ', ' p53-Binding Protein Gene ', ' MDM2 ', ' MDM 2 ', ' Development ', ' developmental ', ' Data ', ' Linkage Disequilibrium ', ' Mediating ', ' Goals ', ' CDK4 gene ', ' PSK-J3 ', ' MGC14458 ', ' CMM3 ', ' CDK4 ', ' Cyclin D1 ', ' cyclin D ', ' c-bcl-1 Proteins ', ' bcl1 Proto-Oncogene Proteins ', ' bcl-1 Proto-Oncogene Proteins ', ' bcl-1 Proto-Oncogene Products ', ' Proto-Oncogene Proteins c-bcl-1 ', ' PRAD1 Protein ', ' G1/S-Specific Cyclin D1 ', ' CCND1 Protein ', ' Hereditary Nonpolyposis Colorectal Neoplasms ', ' hereditary non-polyposis colorectal cancer ', ' Lynch Syndrome ', ' Hereditary Nonpolyposis Colorectal Cancer ', ' Hereditary Nonpolyposis Colon Cancer ', ' Hereditary Non-Polyposis Colon Cancer (hMSH2, hMLH1, hPMS1, hPMS2) ', ' Hereditary Non-Polyposis Colon Cancer ', ' Hereditary Defective Mismatch Repair Syndrome ', ' Hereditary Colorectal Endometrial Cancer Syndrome ', ' Familial Nonpolyposis Colon Cancer ', ' Familial Non-Polyposis Colon Cancer (hMSH2, hMLH1, hPMS1, hPMS2) ', ' National Cancer Institute ', ' NCI Organization ', ' Gene Order ', ' Gene Position ', ' Gene Arrangement ', ' Aspirin ', ' Measurin ', ' Extren ', ' Entericin ', ' Empirin ', ' Ecotrin ', ' Aspergum ', ' Acetylsalicylic Acid ', ' 2-(Acetyloxy)benzoic Acid ', ' mutation carrier ', ' Nonhomologous DNA End Joining ', ' Non-Homologous End Joining ', ' NHEJ ', ' Mismatch Repair ', ' Post-Replication Mismatch Repair ', ' STK6 gene ', ' STK6 ', ' STK15 Gene ', ' STK15 ', ' BTAK ', ' AURORA2 ', ' ARK1 ', ' Nucleotide Excision Repair ', ' cdc Genes ', ' Cell Division Cycle Genes ', ' Cell Cycle Genes ', ' Leukocytes ', ' white blood corpuscle ', ' white blood cell ', ' White Cell ', ' White Blood Cells ', ' Marrow leukocyte ', ' Leukocytes Reticuloendothelial System ', ' Blood leukocyte ', ' Cell Cycle Checkpoint ', ' Gene Mutation ', ' Sequence Alteration ', ' Genetic mutation ', ' Gene Alteration ', ' DNA mutation ', ' DNA Alteration ', ' Classification ', ' Systematics ', ' Budgets ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Ubiquitination ', ' ubiquitin conjugation ', ' ubiquination ', ' Ubiquitinoylation ', ' Ubiquitilation ', ' Base Excision Repairs ', ' DNA Base Excision Repair ', ' Cell Cycle Progression ', ' Trees ', ' Microsatellite Instability ', ' Germ-Line Mutation ', ' Hereditary Mutation ', ' Germline Mutation ', ' CHEK2 gene ', ' RAD53 ', ' PP1425 ', ' CHK2 ', ' CHEK2 ', ' CDS1 ', ' Proteolysis ', ' Protein Cleavage ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Large Intestine Carcinoma ', ' Large Bowel Carcinoma ', ' Colorectal Carcinomas ', ' Age of Onset ', ' gene interaction ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2011,530841,TX-09,0.05480863612393585
"Statistical Methods for Correlated and High-Dimensional Biomedical Data We propose in the renewal of this MERIT award application to continue developing advanced statistical and computational methods for analysis of correlated and high-dimensional data, which arise frequently in health science research, especially in cancer research. Correlated data are often observed in observational studies and clinical trials, such as longitudinal studies and familial studies. High-dimensional data have emerged rapidly in recent years due to the advance of high-throughput 'omics technologies, e.g, in Genome- Wide Association Studies (GWAS), and genome-wide epigenetic (DNA methylation) studies. Massive next generation sequencing data are soon available. There is an urgent need to develop advanced stati stical and computational methods for analyzing such high throughput 'omics data in observational studies and clinical trials. We propose to develop statistical and computational methods for analysis of (1) genome-wide association studies; (2) sequencing data for studying rare variant effects; (3) genome-wide DNA methylation studies; (4) gene-gene and gene-environment interactions. We will develop methods for both case-control studies and cohort studies, such as longitudinal studies and survival studies. We will study the theoretical properties of the proposed methods and evaluate the finite s ample performance using simulation studies. We will develop efficient numerical algorithms and user-friendly statistical software, and disseminate these tools to health sciences researchers. In collaboration with biomedical investigators, we will apply the proposed models methods to data from several genome-wide epidemiological studies in cancer and other chronic diseases. RELEVANCE (See instructions):  Development of new statistical methods for analysis of correlated and high-dimensional data will provide  powerful analytic tools to advance 'omics research in observational studies and clinical trials and to help  understand the roles of genes, gene products, and the environment in causing human diseases.",Statistical Methods for Correlated and High-Dimensional Biomedical Data,8117858,R37CA076404,"['Statistical Methods ', ' human whole genome ', ' Human Genome ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' Genome ', ' genomewide ', ' genome-wide ', ' Goals ', ' Environment ', ' cancer research ', ' anticancer research ', ' environment effect on gene ', ' gene environment interaction ', ' clinical investigation ', ' Clinical Trials ', ' gene product ', ' Proteins ', ' Algorithms ', ' Technology ', ' mRNA ', ' Messenger RNA ', ' DNA Methylation ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' human disease ', ' Genetic ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Knowledge ', ' computer program/software ', ' Software ', ' Computer software ', ' gene interaction ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Dimensions ', ' Biomedical Research ', ' long-term study ', ' Longitudinal Studies ', ' case control ', ' developmental ', ' Development ', ' Collaborations ', ' Investigation ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Genes ', ' Research ', ' Modeling ', ' disease/disorder ', ' Disorder ', ' Disease ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Preventive strategy ', ' Prevention strategy ', ' next generation ', ' Award ', ' Genomics ', ' Health Sciences ', ' Variation ', ' Variant ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' user-friendly ', ' Data ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' LOINC Axis 2 Property ', ' Property ', ' Performance ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Aging ', ' Testing ', ' Techniques ', ' tool ', ' pediatric ', ' Childhood ', ' Scientist ', ' Measures ', ' Methods ', ' programs ', ' Advanced Development ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' novel technologies ', ' new technology ', ' simulation ', ' cancer risk ', ' Concurrent Studies ', ' Cohort Studies ', ' Instruction ', ' epigenome ', ' epigenomics ', ' Statistical Computing ', ' social role ', ' Role ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' novel ', ' Genotype ', ' high throughput analysis ', ' computer science ', ' Explosion ', ' Public Health Schools ', ' Theoretical Studies ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Observational Study ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' health science research ', ' signal processing ', ' data processing ', ' computerized data processing ', ' ']",NCI,HARVARD SCHOOL OF PUBLIC HEALTH,R37,2011,308344,MA-07,0.022314817833540432
"Integrating Genomic and Environmental Perspectives on Internalizing Disorders While biometric genetic studies have long indicated substantial heritability for internalizing disorders, including major depressive and generalized anxiety disorders, progress in mapping this influence onto specific genetic variants has been slow. Expert consensus suggests that finding this missing heritability will require moving beyond the current one SNP at a time genomewide association study (GWAS) paradigm to develop interactive models jointly considering effects across structural and functional genomic units (e.g., genes and biological pathways), as well as modeling gene-environmental interaction (GxE) in the highly dimensional GWAS context. The overarching goal of this proposal is to provide the candidate the training and research opportunities necessary to advance such an interactive model of internalizing disorder etiology, thus supporting the candidates long-term career goal of becoming an independent investigator in the area. General training goals include building proficiency in statistical genetics and bioinformatics, and strengthening knowledge of substantive issues in developmental psychopathology and psychometric statistical modeling/programming. The candidate proposes to acquire a number of specific skills, including data integration techniques for including prior information in GWAS, aggregation methods to capture the possible effects of many markers with very small effects (e.g., gene-based, pathway-based, and polygenic risk profile score analyses) and machine learning applications for investigating epistasis and nonlinear genomic effects. Proposed training in these areas consists of an interlocking program of coursework, intensive mentoring, summer programs, reading groups, seminar series and conferences, with special attention to training in research ethics. Direct mentoring is a key feature of this program, with access to leading experts in each of the proposed training areas (i.e., Drs. Edwin van den Oord and Patrick Sullivan  statistical genetics and bioinformatics, Dr. E. Jane Costello  developmental psychopathology, and Dr. Michael Neale  statistical modeling and programming) representing a core strength of the proposed training plan. The candidate proposes to apply acquired skills in the research portion of the project by conducting a multistage GWAS to investigate genomic influence, both direct and in interaction with environmental risk factors, on developmental trajectories of internalizing disorders. Methodologically, this approach focuses on integrating longitudinal statistical models of phenotypic development and environmental risk with emerging genomic methods. This will be facilitated by bringing together an unprecedented combination of longitudinal GWAS datasets, including a meta-analysis of the four Duke/VCU samples of the Gene, Environment, and Development Initiative (GEDI) (N=3,623). This discovery phase meta-analysis will then be followed by replication in two large independent longitudinal samplesthe National Longitudinal Study of Adolescent Health (N=~12,000) and the Minnesota Twin and Family Study (N=3,762). The exceptional statistical power of this design will be further complimented in a final analytical stage, with next-generation sequencing follow-up using targeted capture methods to extract promising genes/regions and extreme-trait methods to maximize power by selecting subjects from the extremes of the phenotypic distributions. The institutional environment provided by the Virginia Commonwealth University Center for Biomarker Research and Personalized Medicine (CBRPM) represents another core asset to the candidates career development. The CBRPMs mission is to develop and apply novel methods for the purpose of identifying and using biomarkers to improve disease understanding and medical treatment. The Center operates from a strong multidisciplinary perspective with primary applications involving psychiatric outcomes, developmental psychopathology, and substance use disorders. Currently funded research programs at the CBRPM include serving as the data analysis core of the Duke/VCU GEDI project, method development in the design and analysis of adaptive multistage GWAS, a replication study of findings from schizophrenia GWAS, and whole genome profiling to detect schizophrenia methylation markers. These projects offer an ideal context for executing the proposed training and research, as they provide an environment focused on GWAS and next-generation sequencing applications to psychiatric disorderscentral topics of the candidates career development plan. The CBRPM also provides several unique physical resources supporting the current proposal, including a SOLiD 4 next-generation sequencer, which will allow follow-up sequencing to be done in-house, and a Center-dedicated computing cluster, facilitating the computationally intensive analyses proposed. In addition to physical resources, the CBRPM offers a challenging and collegial intellectual environment that promotes collaboration both within and outside of the Center. In sum, the CBRPM provides a stimulating and supportive institutional environment with the all of the statistical, computational and laboratory resources necessary to make this proposal a successful one. Affecting more than one in five Americans annually, internalizing disorders (IDs) (i.e.,  depression and anxiety) are the most common forms of mental illness and leading  causes of the global health burden. Clearly, an improved understanding of the etiology of  IDs would substantially advance both prevention and intervention efforts. This project  aims to improve understanding through advancing an integrative model of genomic,  environmental and developmental influence in the etiology of IDs.",Integrating Genomic and Environmental Perspectives on Internalizing Disorders,8092195,K01MH093731,"['Stratification ', ' global health ', ' Sum ', ' Statistical Models ', ' Probabilistic Models ', ' Psychometrics ', ' Genetic Risk ', ' Substance Use Disorder ', ' Virginia ', ' Custom ', ' depressive symptoms ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Genetic Epistasis ', ' genetic epistases ', ' gene x gene interaction ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' career development ', ' Genotype ', ' Measurement ', ' Mental Depression ', ' depression ', ' Mental disorders ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Training ', ' genome-wide ', ' genomewide ', ' multidisciplinary ', ' Medical ', ' Biometry ', ' Biostatistics ', ' Biometrics ', ' Candidate Disease Gene ', ' Candidate Gene ', ' Data Analyses ', ' Data Analysis ', ' Phenotype ', ' Bioinformatics ', ' Bio-Informatics ', ' Longitudinal Studies ', ' long-term study ', ' biomarker ', ' improved ', ' Series ', ' Structure ', ' Funding ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Mission ', ' Communities ', ' Psychopathology ', ' abnormal psychology ', ' Sampling ', ' Maps ', ' Time ', ' Data ', ' Play ', ' Methods ', ' Area ', ' design ', ' designing ', ' American ', ' genetic variant ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Goals ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Heterogeneity ', ' Variant ', ' Variation ', ' indexing ', ' Genome ', ' Measures ', ' Side ', ' programs ', ' Testing ', ' career ', ' Modeling ', ' Consensus ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Algorithms ', ' Data Set ', ' Dataset ', ' Laboratories ', ' Address ', ' Predisposition ', ' Susceptibility ', ' Techniques ', ' Methylation ', ' Protein Methylation ', ' Environment ', ' Risk ', ' Phase ', ' base ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' symposium ', ' conference ', ' Major Depressive Disorder ', ' major depression ', ' Housing ', ' Affect ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' trait ', ' Medicine ', ' Resources ', ' Research Resources ', ' Pathway interactions ', ' pathway ', ' functional/structural genomics ', ' next generation ', ' Genetic Models ', ' gene environment interaction ', ' environment effect on gene ', ' burden of illness ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' Reading ', ' Schizophrenia ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Anxiety ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Development ', ' developmental ', ' Outcome ', ' method development ', ' Development Plans ', ' Genes ', ' Role ', ' social role ', ' Research ', ' Universities ', ' Genetic ', ' Behavioral ', ' Mentors ', ' Health ', ' Attention ', ' Genomics ', ' Research Training ', ' Knowledge ', ' Biological ', ' Collaborations ', ' Screening procedure ', ' screenings ', ' screening ', ' Investigation ', ' novel ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' skills ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Staging ', ' Genetic Research ', ' Minnesota ', ' Population Control ', ' Twin Studies ', ' Child Care ', ' Puericulture ', ' Generalized Anxiety Disorder ', ' Scoring Method ', ' developmental genetics ', ' cluster computing ', ' grid computing ', ' distributed computing ', ' datagrid ', ' data grid ', ' computational grid ', ' Research Ethics ', ' data integration ', ' Family Study ', ' Heritability ', ' Twin Multiple Birth ', ' Twins ', ' ']",NIMH,VIRGINIA COMMONWEALTH UNIVERSITY,K01,2011,108896,VA-04,0.06577184401967286
"DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk    DESCRIPTION (provided by applicant): My long-term goal is to become an independent molecular epidemiologist with in-depth training in genetics and advanced statistical methods in order to be able to analyze high throughput gene variant data to explore gene-gene and gene-environment interactions in cancer susceptibility. My career development plan include didatic courses/seminars, meetings with mentors in the areas of human genetics, cancer biology and advanced statistical methods. My research proposal will focus on genetic susceptibility of bladder cancer (BC). I propose to capitalize on availability of epidemiologic and genetic marker data from an on-going case-control study, ""Markers of Genetic Susceptibility to Bladder Cancer""(R01 CA74880,PI:Xifeng. Wu). The parent study currently include over 2,500,mostly Caucasian, BC cases and controls, matched on sex, age and ethnicity. My goal is to identify novel loci that confer bladder cancer susceptibility using state-of-the-art genotyping technology and novel statistical and bioinformatics tools. The Specific Aims are: 1) To enhance my knowledge and skills in genetics and statistics to identify novel genetic loci as susceptibility markers of BC by extending the original45 potential functional SNPs to include additional 2112 tagging SNPs in genes in the DNA repair, cell cycle control and apoptotic pathways in 800 Caucasian cases and 800 Caucasian controls using the Illumina Golden Gate Assay; 2) To assess haplotypes and diplotypes as markers of susceptibility; 3) To use bioinformatics tools to assess functional significance of SNPs in the DNA repair, cell cycle control and apoptotic pathways and to correlate genotype data of DNA repair and cell cycle control with functional data derived from phenotypic assays. The secondary aim is to apply hierarchical models to refine risk assessment and to apply novel machine-learning tools to explore any gene-environment and gene-gene interactions influencing BC risk. My project complements the parent grant in that it: 1) adds tagging SNPs to potential functional SNPs addressed in the parent grant; 2) adds haplotype analyses; 3) proposes novel statistical and bioinformatics approaches. RELEVANCE: Bladder cancer is a tobacco-related cancer which is the fourth most common cancer in men in U.S. The fact that only a fraction of smokers develop bladder cancer indicating genetic susceptibility to the disease. This study will identify novel genetic markers may be useful as biomarkers to identify high-risk populations that could then be targeted for intervention programs.          ","DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk",8065522,K07CA134831,"['carcinogenesis ', ' Cancer Induction ', ' Paper ', ' Predictive Value ', ' college ', ' collegiate ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' coping ', ' Environmental Exposure ', ' Genotype ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Parents ', ' career development ', ' Cancer Center ', ' case control ', ' Specimen ', ' Research Specimen ', ' Research Proposals ', ' cancer risk ', ' Journals ', ' Magazine ', ' anticancer research ', ' cancer research ', ' Predisposition ', ' Susceptibility ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' skills ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' Publishing ', ' statistics ', ' Case Study ', ' case report ', ' Erythrocytes ', ' blood corpuscles ', ' Red blood corpuscule ', ' Red Cell ', ' Red Blood Cells ', ' Marrow erythrocyte ', ' Erythrocytic ', ' Erythrocytes Reticuloendothelial System ', ' Blood normocyte ', ' Blood erythrocyte ', ' new technology ', ' novel technologies ', ' Apoptotic ', ' Alleles ', ' Allelomorphs ', ' DNA ', ' Deoxyribonucleic Acid ', ' Lymphocyte ', ' lymph cell ', ' Lymphocytic ', ' Genetic Polymorphism ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Smoker ', ' Apoptosis ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' American ', ' Exposure to ', ' Mentors ', ' Complement ', ' Complement Proteins ', ' Cell physiology ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Training ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Environment ', ' Disease ', ' disease/disorder ', ' Disorder ', ' meetings ', ' Frequencies (time pattern) ', ' Frequency ', ' Algorithms ', ' men ', "" men's "", ' Bioinformatics ', ' Bio-Informatics ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Pathway interactions ', ' pathway ', ' Phenotype ', ' Clinic ', ' high risk ', ' Resources ', ' Research Resources ', ' Outcome ', ' Genomics ', ' Methods ', ' Recruitment Activity ', ' recruit ', ' Physicians ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' biomarker ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Length ', ' base ', ' Sampling ', ' gene environment interaction ', ' environment effect on gene ', ' Modeling ', ' Population ', ' Complex ', ' Genetic ', ' Knowledge ', ' tool ', ' Medicine ', ' Enrollment ', ' enroll ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Gender ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Genes ', ' Variant ', ' Variation ', ' Biological ', ' Individual ', ' Clinical ', ' sex ', ' Age ', ' Cells ', ' Development ', ' developmental ', ' novel ', ' Molecular ', ' Funding ', ' Goals ', ' Area ', ' Address ', ' Medical ', ' Data ', ' Dietary Practices ', ' dietary pattern ', ' Epidemiologist ', ' Suspensions ', ' parent grant ', ' telomere ', ' genotyping technology ', ' Gene Order ', ' Gene Position ', ' Gene Arrangement ', ' Correlation Studies ', ' Statistical Correlation ', ' Malignant neoplasm of urinary bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' Mutagens ', ' genotoxic agent ', ' Genotoxins ', ' Molecular Epidemiology ', ' Tobacco smoke ', ' Carcinogen Metabolism ', ' Penetrance ', ' Journal of the National Cancer Institute ', ' Journal of the NCI ', ' Newly Diagnosed ', ' Tobacco ', ' Risk Assessment ', ' Cell Cycle Checkpoint ', ' Nutritional ', ' Haplotypes ', ' Caucasians ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Development Plans ', ' Doctor of Medicine ', ' M.D. ', ' Human Genetics ', ' Suspension substance ', ' suspension ', ' Occupational ', ' Clinical Oncology ', ' Cell Cycle Regulation ', ' Cell Cycle Control ', ' Statistical Methods ', ' Cancer Biology ', ' Bladder ', ' urinary bladder ', ' Bladder Urinary System ', ' Carcinogens ', ' oncogenic agent ', ' Oncogens ', ' Cancer Causing Agents ', ' Caucasoid Race ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' intervention program ', ' medical specialties ', ' Specialty ', ' gene interaction ', ' Genetic Markers ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,K07,2011,137995,TX-09,0.07071791950245906
"Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning    DESCRIPTION (provided by applicant):       Epistasis is the interaction between two or more genes to affect phenotype. It is now widely accepted that epistasis plays an important role in susceptibility to many common diseases. The advent of high-throughput technologies has enabled genome-wide association studies (GWAS or GWA studies). It is compelling that we be able to detect epistasis using GWAS data. However, so far GWA studies have mainly focused on the association of a single gene or loci with a disease. The crucial challenge to analyzing epistasis using GWAS data is finding a way to efficiently handle high-dimensional data sets. The only possible solution is to design efficient algorithms that allow us to find the most relevant epistasic relationships without doing an exhaustive investigation. To the Principal Investigator's knowledge, no current method can do this.       This career award will investigate this problem. The specific aims are as follows: (Aim 1) develop and evaluate efficient Bayesian network-based methods for learning candidate genes associated with diseases from GWAS sets. Such genes would provide candidates for follow-up biological studies, (Aim 2) implement the methods in a pilot GWAS system for use by researchers when conducting a GWAS, (Aim 3) develop simulated genome-wide data sets and evaluate the pilot system using these data sets, and (Aim 4) conduct GWA studies concerning breast cancer and lung cancer.       Aim 1 will be addressed by developing a succinct Bayesian network model representing epistasis, efficient algorithms which are tailored to investigating such models, integration of the algorithms into methods for learning epistasis, and using simulated datasets to test the effectiveness of the methods and compare their performance to other methods. Aim 2 will be met by implementing the methods in a pilot GWAS system. Aim 3 will be satisfied by developing synthetic data sets similar to those found in GWA studies, and using them to evaluate the system. Aim 4 will be achieved by conducting GWA studies concerning breast and lung cancer. By conducting these studies, we can (1) substantiate previous results concerning the genetic basis of these diseases; (2) possibly obtain interesting new findings pertaining to these diseases.       The main hypothesis is that the proposed method will be an advance over existing methods in that it will make it computationally feasible to learn epistatic relationships from genome-wide data and it will therefore yield better discovery performance than existing methods.              Learning gene-gene interactions from genome-wide association studies (GWAS) data is an important and challenging task in genetic epidemiology. This project will develop and evaluate a pilot GWAS system for performing this task. Advances obtained in analyzing GWAS data sets could enable us to learn the genetic basis of many diseases and thereby substantially improve the quality of personalized patient care.",Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning,8145599,K99LM010822,"['forest ', ' Genetic Epistasis ', ' genetic epistases ', ' gene x gene interaction ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Family history of ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' genetic epidemiology ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Regression Analysis ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' BRCA1 gene ', ' brca 1 gene ', ' RNF53 ', ' Hereditary Breast Cancer 1 ', ' Early Onset Gene Breast Cancer 1 ', ' Breast Cancer Type 1 Susceptibility Gene ', ' Breast Cancer 1 Gene ', ' BRCA1 ', ' Genetic Programming ', ' Genetic Algorithm ', "" Alzheimer's Disease "", ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', ' Joints ', ' Articulation ', ' Predisposition ', ' Susceptibility ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Candidate Disease Gene ', ' Candidate Gene ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' career ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' genetic variant ', ' data mining ', ' datamining ', ' genome-wide analysis ', ' gene interaction ', ' high throughput technology ', ' Biological Neural Networks ', ' neural network ', ' Statistical Methods ', ' combinatorial ', ' Cancer-Predisposing Gene ', ' Cancer Susceptibility Gene ', ' Research ', ' Learning ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' genome-wide ', ' genomewide ', ' Award ', ' Link ', ' Performance ', ' base ', ' Simulate ', ' Affect ', ' System ', ' LOINC Axis 4 System ', ' Work ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Role ', ' social role ', ' interest ', ' Woman ', ' Methods ', ' Modeling ', ' Phenotype ', ' Data ', ' Generations ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Knowledge ', ' Genetic ', ' Complex ', ' Testing ', ' Address ', ' Patient Care ', ' Patient Care Delivery ', ' meetings ', ' design ', ' designing ', ' Effectiveness ', ' follow-up ', ' followed up ', ' follow up ', ' Active Follow-up ', ' Data Analyses ', ' Data Analysis ', ' Solutions ', ' Biological ', ' Algorithms ', ' network models ', ' Disease ', ' disease/disorder ', ' Disorder ', ' cancer cell ', ' Malignant Cell ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Network-based ', ' Data Set ', ' Dataset ', ' Site ', ' Investigation ', ' Play ', ' improved ', ' Principal Investigator ', ' Genes ', ' Methodology ', ' Method LOINC Axis 6 ', ' BRCA2 gene ', ' brca 2 gene ', ' Hereditary Breast Cancer 2 ', ' FANCD1 ', ' FANCB ', ' Early Onset Gene Breast Cancer 2 ', ' Breast Cancer Type 2 Susceptibility Gene ', ' Breast Cancer 2 Gene ', ' BRCA2 ', ' GAB2 gene ', ' GRB2-Associated Binding Protein 2 Gene ', ' GAB2 ', ' Germ-Line Mutation ', ' Hereditary Mutation ', ' Germline Mutation ', ' computer based statistical methods ', ' Bayesian Networks ', ' ']",NLM,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K99,2011,90000,PA-18,0.05095688162974343
"From GWAS to PheWAS: Scanning the EMR phenome for gene-disease associations    DESCRIPTION (provided by applicant): Genomic medicine offers hope for improved diagnostic methods and for more effective, patient-specific therapies. Genome-wide associated studies (GWAS) elucidate genetic markers that improve understanding of risks and causes for many diseases, and may guide diagnosis and therapy on a patient-specific basis. This project will take another approach to identify gene-disease associations: perform ""reverse GWAS,"" or phenome- wide association study (PheWAS), to determine which phenotypes are associated with a given genotype. The project is enabled by a large DNA biobank coupled to a de- identified copy of the electronic medical record. This project has four specific aims. First, the project will develop and validate a standardized approach to extract disease phenotypes from EMR records, integrating national standard terminologies of clinical disorders and descriptors relating to treatment and diagnosis of each disease to create a sharable knowledge base. The project will use natural language processing, structured data queries, and heuristic and machine learning methods to accurately identify patients with each disease and corresponding controls. The second aim is to perform PheWAS analyses using existing genotype data. To validate the method, the project will use PheWAS to ""rediscover"" SNPs with known disease associations. The project will also investigate statistical methods for large-scale multiple hypothesis testing to discover novel phenotype associations. The third aim is to apply the PheWAS algorithms in four other sites with EMR-linked DNA biobanks and compare results. In the fourth aim, the project will validate novel phenotype-genotype associations discovered through PheWAS with new genotyping in a previously untested population. The tools generated from this project will not only make PheWAS possible, but will also broadly enable clinical research and subsequent genetic studies.           The promise of genomic medicine is to predict individuals' disease risk and treatment given their genetic information. This project will develop methods to identify diseases from electronic medical records and then find novel genetic associations from existing genomic data.",From GWAS to PheWAS: Scanning the EMR phenome for gene-disease associations,8042010,R01LM010685,"['genetic association ', ' Diagnostic Procedure ', ' Diagnostic Technique ', ' Diagnostic Method ', ' Appointment ', ' Clinical and Translational Science Awards ', ' biobank ', ' biorepository ', ' Genetic Research ', ' Data Element ', ' analytical method ', ' Computerized Medical Record ', ' Electronic Medical Record ', ' Academic Medical Centers ', ' University Medical Centers ', ' Terminology ', ' heuristics ', ' Natural Language Processing ', ' natural language understanding ', ' Descriptor ', ' Sampling ', ' cohort ', ' tool ', ' Risk ', ' Goals ', ' Characteristics ', ' Structure ', ' Funding ', ' Genotype ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' improved ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Investigation ', ' Individual ', ' Genes ', ' Laboratories ', ' Physicians ', ' Research ', ' Genetic ', ' Techniques ', ' DNA ', ' Deoxyribonucleic Acid ', ' genome-wide ', ' genomewide ', ' Link ', ' Secure ', ' research clinical testing ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' Research Project Grants ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Future ', ' experience ', ' Enrollment ', ' enroll ', ' Diagnostic ', ' Clinical Treatment ', ' trial treatment ', ' trial regimen ', ' Time ', ' phenomics ', ' Clinical Research ', ' Clinical Study ', ' Coupled ', ' Methods ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Diagnosis ', ' Clinic ', ' Institution ', ' Genomics ', ' base ', ' Syndrome ', ' Joints ', ' Articulation ', ' Hand ', ' Medicine ', ' Data ', ' Population ', ' Phenotype ', ' Code ', ' Coding System ', ' Clinical Trials ', ' clinical investigation ', ' Clinical ', ' Positioning Attribute ', ' Position ', ' Patients ', ' novel ', ' Site ', ' Validation ', ' Algorithms ', ' Resources ', ' Research Resources ', ' Testing ', ' Records ', ' disease phenotype ', ' Update ', ' Disease Association ', ' Statistical Methods ', ' DNA Databases ', ' DNA Databanks ', ' DNA Data Banks ', ' phenome ', ' Letters ', ' Blood specimen ', ' Blood Sample ', ' knowledge base ', ' knowledgebase ', ' treatment response ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Manuals ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Text ', ' Expert Systems ', ' Intelligent systems ', ' Names ', ' biomedical informatics ', ' biomed informatics ', ' disorder risk ', ' disease risk ', ' Scanning ', ' patient population ', ' Genetic Markers ', ' case control ', ' ']",NLM,VANDERBILT UNIVERSITY,R01,2011,336864,TN-05,0.050113578073966256
"International Case Control Study of Malignant Glioma    DESCRIPTION (provided by applicant): Glioma comprises about 40% of all primary brain tumors accounting for as many as 26,000 U.S. and European deaths annually. Inherited susceptibility plays a role with 2-fold increased risk of glioma among first-degree relatives of glioma cases. We initiated a multi-center, international linkage study: ""Genetic Epidemiology of Glioma International Consortium"" in 2007 to address the role of inherited susceptibility. Since this study does not allow us currently to address the role of genetic susceptibility in sporadic cases, we propose this case- control study to address this gap. Members of the consortium have conducted genome wide association studies (GWAS) that will be the discovery phase (phase I). While of high value for discovery, we propose to recruit 6,000 newly diagnosed glioma cases and 6,000 age-gender-ethnicity-matched controls, and collect detailed epidemiologic data and biologic samples from the 13 participating Gliogene sites. We hypothesize that novel inherited variation influencing the susceptibility to glioma can be identified by high density SNP analysis, and propose the following specific aims: SA1: Identify common genetic variants contributing to the risk of glioma. We plan to conduct phases 2 and 3 of the 3 phase approach, specifically we will: (SA1a) Validate GWAS findings from the discovery sets, and replicate the top hits (~23,000 SNPs) with lowest p- values from the two phase GWA studies in a series of 2,000 cases and 2,000 controls (phase 2, validation). Validate the top hits from the test set (aim 1a). From stage 2, genes with SNPs displaying an association at pd10-4 (including the complete haplotype tagging - approximately 100 SNPs) will then be genotyped in a further series of 4,000 cases and 4,000 controls (stage 3, validation). SNPs significant at 10-7 or better will be considered in the final analyses. (SA1b). Using an a priori hypothesis that DNA repair in inflammation contribute to glioma risk, we will selectively interrogate DNA repair and inflammation pathway genes using data for select genes derived from the high-density array. We will conduct a hypothesis driven genetic association in DNA repair and in inflammation/immune function related genes with glioma risk using functional genomic and bioinformatic tools to interrogate available databases. (SA2): Evaluate gene-gene (G-G) and gene- environmental (G-E) interactions with strong biologic relevance to identify G-G and G-E interactions for glioma risk using machine-learning tools (MDR, FITF, and CART) in these exploratory analyses. There are no existing glioma case-control studies with sufficient numbers of biological samples and common epidemiologic data to conduct a comprehensive validation and replication study, or to address the issues of tumor heterogeneity as we will in this study.      PUBLIC HEALTH RELEVANCE: Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.                             Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.",International Case Control Study of Malignant Glioma,8048180,R01CA139020,"['cancer site ', ' cancer location ', ' Risk ', ' Exposure to ', ' success ', ' Ensure ', ' Heterogeneity ', ' Family ', ' forest ', ' Variation (Genetics) ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Pathway interactions ', ' pathway ', ' Primary Brain Neoplasms ', ' Primary Brain Tumors ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cessation of life ', ' Death ', ' Validation ', ' Variant ', ' Variation ', ' Infection ', ' novel ', ' Testing ', ' Age ', ' Disease ', ' disease/disorder ', ' Disorder ', ' Site ', ' Environment ', ' European ', ' member ', ' Predisposition ', ' Susceptibility ', ' public health relevance ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' programs ', ' Modeling ', ' Databases ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Sampling ', ' Genotype ', ' Data ', ' Syndrome ', ' tool ', ' Address ', ' Play ', ' Role ', ' social role ', ' Accounting ', ' Inherited ', ' Hereditary ', ' Genes ', ' cohort ', ' base ', ' Recording of previous events ', ' History ', ' Universities ', ' Phase ', ' Ethnicity aspects ', ' Ethnicity ', ' Ethnic Origin ', ' high risk ', ' Genetic ', ' Inflammation ', ' Funding ', ' genetic association ', ' Susceptibility Gene ', ' predisposing gene ', ' Predisposition gene ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Mining ', ' Malignant neoplasm of brain ', ' Malignant Tumor of the Brain ', ' Brain Cancer ', ' Trust ', ' First Degree Relative ', ' Glioblastoma ', ' spongioblastoma multiforme ', ' glioblastoma multiforme ', ' Grade IV Astrocytoma ', ' Grade IV Astrocytic Tumor ', ' Grade IV Astrocytic Neoplasm ', ' Adult Glioma ', ' Malignant Glioma ', ' Malignant Neuroglial Tumor ', ' Malignant Neuroglial Neoplasm ', ' Malignant Glial Tumor ', ' Malignant Glial Neoplasm ', ' Medical History ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' The Cancer Genome Atlas ', ' TCGA ', ' international center ', ' Newly Diagnosed ', ' Classification ', ' Systematics ', ' Bioinformatics ', ' Bio-Informatics ', ' Left ', ' Research Infrastructure ', ' Infrastructure ', ' Staging ', ' Genetic Predisposition to Disease ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Data Set ', ' Dataset ', ' Ionizing radiation ', ' Radiation-Ionizing Total ', ' Ionizing Electromagnetic Radiation ', ' Haplotypes ', ' Histologic ', ' Histologically ', ' density ', ' genome wide association study ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' Recruitment Activity ', ' recruit ', ' DNA Repair ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' tumor ', ' Hypersensitivity ', ' Allergy ', ' Sample Size ', ' Doctor of Medicine ', ' M.D. ', ' Biological ', ' Series ', ' Collection ', ' Specimen ', ' Research Specimen ', ' Histopathology ', ' Gender ', ' genetic epidemiology ', ' Trees ', ' Glioma ', ' neuroglia tumor ', ' neuroglia neoplasm ', ' glial-derived tumor ', ' Neuroglial Tumor ', ' Neuroglial Neoplasm ', ' Glial Tumor ', ' Glial Neoplasm ', ' Glial Cell Tumors ', ' functional genomics ', ' population based ', ' Manuscripts ', ' San Francisco ', ' immune function ', ' Cellular Immune Function ', ' Asthma ', ' Bronchial Asthma ', ' epidemiologic data ', ' International ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' California ', ' Age of Onset ', ' genetic variant ', ' case control ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2011,3962501,TX-09,0.04548659119244625
"Information Explorer: a Suite of Tools for Cross-study Genetic Loci Discovery    DESCRIPTION (provided by applicant): Databases such as dbGaP represent extremely valuable resources of data that have been assembled across multiple cohorts. The increasing development of cost-effective high-throughput genotyping and sequencing technologies are resulting in vast amounts of genetic data. While such databases were formed in order to archive and distribute the results of previously performed genetic association analyses, an increasing number of studies have provided de-identified individual-level genotypic and phenotypic data that are made available to outside researchers who have obtained the appropriate authorization. While the amount of data made available has increased dramatically in recent years, relatively little has been done in order to facilitate phenotype harmonization across studies. Many genetic epidemiologic studies of cardiovascular disease have multiple variables related to any given phenotype, resulting from different definitions and multiple measurements or subsets of data. A researcher searching such databases for the availability of phenotype and genotype combinations is confronted with a veritable mountain of variables to sift through. This often requires visiting multiple websites to gain additional information about variables that are listed on databases, and examination of data distributions to assess similarities across cohorts. While the naming strategy for genetic variants is largely standardized across studies (e.g. ""rs"" numbers for single nucleotide polymorphisms or SNPs), this is often not the case for phenotype variables. For a given study, there are often numerous versions of phenotypic variables. Researchers currently have to analyze and compare increasingly larger numbers of variables that have varying degrees of documentation associated with them to obtain the desired information. This is a time-consuming process that may still miss the most appropriate variables. Moreover, every researcher that wants to compare the same datasets often needs to start from scratch since there are no tools to share the phenotype comparison results. The availability of informatic tools to make phenotype mapping more efficient and improve its accuracy, along with intuitive phenotype query tools, would provide a major resource for researchers utilizing these databases. The tools we are proposing would allow researchers to (1) Quickly obtain the information needed to assess whether a specific study will be useful for the hypothesis of interest; (2) Exclude variables that do not meet research criteria; (3) Ascertain which studies have combinations of phenotype and genetic information of interest; and (4) More easily expand research questions beyond the most basic main-effects to more complex analyses such as gene-by-environment interactions and multivariate tests incorporating multiple phenotypes. The increased utility will also enable larger meta-analyses to be performed, as researchers will be able to more quickly hone in on outcomes, exclusionary variables and covariates of interest, leading to increased statistical power to detect genetic associations.      PUBLIC HEALTH RELEVANCE: While the amount of genomic data (e.g., GWAS, sequencing, etc.) made available has increased dramatically in recent years, relatively little has been done in order to facilitate phenotype harmonization across studies. The tools we are proposing would allow researchers to quickly identify data sets of interest, expand research questions beyond the most basic main-effects to more complex analyses such as gene-by-environment interactions and multivariate test incorporating multiple phenotypes, and perform larger meta-analyses easily by honing in on outcomes, exclusionary variables and covariates of interest with increased statistical power to detect genetic associations.           While the amount of genomic data (e.g., GWAS, sequencing, etc.) made available has increased dramatically in recent years, relatively little has been done in order to facilitate phenotype harmonization across studies. The tools we are proposing would allow researchers to quickly identify data sets of interest, expand research questions beyond the most basic main-effects to more complex analyses such as gene-by-environment interactions and multivariate test incorporating multiple phenotypes, and perform larger meta-analyses easily by honing in on outcomes, exclusionary variables and covariates of interest with increased statistical power to detect genetic associations.         ",Information Explorer: a Suite of Tools for Cross-study Genetic Loci Discovery,8145063,UH2HL108780,"['Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' environment effect on gene ', ' gene environment interaction ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' genetic association ', ' tool ', ' Complex ', ' Foundations ', ' website ', ' web site ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' trait ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Data ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Maps ', ' improved ', ' Research ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Genomics ', ' Link ', ' developmental ', ' Development ', ' Dataset ', ' Data Set ', ' Research Resources ', ' Resources ', ' Testing ', ' Solid ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Performance ', ' Phenotype ', ' Biological ', ' repository ', ' Source ', ' Blood Reticuloendothelial System ', ' Blood ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' Postdoctoral Fellow ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' cohort ', ' Future ', ' Process ', ' Individual ', ' meetings ', ' Measurement ', ' Validation ', ' Information Retrieval ', ' genetic variant ', ' Heart ', ' interest ', ' Technology ', ' experience ', ' Systematics ', ' Classification ', ' conference ', ' symposium ', ' Training ', ' Measures ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' base ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Time ', ' Techniques ', ' Genetic ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' LOINC Axis 4 System ', ' System ', ' Work ', ' Outcome ', ' Sleep ', ' Names ', ' usability ', ' Informatics ', ' graduate student ', ' Visit ', ' Genotype ', ' cost-effective ', ' cost effective ', ' Bio-Informatics ', ' Bioinformatics ', ' scale up ', ' developing computer software ', ' develop software ', ' software development ', ' Documentation ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Archives ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' Systems Integration ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' data structure ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' genetic epidemiology ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' ']",NHLBI,UNIVERSITY OF SOUTHERN CALIFORNIA,UH2,2011,447457,CA-37,0.014170056621020242
"Point Impact and Sparsity in Functional Data Analysis.    DESCRIPTION (provided by applicant): This is a project to develop new methods of functional data analysis directed towards important public health applications in genomics and life course epidemiology. In genome-wide expression and DNA methylation studies, it is of interest to locate genes showing activity that is associated with clinical outcomes, e.g., to use gene expression profiles from the tumors of breast cancer patients to predict estrogen receptor protein concentration, an important prognostic marker for breast tumors. In such studies, the gene expression profile across a chromosome can be regarded a functional predictor, and a gene associated with the clinical outcome is identified by its base pair position along the chromosome. The key aim of the project is to develop new methods of statisti- cal inference for finding such genetic loci, leading to the identification of chromosomal regions that are potentially useful for diagnosis and therapy. Although there is extensive statistical literature on gene expression data, it is almost exclusively concerned with multiple testing procedures for detecting the presence of differentially expressed genes, and statistical methods for locating such genes based on expression profiles (interpreted as functional predictors) are not well developed. Although functional data analysis has reached a mature stage of development over the last ten years, serious problems can arise when the currently available methods are applied in situations involving functional predictors (or trajectories) that have point impact effects (as with gene expression), or in situations in which there is only sparse temporal resolution in the observation of the trajectories. The broad objectives of the project are to exploit fractal behavior in the trajectories to improve statistical learning methodology in functional data analysis. The project will have important implications for understanding a wide variety of complex adaptive systems having fractal behavior. Studies of calorie-intake trajectories and DNA methylation profiles related to cardiovascular risk outcomes, and growth rate trajectories related to neuropsychological outcomes, will be developed as applications of the new methodology. The first specific problem to be addressed is to show that the rates of learning in systems involving trajectories with fractal characteristics are determined by the Hurst parameter (i.e., the exponent of self-similarity scaling) and to show that a type of bootstrap learning can adapt to the full range of fractal behavior. The second specific problem to be addressed is to develop an imputation method for generating missing values of trajectories that have fractal properties (e.g., growth rate curves), and to find a way to carry out functional regression modeling based on the imputed trajectories. 1      PUBLIC HEALTH RELEVANCE: The relevance of the project to public health is that novel statistical methods will be developed for addressing important questions in genomics and life course epidemiology. In particular, rigorous statistical inference for locating genes based on gene expression and DNA methylation profiles, and for studying the effect of growth rate trajectories on adult neuropsychological outcomes, will be developed.            The relevance of the project to public health is that novel statistical methods will be developed for addressing important questions in genomics and life course epidemiology. In particular, rigorous statistical inference for locating genes based on gene expression and DNA methylation profiles, and for studying the effect of growth rate trajectories on adult neuropsychological outcomes, will be developed.          ",Point Impact and Sparsity in Functional Data Analysis.,8023927,R01GM095722,"['Perinatal ', ' Famines ', ' estrophile ', ' estrogen receptor protein ', ' estrophilin ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' Base Pairing ', ' Fractals ', ' Procedures ', ' Learning ', ' Data Analysis ', ' Data Analyses ', ' Clinical ', ' Genetic ', ' Collaborations ', ' Data ', ' genomewide ', ' genome-wide ', ' interest ', ' developmental ', ' Development ', ' adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' Time ', ' Methods ', ' novel ', ' Testing ', ' Measurement ', ' base ', ' Outcome ', ' Public Health ', ' public health medicine (field) ', ' Articulation ', ' Joints ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Dataset ', ' Data Set ', ' Genomics ', ' Genes ', ' Goals ', ' prognostic indicator ', ' prognostic biomarker ', ' Prognosis Marker ', ' Molecular Marker of Prognosis ', ' Prognostic Marker ', ' Collection ', ' Affect ', ' molecular signature ', ' molecuar profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Chromosomes ', ' Resolution ', ' Characteristics ', ' Address ', ' Work ', ' LOINC Axis 2 Property ', ' Property ', ' Accounting ', ' Method LOINC Axis 6 ', ' Methodology ', ' Gene Expression ', ' epidemiology study ', ' Modeling ', ' Diagnosis ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' data modeling ', ' Staging ', ' tumor ', ' Statistical Methods ', ' indexing ', ' LOINC Axis 4 System ', ' System ', ' improved ', ' response ', ' Literature ', ' Complex ', ' Position ', ' Positioning Attribute ', ' Behavior ', ' insight ', ' flexible ', ' flexibility ', ' Cancer Patient ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Public Health Applications ', ' Public Health Applications Research ', ' mammary tumor ', ' Mammary Cancer ', ' Breast Tumors ', ' Breast Neoplasms ', ' Mammary Neoplasms ', ' theories ', ' Linear Regressions ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' PhD ', ' Ph.D. ', ' Doctor of Philosophy ', ' Intake ', ' Students ', ' Disease Outcome ', ' DNA Methylation ', ' cardiovascular risk ', ' cardiovascular risk factor ', ' neuropsychological ', ' Equation ', ' ']",NIGMS,COLUMBIA UNIVERSITY HEALTH SCIENCES,R01,2011,180612,NY-13,-0.0149667351401817
"Informatics Tools for High-Throughput Sequences Data Analysis    DESCRIPTION (provided by applicant): The Genome Analysis Toolkit (GATK) is a suite of best-in-class, widely-used, well-supported, open-source tools for processing and analysis of next-generation DNA sequencing (NGS) data. These tools currently  include a multiple sequence realigner, a covariate-correcting base quality score recalibrator, multi-sample  SNP, INDEL, and CNV genotypers, machine learning algorithms for false positive identification, variant  evaluation modules, somatic SNP and indel callers, and hundreds of other tools. Underlying all of these tools is our structured programming framework (GATK-Engine) that uses the functional programming philosophy of MapReduce to make writing feature-rich, efficient and robust analysis tools easy. By centralizing common data management infrastructure, all GATK-based tools benefit from the engine's correctness, CPU and memory efficiency, as well as automatic distributed and shared memory parallelization, essential capabilities given the massive and growing size of NGS datasets. The GATK currently supports all of the major sequencing technologies including lllumina. Life Sciences 454, and ABI SOLID, from hybrid capture of exomes to 1000s of low-pass samples in the 1000 Genomes Project. Our emphasis on technology-agnostic processing tools has helped to popularize the now standard SAM/BAM and VCFs formats for representing NGS data and variation calls, respectively. In this RFA we propose to  continue to develop the GATK-Engine and data processing tools to (1) achieve complete and accurate  variation discovery and genotyping for all major sequencing study designs and NGS technologies (2)  optimize the GATK-Engine and pipelining infrastructure to operate efficiently on distributed data sets at the  scale of tens of thousands of samples (3) extend the GATK data processing tools to support the upcoming  sequencing technologies of Complete Genomics, lon Torrent, and Pacific Biosciences as well as we do  current technologies, (4) expand significantly our educational and support structures to ensure that the longtail  of future NGS users can benefit from the best-practice data processing and analysis tools in the GATK.      PUBLIC HEALTH RELEVANCE: The proposed project aims to continue to develop the Genome Analysis Toolkit (GATK), a suite of widely used and mission-critical tools for analyzing the next-generation DNA sequencing data. With this grant we will improve these tools, make them more robust, and extend them to new sequencing technologies. This is essential to realize the potential of DNA sequencing to understand human history, diversity, and to discover  new loci associated with human disease, leading to new biologic hypotheses and new drug targets.              The proposed project aims to continue to develop the Genome Analysis Toolkit (GATK), a suite of widely used and mission-critical tools for analyzing the next-generation DNA sequencing data. With this grant we will improve these tools, make them more robust, and extend them to new sequencing technologies. This is essential to realize the potential of DNA sequencing to understand human history, diversity, and to discover  new loci associated with human disease, leading to new biologic hypotheses and new drug targets.            ",Informatics Tools for High-Throughput Sequences Data Analysis,8237596,U01HG006569,"['Life Sciences ', ' Biologic Sciences ', ' Biological Sciences ', ' Algorithms ', ' History ', ' Recording of previous events ', ' Future ', ' Genotype ', ' Medical Genetics ', ' Experimental Designs ', ' Genome ', ' Grant ', ' Flooding ', ' Floods ', ' Data Analysis ', ' Data Analyses ', ' Communities ', ' Memory ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Mission ', ' Hybrids ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' study design ', ' Study Type ', ' Research Design ', ' Technology ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Philosophy ', ' Drug Delivery Systems ', ' Drug Delivery ', ' Dataset ', ' Data Set ', ' base ', ' DNA Sequence ', ' improved ', ' Variation ', ' Variant ', ' Work ', ' Writing ', ' programs ', ' Techniques ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' tool ', ' Site ', ' Evaluation ', ' Ensure ', ' Modeling ', ' Sampling ', ' signal processing ', ' data processing ', ' computerized data processing ', ' cancer genetics ', ' Genomics ', ' novel ', ' Informatics ', ' Structure ', ' data management ', ' distributed data ', ' Process ', ' Documentation ', ' Data ', ' Infrastructure ', ' Research Infrastructure ', ' exomes ', ' exome ', ' open source ', ' SNP genotyping ', ' next generation ', ' human disease ', ' shared memory ', ' distributed memory ', ' ']",NHGRI,"BROAD INSTITUTE, INC.",U01,2012,1010000,MA-07,0.004174537981333463
"Genome-Wide Association Analysis of Bladder Cancer    DESCRIPTION (provided by applicant):       This proposal builds on a rich resource of bladder cancer (BC) cases and controls derived from two ongoing BC studies at the University of Texas M.D. Anderson Cancer Center, and from two large independent U.S. BC studies - the New England BC Study and the New Hampshire BC Study. The goal is to identify genetic loci that predispose individuals to BC through a genome-wide scanning approach. There are five specific aims. Aim 1 is to first perform genome-wide, high-density SNP genotyping using the Illumina HumanHap550 SNP platform on 800 cases and 800 controls from M.D. Anderson, with a target of candidate SNPs of about 28,000; followed by an internal validation to narrow down candidate SNPs to about 1,536 using additional 800 pairs of cases and controls. Illumina's Custom Infinium array will be the genotyping format. In this aim, in addition to individual SNP analysis, we will also implement haplotype-based analyses and pathway aggregation analysis to identify additional genetic loci that might have been overlooked using individual SNP analysis. Aim 2 is the first external validation of the 1,536 SNPs from Aim 1 using 1,000 pairs of cases and controls from the New England BC Study. Illumina's GoldenGate assay will be the genotyping format. After this stage, the candidate SNPs will be narrowed down to about 100. Aim 3 is the second independent external validation using 750 pairs of cases and controls form the New Hampshire BC Study. In this aim, the 100 top candidate SNPs passed from Aims 1 and 2 plus additional functional SNPs in genes containing these SNPs will be genotyped. GoldenGate assay will be used for this aim. Aim 4 is to perform fine mapping studies in the flanking regions of each of the top 25 SNP loci confirmed in Aim 3 to identify causative loci. This will utilize all 6,700 cases and controls. An average of 15 additional SNPs (tagging SNPs and functional SNPs) per gene is expected. Aim 5 is to apply novel machine-learning tools to identify any gene-environment and gene-gene interactions greatly influencing risk for BC in all the 6700 subjects. These analyses will be utilized to examine SNP main effect and develop and validate algorithms that will identify individuals at highest risk for BC, given their personal exposure patterns and their genetic risk profiles. This proposal applies state of art technology to perform a multistage, genome-wide SNP analysis in three largest, well-characterized U.S. population of BC cases and controls, and incorporates complete epidemiologic data and rich and unique functional data. In addition, results from this study will be provided to the International Consortium of BC Case Control Studies for future validation. The ability to identify genetically susceptible, high-risk subgroups that would benefit from intensive screening and/or chemopreventive interventions is of immense clinical and public health benefit. PUBLIC HEALTH RELEVANCE Bladder cancer (BC) is a disease mainly caused by smoking and occupational exposure. However, only a small percentage of exposed individuals develop BC. Inherited host genetic factors may play an important role in determining an individual's susceptibility to BC. This proposal builds on three largest well-characterized U.S. populations of BC cases and controls - the M. D. Anderson BC study, the New England BC Study and the New Hampshire BC Study. A total of 6700 cases and controls will be used. The goal is to identify genetic loci that predispose individuals to BC through a non-biased, discovery- driven, genome-wide scanning approach and to incorporate complete epidemiologic data and rich and unique functional data. About 550,000 genetic variations of human genome will be initially screened in an M.D. Anderson population consisting of an equal number of BC cases and normal controls. About 28,000 top candidate variations that are potentially associated with increased BC risk will be first narrowed down and internally replicated in a second M.D. Anderson population, and then be validated in the other two independent U.S. BC populations. Finally, the causative genetic loci that predispose individuals to BC will be mapped. This study is significant because by identifying BC susceptibility loci, it will shed light into the biological mechanisms of BC etiology. Furthermore, it may facilitate identifying high-risk subgroups of individuals for BC, given their genetic makeup and environmental exposures. The ability to identify high-risk subgroups of individuals for BC will provide immense public health benefit for those high- risk people who may be subjected to close surveillance and chemoprevention.          ",Genome-Wide Association Analysis of Bladder Cancer,8242887,U01CA127615,"['Age ', ' Algorithms ', ' Engineering / Architecture ', ' Architecture ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' urinary bladder ', ' Bladder Urinary System ', ' Bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' Malignant neoplasm of urinary bladder ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Cytogenetics ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Environment ', ' Environmental Exposure ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Future ', ' Genes ', ' human whole genome ', ' Human Genome ', ' Genotype ', ' Goals ', ' Haplotypes ', ' Health ', ' Articulation ', ' Joints ', ' Photoradiation ', ' Light ', ' lymph cell ', ' Lymphocytic ', ' Lymphocyte ', ' Maps ', ' Medicine ', ' genotoxic agent ', ' Genotoxins ', ' Mutagens ', ' Northeastern United States ', ' New England ', ' New Hampshire ', ' Occupational Exposure ', ' Phenotype ', ' Physicians ', ' plasmocyte ', ' Plasmacytes ', ' Blood Plasma Cell ', ' Plasma Cells ', ' Play ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Public Health ', ' public health medicine (field) ', ' recruit ', ' Recruitment Activity ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Smoking ', ' Specialty ', ' medical specialties ', ' Suspensions ', ' Technology ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Gender ', ' telomere ', ' Health Benefit ', ' Case Series ', ' Custom ', ' base ', ' density ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Susceptibility ', ' Predisposition ', ' screenings ', ' screening ', ' Screening procedure ', ' Blood Serum ', ' Serum ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Review Literature ', ' Chemoprevention ', ' Genetic ', ' Staging ', ' tool ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Adopted ', ' Frequency ', ' Frequencies (time pattern) ', ' Hereditary ', ' Inherited ', ' Complex ', ' Clinic ', ' Pattern ', ' Location ', ' Penetrance ', ' One Step ', ' One-Step dentin bonding system ', ' collegiate ', ' college ', ' cancer risk ', ' Cancer Induction ', ' carcinogenesis ', ' gene interaction ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Polymorphism Detection ', ' Polymorphism Analysis ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' case control ', ' repository ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' Cell Cycle Control ', ' Cell Cycle Regulation ', ' p50 ', ' Tumor Necrosis Factor Receptor Superfamily Member 5 Gene ', ' TNFRSF5 ', ' MGC9013 ', ' CDW40 ', ' CD40 ', ' Bp50 ', ' TNFRSF5 gene ', ' suspension ', ' Suspension substance ', ' Length ', ' Data ', ' dietary pattern ', ' Dietary Practices ', ' M.D. ', ' Doctor of Medicine ', ' International ', ' Subgroup ', ' Cancer Center ', ' Cancer Cause ', ' Cancer Etiology ', ' anticarcinogenic ', ' Chemopreventive ', ' Chemopreventive Agent ', ' Genetic Risk ', ' Newly Diagnosed ', ' University of Texas MD Anderson Cancer Center ', ' MDACC ', ' University of Texas M D Anderson Cancer Center ', ' Validation ', ' Molecular ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' cost ', ' Bayesian Networks ', ' computer based statistical methods ', ' designing ', ' design ', ' Outcome ', ' Population ', ' Individual Differences ', ' computer algorithm ', ' Computational algorithm ', ' aggregation pathway ', ' parent grant ', ' high risk ', ' genomewide ', ' genome-wide ', ' epidemiologic data ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,U01,2012,769079,TX-09,0.07403500387646271
"Genome Wide Association Study of Head and Neck Cancer    DESCRIPTION (provided by applicant): Head and neck cancers have well-documented associations with tobacco and alcohol exposure, but the disease develops in only a small fraction of users, which implies an important role for genetic susceptibility. Therefore, head and neck cancers are an excellent model for studying genetic susceptibility to environmental carcinogens. The primary goal of this R01 application is to perform a comprehensive two-stage, high-density, genome-wide single-nucleotide polymorphism (SNP) analysis of head and neck cancer cases and corresponding frequency matched controls to identify novel genetic risk factors for head and neck cancer. This proposal builds upon a well-annotated existing DNA repository of cases and controls. One of the unique features of our study is the availability of DNA repair assay data on most of the cases and controls in this study, which will allow us to conduct genotype/phenotype analyses. We also have access to genome-wide association data from 1200 white control subjects from the same source population. In aim 1, we will perform genotyping on 1000 randomly selected head and neck cancer cases and 500 controls using a 370K Illumina Infinium HapMap HumanCNV370-Duo SNP Chip. We will perform association analyses (1000 cases and 1700 controls) in the first stage using outcome variable as case-control status as well as DNA repair capacity assay data. Our second aim is to perform second-stage analysis of the SNPs selected in stage 1 using 900 additional cases and corresponding controls from the same source and from UCLA. We will use efficient joint analysis of cases and controls from the first and second aims, for a total of 1900 cases and 2600 controls. Finally, in aim 3, we will apply novel statistical tools such as the latent variable approach with Tukey's one-degree-of-freedom test and support vector machines to identify gene-gene and gene-environment (using environmental factors such as smoking and alcohol use) interactions that contribute to the risk of head and neck cancer. We are an experienced investigative team proposing a comprehensive analysis that incorporates epidemiological, behavioral, and functional data. Identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of head and neck cancers. PUBLIC HEALTH RELEVANCE: The identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of the disease and help identify individuals at highest risk for the development of head and neck cancer on the basis of their personal exposure patterns and their genetic risk profiles.              The identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of the disease and help identify individuals at highest risk for the development of head and neck cancer on the basis of their personal exposure patterns and their genetic risk profiles.",Genome Wide Association Study of Head and Neck Cancer,8213566,R01CA131324,"['Age ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Alcohol Chemical Class ', ' Alcohols ', ' 3,4-Benzpyrene ', ' 3,4-Benzopyrene ', ' Benzo(a)pyrene ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Environmental Carcinogens ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasoid Race ', ' Cells ', ' Cytogenetic Abnormalities ', ' Cytogenetic Aberrations ', ' Chromosome Anomalies ', ' Chromosome Alterations ', ' Chromosome Aberrations ', ' Chromosomal Alterations ', ' Chromosomal Abnormalities ', ' Chromosomal Aberrations ', ' Aberrant Chromosome ', ' Chromosome abnormality ', ' Systematics ', ' Classification ', ' Clinic Visits ', ' Control Groups ', ' Death ', ' Cessation of life ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Liberty ', ' Freedom ', ' allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' Genes ', ' Genotype ', ' Goals ', ' Haplotypes ', ' Health ', ' Spanish Americans ', ' Hispanic Americans ', ' In Vitro ', ' Articulation ', ' Joints ', ' voice box ', ' Larynx Head and Neck ', ' Laryngeal ', ' Larynx ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lymph cell ', ' Lymphocytic ', ' Lymphocyte ', ' Study models ', ' genotoxic agent ', ' Genotoxins ', ' Mutagens ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Parents ', ' Patients ', ' Throat ', ' Pharynxs ', ' Pharynx Head and Neck ', ' Pharynx ', ' Pharyngeal structure ', ' Phenotype ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Population Control ', ' Questionnaires ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residencies ', ' Risk ', ' social role ', ' Role ', ' Smoking ', ' Testing ', ' Tobacco ', ' Trees ', ' United States ', ' Caucasians ', ' County ', ' Gender ', ' Measures ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' case report ', ' Case Study ', ' Custom ', ' base ', ' density ', ' Area ', ' Phase ', ' Biological ', ' Histologically ', ' Histologic ', ' Reporter Genes ', ' Squamous Cell ', ' Mouth ', ' Cavitas Oris ', ' Buccal Cavity Head and Neck ', ' Buccal Cavity ', ' Oral cavity ', ' Individual ', ' Trust ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Carcinogen-DNA Adducts ', ' DNA Adducts ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' malignant head and neck tumor ', ' Malignant Head and Neck Neoplasm ', ' Head and Neck Cancer ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' Staging ', ' tool ', ' Smoker ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Frequency ', ' Frequencies (time pattern) ', ' Hereditary ', ' Inherited ', ' Scanning ', ' Source ', ' Pattern ', ' Head and Neck ', ' Head and neck structure ', ' adduct ', ' cancer risk ', ' early detection ', ' Early Diagnosis ', ' experience ', ' environment effect on gene ', ' gene environment interaction ', ' metropolitan ', ' Structure ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Squamous Cell Cancers ', ' Malignant Squamous Cell Tumor ', ' Malignant Epidermoid Cell Tumor ', ' Malignant Epidermoid Cell Neoplasm ', ' Epidermoid Cell Cancer ', ' Malignant Squamous Cell Neoplasm ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Polymorphism Detection ', ' Polymorphism Analysis ', ' inherited factor ', ' genetic risk factor ', ' Sampling ', ' case control ', ' repository ', ' Genomics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' HCR ', ' Chemokine (C-C Motif) Receptor-Like 2 Gene ', ' CRAM-B ', ' CRAM-A ', ' CKRX ', ' CCRL2 ', ' CCRL2 gene ', ' Data ', ' Cancer Center ', ' Cancer Cause ', ' Cancer Etiology ', ' Cancer Patient ', ' enroll ', ' Enrollment ', ' Genetic Risk ', ' sex ', ' developmental ', ' Development ', ' Behavioral ', ' tobacco exposure ', ' disease phenotype ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' cancer genome ', ' Outcome ', ' Population ', ' exposure to alcohol ', ' exposed to alcohol ', ' ethanol exposure ', ' ethanol exposed ', ' alcohol exposed ', ' alcohol exposure ', ' plasmid DNA ', ' high risk ', ' population based ', ' genomewide ', ' genome-wide ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2012,574164,TX-09,-0.00161826834739382
"DEVELOPING STRATEGIES FOR JOINT GENE-ENVIRONMENT ANALYSIS    DESCRIPTION (provided by applicant): A key challenge for genetic analysis today is to account for the bulk of the phenotypic variance in complex traits that is attributable to genetic factors, but remains unexplained after multiple well-powered GWAS (Goldstein 2009; Hirschhorn 2009; Kraft and Hunter 2009). Many believe that systematically testing datasets for joint gene-environment effects (GxE) and gene-gene (GxG) effects will be essential in order to understand the genetics of complex phenotypes. However, the new era of high throughput, high-density genomic data (genotypes and sequencing) has given rise to serious computational and statistical challenges for the analysis of joint effects. The goal of this project is to develop effective strategies for the statistical analysis of joint-gene environment effects. The specific aims are to (1) identify strengths and weaknesses of multiple analytic approaches to joint GxE effects, and (2) develop new methods for coordinated meta-analysis. To accomplish Aim 1, we will systematically examine and compare traditional (e.g. regression based) and modern (e.g. partitioning, machine learning, information theoretic) analysis methods for case-control and quantitative phenotypes. The primary product will be specific guidance as to the conditions under which each method performs well. To accomplish Aim 2, we will extend recent joint-effects methods to a meta-analytic framework and develop improvements to currently used methods. For both aims, we will also analyze real data related to smoking, thereby improving our understanding of genetic and environmental contributors to smoking and addiction risk. These analyses of real data will be guided by bioinformatics-based variant prioritization. This study therefore will provide both guidance and tools needed to move the field of joint effects analysis forward. As a result, it will ultimately have a significant impact on our ability to account for the currently unexplained genetic contribution to phenotypic variance for complex traits.        Many diseases that greatly impact public health (such as heart disease, diabetes, and nicotine addiction) are the result of a complex interplay between genes and environmental factors. The purpose of this grant is to improve data analysis strategies (applicable to a wide variety of diseases) for the detection of joint effects of genes and environment. We will apply these methods to analyze existing data on smokers to improve our understanding of gene-environment effects on nicotine addiction.            ",DEVELOPING STRATEGIES FOR JOINT GENE-ENVIRONMENT ANALYSIS,8330779,R21DA033827,"['Accounting ', ' Age ', ' Parturition ', ' Birth ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Environment ', ' Family ', ' allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' Genes ', ' Genotype ', ' Goals ', ' Grant ', ' Hand ', ' Heart ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' Articulation ', ' Joints ', ' Photoradiation ', ' Light ', ' Methods ', ' nicotine addiction ', ' Nicotine Dependence ', ' Phenotype ', ' Public Health ', ' public health medicine (field) ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Recommendation ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Sensitivity and Specificity ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoke ', ' Smoking ', ' Testing ', ' Dataset ', ' Data Set ', ' Guidelines ', ' base ', ' density ', ' improved ', ' Variation ', ' Variant ', ' Evaluation ', ' Workshop ', ' Educational workshop ', ' Sample Size ', ' Biological Function ', ' Biological Process ', ' Simulate ', ' Genetic ', ' Staging ', ' tool ', ' Smoker ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Education Level ', ' Educational Background ', ' Complex ', ' environment effect on gene ', ' gene environment interaction ', ' Performance ', ' trait ', ' Cigarette ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Reporting ', ' Genetic analyses ', ' genetic analysis ', ' Statistical Methods ', ' case control ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' Address ', ' Data ', ' Detection ', ' sex ', ' pathway ', ' Pathway interactions ', ' Output ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' addictive disorder ', ' addiction ', ' tool development ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' ']",NIDA,WASHINGTON UNIVERSITY,R21,2012,190000,MO-01,0.00901255662904875
"From GWAS to PheWAS: Scanning the EMR phenome for gene-disease associations    DESCRIPTION (provided by applicant): Genomic medicine offers hope for improved diagnostic methods and for more effective, patient-specific therapies. Genome-wide associated studies (GWAS) elucidate genetic markers that improve understanding of risks and causes for many diseases, and may guide diagnosis and therapy on a patient-specific basis. This project will take another approach to identify gene-disease associations: perform ""reverse GWAS,"" or phenome- wide association study (PheWAS), to determine which phenotypes are associated with a given genotype. The project is enabled by a large DNA biobank coupled to a de- identified copy of the electronic medical record. This project has four specific aims. First, the project will develop and validate a standardized approach to extract disease phenotypes from EMR records, integrating national standard terminologies of clinical disorders and descriptors relating to treatment and diagnosis of each disease to create a sharable knowledge base. The project will use natural language processing, structured data queries, and heuristic and machine learning methods to accurately identify patients with each disease and corresponding controls. The second aim is to perform PheWAS analyses using existing genotype data. To validate the method, the project will use PheWAS to ""rediscover"" SNPs with known disease associations. The project will also investigate statistical methods for large-scale multiple hypothesis testing to discover novel phenotype associations. The third aim is to apply the PheWAS algorithms in four other sites with EMR-linked DNA biobanks and compare results. In the fourth aim, the project will validate novel phenotype-genotype associations discovered through PheWAS with new genotyping in a previously untested population. The tools generated from this project will not only make PheWAS possible, but will also broadly enable clinical research and subsequent genetic studies.           The promise of genomic medicine is to predict individuals' disease risk and treatment given their genetic information. This project will develop methods to identify diseases from electronic medical records and then find novel genetic associations from existing genomic data.",From GWAS to PheWAS: Scanning the EMR phenome for gene-disease associations,8326646,R01LM010685,"['University Medical Centers ', ' Academic Medical Centers ', ' Algorithms ', ' Appointment ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Intelligent systems ', ' Expert Systems ', ' Future ', ' Genes ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Hand ', ' Articulation ', ' Joints ', ' Laboratories ', ' Manuals ', ' Medicine ', ' Methods ', ' Names ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' natural language understanding ', ' Natural Language Processing ', ' Terminology ', ' Patients ', ' Phenotype ', ' Physicians ', ' Records ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Syndrome ', ' Testing ', ' Time ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' analytical method ', ' base ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Site ', ' Clinical ', ' Link ', ' Individual ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Genetic Research ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Descriptor ', ' Letters ', ' Genetic ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Investigation ', ' Diagnostic Technique ', ' Diagnostic Method ', ' Diagnostic Procedure ', ' Scanning ', ' Clinic ', ' Techniques ', ' experience ', ' heuristics ', ' cohort ', ' knowledgebase ', ' knowledge base ', ' Structure ', ' novel ', ' disease risk ', ' disorder risk ', ' Position ', ' Positioning Attribute ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Coding System ', ' Code ', ' Statistical Methods ', ' Sampling ', ' case control ', ' Genomics ', ' Institution ', ' genetic association ', ' Data ', ' Data Element ', ' Disease Association ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' enroll ', ' Enrollment ', ' Update ', ' Validation ', ' Characteristics ', ' Text ', ' disease phenotype ', ' biomed informatics ', ' biomedical informatics ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Clinical and Translational Science Awards ', ' patient population ', ' treatment response ', ' genomewide ', ' genome-wide ', ' phenome ', ' phenomics ', ' biorepository ', ' biobank ', ' Secure ', ' ']",NLM,VANDERBILT UNIVERSITY,R01,2012,332514,TN-05,0.050113578073966256
"A MACHINE LEARNING APPROACH FOR FINE-SCALE GENOME WIDE DNA METHYLATION ANALYSIS    DESCRIPTION (provided by applicant): Epigenetic regulation of gene expression through variation in DNA methylation plays a critical role in a range of biological processes including cellular differentiation, human disease and cancer. New methods for determining the fine structure of methylation patterns genome-wide have led to an explosion of research in this field. Methylation near the gene promoter is correlated with gene silencing, while unmethylated promoters are potentially active. Current computational methods classify genes as either methylated and silenced or unmethylated and potentially active based on a coarse calculation of CpG methylation state across a window of a few hundred base pairs around the transcription start site. The detailed spatial pattern of methylation across the promoter may be an important determinant of gene expression, but current computational methods ignore this valuable information. Recent work has found regions proximal to CpG island promoters, dubbed ""CpG island shores"", whose methylation state correlates with transcription. CpG island shores are loosely defined, however, and this concept is difficult to apply in practice. While other methylation signatures are also likely to correlate with gene expression, a general framework to identify and study them has not been established. New computational tools for identification and correlation of detailed methylation patterns with gene expression are critical for advancing our understanding of the epigenetics of gene regulation. We propose to develop software tools to detect new methylation signatures at gene promoters that correlate with expression. This will be done within a formal framework so that these signatures can be used to determine differentially methylated genes in a variety of study designs. Taking advantage of the fact  that methylation over short ranges are highly correlated, we will interpolate methylation data at individual  CpG sites in a 10 kb window around the TSS to yield a methylation signature at each promoter that is  independent of primary sequence features. We will then use a metric from topology, the discrete Frechet distance, to calculate the similarity between methylation signatures, and apply this metric to cluster signatures of similar type. We will then determine clusters with methylation signatures that correlate with expression.  Clusters that contain both silenced and expressed genes will be examined to see if other local primary sequence features can be used to discriminate the genes based on expression. This approach will be used to detect methylation changes in case-control studies and in pairwise comparisons, such as needed for timecourse analysis or for the detection of different states of differentiation. The general framework developed here can be expanded in the future to examine methylation signatures at enhancers and gene bodies, as well as to histone marks or other genomic signals that carry detailed spatial information.          Narrative  DNA methylation, the addition of a methyl group to the cytosine in CpG dinucleotides, is an important  epigenetic regulator of gene expression in cells. DNA methylation has been implicated in a large number of  biological processes including cellular differentiation and cancer. We will develop software tools to analyze  data from new techniques for mapping DNA methylation genome-wide to discover new methylation signatures  that are associated with silenced and active genes. These will include tools to use these signatures to  determine what genes are differentially regulated in different cell types and in human disease.",A MACHINE LEARNING APPROACH FOR FINE-SCALE GENOME WIDE DNA METHYLATION ANALYSIS,8229567,R21LM011199,"['Algorithms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Cells ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Data Analysis ', ' Data Analyses ', ' Explosion ', ' Future ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Histones ', ' In Vitro ', ' Learning ', ' Maps ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Play ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Time ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' Enhancers ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' Dataset ', ' Data Set ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Individual ', ' Biological Function ', ' Biological Process ', ' CpG-Rich Islands ', ' CpG Islands ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cell type ', ' Pattern ', ' Techniques ', ' methyl group ', ' Gene Inactivation ', ' Gene Silencing ', ' Base Pairing ', ' Structure ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Metric ', ' Reporting ', ' Sampling ', ' spatial neglect ', ' developing computer software ', ' develop software ', ' software development ', ' Genomics ', ' Transcription Start Site ', ' Transcription Initiation Site ', ' Data ', ' Detection ', ' Resolution ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Process ', ' computational tools ', ' computerized tools ', ' human disease ', ' genomewide ', ' genome-wide ', ' ']",NLM,WASHINGTON UNIVERSITY,R21,2012,152000,MO-01,0.03449488831525746
"Accelerating Curation of GWAS Catalog by Automatic Text Mining     DESCRIPTION (provided by applicant): A genome-wide association study (GWAS) is an approach to detecting genetic variations associated with particular diseases or traits by scanning markers across the genomes of a large-scale sample of subjects in a high-throughput manner. In less than a decade, GWAS studies have been successfully producing discovery and replication of many new disease loci. Discovered genetic associations have led to development of better strategies to diagnose, treat and prevent diseases. The number of GWAS is growing rapidly. There is a need for a database that allows researchers to easily query and search for previous results. A well-curated database also provides a resource for overview and summarization investigations of associated genetic sites and may help suggest pleiotropic genes. Such a database has been created and maintained by the National Human Genome Research Institute (NHGRI), called ""A Catalog of Published Genome-Wide Association Studies"" (Catalog of GWAS). The catalog has led to interesting characterization of previous results in GWAS and NHGRI has continued to update and curate the catalog regularly. However, this is performed by manually extracting information from published GWAS articles. As a result, the coverage is low compared to the volume of all GWAS publications and would be impossible to catch up the pace of new publications. The goal of this project is to develop a new tool to automatically extract the information from research articles for the curation of the catalog of GWAS. Our proposal is to use the curated data currently available from NHGRI as the training examples and apply novel machine-learning algorithms to train an information extractor to allow accurate automatic extraction. Given our recent success in applying machine learning to biological text mining, we are confident that this will lead to a useful tool to improve the productivity of curators and solve the coverage problem. Our first specific aim is to develop an accurate information extractor. Our second specific aim is to develop an easy-to-use curation tool for curators to efficiently check and correct errors from automatic information extraction so that their curation productivity can be improved by 18 folds. Then we will adapt the tool to extraction and curation of research papers reporting association studies using data from next generation sequencing. Currently, study design and the reporting of GWAS results using NGS data are not standardized. These results have not been considered to be included in the catalog yet. However, we expect that the limitations will be overcome and the methodology will converge soon. We will closely monitor the progress and adapt the tool to allow for inclusion of the NGS data. Finally, we will distribute the software to the public domain so that volunteers or interested parties can create their own catalog locally. It is our goal to share the developed software with the research community to advance the field. The new algorithms developed in this project and the entire development cycle, from design to deployment, will also contribute to the state-of-the- arts of biological text mining.        PUBLIC HEALTH RELEVANCE: The goal of this project is to develop a new tool to automatically extract the information from research articles for the curation of the catalog of GWAS. The catalog contains information about SNP-trait/disease associations that are extracted from published genome-wide association studies. A well-curated catalog of GWAS allows researchers to easily query and search for previous results and provides a useful resource for overview and summarization investigations of associated genetic sites and may help suggest pleiotropic genes.              The goal of this project is to develop a new tool to automatically extract the information from research articles for the curation of the catalog of GWAS. The catalog contains information about SNP-trait/disease associations that are extracted from published genome-wide association studies. A well-curated catalog of GWAS allows researchers to easily query and search for previous results and provides a useful resource for overview and summarization investigations of associated genetic sites and may help suggest pleiotropic genes.            ",Accelerating Curation of GWAS Catalog by Automatic Text Mining,8348769,U01HG006894,"['Cataloging ', ' Algorithms ', ' Goals ', ' Future ', ' Genome ', ' Genes ', ' Communities ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Method LOINC Axis 6 ', ' Methodology ', ' Paper ', ' Manuals ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Human Genetics ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Technology ', ' Publishing ', ' computer program/software ', ' Software ', ' Computer software ', ' Research ', ' Scientific Publication ', ' Publications ', ' Standardization ', ' Survey Instrument ', ' Surveys ', ' study design ', ' Study Type ', ' Research Design ', ' Productivity ', ' Research Resources ', ' Resources ', ' Biological ', ' Public Domains ', ' Workload ', ' Work Load ', ' base ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Scanning ', ' Catalogs ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' interest ', ' Investigation ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' Area ', ' Site ', ' Link ', ' improved ', ' Ensure ', ' Training ', ' Reporting ', ' developing computer software ', ' develop software ', ' software development ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Sampling ', ' success ', ' novel ', ' trait ', ' Text ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' developmental ', ' Development ', ' Update ', ' National Center for Human Genome Research ', ' NHGRI ', ' National Human Genome Research Institute ', ' Monitor ', ' preventing ', ' prevent ', ' Data ', ' Disease Association ', ' genetic association ', ' user-friendly ', ' designing ', ' design ', ' volunteer ', ' next generation ', ' ']",NHGRI,UNIVERSITY OF SOUTHERN CALIFORNIA,U01,2012,247879,CA-37,0.0733402857931471
"Empowering Personalized Medicine: Integrating Imaging, Genetics, and Biomarkers     DESCRIPTION (provided by applicant): This project, Empowering Personalized Medicine: Integrating Imaging, Genetics and Biomarkers, responds to RFA-MH-12-020, entitled Integrating Multi-Dimensional Data to Explore Mechanisms Underlying Mental Disorders. By bringing together experts in neuroimaging, genetics, and mathematics, we plan to create an advanced, portable framework to combine diverse biomedical data from 3D neuroimaging (MRI, amyloid/FDG-PET), gene expression networks, genome-wide association studies (GWAS), and other multidimensional data (e.g., physiological biomarkers, epigenetic data, etc.). Our overall goal is to improve diagnosis and prognosis of disease by combining multiple levels of biological information (personalized medicine). In doing so, novel mathematical tools will automatically discover which biomarkers are most helpful in different contexts. To discover and test relationships between very high-dimensional measures (such as images and genomes), we use novel concepts for data reduction such as penalized regression (elastic nets), adaptive hierarchical clustering, Bayesian networks, and support vector machines. Avoiding the limitations of current work that tests individual gene effects independently, we extend the analysis of gene expression networks to images, to relate signs of disease to their genetic underpinnings and to all available biomarkers. Aim 1 empowers discovery genetic variants (identified in GWAS, whole-exome and whole-genome sequencing) that modulate measures of disease. We will use compressive coding models to discover and verify which sets of genetic variants affect multidimensional images (e.g., co-registered MRI & PET, DTI). We will verify our predictions using k-fold cross-validation and independent replications in new samples and controllable test data. Aim 2 extends our work using weighted gene co-expression network analysis (WGCNA) from single traits to entire databases of 3D images (MRI/PET). Our framework will merge GWAS, eQTL analysis, and expression-phenotype analysis but will be broadly applicable to any future high-throughput biological information (e.g. methylation profiles, DTI, fMRI). In Aim 3, we will quantify the added predictive value derivable from genotyping, gene expression profiling, and multimodal neuroimaging for personalized prognosis and diagnosis. For example, which biomarkers (gene expression, CSF, MRI) are most useful in which cases? To maximize impact of this effort, we and our collaborators will test our tools on existing and new datasets from a range of neuropsychiatric disorders including frontotemporal dementia, Alzheimer's disease, schizophrenia, bipolar disorder, and autism (see Support Letters). All tools will be disseminated and linked to web-accessible databases that store and ease access to high-throughput genetic, genomic, and imaging datasets.        PUBLIC HEALTH RELEVANCE: Our project improves diagnosis and predictions of patient outcomes by integrating diverse types of patient data including neuroimaging, gene expression profiles, cognitive, and behavioral markers of disease diagnosis, progression, and treatment response. To tackle these complex data types, we develop novel machine learning, network analysis, and database methods. Our personalized medicine approach will help researchers study and evaluate neurological and psychiatric conditions such as Alzheimer's disease, frontotemporal dementia, schizophrenia, bipolar disorder, and autism.                  Our project improves diagnosis and predictions of patient outcomes by integrating diverse types of patient data including neuroimaging, gene expression profiles, cognitive, and behavioral markers of disease diagnosis, progression, and treatment response. To tackle these complex data types, we develop novel machine learning, network analysis, and database methods. Our personalized medicine approach will help researchers study and evaluate neurological and psychiatric conditions such as Alzheimer's disease, frontotemporal dementia, schizophrenia, bipolar disorder, and autism.                ","Empowering Personalized Medicine: Integrating Imaging, Genetics, and Biomarkers",8304694,R01MH097268,"['Encephalon ', ' Brain Nervous System ', ' Brain ', ' manic depressive illness ', ' manic depressive disorder ', ' bipolar affective disorder ', ' Manic-Depressive Psychosis ', ' Bipolar Affective Psychosis ', ' Bipolar Disorder ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Amyloid Substance ', ' Amyloid ', ' Affect ', ' Future ', ' Genome ', ' Genotype ', ' Genes ', ' Goals ', ' Gene Expression ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' depression ', ' Mental Depression ', ' Clinical Study ', ' Clinical Research ', ' Medicine ', ' Neurosciences ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Protein Methylation ', ' Methylation ', ' Methods ', ' Mathematics ', ' Prognosis ', ' outcome forecast ', ' Running ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Publishing ', ' Research Resources ', ' Resources ', ' neuronal degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' Patients ', ' Phenotype ', ' Rad.-PET ', ' Positron Emission Tomography Scan ', ' Positron Emission Tomography Medical Imaging ', ' PETT ', ' PETSCAN ', ' PET imaging ', ' PET Scan ', ' PET ', ' Positron-Emission Tomography ', ' Persons ', ' Biological ', ' Measures ', ' Variation ', ' Variant ', ' brain visualization ', ' Brain imaging ', ' Clinical ', ' Weight ', ' improved ', ' base ', ' Dataset ', ' Data Set ', ' Work ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Testing ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' Diagnostic ', ' tool ', ' Equation ', ' Complex ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Letters ', ' frontotemporal lobar dementia ', ' fronto-temporal lobar dementia ', ' fronto-temporal dementia ', ' Frontotemporal Dementia ', ' empowered ', ' prognostic ', ' Neurological ', ' Neurologic ', ' insight ', ' Physiologic ', ' Physiological ', ' Funding ', ' Individual ', ' Site ', ' Genetic ', ' Link ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Modeling ', ' fluorodeoxyglucose PET ', ' FDG PET ', ' fluorodeoxyglucose positron emission tomography ', ' Sampling ', ' gene expression analysis ', ' Transcript Expression Analysis ', ' Transcript Expression Analyses ', ' Gene Expression Pattern Analysis ', ' Gene Expression Monitoring ', ' Gene Expression Profiling ', ' Modality ', ' disease risk ', ' disorder risk ', ' neuropsychiatric ', ' neuropsychiatry ', ' 3D images ', ' 3D image ', ' 3-D image ', ' 3-D Images ', ' Three-Dimensional Image ', ' Genomics ', ' Coding System ', ' Code ', ' Network Analysis ', ' Pathway Analysis ', ' experience ', ' novel ', ' Structure ', ' genetic testing ', ' Genetic screening method ', ' trait ', ' success ', ' neuroimaging ', ' Informatics ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Bayesian Networks ', ' computer based statistical methods ', ' Behavioral ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' pathway ', ' Pathway interactions ', ' imaging ', ' Image ', ' Cognitive ', ' Validation ', ' genome sequencing ', ' Predictive Value ', ' molecular signature ', ' molecuar profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' Data ', ' Address ', ' NCRR ', ' National Center for Research Resources ', ' neurodegenerative dementia ', ' exomes ', ' exome ', ' treatment response ', ' data reduction ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' Outcome ', ' computer algorithm ', ' Computational algorithm ', ' web-accessible ', ' endophenotype ', ' mathematical algorithm ', ' disease diagnosis ', ' ']",NIMH,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2012,486695,CA-33,-0.007532034232288151
"Whole-Genome Prediction of Type-2 Diabetes Susceptibility in Various Populations     DESCRIPTION (provided by applicant): The applicant's career goal is to become a productive independent investigator in the area of statistical genetics, particularly in the area of genomic-based prediction of type-2 diabetes (T2D) risk. To meet this goal, the applicant proposes a career development plan that includes hands- on and didactic training in statistical learning as applied to quantitative genetics, categorical and case-control data analysis, informatics as applied to high dimensional genetic data, and the biology and genetics of T2D. A highly accomplished and diverse set of investigators with proven track records of successful mentoring will oversee the applicant's career development. The research component of this project seeks to improve our ability to use genetic information to predict an individual's risk of developing T2D Publically available genetic and phenotypic data from sources such as dbGaP (The database of Phenotypes and Genotypes) will be used to develop and test various models for prediction of T2D risk among three racial/ethnic groups. This project will capitalize on newly developed statistical methods that are able to incorporate information from tens of thousands of genetic markers at once, which represent a major advance over current methods that typically take fewer than 100 markers into account. The aims of the study are: 1) To test the hypothesis, in different populations, that individualized whole-genome prediction of T2D (along with standard covariates of sex, age, and BMI) will offer major improvements over current genetics-based prediction models, and will offer equal or greater accuracy than prediction based on family history; 2) To impute additional genetic markers to determine whether prediction can be improved, and to identify the subset of markers that is most useful in predicting T2D; 3) To develop prediction models for T2D risk given a certain body mass index (BMI), by including as predictors the interaction of BMI and genotypes. This project will greatly enhance our ability to predict an individual's susceptibility to T2D within various populations, leading to earlier and targeted prevention strategies, will increase our understanding of the genetic basis of T2D, and will provide critical training for Dr. Klimentidis' development as an independent scientist.    PUBLIC HEALTH RELEVANCE: Genetic factors are known to play a substantial role in the etiology of type-2 diabetes (T2D), which is a growing health challenge facing developed and developing countries. In this application, we propose to use state-of-the-art statistical methods that enable us to account for thousands of genetic variants simultaneously, in order to build and test predictive models for T2D susceptibility among individuals of European, Mexican, and African descent. This project has the potential to greatly improve prediction of T2D susceptibility in several ethnic groups, provide a better understanding of the specific genetic factors that play a role in T2D susceptibility, and ultimately bring us closer to the era of personalized medicine in which improved prediction ability results in earlier patient-oriented prevention and treatment.              Genetic factors are known to play a substantial role in the etiology of type-2 diabetes (T2D), which is a growing health challenge facing developed and developing countries. In this application, we propose to use state-of-the-art statistical methods that enable us to account for thousands of genetic variants simultaneously, in order to build and test predictive models for T2D susceptibility among individuals of European, Mexican, and African descent. This project has the potential to greatly improve prediction of T2D susceptibility in several ethnic groups, provide a better understanding of the specific genetic factors that play a role in T2D susceptibility, and ultimately bring us closer to the era of personalized medicine in which improved prediction ability results in earlier patient-oriented prevention and treatment.            ",Whole-Genome Prediction of Type-2 Diabetes Susceptibility in Various Populations,8280757,K01DK095032,"['Biomedical Research ', ' Engineering / Architecture ', ' Architecture ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Biology ', ' Accounting ', ' Age ', ' Affect ', ' Goals ', ' Genotype ', ' Hand ', ' Ethnic group ', ' Genome ', ' Health ', ' genetic biomarker ', ' Genetic Markers ', ' Family ', ' Genes ', ' Grant ', ' Data Analysis ', ' Data Analyses ', ' Data Sources ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Nation ', ' Developing Country ', ' Developing Countries ', ' Methods ', ' Mentors ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Medicine ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' History ', ' Recording of previous events ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Risk ', ' social role ', ' Role ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Publishing ', ' Risk Factors ', ' Play ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Records ', ' Research ', ' Dataset ', ' Data Set ', ' career ', ' Weight ', ' improved ', ' animal breeding ', ' Clinical ', ' base ', ' Variation ', ' Variant ', ' Scoring Method ', ' Testing ', ' Complex ', ' Source ', ' Scientist ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Industrialized Nations ', ' Industrialized Countries ', ' Developed Nations ', ' Developed Nation ', ' Developed Country ', ' Developed Countries ', ' Frequency ', ' Frequencies (time pattern) ', ' meetings ', ' Susceptibility ', ' Predisposition ', ' Development Plans ', ' Genetic ', ' European ', ' Funding ', ' Individual ', ' Area ', ' Mexican ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Family history of ', ' Training ', ' African ', ' Reporting ', ' Genomics ', ' Modeling ', ' diabetes risk ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Prevention ', ' case control ', ' disease risk ', ' disorder risk ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' career development ', ' Preventive strategy ', ' Prevention strategy ', ' Statistical Methods ', ' trait ', ' Height ', ' Informatics ', ' environment effect on gene ', ' gene environment interaction ', ' Genetic Risk ', ' genetic variant ', ' sex ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' computer based prediction ', ' predictive modeling ', ' Data ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' Quantitative Genetics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' racial/ethnic ', ' racial and ethnic ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' patient centered ', ' patient oriented ', ' Population ', ' ']",NIDDK,UNIVERSITY OF ARIZONA,K01,2012,148309,AZ-03,0.010398898100852167
"Novel Strategies to Identify GxE Contributions to MS Pathogenesis    DESCRIPTION (provided by applicant):  Multiple sclerosis (MS) is a complex and heterogeneous inflammatory disorder of the central nervous system characterized by myelin loss, varying degrees of axonal pathology, and progressive neurological dysfunction. The combined effect of many genes, environmental exposures acting during defined periods of life, and their interactions in MS is strongly supported by our own work and others. The involvement of HLA class II genes within the major histocompatibility complex (MHC) on chromosome 6p21 is well-established. The identification of non-MHC determinants of MS susceptibility, while progressing, is far from complete. Similar to other complex diseases, genome-wide association studies (GWAS) have begun to unravel the polygenic etiology of MS. However, variants identified through several large GWAS, to date, explain only a very small proportion of MS heritability. The proposed study describes critical post-GWAS era steps to further our current understanding of MS pathogenesis. First, we will utilize next-generation DNA sequence data, high-throughput genotyping and state-of-the-art bioinformatics methods to fully characterize rare, less frequent and common variants within more than 30 MS genes established through recent GWAS and their contribution to the development of MS and disease expression (Aim 1). Next, we will also comprehensively investigate a number of important life-course exposures including prenatal, perinatal, childhood, adolescent and adult time periods, GxE interactions and risk of MS (Aim 2). Finally, we will study genome-wide DNA methylation profiles in a newly established cohort of clinically isolated syndrome (CIS)/early MS cases and matched controls to identify immune cell specific epigenetic influences on the development of MS (Aim 3). We will utilize extraordinary MS case-control resources nested within the large, population-based membership of Northern California Kaiser Permanente, as well as DNA, genetic and clinical data assembled for this project through the International Multiple Sclerosis Genetics Consortium; more than 10,000 individuals of White/European ancestry will be studied using a suite of statistical methods of analysis. Results from proposed epidemiologic studies of the most important MS genes and causal variants in the context of relevant environmental exposures will inform new functional studies, and have potential to support the development of more effective approaches for prevention, diagnosis and treatment.         The complete identification of genetic and environmental influences and how they contribute independently and jointly to the development of MS and expression of particular disease characteristics would play a major role in understanding disease etiology, and would contribute greatly to disease prevention strategies and development of targeted and more effective therapies.         ",Novel Strategies to Identify GxE Contributions to MS Pathogenesis,8303052,R01ES017080,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' California ', ' Cells ', ' Central Nervous System Disorders ', ' CNS disorder ', ' CNS Diseases ', ' Central Nervous System Diseases ', ' Chromosomes ', ' Chronology ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Environmental Exposure ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Foundations ', ' Genes ', ' MHC Class II ', ' HLA Class II Genes ', ' Class II Genes ', ' MHC Class II Genes ', ' Genotype ', ' Laboratories ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Major Histocompatibility Complices ', ' Histocompatibility Complices ', ' Histocompatibility Complex ', ' Major Histocompatibility Complex ', ' Methods ', ' insular sclerosis ', ' MS (Multiple Sclerosis) ', ' Disseminated Sclerosis ', ' Multiple Sclerosis ', ' Myelin ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Odds Ratio ', ' Pathology ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Survey Instrument ', ' Surveys ', ' Syndrome ', ' Testing ', ' Time ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Work ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' Perinatal ', ' Site ', ' Variation ', ' Variant ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Susceptibility ', ' Predisposition ', ' pediatric ', ' Childhood ', ' Individual ', ' Trust ', ' European ', ' Collaborations ', ' Genetic ', ' Inflammatory ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Dimensions ', ' Immune ', ' Complex ', ' environment effect on gene ', ' gene environment interaction ', ' cohort ', ' disease characteristic ', ' unborn ', ' prenatal ', ' novel ', ' disease prevention ', ' disorder prevention ', ' Preventive strategy ', ' Prevention strategy ', ' disease risk ', ' disorder risk ', ' Pathogenesis ', ' neurological dysfunction ', ' Neurologic Dysfunctions ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' case control ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' International ', ' Clinical Data ', ' Clinical Management ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Risk Estimate ', ' 6p21 ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' insertion/deletion ', ' insertion-deletion mutation ', ' insertion-deletion ', ' insertion/deletion mutation ', ' next generation ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' Heritability ', ' population based ', ' effective treatment ', ' effective therapy ', ' genomewide ', ' genome-wide ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA BERKELEY,R01,2012,615310,CA-13,0.02716744819163121
"International Case Control Study of Malignant Glioma    DESCRIPTION (provided by applicant): Glioma comprises about 40% of all primary brain tumors accounting for as many as 26,000 U.S. and European deaths annually. Inherited susceptibility plays a role with 2-fold increased risk of glioma among first-degree relatives of glioma cases. We initiated a multi-center, international linkage study: ""Genetic Epidemiology of Glioma International Consortium"" in 2007 to address the role of inherited susceptibility. Since this study does not allow us currently to address the role of genetic susceptibility in sporadic cases, we propose this case- control study to address this gap. Members of the consortium have conducted genome wide association studies (GWAS) that will be the discovery phase (phase I). While of high value for discovery, we propose to recruit 6,000 newly diagnosed glioma cases and 6,000 age-gender-ethnicity-matched controls, and collect detailed epidemiologic data and biologic samples from the 13 participating Gliogene sites. We hypothesize that novel inherited variation influencing the susceptibility to glioma can be identified by high density SNP analysis, and propose the following specific aims: SA1: Identify common genetic variants contributing to the risk of glioma. We plan to conduct phases 2 and 3 of the 3 phase approach, specifically we will: (SA1a) Validate GWAS findings from the discovery sets, and replicate the top hits (~23,000 SNPs) with lowest p- values from the two phase GWA studies in a series of 2,000 cases and 2,000 controls (phase 2, validation). Validate the top hits from the test set (aim 1a). From stage 2, genes with SNPs displaying an association at pd10-4 (including the complete haplotype tagging - approximately 100 SNPs) will then be genotyped in a further series of 4,000 cases and 4,000 controls (stage 3, validation). SNPs significant at 10-7 or better will be considered in the final analyses. (SA1b). Using an a priori hypothesis that DNA repair in inflammation contribute to glioma risk, we will selectively interrogate DNA repair and inflammation pathway genes using data for select genes derived from the high-density array. We will conduct a hypothesis driven genetic association in DNA repair and in inflammation/immune function related genes with glioma risk using functional genomic and bioinformatic tools to interrogate available databases. (SA2): Evaluate gene-gene (G-G) and gene- environmental (G-E) interactions with strong biologic relevance to identify G-G and G-E interactions for glioma risk using machine-learning tools (MDR, FITF, and CART) in these exploratory analyses. There are no existing glioma case-control studies with sufficient numbers of biological samples and common epidemiologic data to conduct a comprehensive validation and replication study, or to address the issues of tumor heterogeneity as we will in this study.      PUBLIC HEALTH RELEVANCE: Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.                             Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.",International Case Control Study of Malignant Glioma,8207243,R01CA139020,"['Accounting ', ' Age ', ' Bronchial Asthma ', ' Asthma ', ' California ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Systematics ', ' Classification ', ' Death ', ' Cessation of life ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Genes ', ' Genotype ', ' spongioblastoma multiforme ', ' glioblastoma multiforme ', ' Grade IV Astrocytoma ', ' Grade IV Astrocytic Tumor ', ' Grade IV Astrocytic Neoplasm ', ' Glioblastoma ', ' neuroglia tumor ', ' neuroglia neoplasm ', ' glial-derived tumor ', ' Neuroglial Tumor ', ' Neuroglial Neoplasm ', ' Glial Tumor ', ' Glial Neoplasm ', ' Glial Cell Tumors ', ' Glioma ', ' Haplotypes ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Allergy ', ' Hypersensitivity ', ' Infection ', ' Inflammation ', ' Mining ', ' Play ', ' Radiation-Ionizing Total ', ' Ionizing Electromagnetic Radiation ', ' Ionizing radiation ', ' recruit ', ' Recruitment Activity ', ' Risk ', ' social role ', ' Role ', ' San Francisco ', ' Syndrome ', ' Testing ', ' Trees ', ' Universities ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Gender ', ' forest ', ' Dataset ', ' Data Set ', ' Malignant Tumor of the Brain ', ' Brain Cancer ', ' Malignant neoplasm of brain ', ' base ', ' density ', ' Left ', ' Site ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Histologically ', ' Histologic ', ' Series ', ' Age of Onset ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Trust ', ' European ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Sample Size ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' Staging ', ' tool ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Hereditary ', ' Inherited ', ' Malignant Neuroglial Tumor ', ' Malignant Neuroglial Neoplasm ', ' Malignant Glial Tumor ', ' Malignant Glial Neoplasm ', ' Malignant Glioma ', ' success ', ' international center ', ' cohort ', ' Manuscripts ', ' Histopathology ', ' novel ', ' member ', ' Primary Brain Tumors ', ' Primary Brain Neoplasms ', ' Modeling ', ' Sampling ', ' case control ', ' genetic epidemiology ', ' functional genomics ', ' cancer location ', ' cancer site ', ' Bio-Informatics ', ' Bioinformatics ', ' Cellular Immune Function ', ' immune function ', ' genetic association ', ' Address ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' International ', ' Infrastructure ', ' Research Infrastructure ', ' Collection ', ' First Degree Relative ', ' Newly Diagnosed ', ' Validation ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' Adult Glioma ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' tumor ', ' high risk ', ' public health relevance ', ' population based ', ' epidemiologic data ', ' TCGA ', ' The Cancer Genome Atlas ', ' ']",NCI,BAYLOR COLLEGE OF MEDICINE,R01,2012,3914658,TX-09,0.04548659119244625
"Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning  Detecting Genome-Wide Epistasis with Efficient Bayesian Network Learning Epistasis is the interaction between two or more genes to affect phenotype. It is now widely accepted that epistasis plays an important role in susceptibility to many common diseases. The advent of high-throughput technologies has enabled genome-wide association studies (GWAS or GWA studies). It is compelling that we be able to detect epistasis using GWAS data. However, so far GWA studies have mainly focused on the association of a single gene or loci with a disease. The crucial challenge to analyzing epistasis using GWAS data is finding a way to efficiently handle high-dimensional data sets. The only possible solution is to design efficient algorithms that allow us to find the most relevant epistasic relationships without doing an exhaustive investigation. To the Principal Investigator's knowledge, no current method can do this. This career award will investigate this problem. The specific aims are as follows: (Aim 1) develop and evaluate efficient Bayesian network-based methods for learning candidate genes associated with diseases from GWAS sets. Such genes would provide candidates for follow-up biological studies, (Aim 2) implement the methods in a pilot GWAS system for use by researchers when conducting a GWAS, (Aim 3) develop simulated genome-wide data sets and evaluate the pilot system using these data sets, and (Aim 4) conduct GWA studies concerning breast cancer and lung cancer. Aim 1 will be addressed by developing a succinct Bayesian network model representing epistasis, efficient algorithms which are tailored to investigating such models, integration of the algorithms into methods for learning epistasis, and using simulated datasets to test the effectiveness of the methods and compare their performance to other methods. Aim 2 will be met by implementing the methods in a pilot GWAS system. Aim 3 will be satisfied by developing synthetic data sets similar to those found in GWA studies, and using them to evaluate the system. Aim 4 will be achieved by conducting GWA studies concerning breast and lung cancer. By conducting these studies, we can (1) substantiate previous results concerning the genetic basis of these diseases; (2) possibly obtain interesting new findings pertaining to these diseases. The main hypothesis is that the proposed method will be an advance over existing methods in that it will make it computationally feasible to learn epistatic relationships from genome-wide data and it will therefore yield better discovery performance than existing methods.  Learning gene-gene interactions from genome-wide association studies (GWAS) data is an important and challenging task in genetic epidemiology. This project will develop and evaluate a pilot GWAS system for performing this task. Advances obtained in analyzing GWAS data sets could enable us to learn the genetic basis of many diseases and thereby substantially improve the quality of personalized patient care.",Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning,8372706,R00LM010822,"['Affect ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Award ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Data Analysis ', ' Data Analyses ', ' disease/disorder ', ' Disorder ', ' Disease ', ' genetic epistases ', ' gene x gene interaction ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Patient Care Delivery ', ' Patient Care ', ' Genes ', ' Articulation ', ' Joints ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Phenotype ', ' Play ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Regression Analysis ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Solutions ', ' Testing ', ' Woman ', ' Work ', ' Generations ', ' forest ', ' Dataset ', ' Data Set ', ' base ', ' career ', ' improved ', ' Site ', ' Biological ', ' Hereditary Mutation ', ' Germline Mutation ', ' Germ-Line Mutation ', ' Link ', ' Susceptibility ', ' Predisposition ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Family history of ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Simulate ', ' Genetic ', ' Malignant Cell ', ' cancer cell ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' brca 1 gene ', ' RNF53 ', ' Hereditary Breast Cancer 1 ', ' Early Onset Gene Breast Cancer 1 ', ' Breast Cancer Type 1 Susceptibility Gene ', ' Breast Cancer 1 Gene ', ' BRCA1 ', ' BRCA1 gene ', ' Investigation ', ' Complex ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' meetings ', ' gene interaction ', ' Performance ', ' brca 2 gene ', ' Hereditary Breast Cancer 2 ', ' FANCD1 ', ' FANCB ', ' Early Onset Gene Breast Cancer 2 ', ' Breast Cancer Type 2 Susceptibility Gene ', ' Breast Cancer 2 Gene ', ' BRCA2 ', ' BRCA2 gene ', ' neural network ', ' Biological Neural Networks ', ' Statistical Methods ', ' Modeling ', ' high throughput technology ', ' genetic epidemiology ', ' Cancer Susceptibility Gene ', ' Cancer-Predisposing Gene ', ' Effectiveness ', ' datamining ', ' data mining ', ' Candidate Gene ', ' Candidate Disease Gene ', ' GRB2-Associated Binding Protein 2 Gene ', ' GAB2 ', ' GAB2 gene ', ' Address ', ' Data ', ' Genetic Algorithm ', ' Genetic Programming ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' Bayesian Networks ', ' computer based statistical methods ', ' designing ', ' design ', ' combinatorial ', ' Network-based ', ' network models ', ' genome-wide analysis ', ' genomewide ', ' genome-wide ', ' ']",NLM,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R00,2012,166150,PA-18,0.05007456818860282
"Integrating Genomic and Environmental Perspectives on Internalizing Disorders While biometric genetic studies have long indicated substantial heritability for internalizing disorders, including major depressive and generalized anxiety disorders, progress in mapping this influence onto specific genetic variants has been slow. Expert consensus suggests that finding this missing heritability will require moving beyond the current one SNP at a time genomewide association study (GWAS) paradigm to develop interactive models jointly considering effects across structural and functional genomic units (e.g., genes and biological pathways), as well as modeling gene-environmental interaction (GxE) in the highly dimensional GWAS context. The overarching goal of this proposal is to provide the candidate the training and research opportunities necessary to advance such an interactive model of internalizing disorder etiology, thus supporting the candidates long-term career goal of becoming an independent investigator in the area. General training goals include building proficiency in statistical genetics and bioinformatics, and strengthening knowledge of substantive issues in developmental psychopathology and psychometric statistical modeling/programming. The candidate proposes to acquire a number of specific skills, including data integration techniques for including prior information in GWAS, aggregation methods to capture the possible effects of many markers with very small effects (e.g., gene-based, pathway-based, and polygenic risk profile score analyses) and machine learning applications for investigating epistasis and nonlinear genomic effects. Proposed training in these areas consists of an interlocking program of coursework, intensive mentoring, summer programs, reading groups, seminar series and conferences, with special attention to training in research ethics. Direct mentoring is a key feature of this program, with access to leading experts in each of the proposed training areas (i.e., Drs. Edwin van den Oord and Patrick Sullivan  statistical genetics and bioinformatics, Dr. E. Jane Costello  developmental psychopathology, and Dr. Michael Neale  statistical modeling and programming) representing a core strength of the proposed training plan. The candidate proposes to apply acquired skills in the research portion of the project by conducting a multistage GWAS to investigate genomic influence, both direct and in interaction with environmental risk factors, on developmental trajectories of internalizing disorders. Methodologically, this approach focuses on integrating longitudinal statistical models of phenotypic development and environmental risk with emerging genomic methods. This will be facilitated by bringing together an unprecedented combination of longitudinal GWAS datasets, including a meta-analysis of the four Duke/VCU samples of the Gene, Environment, and Development Initiative (GEDI) (N=3,623). This discovery phase meta-analysis will then be followed by replication in two large independent longitudinal samplesthe National Longitudinal Study of Adolescent Health (N=~12,000) and the Minnesota Twin and Family Study (N=3,762). The exceptional statistical power of this design will be further complimented in a final analytical stage, with next-generation sequencing follow-up using targeted capture methods to extract promising genes/regions and extreme-trait methods to maximize power by selecting subjects from the extremes of the phenotypic distributions. The institutional environment provided by the Virginia Commonwealth University Center for Biomarker Research and Personalized Medicine (CBRPM) represents another core asset to the candidates career development. The CBRPMs mission is to develop and apply novel methods for the purpose of identifying and using biomarkers to improve disease understanding and medical treatment. The Center operates from a strong multidisciplinary perspective with primary applications involving psychiatric outcomes, developmental psychopathology, and substance use disorders. Currently funded research programs at the CBRPM include serving as the data analysis core of the Duke/VCU GEDI project, method development in the design and analysis of adaptive multistage GWAS, a replication study of findings from schizophrenia GWAS, and whole genome profiling to detect schizophrenia methylation markers. These projects offer an ideal context for executing the proposed training and research, as they provide an environment focused on GWAS and next-generation sequencing applications to psychiatric disorderscentral topics of the candidates career development plan. The CBRPM also provides several unique physical resources supporting the current proposal, including a SOLiD 4 next-generation sequencer, which will allow follow-up sequencing to be done in-house, and a Center-dedicated computing cluster, facilitating the computationally intensive analyses proposed. In addition to physical resources, the CBRPM offers a challenging and collegial intellectual environment that promotes collaboration both within and outside of the Center. In sum, the CBRPM provides a stimulating and supportive institutional environment with the all of the statistical, computational and laboratory resources necessary to make this proposal a successful one. Affecting more than one in five Americans annually, internalizing disorders (IDs) (i.e.,  depression and anxiety) are the most common forms of mental illness and leading  causes of the global health burden. Clearly, an improved understanding of the etiology of  IDs would substantially advance both prevention and intervention efforts. This project  aims to improve understanding through advancing an integrative model of genomic,  environmental and developmental influence in the etiology of IDs.",Integrating Genomic and Environmental Perspectives on Internalizing Disorders,8249383,K01MH093731,"['Affect ', ' Algorithms ', ' Anxiety ', ' Attention ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Puericulture ', ' Child Care ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Environment ', ' genetic epistases ', ' gene x gene interaction ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Genes ', ' Genome ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Housing ', ' indexing ', ' Laboratories ', ' long-term study ', ' Longitudinal Studies ', ' Maps ', ' Medicine ', ' Mentors ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Minnesota ', ' Mission ', ' Genetic Models ', ' Probabilistic Models ', ' Statistical Models ', ' Phenotype ', ' Play ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Population Control ', ' Psychometrics ', ' abnormal psychology ', ' Psychopathology ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Scoring Method ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Substance Use Disorder ', ' Testing ', ' Time ', ' Twins ', ' Twin Multiple Birth ', ' Universities ', ' Virginia ', ' Measures ', ' conference ', ' symposium ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' career ', ' method development ', ' improved ', ' Family Study ', ' Area ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Series ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Susceptibility ', ' Predisposition ', ' screenings ', ' screening ', ' Screening procedure ', ' Training ', ' Measurement ', ' Development Plans ', ' Genetic Research ', ' Funding ', ' Generalized Anxiety Disorder ', ' Collaborations ', ' Twin Studies ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Consensus ', ' Knowledge ', ' programs ', ' Investigation ', ' Side ', ' Techniques ', ' American ', ' developmental genetics ', ' environment effect on gene ', ' gene environment interaction ', ' trait ', ' Structure ', ' skills ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Research Ethics ', ' Modeling ', ' Sampling ', ' career development ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' functional/structural genomics ', ' major depression ', ' Major Depressive Disorder ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Address ', ' global health ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' Research Training ', ' Stratification ', ' Sum ', ' Genetic Risk ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' genetic variant ', ' data integration ', ' grid computing ', ' distributed computing ', ' datagrid ', ' data grid ', ' computational grid ', ' cluster computing ', ' designing ', ' design ', ' next generation ', ' Outcome ', ' Heritability ', ' multidisciplinary ', ' biomarker ', ' genomewide ', ' genome-wide ', ' ']",NIMH,VIRGINIA COMMONWEALTH UNIVERSITY,K01,2012,136976,VA-04,0.06577184401967286
"Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers DESCRIPTION (provided by applicant): Epigenetic silencing involving alterations in DNA methylation and chromatin structure at promoter region CpG islands is a common mechanism of tumor suppressor gene inactivation in human cancers. However, the mechanisms underlying this event remain poorly understood. An unresolved question is why are some genes targets of aberrant methylation in human cancers while others are never affected? In preliminary work, we have shown that even in the context of an increased cellular capacity for de novo methylation, CpG islands differ in their potential for aberrant methylation. By applying DNA pattern recognition and machine learning techniques, we have developed an algorithm based on several short sequence patterns that is capable of accurately discriminating methylation-prone and methylation-resistant CpG islands. These studies indicate that the epigenetic status of a CpG island can be predicted based on DNA sequence features, and lead us to propose that one factor contributing to the non-random patterns of CpG island methylation observed in human tumors is an underlying susceptibility conferred by local sequence context. The goal of this proposal is to define the genomic signature associated with aberrant methylation. The long term objectives are (i) to identify and to functionally characterize local sequence attributes that contribute to the propensity towards, or protection from, aberrant methylation, and (ii) to develop and to test novel tumor specific classifiers capable of predicting genomic loci at risk of aberrant methylation. Specifically, we will determine whether sequence features identified in silico act in cis to promote or to prevent de novo methylation in vivo using an episomal transgene approach. In preliminary work, we have identified a relationship between methylation-prone CpG islands and genomic regions bound by the polycomb repressor complex. As a second component of the project, we will determine the role of PRC2 in methylation susceptibility. As a third component of this project we will refine our computational models by 1) determining whether CpG islands predicted to be methylation-prone are in fact targets of aberrant methylation in human cancers, 2) using this information to re-train the prediction model, and 3) developing and testing a novel lung cancer specific classifier based on large-scale CpG island methylation data from primary lung tumors. We anticipate that the information gained from these studies will allow for a better understanding of the mechanisms underlying the epigenetic silencing of tumor suppressor genes that accompanies carcinogenesis. Moreover, the ability to predict the methylation status of CpG islands genome-wide will provide an important resource for the identification of novel gene targets for further study as potential cancer biomarkers. Project Narrative  The overarching goal of this research is to better understand the mechanisms by which  important growth regulatory genes are targeted for epigenetic silencing in human cancers.  Although the consequences of this event are the same as a mutation, there is no molecular  defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the  DNA and the histone proteins it is wrapped around that render certain genes abnormally and  permanently silent. We plan to use a computational approach to identify DNA features that put  certain genes at risk of aberrant methylation. Because genes that are silenced by methylation  are otherwise structurally sound, the potential for reactivating these genes by blocking or  reversing the methylation process represents an exciting molecular target for chemotherapeutic  intervention. A better understanding of the factors that contribute to aberrant methylation,  including the identification of sequence features that attract or repel DNA methylation, will be an  important step in achieving this long-term goal. Moreover, the ability to identify those genes at  risk of epigenetic silencing will provide novel molecular targets for further study as potential  biomarkers for improved cancer diagnosis and treatment planning.",Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers,8246510,R01CA132065,"['Affect ', ' Algorithms ', ' Alu Repetitive Sequences ', ' Alu Family ', ' Alu Elements ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' cell culture ', ' Cell Culture Techniques ', ' Systematics ', ' Classification ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Deoxyribonucleic Acid ', ' DNA ', ' Site-Specific DNA-methyltransferase ', ' Modification Methylases ', ' EC 2.1.1.113 ', ' Dnmt ', ' DNA-Methyltransferases ', ' DNA Modification Methyltransferases ', ' DNA Modification Methylases ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' human whole genome ', ' Human Genome ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Lung Neoplasms ', ' Protein Methylation ', ' Methylation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Play ', ' genetic promoter element ', ' Promotor Regions (Genetics) ', ' Promotor Regions ', ' Promoter Regions ', ' Promoter Regions (Genetics) ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Publishing ', ' recruit ', ' Recruitment Activity ', ' Repression ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' sound ', ' Strikes ', ' Employee Strikes ', ' Testing ', ' Work ', ' Generations ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Tumor Suppressor Genes ', ' Polycomb ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' DNA Sequence ', ' base ', ' improved ', ' Site ', ' Susceptibility ', ' Predisposition ', ' Training ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Gene Targeting ', ' Biological Function ', ' Biological Process ', ' CpG-Rich Islands ', ' CpG Islands ', ' Transgenes ', ' Shapes ', ' Malignant Cell ', ' cancer cell ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' Cancer Induction ', ' carcinogenesis ', ' tumor suppressor ', ' Tumor Suppressor Proteins ', ' Gene Inactivation ', ' Gene Silencing ', ' treatment planning ', ' Primary Tumor ', ' Primary Neoplasm ', ' novel ', ' Coding System ', ' Code ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer therapy ', ' cancer diagnosis ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' preventing ', ' prevent ', ' Defect ', ' Aberrant DNA Methylation ', ' DNA Methyltransferase ', ' Data ', ' Deletion Mutation ', ' Ectopic Expression ', ' Hypermethylation ', ' Molecular Target ', ' in vivo ', ' Chromatin Structure ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Pattern Recognition ', ' Tumor-Suppressor Gene Inactivation ', ' Molecular ', ' Process ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' Cancer cell line ', ' resistant ', ' Resistance ', ' tumor ', ' overexpress ', ' overexpression ', ' biomarker ', ' genomewide ', ' genome-wide ', ' Chip Chip ', ' Chip on Chip ', ' ']",NCI,EMORY UNIVERSITY,R01,2012,306133,GA-05,0.04321429039762594
"Information Explorer: a Suite of Tools for Cross-study Genetic Loci Discovery    DESCRIPTION (provided by applicant): Databases such as dbGaP represent extremely valuable resources of data that have been assembled across multiple cohorts. The increasing development of cost-effective high-throughput genotyping and sequencing technologies are resulting in vast amounts of genetic data. While such databases were formed in order to archive and distribute the results of previously performed genetic association analyses, an increasing number of studies have provided de-identified individual-level genotypic and phenotypic data that are made available to outside researchers who have obtained the appropriate authorization. While the amount of data made available has increased dramatically in recent years, relatively little has been done in order to facilitate phenotype harmonization across studies. Many genetic epidemiologic studies of cardiovascular disease have multiple variables related to any given phenotype, resulting from different definitions and multiple measurements or subsets of data. A researcher searching such databases for the availability of phenotype and genotype combinations is confronted with a veritable mountain of variables to sift through. This often requires visiting multiple websites to gain additional information about variables that are listed on databases, and examination of data distributions to assess similarities across cohorts. While the naming strategy for genetic variants is largely standardized across studies (e.g. ""rs"" numbers for single nucleotide polymorphisms or SNPs), this is often not the case for phenotype variables. For a given study, there are often numerous versions of phenotypic variables. Researchers currently have to analyze and compare increasingly larger numbers of variables that have varying degrees of documentation associated with them to obtain the desired information. This is a time-consuming process that may still miss the most appropriate variables. Moreover, every researcher that wants to compare the same datasets often needs to start from scratch since there are no tools to share the phenotype comparison results. The availability of informatic tools to make phenotype mapping more efficient and improve its accuracy, along with intuitive phenotype query tools, would provide a major resource for researchers utilizing these databases. The tools we are proposing would allow researchers to (1) Quickly obtain the information needed to assess whether a specific study will be useful for the hypothesis of interest; (2) Exclude variables that do not meet research criteria; (3) Ascertain which studies have combinations of phenotype and genetic information of interest; and (4) More easily expand research questions beyond the most basic main-effects to more complex analyses such as gene-by-environment interactions and multivariate tests incorporating multiple phenotypes. The increased utility will also enable larger meta-analyses to be performed, as researchers will be able to more quickly hone in on outcomes, exclusionary variables and covariates of interest, leading to increased statistical power to detect genetic associations.        While the amount of genomic data (e.g., GWAS, sequencing, etc.) made available has increased dramatically in recent years, relatively little has been done in order to facilitate phenotype harmonization across studies. The tools we are proposing would allow researchers to quickly identify data sets of interest, expand research questions beyond the most basic main-effects to more complex analyses such as gene-by-environment interactions and multivariate test incorporating multiple phenotypes, and perform larger meta-analyses easily by honing in on outcomes, exclusionary variables and covariates of interest with increased statistical power to detect genetic associations.         ",Information Explorer: a Suite of Tools for Cross-study Genetic Loci Discovery,8303362,UH2HL108780,"['epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Archives ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Blood Reticuloendothelial System ', ' Blood ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Systematics ', ' Classification ', ' Foundations ', ' Future ', ' Genotype ', ' Heart ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Maps ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Names ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Phenotype ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Sleep ', ' Technology ', ' Testing ', ' Time ', ' Work ', ' Information Retrieval ', ' Measures ', ' conference ', ' symposium ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Solid ', ' Biological ', ' Link ', ' Training ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Systems Integration ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' Source ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' Visit ', ' meetings ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' Postdoctoral Fellow ', ' experience ', ' environment effect on gene ', ' gene environment interaction ', ' Performance ', ' cohort ', ' Informatics ', ' trait ', ' graduate student ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' genetic epidemiology ', ' repository ', ' developing computer software ', ' develop software ', ' software development ', ' Genomics ', ' Documentation ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' genetic association ', ' Data ', ' Validation ', ' Process ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' developmental ', ' Development ', ' website ', ' web site ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' Outcome ', ' scale up ', ' cost-effective ', ' cost effective ', ' data structure ', ' usability ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' ']",NHLBI,UNIVERSITY OF SOUTHERN CALIFORNIA,UH2,2012,440305,CA-37,0.010641247570076206
"DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk My long-term goal is to become an independent molecular epidemiologist with in-depth training in genetics and advanced statistical methods in order to be able to analyzehigh throughput gene variant data to explore gene- gene and gene-environment interactions in cancer susceptibility. Mycareer development plan includedidatic courses/seminars, meetings with mentors in the areas of human genetics, cancer biology and advanced statistical methods. Myresearch proposal will focus on genetic susceptibility of blader cancer (BC). I propose to capitalize on availabilityof epidemiologicand genentic marker data from an on-going case-control study, ""Markers of GeneticSusceptibilityto Bladder Cancer""(R01 CA74880,PI:Xifeng. Wu). The parent study currently include over 2,500,mostly Caucasian,BCcases and controls, matched on sex, age and ethnicity. Mygoal is to identify novel loci that confer bladder cancer susceptibility using state-of-the-art genotyping techology and novel statistical and bioinformaticstools. The Specific Aims are: 1) To enhance my knowledge and skills in genetics and statistics to identify novel genetic loci as susceptibility markers of BC by extending the original45 potential functional SNPs to include additional 2112 tagging SNPs in genes in the DNArepair, cell cycle control and apoptotic pathways in 800 Caucasiancases and 800 Caucasiancontrols using the Illumina Golden Gate Assay; 2) To assess haplotypes and diplotypes as markers of susceptibility; 3) To use bioinformaticstools to assess functional significance of SNPs in the DNArepair, cell cycle control and apoptotic pathways and to correlate genotype data of DNArepair and cell cycle control with functional data derived from phenotypic assays. The secondary aim is to apply hierarchical models to refine risk assessment and to apply novel machine-learning tools to explore any gene-environment and gene-gene interactions influencing BCrisk. My project complements the parent grant in that it: 1) adds tagging SNPs to potential functional SNPs addressed in the parent grant; 2) adds haplotype analyses; 3) proposes novel statistical and bioinformaticsapproaches. RELEVANCE (See instructions): Bladder cancer is a tobacco-related cancer which is the fourth most common cancer in men in U.S. The fact that only a fraction of smokers develop bladder caricer indicating genetic susceptibility to the disease. This study will identify novel genetic markers may be useful as biomarkers to identify high-risk populationsthat could then be targeted for intervention programs. ","DNA repair, Cell cycle Checkpoints and Apoptosis and Bladder Cancer Risk",8268502,K07CA134831,"['Age ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' urinary bladder ', ' Bladder Urinary System ', ' Bladder ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' Malignant neoplasm of urinary bladder ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' oncogenic agent ', ' Oncogens ', ' Cancer Causing Agents ', ' Carcinogens ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasoid Race ', ' Subcellular Process ', ' Cellular Process ', ' Cellular Physiology ', ' Cellular Function ', ' Cell Process ', ' Cell Function ', ' Cell physiology ', ' Cells ', ' Complement Proteins ', ' Complement ', ' Statistical Correlation ', ' Correlation Studies ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Environment ', ' Environmental Exposure ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' blood corpuscles ', ' Red blood corpuscule ', ' Red Cell ', ' Red Blood Cells ', ' Marrow erythrocyte ', ' Erythrocytic ', ' Erythrocytes Reticuloendothelial System ', ' Blood normocyte ', ' Blood erythrocyte ', ' Erythrocytes ', ' Genes ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Haplotypes ', ' Human Genetics ', ' lymph cell ', ' Lymphocytic ', ' Lymphocyte ', ' Medicine ', "" men's "", ' men ', ' Mentors ', ' Methods ', ' genotoxic agent ', ' Genotoxins ', ' Mutagens ', ' Paper ', ' Parents ', ' Phenotype ', ' Physicians ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Publishing ', ' recruit ', ' Recruitment Activity ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Specialty ', ' medical specialties ', ' statistics ', ' Suspensions ', ' Tobacco ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Caucasians ', ' Gender ', ' telomere ', ' case report ', ' Case Study ', ' Risk Assessment ', ' Magazine ', ' Journals ', ' Programmed Cell Death ', ' Apoptosis Pathway ', ' Apoptosis ', ' base ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Molecular Epidemiology ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Individual ', ' Development Plans ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' tool ', ' Smoker ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Tobacco smoke ', ' Clinic ', ' Occupational ', ' Penetrance ', ' meetings ', ' collegiate ', ' college ', ' American ', ' cancer risk ', ' Cancer Induction ', ' carcinogenesis ', ' environment effect on gene ', ' gene environment interaction ', ' gene interaction ', ' intervention program ', ' skills ', ' novel ', ' novel technologies ', ' new technology ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' Gene Position ', ' Gene Arrangement ', ' Gene Order ', ' Genomics ', ' Bio-Informatics ', ' Bioinformatics ', ' Cell Cycle Control ', ' Cell Cycle Regulation ', ' Cell Cycle Checkpoint ', ' Clinical Oncology ', ' suspension ', ' Suspension substance ', ' Address ', ' Length ', ' Data ', ' dietary pattern ', ' Dietary Practices ', ' M.D. ', ' Doctor of Medicine ', ' Predictive Value ', ' Apoptotic ', ' Cancer Biology ', ' Cancer Center ', ' Carcinogen Metabolism ', ' enroll ', ' Enrollment ', ' Epidemiologist ', ' Journal of the NCI ', ' Journal of the National Cancer Institute ', ' Newly Diagnosed ', ' nutritious ', ' Nutritional ', ' Molecular ', ' sex ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' Instruction ', ' cancer research ', ' anticancer research ', ' Outcome ', ' coping ', ' parent grant ', ' high risk ', ' biomarker ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,K07,2012,137537,TX-09,0.06297508127325255
"Optimizing Genetic Testing for Deafness for Clinical Diagnostics   Project Summary  In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. The driving force behind this initiative is the frequency of hearing impairment. As the most common sensory impairment, it is diagnosed in 1 of every 500 newborns and 50% of octogenarians (Morton Ann N Y Acad Sci 1991). With 57 genes implicated in nonsyndromic hearing loss (NSHL), it is also an extremely heterogeneous trait and presents a tremendous challenge to diagnosis.  Current strategies for genetic testing for deafness are inadequate. For most, only a minority of genes is included, with selection criteria typically reflecting: 1) high prevalence as a cause of deafness (i.e. GJB2); 2) association with another recognizable feature (i.e. SLC26A4 and enlarged vestibular aqueduct); or 3) a recognizable audioprofile (i.e. low frequency hearing loss as seen with WFS1) (Hilgert et al Mut Res 2009).  The recent advent of powerful DNA target enrichment and sequencing technologies, however, makes it possible to provide comprehensive genetic testing for deafness that is efficient and cost-effective. We have shown that it is possible to analyze all deafness genes simultaneously on a single platform (called OtoSCOPE) (Shearer et al PNAS 2010). Related to this endeavor, we have also validated AudioGene as a phenotypic tool that uses patient audiograms to predict the genetic cause of ADNSHL (Hildebrand et al Genet Med 2008; Hildebrand et al Laryngoscope 2009).  Building on these findings, in this proposal we will complete two specific aims.  Specific Aim 1: To provide comprehensive, high-throughput, low-cost DNA sequence generation and analysis for deafness genetic testing  Goal 1: Comprehensive, high-throughput, low-cost DNA sequence analysis for genetic testing for deafness is possible at sensitivities and specificities comparable to Sanger sequencing by using targeted sequence enrichment followed by massively parallel sequencing.  Specific Aim 2: To optimize both machine learning-based audioprofiling of audiometric data and phenotypic filtering of genotypic data by expanding and improving the platform we have developed called AudioGene  Goal 2: As a phenome tool, a machine-learning software system trained on an extensive set of audiometric data can be used to predict and to eliminate specific genes or gene variants as causes of deafness based on audiometric data.  Achieving these specific aims will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history, physical examination and audiological assessment.   In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. Achieving this goal will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history and physical exam.",Optimizing Genetic Testing for Deafness for Clinical Diagnostics,8336850,R01DC012049,"['Sensory ', ' LOINC Axis 4 System ', ' System ', ' Persons With Hearing Impairments ', ' Hard of Hearing Persons ', ' Deaf ', ' Hearing Impaired Persons ', ' meetings ', ' trait ', ' genetic testing ', ' Genetic screening method ', ' Sampling ', ' response ', ' Hypoacusis ', ' Hypoacuses ', ' Hearing Loss ', ' hearing impairment ', ' Data ', ' Detection ', ' Sanger Sequencing ', ' Dideoxy Chain Termination DNA Sequencing ', ' High Prevalence ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Funding Opportunities ', ' cost ', ' software systems ', ' Minority ', ' cost-effective ', ' cost effective ', ' driving force ', ' Impairment ', ' phenome ', ' Audiometric Test ', ' Audiogram ', ' Audiometry ', ' Bar Codes ', ' Data Analysis ', ' Data Analyses ', ' Deafness ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Genes ', ' Goals ', ' History ', ' Recording of previous events ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Laboratories ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Persons ', ' Octogenarian ', ' Patients ', ' Medical Inspection ', ' Physical Examination ', ' Research Resources ', ' Resources ', ' Sensitivity and Specificity ', ' Technology ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Vestibular Aqueduct ', ' Generations ', ' Diagnostic tests ', ' Dataset ', ' Data Set ', ' Caring ', ' DNA Sequence ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' DNA Sequence Analyses ', ' DNA Sequence Analysis ', ' base ', ' Laryngoscopes ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' screenings ', ' screening ', ' Screening procedure ', ' Training ', ' Selection Criteria ', ' retinitis pigmentosa-congenital deafness syndrome ', ' dystrophia retinae-dysacousis syndrome ', ' dystrophia retinae pigmentosa-dysostosis syndrome (DRD) ', ' dystrophia retinae pigmentosa-dysostosis syndrome ', "" Usher's syndrome "", ' Usher syndrome (US) ', ' Usher Syndrome ', ' Hallgren syndrome ', ' Graefe-Usher syndrome ', ' Retinitis pigmentosa-deafness syndrome ', ' low frequency hearing loss ', ' Low Frequency Deafness ', ' Genetic ', ' Genets ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Frequency ', ' Frequencies (time pattern) ', ' ']",NIDCD,UNIVERSITY OF IOWA,R01,2012,637782,IA-02,0.005176200267921025
"Genetic Factors in Keratoconus    DESCRIPTION (provided by applicant): The purpose of this grant is to identify susceptibility genes involved in the pathogenesis of keratoconus (KC). We will achieve our goal by: 1) refining criteria for the early detection of KC using videokeratography and wavefront Zernike variables; 2) comprehensively testing genes under newly identified linkage peaks generated through genome wide linkage scans of KC families, and performing comprehensive positional candidate gene association studies; and 3) characterizing specific genetic variants that predispose an individual to developing KC. We will study a cohort comprising: normal controls, patients with 'early' KC, KC 'suspect', and KC relatives with videokeratography and aberrometry in order to determine the best combination of variables that discriminate KC 'suspects' from normals. Study subjects will be followed longitudinally to determine which combination of variables is predictive of progression to KC, and thus define subclinical KC (Aim 1). After genome-wide linkage scan of multiplex KC families, we identified regions with significant or suggestive linkage on chromosomes 4, 5, 9, 11, 12, and 14, confirmed by subsequent fine mapping studies. To follow-up these positive linkage findings, we will conduct a comprehensive positional candidate gene association study by testing all genes in these regions with tagSNPs. Any positive association results will be tested in an independent sample for confirmation (Aim 2). Additionally, using newly identified criteria for defining subclinical markers for KC (combination of videokeratography and aberrometry), we will refine our linkage analysis on families with KC in an attempt identify new linkage peaks which may encompass new potential candidate genes for study. Genes identified by both genetic association studies and expression studies published in the literature to date will be prioritized for further study to identify specific genetic variants that contribute to the susceptibility of KC (Aim 3).  Refining criteria for early detection of KC will provide the tools to prevent many patients from under- going unnecessary surgery and developing post-lasik ectasia, a significant public health issue. It will also facilitate identification of susceptibility genes for KC, which may provide an understanding of the mechanisms contributing to corneal thinning in KC. Ultimately, this work may improve our ability to treat KC and/or prevent the development of KC.          ",Genetic Factors in Keratoconus,8540536,R01EY009052,"['Affect ', ' Biologic Marker ', ' Biological Markers ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' Chromosome 4 ', ' Chromosomes, Human, Pair 4 ', ' corneal ', ' Cornea ', ' cornea disorder ', ' Corneal Disorder ', ' Corneal Diseases ', ' Diagnosis ', ' Pathologic Dilatation ', ' Ectasia ', ' Pathological Dilatation ', ' Discriminant Analyses ', ' Discriminant Analysis ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Epithelial Cells ', ' Family ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Grant ', ' Haplotypes ', ' indexing ', ' Keratoconus ', ' Laboratories ', ' Literature ', ' Maps ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Patients ', ' Phenotype ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Testing ', ' Time ', ' transplant ', ' Transplantation ', ' Work ', ' Relative ', ' Relative (related person) ', ' forest ', ' improved ', ' Clinical ', ' Link ', ' Susceptibility ', ' Predisposition ', ' screenings ', ' screening ', ' Screening procedure ', ' Individual ', ' Record Linkage Study ', ' Data Linkages ', ' Genetic ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Unnecessary Surgery ', ' AQP5 protein ', ' aquaporin 5 ', ' Complex ', ' Scanning ', ' corneal epithelial ', ' corneal epithelium ', ' early detection ', ' Early Diagnosis ', ' success ', ' cohort ', ' Videokeratography ', ' Videokeratographies ', ' Study Subject ', ' Pathogenesis ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' linkage analyses ', ' genetic linkage analyses ', ' family based linkage study ', ' Linkage Analysis ', ' genetic linkage analysis ', ' Sampling ', ' case control ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Data ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' genomewide linkage ', ' genome-wide linkage ', ' ']",NEI,CEDARS-SINAI MEDICAL CENTER,R01,2012,164868,CA-28,0.005529316466804952
"Machine Learning Prediction of Cancer Susceptibility    DESCRIPTION (provided by applicant):       Susceptibility to sporadic forms of cancer is determined by numerous genetic factors that interact in a nonlinear manner in the context of an individual's age and environmental exposure. This complex genetic architecture has important implications for the use of genome-wide association studies for identifying susceptibility genes. The assumption of a simple architecture supports a strategy of testing each single-nucleotide polymorphism (SNP) individually using traditional univariate statistics followed by a correction for multiple tests. However, a complex genetic architecture that is characteristic of most types of cancer requires analytical methods that specifically model combinations of SNPs and environmental exposures. While new and novel methods are available for modeling interactions, exhaustive testing of all combinations of SNPs is not feasible on a genome- wide scale because the number of comparisons is effectively infinite. Thus, it is critical that we develop intelligent strategies for selecting subsets of SNPs prior to combinatorial modeling. The objective of this renewal application is to continue the development of a research strategy for the detection, characterization, and interpretation of gene-gene and gene-environment interactions in genome-wide association studies of bladder cancer susceptibility. To accomplish this objective, we will continue developing and evaluating modifications and extensions to the ReliefF family of algorithms for selecting or filtering subsets of single- nucleotide polymorphisms (SNPs) for multifactor dimensionality reduction (MDR) analysis of gene-gene and gene-environment interactions (AIM 1). We will continue developing and evaluating a stochastic wrapper or search strategy for MDR analysis of interactions that utilizes ReliefF values as a heuristic (AIM 2). We will continue to make available ReliefF algorithms as part of our open-source MDR software package (AIM 3). Finally, we will apply the best ReliefF-MDR analysis strategies to the detection, characterization, and interpretation of gene-gene and gene-environment interactions in large genome-wide association studies of bladder cancer susceptibility (AIM 4). We anticipate the proposed machine learning methods will provide powerful new approaches for identifying genetic variations that are predictive of cancer susceptibility.              PROJECT NARRATIVE The technology to measure information about the human genome is advancing at a rapid pace. Despite these advance, the computational methods for analyzing the data have not kept pace. We will develop new computer algorithms and software that can be used to identify genetic biomarkers of common human diseases. We will then apply these new computational methods to identifying genetic biomarkers of bladder cancer in an epidemiological study from New Hampshire.",Machine Learning Prediction of Cancer Susceptibility,8324692,R01LM009012,"['Age ', ' Algorithms ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Engineering / Architecture ', ' Architecture ', ' Urinary Bladder Malignant Tumor ', ' Urinary Bladder Cancer ', ' Malignant Tumor of the Bladder ', ' Malignant Bladder Neoplasm ', ' Bladder Cancer ', ' Malignant neoplasm of urinary bladder ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Analysis ', ' Data Analyses ', ' Environmental Exposure ', ' Family ', ' Genes ', ' human whole genome ', ' Human Genome ', ' Goals ', ' Methods ', ' New Hampshire ', ' Research ', ' computer program/software ', ' Software ', ' Computer software ', ' statistics ', ' Technology ', ' Testing ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Measures ', ' analytical method ', ' base ', ' improved ', ' Evaluation ', ' Susceptibility ', ' Predisposition ', ' Individual ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' programs ', ' Complex ', ' environment effect on gene ', ' gene environment interaction ', ' heuristics ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Modeling ', ' Detection ', ' Validation ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' cancer type ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' combinatorial ', ' computer algorithm ', ' Computational algorithm ', ' open source ', ' human disease ', ' population based ', ' biomarker ', ' genomewide ', ' genome-wide ', ' ']",NLM,DARTMOUTH COLLEGE,R01,2012,369433,NH-02,0.07505714829497181
"Genetic Factors in Keratoconus    DESCRIPTION (provided by applicant): The purpose of this grant is to identify susceptibility genes involved in the pathogenesis of keratoconus (KC). We will achieve our goal by: 1) refining criteria for the early detection of KC using videokeratography and wavefront Zernike variables; 2) comprehensively testing genes under newly identified linkage peaks generated through genome wide linkage scans of KC families, and performing comprehensive positional candidate gene association studies; and 3) characterizing specific genetic variants that predispose an individual to developing KC. We will study a cohort comprising: normal controls, patients with 'early' KC, KC 'suspect', and KC relatives with videokeratography and aberrometry in order to determine the best combination of variables that discriminate KC 'suspects' from normals. Study subjects will be followed longitudinally to determine which combination of variables is predictive of progression to KC, and thus define subclinical KC (Aim 1). After genome-wide linkage scan of multiplex KC families, we identified regions with significant or suggestive linkage on chromosomes 4, 5, 9, 11, 12, and 14, confirmed by subsequent fine mapping studies. To follow-up these positive linkage findings, we will conduct a comprehensive positional candidate gene association study by testing all genes in these regions with tagSNPs. Any positive association results will be tested in an independent sample for confirmation (Aim 2). Additionally, using newly identified criteria for defining subclinical markers for KC (combination of videokeratography and aberrometry), we will refine our linkage analysis on families with KC in an attempt identify new linkage peaks which may encompass new potential candidate genes for study. Genes identified by both genetic association studies and expression studies published in the literature to date will be prioritized for further study to identify specific genetic variants that contribute to the susceptibility of KC (Aim 3).  Refining criteria for early detection of KC will provide the tools to prevent many patients from under- going unnecessary surgery and developing post-lasik ectasia, a significant public health issue. It will also facilitate identification of susceptibility genes for KC, which may provide an understanding of the mechanisms contributing to corneal thinning in KC. Ultimately, this work may improve our ability to treat KC and/or prevent the development of KC.          ",Genetic Factors in Keratoconus,8215705,R01EY009052,"['Affect ', ' Biologic Marker ', ' Biological Markers ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' Chromosome 4 ', ' Chromosomes, Human, Pair 4 ', ' corneal ', ' Cornea ', ' cornea disorder ', ' Corneal Disorder ', ' Corneal Diseases ', ' Diagnosis ', ' Pathologic Dilatation ', ' Ectasia ', ' Pathological Dilatation ', ' Discriminant Analyses ', ' Discriminant Analysis ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Epithelial Cells ', ' Family ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Grant ', ' Haplotypes ', ' indexing ', ' Keratoconus ', ' Laboratories ', ' Literature ', ' Maps ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Patients ', ' Phenotype ', ' Public Health ', ' public health medicine (field) ', ' Publishing ', ' Testing ', ' Time ', ' transplant ', ' Transplantation ', ' Work ', ' Relative ', ' Relative (related person) ', ' forest ', ' improved ', ' Clinical ', ' Link ', ' Susceptibility ', ' Predisposition ', ' screenings ', ' screening ', ' Screening procedure ', ' Individual ', ' Record Linkage Study ', ' Data Linkages ', ' Genetic ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Unnecessary Surgery ', ' AQP5 protein ', ' aquaporin 5 ', ' Complex ', ' Scanning ', ' corneal epithelial ', ' corneal epithelium ', ' early detection ', ' Early Diagnosis ', ' success ', ' cohort ', ' Videokeratography ', ' Videokeratographies ', ' Study Subject ', ' Pathogenesis ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' linkage analyses ', ' genetic linkage analyses ', ' family based linkage study ', ' Linkage Analysis ', ' genetic linkage analysis ', ' Sampling ', ' case control ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Data ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' genomewide linkage ', ' genome-wide linkage ', ' ']",NEI,CEDARS-SINAI MEDICAL CENTER,R01,2012,672532,CA-28,0.005529316466804952
"A MACHINE LEARNING APPROACH FOR FINE-SCALE GENOME WIDE DNA METHYLATION ANALYSIS    DESCRIPTION (provided by applicant): Epigenetic regulation of gene expression through variation in DNA methylation plays a critical role in a range of biological processes including cellular differentiation, human disease and cancer. New methods for determining the fine structure of methylation patterns genome-wide have led to an explosion of research in this field. Methylation near the gene promoter is correlated with gene silencing, while unmethylated promoters are potentially active. Current computational methods classify genes as either methylated and silenced or unmethylated and potentially active based on a coarse calculation of CpG methylation state across a window of a few hundred base pairs around the transcription start site. The detailed spatial pattern of methylation across the promoter may be an important determinant of gene expression, but current computational methods ignore this valuable information. Recent work has found regions proximal to CpG island promoters, dubbed ""CpG island shores"", whose methylation state correlates with transcription. CpG island shores are loosely defined, however, and this concept is difficult to apply in practice. While other methylation signatures are also likely to correlate with gene expression, a general framework to identify and study them has not been established. New computational tools for identification and correlation of detailed methylation patterns with gene expression are critical for advancing our understanding of the epigenetics of gene regulation. We propose to develop software tools to detect new methylation signatures at gene promoters that correlate with expression. This will be done within a formal framework so that these signatures can be used to determine differentially methylated genes in a variety of study designs. Taking advantage of the fact  that methylation over short ranges are highly correlated, we will interpolate methylation data at individual  CpG sites in a 10 kb window around the TSS to yield a methylation signature at each promoter that is  independent of primary sequence features. We will then use a metric from topology, the discrete Frechet distance, to calculate the similarity between methylation signatures, and apply this metric to cluster signatures of similar type. We will then determine clusters with methylation signatures that correlate with expression.  Clusters that contain both silenced and expressed genes will be examined to see if other local primary sequence features can be used to discriminate the genes based on expression. This approach will be used to detect methylation changes in case-control studies and in pairwise comparisons, such as needed for timecourse analysis or for the detection of different states of differentiation. The general framework developed here can be expanded in the future to examine methylation signatures at enhancers and gene bodies, as well as to histone marks or other genomic signals that carry detailed spatial information.          Narrative  DNA methylation, the addition of a methyl group to the cytosine in CpG dinucleotides, is an important  epigenetic regulator of gene expression in cells. DNA methylation has been implicated in a large number of  biological processes including cellular differentiation and cancer. We will develop software tools to analyze  data from new techniques for mapping DNA methylation genome-wide to discover new methylation signatures  that are associated with silenced and active genes. These will include tools to use these signatures to  determine what genes are differentially regulated in different cell types and in human disease.",A MACHINE LEARNING APPROACH FOR FINE-SCALE GENOME WIDE DNA METHYLATION ANALYSIS,8500440,R21LM011199,"['Algorithms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Cells ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Data Analysis ', ' Data Analyses ', ' Explosion ', ' Future ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Histones ', ' In Vitro ', ' Learning ', ' Maps ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Play ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' computer program/software ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Time ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' Enhancers ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' Dataset ', ' Data Set ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Individual ', ' Biological Function ', ' Biological Process ', ' CpG-Rich Islands ', ' CpG Islands ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cell type ', ' Pattern ', ' Techniques ', ' methyl group ', ' Gene Inactivation ', ' Gene Silencing ', ' Base Pairing ', ' Structure ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Metric ', ' Reporting ', ' Sampling ', ' spatial neglect ', ' developing computer software ', ' develop software ', ' software development ', ' Genomics ', ' Transcription Start Site ', ' Transcription Initiation Site ', ' Data ', ' Detection ', ' Resolution ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Process ', ' computational tools ', ' computerized tools ', ' human disease ', ' genomewide ', ' genome-wide ', ' ']",NLM,WASHINGTON UNIVERSITY,R21,2013,135645,MO-01,0.03449488831525746
"Information Explorer: a Suite of Tools for Cross-study Genetic Loci Discovery    DESCRIPTION (provided by applicant): Databases such as dbGaP represent extremely valuable resources of data that have been assembled across multiple cohorts. The increasing development of cost-effective high-throughput genotyping and sequencing technologies are resulting in vast amounts of genetic data. While such databases were formed in order to archive and distribute the results of previously performed genetic association analyses, an increasing number of studies have provided de-identified individual-level genotypic and phenotypic data that are made available to outside researchers who have obtained the appropriate authorization. While the amount of data made available has increased dramatically in recent years, relatively little has been done in order to facilitate phenotype harmonization across studies. Many genetic epidemiologic studies of cardiovascular disease have multiple variables related to any given phenotype, resulting from different definitions and multiple measurements or subsets of data. A researcher searching such databases for the availability of phenotype and genotype combinations is confronted with a veritable mountain of variables to sift through. This often requires visiting multiple websites to gain additional information about variables that are listed on databases, and examination of data distributions to assess similarities across cohorts. While the naming strategy for genetic variants is largely standardized across studies (e.g. ""rs"" numbers for single nucleotide polymorphisms or SNPs), this is often not the case for phenotype variables. For a given study, there are often numerous versions of phenotypic variables. Researchers currently have to analyze and compare increasingly larger numbers of variables that have varying degrees of documentation associated with them to obtain the desired information. This is a time-consuming process that may still miss the most appropriate variables. Moreover, every researcher that wants to compare the same datasets often needs to start from scratch since there are no tools to share the phenotype comparison results. The availability of informatic tools to make phenotype mapping more efficient and improve its accuracy, along with intuitive phenotype query tools, would provide a major resource for researchers utilizing these databases. The tools we are proposing would allow researchers to (1) Quickly obtain the information needed to assess whether a specific study will be useful for the hypothesis of interest; (2) Exclude variables that do not meet research criteria; (3) Ascertain which studies have combinations of phenotype and genetic information of interest; and (4) More easily expand research questions beyond the most basic main-effects to more complex analyses such as gene-by-environment interactions and multivariate tests incorporating multiple phenotypes. The increased utility will also enable larger meta-analyses to be performed, as researchers will be able to more quickly hone in on outcomes, exclusionary variables and covariates of interest, leading to increased statistical power to detect genetic associations.        While the amount of genomic data (e.g., GWAS, sequencing, etc.) made available has increased dramatically in recent years, relatively little has been done in order to facilitate phenotype harmonization across studies. The tools we are proposing would allow researchers to quickly identify data sets of interest, expand research questions beyond the most basic main-effects to more complex analyses such as gene-by-environment interactions and multivariate test incorporating multiple phenotypes, and perform larger meta-analyses easily by honing in on outcomes, exclusionary variables and covariates of interest with increased statistical power to detect genetic associations.         ",Information Explorer: a Suite of Tools for Cross-study Genetic Loci Discovery,8733017,UH3HL108780,"['epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Archives ', ' Machine Intelligence ', ' Computer Reasoning ', ' Artificial Intelligence ', ' Blood Reticuloendothelial System ', ' Blood ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' Systematics ', ' Classification ', ' Foundations ', ' Future ', ' Genotype ', ' Heart ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' Maps ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Names ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Phenotype ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Sleep ', ' Technology ', ' Testing ', ' Time ', ' Work ', ' Information Retrieval ', ' Measures ', ' conference ', ' symposium ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Solid ', ' Biological ', ' Link ', ' Training ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' Systems Integration ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' Source ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' Visit ', ' meetings ', ' post-doctoral ', ' post-doc ', ' Research Associate ', ' Postdoc ', ' Postdoctoral Fellow ', ' experience ', ' environment effect on gene ', ' gene environment interaction ', ' Performance ', ' cohort ', ' Informatics ', ' trait ', ' graduate student ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' genetic epidemiology ', ' repository ', ' developing computer software ', ' develop software ', ' software development ', ' Genomics ', ' Documentation ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' genetic association ', ' Data ', ' Validation ', ' Process ', ' Permission ', ' Authorization ', ' Authorization documentation ', ' developmental ', ' Development ', ' website ', ' web site ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' Outcome ', ' scale up ', ' cost-effective ', ' cost effective ', ' data structure ', ' usability ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' ']",NHLBI,UNIVERSITY OF SOUTHERN CALIFORNIA,UH3,2013,500000,CA-37,0.010641247570076206
"Novel Strategies to Identify GxE Contributions to MS Pathogenesis    DESCRIPTION (provided by applicant):  Multiple sclerosis (MS) is a complex and heterogeneous inflammatory disorder of the central nervous system characterized by myelin loss, varying degrees of axonal pathology, and progressive neurological dysfunction. The combined effect of many genes, environmental exposures acting during defined periods of life, and their interactions in MS is strongly supported by our own work and others. The involvement of HLA class II genes within the major histocompatibility complex (MHC) on chromosome 6p21 is well-established. The identification of non-MHC determinants of MS susceptibility, while progressing, is far from complete. Similar to other complex diseases, genome-wide association studies (GWAS) have begun to unravel the polygenic etiology of MS. However, variants identified through several large GWAS, to date, explain only a very small proportion of MS heritability. The proposed study describes critical post-GWAS era steps to further our current understanding of MS pathogenesis. First, we will utilize next-generation DNA sequence data, high-throughput genotyping and state-of-the-art bioinformatics methods to fully characterize rare, less frequent and common variants within more than 30 MS genes established through recent GWAS and their contribution to the development of MS and disease expression (Aim 1). Next, we will also comprehensively investigate a number of important life-course exposures including prenatal, perinatal, childhood, adolescent and adult time periods, GxE interactions and risk of MS (Aim 2). Finally, we will study genome-wide DNA methylation profiles in a newly established cohort of clinically isolated syndrome (CIS)/early MS cases and matched controls to identify immune cell specific epigenetic influences on the development of MS (Aim 3). We will utilize extraordinary MS case-control resources nested within the large, population-based membership of Northern California Kaiser Permanente, as well as DNA, genetic and clinical data assembled for this project through the International Multiple Sclerosis Genetics Consortium; more than 10,000 individuals of White/European ancestry will be studied using a suite of statistical methods of analysis. Results from proposed epidemiologic studies of the most important MS genes and causal variants in the context of relevant environmental exposures will inform new functional studies, and have potential to support the development of more effective approaches for prevention, diagnosis and treatment.         The complete identification of genetic and environmental influences and how they contribute independently and jointly to the development of MS and expression of particular disease characteristics would play a major role in understanding disease etiology, and would contribute greatly to disease prevention strategies and development of targeted and more effective therapies.         ",Novel Strategies to Identify GxE Contributions to MS Pathogenesis,8463531,R01ES017080,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' California ', ' Cells ', ' Central Nervous System Disorders ', ' CNS disorder ', ' CNS Diseases ', ' Central Nervous System Diseases ', ' Chromosomes ', ' Chronology ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Environmental Exposure ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Foundations ', ' Genes ', ' MHC Class II ', ' HLA Class II Genes ', ' Class II Genes ', ' MHC Class II Genes ', ' Genotype ', ' Laboratories ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Major Histocompatibility Complices ', ' Histocompatibility Complices ', ' Histocompatibility Complex ', ' Major Histocompatibility Complex ', ' Methods ', ' insular sclerosis ', ' MS (Multiple Sclerosis) ', ' Disseminated Sclerosis ', ' Multiple Sclerosis ', ' Myelin ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Odds Ratio ', ' Pathology ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Survey Instrument ', ' Surveys ', ' Syndrome ', ' Testing ', ' Time ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Work ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' Perinatal ', ' Site ', ' Variation ', ' Variant ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Susceptibility ', ' Predisposition ', ' pediatric ', ' Childhood ', ' Individual ', ' Trust ', ' European ', ' Collaborations ', ' Genetic ', ' Inflammatory ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Dimensions ', ' Immune ', ' Complex ', ' environment effect on gene ', ' gene environment interaction ', ' cohort ', ' disease characteristic ', ' unborn ', ' prenatal ', ' novel ', ' disease prevention ', ' disorder prevention ', ' Preventive strategy ', ' Prevention strategy ', ' disease risk ', ' disorder risk ', ' Pathogenesis ', ' neurological dysfunction ', ' Neurologic Dysfunctions ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' case control ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' International ', ' Clinical Data ', ' Clinical Management ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Risk Estimate ', ' 6p21 ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' insertion/deletion ', ' insertion-deletion mutation ', ' insertion-deletion ', ' insertion/deletion mutation ', ' next generation ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' Heritability ', ' population based ', ' effective treatment ', ' effective therapy ', ' genomewide ', ' genome-wide ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA BERKELEY,R01,2013,587939,CA-13,0.02716744819163121
"Whole-Genome Prediction of Type-2 Diabetes Susceptibility in Various Populations     DESCRIPTION (provided by applicant): The applicant's career goal is to become a productive independent investigator in the area of statistical genetics, particularly in the area of genomic-based prediction of type-2 diabetes (T2D) risk. To meet this goal, the applicant proposes a career development plan that includes hands- on and didactic training in statistical learning as applied to quantitative genetics, categorical and case-control data analysis, informatics as applied to high dimensional genetic data, and the biology and genetics of T2D. A highly accomplished and diverse set of investigators with proven track records of successful mentoring will oversee the applicant's career development. The research component of this project seeks to improve our ability to use genetic information to predict an individual's risk of developing T2D Publically available genetic and phenotypic data from sources such as dbGaP (The database of Phenotypes and Genotypes) will be used to develop and test various models for prediction of T2D risk among three racial/ethnic groups. This project will capitalize on newly developed statistical methods that are able to incorporate information from tens of thousands of genetic markers at once, which represent a major advance over current methods that typically take fewer than 100 markers into account. The aims of the study are: 1) To test the hypothesis, in different populations, that individualized whole-genome prediction of T2D (along with standard covariates of sex, age, and BMI) will offer major improvements over current genetics-based prediction models, and will offer equal or greater accuracy than prediction based on family history; 2) To impute additional genetic markers to determine whether prediction can be improved, and to identify the subset of markers that is most useful in predicting T2D; 3) To develop prediction models for T2D risk given a certain body mass index (BMI), by including as predictors the interaction of BMI and genotypes. This project will greatly enhance our ability to predict an individual's susceptibility to T2D within various populations, leading to earlier and targeted prevention strategies, will increase our understanding of the genetic basis of T2D, and will provide critical training for Dr. Klimentidis' development as an independent scientist.      Genetic factors are known to play a substantial role in the etiology of type-2 diabetes (T2D), which is a growing health challenge facing developed and developing countries. In this application, we propose to use state-of-the-art statistical methods that enable us to account for thousands of genetic variants simultaneously, in order to build and test predictive models for T2D susceptibility among individuals of European, Mexican, and African descent. This project has the potential to greatly improve prediction of T2D susceptibility in several ethnic groups, provide a better understanding of the specific genetic factors that play a role in T2D susceptibility, and ultimately bring us closer to the era of personalized medicine in which improved prediction ability results in earlier patient-oriented prevention and treatment.            ",Whole-Genome Prediction of Type-2 Diabetes Susceptibility in Various Populations,8531237,K01DK095032,"['Accounting ', ' Affect ', ' Age ', ' Engineering / Architecture ', ' Architecture ', ' Biology ', ' Biomedical Research ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Data Analysis ', ' Data Analyses ', ' Data Sources ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Nation ', ' Developing Country ', ' Developing Countries ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Ethnic group ', ' Family ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genome ', ' Genotype ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Medicine ', ' Mentors ', ' Methods ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Play ', ' Publishing ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Records ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Scoring Method ', ' Testing ', ' Weight ', ' Dataset ', ' Data Set ', ' animal breeding ', ' base ', ' career ', ' improved ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Individual ', ' African ', ' European ', ' Mexican ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Family history of ', ' Development Plans ', ' Funding ', ' Industrialized Nations ', ' Industrialized Countries ', ' Developed Nations ', ' Developed Nation ', ' Developed Country ', ' Developed Countries ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Scientist ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Source ', ' Height ', ' meetings ', ' environment effect on gene ', ' gene environment interaction ', ' Informatics ', ' trait ', ' Preventive strategy ', ' Prevention strategy ', ' disease risk ', ' disorder risk ', ' Prevention ', ' Reporting ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Statistical Methods ', ' Modeling ', ' career development ', ' case control ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' diabetes risk ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' Quantitative Genetics ', ' Genetic Risk ', ' sex ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' computer based prediction ', ' predictive modeling ', ' Population ', ' racial/ethnic ', ' racial and ethnic ', ' patient centered ', ' patient oriented ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' ']",NIDDK,UNIVERSITY OF ARIZONA,K01,2013,145584,AZ-03,0.006372623996776734
"Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers DESCRIPTION (provided by applicant): Epigenetic silencing involving alterations in DNA methylation and chromatin structure at promoter region CpG islands is a common mechanism of tumor suppressor gene inactivation in human cancers. However, the mechanisms underlying this event remain poorly understood. An unresolved question is why are some genes targets of aberrant methylation in human cancers while others are never affected? In preliminary work, we have shown that even in the context of an increased cellular capacity for de novo methylation, CpG islands differ in their potential for aberrant methylation. By applying DNA pattern recognition and machine learning techniques, we have developed an algorithm based on several short sequence patterns that is capable of accurately discriminating methylation-prone and methylation-resistant CpG islands. These studies indicate that the epigenetic status of a CpG island can be predicted based on DNA sequence features, and lead us to propose that one factor contributing to the non-random patterns of CpG island methylation observed in human tumors is an underlying susceptibility conferred by local sequence context. The goal of this proposal is to define the genomic signature associated with aberrant methylation. The long term objectives are (i) to identify and to functionally characterize local sequence attributes that contribute to the propensity towards, or protection from, aberrant methylation, and (ii) to develop and to test novel tumor specific classifiers capable of predicting genomic loci at risk of aberrant methylation. Specifically, we will determine whether sequence features identified in silico act in cis to promote or to prevent de novo methylation in vivo using an episomal transgene approach. In preliminary work, we have identified a relationship between methylation-prone CpG islands and genomic regions bound by the polycomb repressor complex. As a second component of the project, we will determine the role of PRC2 in methylation susceptibility. As a third component of this project we will refine our computational models by 1) determining whether CpG islands predicted to be methylation-prone are in fact targets of aberrant methylation in human cancers, 2) using this information to re-train the prediction model, and 3) developing and testing a novel lung cancer specific classifier based on large-scale CpG island methylation data from primary lung tumors. We anticipate that the information gained from these studies will allow for a better understanding of the mechanisms underlying the epigenetic silencing of tumor suppressor genes that accompanies carcinogenesis. Moreover, the ability to predict the methylation status of CpG islands genome-wide will provide an important resource for the identification of novel gene targets for further study as potential cancer biomarkers. Project Narrative  The overarching goal of this research is to better understand the mechanisms by which  important growth regulatory genes are targeted for epigenetic silencing in human cancers.  Although the consequences of this event are the same as a mutation, there is no molecular  defect in the DNA sequence itself. Rather, there is a problem with methylation marks on the  DNA and the histone proteins it is wrapped around that render certain genes abnormally and  permanently silent. We plan to use a computational approach to identify DNA features that put  certain genes at risk of aberrant methylation. Because genes that are silenced by methylation  are otherwise structurally sound, the potential for reactivating these genes by blocking or  reversing the methylation process represents an exciting molecular target for chemotherapeutic  intervention. A better understanding of the factors that contribute to aberrant methylation,  including the identification of sequence features that attract or repel DNA methylation, will be an  important step in achieving this long-term goal. Moreover, the ability to identify those genes at  risk of epigenetic silencing will provide novel molecular targets for further study as potential  biomarkers for improved cancer diagnosis and treatment planning.",Defining Genomic Signatures for Aberrant DNA Methylation in Human Cancers,8459567,R01CA132065,"['Affect ', ' Algorithms ', ' Alu Repetitive Sequences ', ' Alu Family ', ' Alu Elements ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' nonsmall cell lung cancer ', ' Non-Small Cell Lung Cancer ', ' NSCLC - Non-Small Cell Lung Cancer ', ' NSCLC ', ' Non-Small-Cell Lung Carcinoma ', ' cell culture ', ' Cell Culture Techniques ', ' Systematics ', ' Classification ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Deoxyribonucleic Acid ', ' DNA ', ' Site-Specific DNA-methyltransferase ', ' Modification Methylases ', ' EC 2.1.1.113 ', ' Dnmt ', ' DNA-Methyltransferases ', ' DNA Modification Methyltransferases ', ' DNA Modification Methylases ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' human whole genome ', ' Human Genome ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Pulmonary Neoplasms ', ' Lung Tumor ', ' Lung Neoplasms ', ' Protein Methylation ', ' Methylation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Play ', ' genetic promoter element ', ' Promotor Regions (Genetics) ', ' Promotor Regions ', ' Promoter Regions ', ' Promoter Regions (Genetics) ', ' Protein Modification ', ' Posttranslational Protein Processing ', ' Posttranslational Modifications ', ' Post-Translational Protein Modification ', ' Post-Translational Modifications ', ' Post-Translational Modification Protein/Amino Acid Biochemistry ', ' Post-Translational Protein Processing ', ' gene product ', ' Proteins ', ' Publishing ', ' recruit ', ' Recruitment Activity ', ' Repression ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' sound ', ' Strikes ', ' Employee Strikes ', ' Testing ', ' Work ', ' Generations ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Tumor Suppressor Genes ', ' Polycomb ', ' Mediating ', ' Promotor ', ' Promoters (Genetics) ', ' Promoter ', ' Promotor (Genetics) ', ' DNA Sequence ', ' base ', ' improved ', ' Site ', ' Susceptibility ', ' Predisposition ', ' Training ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Gene Targeting ', ' Biological Function ', ' Biological Process ', ' CpG-Rich Islands ', ' CpG Islands ', ' Transgenes ', ' Shapes ', ' Malignant Cell ', ' cancer cell ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Event ', ' Pattern ', ' Techniques ', ' Cancer Induction ', ' carcinogenesis ', ' tumor suppressor ', ' Tumor Suppressor Proteins ', ' Gene Inactivation ', ' Gene Silencing ', ' treatment planning ', ' Primary Tumor ', ' Primary Neoplasm ', ' novel ', ' Coding System ', ' Code ', ' Modeling ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' anticancer therapy ', ' Malignant Neoplasm Treatment ', ' Malignant Neoplasm Therapy ', ' Cancer Treatment ', ' cancer therapy ', ' cancer diagnosis ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' preventing ', ' prevent ', ' Defect ', ' Aberrant DNA Methylation ', ' DNA Methyltransferase ', ' Data ', ' Deletion Mutation ', ' Ectopic Expression ', ' Hypermethylation ', ' Molecular Target ', ' in vivo ', ' Chromatin Structure ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Pattern Recognition ', ' Tumor-Suppressor Gene Inactivation ', ' Molecular ', ' Process ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' Cancer cell line ', ' resistant ', ' Resistance ', ' tumor ', ' overexpress ', ' overexpression ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' Chip Chip ', ' Chip on Chip ', ' ']",NCI,EMORY UNIVERSITY,R01,2013,287765,GA-05,0.04321429039762594
"Empowering Personalized Medicine: Integrating Imaging, Genetics, and Biomarkers     DESCRIPTION (provided by applicant): This project, Empowering Personalized Medicine: Integrating Imaging, Genetics and Biomarkers, responds to RFA-MH-12-020, entitled Integrating Multi-Dimensional Data to Explore Mechanisms Underlying Mental Disorders. By bringing together experts in neuroimaging, genetics, and mathematics, we plan to create an advanced, portable framework to combine diverse biomedical data from 3D neuroimaging (MRI, amyloid/FDG-PET), gene expression networks, genome-wide association studies (GWAS), and other multidimensional data (e.g., physiological biomarkers, epigenetic data, etc.). Our overall goal is to improve diagnosis and prognosis of disease by combining multiple levels of biological information (personalized medicine). In doing so, novel mathematical tools will automatically discover which biomarkers are most helpful in different contexts. To discover and test relationships between very high-dimensional measures (such as images and genomes), we use novel concepts for data reduction such as penalized regression (elastic nets), adaptive hierarchical clustering, Bayesian networks, and support vector machines. Avoiding the limitations of current work that tests individual gene effects independently, we extend the analysis of gene expression networks to images, to relate signs of disease to their genetic underpinnings and to all available biomarkers. Aim 1 empowers discovery genetic variants (identified in GWAS, whole-exome and whole-genome sequencing) that modulate measures of disease. We will use compressive coding models to discover and verify which sets of genetic variants affect multidimensional images (e.g., co-registered MRI & PET, DTI). We will verify our predictions using k-fold cross-validation and independent replications in new samples and controllable test data. Aim 2 extends our work using weighted gene co-expression network analysis (WGCNA) from single traits to entire databases of 3D images (MRI/PET). Our framework will merge GWAS, eQTL analysis, and expression-phenotype analysis but will be broadly applicable to any future high-throughput biological information (e.g. methylation profiles, DTI, fMRI). In Aim 3, we will quantify the added predictive value derivable from genotyping, gene expression profiling, and multimodal neuroimaging for personalized prognosis and diagnosis. For example, which biomarkers (gene expression, CSF, MRI) are most useful in which cases? To maximize impact of this effort, we and our collaborators will test our tools on existing and new datasets from a range of neuropsychiatric disorders including frontotemporal dementia, Alzheimer's disease, schizophrenia, bipolar disorder, and autism (see Support Letters). All tools will be disseminated and linked to web-accessible databases that store and ease access to high-throughput genetic, genomic, and imaging datasets.          Our project improves diagnosis and predictions of patient outcomes by integrating diverse types of patient data including neuroimaging, gene expression profiles, cognitive, and behavioral markers of disease diagnosis, progression, and treatment response. To tackle these complex data types, we develop novel machine learning, network analysis, and database methods. Our personalized medicine approach will help researchers study and evaluate neurological and psychiatric conditions such as Alzheimer's disease, frontotemporal dementia, schizophrenia, bipolar disorder, and autism.                ","Empowering Personalized Medicine: Integrating Imaging, Genetics, and Biomarkers",8464281,R01MH097268,"['Affect ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Amyloid Substance ', ' Amyloid ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' manic depressive illness ', ' manic depressive disorder ', ' bipolar affective disorder ', ' Manic-Depressive Psychosis ', ' Bipolar Affective Psychosis ', ' Bipolar Disorder ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Clinical Study ', ' Clinical Research ', ' depression ', ' Mental Depression ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Future ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genome ', ' Genotype ', ' Goals ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Mathematics ', ' Medicine ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Persons ', ' neuronal degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' Neurosciences ', ' Patients ', ' Phenotype ', ' Rad.-PET ', ' Positron Emission Tomography Scan ', ' Positron Emission Tomography Medical Imaging ', ' PETT ', ' PETSCAN ', ' PET imaging ', ' PET Scan ', ' PET ', ' Positron-Emission Tomography ', ' Prognosis ', ' outcome forecast ', ' Publishing ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Running ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Testing ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Weight ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' brain visualization ', ' Brain imaging ', ' Site ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Physiologic ', ' Physiological ', ' Neurological ', ' Neurologic ', ' Link ', ' prognostic ', ' insight ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Funding ', ' Letters ', ' Genetic ', ' tool ', ' frontotemporal lobar dementia ', ' fronto-temporal lobar dementia ', ' fronto-temporal dementia ', ' Frontotemporal Dementia ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' Complex ', ' Equation ', ' empowered ', ' experience ', ' success ', ' Informatics ', ' trait ', ' Structure ', ' genetic testing ', ' Genetic screening method ', ' neuroimaging ', ' novel ', ' disease risk ', ' disorder risk ', ' Modality ', ' gene expression analysis ', ' Transcript Expression Analysis ', ' Transcript Expression Analyses ', ' Gene Expression Pattern Analysis ', ' Gene Expression Monitoring ', ' Gene Expression Profiling ', ' Coding System ', ' Code ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' neuropsychiatric ', ' neuropsychiatry ', ' fluorodeoxyglucose PET ', ' FDG PET ', ' fluorodeoxyglucose positron emission tomography ', ' Genomics ', ' 3D images ', ' 3D image ', ' 3-D image ', ' 3-D Images ', ' Three-Dimensional Image ', ' genome sequencing ', ' Address ', ' Data ', ' molecular signature ', ' molecuar profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' NCRR ', ' National Center for Research Resources ', ' Predictive Value ', ' Cognitive ', ' Validation ', ' Behavioral ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' Bayesian Networks ', ' computer based statistical methods ', ' neurodegenerative dementia ', ' Outcome ', ' endophenotype ', ' computer algorithm ', ' Computational algorithm ', ' web-accessible ', ' mathematical algorithm ', ' treatment response ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' disease diagnosis ', ' exomes ', ' exome ', ' data reduction ', ' epigenetic biomarker ', ' epigenetic marker ', ' ']",NIMH,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2013,387866,CA-33,0.0006912161916051402
"Enhanced Gene Identification in Complex Traits Using Kernel Machines DESCRIPTION (provided by applicant):  Project Summary/Abstract Genome-wide association studies (GWAS) have mapped thousands of common trait-influencing variants yet the overwhelming majority of trait loci have yet to be discovered. The goal of this proposal is to develop and apply statistical approaches that move beyond the standard GWAS paradigm to map additional trait-influencing variation within the human genome. Most of our proposed tools are based on a flexible high-dimensional framework called kernel machine regression, which we have had past success employing for powerful gene mapping of complex traits in GWAS and next-generation sequencing (NGS) studies. We believe the inherent flexibility of the kernel framework makes it ideal for exploring new paradigms in gene mapping of complex human traits. Aim 1 proposes novel kernel methods for integrated analysis of both single-nucleotide variation data (derived from GWAS and/or NGS) and genomic data (such as gene-expression and methylation patterns) that we believe will provide improved power for trait mapping. Aim 2 proposes novel kernel methods for large scale gene-gene interaction analysis across the genome, as well as a computational approach that enables efficient adjustment for multiple testing when applying such exhaustive testing procedures. Aim 3 establishes novel kernel methods for association mapping of SNVs on the X chromosome. The flexible nature of kernel machines makes it ideal for modeling potential sex-specific effects on this chromosome and the methods further can accommodate random X inactivation. Aim 4 proposes novel kernel approach for robust analysis of rare trait-influencing variation within families; such family-based designs are generally not considered in current rare-variant procedures. We will evaluate these methods on large-scale datasets that we are actively involved in and will implement the methods in user-friendly software for public distribution (Aim 5). PUBLIC HEALTH RELEVANCE:  Project Narrative The goal of this project is to develop novel and powerful statistical tools for identifying genetic loci acting independently or in conjunction with other genetic/environmental factors to influence complex human diseases or disease-related quantitative traits. Application of the proposed methods to applied datasets should improve our understanding of the genetic origins of complex traits and enhance existing risk-prediction models of complex disease.",Enhanced Gene Identification in Complex Traits Using Kernel Machines,8598704,R01HG007508,"['Play ', ' Exhibits ', ' Family ', ' Data Set ', ' Gene Expression ', ' Genes ', ' Genome ', ' Human Genome ', ' public health medicine (field) ', ' abstracting ', ' Health ', ' Goals ', ' Research Personnel ', ' Research Design ', ' Risk ', ' Role ', ' Human ', ' Technology ', ' Computer software ', ' Post-Traumatic Stress Disorders ', ' Methods ', ' Methylation ', ' Linkage Disequilibrium ', ' Maps ', ' Literature ', ' Testing ', ' Joints ', ' Study models ', ' Chromosome Mapping ', ' Chromosomes ', ' genetic pedigree ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Disease ', ' genetic analysis ', ' Nuclear Family ', ' Nucleotides ', ' Work ', ' X Chromosome ', ' X Inactivation ', ' gene interaction ', ' Statistical Methods ', ' interest ', ' Modeling ', ' Epilepsy ', ' Link ', ' Simulate ', ' tool ', ' Performance ', ' case control ', ' Variant ', ' Biological ', ' trait ', ' Individual ', ' Medical ', ' base ', ' Genetic ', ' user friendly software ', ' Sex Bias ', ' Nature ', ' Machine Learning ', ' success ', ' Complex ', ' Genomics ', ' improved ', ' X inherited trait ', ' Procedures ', ' Source ', ' Pattern ', ' novel ', ' Environmental Risk Factor ', ' Gene Localization ', ' Gene Mapping ', ' Gene Mapping Genetics ', ' Linkage Mapping ', ' Total Human and Non-Human Gene Mapping ', ' genetic mapping ', ' Other Genetics ', ' population based ', ' stem ', ' Scientific Advances and Accomplishments ', ' open source ', ' human disease ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' Address ', ' flexibility ', ' next generation sequencing ', ' Adult-Onset Diabetes Mellitus ', ' genome wide association study ', ' Disorder ', ' Epileptic Seizures ', ' Epileptics ', ' Seizure Disorder ', ' epilepsia ', ' epileptiform ', ' epileptogenic ', ' disease/disorder ', ' sex ', ' Ketosis-Resistant Diabetes Mellitus ', ' MODY ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' genetic variant ', ' PTSD ', ' Post-Traumatic Neuroses ', ' Posttraumatic Neuroses ', ' Posttraumatic Stress Disorders ', ' traumatic neurosis ', ' DNA Resequencing ', ' human whole genome ', ' Data ', ' design ', ' Protein Methylation ', ' Lyonization ', ' X-Chromosome Inactivation ', ' Man (Taxonomy) ', ' Modern Man ', ' Pedigree ', ' pedigree structure ', ' Articulation ', ' Public Health ', ' Researchers ', ' kernel methods ', ' statistical learning ', ' support vector machine ', ' social role ', ' Study Type ', ' study design ', ' Investigators ', ' Software ', ' computer program/software ', ' Variation ', ' Gender Bias ', ' Sexism ', ' user friendly computer software ', ' X linked trait ', ' Dataset ', ' Environmental Factor ', ' environmental risk ', ' scientific accomplishments ', ' scientific advances ', ' Resequencing ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' whole-genome scan ', ' flexible ', ' designing ', ' Genetic analyses ', ' GWAS ', ' genome wide analysis ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genome wide screen ', ' genome wide studies ', ' genome-wide identification ', ' genome-wide scan ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' genomewide scan ', ' ']",NHGRI,EMORY UNIVERSITY,R01,2013,350000,GA-05,0.011661410742288544
"Genome Wide Association Study of Head and Neck Cancer    DESCRIPTION (provided by applicant): Head and neck cancers have well-documented associations with tobacco and alcohol exposure, but the disease develops in only a small fraction of users, which implies an important role for genetic susceptibility. Therefore, head and neck cancers are an excellent model for studying genetic susceptibility to environmental carcinogens. The primary goal of this R01 application is to perform a comprehensive two-stage, high-density, genome-wide single-nucleotide polymorphism (SNP) analysis of head and neck cancer cases and corresponding frequency matched controls to identify novel genetic risk factors for head and neck cancer. This proposal builds upon a well-annotated existing DNA repository of cases and controls. One of the unique features of our study is the availability of DNA repair assay data on most of the cases and controls in this study, which will allow us to conduct genotype/phenotype analyses. We also have access to genome-wide association data from 1200 white control subjects from the same source population. In aim 1, we will perform genotyping on 1000 randomly selected head and neck cancer cases and 500 controls using a 370K Illumina Infinium HapMap HumanCNV370-Duo SNP Chip. We will perform association analyses (1000 cases and 1700 controls) in the first stage using outcome variable as case-control status as well as DNA repair capacity assay data. Our second aim is to perform second-stage analysis of the SNPs selected in stage 1 using 900 additional cases and corresponding controls from the same source and from UCLA. We will use efficient joint analysis of cases and controls from the first and second aims, for a total of 1900 cases and 2600 controls. Finally, in aim 3, we will apply novel statistical tools such as the latent variable approach with Tukey's one-degree-of-freedom test and support vector machines to identify gene-gene and gene-environment (using environmental factors such as smoking and alcohol use) interactions that contribute to the risk of head and neck cancer. We are an experienced investigative team proposing a comprehensive analysis that incorporates epidemiological, behavioral, and functional data. Identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of head and neck cancers.  PUBLIC HEALTH RELEVANCE: The identification of novel genetic risk factors and their interactions with environmental factors will contribute to the early diagnosis of the disease and help identify individuals at highest risk for the development of head and neck cancer on the basis of their personal exposure patterns and their genetic risk profiles.            ",Genome Wide Association Study of Head and Neck Cancer,8434277,R01CA131324,"['Age ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Alcohol Chemical Class ', ' Alcohols ', ' 3,4-Benzpyrene ', ' 3,4-Benzopyrene ', ' Benzo(a)pyrene ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Environmental Carcinogens ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' white race ', ' Occidental ', ' Caucasoid ', ' Caucasian Race ', ' Caucasian ', ' Caucasoid Race ', ' Cells ', ' Cytogenetic Abnormalities ', ' Cytogenetic Aberrations ', ' Chromosome Anomalies ', ' Chromosome Alterations ', ' Chromosome Aberrations ', ' Chromosomal Alterations ', ' Chromosomal Abnormalities ', ' Chromosomal Aberrations ', ' Aberrant Chromosome ', ' Chromosome abnormality ', ' Systematics ', ' Classification ', ' Clinic Visits ', ' Control Groups ', ' Death ', ' Cessation of life ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Liberty ', ' Freedom ', ' allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' Genes ', ' Genotype ', ' Goals ', ' Haplotypes ', ' Health ', ' Spanish Americans ', ' Hispanic Americans ', ' In Vitro ', ' Joints ', ' voice box ', ' Larynx Head and Neck ', ' Laryngeal ', ' Larynx ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lymph cell ', ' Lymphocytic ', ' Lymphocyte ', ' Study models ', ' genotoxic agent ', ' Genotoxins ', ' Mutagens ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Parents ', ' Patients ', ' Throat ', ' Pharynxs ', ' Pharynx Head and Neck ', ' Pharynx ', ' Pharyngeal structure ', ' Phenotype ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Population Control ', ' Questionnaires ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Residencies ', ' Risk ', ' social role ', ' Role ', ' Smoking ', ' Testing ', ' Tobacco ', ' Trees ', ' United States ', ' Caucasians ', ' County ', ' Gender ', ' Measures ', ' black American ', ' Black or African American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' case report ', ' Case Study ', ' Custom ', ' base ', ' density ', ' Area ', ' Phase ', ' Biological ', ' Histologically ', ' Histologic ', ' Reporter Genes ', ' Squamous Cell ', ' Mouth ', ' Cavitas Oris ', ' Buccal Cavity Head and Neck ', ' Buccal Cavity ', ' Oral cavity ', ' Individual ', ' Trust ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Carcinogen-DNA Adducts ', ' DNA Adducts ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' malignant head and neck tumor ', ' Malignant Head and Neck Neoplasm ', ' Head and Neck Cancer ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' Staging ', ' tool ', ' Smoker ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Frequency ', ' Frequencies (time pattern) ', ' Hereditary ', ' Inherited ', ' Scanning ', ' Source ', ' Pattern ', ' Head and Neck ', ' Head and neck structure ', ' adduct ', ' cancer risk ', ' early detection ', ' Early Diagnosis ', ' experience ', ' environment effect on gene ', ' gene environment interaction ', ' metropolitan ', ' Structure ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Squamous Cell Cancers ', ' Malignant Squamous Cell Tumor ', ' Malignant Epidermoid Cell Tumor ', ' Malignant Epidermoid Cell Neoplasm ', ' Epidermoid Cell Cancer ', ' Malignant Squamous Cell Neoplasm ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Polymorphism Detection ', ' Polymorphism Analysis ', ' inherited factor ', ' genetic risk factor ', ' Sampling ', ' case control ', ' Genomics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' HCR ', ' Chemokine (C-C Motif) Receptor-Like 2 Gene ', ' CRAM-B ', ' CRAM-A ', ' CKRX ', ' CCRL2 ', ' CCRL2 gene ', ' Data ', ' Cancer Center ', ' Cancer Cause ', ' Cancer Etiology ', ' Cancer Patient ', ' enroll ', ' Enrollment ', ' Genetic Risk ', ' sex ', ' developmental ', ' Development ', ' Behavioral ', ' tobacco exposure ', ' disease phenotype ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' cancer genome ', ' Outcome ', ' Population ', ' exposure to alcohol ', ' exposed to alcohol ', ' ethanol exposure ', ' ethanol exposed ', ' alcohol exposed ', ' alcohol exposure ', ' plasmid DNA ', ' high risk ', ' population based ', ' genomewide ', ' genome-wide ', ' DNA Repository ', ' ']",NCI,UNIVERSITY OF TX MD ANDERSON CAN CTR,R01,2013,472716,TX-09,-0.004400867749367087
"Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning  Detecting Genome-Wide Epistasis with Efficient Bayesian Network Learning Epistasis is the interaction between two or more genes to affect phenotype. It is now widely accepted that epistasis plays an important role in susceptibility to many common diseases. The advent of high-throughput technologies has enabled genome-wide association studies (GWAS or GWA studies). It is compelling that we be able to detect epistasis using GWAS data. However, so far GWA studies have mainly focused on the association of a single gene or loci with a disease. The crucial challenge to analyzing epistasis using GWAS data is finding a way to efficiently handle high-dimensional data sets. The only possible solution is to design efficient algorithms that allow us to find the most relevant epistasic relationships without doing an exhaustive investigation. To the Principal Investigator's knowledge, no current method can do this. This career award will investigate this problem. The specific aims are as follows: (Aim 1) develop and evaluate efficient Bayesian network-based methods for learning candidate genes associated with diseases from GWAS sets. Such genes would provide candidates for follow-up biological studies, (Aim 2) implement the methods in a pilot GWAS system for use by researchers when conducting a GWAS, (Aim 3) develop simulated genome-wide data sets and evaluate the pilot system using these data sets, and (Aim 4) conduct GWA studies concerning breast cancer and lung cancer. Aim 1 will be addressed by developing a succinct Bayesian network model representing epistasis, efficient algorithms which are tailored to investigating such models, integration of the algorithms into methods for learning epistasis, and using simulated datasets to test the effectiveness of the methods and compare their performance to other methods. Aim 2 will be met by implementing the methods in a pilot GWAS system. Aim 3 will be satisfied by developing synthetic data sets similar to those found in GWA studies, and using them to evaluate the system. Aim 4 will be achieved by conducting GWA studies concerning breast and lung cancer. By conducting these studies, we can (1) substantiate previous results concerning the genetic basis of these diseases; (2) possibly obtain interesting new findings pertaining to these diseases. The main hypothesis is that the proposed method will be an advance over existing methods in that it will make it computationally feasible to learn epistatic relationships from genome-wide data and it will therefore yield better discovery performance than existing methods.  Learning gene-gene interactions from genome-wide association studies (GWAS) data is an important and challenging task in genetic epidemiology. This project will develop and evaluate a pilot GWAS system for performing this task. Advances obtained in analyzing GWAS data sets could enable us to learn the genetic basis of many diseases and thereby substantially improve the quality of personalized patient care.",Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning,8440362,R00LM010822,"['Affect ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Award ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Data Analysis ', ' Data Analyses ', ' disease/disorder ', ' Disorder ', ' Disease ', ' genetic epistases ', ' gene x gene interaction ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Patient Care Delivery ', ' Patient Care ', ' Genes ', ' Articulation ', ' Joints ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Phenotype ', ' Play ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Regression Analysis ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Solutions ', ' Testing ', ' Woman ', ' Work ', ' Generations ', ' forest ', ' Dataset ', ' Data Set ', ' base ', ' career ', ' improved ', ' Site ', ' Biological ', ' Hereditary Mutation ', ' Germline Mutation ', ' Germ-Line Mutation ', ' Link ', ' Susceptibility ', ' Predisposition ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Family history of ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Simulate ', ' Genetic ', ' Malignant Cell ', ' cancer cell ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' brca 1 gene ', ' RNF53 ', ' Hereditary Breast Cancer 1 ', ' Early Onset Gene Breast Cancer 1 ', ' Breast Cancer Type 1 Susceptibility Gene ', ' Breast Cancer 1 Gene ', ' BRCA1 ', ' BRCA1 gene ', ' Investigation ', ' Complex ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' meetings ', ' gene interaction ', ' Performance ', ' brca 2 gene ', ' Hereditary Breast Cancer 2 ', ' FANCD1 ', ' FANCB ', ' Early Onset Gene Breast Cancer 2 ', ' Breast Cancer Type 2 Susceptibility Gene ', ' Breast Cancer 2 Gene ', ' BRCA2 ', ' BRCA2 gene ', ' neural network ', ' Biological Neural Networks ', ' Statistical Methods ', ' Modeling ', ' high throughput technology ', ' genetic epidemiology ', ' Cancer Susceptibility Gene ', ' Cancer-Predisposing Gene ', ' Effectiveness ', ' datamining ', ' data mining ', ' Candidate Gene ', ' Candidate Disease Gene ', ' GRB2-Associated Binding Protein 2 Gene ', ' GAB2 ', ' GAB2 gene ', ' Address ', ' Data ', ' Genetic Algorithm ', ' Genetic Programming ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' Bayesian Networks ', ' computer based statistical methods ', ' designing ', ' design ', ' combinatorial ', ' Network-based ', ' network models ', ' genome-wide analysis ', ' genomewide ', ' genome-wide ', ' ']",NLM,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R00,2013,193848,PA-18,0.05007456818860282
"Systems genetic and reverse phenotypic analysis of age and retirement     DESCRIPTION (provided by applicant): High throughput genomic platforms have revealed a profound effect of age on gene expression and gene methylation levels. For example, our integromic analysis of multiple publicly available data sets have identified hundreds of age related genes that can be organized into network modules. These gene sets along with genes and pathways known from the vast literature on aging and longevity provide valuable candidates in allelic association studies of the health and well-being of older Americans. The rich longitudinal data set and the genome wide scans of DNA samples from the Health and Retirement Study (HRS) provide a unique resource for evaluating the phenotypic effects of genetic variants underlying aging related genes, gene sets and for developing multivariable models that include behavioral, psychosocial, and genetic factors. This proposal aims to apply systems biologic and systems genetic methods for identifying gene sets based on existing gene expression, gene methylation, and multiple large scale genome wide association studies (GWAS). Single nucleotide polymorphisms (SNPs) underlying these genes will then be related to health, cognitive, behavioral, and economic phenotypes using multivariable regression-, machine learning-, and weighted network analysis approaches. An iterative process between SNP and phenotype selection facilitates the definition of clinically and economically important phenotypes under genetic control (reverse phenotyping). The proposal will not only elucidate the genetic and molecular underpinnings of retirement relevant phenotypes (cognitive functioning, psychosocial factors, and health related expenditures) but also lead to a phenotypic annotation of aging related genes and pathways.         PUBLIC HEALTH RELEVANCE: State of the art statistical, computational, and network approaches for integrating genomic data with the valuable phenotypic and genetic data provided by the Health and Retirement Study is expected to lead to the identification of genetic markers relevant for improving the lives of America's older adults. Validated genetic markers will inform researchers in many fields including biomedical researchers, epidemiologists, psychologists, sociologists, and economists.            ",Systems genetic and reverse phenotypic analysis of age and retirement,8579754,R01AG042511,"['Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Americas ', ' Parturition ', ' Birth ', ' Concurrent Studies ', ' Cohort Studies ', ' Data Analysis ', ' Data Analyses ', ' Deoxyribonucleic Acid ', ' DNA ', ' Economics ', ' Expenditure ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Economical Income ', ' Economic Income ', ' Income ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' Probabilistic Models ', ' Statistical Models ', ' well-being ', ' Personal Satisfaction ', ' Phenotype ', ' Psychologist ', ' psychosocial variables ', ' Psychosocial Factor ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retirement ', ' sociologist ', ' computer program/software ', ' Software ', ' Computer software ', ' Specificity ', ' statistics ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Weight ', ' Measures ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cognitive function ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Physical Function ', ' psychosocial ', ' interest ', ' American ', ' environment effect on gene ', ' gene environment interaction ', ' cohort ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' repository ', ' Genomics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Data ', ' Subgroup ', ' Cognitive ', ' Epidemiologist ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' reverse genetics ', ' positional cloning ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' genetic variant ', ' designing ', ' design ', ' child depression ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Impairment ', ' endophenotype ', ' public health relevance ', ' social implication ', ' economic implication ', ' exomes ', ' exome ', ' ']",NIA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2013,315700,CA-33,0.03815609646057151
"Informatics Tools for High-Throughput Sequences Data Analysis    DESCRIPTION (provided by applicant): The Genome Analysis Toolkit (GATK) is a suite of best-in-class, widely-used, well-supported, open-source tools for processing and analysis of next-generation DNA sequencing (NGS) data. These tools currently  include a multiple sequence realigner, a covariate-correcting base quality score recalibrator, multi-sample  SNP, INDEL, and CNV genotypers, machine learning algorithms for false positive identification, variant  evaluation modules, somatic SNP and indel callers, and hundreds of other tools. Underlying all of these tools is our structured programming framework (GATK-Engine) that uses the functional programming philosophy of MapReduce to make writing feature-rich, efficient and robust analysis tools easy. By centralizing common data management infrastructure, all GATK-based tools benefit from the engine's correctness, CPU and memory efficiency, as well as automatic distributed and shared memory parallelization, essential capabilities given the massive and growing size of NGS datasets. The GATK currently supports all of the major sequencing technologies including lllumina. Life Sciences 454, and ABI SOLID, from hybrid capture of exomes to 1000s of low-pass samples in the 1000 Genomes Project. Our emphasis on technology-agnostic processing tools has helped to popularize the now standard SAM/BAM and VCFs formats for representing NGS data and variation calls, respectively. In this RFA we propose to  continue to develop the GATK-Engine and data processing tools to (1) achieve complete and accurate  variation discovery and genotyping for all major sequencing study designs and NGS technologies (2)  optimize the GATK-Engine and pipelining infrastructure to operate efficiently on distributed data sets at the  scale of tens of thousands of samples (3) extend the GATK data processing tools to support the upcoming  sequencing technologies of Complete Genomics, lon Torrent, and Pacific Biosciences as well as we do  current technologies, (4) expand significantly our educational and support structures to ensure that the longtail  of future NGS users can benefit from the best-practice data processing and analysis tools in the GATK.        The proposed project aims to continue to develop the Genome Analysis Toolkit (GATK), a suite of widely used and mission-critical tools for analyzing the next-generation DNA sequencing data. With this grant we will improve these tools, make them more robust, and extend them to new sequencing technologies. This is essential to realize the potential of DNA sequencing to understand human history, diversity, and to discover  new loci associated with human disease, leading to new biologic hypotheses and new drug targets.            ",Informatics Tools for High-Throughput Sequences Data Analysis,8416349,U01HG006569,"['Algorithms ', ' Life Sciences ', ' Biologic Sciences ', ' Biological Sciences ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Experimental Designs ', ' Flooding ', ' Floods ', ' Future ', ' Medical Genetics ', ' Genome ', ' Genotype ', ' Grant ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hybrids ', ' Memory ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Mission ', ' Philosophy ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Technology ', ' Work ', ' Writing ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' improved ', ' Site ', ' Variation ', ' Variant ', ' Ensure ', ' Evaluation ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Techniques ', ' data management ', ' Informatics ', ' Structure ', ' novel ', ' cancer genetics ', ' Modeling ', ' Sampling ', ' Genomics ', ' Documentation ', ' signal processing ', ' data processing ', ' computerized data processing ', ' Data ', ' Infrastructure ', ' Research Infrastructure ', ' Process ', ' distributed data ', ' next generation ', ' SNP genotyping ', ' open source ', ' human disease ', ' shared memory ', ' distributed memory ', ' exomes ', ' exome ', ' genome analysis ', ' Drug Targeting ', ' ']",NHGRI,"BROAD INSTITUTE, INC.",U01,2013,964551,MA-07,0.0029685833533512093
"Integrating Genomic and Environmental Perspectives on Internalizing Disorders While biometric genetic studies have long indicated substantial heritability for internalizing disorders, including major depressive and generalized anxiety disorders, progress in mapping this influence onto specific genetic variants has been slow. Expert consensus suggests that finding this missing heritability will require moving beyond the current one SNP at a time genomewide association study (GWAS) paradigm to develop interactive models jointly considering effects across structural and functional genomic units (e.g., genes and biological pathways), as well as modeling gene-environmental interaction (GxE) in the highly dimensional GWAS context. The overarching goal of this proposal is to provide the candidate the training and research opportunities necessary to advance such an interactive model of internalizing disorder etiology, thus supporting the candidates long-term career goal of becoming an independent investigator in the area. General training goals include building proficiency in statistical genetics and bioinformatics, and strengthening knowledge of substantive issues in developmental psychopathology and psychometric statistical modeling/programming. The candidate proposes to acquire a number of specific skills, including data integration techniques for including prior information in GWAS, aggregation methods to capture the possible effects of many markers with very small effects (e.g., gene-based, pathway-based, and polygenic risk profile score analyses) and machine learning applications for investigating epistasis and nonlinear genomic effects. Proposed training in these areas consists of an interlocking program of coursework, intensive mentoring, summer programs, reading groups, seminar series and conferences, with special attention to training in research ethics. Direct mentoring is a key feature of this program, with access to leading experts in each of the proposed training areas (i.e., Drs. Edwin van den Oord and Patrick Sullivan  statistical genetics and bioinformatics, Dr. E. Jane Costello  developmental psychopathology, and Dr. Michael Neale  statistical modeling and programming) representing a core strength of the proposed training plan. The candidate proposes to apply acquired skills in the research portion of the project by conducting a multistage GWAS to investigate genomic influence, both direct and in interaction with environmental risk factors, on developmental trajectories of internalizing disorders. Methodologically, this approach focuses on integrating longitudinal statistical models of phenotypic development and environmental risk with emerging genomic methods. This will be facilitated by bringing together an unprecedented combination of longitudinal GWAS datasets, including a meta-analysis of the four Duke/VCU samples of the Gene, Environment, and Development Initiative (GEDI) (N=3,623). This discovery phase meta-analysis will then be followed by replication in two large independent longitudinal samplesthe National Longitudinal Study of Adolescent Health (N=~12,000) and the Minnesota Twin and Family Study (N=3,762). The exceptional statistical power of this design will be further complimented in a final analytical stage, with next-generation sequencing follow-up using targeted capture methods to extract promising genes/regions and extreme-trait methods to maximize power by selecting subjects from the extremes of the phenotypic distributions. The institutional environment provided by the Virginia Commonwealth University Center for Biomarker Research and Personalized Medicine (CBRPM) represents another core asset to the candidates career development. The CBRPMs mission is to develop and apply novel methods for the purpose of identifying and using biomarkers to improve disease understanding and medical treatment. The Center operates from a strong multidisciplinary perspective with primary applications involving psychiatric outcomes, developmental psychopathology, and substance use disorders. Currently funded research programs at the CBRPM include serving as the data analysis core of the Duke/VCU GEDI project, method development in the design and analysis of adaptive multistage GWAS, a replication study of findings from schizophrenia GWAS, and whole genome profiling to detect schizophrenia methylation markers. These projects offer an ideal context for executing the proposed training and research, as they provide an environment focused on GWAS and next-generation sequencing applications to psychiatric disorderscentral topics of the candidates career development plan. The CBRPM also provides several unique physical resources supporting the current proposal, including a SOLiD 4 next-generation sequencer, which will allow follow-up sequencing to be done in-house, and a Center-dedicated computing cluster, facilitating the computationally intensive analyses proposed. In addition to physical resources, the CBRPM offers a challenging and collegial intellectual environment that promotes collaboration both within and outside of the Center. In sum, the CBRPM provides a stimulating and supportive institutional environment with the all of the statistical, computational and laboratory resources necessary to make this proposal a successful one. Affecting more than one in five Americans annually, internalizing disorders (IDs) (i.e.,  depression and anxiety) are the most common forms of mental illness and leading  causes of the global health burden. Clearly, an improved understanding of the etiology of  IDs would substantially advance both prevention and intervention efforts. This project  aims to improve understanding through advancing an integrative model of genomic,  environmental and developmental influence in the etiology of IDs.",Integrating Genomic and Environmental Perspectives on Internalizing Disorders,8435497,K01MH093731,"['genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' genetic variant ', ' data integration ', ' grid computing ', ' distributed computing ', ' datagrid ', ' data grid ', ' computational grid ', ' cluster computing ', ' designing ', ' design ', ' next generation ', ' Outcome ', ' Heritability ', ' multidisciplinary ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' next generation sequencing ', ' screening ', ' Affect ', ' Algorithms ', ' Anxiety ', ' Attention ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Puericulture ', ' Child Care ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Environment ', ' genetic epistases ', ' gene x gene interaction ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Genes ', ' Genome ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Housing ', ' indexing ', ' Laboratories ', ' long-term study ', ' Longitudinal Studies ', ' Maps ', ' Medicine ', ' Mentors ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Minnesota ', ' Mission ', ' Genetic Models ', ' Probabilistic Models ', ' Statistical Models ', ' Phenotype ', ' Play ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Population Control ', ' Psychometrics ', ' abnormal psychology ', ' Psychopathology ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Scoring Method ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Substance Use Disorder ', ' Testing ', ' Time ', ' Twins ', ' Twin Multiple Birth ', ' Universities ', ' Virginia ', ' Measures ', ' conference ', ' symposium ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' career ', ' method development ', ' improved ', ' Family Study ', ' Area ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Series ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Measurement ', ' Development Plans ', ' Genetic Research ', ' Funding ', ' Generalized Anxiety Disorder ', ' Collaborations ', ' Twin Studies ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Consensus ', ' Knowledge ', ' programs ', ' Investigation ', ' Side ', ' Techniques ', ' American ', ' developmental genetics ', ' environment effect on gene ', ' gene environment interaction ', ' trait ', ' Structure ', ' skills ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Research Ethics ', ' Modeling ', ' Sampling ', ' career development ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' functional/structural genomics ', ' major depression ', ' Major Depressive Disorder ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Address ', ' global health ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' Research Training ', ' Stratification ', ' Sum ', ' Genetic Risk ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' ']",NIMH,VIRGINIA COMMONWEALTH UNIVERSITY,K01,2013,138056,VA-04,0.06577184401967286
"Genetic Susceptibility and Risk Model for Pancreatic Cancer     DESCRIPTION (provided by applicant): Pancreatic cancer (PanC) is the fourth leading cause of cancer-related death for both men and women in the U.S. Better understanding of the etiology and developing risk prediction models for early detection and prevention are urgently needed for this rapidly fatal disease. The majority of PanC are caused by the interplay of both genetic and environmental factors. Known risk factors for PanC include cigarette smoking, obesity, long-term type II diabetes, and family history. In addition, our previous case-control study has shown that excess body mass index (BMI) in young adulthood confers a higher risk of PanC than weight gain at later age. Recent genome-wide association studies (GWAS) have identified several chromosomal regions and genes in association with risk of PanC (PanScan). Our pathway analyses of the PanScan GWAS data have uncovered several novel biological pathways associated with the risk for PanC. However, it remains unknown how environmental or host risk factors modify the association between genetic factors and the PanC risk, which knowledge is critical to better understanding of the etiology and developing a risk prediction model and early intervention strategies for PanC. The goal of this project is to identify gene-environment interactions and develop and validate a risk prediction model including both common and rare genetic variants using the PanScan GWAS data and the exposure information of over 2,200 case-control pairs and an ongoing ExomeChip-based study of PanC genotyping both common SNPs and >240,000 rare functional exonic variants in over 4,100 cases and 4,700 controls from six case-control studies in the Pancreatic Cancer Case Control Consortium (PanC4) and a nested case-control study from Europe (EPIC). We will validate the absolute risk prediction model in two large prospective cohorts: the Atherosclerosis Risk in Communities (ARIC) cohort of 15,000 individuals and the Kaiser Permanente cohort of 100,000 individuals. We will also develop novel statistical methods to identify genes modifying the association between changing BMI at different age periods and PanC risk using the unique dataset from a case-control study of PanC conducted at MD Anderson Cancer Center. Our proposed project hinges on novel integration of GWAS, ExomeChip, exposure data of a large number of PanC cases and controls, recently developed powerful statistical methods and analysis strategies for detecting genome-wide gene/pathway-environment interactions and polygenic approaches to genetic risk prediction. The work proposed here is expected not only to advance our understanding of the etiology of PanC and delineate how genes and lifestyle or host factors modify the risk of PanC, but also to greatly facilitate identification of high-risk individuals, and thus, contribute to early detection, improved survival and prevention of PanC. The novel statistical methods developed here are also applicable to other cancers and complex disease, and we will develop user-friendly software packages for public use.         PUBLIC HEALTH RELEVANCE: Over 43,900 new cases of pancreatic cancer are expected to occur in the US in 2012, almost all rapidly fatal. This project will not only advance our understanding of the etiology of pancreatic cancer and delineate how genes and lifestyle or host factors modify the risk of pancreatic cancer, but also will facilitate identification of high-risk individuals, and thus, contribute to early detection, prevention, and improved survival of pancreatic cancer. The novel statistical methods developed here are also applicable to other cancers and complex disease, and we will develop user-friendly software packages for public use.                 ",Genetic Susceptibility and Risk Model for Pancreatic Cancer,8579657,R01CA169122,"['Age ', ' atherosclerotic vascular disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Communities ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Europe ', ' Family ', ' Genes ', ' Genotype ', ' Goals ', ' History ', ' Recording of previous events ', "" men's "", ' men ', ' Nested Case-Control Study ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Risk ', ' Risk Factors ', ' Smoking ', ' Survival Rate ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' Woman ', ' Work ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Logistic Regressions ', ' Training ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Early Intervention ', ' Host Factor Protein ', ' Host Factor ', ' Integration Host Factors ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Pancreatic Cancer ', ' Pancreas Cancer ', ' Malignant Pancreatic Neoplasm ', ' Malignant neoplasm of pancreas ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Complex ', ' Techniques ', ' cancer risk ', ' early detection ', ' Early Diagnosis ', ' environment effect on gene ', ' gene environment interaction ', ' user friendly computer software ', ' user friendly software ', ' cohort ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Prevention ', ' smoke cigarette ', ' cigarette smoking ', ' Statistical Methods ', ' Modeling ', ' case control ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' cancer diagnosis ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' Cancer Center ', ' Cancer Cause ', ' Cancer Etiology ', ' enroll ', ' Enrollment ', ' Gene-Modified ', ' Genetic Risk ', ' lifestyle factors ', ' Validation ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' prospective ', ' high risk ', ' public health relevance ', ' treatment strategy ', ' effective treatment ', ' effective therapy ', ' genomewide ', ' genome-wide ', ' ']",NCI,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R01,2013,279250,TX-09,0.02751486730525421
"International Case Control Study of Malignant Glioma    DESCRIPTION (provided by applicant): Glioma comprises about 40% of all primary brain tumors accounting for as many as 26,000 U.S. and European deaths annually. Inherited susceptibility plays a role with 2-fold increased risk of glioma among first-degree relatives of glioma cases. We initiated a multi-center, international linkage study: ""Genetic Epidemiology of Glioma International Consortium"" in 2007 to address the role of inherited susceptibility. Since this study does not allow us currently to address the role of genetic susceptibility in sporadic cases, we propose this case- control study to address this gap. Members of the consortium have conducted genome wide association studies (GWAS) that will be the discovery phase (phase I). While of high value for discovery, we propose to recruit 6,000 newly diagnosed glioma cases and 6,000 age-gender-ethnicity-matched controls, and collect detailed epidemiologic data and biologic samples from the 13 participating Gliogene sites. We hypothesize that novel inherited variation influencing the susceptibility to glioma can be identified by high density SNP analysis, and propose the following specific aims: SA1: Identify common genetic variants contributing to the risk of glioma. We plan to conduct phases 2 and 3 of the 3 phase approach, specifically we will: (SA1a) Validate GWAS findings from the discovery sets, and replicate the top hits (~23,000 SNPs) with lowest p- values from the two phase GWA studies in a series of 2,000 cases and 2,000 controls (phase 2, validation). Validate the top hits from the test set (aim 1a). From stage 2, genes with SNPs displaying an association at pd10-4 (including the complete haplotype tagging - approximately 100 SNPs) will then be genotyped in a further series of 4,000 cases and 4,000 controls (stage 3, validation). SNPs significant at 10-7 or better will be considered in the final analyses. (SA1b). Using an a priori hypothesis that DNA repair in inflammation contribute to glioma risk, we will selectively interrogate DNA repair and inflammation pathway genes using data for select genes derived from the high-density array. We will conduct a hypothesis driven genetic association in DNA repair and in inflammation/immune function related genes with glioma risk using functional genomic and bioinformatic tools to interrogate available databases. (SA2): Evaluate gene-gene (G-G) and gene- environmental (G-E) interactions with strong biologic relevance to identify G-G and G-E interactions for glioma risk using machine-learning tools (MDR, FITF, and CART) in these exploratory analyses. There are no existing glioma case-control studies with sufficient numbers of biological samples and common epidemiologic data to conduct a comprehensive validation and replication study, or to address the issues of tumor heterogeneity as we will in this study.       PUBLIC HEALTH RELEVANCE: Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.                           ",International Case Control Study of Malignant Glioma,8464531,R01CA139020,"['Accounting ', ' Age ', ' Bronchial Asthma ', ' Asthma ', ' California ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Systematics ', ' Classification ', ' Death ', ' Cessation of life ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Genes ', ' Genotype ', ' spongioblastoma multiforme ', ' glioblastoma multiforme ', ' Grade IV Astrocytoma ', ' Grade IV Astrocytic Tumor ', ' Grade IV Astrocytic Neoplasm ', ' Glioblastoma ', ' neuroglia tumor ', ' neuroglia neoplasm ', ' glial-derived tumor ', ' Neuroglial Tumor ', ' Neuroglial Neoplasm ', ' Glial Tumor ', ' Glial Neoplasm ', ' Glial Cell Tumors ', ' Glioma ', ' Haplotypes ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Allergy ', ' Hypersensitivity ', ' Infection ', ' Inflammation ', ' Mining ', ' Play ', ' Radiation-Ionizing Total ', ' Ionizing Electromagnetic Radiation ', ' Ionizing radiation ', ' recruit ', ' Recruitment Activity ', ' Risk ', ' social role ', ' Role ', ' San Francisco ', ' Syndrome ', ' Testing ', ' Trees ', ' Universities ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Gender ', ' forest ', ' Dataset ', ' Data Set ', ' Malignant Tumor of the Brain ', ' Brain Cancer ', ' Malignant neoplasm of brain ', ' base ', ' density ', ' Left ', ' Site ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Histologically ', ' Histologic ', ' Series ', ' Age of Onset ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Trust ', ' European ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Sample Size ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' Staging ', ' tool ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Hereditary ', ' Inherited ', ' Malignant Neuroglial Tumor ', ' Malignant Neuroglial Neoplasm ', ' Malignant Glial Tumor ', ' Malignant Glial Neoplasm ', ' Malignant Glioma ', ' success ', ' international center ', ' cohort ', ' Manuscripts ', ' Histopathology ', ' novel ', ' member ', ' Primary Brain Tumors ', ' Primary Brain Neoplasms ', ' Modeling ', ' Sampling ', ' case control ', ' genetic epidemiology ', ' functional genomics ', ' cancer location ', ' cancer site ', ' Bio-Informatics ', ' Bioinformatics ', ' Cellular Immune Function ', ' immune function ', ' genetic association ', ' Address ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' International ', ' Infrastructure ', ' Research Infrastructure ', ' Collection ', ' First Degree Relative ', ' Newly Diagnosed ', ' Validation ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genetic variant ', ' Adult Glioma ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' tumor ', ' high risk ', ' public health relevance ', ' population based ', ' epidemiologic data ', ' TCGA ', ' The Cancer Genome Atlas ', ' ']",NCI,BAYLOR COLLEGE OF MEDICINE,R01,2013,1862222,TX-09,0.06388859533533715
"Accelerating Curation of GWAS Catalog by Automatic Text Mining     DESCRIPTION (provided by applicant): A genome-wide association study (GWAS) is an approach to detecting genetic variations associated with particular diseases or traits by scanning markers across the genomes of a large-scale sample of subjects in a high-throughput manner. In less than a decade, GWAS studies have been successfully producing discovery and replication of many new disease loci. Discovered genetic associations have led to development of better strategies to diagnose, treat and prevent diseases. The number of GWAS is growing rapidly. There is a need for a database that allows researchers to easily query and search for previous results. A well-curated database also provides a resource for overview and summarization investigations of associated genetic sites and may help suggest pleiotropic genes. Such a database has been created and maintained by the National Human Genome Research Institute (NHGRI), called ""A Catalog of Published Genome-Wide Association Studies"" (Catalog of GWAS). The catalog has led to interesting characterization of previous results in GWAS and NHGRI has continued to update and curate the catalog regularly. However, this is performed by manually extracting information from published GWAS articles. As a result, the coverage is low compared to the volume of all GWAS publications and would be impossible to catch up the pace of new publications. The goal of this project is to develop a new tool to automatically extract the information from research articles for the curation of the catalog of GWAS. Our proposal is to use the curated data currently available from NHGRI as the training examples and apply novel machine-learning algorithms to train an information extractor to allow accurate automatic extraction. Given our recent success in applying machine learning to biological text mining, we are confident that this will lead to a useful tool to improve the productivity of curators and solve the coverage problem. Our first specific aim is to develop an accurate information extractor. Our second specific aim is to develop an easy-to-use curation tool for curators to efficiently check and correct errors from automatic information extraction so that their curation productivity can be improved by 18 folds. Then we will adapt the tool to extraction and curation of research papers reporting association studies using data from next generation sequencing. Currently, study design and the reporting of GWAS results using NGS data are not standardized. These results have not been considered to be included in the catalog yet. However, we expect that the limitations will be overcome and the methodology will converge soon. We will closely monitor the progress and adapt the tool to allow for inclusion of the NGS data. Finally, we will distribute the software to the public domain so that volunteers or interested parties can create their own catalog locally. It is our goal to share the developed software with the research community to advance the field. The new algorithms developed in this project and the entire development cycle, from design to deployment, will also contribute to the state-of-the- arts of biological text mining.         PUBLIC HEALTH RELEVANCE: The goal of this project is to develop a new tool to automatically extract the information from research articles for the curation of the catalog of GWAS. The catalog contains information about SNP-trait/disease associations that are extracted from published genome-wide association studies. A well-curated catalog of GWAS allows researchers to easily query and search for previous results and provides a useful resource for overview and summarization investigations of associated genetic sites and may help suggest pleiotropic genes.            ",Accelerating Curation of GWAS Catalog by Automatic Text Mining,8549925,U01HG006894,"['Algorithms ', ' Cataloging ', ' Communities ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Future ', ' Genes ', ' Genome ', ' Goals ', ' Human Genetics ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Manuals ', ' Method LOINC Axis 6 ', ' Methodology ', ' Paper ', ' Productivity ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' computer program/software ', ' Software ', ' Computer software ', ' Standardization ', ' Survey Instrument ', ' Surveys ', ' Technology ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Work Load ', ' Workload ', ' Public Domains ', ' base ', ' improved ', ' Site ', ' Area ', ' Biological ', ' Link ', ' Ensure ', ' Training ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Catalogs ', ' Investigation ', ' Scanning ', ' interest ', ' success ', ' trait ', ' novel ', ' Reporting ', ' Sampling ', ' developing computer software ', ' develop software ', ' software development ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' preventing ', ' prevent ', ' genetic association ', ' Data ', ' Disease Association ', ' Update ', ' Monitor ', ' Text ', ' developmental ', ' Development ', ' National Center for Human Genome Research ', ' NHGRI ', ' National Human Genome Research Institute ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' designing ', ' design ', ' user-friendly ', ' volunteer ', ' public health relevance ', ' next generation sequencing ', ' ']",NHGRI,UNIVERSITY OF SOUTHERN CALIFORNIA,U01,2013,54233,CA-37,0.07449279659731278
"From GWAS to PheWAS: Scanning the EMR phenome for gene-disease associations    DESCRIPTION (provided by applicant): Genomic medicine offers hope for improved diagnostic methods and for more effective, patient-specific therapies. Genome-wide associated studies (GWAS) elucidate genetic markers that improve understanding of risks and causes for many diseases, and may guide diagnosis and therapy on a patient-specific basis. This project will take another approach to identify gene-disease associations: perform ""reverse GWAS,"" or phenome- wide association study (PheWAS), to determine which phenotypes are associated with a given genotype. The project is enabled by a large DNA biobank coupled to a de- identified copy of the electronic medical record. This project has four specific aims. First, the project will develop and validate a standardized approach to extract disease phenotypes from EMR records, integrating national standard terminologies of clinical disorders and descriptors relating to treatment and diagnosis of each disease to create a sharable knowledge base. The project will use natural language processing, structured data queries, and heuristic and machine learning methods to accurately identify patients with each disease and corresponding controls. The second aim is to perform PheWAS analyses using existing genotype data. To validate the method, the project will use PheWAS to ""rediscover"" SNPs with known disease associations. The project will also investigate statistical methods for large-scale multiple hypothesis testing to discover novel phenotype associations. The third aim is to apply the PheWAS algorithms in four other sites with EMR-linked DNA biobanks and compare results. In the fourth aim, the project will validate novel phenotype-genotype associations discovered through PheWAS with new genotyping in a previously untested population. The tools generated from this project will not only make PheWAS possible, but will also broadly enable clinical research and subsequent genetic studies.           The promise of genomic medicine is to predict individuals' disease risk and treatment given their genetic information. This project will develop methods to identify diseases from electronic medical records and then find novel genetic associations from existing genomic data.",From GWAS to PheWAS: Scanning the EMR phenome for gene-disease associations,8528722,R01LM010685,"['University Medical Centers ', ' Academic Medical Centers ', ' Algorithms ', ' Appointment ', ' Clinical Study ', ' Clinical Research ', ' clinical investigation ', ' Clinical Trials ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Intelligent systems ', ' Expert Systems ', ' Future ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Hand ', ' Articulation ', ' Joints ', ' Laboratories ', ' Manuals ', ' Medicine ', ' Methods ', ' Names ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' natural language understanding ', ' Natural Language Processing ', ' Terminology ', ' Patients ', ' Phenotype ', ' Physicians ', ' Records ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' Syndrome ', ' Testing ', ' Time ', ' Electronic Medical Record ', ' Computerized Medical Record ', ' analytical method ', ' base ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Site ', ' Clinical ', ' Link ', ' Individual ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Genetic Research ', ' Funding ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Descriptor ', ' Letters ', ' Genetic ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Investigation ', ' Diagnostic Technique ', ' Diagnostic Method ', ' Diagnostic Procedure ', ' Scanning ', ' Clinic ', ' Techniques ', ' experience ', ' heuristics ', ' cohort ', ' knowledgebase ', ' knowledge base ', ' Structure ', ' novel ', ' disease risk ', ' disorder risk ', ' Position ', ' Positioning Attribute ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Coding System ', ' Code ', ' Statistical Methods ', ' Sampling ', ' case control ', ' Genomics ', ' Institution ', ' genetic association ', ' Data ', ' Data Element ', ' Disease Association ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' trial treatment ', ' trial regimen ', ' Clinical Treatment ', ' enroll ', ' Enrollment ', ' Update ', ' Validation ', ' Characteristics ', ' Text ', ' disease phenotype ', ' biomed informatics ', ' biomedical informatics ', ' new approaches ', ' novel strategy ', ' novel approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Clinical and Translational Science Awards ', ' patient population ', ' treatment response ', ' genomewide ', ' genome-wide ', ' phenome ', ' phenomics ', ' biorepository ', ' biobank ', ' Secure ', ' ']",NLM,VANDERBILT UNIVERSITY,R01,2013,305913,TN-05,0.050113578073966256
"Optimizing Genetic Testing for Deafness for Clinical Diagnostics   Project Summary  In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. The driving force behind this initiative is the frequency of hearing impairment. As the most common sensory impairment, it is diagnosed in 1 of every 500 newborns and 50% of octogenarians (Morton Ann N Y Acad Sci 1991). With 57 genes implicated in nonsyndromic hearing loss (NSHL), it is also an extremely heterogeneous trait and presents a tremendous challenge to diagnosis.  Current strategies for genetic testing for deafness are inadequate. For most, only a minority of genes is included, with selection criteria typically reflecting: 1) high prevalence as a cause of deafness (i.e. GJB2); 2) association with another recognizable feature (i.e. SLC26A4 and enlarged vestibular aqueduct); or 3) a recognizable audioprofile (i.e. low frequency hearing loss as seen with WFS1) (Hilgert et al Mut Res 2009).  The recent advent of powerful DNA target enrichment and sequencing technologies, however, makes it possible to provide comprehensive genetic testing for deafness that is efficient and cost-effective. We have shown that it is possible to analyze all deafness genes simultaneously on a single platform (called OtoSCOPE) (Shearer et al PNAS 2010). Related to this endeavor, we have also validated AudioGene as a phenotypic tool that uses patient audiograms to predict the genetic cause of ADNSHL (Hildebrand et al Genet Med 2008; Hildebrand et al Laryngoscope 2009).  Building on these findings, in this proposal we will complete two specific aims.  Specific Aim 1: To provide comprehensive, high-throughput, low-cost DNA sequence generation and analysis for deafness genetic testing  Goal 1: Comprehensive, high-throughput, low-cost DNA sequence analysis for genetic testing for deafness is possible at sensitivities and specificities comparable to Sanger sequencing by using targeted sequence enrichment followed by massively parallel sequencing.  Specific Aim 2: To optimize both machine learning-based audioprofiling of audiometric data and phenotypic filtering of genotypic data by expanding and improving the platform we have developed called AudioGene  Goal 2: As a phenome tool, a machine-learning software system trained on an extensive set of audiometric data can be used to predict and to eliminate specific genes or gene variants as causes of deafness based on audiometric data.  Achieving these specific aims will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history, physical examination and audiological assessment.   In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. Achieving this goal will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history and physical exam.",Optimizing Genetic Testing for Deafness for Clinical Diagnostics,8514562,R01DC012049,"['Audiometric Test ', ' Audiogram ', ' Audiometry ', ' Bar Codes ', ' Data Analysis ', ' Data Analyses ', ' Deafness ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Genes ', ' Goals ', ' History ', ' Recording of previous events ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Laboratories ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Persons ', ' Octogenarian ', ' Patients ', ' Medical Inspection ', ' Physical Examination ', ' Research Resources ', ' Resources ', ' Sensitivity and Specificity ', ' Technology ', ' allelic variant ', ' Genetic Variation ', ' Genetic Diversity ', ' Gene variant ', ' Variation (Genetics) ', ' Vestibular Aqueduct ', ' Generations ', ' Diagnostic tests ', ' Dataset ', ' Data Set ', ' Caring ', ' DNA Sequence ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' DNA Sequence Analyses ', ' DNA Sequence Analysis ', ' base ', ' Laryngoscopes ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' Training ', ' Selection Criteria ', ' retinitis pigmentosa-congenital deafness syndrome ', ' dystrophia retinae-dysacousis syndrome ', ' dystrophia retinae pigmentosa-dysostosis syndrome (DRD) ', ' dystrophia retinae pigmentosa-dysostosis syndrome ', "" Usher's syndrome "", ' Usher syndrome (US) ', ' Usher Syndrome ', ' Hallgren syndrome ', ' Graefe-Usher syndrome ', ' Retinitis pigmentosa-deafness syndrome ', ' low frequency hearing loss ', ' Low Frequency Deafness ', ' Genetic ', ' Genets ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Frequency ', ' Frequencies (time pattern) ', ' Sensory ', ' LOINC Axis 4 System ', ' System ', ' Persons With Hearing Impairments ', ' Hard of Hearing Persons ', ' Deaf ', ' Hearing Impaired Persons ', ' meetings ', ' trait ', ' genetic testing ', ' Genetic screening method ', ' Sampling ', ' response ', ' Hypoacusis ', ' Hypoacuses ', ' Hearing Loss ', ' hearing impairment ', ' Data ', ' Detection ', ' Sanger Sequencing ', ' Dideoxy Chain Termination DNA Sequencing ', ' High Prevalence ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Funding Opportunities ', ' cost ', ' software systems ', ' Minority ', ' cost-effective ', ' cost effective ', ' driving force ', ' Impairment ', ' phenome ', ' screening ', ' ']",NIDCD,UNIVERSITY OF IOWA,R01,2013,588237,IA-02,0.005176200267921025
"Genetic Susceptibility and Risk Model for Pancreatic Cancer     DESCRIPTION (provided by applicant): Pancreatic cancer (PanC) is the fourth leading cause of cancer-related death for both men and women in the U.S. Better understanding of the etiology and developing risk prediction models for early detection and prevention are urgently needed for this rapidly fatal disease. The majority of PanC are caused by the interplay of both genetic and environmental factors. Known risk factors for PanC include cigarette smoking, obesity, long-term type II diabetes, and family history. In addition, our previous case-control study has shown that excess body mass index (BMI) in young adulthood confers a higher risk of PanC than weight gain at later age. Recent genome-wide association studies (GWAS) have identified several chromosomal regions and genes in association with risk of PanC (PanScan). Our pathway analyses of the PanScan GWAS data have uncovered several novel biological pathways associated with the risk for PanC. However, it remains unknown how environmental or host risk factors modify the association between genetic factors and the PanC risk, which knowledge is critical to better understanding of the etiology and developing a risk prediction model and early intervention strategies for PanC. The goal of this project is to identify gene-environment interactions and develop and validate a risk prediction model including both common and rare genetic variants using the PanScan GWAS data and the exposure information of over 2,200 case-control pairs and an ongoing ExomeChip-based study of PanC genotyping both common SNPs and >240,000 rare functional exonic variants in over 4,100 cases and 4,700 controls from six case-control studies in the Pancreatic Cancer Case Control Consortium (PanC4) and a nested case-control study from Europe (EPIC). We will validate the absolute risk prediction model in two large prospective cohorts: the Atherosclerosis Risk in Communities (ARIC) cohort of 15,000 individuals and the Kaiser Permanente cohort of 100,000 individuals. We will also develop novel statistical methods to identify genes modifying the association between changing BMI at different age periods and PanC risk using the unique dataset from a case-control study of PanC conducted at MD Anderson Cancer Center. Our proposed project hinges on novel integration of GWAS, ExomeChip, exposure data of a large number of PanC cases and controls, recently developed powerful statistical methods and analysis strategies for detecting genome-wide gene/pathway-environment interactions and polygenic approaches to genetic risk prediction. The work proposed here is expected not only to advance our understanding of the etiology of PanC and delineate how genes and lifestyle or host factors modify the risk of PanC, but also to greatly facilitate identification of high-risk individuals, and thus, contribute to early detection, improved survival and prevention of PanC. The novel statistical methods developed here are also applicable to other cancers and complex disease, and we will develop user-friendly software packages for public use.         PUBLIC HEALTH RELEVANCE: Over 43,900 new cases of pancreatic cancer are expected to occur in the US in 2012, almost all rapidly fatal. This project will not only advance our understanding of the etiology of pancreatic cancer and delineate how genes and lifestyle or host factors modify the risk of pancreatic cancer, but also will facilitate identification of high-risk individuals, and thus, contribute to early detection, prevention, and improved survival of pancreatic cancer. The novel statistical methods developed here are also applicable to other cancers and complex disease, and we will develop user-friendly software packages for public use.                 ",Genetic Susceptibility and Risk Model for Pancreatic Cancer,8735889,R01CA169122,"['Age ', ' atherosclerotic vascular disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Communities ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Europe ', ' Family ', ' Genes ', ' Genotype ', ' Goals ', ' History ', ' Recording of previous events ', "" men's "", ' men ', ' Nested Case-Control Study ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Risk ', ' Risk Factors ', ' Smoking ', ' Survival Rate ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' Woman ', ' Work ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Logistic Regressions ', ' Training ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Early Intervention ', ' Host Factor Protein ', ' Host Factor ', ' Integration Host Factors ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Pancreatic Cancer ', ' Pancreas Cancer ', ' Malignant Pancreatic Neoplasm ', ' Malignant neoplasm of pancreas ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Complex ', ' Techniques ', ' cancer risk ', ' early detection ', ' Early Diagnosis ', ' environment effect on gene ', ' gene environment interaction ', ' user friendly computer software ', ' user friendly software ', ' cohort ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Prevention ', ' smoke cigarette ', ' cigarette smoking ', ' Statistical Methods ', ' Modeling ', ' case control ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' cancer diagnosis ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' Cancer Center ', ' Cancer Cause ', ' Cancer Etiology ', ' enroll ', ' Enrollment ', ' gene modification ', ' Gene-Modified ', ' Genetic Risk ', ' lifestyle factors ', ' Validation ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' prospective ', ' high risk ', ' public health relevance ', ' treatment strategy ', ' effective treatment ', ' effective therapy ', ' genomewide ', ' genome-wide ', ' ']",NCI,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R01,2014,254296,TX-09,0.02751486730525421
"Accelerating Curation of GWAS Catalog by Automatic Text Mining     DESCRIPTION (provided by applicant): A genome-wide association study (GWAS) is an approach to detecting genetic variations associated with particular diseases or traits by scanning markers across the genomes of a large-scale sample of subjects in a high-throughput manner. In less than a decade, GWAS studies have been successfully producing discovery and replication of many new disease loci. Discovered genetic associations have led to development of better strategies to diagnose, treat and prevent diseases. The number of GWAS is growing rapidly. There is a need for a database that allows researchers to easily query and search for previous results. A well-curated database also provides a resource for overview and summarization investigations of associated genetic sites and may help suggest pleiotropic genes. Such a database has been created and maintained by the National Human Genome Research Institute (NHGRI), called ""A Catalog of Published Genome-Wide Association Studies"" (Catalog of GWAS). The catalog has led to interesting characterization of previous results in GWAS and NHGRI has continued to update and curate the catalog regularly. However, this is performed by manually extracting information from published GWAS articles. As a result, the coverage is low compared to the volume of all GWAS publications and would be impossible to catch up the pace of new publications. The goal of this project is to develop a new tool to automatically extract the information from research articles for the curation of the catalog of GWAS. Our proposal is to use the curated data currently available from NHGRI as the training examples and apply novel machine-learning algorithms to train an information extractor to allow accurate automatic extraction. Given our recent success in applying machine learning to biological text mining, we are confident that this will lead to a useful tool to improve the productivity of curators and solve the coverage problem. Our first specific aim is to develop an accurate information extractor. Our second specific aim is to develop an easy-to-use curation tool for curators to efficiently check and correct errors from automatic information extraction so that their curation productivity can be improved by 18 folds. Then we will adapt the tool to extraction and curation of research papers reporting association studies using data from next generation sequencing. Currently, study design and the reporting of GWAS results using NGS data are not standardized. These results have not been considered to be included in the catalog yet. However, we expect that the limitations will be overcome and the methodology will converge soon. We will closely monitor the progress and adapt the tool to allow for inclusion of the NGS data. Finally, we will distribute the software to the public domain so that volunteers or interested parties can create their own catalog locally. It is our goal to share the developed software with the research community to advance the field. The new algorithms developed in this project and the entire development cycle, from design to deployment, will also contribute to the state-of-the- arts of biological text mining.         PUBLIC HEALTH RELEVANCE: The goal of this project is to develop a new tool to automatically extract the information from research articles for the curation of the catalog of GWAS. The catalog contains information about SNP-trait/disease associations that are extracted from published genome-wide association studies. A well-curated catalog of GWAS allows researchers to easily query and search for previous results and provides a useful resource for overview and summarization investigations of associated genetic sites and may help suggest pleiotropic genes.            ",Accelerating Curation of GWAS Catalog by Automatic Text Mining,8686917,U01HG006894,"['Algorithms ', ' Cataloging ', ' Communities ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Future ', ' Genes ', ' Genome ', ' Goals ', ' Human Genetics ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Manuals ', ' Method LOINC Axis 6 ', ' Methodology ', ' Paper ', ' Productivity ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' computer program/software ', ' Software ', ' Computer software ', ' Standardization ', ' Survey Instrument ', ' Surveys ', ' Technology ', ' Genetic Variation ', ' Genetic Diversity ', ' Variation (Genetics) ', ' Work Load ', ' Workload ', ' Public Domains ', ' base ', ' improved ', ' Site ', ' Area ', ' Biological ', ' Link ', ' Ensure ', ' Training ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Catalogs ', ' Investigation ', ' Scanning ', ' interest ', ' success ', ' trait ', ' novel ', ' Reporting ', ' Sampling ', ' developing computer software ', ' develop software ', ' software development ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' preventing ', ' prevent ', ' genetic association ', ' Data ', ' Disease Association ', ' Update ', ' Monitor ', ' Text ', ' developmental ', ' Development ', ' National Center for Human Genome Research ', ' NHGRI ', ' National Human Genome Research Institute ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' designing ', ' design ', ' user-friendly ', ' volunteer ', ' public health relevance ', ' next generation sequencing ', ' ']",NHGRI,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",U01,2014,277488,CA-52,0.07449279659731278
"International Case Control Study of Malignant Glioma    DESCRIPTION (provided by applicant): Glioma comprises about 40% of all primary brain tumors accounting for as many as 26,000 U.S. and European deaths annually. Inherited susceptibility plays a role with 2-fold increased risk of glioma among first-degree relatives of glioma cases. We initiated a multi-center, international linkage study: ""Genetic Epidemiology of Glioma International Consortium"" in 2007 to address the role of inherited susceptibility. Since this study does not allow us currently to address the role of genetic susceptibility in sporadic cases, we propose this case- control study to address this gap. Members of the consortium have conducted genome wide association studies (GWAS) that will be the discovery phase (phase I). While of high value for discovery, we propose to recruit 6,000 newly diagnosed glioma cases and 6,000 age-gender-ethnicity-matched controls, and collect detailed epidemiologic data and biologic samples from the 13 participating Gliogene sites. We hypothesize that novel inherited variation influencing the susceptibility to glioma can be identified by high density SNP analysis, and propose the following specific aims: SA1: Identify common genetic variants contributing to the risk of glioma. We plan to conduct phases 2 and 3 of the 3 phase approach, specifically we will: (SA1a) Validate GWAS findings from the discovery sets, and replicate the top hits (~23,000 SNPs) with lowest p- values from the two phase GWA studies in a series of 2,000 cases and 2,000 controls (phase 2, validation). Validate the top hits from the test set (aim 1a). From stage 2, genes with SNPs displaying an association at pd10-4 (including the complete haplotype tagging - approximately 100 SNPs) will then be genotyped in a further series of 4,000 cases and 4,000 controls (stage 3, validation). SNPs significant at 10-7 or better will be considered in the final analyses. (SA1b). Using an a priori hypothesis that DNA repair in inflammation contribute to glioma risk, we will selectively interrogate DNA repair and inflammation pathway genes using data for select genes derived from the high-density array. We will conduct a hypothesis driven genetic association in DNA repair and in inflammation/immune function related genes with glioma risk using functional genomic and bioinformatic tools to interrogate available databases. (SA2): Evaluate gene-gene (G-G) and gene- environmental (G-E) interactions with strong biologic relevance to identify G-G and G-E interactions for glioma risk using machine-learning tools (MDR, FITF, and CART) in these exploratory analyses. There are no existing glioma case-control studies with sufficient numbers of biological samples and common epidemiologic data to conduct a comprehensive validation and replication study, or to address the issues of tumor heterogeneity as we will in this study.       PUBLIC HEALTH RELEVANCE: Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.                           ",International Case Control Study of Malignant Glioma,8633419,R01CA139020,"['Accounting ', ' Age ', ' Bronchial Asthma ', ' Asthma ', ' California ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Systematics ', ' Classification ', ' Death ', ' Cessation of life ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Genes ', ' Genotype ', ' spongioblastoma multiforme ', ' glioblastoma multiforme ', ' Grade IV Astrocytoma ', ' Grade IV Astrocytic Tumor ', ' Grade IV Astrocytic Neoplasm ', ' Glioblastoma ', ' neuroglia tumor ', ' neuroglia neoplasm ', ' glial-derived tumor ', ' Neuroglial Tumor ', ' Neuroglial Neoplasm ', ' Glial Tumor ', ' Glial Neoplasm ', ' Glial Cell Tumors ', ' Glioma ', ' Haplotypes ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Allergy ', ' Hypersensitivity ', ' Infection ', ' Inflammation ', ' Mining ', ' Play ', ' Radiation-Ionizing Total ', ' Ionizing Electromagnetic Radiation ', ' Ionizing radiation ', ' recruit ', ' Recruitment Activity ', ' Risk ', ' social role ', ' Role ', ' San Francisco ', ' Syndrome ', ' Testing ', ' Trees ', ' Universities ', ' Genetic Variation ', ' Genetic Diversity ', ' Variation (Genetics) ', ' Gender ', ' forest ', ' Dataset ', ' Data Set ', ' Malignant Tumor of the Brain ', ' Brain Cancer ', ' Malignant neoplasm of brain ', ' base ', ' density ', ' Left ', ' Site ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Histologically ', ' Histologic ', ' Series ', ' Age of Onset ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Trust ', ' European ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Sample Size ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' Staging ', ' tool ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Hereditary ', ' Inherited ', ' Malignant Neuroglial Tumor ', ' Malignant Neuroglial Neoplasm ', ' Malignant Glial Tumor ', ' Malignant Glial Neoplasm ', ' Malignant Glioma ', ' success ', ' international center ', ' cohort ', ' Manuscripts ', ' Histopathology ', ' novel ', ' member ', ' Primary Brain Tumors ', ' Primary Brain Neoplasms ', ' Modeling ', ' Sampling ', ' case control ', ' genetic epidemiology ', ' functional genomics ', ' cancer location ', ' cancer site ', ' Bio-Informatics ', ' Bioinformatics ', ' Cellular Immune Function ', ' immune function ', ' genetic association ', ' Address ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' International ', ' Infrastructure ', ' Research Infrastructure ', ' Collection ', ' First Degree Relative ', ' Newly Diagnosed ', ' Validation ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' Adult Glioma ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' tumor ', ' high risk ', ' public health relevance ', ' population based ', ' epidemiologic data ', ' TCGA ', ' The Cancer Genome Atlas ', ' ']",NCI,BAYLOR COLLEGE OF MEDICINE,R01,2014,1836550,TX-09,0.06388859533533715
"Novel Strategies to Identify GxE Contributions to MS Pathogenesis    DESCRIPTION (provided by applicant):  Multiple sclerosis (MS) is a complex and heterogeneous inflammatory disorder of the central nervous system characterized by myelin loss, varying degrees of axonal pathology, and progressive neurological dysfunction. The combined effect of many genes, environmental exposures acting during defined periods of life, and their interactions in MS is strongly supported by our own work and others. The involvement of HLA class II genes within the major histocompatibility complex (MHC) on chromosome 6p21 is well-established. The identification of non-MHC determinants of MS susceptibility, while progressing, is far from complete. Similar to other complex diseases, genome-wide association studies (GWAS) have begun to unravel the polygenic etiology of MS. However, variants identified through several large GWAS, to date, explain only a very small proportion of MS heritability. The proposed study describes critical post-GWAS era steps to further our current understanding of MS pathogenesis. First, we will utilize next-generation DNA sequence data, high-throughput genotyping and state-of-the-art bioinformatics methods to fully characterize rare, less frequent and common variants within more than 30 MS genes established through recent GWAS and their contribution to the development of MS and disease expression (Aim 1). Next, we will also comprehensively investigate a number of important life-course exposures including prenatal, perinatal, childhood, adolescent and adult time periods, GxE interactions and risk of MS (Aim 2). Finally, we will study genome-wide DNA methylation profiles in a newly established cohort of clinically isolated syndrome (CIS)/early MS cases and matched controls to identify immune cell specific epigenetic influences on the development of MS (Aim 3). We will utilize extraordinary MS case-control resources nested within the large, population-based membership of Northern California Kaiser Permanente, as well as DNA, genetic and clinical data assembled for this project through the International Multiple Sclerosis Genetics Consortium; more than 10,000 individuals of White/European ancestry will be studied using a suite of statistical methods of analysis. Results from proposed epidemiologic studies of the most important MS genes and causal variants in the context of relevant environmental exposures will inform new functional studies, and have potential to support the development of more effective approaches for prevention, diagnosis and treatment.         The complete identification of genetic and environmental influences and how they contribute independently and jointly to the development of MS and expression of particular disease characteristics would play a major role in understanding disease etiology, and would contribute greatly to disease prevention strategies and development of targeted and more effective therapies.         ",Novel Strategies to Identify GxE Contributions to MS Pathogenesis,8650880,R01ES017080,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' California ', ' Cells ', ' Central Nervous System Disorders ', ' CNS disorder ', ' CNS Diseases ', ' Central Nervous System Diseases ', ' Chromosomes ', ' Chronology ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Environmental Exposure ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Foundations ', ' Genes ', ' MHC Class II ', ' HLA Class II Genes ', ' Class II Genes ', ' MHC Class II Genes ', ' Genotype ', ' Laboratories ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Major Histocompatibility Complices ', ' Histocompatibility Complices ', ' Histocompatibility Complex ', ' Major Histocompatibility Complex ', ' Methods ', ' insular sclerosis ', ' MS (Multiple Sclerosis) ', ' Disseminated Sclerosis ', ' Multiple Sclerosis ', ' Myelin ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Odds Ratio ', ' Pathology ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Survey Instrument ', ' Surveys ', ' Syndrome ', ' Testing ', ' Time ', ' Work ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' Perinatal ', ' Site ', ' Variation ', ' Variant ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Susceptibility ', ' Predisposition ', ' pediatric ', ' Childhood ', ' Individual ', ' Trust ', ' European ', ' Collaborations ', ' Genetic ', ' Inflammatory ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Dimensions ', ' Immune ', ' Complex ', ' environment effect on gene ', ' gene environment interaction ', ' cohort ', ' disease characteristic ', ' unborn ', ' prenatal ', ' novel ', ' disease prevention ', ' disorder prevention ', ' Preventive strategy ', ' Prevention strategy ', ' disease risk ', ' disorder risk ', ' Pathogenesis ', ' neurological dysfunction ', ' Neurologic Dysfunctions ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' case control ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' International ', ' Clinical Data ', ' Clinical Management ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Risk Estimate ', ' 6p21 ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' insertion/deletion ', ' insertion-deletion mutation ', ' insertion-deletion ', ' insertion/deletion mutation ', ' next generation ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' Heritability ', ' population based ', ' effective treatment ', ' effective therapy ', ' genomewide ', ' genome-wide ', ' rare allele ', ' rare variant ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA BERKELEY,R01,2014,580216,CA-13,0.02716744819163121
"Integrating epigenomic maps to predict regulatory functions of genetic variants     DESCRIPTION (provided by applicant): Mental illnesses are some of the most devastating diseases affecting human populations, placing a huge burden on individuals, families and society. Genome-wide association studies (GWAS) have identified dozens of common single nucleotide polymorphisms (SNPs) that are associated with psychiatric diseases, but a majority of those SNPs have been mapped to intergenic or intronic regions and are functionally unclassified. Existing software or algorithms only query multiple databases and produce lists of hits without intelligent integration and ignore much of the valuable regulatory information. The overall goal of this proposal is to integrate all available genetic, genomic and epigenomic data to generate a probability-based prediction about a SNP's influence on gene expression level in brain. Our previous studies have shown that psychiatric GWAS signals are enriched with brain eQTL SNPs (eSNPs), and these brain eSNPs are likely to be functional and contribute to disease susceptibilities. We will use SNPs in eQTLs to anchor a chain of evidence incorporating histone marks, conserved sequences, transcription factor binding sites, DNA methylation, accessible chromatins, non-coding RNA, and other data. We will use a machine learning method to predict regulatory SNPs based on known relationships between these epigenetic marks and their target genes, as well as their distinct patterns in genome. We will also use our novel unsupervised deconvolution algorithm to extract cell-type (i.e., neuron vs. non-neuron) specific measures from heterogeneous brain tissue data to improve our predictions. We will use both statistical and experimental methods to validate the predictions. Quantitative PCR and CRISPR-cas9 will be used on induced pluripotent cell lines to compare gene expression levels of alleles of predicted functional SNPs. Both algorithm and predicted functional variants will made public via a website and standalone application. The novel algorithm will significantly improve our understanding of psychiatric disease genetics by uncovering the gene-regulatory functions for disease-associated, non-coding SNPs.         PUBLIC HEALTH RELEVANCE: Genome-wide association studies (GWAS) have identified thousands of common SNPs associated with major complex diseases, but the majority of those SNPs are located in non-coding regions, leaving those genetic associations functionally unexplained. Existing functional predication software or algorithms only query some databases without providing statistical or biological integration, and dismiss much valuable regulatory information. We propose to integrate all the available genetic, genomic and epigenomic data and use machine learning to produce a probability-based prediction about a SNP's influence on gene expression levels in brain. We will also use a novel unsupervised deconvolution algorithm to extract cell-type specific measures from heterogeneous brain tissue data to improve our prediction. We will use both statistical and experimental methods to validate the predictions. Both algorithm and predicted functional variants will be made public via a website and standalone application. The novel algorithm will significantly improve our understanding of psychiatric disease genetics by giving those non-coding, disease-associated SNPs meaningful biological functions.            ",Integrating epigenomic maps to predict regulatory functions of genetic variants,8815564,R01ES024988,"['Affect ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' Biology ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cells ', ' Chromatin ', ' Conserved Sequence ', ' disease/disorder ', ' Disorder ', ' Disease ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' Disease susceptibility ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' human whole genome ', ' Human Genome ', ' Goals ', ' histocompatibility typing ', ' Tissue Typing ', ' Tissue Crossmatching ', ' Histocompatibility Testing ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Linkage Disequilibrium ', ' Maps ', ' Methods ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Play ', ' Probability ', ' Random Selection ', ' Random Allocation ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Societies ', ' computer program/software ', ' Software ', ' Computer software ', ' Testing ', ' Body Tissues ', ' Tissues ', ' transcription factor ', ' Benzoic acid, 4-(((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)amino)carbonyl)- ', ' Am80 ', ' Am 80 ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Left ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Gene Targeting ', ' Biological Function ', ' Biological Process ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Complex ', ' cell type ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' brain tissue ', ' interest ', ' Performance ', ' QTL ', ' Quantitative Trait Loci ', ' trait ', ' novel ', ' disease risk ', ' disorder risk ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Coding System ', ' Code ', ' Sampling ', ' Genomics ', ' histone modification ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Data ', ' Disease Association ', ' Reproducibility ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Other Genetics ', ' Validation ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' website ', ' web site ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' epigenomics ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' Heritability ', ' iPSC ', ' iPS ', ' induced pluripotent stem cell ', ' public health relevance ', ' genomewide ', ' genome-wide ', ' next generation sequencing ', ' Cas nuclease technology ', ' CRISPR/Cas system ', ' CRISPR ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' Software Algorithm ', ' Algorithmic Tools ', ' Algorithmic Software ', ' ']",NIEHS,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2014,325984,IL-07,0.04683863316642571
"Genome analysis based on the integration of DNA sequence and shape  Title: Genome analysis based on the integration of DNA sequence and shape PI: Rohs, Remo (USC); Co-I: Noble, William Stafford (UW); Co-I: Tullius, Thomas D. (BU) PROJECT SUMMARY Current techniques for genome analysis are mainly based on the one-dimensional DNA sequence, comprised of the letters A, C, G, and T. However, proteins recognize DNA as a three-dimensional (3D) object. Nuances in DNA shape at single nucleotide resolution play a crucial role in the binding specificity of transcription factors (TFs), including those involved in embryonic development and human cancer. This project involves the development of a battery of tools for genome analysis, through the integration of information derived from the DNA sequence and the 3D structure of DNA, or ""DNA shape"". The basis for these novel tools is a high- throughput (HT) method for the prediction of multiple features of local DNA shape at the genomic scale. Data will be made available to the community in the UCSC Genome Browser track format through a web server interface. These tools will enable users to analyze the shape of any number or length of DNA sequences, including whole genomes and the effect of DNA methylation. HT shape predictions will be validated based on X-ray crystallography, NMR spectroscopy, and hydroxyl radical cleavage data. Predictions will be combined with ORChID, an ENCODE project that infers DNA minor groove geometry from hydroxyl radical cleavage experiments. The HT method will be used to study how paralogous TFs select different target sites in vivo despite sharing core-binding motifs or having similar binding properties in vitro. To study this question, we will investigate the effect of flanking sequences on multiple structural features of TF binding sites (TFBSs). The initial focus of this study will be homeodomains and basic helix-loop-helix (bHLH) TFs. Other protein families will later be included and used to construct a comprehensive TFBS database that provides shape features for binding motifs derived from JASPAR and other motif databases. Structural effects of single nucleotide polymorphisms (SNPs) will also be analyzed. Some SNPs are associated with deleterious functions, whereas others have no apparent effect. The HT shape prediction method will be used to predict the function of SNPs in non-coding regions based on DNA shape. We will correlate quantitative effects of SNPs on DNA structure with expression quantitative trait loci (eQTLs) and genome-wide association study (GWAS) signals, to develop a predictive tool for the functional effect of SNPs. The HT shape prediction approach will be used to design DNA sequences with different AT/GC contents but similar shapes. The relative contributions of sequence and shape to binding will be tested with analytic models including multiple linear regression (MLR) and support vector regression (SVR). For systems in which the integration of sequence and shape proves advantageous, novel motif finding tools will be developed based on an extended alphabet that combines sequence with informative structural features, selected by machine learning and feature selection approaches. Sequence+shape motifs will be tested by motif scanning, compared to sequence-only motifs, and integrated into the MEME Suite. The goal of this sequence-shape integration is to increase the accuracy of finding in vivo TFBSs in the genome. PUBLIC HEALTH RELEVANCE: Protein-DNA recognition is a critical yet poorly understood component of gene regulation. This proposal will connect the fields of DNA sequence and structure analysis, which so far have been developed in parallel but largely disconnected from each other. Integration of the one-dimensional DNA sequence at a genome-wide scale with the three-dimensional DNA structure at atomic resolution will lead to the development of novel genome analysis tools and will advance our understanding of genome function, leading to fundamentally new insights into the mechanisms of gene regulation and its impact on human disease.            ",Genome analysis based on the integration of DNA sequence and shape,8632246,R01GM106056,"['Affect ', ' Algorithms ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Thymonuclease ', ' Pancreatic DNase ', ' DNase I ', ' DNA Endonuclease ', ' Deoxyribonuclease I ', ' Deoxyribonucleic Acid ', ' DNA ', ' DNA-Binding Proteins ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Family ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genome ', ' Goals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hybrids ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Linear Regressions ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Nucleotides ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Protein Binding ', ' gene product ', ' Proteins ', ' Publishing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Technology ', ' Testing ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Yeasts ', ' Hydroxyl ', ' Hydroxyl Radical ', ' Measures ', ' Relative ', ' Relative (related person) ', ' DNA Sequence ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Xray Crystallography ', ' X-Ray/Neutron Crystallography ', ' X-Ray Diffraction Crystallography ', ' X Ray Crystallographies ', ' Single Crystal Diffraction ', ' X-Ray Crystallography ', ' Training ', ' insight ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Biological Function ', ' Biological Process ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Letters ', ' helix turn helix ', ' helix loop helix ', ' HTH Motifs ', ' HTH DNA Binding Domain ', ' Helix-Turn-Helix Motifs ', ' Basic Helix-Loop-Helix Transcription Factors ', ' Basic Helix-Loop-Helix Protein ', ' Basic HLH Protein ', ' BHLH Protein ', ' Shapes ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Width ', ' Best Practice Analysis ', ' Benchmarking ', ' QTL ', ' Quantitative Trait Loci ', ' Homeo Domain ', ' homeodomain ', ' Base Pairing ', ' Structure ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' Genomics ', ' Guanine + Cytosine Content ', ' GC Content ', ' GC Composition ', ' G+C Content ', ' G+C Compositions ', ' Guanine + Cytosine Composition ', ' DNA Binding Interaction ', ' DNA Binding ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' genetic evolution ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Protein Family ', ' Length ', ' Affinity ', ' DNA Structure ', ' Data ', ' DNase-I Footprinting ', ' Minor Groove ', ' Resolution ', ' in vivo ', ' Genome Scan ', ' Validation ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' vector ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' three dimensional structure ', ' computer algorithm ', ' Computational algorithm ', ' human disease ', ' public health relevance ', ' genomewide ', ' genome-wide ', ' flexible ', ' flexibility ', ' Chip sequencing ', ' Chip seq ', ' Chip Chip ', ' Chip on Chip ', ' genome analysis ', ' Geometry ', ' ']",NIGMS,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2014,334303,CA-37,0.009430190922631497
"Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning  Detecting Genome-Wide Epistasis with Efficient Bayesian Network Learning Epistasis is the interaction between two or more genes to affect phenotype. It is now widely accepted that epistasis plays an important role in susceptibility to many common diseases. The advent of high-throughput technologies has enabled genome-wide association studies (GWAS or GWA studies). It is compelling that we be able to detect epistasis using GWAS data. However, so far GWA studies have mainly focused on the association of a single gene or loci with a disease. The crucial challenge to analyzing epistasis using GWAS data is finding a way to efficiently handle high-dimensional data sets. The only possible solution is to design efficient algorithms that allow us to find the most relevant epistasic relationships without doing an exhaustive investigation. To the Principal Investigator's knowledge, no current method can do this. This career award will investigate this problem. The specific aims are as follows: (Aim 1) develop and evaluate efficient Bayesian network-based methods for learning candidate genes associated with diseases from GWAS sets. Such genes would provide candidates for follow-up biological studies, (Aim 2) implement the methods in a pilot GWAS system for use by researchers when conducting a GWAS, (Aim 3) develop simulated genome-wide data sets and evaluate the pilot system using these data sets, and (Aim 4) conduct GWA studies concerning breast cancer and lung cancer. Aim 1 will be addressed by developing a succinct Bayesian network model representing epistasis, efficient algorithms which are tailored to investigating such models, integration of the algorithms into methods for learning epistasis, and using simulated datasets to test the effectiveness of the methods and compare their performance to other methods. Aim 2 will be met by implementing the methods in a pilot GWAS system. Aim 3 will be satisfied by developing synthetic data sets similar to those found in GWA studies, and using them to evaluate the system. Aim 4 will be achieved by conducting GWA studies concerning breast and lung cancer. By conducting these studies, we can (1) substantiate previous results concerning the genetic basis of these diseases; (2) possibly obtain interesting new findings pertaining to these diseases. The main hypothesis is that the proposed method will be an advance over existing methods in that it will make it computationally feasible to learn epistatic relationships from genome-wide data and it will therefore yield better discovery performance than existing methods.  Learning gene-gene interactions from genome-wide association studies (GWAS) data is an important and challenging task in genetic epidemiology. This project will develop and evaluate a pilot GWAS system for performing this task. Advances obtained in analyzing GWAS data sets could enable us to learn the genetic basis of many diseases and thereby substantially improve the quality of personalized patient care.",Detecting Genome Wide Epistasis with Efficient Bayesian Network Learning,8628875,R00LM010822,"['Affect ', ' Algorithms ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Award ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Data Analysis ', ' Data Analyses ', ' disease/disorder ', ' Disorder ', ' Disease ', ' genetic epistases ', ' gene x gene interaction ', ' epistatic relationship ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Patient Care Delivery ', ' Patient Care ', ' Genes ', ' Articulation ', ' Joints ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Phenotype ', ' Play ', ' Statistical Regression ', ' Regression Diagnostics ', ' Regression Analyses ', ' Regression Analysis ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' Solutions ', ' Testing ', ' Woman ', ' Work ', ' Generations ', ' forest ', ' Dataset ', ' Data Set ', ' base ', ' career ', ' improved ', ' Site ', ' Biological ', ' Hereditary Mutation ', ' Germline Mutation ', ' Germ-Line Mutation ', ' Link ', ' Susceptibility ', ' Predisposition ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Family history of ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Simulate ', ' Genetic ', ' Malignant Cell ', ' cancer cell ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' brca 1 gene ', ' RNF53 ', ' Hereditary Breast Cancer 1 ', ' Early Onset Gene Breast Cancer 1 ', ' Breast Cancer Type 1 Susceptibility Gene ', ' Breast Cancer 1 Gene ', ' BRCA1 ', ' BRCA1 gene ', ' Investigation ', ' Complex ', ' LOINC Axis 4 System ', ' System ', ' interest ', ' meetings ', ' gene interaction ', ' Performance ', ' brca 2 gene ', ' Hereditary Breast Cancer 2 ', ' FANCD1 ', ' FANCB ', ' Early Onset Gene Breast Cancer 2 ', ' Breast Cancer Type 2 Susceptibility Gene ', ' Breast Cancer 2 Gene ', ' BRCA2 ', ' BRCA2 gene ', ' neural network ', ' Biological Neural Networks ', ' Statistical Methods ', ' Modeling ', ' high throughput technology ', ' genetic epidemiology ', ' Cancer Susceptibility Gene ', ' Cancer-Predisposing Gene ', ' Effectiveness ', ' datamining ', ' data mining ', ' Candidate Gene ', ' Candidate Disease Gene ', ' GRB2-Associated Binding Protein 2 Gene ', ' GAB2 ', ' GAB2 gene ', ' Address ', ' Data ', ' Genetic Algorithm ', ' Genetic Programming ', ' Principal Investigator ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' designing ', ' design ', ' combinatorial ', ' Network-based ', ' genome-wide analysis ', ' genomewide ', ' genome-wide ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' ']",NLM,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R00,2014,204812,PA-18,0.05007456818860282
"Systems genetic and reverse phenotypic analysis of age and retirement     DESCRIPTION (provided by applicant): High throughput genomic platforms have revealed a profound effect of age on gene expression and gene methylation levels. For example, our integromic analysis of multiple publicly available data sets have identified hundreds of age related genes that can be organized into network modules. These gene sets along with genes and pathways known from the vast literature on aging and longevity provide valuable candidates in allelic association studies of the health and well-being of older Americans. The rich longitudinal data set and the genome wide scans of DNA samples from the Health and Retirement Study (HRS) provide a unique resource for evaluating the phenotypic effects of genetic variants underlying aging related genes, gene sets and for developing multivariable models that include behavioral, psychosocial, and genetic factors. This proposal aims to apply systems biologic and systems genetic methods for identifying gene sets based on existing gene expression, gene methylation, and multiple large scale genome wide association studies (GWAS). Single nucleotide polymorphisms (SNPs) underlying these genes will then be related to health, cognitive, behavioral, and economic phenotypes using multivariable regression-, machine learning-, and weighted network analysis approaches. An iterative process between SNP and phenotype selection facilitates the definition of clinically and economically important phenotypes under genetic control (reverse phenotyping). The proposal will not only elucidate the genetic and molecular underpinnings of retirement relevant phenotypes (cognitive functioning, psychosocial factors, and health related expenditures) but also lead to a phenotypic annotation of aging related genes and pathways.         PUBLIC HEALTH RELEVANCE: State of the art statistical, computational, and network approaches for integrating genomic data with the valuable phenotypic and genetic data provided by the Health and Retirement Study is expected to lead to the identification of genetic markers relevant for improving the lives of America's older adults. Validated genetic markers will inform researchers in many fields including biomedical researchers, epidemiologists, psychologists, sociologists, and economists.            ",Systems genetic and reverse phenotypic analysis of age and retirement,8691636,R01AG042511,"['Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Americas ', ' Parturition ', ' Birth ', ' Concurrent Studies ', ' Cohort Studies ', ' Data Analysis ', ' Data Analyses ', ' Deoxyribonucleic Acid ', ' DNA ', ' Economics ', ' Expenditure ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Economical Income ', ' Economic Income ', ' Income ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' well-being ', ' Personal Satisfaction ', ' Phenotype ', ' Psychologist ', ' psychosocial variables ', ' Psychosocial Factor ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retirement ', ' sociologist ', ' computer program/software ', ' Software ', ' Computer software ', ' Specificity ', ' statistics ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Weight ', ' Measures ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cognitive function ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Physical Function ', ' psychosocial ', ' interest ', ' American ', ' environment effect on gene ', ' gene environment interaction ', ' cohort ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' repository ', ' Genomics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Data ', ' Subgroup ', ' Cognitive ', ' Epidemiologist ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' reverse genetics ', ' positional cloning ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' pediatric depression ', ' childhood depression ', ' adolescent depression ', ' child depression ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Impairment ', ' endophenotype ', ' public health relevance ', ' social implication ', ' economic implication ', ' exomes ', ' exome ', ' ']",NIA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2014,315700,CA-33,0.03815609646057151
"Enhanced Gene Identification in Complex Traits Using Kernel Machines     DESCRIPTION (provided by applicant):     Project Summary/Abstract Genome-wide association studies (GWAS) have mapped thousands of common trait-influencing variants yet the overwhelming majority of trait loci have yet to be discovered. The goal of this proposal is to develop and apply statistical approaches that move beyond the standard GWAS paradigm to map additional trait-influencing variation within the human genome. Most of our proposed tools are based on a flexible high-dimensional framework called kernel machine regression, which we have had past success employing for powerful gene mapping of complex traits in GWAS and next-generation sequencing (NGS) studies. We believe the inherent flexibility of the kernel framework makes it ideal for exploring new paradigms in gene mapping of complex human traits. Aim 1 proposes novel kernel methods for integrated analysis of both single-nucleotide variation data (derived from GWAS and/or NGS) and genomic data (such as gene-expression and methylation patterns) that we believe will provide improved power for trait mapping. Aim 2 proposes novel kernel methods for large scale gene-gene interaction analysis across the genome, as well as a computational approach that enables efficient adjustment for multiple testing when applying such exhaustive testing procedures. Aim 3 establishes novel kernel methods for association mapping of SNVs on the X chromosome. The flexible nature of kernel machines makes it ideal for modeling potential sex-specific effects on this chromosome and the methods further can accommodate random X inactivation. Aim 4 proposes novel kernel approach for robust analysis of rare trait-influencing variation within families; such family-based designs are generally not considered in current rare-variant procedures. We will evaluate these methods on large-scale datasets that we are actively involved in and will implement the methods in user-friendly software for public distribution (Aim 5).         PUBLIC HEALTH RELEVANCE:     Project Narrative The goal of this project is to develop novel and powerful statistical tools for identifying genetic loci acting independently or in conjunction with other genetic/environmental factors to influence complex human diseases or disease-related quantitative traits. Application of the proposed methods to applied datasets should improve our understanding of the genetic origins of complex traits and enhance existing risk-prediction models of complex disease.            ",Enhanced Gene Identification in Complex Traits Using Kernel Machines,8729618,R01HG007508,"['abstracting ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' Chromosomes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' epileptogenic ', ' epileptiform ', ' epilepsia ', ' Seizure Disorder ', ' Epileptics ', ' Epileptic Seizures ', ' Epilepsy ', ' Exhibits ', ' Family ', ' Gene Expression ', ' Genes ', ' Genome ', ' human whole genome ', ' Human Genome ', ' Goals ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Articulation ', ' Joints ', ' Linkage Disequilibrium ', ' Literature ', ' Maps ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Study models ', ' Nuclear Family ', ' Nucleotides ', ' pedigree structure ', ' Pedigree ', ' genetic pedigree ', ' Play ', ' Public Health ', ' public health medicine (field) ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' social role ', ' Role ', ' computer program/software ', ' Software ', ' Computer software ', ' traumatic neurosis ', ' Posttraumatic Stress Disorders ', ' Posttraumatic Neuroses ', ' Post-Traumatic Neuroses ', ' PTSD ', ' Post-Traumatic Stress Disorders ', ' Technology ', ' Testing ', ' Work ', ' X Chromosome ', ' X-Chromosome Inactivation ', ' Lyonization ', ' X Inactivation ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Procedures ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Sexism ', ' Gender Bias ', ' Sex Bias ', ' Link ', ' Individual ', ' Simulate ', ' Genetic ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' Source ', ' Pattern ', ' interest ', ' gene interaction ', ' Performance ', ' success ', ' user friendly computer software ', ' user friendly software ', ' X linked trait ', ' X inherited trait ', ' trait ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Genetic analyses ', ' genetic analysis ', ' Statistical Methods ', ' Modeling ', ' case control ', ' Genomics ', ' Address ', ' Resequencing ', ' DNA Resequencing ', ' Data ', ' Other Genetics ', ' scientific advances ', ' scientific accomplishments ', ' Scientific Advances and Accomplishments ', ' sex ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' open source ', ' human disease ', ' stem ', ' public health relevance ', ' population based ', ' flexible ', ' flexibility ', ' next generation sequencing ', ' rare allele ', ' rare variant ', ' ']",NHGRI,EMORY UNIVERSITY,R01,2014,343000,GA-05,0.011661410742288544
"Integrating Genomic and Environmental Perspectives on Internalizing Disorders While biometric genetic studies have long indicated substantial heritability for internalizing disorders, including major depressive and generalized anxiety disorders, progress in mapping this influence onto specific genetic variants has been slow. Expert consensus suggests that finding this missing heritability will require moving beyond the current one SNP at a time genomewide association study (GWAS) paradigm to develop interactive models jointly considering effects across structural and functional genomic units (e.g., genes and biological pathways), as well as modeling gene-environmental interaction (GxE) in the highly dimensional GWAS context. The overarching goal of this proposal is to provide the candidate the training and research opportunities necessary to advance such an interactive model of internalizing disorder etiology, thus supporting the candidates long-term career goal of becoming an independent investigator in the area. General training goals include building proficiency in statistical genetics and bioinformatics, and strengthening knowledge of substantive issues in developmental psychopathology and psychometric statistical modeling/programming. The candidate proposes to acquire a number of specific skills, including data integration techniques for including prior information in GWAS, aggregation methods to capture the possible effects of many markers with very small effects (e.g., gene-based, pathway-based, and polygenic risk profile score analyses) and machine learning applications for investigating epistasis and nonlinear genomic effects. Proposed training in these areas consists of an interlocking program of coursework, intensive mentoring, summer programs, reading groups, seminar series and conferences, with special attention to training in research ethics. Direct mentoring is a key feature of this program, with access to leading experts in each of the proposed training areas (i.e., Drs. Edwin van den Oord and Patrick Sullivan  statistical genetics and bioinformatics, Dr. E. Jane Costello  developmental psychopathology, and Dr. Michael Neale  statistical modeling and programming) representing a core strength of the proposed training plan. The candidate proposes to apply acquired skills in the research portion of the project by conducting a multistage GWAS to investigate genomic influence, both direct and in interaction with environmental risk factors, on developmental trajectories of internalizing disorders. Methodologically, this approach focuses on integrating longitudinal statistical models of phenotypic development and environmental risk with emerging genomic methods. This will be facilitated by bringing together an unprecedented combination of longitudinal GWAS datasets, including a meta-analysis of the four Duke/VCU samples of the Gene, Environment, and Development Initiative (GEDI) (N=3,623). This discovery phase meta-analysis will then be followed by replication in two large independent longitudinal samplesthe National Longitudinal Study of Adolescent Health (N=~12,000) and the Minnesota Twin and Family Study (N=3,762). The exceptional statistical power of this design will be further complimented in a final analytical stage, with next-generation sequencing follow-up using targeted capture methods to extract promising genes/regions and extreme-trait methods to maximize power by selecting subjects from the extremes of the phenotypic distributions. The institutional environment provided by the Virginia Commonwealth University Center for Biomarker Research and Personalized Medicine (CBRPM) represents another core asset to the candidates career development. The CBRPMs mission is to develop and apply novel methods for the purpose of identifying and using biomarkers to improve disease understanding and medical treatment. The Center operates from a strong multidisciplinary perspective with primary applications involving psychiatric outcomes, developmental psychopathology, and substance use disorders. Currently funded research programs at the CBRPM include serving as the data analysis core of the Duke/VCU GEDI project, method development in the design and analysis of adaptive multistage GWAS, a replication study of findings from schizophrenia GWAS, and whole genome profiling to detect schizophrenia methylation markers. These projects offer an ideal context for executing the proposed training and research, as they provide an environment focused on GWAS and next-generation sequencing applications to psychiatric disorderscentral topics of the candidates career development plan. The CBRPM also provides several unique physical resources supporting the current proposal, including a SOLiD 4 next-generation sequencer, which will allow follow-up sequencing to be done in-house, and a Center-dedicated computing cluster, facilitating the computationally intensive analyses proposed. In addition to physical resources, the CBRPM offers a challenging and collegial intellectual environment that promotes collaboration both within and outside of the Center. In sum, the CBRPM provides a stimulating and supportive institutional environment with the all of the statistical, computational and laboratory resources necessary to make this proposal a successful one. Affecting more than one in five Americans annually, internalizing disorders (IDs) (i.e.,  depression and anxiety) are the most common forms of mental illness and leading  causes of the global health burden. Clearly, an improved understanding of the etiology of  IDs would substantially advance both prevention and intervention efforts. This project  aims to improve understanding through advancing an integrative model of genomic,  environmental and developmental influence in the etiology of IDs.",Integrating Genomic and Environmental Perspectives on Internalizing Disorders,8627047,K01MH093731,"['Affect ', ' Algorithms ', ' Anxiety ', ' Attention ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Puericulture ', ' Child Care ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Environment ', ' genetic epistases ', ' gene x gene interaction ', ' epistatic relationship ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Genes ', ' Genome ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Housing ', ' indexing ', ' Laboratories ', ' long-term study ', ' Longitudinal Studies ', ' Maps ', ' Medicine ', ' Mentors ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Minnesota ', ' Mission ', ' Genetic Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Phenotype ', ' Play ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Population Control ', ' Psychometrics ', ' abnormal psychology ', ' Psychopathology ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Scoring Method ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Substance Use Disorder ', ' Testing ', ' Time ', ' Twins ', ' Twin Multiple Birth ', ' Universities ', ' Virginia ', ' Measures ', ' conference ', ' symposium ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' career ', ' method development ', ' improved ', ' Family Study ', ' Area ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Series ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Measurement ', ' Development Plans ', ' Genetic Research ', ' Funding ', ' Generalized Anxiety Disorder ', ' Collaborations ', ' Twin Studies ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Consensus ', ' Knowledge ', ' programs ', ' Investigation ', ' Side ', ' Techniques ', ' American ', ' developmental genetics ', ' environment effect on gene ', ' gene environment interaction ', ' trait ', ' Structure ', ' skills ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Research Ethics ', ' Modeling ', ' Sampling ', ' career development ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' functional/structural genomics ', ' major depression ', ' Major Depressive Disorder ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Address ', ' global health ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' Research Training ', ' Stratification ', ' Sum ', ' Genetic Risk ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' data integration ', ' grid computing ', ' distributed computing ', ' datagrid ', ' data grid ', ' computational grid ', ' cluster computing ', ' designing ', ' design ', ' next generation ', ' Outcome ', ' Heritability ', ' multidisciplinary ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' next generation sequencing ', ' screening ', ' rare allele ', ' rare variant ', ' ']",NIMH,VIRGINIA COMMONWEALTH UNIVERSITY,K01,2014,131576,VA-04,0.06577184401967286
"Empowering Personalized Medicine: Integrating Imaging, Genetics, and Biomarkers     DESCRIPTION (provided by applicant): This project, Empowering Personalized Medicine: Integrating Imaging, Genetics and Biomarkers, responds to RFA-MH-12-020, entitled Integrating Multi-Dimensional Data to Explore Mechanisms Underlying Mental Disorders. By bringing together experts in neuroimaging, genetics, and mathematics, we plan to create an advanced, portable framework to combine diverse biomedical data from 3D neuroimaging (MRI, amyloid/FDG-PET), gene expression networks, genome-wide association studies (GWAS), and other multidimensional data (e.g., physiological biomarkers, epigenetic data, etc.). Our overall goal is to improve diagnosis and prognosis of disease by combining multiple levels of biological information (personalized medicine). In doing so, novel mathematical tools will automatically discover which biomarkers are most helpful in different contexts. To discover and test relationships between very high-dimensional measures (such as images and genomes), we use novel concepts for data reduction such as penalized regression (elastic nets), adaptive hierarchical clustering, Bayesian networks, and support vector machines. Avoiding the limitations of current work that tests individual gene effects independently, we extend the analysis of gene expression networks to images, to relate signs of disease to their genetic underpinnings and to all available biomarkers. Aim 1 empowers discovery genetic variants (identified in GWAS, whole-exome and whole-genome sequencing) that modulate measures of disease. We will use compressive coding models to discover and verify which sets of genetic variants affect multidimensional images (e.g., co-registered MRI & PET, DTI). We will verify our predictions using k-fold cross-validation and independent replications in new samples and controllable test data. Aim 2 extends our work using weighted gene co-expression network analysis (WGCNA) from single traits to entire databases of 3D images (MRI/PET). Our framework will merge GWAS, eQTL analysis, and expression-phenotype analysis but will be broadly applicable to any future high-throughput biological information (e.g. methylation profiles, DTI, fMRI). In Aim 3, we will quantify the added predictive value derivable from genotyping, gene expression profiling, and multimodal neuroimaging for personalized prognosis and diagnosis. For example, which biomarkers (gene expression, CSF, MRI) are most useful in which cases? To maximize impact of this effort, we and our collaborators will test our tools on existing and new datasets from a range of neuropsychiatric disorders including frontotemporal dementia, Alzheimer's disease, schizophrenia, bipolar disorder, and autism (see Support Letters). All tools will be disseminated and linked to web-accessible databases that store and ease access to high-throughput genetic, genomic, and imaging datasets.          Our project improves diagnosis and predictions of patient outcomes by integrating diverse types of patient data including neuroimaging, gene expression profiles, cognitive, and behavioral markers of disease diagnosis, progression, and treatment response. To tackle these complex data types, we develop novel machine learning, network analysis, and database methods. Our personalized medicine approach will help researchers study and evaluate neurological and psychiatric conditions such as Alzheimer's disease, frontotemporal dementia, schizophrenia, bipolar disorder, and autism.                ","Empowering Personalized Medicine: Integrating Imaging, Genetics, and Biomarkers",8659510,R01MH097268,"['Affect ', ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Amyloid Substance ', ' Amyloid ', "" Kanner's Syndrome "", ' Infantile Autism ', ' Early Infantile Autism ', ' Autism ', ' Autistic Disorder ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' manic depressive illness ', ' manic depressive disorder ', ' bipolar affective disorder ', ' Manic-Depressive Psychosis ', ' Bipolar Affective Psychosis ', ' Bipolar Disorder ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Clinical Study ', ' Clinical Research ', ' depression ', ' Mental Depression ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Future ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genome ', ' Genotype ', ' Goals ', ' Zeugmatography ', ' Nuclear Magnetic Resonance Imaging ', ' NMR Tomography ', ' NMR Imaging ', ' Medical Imaging, Magnetic Resonance / Nuclear Magnetic Resonance ', ' Magnetic Resonance Imaging Scan ', ' MRI ', ' MR Tomography ', ' MR Imaging ', ' Magnetic Resonance Imaging ', ' Math ', ' Mathematics ', ' Medicine ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Persons ', ' neuronal degeneration ', ' neurodegenerative ', ' neurodegeneration ', ' neural degeneration ', ' Neuron Degeneration ', ' Nerve Degeneration ', ' Neurosciences ', ' Patients ', ' Phenotype ', ' Rad.-PET ', ' Positron Emission Tomography Scan ', ' Positron Emission Tomography Medical Imaging ', ' PETT ', ' PETSCAN ', ' PET imaging ', ' PET Scan ', ' PET ', ' Positron-Emission Tomography ', ' Prognosis ', ' outcome forecast ', ' Publishing ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Running ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Testing ', ' Genetic Variation ', ' Genetic Diversity ', ' Variation (Genetics) ', ' Weight ', ' Work ', ' Measures ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' brain visualization ', ' Brain imaging ', ' Site ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Physiologic ', ' Physiological ', ' Neurological ', ' Neurologic ', ' Link ', ' prognostic ', ' insight ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Funding ', ' Letters ', ' Genetic ', ' tool ', ' frontotemporal lobar dementia ', ' fronto-temporal lobar dementia ', ' fronto-temporal dementia ', ' Frontal Temporal Dementia ', ' Frontotemporal Dementia ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' fMRI ', ' Functional MRI ', ' Functional Magnetic Resonance Imaging ', ' Complex ', ' Equation ', ' empowered ', ' experience ', ' success ', ' Informatics ', ' trait ', ' Structure ', ' genetic testing ', ' Genetic screening method ', ' neuroimaging ', ' novel ', ' disease risk ', ' disorder risk ', ' Modality ', ' gene expression analysis ', ' Transcript Expression Analysis ', ' Transcript Expression Analyses ', ' Gene Expression Pattern Analysis ', ' Gene Expression Monitoring ', ' Gene Expression Profiling ', ' Coding System ', ' Code ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' neuropsychiatric ', ' neuropsychiatry ', ' fluorodeoxyglucose PET ', ' FDG PET ', ' fluorodeoxyglucose positron emission tomography ', ' Genomics ', ' 3D images ', ' 3D image ', ' 3-D image ', ' 3-D Images ', ' Three-Dimensional Image ', ' genome sequencing ', ' Address ', ' Data ', ' molecular signature ', ' molecular profile ', ' Molecular Fingerprinting ', ' Expression Signature ', ' Expression Profiling ', ' Molecular Profiling ', ' NCRR ', ' National Center for Research Resources ', ' Predictive Value ', ' Cognitive ', ' Validation ', ' Behavioral ', ' imaging ', ' Image ', ' pathway ', ' Pathway interactions ', ' transcriptome ', ' gene expression signature ', ' gene expression pattern ', ' Gene Expression Profile ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' neurodegenerative dementia ', ' Outcome ', ' endophenotype ', ' computer algorithm ', ' Computational algorithm ', ' web-accessible ', ' mathematic algorithm ', ' math algorithm ', ' mathematical algorithm ', ' treatment response ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' disease diagnosis ', ' exomes ', ' exome ', ' data reduction ', ' epigenetic biomarker ', ' epigenetic marker ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' ']",NIMH,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2014,394750,CA-33,0.0006912161916051402
"Machine Learning Prediction of Cancer Susceptibility DESCRIPTION (provided by applicant):       Susceptibility to sporadic forms of cancer is determined by numerous genetic factors that interact in a nonlinear manner in the context of an individual's age and environmental exposure. This complex genetic architecture has important implications for the use of genome-wide association studies for identifying susceptibility genes. The assumption of a simple architecture supports a strategy of testing each single-nucleotide polymorphism (SNP) individually using traditional univariate statistics followed by a correction for multiple tests. However, a complex genetic architecture that is characteristic of most types of cancer requires analytical methods that specifically model combinations of SNPs and environmental exposures. While new and novel methods are available for modeling interactions, exhaustive testing of all combinations of SNPs is not feasible on a genome- wide scale because the number of comparisons is effectively infinite. Thus, it is critical that we develop intelligent strategies for selecting subsets of SNPs prior to combinatorial modeling. The objective of this renewal application is to continue the development of a research strategy for the detection, characterization, and interpretation of gene-gene and gene-environment interactions in genome-wide association studies of bladder cancer susceptibility. To accomplish this objective, we will continue developing and evaluating modifications and extensions to the ReliefF family of algorithms for selecting or filtering subsets of single- nucleotide polymorphisms (SNPs) for multifactor dimensionality reduction (MDR) analysis of gene-gene and gene-environment interactions (AIM 1). We will continue developing and evaluating a stochastic wrapper or search strategy for MDR analysis of interactions that utilizes ReliefF values as a heuristic (AIM 2). We will continue to make available ReliefF algorithms as part of our open-source MDR software package (AIM 3). Finally, we will apply the best ReliefF-MDR analysis strategies to the detection, characterization, and interpretation of gene-gene and gene-environment interactions in large genome-wide association studies of bladder cancer susceptibility (AIM 4). We anticipate the proposed machine learning methods will provide powerful new approaches for identifying genetic variations that are predictive of cancer susceptibility. PROJECT NARRATIVE The technology to measure information about the human genome is advancing at a rapid pace. Despite these advance, the computational methods for analyzing the data have not kept pace. We will develop new computer algorithms and software that can be used to identify genetic biomarkers of common human diseases. We will then apply these new computational methods to identifying genetic biomarkers of bladder cancer in an epidemiological study from New Hampshire.",Machine Learning Prediction of Cancer Susceptibility,9019684,R01LM009012,[''],NLM,UNIVERSITY OF PENNSYLVANIA,R01,2014,358350,PA-03,0.07505714829497181
"Whole-Genome Prediction of Type-2 Diabetes Susceptibility in Various Populations     DESCRIPTION (provided by applicant): The applicant's career goal is to become a productive independent investigator in the area of statistical genetics, particularly in the area of genomic-based prediction of type-2 diabetes (T2D) risk. To meet this goal, the applicant proposes a career development plan that includes hands- on and didactic training in statistical learning as applied to quantitative genetics, categorical and case-control data analysis, informatics as applied to high dimensional genetic data, and the biology and genetics of T2D. A highly accomplished and diverse set of investigators with proven track records of successful mentoring will oversee the applicant's career development. The research component of this project seeks to improve our ability to use genetic information to predict an individual's risk of developing T2D Publically available genetic and phenotypic data from sources such as dbGaP (The database of Phenotypes and Genotypes) will be used to develop and test various models for prediction of T2D risk among three racial/ethnic groups. This project will capitalize on newly developed statistical methods that are able to incorporate information from tens of thousands of genetic markers at once, which represent a major advance over current methods that typically take fewer than 100 markers into account. The aims of the study are: 1) To test the hypothesis, in different populations, that individualized whole-genome prediction of T2D (along with standard covariates of sex, age, and BMI) will offer major improvements over current genetics-based prediction models, and will offer equal or greater accuracy than prediction based on family history; 2) To impute additional genetic markers to determine whether prediction can be improved, and to identify the subset of markers that is most useful in predicting T2D; 3) To develop prediction models for T2D risk given a certain body mass index (BMI), by including as predictors the interaction of BMI and genotypes. This project will greatly enhance our ability to predict an individual's susceptibility to T2D within various populations, leading to earlier and targeted prevention strategies, will increase our understanding of the genetic basis of T2D, and will provide critical training for Dr. Klimentidis' development as an independent scientist.      Genetic factors are known to play a substantial role in the etiology of type-2 diabetes (T2D), which is a growing health challenge facing developed and developing countries. In this application, we propose to use state-of-the-art statistical methods that enable us to account for thousands of genetic variants simultaneously, in order to build and test predictive models for T2D susceptibility among individuals of European, Mexican, and African descent. This project has the potential to greatly improve prediction of T2D susceptibility in several ethnic groups, provide a better understanding of the specific genetic factors that play a role in T2D susceptibility, and ultimately bring us closer to the era of personalized medicine in which improved prediction ability results in earlier patient-oriented prevention and treatment.            ",Whole-Genome Prediction of Type-2 Diabetes Susceptibility in Various Populations,8704374,K01DK095032,"['Accounting ', ' Affect ', ' Age ', ' Engineering / Architecture ', ' Architecture ', ' Biology ', ' Biomedical Research ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Data Analysis ', ' Data Analyses ', ' Data Sources ', ' Under-Developed Nations ', ' Under-Developed Countries ', ' Third-World Nations ', ' Third-World Countries ', ' Less-Developed Nations ', ' Less-Developed Countries ', ' Developing Nations ', ' Developing Nation ', ' Developing Country ', ' Developing Countries ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Ethnic group ', ' Family ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genome ', ' Genotype ', ' Goals ', ' Grant ', ' Hand ', ' Health ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Medicine ', ' Mentors ', ' Methods ', ' Chicanos ', ' Chicanas ', ' Mexican Americans ', ' Play ', ' Publishing ', ' Racial Stocks ', ' Racial Group ', ' Race ', ' Records ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Scoring Method ', ' Testing ', ' Weight ', ' Dataset ', ' Data Set ', ' animal breeding ', ' base ', ' career ', ' improved ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Individual ', ' African ', ' European ', ' Mexican ', ' Family Medical History Epidemiology ', ' Family Medical History ', ' Family history of ', ' Development Plans ', ' Funding ', ' Industrialized Nations ', ' Industrialized Countries ', ' Developed Nations ', ' Developed Nation ', ' Developed Country ', ' Developed Countries ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Scientist ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' Source ', ' Height ', ' meetings ', ' environment effect on gene ', ' gene environment interaction ', ' Informatics ', ' trait ', ' Preventive strategy ', ' Prevention strategy ', ' disease risk ', ' disorder risk ', ' Prevention ', ' Reporting ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Statistical Methods ', ' Modeling ', ' career development ', ' case control ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' diabetes risk ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' Quantitative Genetics ', ' Genetic Risk ', ' sex ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' computer based prediction ', ' predictive modeling ', ' Population ', ' racial/ethnic ', ' racial and ethnic ', ' patient centered ', ' patient oriented ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' ']",NIDDK,UNIVERSITY OF ARIZONA,K01,2014,146298,AZ-03,0.006372623996776734
"Informatics Tools for High-Throughput Sequences Data Analysis    DESCRIPTION (provided by applicant): The Genome Analysis Toolkit (GATK) is a suite of best-in-class, widely-used, well-supported, open-source tools for processing and analysis of next-generation DNA sequencing (NGS) data. These tools currently  include a multiple sequence realigner, a covariate-correcting base quality score recalibrator, multi-sample  SNP, INDEL, and CNV genotypers, machine learning algorithms for false positive identification, variant  evaluation modules, somatic SNP and indel callers, and hundreds of other tools. Underlying all of these tools is our structured programming framework (GATK-Engine) that uses the functional programming philosophy of MapReduce to make writing feature-rich, efficient and robust analysis tools easy. By centralizing common data management infrastructure, all GATK-based tools benefit from the engine's correctness, CPU and memory efficiency, as well as automatic distributed and shared memory parallelization, essential capabilities given the massive and growing size of NGS datasets. The GATK currently supports all of the major sequencing technologies including lllumina. Life Sciences 454, and ABI SOLID, from hybrid capture of exomes to 1000s of low-pass samples in the 1000 Genomes Project. Our emphasis on technology-agnostic processing tools has helped to popularize the now standard SAM/BAM and VCFs formats for representing NGS data and variation calls, respectively. In this RFA we propose to  continue to develop the GATK-Engine and data processing tools to (1) achieve complete and accurate  variation discovery and genotyping for all major sequencing study designs and NGS technologies (2)  optimize the GATK-Engine and pipelining infrastructure to operate efficiently on distributed data sets at the  scale of tens of thousands of samples (3) extend the GATK data processing tools to support the upcoming  sequencing technologies of Complete Genomics, lon Torrent, and Pacific Biosciences as well as we do  current technologies, (4) expand significantly our educational and support structures to ensure that the longtail  of future NGS users can benefit from the best-practice data processing and analysis tools in the GATK.        The proposed project aims to continue to develop the Genome Analysis Toolkit (GATK), a suite of widely used and mission-critical tools for analyzing the next-generation DNA sequencing data. With this grant we will improve these tools, make them more robust, and extend them to new sequencing technologies. This is essential to realize the potential of DNA sequencing to understand human history, diversity, and to discover  new loci associated with human disease, leading to new biologic hypotheses and new drug targets.            ",Informatics Tools for High-Throughput Sequences Data Analysis,8601147,U01HG006569,"['Algorithms ', ' Life Sciences ', ' Biologic Sciences ', ' Biological Sciences ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Experimental Designs ', ' Flooding ', ' Floods ', ' Future ', ' Medical Genetics ', ' Genome ', ' Genotype ', ' Grant ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hybrids ', ' Memory ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Mission ', ' Philosophy ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Technology ', ' Work ', ' Writing ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' improved ', ' Site ', ' Variation ', ' Variant ', ' Ensure ', ' Evaluation ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Techniques ', ' data management ', ' Informatics ', ' Structure ', ' novel ', ' cancer genetics ', ' Modeling ', ' Sampling ', ' Genomics ', ' Documentation ', ' data processing ', ' computerized data processing ', ' Data ', ' Infrastructure ', ' Research Infrastructure ', ' Process ', ' distributed data ', ' next generation ', ' SNP genotyping ', ' open source ', ' human disease ', ' shared memory ', ' distributed memory ', ' exomes ', ' exome ', ' genome analysis ', ' Drug Targeting ', ' High-Throughput Sequencing ', ' High-Throughput Nucleotide Sequencing ', ' ']",NHGRI,"BROAD INSTITUTE, INC.",U01,2014,989800,MA-07,0.0029685833533512093
"Data-Driven Statistical Learning with Applications to Genomics     DESCRIPTION (provided by applicant): This project involves the development of statistical and computational methods for the analysis of high throughput biological data. Effective methods for analyzing this data must balance two opposing ideals. They must be (a) flexible and sufficiently data-adaptive to deal with the data's complex structure, yet (b) sufficiently simpe and transparent to interpret their results and analyze their uncertainty (so as not to mislead with conviction). This is additionally challenging because these datasets are massive, so attacking these problems requires a marriage of statistical and computational ideas. This project develops frameworks for attacking several problems involving this biological data. These frameworks balance flexibility and simplicity and are computationally tractable even on massive datasets. This application has three specific aims. Aim 1: A flexible and computationally tractable framework for building predictive models. Commonly we are interested in modelling phenotypic traits of an individual using omics data. We would like to find a small subset of genetic features which are important in phenotype expression level. In this approach, I propose a method for flexibly modelling a response variable (e.g. phenotype) with a small, adaptively chosen subset of features, in a computationally scalable fashion. Aim 2: A framework for jointly identifying and testing regions which differ across conditions. For example, in the context of methylation data measured in normal and cancer tissue samples, one might expect that some regions are more methylated in one tissue type or the other. These regions might suggest targets for therapy. However, we do not have the background biological knowledge to pre-specify regions to test. I propose an approach which adaptively selects regions and then tests them in a principled way. This approach is based on a convex formulation to the problem, using shrinkage to achieve sparse differences. Aim 3: A principled framework for developing and evaluating predictive biomarkers during clinical trials. Modern treatments target specific genetic abnormalities that are generally present in only a subset of patients with a disease. A major current goal in medicine is to develop biomarkers that identify those patients likely to benefit from treatment. I propose a framework for developing and testing biomarkers during large-scale clinical trials. This framework simultaneously builds these biomarkers and applies them to restrict enrollment into the trial to only those likely to benefit from treatment. The statistical tools that result from th proposed research will be implemented in freely available software.         PUBLIC HEALTH RELEVANCE: Recent advances in high-throughput biotechnology have provided us with a wealth of new biological data, a large step towards unlocking the tantalizing promise of personalized medicine: the tailoring of treatment to the genetic makeup of each individual and disease. However, classical statistical and computational tools have proven unable to exploit the extensive information these new experimental technologies bring to bear. This project focuses on building new flexible, data-adaptive tools to translate this wealth of low level information into actionable discoveries, and actual biological understanding.            ",Data-Driven Statistical Learning with Applications to Genomics,8796068,DP5OD019820,"['Accounting ', ' bear ', ' Ursidae ', ' Bears ', ' Ursidae Family ', ' Biology ', ' Biotechnology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' clinical investigation ', ' Clinical Trials ', ' Computers ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Analysis ', ' Data Analyses ', ' disease/disorder ', ' Disorder ', ' Disease ', ' balance function ', ' balance ', ' Equilibrium ', ' Gene Expression ', ' genetic biomarker ', ' Genetic Markers ', ' Goals ', ' histocompatibility typing ', ' Tissue Typing ', ' Tissue Crossmatching ', ' Histocompatibility Testing ', ' Marriage ', ' Medicine ', ' Memory ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Patients ', ' Phenotype ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Science ', ' computer program/software ', ' Software ', ' Computer software ', ' statistics ', ' Technology ', ' Testing ', ' Time ', ' Translating ', ' Work ', ' Measures ', ' Telomerase ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' base ', ' Site ', ' Specified ', ' Specific qualifier value ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' Measurement ', ' Genetic Abnormality ', ' Cytogenetic or Molecular Genetic Abnormality ', ' Chromosomal, Gene, or Protein Abnormality ', ' Molecular Abnormality ', ' Simulate ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Dimensions ', ' Complex ', ' Dependence ', ' Event ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Formulation ', ' Drug Formulations ', ' interest ', ' Somatic Mutation ', ' Performance ', ' neural ', ' relating to nervous system ', ' trait ', ' Structure ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Coding System ', ' Code ', ' Statistical Methods ', ' Modeling ', ' response ', ' high throughput analysis ', ' Proteomics ', ' Genomics ', ' Tissue Sample ', ' Address ', ' Data ', ' Cancer Patient ', ' trial design ', ' Clinical Trials Design ', ' enroll ', ' Enrollment ', ' Update ', ' developmental ', ' Development ', ' computer based prediction ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' Outcome ', ' Population ', ' public health relevance ', ' patient population ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' flexible ', ' flexibility ', ' RNA-seq ', ' transcriptome sequencing ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' ']",OD,UNIVERSITY OF WASHINGTON,DP5,2014,361064,WA-07,0.03241670064550863
"Integrative Analysis of Genomic Risk Factors in Juvenile Idiopathic Arthritis DESCRIPTION (provided by applicant): Juvenile Idiopathic Arthritis (JIA), afflicting ~1 in 10,000 North American Children, encompasses a highly heterogeneous group of chronic, immune-mediated joint disorders. Aside from causing severe pain, tissue damage, and physical immobility, chronic disease activity leads to permanent short stature and limb disfigurement. Similar to a number of other complex polygenic autoimmune diseases, there is a clear heritable component to JIA, but all known genetic risk factors explain less than 20% of disease heritability. The majority of this is attributable to variation across the Major Histocompatibility  (MHC) locus, yet definitive high-resolution identification of MHC associations in JIA have not been conclusive. JIA is currently classified into seven clinical subtypes, based on a classification schema that has little research or clinical utility, since 10-50% of cases are classified as ""undifferentiated"". Biological and molecular evidence based on the presence of serum autoantibodies and other molecular biomarkers of immunological defects suggest that the existing seven JIA subtypes could be grouped into two major classes-subtypes that represent either predominantly seropositive autoimmune (AID) diseases or seronegative autoinflammatory (AIF) diseases. Whether genetic risk factors differ for AID versus AIF-like JIA subtypes is unknown, especially since the traditional approach to genetic association studies is poorly powered to identify loci with subtype- specific effects in the presence of significant phenotypic heterogeneity. To test the hypothesis that distinct genetic risk factors underlie the clinically observed differences in AID versus AIF-like JIA subtypes and identify both shared and subtype-distinct genetic susceptibility loci, I propose to use a subtype-sensitive GWAS to identify JIA disease subtype-specific genetics associations, evaluate evidence for functional HLA associations that are distinct or shared across JIA subtypes, and test if the identified genetic associations can be used to predict disease susceptibility, distinguish patients who belong to AID versus AIF-like JIA classes, and reclassify patients currently defined as having undifferentiated disease. The analysis approach proposed here integrates genomic screening, disease modeling and prediction, and the use of expression and functional data resources to better understand the etiology of JIA. The successful completion of this work will likely yield novel biomolecular or pathway-based targets for the development of therapeutic agents for children with JIA and patients with other related rheumatological or immunological diseases. PUBLIC HEALTH RELEVANCE: Juvenile Idiopathic Arthritis is a severe pediatric form of immune-mediate joint disease that can result in significant morbidity and life-long disability. While the etiology of JIA, similar to other complex autoimmune and inflammatory disorders that together affect nearly 10% of the United States population, is not well-understood, a strong genetic component has been demonstrated. My proposal aims to develop novel genome-wide analysis tools and applies these tools to the identification of genetic risk susceptibility factorsin JIA and other heterogeneous, complex hereditary disorders, which have the potential to yield promising disease-specific molecular and pharmacologic targets.",Integrative Analysis of Genomic Risk Factors in Juvenile Idiopathic Arthritis,8717915,F30AR066486,"['Accounting ', ' Affect ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' aminoacid ', ' Amino Acids ', ' Binding Determinants ', ' Antigenic Determinants ', ' Epitopes ', ' Antigenic Variability ', ' Antigen Variation ', ' Antigenic Variation ', ' immunogen ', ' ATGN ', ' Antigens ', ' joint inflammation ', ' arthritic ', ' Arthritis ', ' Inflammatory Arthritis ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantibodies ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Systematics ', ' Classification ', ' Complement Proteins ', ' Complement ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' regional enteritis ', ' eleocolitis ', ' Granulomatous Enteritis ', "" Crohn's disorder "", ' Crohn disease ', "" Crohn's disease "", ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' Disease susceptibility ', ' genetic epistases ', ' gene x gene interaction ', ' epistatic relationship ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Non-Trunk ', ' Limbs ', ' Extremities ', ' Limb structure ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Health ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Heterogeneity ', ' Tissue Compatibility ', ' Histocompatibility ', ' Leukocyte Antigens ', ' Human Leukocyte Antigens ', ' HL-A Antigens ', ' HLA Antigens ', ' Immunological Diseases ', ' Immunologic Diseases ', ' Immune System Disorder ', ' Immune Dysfunction ', ' Immune Disorders ', ' Immune Diseases ', ' Immune System Diseases ', ' joint disorder ', ' arthropathy ', ' arthropathic ', ' Joint Diseases ', ' arthropathies ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Painful ', ' Pain ', ' Patients ', ' psoriatiform ', ' psoriatic ', ' psoriasiform ', ' Psoriasis ', ' Cell Surface Receptors ', ' Recurrent ', ' Recurrence ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Siblings ', ' Specificity ', ' Testing ', ' Body Tissues ', ' Tissues ', ' United States ', ' Work ', ' Mediating ', ' Dataset ', ' Data Set ', ' Polyarthritides ', ' base ', ' Left ', ' Chronic ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Serologic ', ' Serological ', ' Undifferentiated ', ' Link ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Blood Serum ', ' Serum ', ' disability ', ' pediatric ', ' Childhood ', ' Therapeutic Agents ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Inflammatory ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Immune ', ' Complex ', ' Autoimmune ', ' Autoimmune Process ', ' juvenile idiopathic arthritis ', ' juvenile arthritis ', ' Juvenile Rheumatoid Arthritis ', ' Juvenile Chronic Arthritis ', ' Chronic Childhood Arthritis ', ' American ', ' early detection ', ' Early Diagnosis ', ' cohort ', ' novel ', ' Exclusion ', ' nosology ', ' disorder classification ', ' disease classification ', ' disease risk ', ' disorder risk ', ' disorder model ', ' Disease model ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' inherited factor ', ' genetic risk factor ', ' Modeling ', ' case control ', ' disease subtype ', ' disorder subtype ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' TRAILR1 ', ' TRAILR-1 ', ' TNFRSF10A ', ' MGC9365 ', ' DR4 ', ' APO2 ', ' TNFRSF10A gene ', ' Defect ', ' Data ', ' Resolution ', ' Genetic Risk ', ' Validation ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' Population ', ' Heritability ', ' early therapy ', ' Early treatment ', ' genome-wide analysis ', ' evidence base ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' risk variant ', ' screening ', ' ']",NIAMS,UNIVERSITY OF PENNSYLVANIA,F30,2014,46078,PA-03,0.01637195177969859
"Optimizing Genetic Testing for Deafness for Clinical Diagnostics   Project Summary  In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. The driving force behind this initiative is the frequency of hearing impairment. As the most common sensory impairment, it is diagnosed in 1 of every 500 newborns and 50% of octogenarians (Morton Ann N Y Acad Sci 1991). With 57 genes implicated in nonsyndromic hearing loss (NSHL), it is also an extremely heterogeneous trait and presents a tremendous challenge to diagnosis.  Current strategies for genetic testing for deafness are inadequate. For most, only a minority of genes is included, with selection criteria typically reflecting: 1) high prevalence as a cause of deafness (i.e. GJB2); 2) association with another recognizable feature (i.e. SLC26A4 and enlarged vestibular aqueduct); or 3) a recognizable audioprofile (i.e. low frequency hearing loss as seen with WFS1) (Hilgert et al Mut Res 2009).  The recent advent of powerful DNA target enrichment and sequencing technologies, however, makes it possible to provide comprehensive genetic testing for deafness that is efficient and cost-effective. We have shown that it is possible to analyze all deafness genes simultaneously on a single platform (called OtoSCOPE) (Shearer et al PNAS 2010). Related to this endeavor, we have also validated AudioGene as a phenotypic tool that uses patient audiograms to predict the genetic cause of ADNSHL (Hildebrand et al Genet Med 2008; Hildebrand et al Laryngoscope 2009).  Building on these findings, in this proposal we will complete two specific aims.  Specific Aim 1: To provide comprehensive, high-throughput, low-cost DNA sequence generation and analysis for deafness genetic testing  Goal 1: Comprehensive, high-throughput, low-cost DNA sequence analysis for genetic testing for deafness is possible at sensitivities and specificities comparable to Sanger sequencing by using targeted sequence enrichment followed by massively parallel sequencing.  Specific Aim 2: To optimize both machine learning-based audioprofiling of audiometric data and phenotypic filtering of genotypic data by expanding and improving the platform we have developed called AudioGene  Goal 2: As a phenome tool, a machine-learning software system trained on an extensive set of audiometric data can be used to predict and to eliminate specific genes or gene variants as causes of deafness based on audiometric data.  Achieving these specific aims will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history, physical examination and audiological assessment.   In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. Achieving this goal will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history and physical exam.",Optimizing Genetic Testing for Deafness for Clinical Diagnostics,8712451,R01DC012049,"['Audiometric Test ', ' Audiogram ', ' Audiometry ', ' Bar Codes ', ' Data Analysis ', ' Data Analyses ', ' Deafness ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Genes ', ' Goals ', ' History ', ' Recording of previous events ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Laboratories ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Persons ', ' Octogenarian ', ' Patients ', ' Medical Inspection ', ' Physical Examination ', ' Research Resources ', ' Resources ', ' Sensitivity and Specificity ', ' Technology ', ' Vestibular Aqueduct ', ' Generations ', ' Diagnostic tests ', ' Dataset ', ' Data Set ', ' Caring ', ' DNA Sequence ', ' DNA Sequence Analyses ', ' DNA Sequence Analysis ', ' base ', ' Laryngoscopes ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' Training ', ' Selection Criteria ', ' retinitis pigmentosa-congenital deafness syndrome ', ' dystrophia retinae-dysacousis syndrome ', ' dystrophia retinae pigmentosa-dysostosis syndrome (DRD) ', ' dystrophia retinae pigmentosa-dysostosis syndrome ', "" Usher's syndrome "", ' Usher syndrome (US) ', ' Hallgren syndrome ', ' Graefe-Usher syndrome ', ' Usher Syndrome ', ' Retinitis pigmentosa-deafness syndrome ', ' low frequency hearing loss ', ' Low Frequency Deafness ', ' Genetic ', ' Genets ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Frequency ', ' Frequencies (time pattern) ', ' Sensory ', ' LOINC Axis 4 System ', ' System ', ' Persons With Hearing Impairments ', ' Hard of Hearing Persons ', ' Deaf ', ' Hearing Impaired Persons ', ' meetings ', ' trait ', ' genetic testing ', ' Genetic screening method ', ' Sampling ', ' response ', ' Hypoacusis ', ' Hypoacuses ', ' Hearing Loss ', ' hearing impairment ', ' Data ', ' Detection ', ' Sanger Sequencing ', ' Dideoxy Chain Termination DNA Sequencing ', ' High Prevalence ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Funding Opportunities ', ' cost ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' software systems ', ' Minority ', ' cost-effective ', ' cost effective ', ' driving force ', ' Impairment ', ' phenome ', ' screening ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' Massive Parallel Sequencing ', ' ']",NIDCD,UNIVERSITY OF IOWA,R01,2014,606168,IA-02,0.005176200267921025
"Optimizing Genetic Testing for Deafness for Clinical Diagnostics Project Summary  In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. The driving force behind this initiative is the frequency of hearing impairment. As the most common sensory impairment, it is diagnosed in 1 of every 500 newborns and 50% of octogenarians (Morton Ann N Y Acad Sci 1991). With 57 genes implicated in nonsyndromic hearing loss (NSHL), it is also an extremely heterogeneous trait and presents a tremendous challenge to diagnosis.  Current strategies for genetic testing for deafness are inadequate. For most, only a minority of genes is included, with selection criteria typically reflecting: 1) high prevalence as a cause of deafness (i.e. GJB2); 2) association with another recognizable feature (i.e. SLC26A4 and enlarged vestibular aqueduct); or 3) a recognizable audioprofile (i.e. low frequency hearing loss as seen with WFS1) (Hilgert et al Mut Res 2009).  The recent advent of powerful DNA target enrichment and sequencing technologies, however, makes it possible to provide comprehensive genetic testing for deafness that is efficient and cost-effective. We have shown that it is possible to analyze all deafness genes simultaneously on a single platform (called OtoSCOPE) (Shearer et al PNAS 2010). Related to this endeavor, we have also validated AudioGene as a phenotypic tool that uses patient audiograms to predict the genetic cause of ADNSHL (Hildebrand et al Genet Med 2008; Hildebrand et al Laryngoscope 2009).  Building on these findings, in this proposal we will complete two specific aims.  Specific Aim 1: To provide comprehensive, high-throughput, low-cost DNA sequence generation and analysis for deafness genetic testing  Goal 1: Comprehensive, high-throughput, low-cost DNA sequence analysis for genetic testing for deafness is possible at sensitivities and specificities comparable to Sanger sequencing by using targeted sequence enrichment followed by massively parallel sequencing.  Specific Aim 2: To optimize both machine learning-based audioprofiling of audiometric data and phenotypic filtering of genotypic data by expanding and improving the platform we have developed called AudioGene  Goal 2: As a phenome tool, a machine-learning software system trained on an extensive set of audiometric data can be used to predict and to eliminate specific genes or gene variants as causes of deafness based on audiometric data.  Achieving these specific aims will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history, physical examination and audiological assessment. In this goal-driven proposal, submitted in response to Funding Opportunity Announcement (FOA) Number PAR-11-003, we will make comprehensive genetic testing for deafness available to clinicians for under $500 per person. Achieving this goal will change the clinical evaluation of deaf and hard-of-hearing persons by making genetic testing the most important diagnostic test after a history and physical exam.",Optimizing Genetic Testing for Deafness for Clinical Diagnostics,8899486,R01DC012049,"['Audiometric Test ', ' Audiogram ', ' Audiometry ', ' Bar Codes ', ' Data Analysis ', ' Data Analyses ', ' Deafness ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Genes ', ' Goals ', ' History ', ' Recording of previous events ', ' newborn human (0-6 weeks) ', ' Newborns ', ' 0-6 weeks old ', ' Newborn Infant ', ' Laboratories ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Persons ', ' Octogenarian ', ' Patients ', ' Medical Inspection ', ' Physical Examination ', ' Research Resources ', ' Resources ', ' Sensitivity and Specificity ', ' Technology ', ' Vestibular Aqueduct ', ' Generations ', ' Diagnostic tests ', ' Dataset ', ' Data Set ', ' Caring ', ' DNA Sequence ', ' DNA Sequence Analyses ', ' DNA Sequence Analysis ', ' base ', ' Laryngoscopes ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' Training ', ' Selection Criteria ', ' retinitis pigmentosa-congenital deafness syndrome ', ' dystrophia retinae-dysacousis syndrome ', ' dystrophia retinae pigmentosa-dysostosis syndrome (DRD) ', ' dystrophia retinae pigmentosa-dysostosis syndrome ', "" Usher's syndrome "", ' Usher syndrome (US) ', ' Hallgren syndrome ', ' Graefe-Usher syndrome ', ' Usher Syndrome ', ' low frequency hearing loss ', ' Low Frequency Deafness ', ' Genetic ', ' Genets ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Frequency ', ' Frequencies (time pattern) ', ' Sensory ', ' LOINC Axis 4 System ', ' System ', ' Persons With Hearing Impairments ', ' Hard of Hearing Persons ', ' Deaf ', ' Hearing Impaired Persons ', ' meetings ', ' trait ', ' genetic testing ', ' Genetic screening method ', ' Sampling ', ' response ', ' Hypoacusis ', ' Hypoacuses ', ' Hearing Loss ', ' hearing impairment ', ' Data ', ' Detection ', ' Sanger Sequencing ', ' Dideoxy Chain Termination DNA Sequencing ', ' High Prevalence ', ' clinical test ', ' Clinical Testing ', ' Clinical Evaluation ', ' research clinical testing ', ' Funding Opportunities ', ' cost ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' software systems ', ' Minority ', ' cost-effective ', ' cost effective ', ' driving force ', ' Impairment ', ' phenome ', ' screening ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' Massive Parallel Sequencing ', ' ']",NIDCD,UNIVERSITY OF IOWA,R01,2015,574693,IA-02,0.005176200267921025
"Integrative Analysis of Genomic Risk Factors in Juvenile Idiopathic Arthritis DESCRIPTION (provided by applicant): Juvenile Idiopathic Arthritis (JIA), afflicting ~1 in 10,000 North American Children, encompasses a highly heterogeneous group of chronic, immune-mediated joint disorders. Aside from causing severe pain, tissue damage, and physical immobility, chronic disease activity leads to permanent short stature and limb disfigurement. Similar to a number of other complex polygenic autoimmune diseases, there is a clear heritable component to JIA, but all known genetic risk factors explain less than 20% of disease heritability. The majority of this is attributable to variation across the Major Histocompatibility  (MHC) locus, yet definitive high-resolution identification of MHC associations in JIA have not been conclusive. JIA is currently classified into seven clinical subtypes, based on a classification schema that has little research or clinical utility, since 10-50% of cases are classified as ""undifferentiated"". Biological and molecular evidence based on the presence of serum autoantibodies and other molecular biomarkers of immunological defects suggest that the existing seven JIA subtypes could be grouped into two major classes-subtypes that represent either predominantly seropositive autoimmune (AID) diseases or seronegative autoinflammatory (AIF) diseases. Whether genetic risk factors differ for AID versus AIF-like JIA subtypes is unknown, especially since the traditional approach to genetic association studies is poorly powered to identify loci with subtype- specific effects in the presence of significant phenotypic heterogeneity. To test the hypothesis that distinct genetic risk factors underlie the clinically observed differences in AID versus AIF-like JIA subtypes and identify both shared and subtype-distinct genetic susceptibility loci, I propose to use a subtype-sensitive GWAS to identify JIA disease subtype-specific genetics associations, evaluate evidence for functional HLA associations that are distinct or shared across JIA subtypes, and test if the identified genetic associations can be used to predict disease susceptibility, distinguish patients who belong to AID versus AIF-like JIA classes, and reclassify patients currently defined as having undifferentiated disease. The analysis approach proposed here integrates genomic screening, disease modeling and prediction, and the use of expression and functional data resources to better understand the etiology of JIA. The successful completion of this work will likely yield novel biomolecular or pathway-based targets for the development of therapeutic agents for children with JIA and patients with other related rheumatological or immunological diseases. PUBLIC HEALTH RELEVANCE: Juvenile Idiopathic Arthritis is a severe pediatric form of immune-mediate joint disease that can result in significant morbidity and life-long disability. While the etiology of JIA, similar to other complex autoimmune and inflammatory disorders that together affect nearly 10% of the United States population, is not well-understood, a strong genetic component has been demonstrated. My proposal aims to develop novel genome-wide analysis tools and applies these tools to the identification of genetic risk susceptibility factorsin JIA and other heterogeneous, complex hereditary disorders, which have the potential to yield promising disease-specific molecular and pharmacologic targets.",Integrative Analysis of Genomic Risk Factors in Juvenile Idiopathic Arthritis,8879958,F30AR066486,"['Accounting ', ' Affect ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' aminoacid ', ' Amino Acids ', ' Binding Determinants ', ' Antigenic Determinants ', ' Epitopes ', ' Antigenic Variability ', ' Antigen Variation ', ' Antigenic Variation ', ' immunogen ', ' ATGN ', ' Antigens ', ' joint inflammation ', ' arthritic ', ' Arthritis ', ' Inflammatory Arthritis ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantibodies ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' Child Human ', ' 0-11 years old ', ' Child ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Systematics ', ' Classification ', ' Complement Proteins ', ' Complement ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' regional enteritis ', ' eleocolitis ', ' Granulomatous Enteritis ', "" Crohn's disorder "", ' Crohn disease ', "" Crohn's disease "", ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' Disease susceptibility ', ' genetic epistases ', ' gene x gene interaction ', ' epistatic relationship ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Non-Trunk ', ' Limbs ', ' Extremities ', ' Limb structure ', ' Genetic Markers ', ' genetic biomarker ', ' Genotype ', ' Health ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Heterogeneity ', ' Tissue Compatibility ', ' Histocompatibility ', ' Leukocyte Antigens ', ' Human Leukocyte Antigens ', ' HL-A Antigens ', ' HLA Antigens ', ' Immunological Diseases ', ' Immunologic Diseases ', ' Immune System Disorder ', ' Immune Dysfunction ', ' Immune Disorders ', ' Immune Diseases ', ' Immune System Diseases ', ' joint disorder ', ' arthropathy ', ' arthropathic ', ' Joint Diseases ', ' arthropathies ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Methods ', ' Morbidity ', ' Morbidity - disease rate ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Painful ', ' Pain ', ' Patients ', ' psoriatiform ', ' psoriatic ', ' psoriasiform ', ' Psoriasis ', ' Cell Surface Receptors ', ' Recurrent ', ' Recurrence ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' Siblings ', ' Specificity ', ' Testing ', ' Body Tissues ', ' Tissues ', ' United States ', ' Work ', ' Mediating ', ' Dataset ', ' Data Set ', ' Polyarthritides ', ' base ', ' Left ', ' Chronic ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Serologic ', ' Serological ', ' Undifferentiated ', ' Link ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Blood Serum ', ' Serum ', ' disability ', ' pediatric ', ' Childhood ', ' Therapeutic Agents ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Inflammatory ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Life ', ' Immune ', ' Complex ', ' Autoimmune ', ' Autoimmune Process ', ' juvenile idiopathic arthritis ', ' juvenile arthritis ', ' Juvenile Rheumatoid Arthritis ', ' Juvenile Chronic Arthritis ', ' Chronic Childhood Arthritis ', ' American ', ' early detection ', ' Early Diagnosis ', ' cohort ', ' novel ', ' Exclusion ', ' nosology ', ' disorder classification ', ' disease classification ', ' disease risk ', ' disorder risk ', ' disorder model ', ' Disease model ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' inherited factor ', ' genetic risk factor ', ' Modeling ', ' case control ', ' disease subtype ', ' disorder subtype ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' Genomics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' TRAILR1 ', ' TRAILR-1 ', ' TNFRSF10A ', ' MGC9365 ', ' DR4 ', ' APO2 ', ' TNFRSF10A gene ', ' Defect ', ' Data ', ' Resolution ', ' Genetic Risk ', ' Validation ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' Population ', ' Heritability ', ' early therapy ', ' Early treatment ', ' genome-wide analysis ', ' evidence base ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' screening ', ' ']",NIAMS,UNIVERSITY OF PENNSYLVANIA,F30,2015,46443,PA-03,0.01637195177969859
"Data-Driven Statistical Learning with Applications to Genomics DESCRIPTION (provided by applicant): This project involves the development of statistical and computational methods for the analysis of high throughput biological data. Effective methods for analyzing this data must balance two opposing ideals. They must be (a) flexible and sufficiently data-adaptive to deal with the data's complex structure, yet (b) sufficiently simpe and transparent to interpret their results and analyze their uncertainty (so as not to mislead with conviction). This is additionally challenging because these datasets are massive, so attacking these problems requires a marriage of statistical and computational ideas. This project develops frameworks for attacking several problems involving this biological data. These frameworks balance flexibility and simplicity and are computationally tractable even on massive datasets. This application has three specific aims. Aim 1: A flexible and computationally tractable framework for building predictive models. Commonly we are interested in modelling phenotypic traits of an individual using omics data. We would like to find a small subset of genetic features which are important in phenotype expression level. In this approach, I propose a method for flexibly modelling a response variable (e.g. phenotype) with a small, adaptively chosen subset of features, in a computationally scalable fashion. Aim 2: A framework for jointly identifying and testing regions which differ across conditions. For example, in the context of methylation data measured in normal and cancer tissue samples, one might expect that some regions are more methylated in one tissue type or the other. These regions might suggest targets for therapy. However, we do not have the background biological knowledge to pre-specify regions to test. I propose an approach which adaptively selects regions and then tests them in a principled way. This approach is based on a convex formulation to the problem, using shrinkage to achieve sparse differences. Aim 3: A principled framework for developing and evaluating predictive biomarkers during clinical trials. Modern treatments target specific genetic abnormalities that are generally present in only a subset of patients with a disease. A major current goal in medicine is to develop biomarkers that identify those patients likely to benefit from treatment. I propose a framework for developing and testing biomarkers during large-scale clinical trials. This framework simultaneously builds these biomarkers and applies them to restrict enrollment into the trial to only those likely to benefit from treatment. The statistical tools that result from th proposed research will be implemented in freely available software. PUBLIC HEALTH RELEVANCE: Recent advances in high-throughput biotechnology have provided us with a wealth of new biological data, a large step towards unlocking the tantalizing promise of personalized medicine: the tailoring of treatment to the genetic makeup of each individual and disease. However, classical statistical and computational tools have proven unable to exploit the extensive information these new experimental technologies bring to bear. This project focuses on building new flexible, data-adaptive tools to translate this wealth of low level information into actionable discoveries, and actual biological understanding.",Data-Driven Statistical Learning with Applications to Genomics,8929328,DP5OD019820,"['Accounting ', ' bear ', ' Ursidae ', ' Bears ', ' Ursidae Family ', ' Biology ', ' Biotechnology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' clinical investigation ', ' Clinical Trials ', ' Computers ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Data Analysis ', ' Data Analyses ', ' disease/disorder ', ' Disorder ', ' Disease ', ' balance function ', ' balance ', ' Equilibrium ', ' Gene Expression ', ' Genetic Markers ', ' genetic biomarker ', ' Goals ', ' Health ', ' histocompatibility typing ', ' Tissue Typing ', ' Tissue Crossmatching ', ' Histocompatibility Testing ', ' Marriage ', ' Medicine ', ' Memory ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Patients ', ' Phenotype ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Science ', ' computer program/software ', ' Software ', ' Computer software ', ' statistics ', ' Technology ', ' Testing ', ' Time ', ' Translating ', ' Work ', ' Measures ', ' Telomerase ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' base ', ' Site ', ' Specified ', ' Specific qualifier value ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' Measurement ', ' Genetic Abnormality ', ' Cytogenetic or Molecular Genetic Abnormality ', ' Chromosomal, Gene, or Protein Abnormality ', ' Molecular Abnormality ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Dimensions ', ' Complex ', ' Dependence ', ' Event ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Formulation ', ' Drug Formulations ', ' interest ', ' Somatic Mutation ', ' Performance ', ' neural ', ' relating to nervous system ', ' trait ', ' Structure ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Coding System ', ' Code ', ' Statistical Methods ', ' Modeling ', ' response ', ' high throughput analysis ', ' Proteomics ', ' Genomics ', ' Tissue Sample ', ' Address ', ' Data ', ' Cancer Patient ', ' trial design ', ' Clinical Trials Design ', ' enroll ', ' Enrollment ', ' Update ', ' developmental ', ' Development ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' Outcome ', ' Population ', ' patient population ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' flexible ', ' flexibility ', ' RNAseq ', ' RNA-seq ', ' transcriptome sequencing ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' unique treatment ', ' targeted treatment ', ' tailored treatment ', ' individualized treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalized medicine ', ' ']",OD,UNIVERSITY OF WASHINGTON,DP5,2015,329423,WA-07,0.03241670064550863
"Fast and Robust Methods for Large Scale Genotype Phenotype Association Study     DESCRIPTION (provided by applicant): A fundamental challenge in life sciences is the characterization of genetic factors that underlie phenotypic differences. Thanks to the advanced sequencing technologies, an enormous amount of genetic variants have been identified and cataloged. Such data hold great potential to understand how genes affect phenotypes and contribute to the susceptibility to environmental stimulus. However, the existing computational methods for analyzing and interpreting the highthroughput genetic data are still in their infancy.    We propose to systematically investigate the computational and statistical principles in modeling and discovering genetic basis of complex phenotypes. The proposed research provides answers to the following fundamental questions in genetic association study: (1) How to effectively and efficiently assess statistical significance of the findings? (2) How to account for the relatedness between samples in genetic association study? (3) How to accurately capture possible interactions between multiple genetic factors and their joint contribution to phenotypic variation? In particular, we will develop data structures and efficient algorithms for accurate and robust significance assessment that account for local population structure and joint effect of multiple genetic factors.    The proposed computational tools will be integrated into software packages under common application framework adopted by the broad scientific community.         PUBLIC HEALTH RELEVANCE: A fundamental challenge in life sciences is the characterization of genetic factors that underlie phenotypic differences. Existing methods are not able to adequately address the complexity of high throughput data. Innovative computational models and methods developed in this project will enable scientists more effectively analyze the research data, thus further understanding of human diseases and speed the development diagnostic tools, cures, and therapies.              ",Fast and Robust Methods for Large Scale Genotype Phenotype Association Study,8946076,R01GM115833,"['Accounting ', ' Affect ', ' Algorithms ', ' Life Sciences ', ' Biologic Sciences ', ' Biological Sciences ', ' Cataloging ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Foundations ', ' Gene Expression ', ' Genes ', ' Genetic Markers ', ' genetic biomarker ', ' Genotype ', ' Information Networks ', ' Articulation ', ' Joints ', ' Maps ', ' Methods ', ' Mining ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Noise ', ' Phenotype ', ' Phylogeny ', ' pilot study ', ' Pilot Projects ', ' Scientific Publication ', ' Publications ', ' Research ', ' Research Institute ', ' computer program/software ', ' Software ', ' Computer software ', ' Technology ', ' Testing ', ' Trees ', ' Measures ', ' base ', ' improved ', ' Area ', ' Variation ', ' Variant ', ' Susceptibility ', ' Predisposition ', ' infantile ', ' infancy ', ' Stimulus ', ' Genetic ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Computational Biology ', ' Catalogs ', ' Scientist ', ' Adopted ', ' Complex ', ' interest ', ' experience ', ' Performance ', ' QTL ', ' Quantitative Trait Loci ', ' trait ', ' Genetic Marker Expression ', ' Speed ', ' Speed (motion) ', ' Structure ', ' novel ', ' Modeling ', ' Sampling ', ' LOINC Axis 2 Property ', ' Property ', ' Bio-Informatics ', ' Bioinformatics ', ' datamining ', ' data mining ', ' genetic association ', ' Address ', ' Data ', ' developmental ', ' Development ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' computational tools ', ' computerized tools ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' human disease ', ' public health relevance ', ' ']",NIGMS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2015,294994,CA-33,0.011690470210707378
"International Case Control Study of Malignant Glioma DESCRIPTION (provided by applicant): Glioma comprises about 40% of all primary brain tumors accounting for as many as 26,000 U.S. and European deaths annually. Inherited susceptibility plays a role with 2-fold increased risk of glioma among first-degree relatives of glioma cases. We initiated a multi-center, international linkage study: ""Genetic Epidemiology of Glioma International Consortium"" in 2007 to address the role of inherited susceptibility. Since this study does not allow us currently to address the role of genetic susceptibility in sporadic cases, we propose this case- control study to address this gap. Members of the consortium have conducted genome wide association studies (GWAS) that will be the discovery phase (phase I). While of high value for discovery, we propose to recruit 6,000 newly diagnosed glioma cases and 6,000 age-gender-ethnicity-matched controls, and collect detailed epidemiologic data and biologic samples from the 13 participating Gliogene sites. We hypothesize that novel inherited variation influencing the susceptibility to glioma can be identified by high density SNP analysis, and propose the following specific aims: SA1: Identify common genetic variants contributing to the risk of glioma. We plan to conduct phases 2 and 3 of the 3 phase approach, specifically we will: (SA1a) Validate GWAS findings from the discovery sets, and replicate the top hits (~23,000 SNPs) with lowest p- values from the two phase GWA studies in a series of 2,000 cases and 2,000 controls (phase 2, validation). Validate the top hits from the test set (aim 1a). From stage 2, genes with SNPs displaying an association at pd10-4 (including the complete haplotype tagging - approximately 100 SNPs) will then be genotyped in a further series of 4,000 cases and 4,000 controls (stage 3, validation). SNPs significant at 10-7 or better will be considered in the final analyses. (SA1b). Using an a priori hypothesis that DNA repair in inflammation contribute to glioma risk, we will selectively interrogate DNA repair and inflammation pathway genes using data for select genes derived from the high-density array. We will conduct a hypothesis driven genetic association in DNA repair and in inflammation/immune function related genes with glioma risk using functional genomic and bioinformatic tools to interrogate available databases. (SA2): Evaluate gene-gene (G-G) and gene- environmental (G-E) interactions with strong biologic relevance to identify G-G and G-E interactions for glioma risk using machine-learning tools (MDR, FITF, and CART) in these exploratory analyses. There are no existing glioma case-control studies with sufficient numbers of biological samples and common epidemiologic data to conduct a comprehensive validation and replication study, or to address the issues of tumor heterogeneity as we will in this study. PUBLIC HEALTH RELEVANCE: Gliomas are a rare and understudied disease that is rapidly fatal. The proposed case-control study of primary malignant glioma (Gliogene Consortium) includes 13-centers, and will address the role of genetic susceptibility in sporadic cases. It will identify common genetic variants contributing to the risk of glioma from a genome wide association study.",International Case Control Study of Malignant Glioma,8843376,R01CA139020,"['Accounting ', ' Age ', ' Bronchial Asthma ', ' Asthma ', ' California ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Systematics ', ' Classification ', ' Death ', ' Cessation of life ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Unscheduled DNA Synthesis ', ' DNA Damage Repair ', ' DNA Repair ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Family ', ' Genes ', ' Genotype ', ' Glioblastoma ', ' spongioblastoma multiforme ', ' glioblastoma multiforme ', ' Grade IV Astrocytoma ', ' Grade IV Astrocytic Tumor ', ' Grade IV Astrocytic Neoplasm ', ' Glioma ', ' neuroglia tumor ', ' neuroglia neoplasm ', ' glial-derived tumor ', ' Neuroglial Tumor ', ' Neuroglial Neoplasm ', ' Glial Tumor ', ' Glial Neoplasm ', ' Glial Cell Tumors ', ' Haplotypes ', ' Health ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Allergy ', ' Hypersensitivity ', ' Infection ', ' Inflammation ', ' Mining ', ' Play ', ' Radiation-Ionizing Total ', ' Ionizing Electromagnetic Radiation ', ' Ionizing radiation ', ' recruit ', ' Recruitment Activity ', ' Risk ', ' social role ', ' Role ', ' San Francisco ', ' Syndrome ', ' Testing ', ' Trees ', ' Universities ', ' Genetic Variation ', ' Genetic Diversity ', ' Variation (Genetics) ', ' Gender ', ' forest ', ' Dataset ', ' Data Set ', ' Malignant Tumor of the Brain ', ' Brain Cancer ', ' Malignant neoplasm of brain ', ' base ', ' density ', ' Left ', ' Site ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Histologically ', ' Histologic ', ' Series ', ' Age of Onset ', ' Ensure ', ' Susceptibility ', ' Predisposition ', ' Trust ', ' European ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Sample Size ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Ethnicity aspects ', ' Personal Medical History Epidemiology ', ' Personal Medical History ', ' Medical History ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' Staging ', ' tool ', ' Research Specimen ', ' Specimen ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Hereditary ', ' Inherited ', ' Malignant Neuroglial Tumor ', ' Malignant Neuroglial Neoplasm ', ' Malignant Glial Tumor ', ' Malignant Glial Neoplasm ', ' Malignant Glioma ', ' success ', ' international center ', ' cohort ', ' Manuscripts ', ' Histopathology ', ' novel ', ' member ', ' Primary Brain Tumors ', ' Primary Brain Neoplasms ', ' Modeling ', ' Sampling ', ' case control ', ' genetic epidemiology ', ' functional genomics ', ' cancer location ', ' cancer site ', ' Bio-Informatics ', ' Bioinformatics ', ' Cellular Immune Function ', ' immune function ', ' genetic association ', ' Address ', ' Data ', ' M.D. ', ' Doctor of Medicine ', ' International ', ' Infrastructure ', ' Research Infrastructure ', ' Collection ', ' First Degree Relative ', ' Newly Diagnosed ', ' Validation ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' Adult Glioma ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' tumor ', ' high risk ', ' population based ', ' epidemiologic data ', ' TCGA ', ' The Cancer Genome Atlas ', ' ']",NCI,BAYLOR COLLEGE OF MEDICINE,R01,2015,1177060,TX-09,0.06388859533533715
"Genetic Susceptibility and Risk Model for Pancreatic Cancer DESCRIPTION (provided by applicant): Pancreatic cancer (PanC) is the fourth leading cause of cancer-related death for both men and women in the U.S. Better understanding of the etiology and developing risk prediction models for early detection and prevention are urgently needed for this rapidly fatal disease. The majority of PanC are caused by the interplay of both genetic and environmental factors. Known risk factors for PanC include cigarette smoking, obesity, long-term type II diabetes, and family history. In addition, our previous case-control study has shown that excess body mass index (BMI) in young adulthood confers a higher risk of PanC than weight gain at later age. Recent genome-wide association studies (GWAS) have identified several chromosomal regions and genes in association with risk of PanC (PanScan). Our pathway analyses of the PanScan GWAS data have uncovered several novel biological pathways associated with the risk for PanC. However, it remains unknown how environmental or host risk factors modify the association between genetic factors and the PanC risk, which knowledge is critical to better understanding of the etiology and developing a risk prediction model and early intervention strategies for PanC. The goal of this project is to identify gene-environment interactions and develop and validate a risk prediction model including both common and rare genetic variants using the PanScan GWAS data and the exposure information of over 2,200 case-control pairs and an ongoing ExomeChip-based study of PanC genotyping both common SNPs and >240,000 rare functional exonic variants in over 4,100 cases and 4,700 controls from six case-control studies in the Pancreatic Cancer Case Control Consortium (PanC4) and a nested case-control study from Europe (EPIC). We will validate the absolute risk prediction model in two large prospective cohorts: the Atherosclerosis Risk in Communities (ARIC) cohort of 15,000 individuals and the Kaiser Permanente cohort of 100,000 individuals. We will also develop novel statistical methods to identify genes modifying the association between changing BMI at different age periods and PanC risk using the unique dataset from a case-control study of PanC conducted at MD Anderson Cancer Center. Our proposed project hinges on novel integration of GWAS, ExomeChip, exposure data of a large number of PanC cases and controls, recently developed powerful statistical methods and analysis strategies for detecting genome-wide gene/pathway-environment interactions and polygenic approaches to genetic risk prediction. The work proposed here is expected not only to advance our understanding of the etiology of PanC and delineate how genes and lifestyle or host factors modify the risk of PanC, but also to greatly facilitate identification of high-risk individuals, and thus, contribute to early detection, improved survival and prevention of PanC. The novel statistical methods developed here are also applicable to other cancers and complex disease, and we will develop user-friendly software packages for public use. PUBLIC HEALTH RELEVANCE: Over 43,900 new cases of pancreatic cancer are expected to occur in the US in 2012, almost all rapidly fatal. This project will not only advance our understanding of the etiology of pancreatic cancer and delineate how genes and lifestyle or host factors modify the risk of pancreatic cancer, but also will facilitate identification of high-risk individuals, and thus, contribute to early detection, prevention, and improved survival of pancreatic cancer. The novel statistical methods developed here are also applicable to other cancers and complex disease, and we will develop user-friendly software packages for public use.",Genetic Susceptibility and Risk Model for Pancreatic Cancer,8867170,R01CA169122,"['Age ', ' atherosclerotic vascular disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Communities ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Europe ', ' Family ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' History ', ' Recording of previous events ', "" men's "", ' men ', ' Nested Case-Control Study ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Risk ', ' Risk Factors ', ' Smoking ', ' Survival Rate ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Weight Gain ', ' Woman ', ' Work ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Logistic Regressions ', ' Training ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Early Intervention ', ' Host Factor Protein ', ' Host Factor ', ' Integration Host Factors ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Pancreatic Cancer ', ' Pancreas Cancer ', ' Malignant Pancreatic Neoplasm ', ' Malignant neoplasm of pancreas ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Complex ', ' Techniques ', ' cancer risk ', ' early detection ', ' Early Diagnosis ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' user friendly computer software ', ' user friendly software ', ' cohort ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Prevention ', ' smoke cigarette ', ' cigarette smoking ', ' Statistical Methods ', ' Modeling ', ' case control ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' cancer diagnosis ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' Cancer Center ', ' Cancer Cause ', ' Cancer Etiology ', ' enroll ', ' Enrollment ', ' gene modification ', ' Gene-Modified ', ' Genetic Risk ', ' lifestyle factors ', ' Validation ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' prospective ', ' high risk ', ' treatment strategy ', ' effective treatment ', ' effective therapy ', ' genomewide ', ' genome-wide ', ' ']",NCI,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R01,2015,282706,TX-09,0.02751486730525421
"Integrating Genomic and Environmental Perspectives on Internalizing Disorders While biometric genetic studies have long indicated substantial heritability for internalizing disorders, including major depressive and generalized anxiety disorders, progress in mapping this influence onto specific genetic variants has been slow. Expert consensus suggests that finding this ""missing heritability"" will require moving beyond the current ""one SNP at a time"" genomewide association study (GWAS) paradigm to develop interactive models jointly considering effects across structural and functional genomic units (e.g., genes and biological pathways), as well as modeling gene-environmental interaction (GxE) in the highly dimensional GWAS context. The overarching goal of this proposal is to provide the candidate the training and research opportunities necessary to advance such an interactive model of internalizing disorder etiology, thus supporting the candidate's long-term career goal of becoming an independent investigator in the area. General training goals include building proficiency in statistical genetics and bioinformatics, and strengthening knowledge of substantive issues in developmental psychopathology and psychometric statistical modeling/programming. The candidate proposes to acquire a number of specific skills, including data integration techniques for including prior information in GWAS, aggregation methods to capture the possible effects of many markers with very small effects (e.g., gene-based, pathway-based, and polygenic ""risk profile"" score analyses) and machine learning applications for investigating epistasis and nonlinear genomic effects. Proposed training in these areas consists of an interlocking program of coursework, intensive mentoring, summer programs, reading groups, seminar series and conferences, with special attention to training in research ethics. Direct mentoring is a key feature of this program, with access to leading experts in each of the proposed training areas (i.e., Drs. Edwin van den Oord and Patrick Sullivan - statistical genetics and bioinformatics, Dr. E. Jane Costello - developmental psychopathology, and Dr. Michael Neale - statistical modeling and programming) representing a core strength of the proposed training plan. The candidate proposes to apply acquired skills in the research portion of the project by conducting a multistage GWAS to investigate genomic influence, both direct and in interaction with environmental risk factors, on developmental trajectories of internalizing disorders. Methodologically, this approach focuses on integrating longitudinal statistical models of phenotypic development and environmental risk with emerging genomic methods. This will be facilitated by bringing together an unprecedented combination of longitudinal GWAS datasets, including a meta-analysis of the four Duke/VCU samples of the Gene, Environment, and Development Initiative (GEDI) (N=3,623). This ""discovery"" phase meta-analysis will then be followed by replication in two large independent longitudinal samples - the National Longitudinal Study of Adolescent Health (N=~12,000) and the Minnesota Twin and Family Study (N=3,762). The exceptional statistical power of this design will be further complimented in a final analytical stage, with next-generation sequencing follow-up using targeted capture methods to extract promising genes/regions and extreme-trait methods to maximize power by selecting subjects from the extremes of the phenotypic distributions. The institutional environment provided by the Virginia Commonwealth University Center for Biomarker Research and Personalized Medicine (CBRPM) represents another core asset to the candidate's career development. The CBRPM's mission is to develop and apply novel methods for the purpose of identifying and using biomarkers to improve disease understanding and medical treatment. The Center operates from a strong multidisciplinary perspective with primary applications involving psychiatric outcomes, developmental psychopathology, and substance use disorders. Currently funded research programs at the CBRPM include serving as the data analysis core of the Duke/VCU GEDI project, method development in the design and analysis of adaptive multistage GWAS, a replication study of findings from schizophrenia GWAS, and whole genome profiling to detect schizophrenia methylation markers. These projects offer an ideal context for executing the proposed training and research, as they provide an environment focused on GWAS and next-generation sequencing applications to psychiatric disorders - central topics of the candidate's career development plan. The CBRPM also provides several unique physical resources supporting the current proposal, including a SOLiD 4 next-generation sequencer, which will allow follow-up sequencing to be done in-house, and a Center-dedicated computing cluster, facilitating the computationally intensive analyses proposed. In addition to physical resources, the CBRPM offers a challenging and collegial intellectual environment that promotes collaboration both within and outside of the Center. In sum, the CBRPM provides a stimulating and supportive institutional environment with the all of the statistical, computational and laboratory resources necessary to make this proposal a successful one. Affecting more than one in five Americans annually, internalizing disorders (IDs) (i.e.,  depression and anxiety) are the most common forms of mental illness and leading  causes of the global health burden. Clearly, an improved understanding of the etiology of  IDs would substantially advance both prevention and intervention efforts. This project  aims to improve understanding through advancing an integrative model of genomic,  environmental and developmental influence in the etiology of IDs.",Integrating Genomic and Environmental Perspectives on Internalizing Disorders,8843959,K01MH093731,"['Affect ', ' Algorithms ', ' Anxiety ', ' Attention ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Biostatistics ', ' Biometrics ', ' Biometry ', ' Puericulture ', ' Child Care ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' depression ', ' Mental Depression ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Environment ', ' genetic epistases ', ' gene x gene interaction ', ' epistatic relationship ', ' Interaction Deviation ', ' Epistatic Deviation ', ' Epistasis ', ' Genetic Epistasis ', ' Genes ', ' Genome ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Housing ', ' indexing ', ' Laboratories ', ' long-term study ', ' Longitudinal Studies ', ' Maps ', ' Mentors ', ' Methods ', ' Minnesota ', ' Mission ', ' Genetic Models ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' Phenotype ', ' Play ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Population Control ', ' Psychometrics ', ' abnormal psychology ', ' Psychopathology ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' Scoring Method ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Substance Use Disorder ', ' Testing ', ' Time ', ' Twins ', ' Twin Multiple Birth ', ' Universities ', ' Virginia ', ' Measures ', ' conference ', ' symposium ', ' depressive ', ' depression symptom ', ' Emotional Depression ', ' depressive symptoms ', ' Dataset ', ' Data Set ', ' Custom ', ' base ', ' career ', ' method development ', ' improved ', ' Family Study ', ' Area ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Series ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Susceptibility ', ' Predisposition ', ' Training ', ' Measurement ', ' Development Plans ', ' Genetic Research ', ' Funding ', ' Generalized Anxiety Disorder ', ' Collaborations ', ' Twin Studies ', ' Genetic ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Consensus ', ' Knowledge ', ' programs ', ' Investigation ', ' Side ', ' Techniques ', ' American ', ' developmental genetics ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' trait ', ' Structure ', ' skills ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Research Ethics ', ' Modeling ', ' Sampling ', ' career development ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' functional/structural genomics ', ' major depression ', ' Major Depressive Disorder ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Candidate Gene ', ' Candidate Disease Gene ', ' Address ', ' global health ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventive Intervention ', ' Research Training ', ' Stratification ', ' Sum ', ' Genetic Risk ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' data integration ', ' grid computing ', ' distributed computing ', ' datagrid ', ' data grid ', ' computational grid ', ' cluster computing ', ' designing ', ' design ', ' next generation ', ' Outcome ', ' Heritability ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' multidisciplinary ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' next generation sequencing ', ' screening ', ' rare allele ', ' rare variant ', ' personalized treatment ', ' personalized therapy ', ' personalized medicine ', ' ']",NIMH,VIRGINIA COMMONWEALTH UNIVERSITY,K01,2015,133736,VA-04,0.0646836729540213
"Toward Diagnostics and Therapies of Molecular Subcategories of CAD     DESCRIPTION (provided by applicant): Coronary artery disease (CAD) is a leading cause of death worldwide and in the US. While the genetics of this disease are intrinsically complex, thanks to huge research investments during the last 5-10 years, particularly in genome-wide association studies (GWAS), a more unbiased, data-driven and realistic view of CAD has been achieved. As part of this achievement, ~160 common risk loci for CAD/myocardial infarction (MI) have been identified. An important task is now to understand the molecular mechanisms/pathways by which these loci exert risk for CAD/MI allowing to translating the initial findings into new therapies and diagnostics. However, since the loci identified thus far explain only ~10% of variation in CAD/MI risk, it is also essential to define additional CAD pathways operating in parallel with GWA loci. In recent years, clinical studies that consider intermediate phenotypes (between DNA and disease) have greatly enhanced interpretations of risk loci identified in GWA datasets. In addition, disease networks that can be identified from intermediate molecular phenotypes provide an essential framework to identify novel CAD pathways and targets for new CAD therapies. Over the last 6 years, we have performed a clinical study considering many intermediate phenotypes in CAD patients (the STARNET study). In this proposal we intend to use newly generated DNA genotype and RNA sequence data from the STARNET study to identify atherosclerosis and metabolic networks underlying CAD. We then propose a new prospective study of CAD (the NGS-PREDICT study) with the main purpose of validating findings from the STARNET study. We hypothesize that the extent and stability of coronary lesions, thus clinical outcomes can be accurately assessed by defining the status of key atherosclerosis gene networks. In turn, metabolic networks active in liver, abdominal fat, and skeletal muscle influence the status of the atherosclerosis gene networks. In addition, molecular data isolated from easily obtainable tissues (e.g., blood, subcutaneous fat and plasma) can be used to identify biomarkers that can predict risk for clinical events caused by CAD. To test these hypotheses, we propose the following specific aims. Aim 1: To identify regulatory Bayesian gene networks causally linked to CAD and/or CAD sub-phenotypes using the STARNET datasets and the CARDIoGRAM meta-analysis GWA datasets. Aim 2: Identify biomarkers predicting clinical events of CAD (reflected in SYNTAX score) by applying machine learning on DNA genotype, RNA sequence and CAD plasma protein data from easily obtainable tissues of the STARNET cases. Aim 3: To validate the identified causal CAD eQTLs/networks and the biomarkers using the NGS-PREDICT study performed at the Mt. Sinai Hospital, the Swedish Twin study and CAD cell and animal models. We believe the proposed studies can lead to a significantly better molecular understanding of CAD and thus, serve the more long-term goal of preventive and personalized therapies of CAD patients diagnosed in well-defined molecular subcategories.         PUBLIC HEALTH RELEVANCE:  Coronary artery disease (CAD) is the world's leading cause of death. We will perform systems genetic analysis of DNA and RNAseq data from 9 CAD-relevant tissues in 700 well-characterized patients (STARNET) integrated with genome-wide association data to reveal CAD-causing metabolic and atherosclerosis gene networks, and within these, new inherited risk variants, CAD-mechanisms, therapeutic targets and biomarkers will be identified and validated in a new prospective clinical study of CAD (NGS-PREDICT). Our studies promise to significantly advance understanding of CAD towards achieving preventive and personalized care.                ",Toward Diagnostics and Therapies of Molecular Subcategories of CAD,8964154,R01HL125863,"['Abdominal ', ' Abdomen ', ' Achievement Attainment ', ' Achievement ', ' Allelomorphs ', ' Alleles ', ' angiographic imaging ', ' Angiogram ', ' Angiography ', ' atherosclerotic vascular disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' Biology ', ' Biopsy ', ' Blood Reticuloendothelial System ', ' Blood ', ' vascular ', ' Blood Vessels ', ' Cardiovascular Disease (Specialty) ', ' Cardiology ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular system (all sites) ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardiovascular system ', ' Cause of Death ', ' Clinical Study ', ' Clinical Research ', ' Coronary Atherosclerosis ', ' Coronary Artery Disorder ', ' Coronary Artery Disease ', ' Coronary Arteriosclerosis ', ' coronary bypass ', ' Coronary Artery Bypass Surgery ', ' Coronary Artery Bypass Grafting ', ' Aortocoronary Bypass ', ' Coronary Artery Bypass ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Drug Therapy ', ' Pharmacotherapy ', ' Engineering ', ' Family ', ' Fats ', ' Fatty acid glycerol esters ', ' Foam Cells ', ' Foundations ', ' Future ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genotype ', ' Goals ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Hospitals ', ' In Vitro ', ' Institutes ', ' Investments ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' macrophage ', ' Maps ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' Marrow monocyte ', ' Blood monocyte ', ' monocyte ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' New York ', ' Patients ', ' Phenotype ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Plasma Proteins ', ' Prospective Studies ', ' gene product ', ' Proteins ', ' Reading ', ' recruit ', ' Recruitment Activity ', ' Research ', ' Research Proposals ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' school of medicine ', ' medical college ', ' medical schools ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Twins ', ' Twin Multiple Birth ', ' Weight ', ' Dataset ', ' Data Set ', ' RNA Sequences ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' Lesion ', ' Individual ', ' Voluntary Muscle ', ' Skeletal Muscle Tissue ', ' Skeletal Muscle ', ' Skeletal muscle structure ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Twin Studies ', ' Metabolic ', ' Genetic ', ' Diagnostic ', ' Whole Blood ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Hereditary ', ' Inherited ', ' Complex ', ' Event ', ' subcutaneous ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Best Practice Analysis ', ' Benchmarking ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Operative Surgical Procedures ', ' QTL ', ' Quantitative Trait Loci ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' trait ', ' novel ', ' disease risk ', ' disorder risk ', ' disorder model ', ' Disease model ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Address ', ' Preventive ', ' Data ', ' Disease Pathway ', ' Subcategory ', ' in vivo Model ', ' Opening of the Thorax ', ' Molecular ', ' Coronary ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' percutaneous coronary intervention ', ' abdominal adiposity ', ' abdominal fat ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' Outcome ', ' prospective ', ' Heritability ', ' Cellular model ', ' Cell model ', ' multidisciplinary ', ' therapeutic target ', ' public health relevance ', ' molecular phenotype ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' biological systems ', ' RNAseq ', ' RNA-seq ', ' transcriptome sequencing ', ' clinical risk ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' personalized treatment ', ' personalized therapy ', ' personalized medicine ', ' ']",NHLBI,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2015,828928,NY-13,0.02933024705622009
"Genetic and epigenetic contributions to Sjogren's syndrome     DESCRIPTION (provided by applicant): High throughput whole genome platforms to quantitatively and efficiently assay human DNA methylation provide an extraordinary opportunity to accelerate progress in the identification of epigenetic mechanisms for complex human autoimmune diseases such as Sjogren's Syndrome (SS). Epigenetic modifications, such as methylation of the 5' carbon of cytosine which occurs in the context of CpG dinucleotides, do not affect the genetic sequence; however, they do play a critical role in transcriptional regulation of a gene and subsequent gene expression. We have applied this technology, in conjunction with whole genome SNP genotyping to a clinically well-characterized collection of SS cases and controls developed specifically for genetic and epigenetic studies. Samples from the Sjogren's International Collaborative Clinical Alliance (SICCA) repository (total n=3,500 individuals) will b utilized, given the careful phenotype characterization and standardized collection of biospecimens that has been performed for each participant. For this proposal, we have initially obtained DNA from peripheral blood mononuclear cells (PBMCs) and sorted cell populations with high purity, including CD14+ monocytes, CD19+ B cells, CD4+ T cells, as well as labial salivary gland biopsy tissue from 120 SICCA participants (100 SS cases and 20 controls). Data collected for ~450,000 highly informative CpG sites spanning 22,000 genes across the genome will provide a comprehensive assessment of DNA methylation for each individual for our proposed study Aims. As part of Aim 1, DNA methylation profiles will be examined using three main approaches: 1) Global DNA methylation profiles will be analyzed for association with SS risk in all sample types; 2) Multidimensional scaling analysis (MDS) and principal components analysis (PCA) will be performed to determine whether SS case samples can be distinguished from control samples; and 3) Local analyses will also be performed and will focus specifically on DNA methylation changes within candidate SS genes and genes demonstrating at least 1.5 fold methylation differences between cases and controls. Our proposal will take advantage of available whole genome data for each study participant and results from the largest genome wide association study (GWAS) in SS. In Aim 2, we will utilize DNA methylation profiles and methods from Aim 1 to determine whether important SS case phenotypes can be distinguished from one another. We will identify top ranked CpG sites that are either hypo or hyper methylated in specific SS case groups or that distinguish cases from controls using supervised machine learning algorithms. We will attempt replication for all top findings in an independent dataset, followed by random effects meta-analysis to incorporate other SS risk factors. Finally, we will determine whether DNA methylation profiles of interest from Aims 1 and 2 can be detected in DNA from whole blood for potential use as a biomarker. The identification of unique epigenetic profiles in SS, and an understanding of these profiles in the context of different cell and tissue types and genetic background have the potential to significantly transform our understanding of SS etiology.         PUBLIC HEALTH RELEVANCE New molecular genetic assays offer an extraordinary opportunity to accelerate progress in the identification of epigenetic mechanisms for complex human autoimmune diseases such as Sjogren's Syndrome (SS). We propose to perform a comprehensive screen of more than 450,000 highly informative CpG sites spanning 22,000 genes across the genome using DNA derived from peripheral blood mononuclear cells (PBMCs), sorted cell populations, and labial salivary gland biopsy tissue from SS cases and control individuals to identify epigenetic profiles that are predictive of disease risk and specifi clinical phenotypes. The identification of unique epigenetic profiles in SS, and an understanding of these profiles in the context of several different cell and tissue types and whole genome SNP data have the potential to significantly transform our understanding of SS etiology, and may lead to more effective approaches to prevention, diagnosis and treatment.                ",Genetic and epigenetic contributions to Sjogren's syndrome,8829521,R03DE024316,"['Affect ', ' Algorithms ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantibodies ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' self recognition (immune) ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' Blood Reticuloendothelial System ', ' Blood ', ' Budgets ', ' C element ', ' Carbon ', ' cell sorting ', ' Cell Separation Technology ', ' Cell Segregation ', ' Cell Isolation ', ' Cell Separation ', ' Cells ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' Data Analysis ', ' Data Analyses ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Gene Expression ', ' Genes ', ' Genome ', ' Genotype ', ' histocompatibility typing ', ' Tissue Typing ', ' Tissue Crossmatching ', ' Histocompatibility Testing ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Protein Methylation ', ' Methylation ', ' Marrow monocyte ', ' Blood monocyte ', ' monocyte ', ' Patients ', ' Phenotype ', ' Play ', ' Production ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' San Francisco ', ' Syndrome ', ' helper T cell ', ' T4 Lymphocytes ', ' T4 Cells ', ' CD4-Positive Lymphocytes ', ' CD4+ T-Lymphocyte ', ' CD4+ T cell ', ' CD4 lymphocyte ', ' CD4 T cells ', ' CD4 Cells ', ' CD4 Positive T Lymphocytes ', ' Technology ', ' Body Tissues ', ' Tissues ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' T-Cell Subsets ', ' T-Lymphocyte Subsets ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' base ', ' Blood Sample ', ' Blood specimen ', ' Site ', ' Clinical ', ' Individual ', ' European ', ' Sample Size ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Genetic ', ' Whole Blood ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Complex ', ' Oral ', ' cell type ', ' Country ', ' interest ', ' PBMC ', ' Peripheral Blood Mononuclear Cell ', ' Participant ', ' member ', ' Study Subject ', ' disease risk ', ' disorder risk ', ' Modeling ', ' Sampling ', ' high throughput technology ', ' case control ', ' repository ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Labial Salivary Gland ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' CD14 ', ' CD14 gene ', ' CD19 ', ' CD19 gene ', ' Data ', ' International ', ' National Institute of Dental Research ', ' NIDR ', ' NIDCR ', ' National Institute of Dental and Craniofacial Research ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' clinical phenotype ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' SNP genotyping ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' human DNA ', ' systemic autoimmune disorder ', ' systemic autoimmune disease ', ' ']",NIDCR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R03,2015,236912,CA-12,0.03129507124967038
"Informatics Tools for High-Throughput Sequences Data Analysis DESCRIPTION (provided by applicant): The Genome Analysis Toolkit (GATK) is a suite of best-in-class, widely-used, well-supported, open-source tools for processing and analysis of next-generation DNA sequencing (NGS) data. These tools currently  include a multiple sequence realigner, a covariate-correcting base quality score recalibrator, multi-sample  SNP, INDEL, and CNV genotypers, machine learning algorithms for false positive identification, variant  evaluation modules, somatic SNP and indel callers, and hundreds of other tools. Underlying all of these tools is our structured programming framework (GATK-Engine) that uses the functional programming philosophy of MapReduce to make writing feature-rich, efficient and robust analysis tools easy. By centralizing common data management infrastructure, all GATK-based tools benefit from the engine's correctness, CPU and memory efficiency, as well as automatic distributed and shared memory parallelization, essential capabilities given the massive and growing size of NGS datasets. The GATK currently supports all of the major sequencing technologies including lllumina. Life Sciences 454, and ABI SOLID, from hybrid capture of exomes to 1000s of low-pass samples in the 1000 Genomes Project. Our emphasis on technology-agnostic processing tools has helped to popularize the now standard SAM/BAM and VCFs formats for representing NGS data and variation calls, respectively. In this RFA we propose to  continue to develop the GATK-Engine and data processing tools to (1) achieve complete and accurate  variation discovery and genotyping for all major sequencing study designs and NGS technologies (2)  optimize the GATK-Engine and pipelining infrastructure to operate efficiently on distributed data sets at the  scale of tens of thousands of samples (3) extend the GATK data processing tools to support the upcoming  sequencing technologies of Complete Genomics, lon Torrent, and Pacific Biosciences as well as we do  current technologies, (4) expand significantly our educational and support structures to ensure that the longtail  of future NGS users can benefit from the best-practice data processing and analysis tools in the GATK. The proposed project aims to continue to develop the Genome Analysis Toolkit (GATK), a suite of widely used and mission-critical tools for analyzing the next-generation DNA sequencing data. With this grant we will improve these tools, make them more robust, and extend them to new sequencing technologies. This is essential to realize the potential of DNA sequencing to understand human history, diversity, and to discover  new loci associated with human disease, leading to new biologic hypotheses and new drug targets.",Informatics Tools for High-Throughput Sequences Data Analysis,8788050,U01HG006569,"['Algorithms ', ' Life Sciences ', ' Biologic Sciences ', ' Biological Sciences ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Experimental Designs ', ' Flooding ', ' Floods ', ' Future ', ' Medical Genetics ', ' Genome ', ' Genotype ', ' Grant ', ' History ', ' Recording of previous events ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hybrids ', ' Memory ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Mission ', ' Philosophy ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Technology ', ' Work ', ' Writing ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' improved ', ' Site ', ' Variation ', ' Variant ', ' Ensure ', ' Evaluation ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Techniques ', ' data management ', ' Informatics ', ' Structure ', ' novel ', ' cancer genetics ', ' Modeling ', ' Sampling ', ' Genomics ', ' Documentation ', ' data processing ', ' computerized data processing ', ' Data ', ' Infrastructure ', ' Research Infrastructure ', ' Process ', ' insertion/deletion ', ' insertion-deletion mutation ', ' insertion-deletion ', ' insertion/deletion mutation ', ' distributed data ', ' next generation ', ' SNP genotyping ', ' open source ', ' human disease ', ' shared memory ', ' distributed memory ', ' exomes ', ' exome ', ' genome analysis ', ' Drug Targeting ', ' High-Throughput Sequencing ', ' High-Throughput Nucleotide Sequencing ', ' ']",NHGRI,"BROAD INSTITUTE, INC.",U01,2015,967608,MA-07,0.0029685833533512093
"Systems genetic and reverse phenotypic analysis of age and retirement DESCRIPTION (provided by applicant): High throughput genomic platforms have revealed a profound effect of age on gene expression and gene methylation levels. For example, our integromic analysis of multiple publicly available data sets have identified hundreds of age related genes that can be organized into network modules. These gene sets along with genes and pathways known from the vast literature on aging and longevity provide valuable candidates in allelic association studies of the health and well-being of older Americans. The rich longitudinal data set and the genome wide scans of DNA samples from the Health and Retirement Study (HRS) provide a unique resource for evaluating the phenotypic effects of genetic variants underlying aging related genes, gene sets and for developing multivariable models that include behavioral, psychosocial, and genetic factors. This proposal aims to apply systems biologic and systems genetic methods for identifying gene sets based on existing gene expression, gene methylation, and multiple large scale genome wide association studies (GWAS). Single nucleotide polymorphisms (SNPs) underlying these genes will then be related to health, cognitive, behavioral, and economic phenotypes using multivariable regression-, machine learning-, and weighted network analysis approaches. An iterative process between SNP and phenotype selection facilitates the definition of clinically and economically important phenotypes under genetic control (reverse phenotyping). The proposal will not only elucidate the genetic and molecular underpinnings of retirement relevant phenotypes (cognitive functioning, psychosocial factors, and health related expenditures) but also lead to a phenotypic annotation of aging related genes and pathways. PUBLIC HEALTH RELEVANCE: State of the art statistical, computational, and network approaches for integrating genomic data with the valuable phenotypic and genetic data provided by the Health and Retirement Study is expected to lead to the identification of genetic markers relevant for improving the lives of America's older adults. Validated genetic markers will inform researchers in many fields including biomedical researchers, epidemiologists, psychologists, sociologists, and economists.",Systems genetic and reverse phenotypic analysis of age and retirement,8882214,R01AG042511,"['Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Americas ', ' Parturition ', ' Birth ', ' Concurrent Studies ', ' Cohort Studies ', ' Data Analysis ', ' Data Analyses ', ' Deoxyribonucleic Acid ', ' DNA ', ' Expenditure ', ' Gene Expression ', ' Genes ', ' Genetic Markers ', ' genetic biomarker ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Economical Income ', ' Economic Income ', ' Income ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Method LOINC Axis 6 ', ' Methodology ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' well-being ', ' Personal Satisfaction ', ' Phenotype ', ' Psychologist ', ' psychosocial variables ', ' Psychosocial Factor ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retirement ', ' sociologist ', ' computer program/software ', ' Software ', ' Computer software ', ' Specificity ', ' statistics ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Weight ', ' Measures ', ' Molecular Genetics ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cognitive function ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Physical Function ', ' psychosocial ', ' interest ', ' American ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' cohort ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' repository ', ' Genomics ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Data ', ' Subgroup ', ' Cognitive ', ' Epidemiologist ', ' Genome Scan ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' pediatric depression ', ' childhood depression ', ' adolescent depression ', ' child depression ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Impairment ', ' endophenotype ', ' social implication ', ' economic implication ', ' exomes ', ' exome ', ' ']",NIA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2015,306229,CA-33,0.03815609646057151
"Accelerating Curation of GWAS Catalog by Automatic Text Mining     DESCRIPTION (provided by applicant): A genome-wide association study (GWAS) is an approach to detecting genetic variations associated with particular diseases or traits by scanning markers across the genomes of a large-scale sample of subjects in a high-throughput manner. In less than a decade, GWAS studies have been successfully producing discovery and replication of many new disease loci. Discovered genetic associations have led to development of better strategies to diagnose, treat and prevent diseases. The number of GWAS is growing rapidly. There is a need for a database that allows researchers to easily query and search for previous results. A well-curated database also provides a resource for overview and summarization investigations of associated genetic sites and may help suggest pleiotropic genes. Such a database has been created and maintained by the National Human Genome Research Institute (NHGRI), called ""A Catalog of Published Genome-Wide Association Studies"" (Catalog of GWAS). The catalog has led to interesting characterization of previous results in GWAS and NHGRI has continued to update and curate the catalog regularly. However, this is performed by manually extracting information from published GWAS articles. As a result, the coverage is low compared to the volume of all GWAS publications and would be impossible to catch up the pace of new publications. The goal of this project is to develop a new tool to automatically extract the information from research articles for the curation of the catalog of GWAS. Our proposal is to use the curated data currently available from NHGRI as the training examples and apply novel machine-learning algorithms to train an information extractor to allow accurate automatic extraction. Given our recent success in applying machine learning to biological text mining, we are confident that this will lead to a useful tool to improve the productivity of curators and solve the coverage problem. Our first specific aim is to develop an accurate information extractor. Our second specific aim is to develop an easy-to-use curation tool for curators to efficiently check and correct errors from automatic information extraction so that their curation productivity can be improved by 18 folds. Then we will adapt the tool to extraction and curation of research papers reporting association studies using data from next generation sequencing. Currently, study design and the reporting of GWAS results using NGS data are not standardized. These results have not been considered to be included in the catalog yet. However, we expect that the limitations will be overcome and the methodology will converge soon. We will closely monitor the progress and adapt the tool to allow for inclusion of the NGS data. Finally, we will distribute the software to the public domain so that volunteers or interested parties can create their own catalog locally. It is our goal to share the developed software with the research community to advance the field. The new algorithms developed in this project and the entire development cycle, from design to deployment, will also contribute to the state-of-the- arts of biological text mining.         PUBLIC HEALTH RELEVANCE: The goal of this project is to develop a new tool to automatically extract the information from research articles for the curation of the catalog of GWAS. The catalog contains information about SNP-trait/disease associations that are extracted from published genome-wide association studies. A well-curated catalog of GWAS allows researchers to easily query and search for previous results and provides a useful resource for overview and summarization investigations of associated genetic sites and may help suggest pleiotropic genes.            ",Accelerating Curation of GWAS Catalog by Automatic Text Mining,9052542,U01HG006894,"['Algorithms ', ' Cataloging ', ' Communities ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Future ', ' Genes ', ' Genome ', ' Goals ', ' Human Genetics ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Manuals ', ' Method LOINC Axis 6 ', ' Methodology ', ' Paper ', ' Productivity ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' computer program/software ', ' Software ', ' Computer software ', ' Standardization ', ' Survey Instrument ', ' Surveys ', ' Technology ', ' Genetic Variation ', ' Genetic Diversity ', ' Variation (Genetics) ', ' Workload ', ' Work Load ', ' Public Domains ', ' base ', ' improved ', ' Site ', ' Area ', ' Biological ', ' Link ', ' Ensure ', ' Training ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Catalogs ', ' Investigation ', ' Scanning ', ' interest ', ' success ', ' trait ', ' novel ', ' Reporting ', ' Sampling ', ' developing computer software ', ' develop software ', ' software development ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' preventing ', ' prevent ', ' genetic association ', ' Data ', ' Update ', ' Monitor ', ' Text ', ' developmental ', ' Development ', ' National Center for Human Genome Research ', ' NHGRI ', ' National Human Genome Research Institute ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' designing ', ' design ', ' user-friendly ', ' volunteer ', ' public health relevance ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' next generation sequencing ', ' ']",NHGRI,"UNIVERSITY OF CALIFORNIA, SAN DIEGO",U01,2015,130994,CA-52,0.07449279659731278
"Bioinformatics strategies to relate age of onset with gene-gene interaction     DESCRIPTION (provided by applicant):         Time to onset of chronic diseases such as cancer, cardiovascular disease, and diabetes is expected to be influenced by multiple gene-gene interactions that add to the complexity of the genotype-phenotype mapping relationship. Unfortunately, parametric statistical methods such as Cox regression lack sufficient power to detect high-order gene-gene interactions due to the sparseness of the data. Machine learning methods offer a more powerful alternative but rely on computationally-intensive searching methods to identify the top models. We propose here to develop a powerful and computationally efficient bioinformatics strategy that combines machine learning algorithm and Cox regression for identifying gene-gene and gene-environment interaction models that are associated with time of onset of chronic disease. Specifically, we firs propose to develop a novel Robust Survival Multifactor Dimensionality Reduction method (RS-MDR) for the detection of gene-gene interactions in rare variants that influence time of onset of human disease (AIM 1). The power of RS-MDR method will be evaluated by comparing it to other existing methods in simulation studies. We then propose to change the representation space of the gene-gene interaction models using RS-MDR's construction induction method and apply L1 penalized Cox regression to identify a set of interaction models that can predict patients' survival probability (AIM 2). We hypothesize that RS-MDR can effectively identify high order interaction models and the combined approach provides a powerful and computational efficient way to select a set of interaction models. We will use extensive simulations that are derived from GWAS studies to thoroughly evaluate this hypothesis. Next, we will apply the new combined method for detecting and characterizing gene-gene and gene-environment interactions in genome-wide association study (GWAS) data from large population-based studies of lung cancer and rheumatoid arthritis (AIM 3). Results from the real data analysis will be used to refine the method. Finally, we will distribute the proposed method as part of an open- source R software package (AIM 4). We anticipate that the proposed method will combine the strength from both parametric and non-parametric methods and enable detection of interaction models that are jointly affecting time of onset of chronic diseases. This is important because time of onset has more variation than case-control status and it may be more clinically relevant. Furthermore, studies of genetic factors predicting time of onset have not been pursued aggressively using GWAS studies, despite the relevance of this information for the discovery of high risk variants like mutations in BRCA1.             Narrative This project will provide a general method for genome data analysis that can be potentially apply to any specific disease. We focus the application of this method on an investigation into the role of genetic polymorphisms in lung cancer and rheumatoid arthritis. This will increase our knowledge of the basic biology and lead for screening and targeted therapy.",Bioinformatics strategies to relate age of onset with gene-gene interaction,8962812,R01LM012012,"['Affect ', ' Algorithms ', ' Inflammatory Arthritis ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' Biology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' chronic disorder ', ' chronic disease/disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Europe ', ' Genes ', ' Genome ', ' Genotype ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Methods ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' North America ', ' Patients ', ' Phenotype ', ' polymorphism ', ' Polymorphism (Genetics) ', ' Genetic Polymorphism ', ' Probability ', ' Research ', ' Risk ', ' social role ', ' Role ', ' computer program/software ', ' Software ', ' Computer software ', ' Testing ', ' Texas ', ' Time ', ' United Kingdom ', ' base ', ' Variation ', ' Variant ', ' Age of Onset ', ' Link ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' brca 1 gene ', ' RNF53 ', ' Hereditary Breast Cancer 1 ', ' Early Onset Gene Breast Cancer 1 ', ' Breast Cancer Type 1 Susceptibility Gene ', ' Breast Cancer 1 Gene ', ' BRCA1 ', ' BRCA1 gene ', ' Investigation ', ' Dimensions ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' gene interaction ', ' simulation ', ' novel ', ' Statistical Methods ', ' Modeling ', ' case control ', ' Gene Position ', ' Gene Arrangement ', ' Gene Order ', ' Bio-Informatics ', ' Bioinformatics ', ' Data ', ' Detection ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' cancer genome ', ' Outcome ', ' clinical relevance ', ' clinically relevant ', ' open source ', ' human disease ', ' high risk ', ' population based ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' screening ', ' rare allele ', ' rare variant ', ' ']",NLM,DARTMOUTH COLLEGE,R01,2015,352350,NH-02,0.005155430180847282
"Enhanced Gene Identification in Complex Traits Using Kernel Machines DESCRIPTION (provided by applicant):     Project Summary/Abstract Genome-wide association studies (GWAS) have mapped thousands of common trait-influencing variants yet the overwhelming majority of trait loci have yet to be discovered. The goal of this proposal is to develop and apply statistical approaches that move beyond the standard GWAS paradigm to map additional trait-influencing variation within the human genome. Most of our proposed tools are based on a flexible high-dimensional framework called kernel machine regression, which we have had past success employing for powerful gene mapping of complex traits in GWAS and next-generation sequencing (NGS) studies. We believe the inherent flexibility of the kernel framework makes it ideal for exploring new paradigms in gene mapping of complex human traits. Aim 1 proposes novel kernel methods for integrated analysis of both single-nucleotide variation data (derived from GWAS and/or NGS) and genomic data (such as gene-expression and methylation patterns) that we believe will provide improved power for trait mapping. Aim 2 proposes novel kernel methods for large scale gene-gene interaction analysis across the genome, as well as a computational approach that enables efficient adjustment for multiple testing when applying such exhaustive testing procedures. Aim 3 establishes novel kernel methods for association mapping of SNVs on the X chromosome. The flexible nature of kernel machines makes it ideal for modeling potential sex-specific effects on this chromosome and the methods further can accommodate random X inactivation. Aim 4 proposes novel kernel approach for robust analysis of rare trait-influencing variation within families; such family-based designs are generally not considered in current rare-variant procedures. We will evaluate these methods on large-scale datasets that we are actively involved in and will implement the methods in user-friendly software for public distribution (Aim 5). PUBLIC HEALTH RELEVANCE:     Project Narrative The goal of this project is to develop novel and powerful statistical tools for identifying genetic loci acting independently or in conjunction with other genetic/environmental factors to influence complex human diseases or disease-related quantitative traits. Application of the proposed methods to applied datasets should improve our understanding of the genetic origins of complex traits and enhance existing risk-prediction models of complex disease.",Enhanced Gene Identification in Complex Traits Using Kernel Machines,8894057,R01HG007508,"['abstracting ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' Chromosomes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' disease/disorder ', ' Disorder ', ' Disease ', ' epileptogenic ', ' epileptiform ', ' epilepsia ', ' Seizure Disorder ', ' Epileptics ', ' Epileptic Seizures ', ' Epilepsy ', ' Exhibits ', ' Family ', ' Gene Expression ', ' Genes ', ' Genome ', ' Human Genome ', ' human whole genome ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Articulation ', ' Joints ', ' Linkage Disequilibrium ', ' Literature ', ' Maps ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Study models ', ' Nuclear Family ', ' Nucleotides ', ' pedigree structure ', ' Pedigree ', ' genetic pedigree ', ' Play ', ' Public Health ', ' public health medicine (field) ', ' study design ', ' Study Type ', ' Research Design ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' social role ', ' Role ', ' computer program/software ', ' Software ', ' Computer software ', ' traumatic neurosis ', ' Posttraumatic Stress Disorders ', ' Posttraumatic Neuroses ', ' Post-Traumatic Neuroses ', ' PTSD ', ' Post-Traumatic Stress Disorders ', ' Technology ', ' Testing ', ' Work ', ' X Chromosome ', ' X-Chromosome Inactivation ', ' Lyonization ', ' X Inactivation ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Procedures ', ' Variation ', ' Variant ', ' Biological ', ' Medical ', ' Sexism ', ' Gender Bias ', ' Sex Bias ', ' Link ', ' Individual ', ' Genetic ', ' tool ', ' Nature ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Complex ', ' Source ', ' interest ', ' gene interaction ', ' Performance ', ' success ', ' user friendly computer software ', ' user friendly software ', ' X linked trait ', ' X inherited trait ', ' trait ', ' genetic testing ', ' Genetic screening method ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Genetic analyses ', ' genetic analysis ', ' Statistical Methods ', ' Modeling ', ' case control ', ' Genomics ', ' Address ', ' Resequencing ', ' DNA Resequencing ', ' Data ', ' Other Genetics ', ' scientific advances ', ' scientific accomplishments ', ' Scientific Advances and Accomplishments ', ' sex ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' designing ', ' design ', ' open source ', ' human disease ', ' stem ', ' population based ', ' flexible ', ' flexibility ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' next generation sequencing ', ' rare allele ', ' rare variant ', ' ']",NHGRI,EMORY UNIVERSITY,R01,2015,341249,GA-05,0.011661410742288544
"Novel Strategies to Identify GxE Contributions to MS Pathogenesis DESCRIPTION (provided by applicant):  Multiple sclerosis (MS) is a complex and heterogeneous inflammatory disorder of the central nervous system characterized by myelin loss, varying degrees of axonal pathology, and progressive neurological dysfunction. The combined effect of many genes, environmental exposures acting during defined periods of life, and their interactions in MS is strongly supported by our own work and others. The involvement of HLA class II genes within the major histocompatibility complex (MHC) on chromosome 6p21 is well-established. The identification of non-MHC determinants of MS susceptibility, while progressing, is far from complete. Similar to other complex diseases, genome-wide association studies (GWAS) have begun to unravel the polygenic etiology of MS. However, variants identified through several large GWAS, to date, explain only a very small proportion of MS heritability. The proposed study describes critical post-GWAS era steps to further our current understanding of MS pathogenesis. First, we will utilize next-generation DNA sequence data, high-throughput genotyping and state-of-the-art bioinformatics methods to fully characterize rare, less frequent and common variants within more than 30 MS genes established through recent GWAS and their contribution to the development of MS and disease expression (Aim 1). Next, we will also comprehensively investigate a number of important life-course exposures including prenatal, perinatal, childhood, adolescent and adult time periods, GxE interactions and risk of MS (Aim 2). Finally, we will study genome-wide DNA methylation profiles in a newly established cohort of clinically isolated syndrome (CIS)/early MS cases and matched controls to identify immune cell specific epigenetic influences on the development of MS (Aim 3). We will utilize extraordinary MS case-control resources nested within the large, population-based membership of Northern California Kaiser Permanente, as well as DNA, genetic and clinical data assembled for this project through the International Multiple Sclerosis Genetics Consortium; more than 10,000 individuals of White/European ancestry will be studied using a suite of statistical methods of analysis. Results from proposed epidemiologic studies of the most important MS genes and causal variants in the context of relevant environmental exposures will inform new functional studies, and have potential to support the development of more effective approaches for prevention, diagnosis and treatment. The complete identification of genetic and environmental influences and how they contribute independently and jointly to the development of MS and expression of particular disease characteristics would play a major role in understanding disease etiology, and would contribute greatly to disease prevention strategies and development of targeted and more effective therapies.",Novel Strategies to Identify GxE Contributions to MS Pathogenesis,8829259,R01ES017080,"['adulthood ', ' adult human (21+) ', ' Adult Human ', ' 21+ years old ', ' Adult ', ' epidemiologic investigation ', ' Epidemiology Research ', ' Epidemiological Studies ', ' Epidemiologic Research ', ' Epidemiologic Studies ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' California ', ' Cells ', ' Central Nervous System Disorders ', ' CNS disorder ', ' CNS Diseases ', ' Central Nervous System Diseases ', ' Chromosomes ', ' Chronology ', ' Diagnosis ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Environmental Exposure ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Foundations ', ' Genes ', ' MHC Class II Genes ', ' MHC Class II ', ' HLA Class II Genes ', ' Class II Genes ', ' Genotype ', ' Laboratories ', ' life course ', ' Life Cycle ', ' Life Cycle Stages ', ' Major Histocompatibility Complices ', ' Histocompatibility Complices ', ' Histocompatibility Complex ', ' Major Histocompatibility Complex ', ' Methods ', ' insular sclerosis ', ' MS (Multiple Sclerosis) ', ' Disseminated Sclerosis ', ' Multiple Sclerosis ', ' Myelin ', ' Risk Ratio ', ' Relative Odds ', ' Cross-Product Ratio ', ' Odds Ratio ', ' Pathology ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Research Resources ', ' Resources ', ' Risk ', ' social role ', ' Role ', ' Survey Instrument ', ' Surveys ', ' Syndrome ', ' Testing ', ' Time ', ' Work ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Perinatal ', ' Site ', ' Variation ', ' Variant ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Adolescent ', ' Susceptibility ', ' Predisposition ', ' pediatric ', ' Childhood ', ' Individual ', ' Trust ', ' European ', ' Collaborations ', ' Genetic ', ' Inflammatory ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Life ', ' Dimensions ', ' Immune ', ' Complex ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' cohort ', ' unborn ', ' prenatal ', ' genetic testing ', ' Genetic screening method ', ' novel ', ' disease prevention ', ' disorder prevention ', ' Preventive strategy ', ' Prevention strategy ', ' disease risk ', ' disorder risk ', ' Pathogenesis ', ' neurological dysfunction ', ' Neurologic Dysfunctions ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' case control ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Bio-Informatics ', ' Bioinformatics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' copy number variation ', ' Copy Number Polymorphism ', ' Data ', ' International ', ' Clinical Data ', ' Clinical Management ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Risk Estimate ', ' 6p21 ', ' Characteristics ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' insertion/deletion ', ' insertion-deletion mutation ', ' insertion-deletion ', ' insertion/deletion mutation ', ' next generation ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Approaches to prevention ', ' Prevention approach ', ' Population ', ' Heritability ', ' genome-wide analysis ', ' population based ', ' effective treatment ', ' effective therapy ', ' genomewide ', ' genome-wide ', ' rare allele ', ' rare variant ', ' ']",NIEHS,UNIVERSITY OF CALIFORNIA BERKELEY,R01,2015,572704,CA-13,0.02716744819163121
"Signals of Epigenetic Modification in Sjogrens Syndrome     DESCRIPTION (provided by applicant): The objective of the project is to characterize the potential role of DNA methylation patterns in Sjgren's Syndrome (SS) disease etiology and mechanism. A growing body of evidence indicates that epigenetic changes, in particular, altered patterns of DNA methylation, contribute to the development of autoimmune disease and can mediate genetic risk factors. To date, aberrant DNA methylation has been associated with several human autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. My proposal focuses on the identification of unique epigenetic profiles in SS, focusing primarily on T cells, B cells, and salivary gland tissue, a primary site of the inflammatory disease. An understanding of these profiles in the context of genetic background, publicly available genomic data (RNA, ChIP-seq, WGBS) and annotation data (TF binding motifs, genomic QTLs), and cell types have the potential to significantly transform our understanding of SS etiology, particularly given the well-established heterogeneity in clinical manifestations. Further, these DNA methylation profiles could become useful clinical biomarkers for determining risk and prognosis in SS, especially if their biological relevance can be validated in future functional studies. The overall hypothesis of this project is that DNA methylation changes in key genomic regions are associated with SS status and phenotype. The project will use genome-wide SNP data, epigenome-wide methylation array data, and clinical characteristics abstracted from 100 SS cases and 20 controls to address 3 related hypotheses: First, that epigenome-wide DNA methylation patterns in T cells, B cells (both derived from peripheral blood), and salivary gland biopsy tissue are associated with primary SS status after correcting for cell-type heterogeneity. Case-control differences will be tested using supervised machine learning algorithms, new region-discovery methods, and cell-mixture inference techniques. Publicly available data (listed above) will be used to infer biological relevance. Second, that epigenome-wide DNA methylation patterns in these samples are representative of SS sub-phenotypes. Cases (and initially controls) will be clustered using principal component analysis (PCA) applied to all relevant DNA methylation probes and subsets of probes measuring CpGs implicated in specific pathways relevant to SS. The reduced representations will be tested for association with specific clinical and serological profiles. Third, that risk alleles identifie by genome-wide association studies (GWAS) are directly or indirectly associated with SS-specific DNA methylation patterns. Allelic dosage and random forest selection frequency (RFSF) analyses will be used to identify novel methylation quantitative trait loci within SS-associated genes in cases and controls (separately), and we will test whether cell-proportion or eQTLs can explain SS-specific methylation patterns.         PUBLIC HEALTH RELEVANCE: Sjgren's Syndrome is a chronic, highly heterogenous, multisystem autoimmune disease predominantly affecting women. This disease is known to be associated with epigenetic changes, including DNA methylation, an axis of epigenetic variation that has been implicated as a mediator of disease risk in other autoimmune diseases. Full characterization of DNA methylation patterns across different cell types and affected tissues will provide new insights into disease etiology, phenotype classification, and targets for future therapeutic strategies.                ",Signals of Epigenetic Modification in Sjogrens Syndrome,8910299,F31DE025176,"['epigenome ', ' abstracting ', ' Affect ', ' Age ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' Inflammatory Arthritis ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' self recognition (immune) ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' C element ', ' Carbon ', ' cell sorting ', ' Cell Separation Technology ', ' Cell Segregation ', ' Cell Isolation ', ' Cell Separation ', ' Cells ', ' Systematics ', ' Classification ', ' 2(1H)-Pyrimidinone, 4-amino- ', ' Cytosine ', ' disease/disorder ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Fellowship ', ' Female ', ' Future ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genome ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' systemic lupus erythematosis ', ' disseminated lupus erythematosus ', ' Systemic SLE - Lupus Erythematosus ', ' Systemic Lupus Erythmatosus ', ' SLE ', ' Lupus Erythematosus Disseminatus ', ' Systemic Lupus Erythematosus ', ' Mentors ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Parents ', ' Patients ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Research Resources ', ' Resources ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' social role ', ' Role ', ' Salivary Glands Head and Neck ', ' Salivary Glands ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' thymus derived lymphocyte ', ' Thymus-Dependent Lymphocytes ', ' T-Cells ', ' T-Lymphocyte ', ' Testing ', ' Body Tissues ', ' Tissues ', ' trans acting factor (genetic) ', ' Transactivators ', ' Trans-Acting Factors ', ' Trans-Activators ', ' transcription factor ', ' Woman ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' Measures ', ' forest ', ' Mediating ', ' Lasso ', ' Dataset ', ' Data Set ', ' base ', ' dosage ', ' Site ', ' Chronic ', ' Clinical ', ' Biological ', ' Serologic ', ' Serological ', ' Logistic Regressions ', ' Link ', ' peripheral blood ', ' insight ', ' European ', ' Therapeutic ', ' Genetic ', ' Staging ', ' Inflammatory ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Frequency ', ' Frequencies (time pattern) ', ' Complex ', ' cell type ', ' Pattern ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Country ', ' disease severity ', ' Severity of illness ', ' QTL ', ' Quantitative Trait Loci ', ' novel ', ' Participant ', ' disease risk ', ' disorder risk ', ' Pathogenesis ', ' inherited factor ', ' genetic risk factor ', ' Sampling ', ' high throughput technology ', ' case control ', ' repository ', ' Genomics ', ' Labial Salivary Gland ', ' histone modification ', ' chromatin remodeling ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Aberrant DNA Methylation ', ' Data ', ' International ', ' F31 Award ', ' Predoctoral Individual National Research Service Award ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Salivary Gland Tissue ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' Population ', ' epigenetic variation ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' Biological Markers ', ' genomewide ', ' genome-wide ', ' ChIP Sequencing ', ' ChIP-seq ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' ']",NIDCR,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2015,38673,CA-13,0.04957654797638651
"Integrating epigenomic maps to predict regulatory functions of genetic variants DESCRIPTION (provided by applicant): Mental illnesses are some of the most devastating diseases affecting human populations, placing a huge burden on individuals, families and society. Genome-wide association studies (GWAS) have identified dozens of common single nucleotide polymorphisms (SNPs) that are associated with psychiatric diseases, but a majority of those SNPs have been mapped to intergenic or intronic regions and are functionally unclassified. Existing software or algorithms only query multiple databases and produce lists of hits without intelligent integration and ignore much of the valuable regulatory information. The overall goal of this proposal is to integrate all available genetic, genomic and epigenomic data to generate a probability-based prediction about a SNP's influence on gene expression level in brain. Our previous studies have shown that psychiatric GWAS signals are enriched with brain eQTL SNPs (eSNPs), and these brain eSNPs are likely to be functional and contribute to disease susceptibilities. We will use SNPs in eQTLs to anchor a chain of evidence incorporating histone marks, conserved sequences, transcription factor binding sites, DNA methylation, accessible chromatins, non-coding RNA, and other data. We will use a machine learning method to predict regulatory SNPs based on known relationships between these epigenetic marks and their target genes, as well as their distinct patterns in genome. We will also use our novel unsupervised deconvolution algorithm to extract cell-type (i.e., neuron vs. non-neuron) specific measures from heterogeneous brain tissue data to improve our predictions. We will use both statistical and experimental methods to validate the predictions. Quantitative PCR and CRISPR-cas9 will be used on induced pluripotent cell lines to compare gene expression levels of alleles of predicted functional SNPs. Both algorithm and predicted functional variants will made public via a website and standalone application. The novel algorithm will significantly improve our understanding of psychiatric disease genetics by uncovering the gene-regulatory functions for disease-associated, non-coding SNPs. PUBLIC HEALTH RELEVANCE: Genome-wide association studies (GWAS) have identified thousands of common SNPs associated with major complex diseases, but the majority of those SNPs are located in non-coding regions, leaving those genetic associations functionally unexplained. Existing functional predication software or algorithms only query some databases without providing statistical or biological integration, and dismiss much valuable regulatory information. We propose to integrate all the available genetic, genomic and epigenomic data and use machine learning to produce a probability-based prediction about a SNP's influence on gene expression levels in brain. We will also use a novel unsupervised deconvolution algorithm to extract cell-type specific measures from heterogeneous brain tissue data to improve our prediction. We will use both statistical and experimental methods to validate the predictions. Both algorithm and predicted functional variants will be made public via a website and standalone application. The novel algorithm will significantly improve our understanding of psychiatric disease genetics by giving those non-coding, disease-associated SNPs meaningful biological functions.",Integrating epigenomic maps to predict regulatory functions of genetic variants,8925886,R01ES024988,"['Affect ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' psychological disorder ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' Biology ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cells ', ' Chromatin ', ' Conserved Sequence ', ' disease/disorder ', ' Disorder ', ' Disease ', ' liability to disease ', ' disease/disorder proneness/risk ', ' Diathesis ', ' Disease susceptibility ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genome ', ' Human Genome ', ' human whole genome ', ' Goals ', ' Health ', ' histocompatibility typing ', ' Tissue Typing ', ' Tissue Crossmatching ', ' Histocompatibility Testing ', ' Histones ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Linkage Disequilibrium ', ' Maps ', ' Methods ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' web based ', ' online computer ', ' On-Line Systems ', ' Online Systems ', ' Play ', ' Probability ', ' Random Selection ', ' Random Allocation ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Societies ', ' computer program/software ', ' Software ', ' Computer software ', ' Testing ', ' Body Tissues ', ' Tissues ', ' transcription factor ', ' Benzoic acid, 4-(((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)amino)carbonyl)- ', ' Am80 ', ' Am 80 ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Left ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Gene Targeting ', ' Biological Function ', ' Biological Process ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Complex ', ' cell type ', ' Pattern ', ' LOINC Axis 4 System ', ' System ', ' Location ', ' brain tissue ', ' interest ', ' Performance ', ' QTL ', ' Quantitative Trait Loci ', ' trait ', ' novel ', ' disease risk ', ' disorder risk ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Coding System ', ' Code ', ' Sampling ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Untranslated RNA ', ' Genomics ', ' histone modification ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' Data ', ' Reproducibility ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Other Genetics ', ' Validation ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' website ', ' web site ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' epigenomics ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' Population ', ' innovative ', ' innovate ', ' innovation ', ' Heritability ', ' iPSC ', ' iPS ', ' induced pluripotent stem cell ', ' genomewide ', ' genome-wide ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' next generation sequencing ', ' Cas nuclease technology ', ' CRISPR/Cas system ', ' CRISPR ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' Software Algorithm ', ' Algorithmic Tools ', ' Algorithmic Software ', ' ']",NIEHS,UNIVERSITY OF ILLINOIS AT CHICAGO,R01,2015,299400,IL-07,0.04683863316642571
"Genome analysis based on the integration of DNA sequence and shape DESCRIPTION (provided by applicant): Current techniques for genome analysis are mainly based on the one-dimensional DNA sequence, comprised of the letters A, C, G, and T. However, proteins recognize DNA as a three-dimensional (3D) object. Nuances in DNA shape at single nucleotide resolution play a crucial role in the binding specificity of transcription facors (TFs), including those involved in embryonic development and human cancer. This project involves the development of a battery of tools for genome analysis, through the integration of information derived from the DNA sequence and the 3D structure of DNA, or ""DNA shape"". The basis for these novel tools is a high- throughput (HT) method for the prediction of multiple features of local DNA shape at the genomic scale. Data will be made available to the community in the UCSC Genome Browser track format through a web server interface. These tools will enable users to analyze the shape of any number or length of DNA sequences, including whole genomes and the effect of DNA methylation. HT shape predictions will be validated based on X-ray crystallography, NMR spectroscopy, and hydroxyl radical cleavage data. Predictions will be combined with ORChID, an ENCODE project that infers DNA minor groove geometry from hydroxyl radical cleavage experiments. The HT method will be used to study how paralogous TFs select different target sites in vivo despite sharing core-binding motifs or having similar binding properties in vitro. To study this question, we will investigate the effect of flanking sequences on multiple structural features of TF binding sites (TFBSs). The initial focus of this study will be homeodomains and basic helix-loop-helix (bHLH) TFs. Other protein families will later be included and used to construct a comprehensive TFBS database that provides shape features for binding motifs derived from JASPAR and other motif databases. Structural effects of single nucleotide polymorphisms (SNPs) will also be analyzed. Some SNPs are associated with deleterious functions, whereas others have no apparent effect. The HT shape prediction method will be used to predict the function of SNPs in non-coding regions based on DNA shape. We will correlate quantitative effects of SNPs on DNA structure with expression quantitative trait loci (eQTLs) and genome-wide association study (GWAS) signals, to develop a predictive tool for the functional effect of SNPs. The HT shape prediction approach will be used to design DNA sequences with different AT/GC contents but similar shapes. The relative contributions of sequence and shape to binding will be tested with analytic models including multiple linear regression (MLR) and support vector regression (SVR). For systems in which the integration of sequence and shape proves advantageous, novel motif finding tools will be developed based on an extended alphabet that combines sequence with informative structural features, selected by machine learning and feature selection approaches. Sequence+shape motifs will be tested by motif scanning, compared to sequence-only motifs, and integrated into the MEME Suite. The goal of this sequence-shape integration is to increase the accuracy of finding in vivo TFBSs in the genome. PUBLIC HEALTH RELEVANCE: Protein-DNA recognition is a critical yet poorly understood component of gene regulation. This proposal will connect the fields of DNA sequence and structure analysis, which so far have been developed in parallel but largely disconnected from each other. Integration of the one-dimensional DNA sequence at a genome-wide scale with the three-dimensional DNA structure at atomic resolution will lead to the development of novel genome analysis tools and will advance our understanding of genome function, leading to fundamentally new insights into the mechanisms of gene regulation and its impact on human disease.",Genome analysis based on the integration of DNA sequence and shape,8795204,R01GM106056,"['Affect ', ' Algorithms ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' Data Analysis ', ' Data Analyses ', ' Thymonuclease ', ' Pancreatic DNase ', ' DNase I ', ' DNA Endonuclease ', ' Deoxyribonuclease I ', ' Deoxyribonucleic Acid ', ' DNA ', ' DNA-Binding Proteins ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Family ', ' Gene Expression Regulation ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Genome ', ' Goals ', ' Health ', ' Modern Man ', ' Man (Taxonomy) ', ' Human ', ' Hybrids ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Linear Regressions ', ' Methods ', ' Protein Methylation ', ' Methylation ', ' Mining ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Nucleotides ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Protein Binding ', ' gene product ', ' Proteins ', ' Publishing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Technology ', ' Testing ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Yeasts ', ' Hydroxyl ', ' Hydroxyl Radical ', ' Measures ', ' Relative ', ' Relative (related person) ', ' DNA Sequence ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Xray Crystallography ', ' X-Ray/Neutron Crystallography ', ' X-Ray Diffraction Crystallography ', ' X Ray Crystallographies ', ' Single Crystal Diffraction ', ' X-Ray Crystallography ', ' Training ', ' insight ', ' data repository ', ' clinical data repository ', ' Electronic Database ', ' Electronic Databank ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Biological Function ', ' Biological Process ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Letters ', ' helix turn helix ', ' helix loop helix ', ' HTH Motifs ', ' HTH DNA Binding Domain ', ' Helix-Turn-Helix Motifs ', ' Basic Helix-Loop-Helix Transcription Factors ', ' Basic Helix-Loop-Helix Protein ', ' Basic HLH Protein ', ' BHLH Protein ', ' Shapes ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Scanning ', ' Techniques ', ' LOINC Axis 4 System ', ' System ', ' Width ', ' Best Practice Analysis ', ' Benchmarking ', ' QTL ', ' Quantitative Trait Loci ', ' Homeo Domain ', ' homeodomain ', ' Base Pairing ', ' Structure ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Modeling ', ' LOINC Axis 2 Property ', ' Property ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectroscopy ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Untranslated RNA ', ' Genomics ', ' Guanine + Cytosine Content ', ' GC Content ', ' GC Composition ', ' G+C Content ', ' G+C Compositions ', ' Guanine + Cytosine Composition ', ' DNA Binding Interaction ', ' DNA Binding ', ' Molecular Interaction ', ' Binding ', ' Binding (Molecular Function) ', ' genetic evolution ', ' Protein Family ', ' Length ', ' Affinity ', ' DNA Structure ', ' Data ', ' DNase-I Footprinting ', ' Minor Groove ', ' Resolution ', ' in vivo ', ' Genome Scan ', ' Validation ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' vector ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' three dimensional structure ', ' computer algorithm ', ' Computational algorithm ', ' human disease ', ' genomewide ', ' genome-wide ', ' flexible ', ' flexibility ', ' ChIP Sequencing ', ' ChIP-seq ', ' ChIP-chip ', ' ChIP-on-chip ', ' genome analysis ', ' Geometry ', ' ']",NIGMS,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2015,304719,CA-37,0.008765299306704591
"Genetic Factors in Keratoconus     DESCRIPTION (provided by applicant): The purpose of this grant is to develop techniques for use in the 'early' detection of keratoconus (KC) and identify genetic variants that contribute to is development. KC is a complex genetic eye disorder and a leading cause of corneal transplantation in the young, with approximately 300,000 affected individuals in the US. Undiagnosed, subclinical KC is one of the major causes for complications of LASIK (Laser-in-situ- Keratomilieusis) surgery, commonly performed for vision correction. In the past two decades we have made major improvements to the early diagnosis of KC and have also made significant contributions to the delineation of major genetic determinants of KC through genome wide linkage studies (GWLS), fine mapping, and genome wide association studies (GWAS). In this proposal, we intend to follow up on these studies using new powerful approaches to achieve the following specific aims: In Aim 1 we will combine corneal optical coherence tomography (OCT) and Pentacam HR Scheimpflug Tomography (PST), new technologies that measure both the anterior and posterior surface of the cornea, with videokeratography (VK), a method which revolutionized KC diagnosis, to characterize criteria and to improve the diagnosis of subclinical KC. In Aim 2, to identify additional KC genes, we will perform a 2.5 million SNP GWAS, with an additional 6,000 SNPs, to fine- map already identified genes. We will confirm these results in a separate cohort of KC patients. For this two- stage GWAS design we are assembling the largest group of KC patients described to date: 2000 KC patients in total, 1,000 for the GWAS discovery stage and 1,000 for the confirmation stage. The controls for GWAS discovery will come from the Cardiovascular Health Study (CHS; 3300) and for confirmation will come from 400 subjects with VK, PST, and OCT measurements under Aim 1 and 600 ""convenience controls"" from the Cholesterol and Pharmacogenetics (CAP) study. In our current state of knowledge, the most cost-effective approach to increase the number of identified KC genes is to proceed with the expanded GWAS proposed herein. In Aim 3, we will test the impact of the genes identified in Aim 2 on the 'early' subclinical phenotypes identified through the use o VK, PST and OCT measures in Aim 1. Lastly, for the second part of Aim 3, we will investigate the potential function of KC variants by testing their ability to influence gene structure, expression and function in corneal cell models, including iPS cells derived from corneal keratocytes developed by our research team. The results of these studies will help advance our understanding of the genetic susceptibility to KC and may result in novel treatment options to slow the progression of the disease.         PUBLIC HEALTH RELEVANCE: Improving methods for the 'early' detection of keratoconus will help patients avoid complications of LASIK surgery, allow us to identify genetic variants that contribute to its development, and design therapies to retard its progression.            ",Genetic Factors in Keratoconus,8817912,R01EY009052,"['Affect ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cells ', ' corneal ', ' Cornea ', ' corneal transplant ', ' corneal keratoplasty ', ' Corneal Transplantation ', ' Corneal Grafting ', ' Cornea Transplantation ', ' Keratoplasty ', ' Diagnosis ', ' Discriminant Analyses ', ' Discriminant Analysis ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Eyeball ', ' Eye ', ' ophthalmopathy ', ' eye disorder ', ' Eye diseases ', ' Genes ', ' Genotype ', ' Grant ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry ', ' indexing ', ' Keratoconus ', ' Laser Radiation ', ' Laser Electromagnetic ', ' Lasers ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' Maps ', ' Methods ', ' Patients ', ' Pharmacogenetics ', ' Phenotype ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Risk ', ' Testing ', ' Time ', ' tomography ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Genetic Variation ', ' Genetic Diversity ', ' Variation (Genetics) ', ' visual function ', ' Sight ', ' Vision ', ' Measures ', ' Relative ', ' Relative (related person) ', ' Family member ', ' Custom ', ' base ', ' improved ', ' Anterior ', ' Surface ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Collaborations ', ' Genetic ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Staging ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Complex ', ' In Situ ', ' Techniques ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Operative Surgical Procedures ', ' early detection ', ' Early Diagnosis ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' cohort ', ' trait ', ' Videokeratography ', ' Videokeratographies ', ' novel ', ' novel technologies ', ' new technology ', ' Pathogenesis ', ' OCT Tomography ', ' Doppler OCT ', ' Optical Coherence Tomography ', ' genetic determinant ', ' Genetic Determinism ', ' Bio-Informatics ', ' Bioinformatics ', ' protein expression ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' therapy design/development ', ' genetic association ', ' Data ', ' Gene Structure/Organization ', ' Gene Organization ', ' Gene Structure ', ' Molecular ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' protein function ', ' developmental ', ' Development ', ' whole-genome scan ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide scan ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome-wide scan ', ' genome-wide identification ', ' genome wide studies ', ' genome wide screen ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' genome wide analysis ', ' GWAS ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' cost-effective ', ' cost effective ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' Cellular model ', ' Cell model ', ' manage cholesterol ', ' cholesterol management ', ' cholesterol control ', ' iPSC ', ' iPS ', ' induced pluripotent stem cell ', ' genomewide linkage ', ' genome-wide linkage ', ' public health relevance ', ' ']",NEI,CEDARS-SINAI MEDICAL CENTER,R01,2015,661520,CA-28,0.03201496200991613
"Toward Diagnostics and Therapies of Molecular Subcategories of CAD     DESCRIPTION (provided by applicant): Coronary artery disease (CAD) is a leading cause of death worldwide and in the US. While the genetics of this disease are intrinsically complex, thanks to huge research investments during the last 5-10 years, particularly in genome-wide association studies (GWAS), a more unbiased, data-driven and realistic view of CAD has been achieved. As part of this achievement, ~160 common risk loci for CAD/myocardial infarction (MI) have been identified. An important task is now to understand the molecular mechanisms/pathways by which these loci exert risk for CAD/MI allowing to translating the initial findings into new therapies and diagnostics. However, since the loci identified thus far explain only ~10% of variation in CAD/MI risk, it is also essential to define additional CAD pathways operating in parallel with GWA loci. In recent years, clinical studies that consider intermediate phenotypes (between DNA and disease) have greatly enhanced interpretations of risk loci identified in GWA datasets. In addition, disease networks that can be identified from intermediate molecular phenotypes provide an essential framework to identify novel CAD pathways and targets for new CAD therapies. Over the last 6 years, we have performed a clinical study considering many intermediate phenotypes in CAD patients (the STARNET study). In this proposal we intend to use newly generated DNA genotype and RNA sequence data from the STARNET study to identify atherosclerosis and metabolic networks underlying CAD. We then propose a new prospective study of CAD (the NGS-PREDICT study) with the main purpose of validating findings from the STARNET study. We hypothesize that the extent and stability of coronary lesions, thus clinical outcomes can be accurately assessed by defining the status of key atherosclerosis gene networks. In turn, metabolic networks active in liver, abdominal fat, and skeletal muscle influence the status of the atherosclerosis gene networks. In addition, molecular data isolated from easily obtainable tissues (e.g., blood, subcutaneous fat and plasma) can be used to identify biomarkers that can predict risk for clinical events caused by CAD. To test these hypotheses, we propose the following specific aims. Aim 1: To identify regulatory Bayesian gene networks causally linked to CAD and/or CAD sub-phenotypes using the STARNET datasets and the CARDIoGRAM meta-analysis GWA datasets. Aim 2: Identify biomarkers predicting clinical events of CAD (reflected in SYNTAX score) by applying machine learning on DNA genotype, RNA sequence and CAD plasma protein data from easily obtainable tissues of the STARNET cases. Aim 3: To validate the identified causal CAD eQTLs/networks and the biomarkers using the NGS-PREDICT study performed at the Mt. Sinai Hospital, the Swedish Twin study and CAD cell and animal models. We believe the proposed studies can lead to a significantly better molecular understanding of CAD and thus, serve the more long-term goal of preventive and personalized therapies of CAD patients diagnosed in well-defined molecular subcategories. PUBLIC HEALTH RELEVANCE:  Coronary artery disease (CAD) is the world's leading cause of death. We will perform systems genetic analysis of DNA and RNAseq data from 9 CAD-relevant tissues in 700 well-characterized patients (STARNET) integrated with genome-wide association data to reveal CAD-causing metabolic and atherosclerosis gene networks, and within these, new inherited risk variants, CAD-mechanisms, therapeutic targets and biomarkers will be identified and validated in a new prospective clinical study of CAD (NGS-PREDICT). Our studies promise to significantly advance understanding of CAD towards achieving preventive and personalized care.",Toward Diagnostics and Therapies of Molecular Subcategories of CAD,9134865,R01HL125863,"['Abdominal ', ' Abdomen ', ' Achievement Attainment ', ' Achievement ', ' Allelomorphs ', ' Alleles ', ' angiographic imaging ', ' Angiogram ', ' Angiography ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' Biology ', ' Biopsy ', ' Blood Reticuloendothelial System ', ' Blood ', ' vascular ', ' Blood Vessels ', ' Cardiology ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' Cause of Death ', ' Clinical Study ', ' Clinical Research ', ' coronary arterial disease ', ' atherosclerotic coronary disease ', ' Coronary Atherosclerosis ', ' Coronary Artery Disorder ', ' Coronary Artery Disease ', ' Coronary Arteriosclerosis ', ' coronary bypass ', ' Coronary Artery Bypass Surgery ', ' Coronary Artery Bypass Grafting ', ' Aortocoronary Bypass ', ' Coronary Artery Bypass ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Engineering ', ' Family ', ' Fats ', ' Fatty acid glycerol esters ', ' Foam Cells ', ' Foundations ', ' Future ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genotype ', ' Goals ', ' Health ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Hospitals ', ' In Vitro ', ' Institutes ', ' Investments ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' hepatic organ system ', ' hepatic body system ', ' Liver ', ' macrophage ', ' Maps ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' Marrow monocyte ', ' Blood monocyte ', ' monocyte ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' Myocardial Infarction ', ' New York ', ' Patients ', ' Phenotype ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Plasma Proteins ', ' Prospective Studies ', ' Reading ', ' recruit ', ' active recruitment ', ' Recruitment Activity ', ' Research ', ' Research Proposals ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' school of medicine ', ' medical college ', ' medical schools ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Twin Multiple Birth ', ' Twins ', ' Weight ', ' Data Set ', ' Dataset ', ' RNA Sequences ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' Lesion ', ' Individual ', ' Voluntary Muscle ', ' Skeletal Muscle ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Twin Studies ', ' Metabolic ', ' Genetic ', ' Diagnostic ', ' Whole Blood ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Hereditary ', ' Inherited ', ' Complex ', ' Event ', ' subcutaneous ', ' Techniques ', ' System ', ' Best Practice Analysis ', ' Benchmarking ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Operative Surgical Procedures ', ' QTL ', ' Quantitative Trait Loci ', ' model organism ', ' Animal Models and Related Studies ', ' Animal Model ', ' trait ', ' novel ', ' disease risk ', ' disorder risk ', ' disorder model ', ' Disease model ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Address ', ' Preventive ', ' Data ', ' Disease Pathway ', ' Subcategory ', ' in vivo Model ', ' Opening of the Thorax ', ' Molecular ', ' Coronary ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' percutaneous coronary intervention ', ' abdominal adiposity ', ' abdominal fat ', ' pathway ', ' Pathway interactions ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' Outcome ', ' prospective ', ' Heritability ', ' Cell model ', ' Cellular model ', ' multidisciplinary ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' therapeutic target ', ' molecular phenotype ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' biological systems ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' clinical risk ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized diagnostics ', ' precision diagnostics ', ' personalized diagnosis ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' personalized care ', ' personalized patient care ', ' individualized patient care ', ' individualized care ', ' Precision care ', ' protein biomarkers ', ' protein markers ', ' Preventive care ', ' Preventative care ', ' Preventive therapy ', ' Preventative therapy ', ' therapeutic biomarker ', ' therapeutic marker ', ' ']",NHLBI,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2016,807678,NY-13,0.02933024705622009
"Fast and Robust Methods for Large Scale Genotype Phenotype Association Study     DESCRIPTION (provided by applicant): A fundamental challenge in life sciences is the characterization of genetic factors that underlie phenotypic differences. Thanks to the advanced sequencing technologies, an enormous amount of genetic variants have been identified and cataloged. Such data hold great potential to understand how genes affect phenotypes and contribute to the susceptibility to environmental stimulus. However, the existing computational methods for analyzing and interpreting the highthroughput genetic data are still in their infancy.    We propose to systematically investigate the computational and statistical principles in modeling and discovering genetic basis of complex phenotypes. The proposed research provides answers to the following fundamental questions in genetic association study: (1) How to effectively and efficiently assess statistical significance of the findings? (2) How to account for the relatedness between samples in genetic association study? (3) How to accurately capture possible interactions between multiple genetic factors and their joint contribution to phenotypic variation? In particular, we will develop data structures and efficient algorithms for accurate and robust significance assessment that account for local population structure and joint effect of multiple genetic factors.    The proposed computational tools will be integrated into software packages under common application framework adopted by the broad scientific community. PUBLIC HEALTH RELEVANCE: A fundamental challenge in life sciences is the characterization of genetic factors that underlie phenotypic differences. Existing methods are not able to adequately address the complexity of high throughput data. Innovative computational models and methods developed in this project will enable scientists more effectively analyze the research data, thus further understanding of human diseases and speed the development diagnostic tools, cures, and therapies.",Fast and Robust Methods for Large Scale Genotype Phenotype Association Study,9272965,R01GM115833,"['Research Institute ', ' Software ', ' Computer software ', ' Technology ', ' Testing ', ' Trees ', ' Measures ', ' base ', ' improved ', ' Area ', ' Variation ', ' Variant ', ' Susceptibility ', ' Predisposition ', ' infantile ', ' infancy ', ' Stimulus ', ' Genetic ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' computer biology ', ' Computational Biology ', ' Catalogs ', ' Scientist ', ' Adopted ', ' Complex ', ' interest ', ' experience ', ' Performance ', ' QTL ', ' Quantitative Trait Loci ', ' trait ', ' Genetic Marker Expression ', ' Speed ', ' Structure ', ' novel ', ' Modeling ', ' Sampling ', ' Property ', ' Bio-Informatics ', ' Bioinformatics ', ' datamining ', ' data mining ', ' genetic association ', ' Address ', ' Data ', ' developmental ', ' Development ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' computational tools ', ' computerized tools ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' human disease ', ' Accounting ', ' Affect ', ' Algorithms ', ' Life Sciences ', ' Bioscience ', ' Biologic Sciences ', ' Biological Sciences ', ' Cataloging ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Foundations ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Health ', ' Information Networks ', ' Articulation ', ' Joints ', ' Maps ', ' Methods ', ' Mining ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Noise ', ' Phenotype ', ' Phylogeny ', ' pilot study ', ' Pilot Projects ', ' Scientific Publication ', ' Publications ', ' Research ', ' ']",NIGMS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2016,85370,CA-33,0.011690470210707378
"Bioinformatics strategies to relate age of onset with gene-gene interaction     DESCRIPTION (provided by applicant):         Time to onset of chronic diseases such as cancer, cardiovascular disease, and diabetes is expected to be influenced by multiple gene-gene interactions that add to the complexity of the genotype-phenotype mapping relationship. Unfortunately, parametric statistical methods such as Cox regression lack sufficient power to detect high-order gene-gene interactions due to the sparseness of the data. Machine learning methods offer a more powerful alternative but rely on computationally-intensive searching methods to identify the top models. We propose here to develop a powerful and computationally efficient bioinformatics strategy that combines machine learning algorithm and Cox regression for identifying gene-gene and gene-environment interaction models that are associated with time of onset of chronic disease. Specifically, we firs propose to develop a novel Robust Survival Multifactor Dimensionality Reduction method (RS-MDR) for the detection of gene-gene interactions in rare variants that influence time of onset of human disease (AIM 1). The power of RS-MDR method will be evaluated by comparing it to other existing methods in simulation studies. We then propose to change the representation space of the gene-gene interaction models using RS-MDR's construction induction method and apply L1 penalized Cox regression to identify a set of interaction models that can predict patients' survival probability (AIM 2). We hypothesize that RS-MDR can effectively identify high order interaction models and the combined approach provides a powerful and computational efficient way to select a set of interaction models. We will use extensive simulations that are derived from GWAS studies to thoroughly evaluate this hypothesis. Next, we will apply the new combined method for detecting and characterizing gene-gene and gene-environment interactions in genome-wide association study (GWAS) data from large population-based studies of lung cancer and rheumatoid arthritis (AIM 3). Results from the real data analysis will be used to refine the method. Finally, we will distribute the proposed method as part of an open- source R software package (AIM 4). We anticipate that the proposed method will combine the strength from both parametric and non-parametric methods and enable detection of interaction models that are jointly affecting time of onset of chronic diseases. This is important because time of onset has more variation than case-control status and it may be more clinically relevant. Furthermore, studies of genetic factors predicting time of onset have not been pursued aggressively using GWAS studies, despite the relevance of this information for the discovery of high risk variants like mutations in BRCA1. Narrative This project will provide a general method for genome data analysis that can be potentially apply to any specific disease. We focus the application of this method on an investigation into the role of genetic polymorphisms in lung cancer and rheumatoid arthritis. This will increase our knowledge of the basic biology and lead for screening and targeted therapy.",Bioinformatics strategies to relate age of onset with gene-gene interaction,9097781,R01LM012012,"['Affect ', ' Algorithms ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' Biology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Europe ', ' Genes ', ' Genome ', ' Genotype ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Methods ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' North America ', ' Patients ', ' Phenotype ', ' polymorphism ', ' Genetic Polymorphism ', ' Probability ', ' Research ', ' Risk ', ' social role ', ' Role ', ' Software ', ' Computer software ', ' Testing ', ' Texas ', ' Time ', ' United Kingdom ', ' base ', ' Variation ', ' Variant ', ' Age of Onset ', ' Link ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Staging ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' brca 1 gene ', ' RNF53 ', ' Hereditary Breast Cancer 1 ', ' Early Onset Gene Breast Cancer 1 ', ' Breast Cancer Type 1 Susceptibility Gene ', ' Breast Cancer 1 Gene ', ' BRCA1 ', ' BRCA1 gene ', ' Investigation ', ' Dimensions ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' gene interaction ', ' simulation ', ' novel ', ' Statistical Methods ', ' Modeling ', ' case control ', ' Gene Position ', ' Gene Arrangement ', ' Gene Order ', ' Bio-Informatics ', ' Bioinformatics ', ' Data ', ' Detection ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' tumor genome ', ' cancer cell genome ', ' cancer genome ', ' clinically relevant ', ' clinical relevance ', ' open source ', ' human disease ', ' high risk ', ' population based ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' screening ', ' rare variant ', ' rare allele ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' Genetic study ', ' learning strategy ', ' learning method ', ' learning activity ', ' survival outcome ', ' ']",NLM,DARTMOUTH COLLEGE,R01,2016,352350,NH-02,0.005155430180847282
"The Neural Mechanisms of Peer Influence on Risky Decision-Making     DESCRIPTION (provided by applicant): Risky behaviors such as smoking, drug and alcohol use, and teenaged sexual intercourse are all heavily influenced by the behaviors of one's peers. While much is known about the neural networks involved in risky decision-making, this research has largely been conducted in the absence of the rich network of social information available when making risky decisions in real-life. Given the large body of evidence suggesting the importance of information about peers' choices when making risky decisions, it is of great public-health relevance to understand how the integration of this information into the risky decision takes place at the neural level, and, particularly, what differences in processing of this information lead some people to be more susceptible to peer influence than others. The proposed research aims to answer these questions by having a sample of 50 14-19 year olds perform a novel real-stakes social gambling task in the scanner. In this task, participants will make choices about a series of risky gambles, on each trial receiving false information about the decisions of four of their friends who previously completed the task. Using the reported percentage of risk acceptance as a parametric modulator, we will identify regions in the brain where BOLD activation encodes information about others' choice behavior. Second, we will calculate a peer susceptibility score for each subject based on their choices in the task, reflecting how much their choices were swayed by the reported actions of others. We will then use a machine-learning based regression technique to generate a spatial pattern of regression weights that can predict each participant's behavioral susceptibility to peer influence. The strength of these regression weights in different areas of the brain reflects how strongly encoding of others' choices in that region predicts individuals' peer susceptibility scores. These data allow us to: 1) Identify patterns of encoding of others' choice information that are most strongly predictive of being highly susceptible to peer influence, and 2) Generate a neurologic signature that can be used in new samples of participants to predict their level of susceptibility to peer influence. We will then compare predictions of peer susceptibility derived from the brain data to patterns of real-world risk-taking of the participant and their peers. We believe that thes findings can set the stage for future work examining developmental changes in these networks, and how responses in these networks can be altered by exposure to different types of peers or by potential interventions designed to reduce susceptibility to peer influence in specific domains. These avenues of research will allow for the accelerated development of more precise and effective intervention strategies to reduce susceptibility to peer influence in the domain of publi-health relevant risk-taking.         PUBLIC HEALTH RELEVANCE: The risky actions of peers strongly influence individuals' risk-taking behavior. This research will examine how information about peers' risky choices are represented in the brain, develop a set of neural markers that can predict the extent to which an individual will be influenced by the actions of their peers, based on their encoding of the peers' choices, and examine relations between these neural markers and susceptibility to peer influence in real-world risk-taking.        ",The Neural Mechanisms of Peer Influence on Risky Decision-Making,9112119,R21HD086375,"['Behavior ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Choice Behavior ', ' Sexual Intercourse ', ' Coitus ', ' Costs and Benefits ', ' Decision Making ', ' Divorced state ', ' Divorce ', ' Economics ', ' Environment ', ' Exercise ', ' Future ', ' Gambling ', ' Health ', ' Laboratories ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Learning ', ' Maps ', ' Neighborhoods ', ' Perception ', ' Public Health ', ' Punishment ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Rewards ', ' Risk ', ' Risk-Taking ', ' social role ', ' Role ', ' Smoking ', ' socioenvironment ', ' social context ', ' social climate ', ' Social Environment ', ' Weight ', ' Work ', ' Friends ', ' Measures ', ' Risk Behaviors ', ' at risk behavior ', ' Risky Behavior ', ' Socioeconomic Status ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Social Network ', ' Workplace ', ' work setting ', ' Worksite ', ' Work-Site ', ' Work Place ', ' Work Location ', ' Job Site ', ' Job Setting ', ' Job Place ', ' Job Location ', ' Prefrontal Cortex ', ' base ', ' Area ', ' Neurological ', ' Neurologic ', ' Series ', ' Link ', ' Susceptibility ', ' Predisposition ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' drug use ', ' Drug usage ', ' Exposure to ', ' Staging ', ' Shapes ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Life ', ' Parietal ', ' Pattern ', ' Techniques ', ' interest ', ' preference ', ' neural network ', ' Biological Neural Networks ', ' neural ', ' relating to nervous system ', ' neuro-imaging ', ' neuroimaging ', ' novel ', ' Participant ', ' peer ', ' member ', ' youth alcohol consumption ', ' underage alcohol use ', ' underage alcohol consumption ', ' under age alcohol use ', ' under age alcohol consumption ', ' teenager alcohol use ', ' teenage drinking ', ' teenage alcohol use ', ' teen drinking ', ' ethanol during adolescence ', ' drinking during adolescence ', ' alcohol use in adolescents ', ' alcohol use in adolescence ', ' alcohol use during adolescence ', ' alcohol use among adolescents ', ' alcohol intake among adolescents ', ' alcohol during adolescence ', ' adolescent drinking ', ' adolescent alcohol use ', ' adolescent alcohol consumption ', ' Youth Drinking ', ' underage drinking ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Reporting ', ' social ', ' Ventral Striatum ', ' Sampling ', ' response ', ' behavioral influence ', ' behavior influence ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' behavioral assessment ', ' Behavior assessment ', ' Brain region ', ' Address ', ' Base of the Brain ', ' Data ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' willingness ', ' Outcome ', ' Adolescent Risk Behavior ', ' risk behavior in youth ', ' adolescent risk taking ', ' Youth Risk Behavior ', ' neuromechanism ', ' neural mechanism ', ' 19 year old ', ' nineteen year old ', ' age 19 years ', ' parental involvement ', ' peer influence ', ' cognitive control ', ' therapy design ', ' treatment design ', ' intervention design ', ' information processing ', ' public health relevance ', ' effective intervention ', ' ']",NICHD,"UNIV OF MARYLAND, COLLEGE PARK",R21,2016,228000,MD-05,0.005911248916360429
"Fast and Robust Methods for Large Scale Genotype Phenotype Association Study     DESCRIPTION (provided by applicant): A fundamental challenge in life sciences is the characterization of genetic factors that underlie phenotypic differences. Thanks to the advanced sequencing technologies, an enormous amount of genetic variants have been identified and cataloged. Such data hold great potential to understand how genes affect phenotypes and contribute to the susceptibility to environmental stimulus. However, the existing computational methods for analyzing and interpreting the highthroughput genetic data are still in their infancy.    We propose to systematically investigate the computational and statistical principles in modeling and discovering genetic basis of complex phenotypes. The proposed research provides answers to the following fundamental questions in genetic association study: (1) How to effectively and efficiently assess statistical significance of the findings? (2) How to account for the relatedness between samples in genetic association study? (3) How to accurately capture possible interactions between multiple genetic factors and their joint contribution to phenotypic variation? In particular, we will develop data structures and efficient algorithms for accurate and robust significance assessment that account for local population structure and joint effect of multiple genetic factors.    The proposed computational tools will be integrated into software packages under common application framework adopted by the broad scientific community. PUBLIC HEALTH RELEVANCE: A fundamental challenge in life sciences is the characterization of genetic factors that underlie phenotypic differences. Existing methods are not able to adequately address the complexity of high throughput data. Innovative computational models and methods developed in this project will enable scientists more effectively analyze the research data, thus further understanding of human diseases and speed the development diagnostic tools, cures, and therapies.",Fast and Robust Methods for Large Scale Genotype Phenotype Association Study,9144814,R01GM115833,"['Accounting ', ' Affect ', ' Algorithms ', ' Life Sciences ', ' Bioscience ', ' Biologic Sciences ', ' Biological Sciences ', ' Cataloging ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Foundations ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Health ', ' Information Networks ', ' Articulation ', ' Joints ', ' Maps ', ' Methods ', ' Mining ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' Noise ', ' Phenotype ', ' Phylogeny ', ' pilot study ', ' Pilot Projects ', ' Scientific Publication ', ' Publications ', ' Research ', ' Research Institute ', ' Software ', ' Computer software ', ' Technology ', ' Testing ', ' Trees ', ' Measures ', ' base ', ' improved ', ' Area ', ' Variation ', ' Variant ', ' Susceptibility ', ' Predisposition ', ' infantile ', ' infancy ', ' Stimulus ', ' Genetic ', ' tool ', ' Diagnostic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' computer biology ', ' Computational Biology ', ' Catalogs ', ' Scientist ', ' Adopted ', ' Complex ', ' interest ', ' experience ', ' Performance ', ' QTL ', ' Quantitative Trait Loci ', ' trait ', ' Genetic Marker Expression ', ' Speed ', ' Structure ', ' novel ', ' Modeling ', ' Sampling ', ' Property ', ' Bio-Informatics ', ' Bioinformatics ', ' datamining ', ' data mining ', ' genetic association ', ' Address ', ' Data ', ' developmental ', ' Development ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' computational tools ', ' computerized tools ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' human disease ', ' ']",NIGMS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2016,278157,CA-33,0.011690470210707378
"Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia     DESCRIPTION (provided by applicant): Schizophrenia (SZ) represents a significant and costly public health burden. Recently, we have witnessed the emergence of the first molecular insights into the etiopathogenic mechanisms of SZ, via the first genome-wide association studies (GWAS) with sufficient case-control sample sizes to detect allelic effects. Importantly, a polygenic signature, which includes genome-wide significant common genetic variants of small effect, has been clearly demonstrated to influence SZ risk. The availability of well-defined risk factors makes it possible, for the first time, to address several critical questions about the genetic architecture of SZ and its component phenotypes and endophenotypes. The overarching goals of this K01 proposal are 1) to test polygenic risk score prediction of dimensional SZ and schizotypy phenotypes across large case, high-density SZ pedigree, and prodromal-aged GWAS samples, and 2) to develop and test, with leaders of the Psychiatric Genomics Consortium, innovative statistical methods to identify and characterize ""genetic subtypes"" of SZ.  This proposal delineates a series of training and research goals for the candidate that incorporates strengths from phenotypic assessment, statistical genetics, and molecular genetics and combines samples reflecting a broad range of genetic risk. The candidate will capitalize on previously established expertise in schizotypy and clinical risk assessment, as well as expertise in the familial transmission of dimensional traits, to establish a program of translational research wherein the application of statistical genetic/bioinformatic techniques to genetic subtyping analyses will be used to generate promising candidates for further exploration in human genomic data. Empirically-based genetic subtyping methods will be developed and tested in the largest SZ case sample to date, and subtypes will be characterized with respect to dimensional phenotypic traits. Top loci hits in subtype analyses of dimensional symptoms will be validated in secondary analyses of differential gene expression in post-mortem SZ brain. This will allow for a detailed analysis of function at both the SNP and gene levels, and will provide the candidate with substantive training in both statistical and molecular genetics methods. The institutional environment is ideal for the candidate's goal of developing a comprehensive program in SZ research, and the proposed research represents an important contribution toward advancing the understanding of SZ through a combination of clinical, statistical, molecular, and translational methods, consistent with the mission of the NIMH.         PUBLIC HEALTH RELEVANCE: Mental illnesses such as schizophrenia constitute 13% of the global burden of disease and schizophrenia, although relatively rare, is highly heritable (80%) and one of the most severe mental disorders. This project aims to elucidate the influence of genetic factors and gene function on dimensional schizophrenia and schizotypy symptoms with multiple measures, across multiple samples of varying genetic risk. Insights gained from this research will inform prediction, prevention, intervention, and treatment efforts by clarifying the biological mechanisms underlying SZ symptoms.        ",Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia,9284856,K01MH109765,"['Students ', ' suicidal attempt ', ' non fatal attempt ', ' Suicide attempt ', ' Testing ', ' Time ', ' Trees ', ' Wisconsin ', ' Measures ', ' Molecular Genetics ', ' Risk Assessment ', ' Prefrontal Cortex ', ' base ', ' density ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Series ', ' Age of Onset ', ' Training ', ' insight ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Measurement ', ' Sample Size ', ' Genetic Heterogeneity ', ' Collaborations ', ' Genetic ', ' gene function ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Dimensions ', ' Complex ', ' Techniques ', ' brain tissue ', ' brain control ', ' mind control ', ' Performance ', ' trait ', ' Structure ', ' novel ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' response ', ' theories ', ' case control ', ' disease subtype ', ' disorder subtype ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' ovarian cancer ', ' Ovary Cancer ', ' Malignant Tumor of the Ovary ', ' Malignant Ovarian Tumor ', ' Malignant Ovarian Neoplasm ', ' Malignant neoplasm of ovary ', ' Bio-Informatics ', ' Bioinformatics ', ' Address ', ' Symptoms ', ' Applied Genetics ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' Research Training ', ' Stratification ', ' Subgroup ', ' Genetic Risk ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' Transcript ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Validation ', ' Transmission ', ' transmission process ', ' Molecular ', ' Process ', ' sex ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' severe mental illness ', ' Outcome ', ' Population ', ' aged ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' endophenotype ', ' public health relevance ', ' genome-wide ', ' genomewide ', ' genome scale ', ' cocaine use ', ' clinical risk ', ' Research Domain Criteria ', ' RDoC ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' marijuana use ', ' cannabis use ', ' training opportunity ', ' genomic data ', ' symptomatology ', ' substance misuse ', ' Accounting ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Engineering / Architecture ', ' Architecture ', ' postmortem ', ' necropsy ', ' Autopsy ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' Systematics ', ' Classification ', ' Disorder ', ' Disease ', ' Environment ', ' Gene Expression ', ' Genes ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Mentors ', ' Methods ', ' Mission ', ' NIMH ', ' National Institute of Mental Health ', ' Nicotine ', ' pedigree structure ', ' Pedigree ', ' genetic pedigree ', ' Personality ', ' Phenotype ', ' polymorphism ', ' Genetic Polymorphism ', ' psychotic illness ', ' Psychoses ', ' Psychotic Disorders ', ' Public Health ', ' Questionnaires ', ' Research ', ' Risk ', ' Risk Factors ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' schizotypal ', ' Schizotypal Personality Disorder ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' ']",NIMH,UNIVERSITY OF UTAH,K01,2016,133475,UT-02,0.029512319638808373
"Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia     DESCRIPTION (provided by applicant): Schizophrenia (SZ) represents a significant and costly public health burden. Recently, we have witnessed the emergence of the first molecular insights into the etiopathogenic mechanisms of SZ, via the first genome-wide association studies (GWAS) with sufficient case-control sample sizes to detect allelic effects. Importantly, a polygenic signature, which includes genome-wide significant common genetic variants of small effect, has been clearly demonstrated to influence SZ risk. The availability of well-defined risk factors makes it possible, for the first time, to address several critical questions about the genetic architecture of SZ and its component phenotypes and endophenotypes. The overarching goals of this K01 proposal are 1) to test polygenic risk score prediction of dimensional SZ and schizotypy phenotypes across large case, high-density SZ pedigree, and prodromal-aged GWAS samples, and 2) to develop and test, with leaders of the Psychiatric Genomics Consortium, innovative statistical methods to identify and characterize ""genetic subtypes"" of SZ.  This proposal delineates a series of training and research goals for the candidate that incorporates strengths from phenotypic assessment, statistical genetics, and molecular genetics and combines samples reflecting a broad range of genetic risk. The candidate will capitalize on previously established expertise in schizotypy and clinical risk assessment, as well as expertise in the familial transmission of dimensional traits, to establish a program of translational research wherein the application of statistical genetic/bioinformatic techniques to genetic subtyping analyses will be used to generate promising candidates for further exploration in human genomic data. Empirically-based genetic subtyping methods will be developed and tested in the largest SZ case sample to date, and subtypes will be characterized with respect to dimensional phenotypic traits. Top loci hits in subtype analyses of dimensional symptoms will be validated in secondary analyses of differential gene expression in post-mortem SZ brain. This will allow for a detailed analysis of function at both the SNP and gene levels, and will provide the candidate with substantive training in both statistical and molecular genetics methods. The institutional environment is ideal for the candidate's goal of developing a comprehensive program in SZ research, and the proposed research represents an important contribution toward advancing the understanding of SZ through a combination of clinical, statistical, molecular, and translational methods, consistent with the mission of the NIMH.         PUBLIC HEALTH RELEVANCE: Mental illnesses such as schizophrenia constitute 13% of the global burden of disease and schizophrenia, although relatively rare, is highly heritable (80%) and one of the most severe mental disorders. This project aims to elucidate the influence of genetic factors and gene function on dimensional schizophrenia and schizotypy symptoms with multiple measures, across multiple samples of varying genetic risk. Insights gained from this research will inform prediction, prevention, intervention, and treatment efforts by clarifying the biological mechanisms underlying SZ symptoms.        ",Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia,9088679,K01MH109765,"['Accounting ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Engineering / Architecture ', ' Architecture ', ' postmortem ', ' necropsy ', ' Autopsy ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' Systematics ', ' Classification ', ' Disorder ', ' Disease ', ' Environment ', ' Gene Expression ', ' Genes ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Mentors ', ' Methods ', ' Mission ', ' NIMH ', ' National Institute of Mental Health ', ' Nicotine ', ' pedigree structure ', ' Pedigree ', ' genetic pedigree ', ' Personality ', ' Phenotype ', ' polymorphism ', ' Genetic Polymorphism ', ' psychotic illness ', ' Psychoses ', ' Psychotic Disorders ', ' Public Health ', ' Questionnaires ', ' Research ', ' Risk ', ' Risk Factors ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' schizotypal ', ' Schizotypal Personality Disorder ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Students ', ' suicidal attempt ', ' non fatal attempt ', ' Suicide attempt ', ' Testing ', ' Time ', ' Trees ', ' Wisconsin ', ' Measures ', ' Molecular Genetics ', ' Risk Assessment ', ' Prefrontal Cortex ', ' base ', ' density ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Series ', ' Age of Onset ', ' Training ', ' insight ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Measurement ', ' Sample Size ', ' Genetic Heterogeneity ', ' Collaborations ', ' Genetic ', ' gene function ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' programs ', ' Dimensions ', ' Complex ', ' Techniques ', ' brain tissue ', ' brain control ', ' mind control ', ' Performance ', ' trait ', ' Structure ', ' novel ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' response ', ' theories ', ' case control ', ' disease subtype ', ' disorder subtype ', ' Genomics ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' ovarian cancer ', ' Ovary Cancer ', ' Malignant Tumor of the Ovary ', ' Malignant Ovarian Tumor ', ' Malignant Ovarian Neoplasm ', ' Malignant neoplasm of ovary ', ' Bio-Informatics ', ' Bioinformatics ', ' Address ', ' Symptoms ', ' Applied Genetics ', ' Data ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Preventive Intervention ', ' Research Training ', ' Stratification ', ' Subgroup ', ' Genetic Risk ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' Transcript ', ' translation research enterprise ', ' translation research ', ' Translational Science ', ' Translational Research Enterprise ', ' Translational Research ', ' Validation ', ' Transmission ', ' transmission process ', ' Molecular ', ' Process ', ' sex ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' severe mental illness ', ' Outcome ', ' Population ', ' aged ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' endophenotype ', ' public health relevance ', ' genome-wide ', ' genomewide ', ' genome scale ', ' cocaine use ', ' clinical risk ', ' Research Domain Criteria ', ' RDoC ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' marijuana use ', ' cannabis use ', ' training opportunity ', ' genomic data ', ' symptomatology ', ' substance misuse ', ' ']",NIMH,VIRGINIA COMMONWEALTH UNIVERSITY,K01,2016,27464,VA-04,0.029512319638808373
"Genetic and epigenetic contributions to Sjogren's syndrome DESCRIPTION (provided by applicant): High throughput whole genome platforms to quantitatively and efficiently assay human DNA methylation provide an extraordinary opportunity to accelerate progress in the identification of epigenetic mechanisms for complex human autoimmune diseases such as Sjogren's Syndrome (SS). Epigenetic modifications, such as methylation of the 5' carbon of cytosine which occurs in the context of CpG dinucleotides, do not affect the genetic sequence; however, they do play a critical role in transcriptional regulation of a gene and subsequent gene expression. We have applied this technology, in conjunction with whole genome SNP genotyping to a clinically well-characterized collection of SS cases and controls developed specifically for genetic and epigenetic studies. Samples from the Sjogren's International Collaborative Clinical Alliance (SICCA) repository (total n=3,500 individuals) will b utilized, given the careful phenotype characterization and standardized collection of biospecimens that has been performed for each participant. For this proposal, we have initially obtained DNA from peripheral blood mononuclear cells (PBMCs) and sorted cell populations with high purity, including CD14+ monocytes, CD19+ B cells, CD4+ T cells, as well as labial salivary gland biopsy tissue from 120 SICCA participants (100 SS cases and 20 controls). Data collected for ~450,000 highly informative CpG sites spanning 22,000 genes across the genome will provide a comprehensive assessment of DNA methylation for each individual for our proposed study Aims. As part of Aim 1, DNA methylation profiles will be examined using three main approaches: 1) Global DNA methylation profiles will be analyzed for association with SS risk in all sample types; 2) Multidimensional scaling analysis (MDS) and principal components analysis (PCA) will be performed to determine whether SS case samples can be distinguished from control samples; and 3) Local analyses will also be performed and will focus specifically on DNA methylation changes within candidate SS genes and genes demonstrating at least 1.5 fold methylation differences between cases and controls. Our proposal will take advantage of available whole genome data for each study participant and results from the largest genome wide association study (GWAS) in SS. In Aim 2, we will utilize DNA methylation profiles and methods from Aim 1 to determine whether important SS case phenotypes can be distinguished from one another. We will identify top ranked CpG sites that are either hypo or hyper methylated in specific SS case groups or that distinguish cases from controls using supervised machine learning algorithms. We will attempt replication for all top findings in an independent dataset, followed by random effects meta-analysis to incorporate other SS risk factors. Finally, we will determine whether DNA methylation profiles of interest from Aims 1 and 2 can be detected in DNA from whole blood for potential use as a biomarker. The identification of unique epigenetic profiles in SS, and an understanding of these profiles in the context of different cell and tissue types and genetic background have the potential to significantly transform our understanding of SS etiology. PUBLIC HEALTH RELEVANCE New molecular genetic assays offer an extraordinary opportunity to accelerate progress in the identification of epigenetic mechanisms for complex human autoimmune diseases such as Sjogren's Syndrome (SS). We propose to perform a comprehensive screen of more than 450,000 highly informative CpG sites spanning 22,000 genes across the genome using DNA derived from peripheral blood mononuclear cells (PBMCs), sorted cell populations, and labial salivary gland biopsy tissue from SS cases and control individuals to identify epigenetic profiles that are predictive of disease risk and specifi clinical phenotypes. The identification of unique epigenetic profiles in SS, and an understanding of these profiles in the context of several different cell and tissue types and whole genome SNP data have the potential to significantly transform our understanding of SS etiology, and may lead to more effective approaches to prevention, diagnosis and treatment.",Genetic and epigenetic contributions to Sjogren's syndrome,8991063,R03DE024316,"['Affect ', ' Algorithms ', ' self reactive antibody ', ' autoimmune antibody ', ' Autoantibodies ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' Blood Reticuloendothelial System ', ' Blood ', ' Budgets ', ' C element ', ' Carbon ', ' cell sorting ', ' Cell Separation Technology ', ' Cell Segregation ', ' Cell Isolation ', ' Cell Separation ', ' Cell Body ', ' Cells ', ' Cytosine ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Diagnosis ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Gene Expression ', ' Genes ', ' Genome ', ' Genotype ', ' Health ', ' histocompatibility typing ', ' Tissue Typing ', ' Tissue Crossmatching ', ' Histocompatibility Testing ', ' Modern Man ', ' Human ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Methods ', ' Methodology ', ' Methylation ', ' Marrow monocyte ', ' Blood monocyte ', ' monocyte ', ' Patients ', ' Phenotype ', ' Play ', ' Production ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' San Francisco ', ' Syndrome ', ' helper T cell ', ' T4 Lymphocytes ', ' T4 Cells ', ' CD4-Positive Lymphocytes ', ' CD4+ T-Lymphocyte ', ' CD4+ T cell ', ' CD4 lymphocyte ', ' CD4 T cells ', ' CD4 Cells ', ' CD4 Positive T Lymphocytes ', ' Technology ', ' Body Tissues ', ' Tissues ', ' Work ', ' CpG dinucleotide ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' T-Lymphocyte Subsets ', ' T-Cell Subsets ', ' Molecular Genetics ', ' Data Set ', ' Dataset ', ' base ', ' Blood Sample ', ' Blood specimen ', ' Site ', ' Clinical ', ' Individual ', ' European ', ' Sample Size ', ' Research Projects ', ' Research Grants ', ' R01 Program ', ' R01 Mechanism ', ' R-Series Research Projects ', ' Research Project Grants ', ' Genetic ', ' Whole Blood ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Complex ', ' Oral ', ' cell type ', ' Country ', ' interest ', ' PBMC ', ' Peripheral Blood Mononuclear Cell ', ' Participant ', ' member ', ' Study Subject ', ' disease risk ', ' disorder risk ', ' Modeling ', ' Sampling ', ' high throughput technology ', ' case control ', ' repository ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Meta-Analysis ', ' Labial Salivary Gland ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' CD14 ', ' CD14 gene ', ' CD19 ', ' CD19 gene ', ' Data ', ' International ', ' National Institute of Dental Research ', ' NIDR ', ' NIDCR ', ' National Institute of Dental and Craniofacial Research ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' clinical phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' SNP genotyping ', ' Prevention approach ', ' Approaches to prevention ', ' Population ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' human DNA ', ' systemic autoimmune disease ', ' systemic autoimmune disorder ', ' whole genome ', ' entire genome ', ' ']",NIDCR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R03,2016,237102,CA-12,0.03129507124967038
"Genetic Susceptibility and Risk Model for Pancreatic Cancer DESCRIPTION (provided by applicant): Pancreatic cancer (PanC) is the fourth leading cause of cancer-related death for both men and women in the U.S. Better understanding of the etiology and developing risk prediction models for early detection and prevention are urgently needed for this rapidly fatal disease. The majority of PanC are caused by the interplay of both genetic and environmental factors. Known risk factors for PanC include cigarette smoking, obesity, long-term type II diabetes, and family history. In addition, our previous case-control study has shown that excess body mass index (BMI) in young adulthood confers a higher risk of PanC than weight gain at later age. Recent genome-wide association studies (GWAS) have identified several chromosomal regions and genes in association with risk of PanC (PanScan). Our pathway analyses of the PanScan GWAS data have uncovered several novel biological pathways associated with the risk for PanC. However, it remains unknown how environmental or host risk factors modify the association between genetic factors and the PanC risk, which knowledge is critical to better understanding of the etiology and developing a risk prediction model and early intervention strategies for PanC. The goal of this project is to identify gene-environment interactions and develop and validate a risk prediction model including both common and rare genetic variants using the PanScan GWAS data and the exposure information of over 2,200 case-control pairs and an ongoing ExomeChip-based study of PanC genotyping both common SNPs and >240,000 rare functional exonic variants in over 4,100 cases and 4,700 controls from six case-control studies in the Pancreatic Cancer Case Control Consortium (PanC4) and a nested case-control study from Europe (EPIC). We will validate the absolute risk prediction model in two large prospective cohorts: the Atherosclerosis Risk in Communities (ARIC) cohort of 15,000 individuals and the Kaiser Permanente cohort of 100,000 individuals. We will also develop novel statistical methods to identify genes modifying the association between changing BMI at different age periods and PanC risk using the unique dataset from a case-control study of PanC conducted at MD Anderson Cancer Center. Our proposed project hinges on novel integration of GWAS, ExomeChip, exposure data of a large number of PanC cases and controls, recently developed powerful statistical methods and analysis strategies for detecting genome-wide gene/pathway-environment interactions and polygenic approaches to genetic risk prediction. The work proposed here is expected not only to advance our understanding of the etiology of PanC and delineate how genes and lifestyle or host factors modify the risk of PanC, but also to greatly facilitate identification of high-risk individuals, and thus, contribute to early detection, improved survival and prevention of PanC. The novel statistical methods developed here are also applicable to other cancers and complex disease, and we will develop user-friendly software packages for public use. PUBLIC HEALTH RELEVANCE: Over 43,900 new cases of pancreatic cancer are expected to occur in the US in 2012, almost all rapidly fatal. This project will not only advance our understanding of the etiology of pancreatic cancer and delineate how genes and lifestyle or host factors modify the risk of pancreatic cancer, but also will facilitate identification of high-risk individuals, and thus, contribute to early detection, prevention, and improved survival of pancreatic cancer. The novel statistical methods developed here are also applicable to other cancers and complex disease, and we will develop user-friendly software packages for public use.",Genetic Susceptibility and Risk Model for Pancreatic Cancer,9059046,R01CA169122,"['Age ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Communities ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Death ', ' Cessation of life ', ' diabetes ', ' Diabetes Mellitus ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Environment ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Europe ', ' Family ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' History ', ' Recording of previous events ', "" men's "", ' men ', ' Nested Case-Control Study ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Risk ', ' Risk Factors ', ' Smoking ', ' Survival Rate ', ' Weight Gain ', ' wt gain ', ' body weight increase ', ' body weight gain ', ' Weight Increase ', ' Woman ', ' Work ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Logistic Regressions ', ' Training ', ' Individual ', ' young adulthood ', ' adult youth ', ' young adult ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Early Intervention ', ' Host Factor Protein ', ' Host Factor ', ' Integration Host Factors ', ' Genetic ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Pancreatic Cancer ', ' Pancreas Cancer ', ' Malignant Pancreatic Neoplasm ', ' Malignant neoplasm of pancreas ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Complex ', ' Techniques ', ' cancer risk ', ' early detection ', ' Early Diagnosis ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' user friendly computer software ', ' user friendly software ', ' cohort ', ' novel ', ' environmental risk ', ' Environmental Factor ', ' Environmental Risk Factor ', ' Prevention ', ' smoke cigarette ', ' cigarette smoking ', ' Statistical Methods ', ' Modeling ', ' case control ', ' interventional strategy ', ' Intervention Strategies ', ' Intervention ', ' cancer diagnosis ', ' Quetelet index ', ' BMI z-score ', ' BMI percentile ', ' Body mass index ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Data ', ' Cancer Center ', ' Cancer Cause ', ' Cancer Etiology ', ' enroll ', ' Enrollment ', ' gene modification ', ' Gene-Modified ', ' Genetic Risk ', ' lifestyle factors ', ' Validation ', ' pathway ', ' Pathway interactions ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' prospective ', ' high risk ', ' treatment strategy ', ' effective therapy ', ' effective treatment ', ' genome-wide ', ' genomewide ', ' genome scale ', ' ']",NCI,UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON,R01,2016,27681,TX-09,0.02751486730525421
"Signals of Epigenetic Modification in Sjogrens Syndrome     DESCRIPTION (provided by applicant): The objective of the project is to characterize the potential role of DNA methylation patterns in Sjgren's Syndrome (SS) disease etiology and mechanism. A growing body of evidence indicates that epigenetic changes, in particular, altered patterns of DNA methylation, contribute to the development of autoimmune disease and can mediate genetic risk factors. To date, aberrant DNA methylation has been associated with several human autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. My proposal focuses on the identification of unique epigenetic profiles in SS, focusing primarily on T cells, B cells, and salivary gland tissue, a primary site of the inflammatory disease. An understanding of these profiles in the context of genetic background, publicly available genomic data (RNA, ChIP-seq, WGBS) and annotation data (TF binding motifs, genomic QTLs), and cell types have the potential to significantly transform our understanding of SS etiology, particularly given the well-established heterogeneity in clinical manifestations. Further, these DNA methylation profiles could become useful clinical biomarkers for determining risk and prognosis in SS, especially if their biological relevance can be validated in future functional studies. The overall hypothesis of this project is that DNA methylation changes in key genomic regions are associated with SS status and phenotype. The project will use genome-wide SNP data, epigenome-wide methylation array data, and clinical characteristics abstracted from 100 SS cases and 20 controls to address 3 related hypotheses: First, that epigenome-wide DNA methylation patterns in T cells, B cells (both derived from peripheral blood), and salivary gland biopsy tissue are associated with primary SS status after correcting for cell-type heterogeneity. Case-control differences will be tested using supervised machine learning algorithms, new region-discovery methods, and cell-mixture inference techniques. Publicly available data (listed above) will be used to infer biological relevance. Second, that epigenome-wide DNA methylation patterns in these samples are representative of SS sub-phenotypes. Cases (and initially controls) will be clustered using principal component analysis (PCA) applied to all relevant DNA methylation probes and subsets of probes measuring CpGs implicated in specific pathways relevant to SS. The reduced representations will be tested for association with specific clinical and serological profiles. Third, that risk alleles identifie by genome-wide association studies (GWAS) are directly or indirectly associated with SS-specific DNA methylation patterns. Allelic dosage and random forest selection frequency (RFSF) analyses will be used to identify novel methylation quantitative trait loci within SS-associated genes in cases and controls (separately), and we will test whether cell-proportion or eQTLs can explain SS-specific methylation patterns.         PUBLIC HEALTH RELEVANCE: Sjgren's Syndrome is a chronic, highly heterogenous, multisystem autoimmune disease predominantly affecting women. This disease is known to be associated with epigenetic changes, including DNA methylation, an axis of epigenetic variation that has been implicated as a mediator of disease risk in other autoimmune diseases. Full characterization of DNA methylation patterns across different cell types and affected tissues will provide new insights into disease etiology, phenotype classification, and targets for future therapeutic strategies.                ",Signals of Epigenetic Modification in Sjogrens Syndrome,9038173,F31DE025176,"['abstracting ', ' Affect ', ' Age ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' autoimmune disorder ', ' Autoimmune Diseases ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-Cells ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' C element ', ' Carbon ', ' cell sorting ', ' Cell Separation Technology ', ' Cell Segregation ', ' Cell Isolation ', ' Cell Separation ', ' Cell Body ', ' Cells ', ' Systematics ', ' Classification ', ' Cytosine ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Fellowship ', ' Female ', ' Future ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' systemic lupus erythematosis ', ' disseminated lupus erythematosus ', ' Systemic SLE - Lupus Erythematosus ', ' Systemic Lupus Erythmatosus ', ' SLE ', ' Lupus Erythematosus Disseminatus ', ' Systemic Lupus Erythematosus ', ' Mentors ', ' Methods ', ' Methylation ', ' Parents ', ' Patients ', ' Phenotype ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Research Resources ', ' Resources ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' social role ', ' Role ', ' Salivary Glands Head and Neck ', ' Salivary Glands ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' thymus derived lymphocyte ', ' Thymus-Dependent Lymphocytes ', ' T-Cells ', ' T-Lymphocyte ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transactivators ', ' Trans-Acting Factors ', ' Trans-Activators ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Woman ', ' Work ', ' CpG dinucleotide ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' Measures ', ' forest ', ' Mediating ', ' Lasso ', ' Data Set ', ' Dataset ', ' base ', ' dosage ', ' Site ', ' Chronic ', ' Clinical ', ' Biological ', ' Serologic ', ' Serological ', ' Logistic Regressions ', ' Link ', ' peripheral blood ', ' insight ', ' European ', ' Therapeutic ', ' Genetic ', ' Staging ', ' Inflammatory ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Principal Component Analyses ', ' Principal Component Analysis ', ' Frequencies ', ' Complex ', ' cell type ', ' Pattern ', ' Techniques ', ' System ', ' Country ', ' disease severity ', ' Severity of illness ', ' QTL ', ' Quantitative Trait Loci ', ' novel ', ' Participant ', ' disease risk ', ' disorder risk ', ' Pathogenesis ', ' inherited factor ', ' genetic risk factor ', ' Sampling ', ' high throughput technology ', ' case control ', ' repository ', ' Genomics ', ' Labial Salivary Gland ', ' histone modification ', ' chromatin remodeling ', ' Transcriptional Control ', ' Transcription Regulation ', ' Transcriptional Regulation ', ' Molecular Interaction ', ' Binding ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Mediator of Activation ', ' Mediator ', ' Mediator of activation protein ', ' Address ', ' Aberrant DNA Methylation ', ' Data ', ' NIH National Research Service Award for Individual ', ' Individual National Research Service Award ', ' International ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Salivary Gland Tissue ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' Population ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' epigenetic variation ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' epigenome ', ' methylation pattern ', ' bead chip ', ' BeadChip ', ' epigenome-wide association studies ', ' epigenome wide association analysis ', ' EWAS ', ' clinical biomarkers ', ' clinically useful biomarkers ', ' disease heterogeneity ', ' whole genome ', ' entire genome ', ' genomic data ', ' ']",NIDCR,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2016,39129,CA-13,0.04957654797638651
"Data-Driven Statistical Learning with Applications to Genomics DESCRIPTION (provided by applicant): This project involves the development of statistical and computational methods for the analysis of high throughput biological data. Effective methods for analyzing this data must balance two opposing ideals. They must be (a) flexible and sufficiently data-adaptive to deal with the data's complex structure, yet (b) sufficiently simpe and transparent to interpret their results and analyze their uncertainty (so as not to mislead with conviction). This is additionally challenging because these datasets are massive, so attacking these problems requires a marriage of statistical and computational ideas. This project develops frameworks for attacking several problems involving this biological data. These frameworks balance flexibility and simplicity and are computationally tractable even on massive datasets. This application has three specific aims. Aim 1: A flexible and computationally tractable framework for building predictive models. Commonly we are interested in modelling phenotypic traits of an individual using omics data. We would like to find a small subset of genetic features which are important in phenotype expression level. In this approach, I propose a method for flexibly modelling a response variable (e.g. phenotype) with a small, adaptively chosen subset of features, in a computationally scalable fashion. Aim 2: A framework for jointly identifying and testing regions which differ across conditions. For example, in the context of methylation data measured in normal and cancer tissue samples, one might expect that some regions are more methylated in one tissue type or the other. These regions might suggest targets for therapy. However, we do not have the background biological knowledge to pre-specify regions to test. I propose an approach which adaptively selects regions and then tests them in a principled way. This approach is based on a convex formulation to the problem, using shrinkage to achieve sparse differences. Aim 3: A principled framework for developing and evaluating predictive biomarkers during clinical trials. Modern treatments target specific genetic abnormalities that are generally present in only a subset of patients with a disease. A major current goal in medicine is to develop biomarkers that identify those patients likely to benefit from treatment. I propose a framework for developing and testing biomarkers during large-scale clinical trials. This framework simultaneously builds these biomarkers and applies them to restrict enrollment into the trial to only those likely to benefit from treatment. The statistical tools that result from th proposed research will be implemented in freely available software. PUBLIC HEALTH RELEVANCE: Recent advances in high-throughput biotechnology have provided us with a wealth of new biological data, a large step towards unlocking the tantalizing promise of personalized medicine: the tailoring of treatment to the genetic makeup of each individual and disease. However, classical statistical and computational tools have proven unable to exploit the extensive information these new experimental technologies bring to bear. This project focuses on building new flexible, data-adaptive tools to translate this wealth of low level information into actionable discoveries, and actual biological understanding.",Data-Driven Statistical Learning with Applications to Genomics,9135552,DP5OD019820,"['Accounting ', ' bear ', ' Ursidae ', ' Bears ', ' Ursidae Family ', ' Biology ', ' Biotech ', ' Biotechnology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Clinical Trials ', ' Computers ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Disorder ', ' Disease ', ' balance function ', ' balance ', ' Equilibrium ', ' Gene Expression ', ' genetic biomarker ', ' Genetic Markers ', ' Goals ', ' Health ', ' histocompatibility typing ', ' Tissue Typing ', ' Tissue Crossmatching ', ' Histocompatibility Testing ', ' Marriage ', ' Medicine ', ' Memory ', ' Methods ', ' Methylation ', ' polynomials ', ' Polynomial Models ', ' Patients ', ' Phenotype ', ' Reading ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Science ', ' Software ', ' Computer software ', ' statistics ', ' Technology ', ' Testing ', ' Time ', ' Translating ', ' Work ', ' Measures ', ' Telomerase ', ' Uncertainty ', ' doubt ', ' Data Set ', ' Dataset ', ' base ', ' Site ', ' Specified ', ' Specific qualifier value ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' Measurement ', ' molecular aberrations ', ' Genetic Abnormality ', ' Cytogenetic or Molecular Genetic Abnormality ', ' Chromosomal, Gene, or Protein Abnormality ', ' Molecular Abnormality ', ' Genetic ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Dimensions ', ' Complex ', ' Dependence ', ' Event ', ' Techniques ', ' System ', ' interest ', ' Somatic Mutation ', ' Performance ', ' neural ', ' relating to nervous system ', ' trait ', ' Structure ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Coding System ', ' Code ', ' Statistical Methods ', ' Modeling ', ' response ', ' high throughput analysis ', ' Proteomics ', ' Genomics ', ' Tissue Sample ', ' Address ', ' Data ', ' Cancer Patient ', ' Clinical Trials Design ', ' enroll ', ' Enrollment ', ' Update ', ' developmental ', ' Development ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' Outcome ', ' Population ', ' patient population ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' flexibility ', ' flexible ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' Bayesian Modeling ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' genetic makeup ', ' genetic make-up ', ' genetic signature ', ' gene signatures ', ' Formulation ', ' data to knowledge ', ' data into knowledge ', ' patient subsets ', ' patient subtypes ', ' ']",OD,UNIVERSITY OF WASHINGTON,DP5,2016,324170,WA-07,0.03241670064550863
"Genome analysis based on the integration of DNA sequence and shape DESCRIPTION (provided by applicant): Current techniques for genome analysis are mainly based on the one-dimensional DNA sequence, comprised of the letters A, C, G, and T. However, proteins recognize DNA as a three-dimensional (3D) object. Nuances in DNA shape at single nucleotide resolution play a crucial role in the binding specificity of transcription facors (TFs), including those involved in embryonic development and human cancer. This project involves the development of a battery of tools for genome analysis, through the integration of information derived from the DNA sequence and the 3D structure of DNA, or ""DNA shape"". The basis for these novel tools is a high- throughput (HT) method for the prediction of multiple features of local DNA shape at the genomic scale. Data will be made available to the community in the UCSC Genome Browser track format through a web server interface. These tools will enable users to analyze the shape of any number or length of DNA sequences, including whole genomes and the effect of DNA methylation. HT shape predictions will be validated based on X-ray crystallography, NMR spectroscopy, and hydroxyl radical cleavage data. Predictions will be combined with ORChID, an ENCODE project that infers DNA minor groove geometry from hydroxyl radical cleavage experiments. The HT method will be used to study how paralogous TFs select different target sites in vivo despite sharing core-binding motifs or having similar binding properties in vitro. To study this question, we will investigate the effect of flanking sequences on multiple structural features of TF binding sites (TFBSs). The initial focus of this study will be homeodomains and basic helix-loop-helix (bHLH) TFs. Other protein families will later be included and used to construct a comprehensive TFBS database that provides shape features for binding motifs derived from JASPAR and other motif databases. Structural effects of single nucleotide polymorphisms (SNPs) will also be analyzed. Some SNPs are associated with deleterious functions, whereas others have no apparent effect. The HT shape prediction method will be used to predict the function of SNPs in non-coding regions based on DNA shape. We will correlate quantitative effects of SNPs on DNA structure with expression quantitative trait loci (eQTLs) and genome-wide association study (GWAS) signals, to develop a predictive tool for the functional effect of SNPs. The HT shape prediction approach will be used to design DNA sequences with different AT/GC contents but similar shapes. The relative contributions of sequence and shape to binding will be tested with analytic models including multiple linear regression (MLR) and support vector regression (SVR). For systems in which the integration of sequence and shape proves advantageous, novel motif finding tools will be developed based on an extended alphabet that combines sequence with informative structural features, selected by machine learning and feature selection approaches. Sequence+shape motifs will be tested by motif scanning, compared to sequence-only motifs, and integrated into the MEME Suite. The goal of this sequence-shape integration is to increase the accuracy of finding in vivo TFBSs in the genome. PUBLIC HEALTH RELEVANCE: Protein-DNA recognition is a critical yet poorly understood component of gene regulation. This proposal will connect the fields of DNA sequence and structure analysis, which so far have been developed in parallel but largely disconnected from each other. Integration of the one-dimensional DNA sequence at a genome-wide scale with the three-dimensional DNA structure at atomic resolution will lead to the development of novel genome analysis tools and will advance our understanding of genome function, leading to fundamentally new insights into the mechanisms of gene regulation and its impact on human disease.",Genome analysis based on the integration of DNA sequence and shape,8998963,R01GM106056,"['Affect ', ' Algorithms ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Thymonuclease ', ' Pancreatic DNase ', ' DNase I ', ' DNA Endonuclease ', ' Deoxyribonuclease I ', ' Deoxyribonucleic Acid ', ' DNA ', ' DNA-Binding Proteins ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Family ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genome ', ' Goals ', ' Health ', ' Modern Man ', ' Human ', ' Hybrids ', ' In Vitro ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Linear Regressions ', ' Methods ', ' Methylation ', ' Mining ', ' DNA Molecular Biology ', ' Molecular Biology ', ' Nucleotides ', ' pilot study ', ' Pilot Projects ', ' Play ', ' Proteins ', ' Publishing ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Specificity ', ' Technology ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Yeasts ', ' Hydroxyl Radical ', ' Hydroxyl ', ' Measures ', ' DNA Sequence ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Xray Crystallography ', ' X-Ray/Neutron Crystallography ', ' X-Ray Diffraction Crystallography ', ' X Ray Crystallographies ', ' Single Crystal Diffraction ', ' X-Ray Crystallography ', ' Training ', ' insight ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Biological Function ', ' Biological Process ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Letters ', ' helix turn helix ', ' helix loop helix ', ' HTH Motifs ', ' HTH DNA Binding Domain ', ' Helix-Turn-Helix Motifs ', ' Basic Helix-Loop-Helix Transcription Factors ', ' Basic Helix-Loop-Helix Protein ', ' Basic HLH Protein ', ' BHLH Protein ', ' Shapes ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' Scanning ', ' Techniques ', ' System ', ' Width ', ' Best Practice Analysis ', ' Benchmarking ', ' QTL ', ' Quantitative Trait Loci ', ' Homeo Domain ', ' homeodomain ', ' Base Pairing ', ' Structure ', ' novel ', ' member ', ' experimental study ', ' experimental research ', ' experiment ', ' research study ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Modeling ', ' Property ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' NMR Spectroscopy ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Untranslated RNA ', ' Genomics ', ' Guanine + Cytosine Content ', ' GC Content ', ' GC Composition ', ' G+C Content ', ' G+C Compositions ', ' Guanine + Cytosine Composition ', ' DNA Binding Interaction ', ' DNA Binding ', ' Molecular Interaction ', ' Binding ', ' genetic evolution ', ' Protein Family ', ' Length ', ' Affinity ', ' DNA Structure ', ' Data ', ' DNase-I Footprinting ', ' Minor Groove ', ' Resolution ', ' in vivo ', ' whole-genome scan ', ' genomewide scan ', ' genome-wide scan ', ' Genome Scan ', ' Validation ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' vector ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' Computational algorithm ', ' computer algorithm ', ' human disease ', ' genome-wide ', ' genomewide ', ' genome scale ', ' flexibility ', ' flexible ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' ChIP-on-chip ', ' ChIP-chip ', ' genome analysis ', ' Geometry ', ' whole genome ', ' entire genome ', ' predictive tools ', ' genome browser ', ' ']",NIGMS,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2016,306949,CA-37,0.008765299306704591
"Genetic Factors in Keratoconus DESCRIPTION (provided by applicant): The purpose of this grant is to develop techniques for use in the 'early' detection of keratoconus (KC) and identify genetic variants that contribute to is development. KC is a complex genetic eye disorder and a leading cause of corneal transplantation in the young, with approximately 300,000 affected individuals in the US. Undiagnosed, subclinical KC is one of the major causes for complications of LASIK (Laser-in-situ- Keratomilieusis) surgery, commonly performed for vision correction. In the past two decades we have made major improvements to the early diagnosis of KC and have also made significant contributions to the delineation of major genetic determinants of KC through genome wide linkage studies (GWLS), fine mapping, and genome wide association studies (GWAS). In this proposal, we intend to follow up on these studies using new powerful approaches to achieve the following specific aims: In Aim 1 we will combine corneal optical coherence tomography (OCT) and Pentacam HR Scheimpflug Tomography (PST), new technologies that measure both the anterior and posterior surface of the cornea, with videokeratography (VK), a method which revolutionized KC diagnosis, to characterize criteria and to improve the diagnosis of subclinical KC. In Aim 2, to identify additional KC genes, we will perform a 2.5 million SNP GWAS, with an additional 6,000 SNPs, to fine- map already identified genes. We will confirm these results in a separate cohort of KC patients. For this two- stage GWAS design we are assembling the largest group of KC patients described to date: 2000 KC patients in total, 1,000 for the GWAS discovery stage and 1,000 for the confirmation stage. The controls for GWAS discovery will come from the Cardiovascular Health Study (CHS; 3300) and for confirmation will come from 400 subjects with VK, PST, and OCT measurements under Aim 1 and 600 ""convenience controls"" from the Cholesterol and Pharmacogenetics (CAP) study. In our current state of knowledge, the most cost-effective approach to increase the number of identified KC genes is to proceed with the expanded GWAS proposed herein. In Aim 3, we will test the impact of the genes identified in Aim 2 on the 'early' subclinical phenotypes identified through the use o VK, PST and OCT measures in Aim 1. Lastly, for the second part of Aim 3, we will investigate the potential function of KC variants by testing their ability to influence gene structure, expression and function in corneal cell models, including iPS cells derived from corneal keratocytes developed by our research team. The results of these studies will help advance our understanding of the genetic susceptibility to KC and may result in novel treatment options to slow the progression of the disease. PUBLIC HEALTH RELEVANCE: Improving methods for the 'early' detection of keratoconus will help patients avoid complications of LASIK surgery, allow us to identify genetic variants that contribute to its development, and design therapies to retard its progression.",Genetic Factors in Keratoconus,8984882,R01EY009052,"['Affect ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cell Body ', ' Cells ', ' corneal ', ' Cornea ', ' corneal transplant ', ' corneal keratoplasty ', ' Corneal Transplantation ', ' Corneal Grafting ', ' Cornea Transplantation ', ' Keratoplasty ', ' Diagnosis ', ' Discriminant Analyses ', ' Discriminant Analysis ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Eyeball ', ' Eye ', ' ophthalmopathy ', ' eye disorder ', ' Eye diseases ', ' Genes ', ' Genotype ', ' Grant ', ' Health ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry ', ' indexing ', ' Keratoconus ', ' Laser Radiation ', ' Laser Electromagnetic ', ' Lasers ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' Maps ', ' Methods ', ' Patients ', ' Pharmacogenetics ', ' Phenotype ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Risk ', ' Testing ', ' Time ', ' tomography ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Variation (Genetics) ', ' Genetic Variation ', ' Genetic Diversity ', ' Vision ', ' visual function ', ' Sight ', ' Measures ', ' Family member ', ' Custom ', ' base ', ' improved ', ' Anterior ', ' Surface ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Collaborations ', ' Genetic ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Genetic Predisposition to Disease ', ' Staging ', ' tool ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' Knowledge ', ' Complex ', ' In Situ ', ' Techniques ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Operative Surgical Procedures ', ' early detection ', ' Early Diagnosis ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' cohort ', ' trait ', ' Videokeratography ', ' Videokeratographies ', ' novel ', ' novel technologies ', ' new technology ', ' Pathogenesis ', ' optical coherence Doppler tomography ', ' optical Doppler tomography ', ' OCT Tomography ', ' Doppler OCT ', ' Optical Coherence Tomography ', ' genetic determinant ', ' Genetic Determinism ', ' Bio-Informatics ', ' Bioinformatics ', ' protein expression ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' therapy design/development ', ' genetic association ', ' Data ', ' Gene Structure/Organization ', ' Gene Organization ', ' Gene Structure ', ' Molecular ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' protein function ', ' developmental ', ' Development ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' cost effective ', ' cost-effective ', ' Susceptibility Gene ', ' susceptibility variant ', ' susceptibility locus ', ' susceptibility allele ', ' predisposing gene ', ' Predisposition gene ', ' Cell model ', ' Cellular model ', ' cholesterol control ', ' manage cholesterol ', ' cholesterol management ', ' induced pluripotent stem cell ', ' iPSCs ', ' iPSC ', ' iPS ', ' genome-wide linkage ', ' genomewide linkage ', ' cardiovascular health ', ' bead chip ', ' BeadChip ', ' ']",NEI,CEDARS-SINAI MEDICAL CENTER,R01,2016,652794,CA-28,0.03201496200991613
"Systems genetic and reverse phenotypic analysis of age and retirement DESCRIPTION (provided by applicant): High throughput genomic platforms have revealed a profound effect of age on gene expression and gene methylation levels. For example, our integromic analysis of multiple publicly available data sets have identified hundreds of age related genes that can be organized into network modules. These gene sets along with genes and pathways known from the vast literature on aging and longevity provide valuable candidates in allelic association studies of the health and well-being of older Americans. The rich longitudinal data set and the genome wide scans of DNA samples from the Health and Retirement Study (HRS) provide a unique resource for evaluating the phenotypic effects of genetic variants underlying aging related genes, gene sets and for developing multivariable models that include behavioral, psychosocial, and genetic factors. This proposal aims to apply systems biologic and systems genetic methods for identifying gene sets based on existing gene expression, gene methylation, and multiple large scale genome wide association studies (GWAS). Single nucleotide polymorphisms (SNPs) underlying these genes will then be related to health, cognitive, behavioral, and economic phenotypes using multivariable regression-, machine learning-, and weighted network analysis approaches. An iterative process between SNP and phenotype selection facilitates the definition of clinically and economically important phenotypes under genetic control (reverse phenotyping). The proposal will not only elucidate the genetic and molecular underpinnings of retirement relevant phenotypes (cognitive functioning, psychosocial factors, and health related expenditures) but also lead to a phenotypic annotation of aging related genes and pathways. PUBLIC HEALTH RELEVANCE: State of the art statistical, computational, and network approaches for integrating genomic data with the valuable phenotypic and genetic data provided by the Health and Retirement Study is expected to lead to the identification of genetic markers relevant for improving the lives of America's older adults. Validated genetic markers will inform researchers in many fields including biomedical researchers, epidemiologists, psychologists, sociologists, and economists.",Systems genetic and reverse phenotypic analysis of age and retirement,9015301,R01AG042511,"['Affect ', ' Age ', ' senior citizen ', ' over 65 Elderly ', ' older person ', ' older adult ', ' later life ', ' late life ', ' geriatric ', ' elders ', ' advanced age ', ' Aged 65 and Over ', ' Elderly ', ' Aging ', ' Americas ', ' Parturition ', ' Birth ', ' Concurrent Studies ', ' Cohort Studies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Deoxyribonucleic Acid ', ' DNA ', ' Expenditure ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Economical Income ', ' Economic Income ', ' Income ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' lifespan ', ' life span ', ' Length of Life ', ' Longevity ', ' Psychological Health ', ' Mental Hygiene ', ' Mental Health ', ' Methods ', ' Methodology ', ' Methylation ', ' Mining ', ' statistical linear models ', ' statistical linear mixed models ', ' Probability Models ', ' Probabilistic Models ', ' Statistical Models ', ' well-being ', ' Personal Satisfaction ', ' Phenotype ', ' Psychologist ', ' psychosocial variables ', ' Psychosocial Factor ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' Retirement ', ' sociologist ', ' Software ', ' Computer software ', ' Specificity ', ' statistics ', ' Survey Instrument ', ' Surveys ', ' Testing ', ' Time ', ' Weight ', ' Measures ', ' Molecular Genetics ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' Individual ', ' data repository ', ' clinical data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Machine Learning ', ' DNA Methylation ', ' cognitive function ', ' Scanning ', ' Techniques ', ' System ', ' Physical Function ', ' psychosocial ', ' interest ', ' American ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene environment interaction ', ' cohort ', ' novel ', ' Single Base Polymorphism ', ' Single Nucleotide Polymorphism ', ' Genetic analyses ', ' genetic analysis ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' repository ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' Data ', ' Subgroup ', ' Cognitive ', ' Epidemiologist ', ' whole-genome scan ', ' genomewide scan ', ' genome-wide scan ', ' Genome Scan ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' pathway ', ' Pathway interactions ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' youth depression ', ' pediatric depression ', ' depression in adolescence ', ' depressed adolescents ', ' childhood onset depression ', ' childhood depression ', ' adolescents with depression ', ' adolescent depression ', ' child depression ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Coupled ', ' Impairment ', ' endophenotype ', ' social implication ', ' economic implication ', ' exome ', ' exomes ', ' health data ', ' behavioral economics ', ' reverse genetics ', ' bead chip ', ' BeadChip ', ' learning strategy ', ' learning method ', ' learning activity ', ' genomic platform ', ' phenotypic data ', ' genomic data ', ' ']",NIA,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2016,315700,CA-33,0.03815609646057151
"Toward Diagnostics and Therapies of Molecular Subcategories of CAD     DESCRIPTION (provided by applicant): Coronary artery disease (CAD) is a leading cause of death worldwide and in the US. While the genetics of this disease are intrinsically complex, thanks to huge research investments during the last 5-10 years, particularly in genome-wide association studies (GWAS), a more unbiased, data-driven and realistic view of CAD has been achieved. As part of this achievement, ~160 common risk loci for CAD/myocardial infarction (MI) have been identified. An important task is now to understand the molecular mechanisms/pathways by which these loci exert risk for CAD/MI allowing to translating the initial findings into new therapies and diagnostics. However, since the loci identified thus far explain only ~10% of variation in CAD/MI risk, it is also essential to define additional CAD pathways operating in parallel with GWA loci. In recent years, clinical studies that consider intermediate phenotypes (between DNA and disease) have greatly enhanced interpretations of risk loci identified in GWA datasets. In addition, disease networks that can be identified from intermediate molecular phenotypes provide an essential framework to identify novel CAD pathways and targets for new CAD therapies. Over the last 6 years, we have performed a clinical study considering many intermediate phenotypes in CAD patients (the STARNET study). In this proposal we intend to use newly generated DNA genotype and RNA sequence data from the STARNET study to identify atherosclerosis and metabolic networks underlying CAD. We then propose a new prospective study of CAD (the NGS-PREDICT study) with the main purpose of validating findings from the STARNET study. We hypothesize that the extent and stability of coronary lesions, thus clinical outcomes can be accurately assessed by defining the status of key atherosclerosis gene networks. In turn, metabolic networks active in liver, abdominal fat, and skeletal muscle influence the status of the atherosclerosis gene networks. In addition, molecular data isolated from easily obtainable tissues (e.g., blood, subcutaneous fat and plasma) can be used to identify biomarkers that can predict risk for clinical events caused by CAD. To test these hypotheses, we propose the following specific aims. Aim 1: To identify regulatory Bayesian gene networks causally linked to CAD and/or CAD sub-phenotypes using the STARNET datasets and the CARDIoGRAM meta-analysis GWA datasets. Aim 2: Identify biomarkers predicting clinical events of CAD (reflected in SYNTAX score) by applying machine learning on DNA genotype, RNA sequence and CAD plasma protein data from easily obtainable tissues of the STARNET cases. Aim 3: To validate the identified causal CAD eQTLs/networks and the biomarkers using the NGS-PREDICT study performed at the Mt. Sinai Hospital, the Swedish Twin study and CAD cell and animal models. We believe the proposed studies can lead to a significantly better molecular understanding of CAD and thus, serve the more long-term goal of preventive and personalized therapies of CAD patients diagnosed in well-defined molecular subcategories. PUBLIC HEALTH RELEVANCE:  Coronary artery disease (CAD) is the world's leading cause of death. We will perform systems genetic analysis of DNA and RNAseq data from 9 CAD-relevant tissues in 700 well-characterized patients (STARNET) integrated with genome-wide association data to reveal CAD-causing metabolic and atherosclerosis gene networks, and within these, new inherited risk variants, CAD-mechanisms, therapeutic targets and biomarkers will be identified and validated in a new prospective clinical study of CAD (NGS-PREDICT). Our studies promise to significantly advance understanding of CAD towards achieving preventive and personalized care.",Toward Diagnostics and Therapies of Molecular Subcategories of CAD,9278295,R01HL125863,"['Abdominal ', ' Abdomen ', ' Achievement Attainment ', ' Achievement ', ' Allelomorphs ', ' Alleles ', ' angiographic imaging ', ' Angiogram ', ' Angiography ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' Biology ', ' Biopsy ', ' Blood Reticuloendothelial System ', ' Blood ', ' vascular ', ' Blood Vessels ', ' Cardiology ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cardio-vascular ', ' Cardiovascular system ', ' Cause of Death ', ' Cell Differentiation ', ' Cell Differentiation process ', ' Clinical Study ', ' Clinical Research ', ' coronary arterial disease ', ' atherosclerotic coronary disease ', ' Coronary Atherosclerosis ', ' Coronary Artery Disorder ', ' Coronary Artery Disease ', ' Coronary Arteriosclerosis ', ' coronary bypass ', ' Coronary Artery Bypass Surgery ', ' Coronary Artery Bypass Grafting ', ' Aortocoronary Bypass ', ' Coronary Artery Bypass ', ' Diagnosis ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' drug treatment ', ' Drug Therapy ', ' Pharmacotherapy ', ' Engineering ', ' Family ', ' Fats ', ' Fatty acid glycerol esters ', ' Foam Cells ', ' Foundations ', ' Future ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genotype ', ' Goals ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Hospitals ', ' In Vitro ', ' Institutes ', ' Investments ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' macrophage ', ' Maps ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Genetic Models ', ' monocyte ', ' Marrow monocyte ', ' Blood monocyte ', ' Myocardial Infarction ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' New York ', ' Patients ', ' Phenotype ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma Proteins ', ' Prospective Studies ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Research Proposals ', ' Risk ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' medical schools ', ' school of medicine ', ' medical college ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Twins ', ' Twin Multiple Birth ', ' Dataset ', ' Data Set ', ' RNA Sequences ', ' DNA analysis ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' Lesion ', ' Individual ', ' Voluntary Muscle ', ' Skeletal Muscle ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Twin Studies ', ' Metabolic ', ' Genetic ', ' Diagnostic ', ' Whole Blood ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Inherited ', ' Hereditary ', ' Complex ', ' Event ', ' subcutaneous ', ' Techniques ', ' System ', ' Benchmarking ', ' Best Practice Analysis ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Quantitative Trait Loci ', ' QTL ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' trait ', ' novel ', ' disorder risk ', ' disease risk ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' genetic analysis ', ' Genetic analyses ', ' Chest ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' Sampling ', ' Genomics ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Address ', ' Preventive ', ' Data ', ' Disease Pathway ', ' Subcategory ', ' in vivo Model ', ' Molecular ', ' Coronary ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' percutaneous coronary intervention ', ' abdominal adiposity ', ' abdominal fat ', ' pathway ', ' Pathway interactions ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' Outcome ', ' prospective ', ' Heritability ', ' Cell model ', ' Cellular model ', ' multidisciplinary ', ' novel therapeutics ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel diagnostics ', ' next generation diagnostics ', ' new diagnostics ', ' therapeutic target ', ' public health relevance ', ' molecular phenotype ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' biological systems ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' clinical risk ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized diagnostics ', ' precision diagnostics ', ' personalized diagnosis ', ' clinical predictors ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' personalized care ', ' personalized patient care ', ' individualized patient care ', ' individualized care ', ' Precision care ', ' protein biomarkers ', ' protein markers ', ' Preventive care ', ' Preventative care ', ' Preventive therapy ', ' Preventative therapy ', ' therapeutic biomarker ', ' therapeutic marker ', ' ']",NHLBI,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2017,802881,NY-13,0.02933024705622009
"Genetic Factors in Keratoconus DESCRIPTION (provided by applicant): The purpose of this grant is to develop techniques for use in the 'early' detection of keratoconus (KC) and identify genetic variants that contribute to is development. KC is a complex genetic eye disorder and a leading cause of corneal transplantation in the young, with approximately 300,000 affected individuals in the US. Undiagnosed, subclinical KC is one of the major causes for complications of LASIK (Laser-in-situ- Keratomilieusis) surgery, commonly performed for vision correction. In the past two decades we have made major improvements to the early diagnosis of KC and have also made significant contributions to the delineation of major genetic determinants of KC through genome wide linkage studies (GWLS), fine mapping, and genome wide association studies (GWAS). In this proposal, we intend to follow up on these studies using new powerful approaches to achieve the following specific aims: In Aim 1 we will combine corneal optical coherence tomography (OCT) and Pentacam HR Scheimpflug Tomography (PST), new technologies that measure both the anterior and posterior surface of the cornea, with videokeratography (VK), a method which revolutionized KC diagnosis, to characterize criteria and to improve the diagnosis of subclinical KC. In Aim 2, to identify additional KC genes, we will perform a 2.5 million SNP GWAS, with an additional 6,000 SNPs, to fine- map already identified genes. We will confirm these results in a separate cohort of KC patients. For this two- stage GWAS design we are assembling the largest group of KC patients described to date: 2000 KC patients in total, 1,000 for the GWAS discovery stage and 1,000 for the confirmation stage. The controls for GWAS discovery will come from the Cardiovascular Health Study (CHS; 3300) and for confirmation will come from 400 subjects with VK, PST, and OCT measurements under Aim 1 and 600 ""convenience controls"" from the Cholesterol and Pharmacogenetics (CAP) study. In our current state of knowledge, the most cost-effective approach to increase the number of identified KC genes is to proceed with the expanded GWAS proposed herein. In Aim 3, we will test the impact of the genes identified in Aim 2 on the 'early' subclinical phenotypes identified through the use o VK, PST and OCT measures in Aim 1. Lastly, for the second part of Aim 3, we will investigate the potential function of KC variants by testing their ability to influence gene structure, expression and function in corneal cell models, including iPS cells derived from corneal keratocytes developed by our research team. The results of these studies will help advance our understanding of the genetic susceptibility to KC and may result in novel treatment options to slow the progression of the disease. PUBLIC HEALTH RELEVANCE: Improving methods for the 'early' detection of keratoconus will help patients avoid complications of LASIK surgery, allow us to identify genetic variants that contribute to its development, and design therapies to retard its progression.",Genetic Factors in Keratoconus,9238774,R01EY009052,"['Affect ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Cell Body ', ' Cells ', ' corneal ', ' Cornea ', ' corneal transplant ', ' corneal keratoplasty ', ' Corneal Transplantation ', ' Corneal Grafting ', ' Cornea Transplantation ', ' Keratoplasty ', ' Diagnosis ', ' Discriminant Analyses ', ' Discriminant Analysis ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Eyeball ', ' Eye ', ' ophthalmopathy ', ' eye disorder ', ' Eye diseases ', ' Genes ', ' Genotype ', ' Grant ', ' Immunohistochemistry ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' indexing ', ' Keratoconus ', ' Lasers ', ' Laser Radiation ', ' Laser Electromagnetic ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Literature ', ' Maps ', ' Methods ', ' Patients ', ' Pharmacogenetics ', ' Phenotype ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Risk ', ' Testing ', ' Time ', ' tomography ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Genetic Diversity ', ' Genetic Variation ', ' visual function ', ' Sight ', ' Vision ', ' Measures ', ' Family member ', ' Custom ', ' base ', ' improved ', ' Anterior ', ' Surface ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Collaborations ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' In Situ ', ' Techniques ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Early Diagnosis ', ' early detection ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' cohort ', ' trait ', ' Videokeratographies ', ' Videokeratography ', ' novel ', ' new technology ', ' novel technologies ', ' Pathogenesis ', ' Optical Coherence Tomography ', ' optical coherence Doppler tomography ', ' optical Doppler tomography ', ' OCT Tomography ', ' Doppler OCT ', ' Genetic Determinism ', ' genetic determinant ', ' Bioinformatics ', ' Bio-Informatics ', ' protein expression ', ' prevent ', ' preventing ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' Data ', ' Gene Structure/Organization ', ' Gene Organization ', ' Gene Structure ', ' Molecular ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' protein function ', ' developmental ', ' Development ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' cost effective ', ' cost-effective ', ' Susceptibility Gene ', ' susceptibility variant ', ' susceptibility locus ', ' susceptibility allele ', ' predisposing gene ', ' Predisposition gene ', ' Cell model ', ' Cellular model ', ' cholesterol control ', ' manage cholesterol ', ' cholesterol management ', ' induced pluripotent stem cell ', ' iPSCs ', ' iPSC ', ' iPS ', ' therapy design ', ' treatment design ', ' intervention design ', ' genome-wide linkage ', ' genomewide linkage ', ' public health relevance ', ' cardiovascular health ', ' bead chip ', ' BeadChip ', ' ']",NEI,CEDARS-SINAI MEDICAL CENTER,R01,2017,770725,CA-28,0.03201496200991613
"Estimating disease risk using genetic data Project Summary In the past 10 years, over 21,000 genetic variants have been linked to complex human traits through genome-wide association studies (GWAS). However, the predictive power of many of these variants remains limited, and it is still unclear how best to use the wealth of information generated by GWAS to impact personal health and clinical practice. For nearly 10 years, 23andMe has been not only a driving force in direct-to-consumer genetic testing but also has established an innovative crowd-sourced genetics research platform. This platform has yielded a compelling data resource and many genetic discoveries. In this proposal, we will address the next phase of 23andMe human genetics research: the development of highly scalable and accurate disease risk estimation. Two of the key challenges in human genetics research are (1) to determine how to use results of GWAS to paint an accurate picture of an individual's disease risk, and (2) to determine how these estimates can provide information of personal and clinical utility. These challenges are difficult due to many factors including the wide spectrum of disease classes, the paucity of genetic and phenotypic data and significant methodological and computational challenges. In this proposal, we present a plan to utilize the genetic and phenotypic data stores at 23andMe to develop validated risk estimation algorithms. In Phase I, we will build a computational pipeline that will be used to develop predictive algorithms for estimating disease risk (Aim #1) and use this pipeline to evaluate predictive ability of different estimation approaches in a broad class of human complex traits (Aim #2). In Phase II, we will validate these algorithms in external cohorts and build customer-facing reports that we will test for user comprehension. We believe that the development of accurate risk estimation capability will have a major impact on both consumer genetics and clinical genetics markets.   Project Narrative  The promise of genetics-based estimation of disease risk has yet to be realized. In this project, 23andMe will use its database of genetic and phenotypic information from over 1,000,000 research participants who have contributed more than 285,000,000 phenotypic data points on a wide spectrum of disease to build risk estimation algorithms. This project will enable 23andMe to produce the first validated risk estimation algorithms that provide both personal and clinical utility.  ",Estimating disease risk using genetic data,9255753,R43HG009089,"['Algorithms ', ' Communities ', ' Complement Proteins ', ' Complement ', ' data representation ', ' Data Reporting ', ' Disorder ', ' Disease ', ' Foundations ', ' genetic biomarker ', ' Genetic Markers ', ' Clinical genetics ', ' Medical Genetics ', ' Genome ', ' Genotype ', ' Goals ', ' Grant ', ' Health ', ' Modern Man ', ' Human ', ' Human Genetics ', ' Methods ', ' Methodology ', ' Mission ', ' Genetic Models ', ' Myopia ', ' near vision ', ' Nearsightedness ', ' Online Systems ', ' web based ', ' online computer ', ' On-Line Systems ', ' Paint ', ' Peer Review ', ' Phenotype ', ' Public Health ', ' Publications ', ' Scientific Publication ', ' Research ', ' research and development ', ' R&D ', ' R & D ', ' Development and Research ', ' Risk ', ' Role ', ' social role ', ' Testing ', ' Work ', ' Comprehension ', ' base ', ' improved ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Link ', ' Individual ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Logistics ', ' Genetic Research ', ' Genetic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Catalogs ', ' Frequencies ', ' Complex ', ' Services ', ' Performance ', ' cohort ', ' trait ', ' Genetic screening method ', ' genetic testing ', ' gene-based testing ', ' gene testing ', ' Participant ', ' Patient Self-Report ', ' Self-Report ', ' disorder risk ', ' disease risk ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' Reporting ', ' Modeling ', ' drug development ', ' Genetic Databases ', ' Genetic Information Databases ', ' Genetic Databanks ', ' Genetic Data Bases ', ' Genetic Data Banks ', ' Address ', ' Data ', ' Applications Grants ', ' Grant Proposals ', ' Industry Collaboration ', ' Industry Collaborators ', ' Genetic Risk ', ' lifestyle factors ', ' Small Business Innovation Research ', ' SBIR ', ' Small Business Innovation Research Grant ', ' Validation ', ' developmental ', ' Development ', ' National Center for Human Genome Research ', ' NHGRI ', ' National Human Genome Research Institute ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' innovation ', ' innovative ', ' innovate ', ' driving force ', ' clinically relevant ', ' clinical relevance ', ' health practice ', ' human disease ', ' new therapeutic target ', ' novel therapy target ', ' novel therapeutic target ', ' novel pharmacotherapy target ', ' novel druggable target ', ' novel drug target ', ' new therapy target ', ' new pharmacotherapy target ', ' new druggable target ', ' new drug target ', ' non-genetic ', ' nongenetic ', ' clinical practice ', ' flexibility ', ' flexible ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' Precision Medicine Initiative ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' genetic predictors ', ' Mendelian disorder ', ' single-gene disorder ', ' single-gene disease ', ' monogenic disorder ', ' monogenic disease ', ' Mendelian genetic disorder ', ' Mendelian disease ', ' crowdsourcing ', ' crowdsource ', ' crowd-sourcing ', ' crowd source ', ' learning strategy ', ' learning method ', ' learning activity ', ' phenotypic data ', ' prediction algorithm ', ' predictor algorithm ', ' predictive algorithm ', ' data resource ', ' ']",NHGRI,"23ANDME, INC.",R43,2017,241905,CA-18,-0.0054206418153945396
"Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia     DESCRIPTION (provided by applicant): Schizophrenia (SZ) represents a significant and costly public health burden. Recently, we have witnessed the emergence of the first molecular insights into the etiopathogenic mechanisms of SZ, via the first genome-wide association studies (GWAS) with sufficient case-control sample sizes to detect allelic effects. Importantly, a polygenic signature, which includes genome-wide significant common genetic variants of small effect, has been clearly demonstrated to influence SZ risk. The availability of well-defined risk factors makes it possible, for the first time, to address several critical questions about the genetic architecture of SZ and its component phenotypes and endophenotypes. The overarching goals of this K01 proposal are 1) to test polygenic risk score prediction of dimensional SZ and schizotypy phenotypes across large case, high-density SZ pedigree, and prodromal-aged GWAS samples, and 2) to develop and test, with leaders of the Psychiatric Genomics Consortium, innovative statistical methods to identify and characterize ""genetic subtypes"" of SZ.  This proposal delineates a series of training and research goals for the candidate that incorporates strengths from phenotypic assessment, statistical genetics, and molecular genetics and combines samples reflecting a broad range of genetic risk. The candidate will capitalize on previously established expertise in schizotypy and clinical risk assessment, as well as expertise in the familial transmission of dimensional traits, to establish a program of translational research wherein the application of statistical genetic/bioinformatic techniques to genetic subtyping analyses will be used to generate promising candidates for further exploration in human genomic data. Empirically-based genetic subtyping methods will be developed and tested in the largest SZ case sample to date, and subtypes will be characterized with respect to dimensional phenotypic traits. Top loci hits in subtype analyses of dimensional symptoms will be validated in secondary analyses of differential gene expression in post-mortem SZ brain. This will allow for a detailed analysis of function at both the SNP and gene levels, and will provide the candidate with substantive training in both statistical and molecular genetics methods. The institutional environment is ideal for the candidate's goal of developing a comprehensive program in SZ research, and the proposed research represents an important contribution toward advancing the understanding of SZ through a combination of clinical, statistical, molecular, and translational methods, consistent with the mission of the NIMH.         PUBLIC HEALTH RELEVANCE: Mental illnesses such as schizophrenia constitute 13% of the global burden of disease and schizophrenia, although relatively rare, is highly heritable (80%) and one of the most severe mental disorders. This project aims to elucidate the influence of genetic factors and gene function on dimensional schizophrenia and schizotypy symptoms with multiple measures, across multiple samples of varying genetic risk. Insights gained from this research will inform prediction, prevention, intervention, and treatment efforts by clarifying the biological mechanisms underlying SZ symptoms.        ",Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia,9243309,K01MH109765,"['Accounting ', ' etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Allelomorphs ', ' Alleles ', ' Engineering / Architecture ', ' Architecture ', ' postmortem ', ' necropsy ', ' Autopsy ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Mental disorders ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' Systematics ', ' Classification ', ' Disorder ', ' Disease ', ' Environment ', ' Gene Expression ', ' Genes ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Interview ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Maps ', ' Mentors ', ' Methods ', ' Mission ', ' National Institute of Mental Health ', ' NIMH ', ' Nicotine ', ' genetic pedigree ', ' pedigree structure ', ' Pedigree ', ' Personality ', ' Phenotype ', ' Genetic Polymorphism ', ' polymorphism ', ' Psychotic Disorders ', ' psychotic illness ', ' Psychoses ', ' Public Health ', ' Questionnaires ', ' Research ', ' Risk ', ' Risk Factors ', ' Sampling Studies ', ' Schizophrenia ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizotypal Personality Disorder ', ' schizotypal ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Students ', ' Suicide attempt ', ' suicidal attempt ', ' non fatal attempt ', ' Testing ', ' Time ', ' Trees ', ' Wisconsin ', ' Measures ', ' Molecular Genetics ', ' Risk Assessment ', ' Prefrontal Cortex ', ' base ', ' density ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Series ', ' Age of Onset ', ' Training ', ' insight ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Measurement ', ' Sample Size ', ' Genetic Heterogeneity ', ' Collaborations ', ' Genetic ', ' gene function ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Dimensions ', ' Complex ', ' Techniques ', ' brain tissue ', ' mind control ', ' brain control ', ' Performance ', ' trait ', ' Structure ', ' novel ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' response ', ' theories ', ' case control ', ' disorder subtype ', ' disease subtype ', ' Genomics ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Malignant neoplasm of ovary ', ' ovarian cancer ', ' Ovary Cancer ', ' Malignant Tumor of the Ovary ', ' Malignant Ovarian Tumor ', ' Malignant Ovarian Neoplasm ', ' Bioinformatics ', ' Bio-Informatics ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Address ', ' Symptoms ', ' Data ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Subgroup ', ' Genetic Risk ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' Transcript ', ' Validation ', ' Transmission ', ' transmission process ', ' Molecular ', ' Process ', ' sex ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' cost ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' severe mental illness ', ' Outcome ', ' aged ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' endophenotype ', ' public health relevance ', ' genome-wide ', ' genomewide ', ' genome scale ', ' cocaine use ', ' clinical risk ', ' Research Domain Criteria ', ' RDoC ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' marijuana use ', ' cannabis use ', ' Gaussian model ', ' Gaussianity model ', ' Gaussianity ', ' Gaussian statistics ', ' training opportunity ', ' dimensional analysis ', ' genomic data ', ' symptomatology ', ' substance misuse ', ' population stratification ', ' secondary analysis ', ' translational research program ', ' translation research enterprise ', ' Translational Research Enterprise ', ' ']",NIMH,UNIVERSITY OF UTAH,K01,2017,158132,UT-02,0.029512319638808373
"IBD Gene Mapping by Clinical and Population Subset PROJECT SUMMARY Inflammatory bowel disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC) are complex genetic disorders of the gastrointestinal tract, and a major health burden to patients and society. Tremendous progress has been made in dissecting IBD genetic etiology with identification of over 200 IBD loci by genome wide association studies (GWAS) but mainly limited to persons of European ancestry. The IBD Genetics Consortium (IBDGC) was established to facilitate multicenter collaborative studies of 6 Genetics Research Centers (GRCs) organized with a Data Coordinating Center (DCC). Our GRC at Johns Hopkins (JHGRC) has contributed to all IBDGC studies, meeting recruitment objectives and taking roles in IBDGC leadership positions. Our particular focus is on African American (AA) IBD genetics. We performed the first large-scale evaluation of European loci in the AA population, replicating several genes, but also finding unique African-ancestral variants within these loci, as well as identified multiple admixture significant loci. We also published the first AA IBD genome-wide association study (GWAS), a collaborative effort that identified two African-specific gene loci, and replicated multiple additional European loci. We have also explored why some loci with proven risk variants in Europeans and other populations only cause disease in one ancestral population but not others. More research in AA IBD is needed to understand the etiology of IBD in this ancestrally distinct, major American population. In this application we will re-evaluate the AA GWAS by better imputation, evaluate whole genome sequencing data to test low frequency and rare variants, and perform an evaluation for chromosome X variants. We will recruit a large number of AA IBD patients through our own and multiple Satellite Recruitment Centers to power a second AA IBD GWAS, both UC and CD, and meta-analyze with the first to identify more novel loci, identify more African specific risk variants, and replicate known loci for this population and replicate our admixture loci. We will also incorporate diverse data sources to incorporate into our GWAS analyses including RNA-Seq currently being generated on lymophoblastoid cell lines from AA CD cases and controls, and RNA-Seq that we will generate in colonic biopsies from UC cases and controls. We will evaluate chromatin differences and expression of genes in cell types relevant to IBD from European, AA and East Asian ancestries in an effort to better understand locus heterogeneity by ancestry. We will continue to participate in all IBDGC activities to maximize the Impact of IBD genetics research by this cooperative funding mechanism. According to the Center for Disease Control and Prevention, an estimated 1.4 million Americans suffer from Inflammatory Bowel Disease (IBD), a chronic debilitating disorder with no cure that includes Crohn's disease and ulcerative colitis. IBD ranks in the top 5 in prevalence for gastrointestinal disorders and represents a significant financial burden to society requiring a lifetime of medical care. This proposed research aims to determine the genetic variations that cause IBD which will aid in developing preventive measures, improving the quality of care with better treatments and educating patients through genetic counseling.",IBD Gene Mapping by Clinical and Population Subset,9402477,U01DK062431,"['Algorithms ', ' Biopsy ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Charge ', ' Chromatin ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' Concurrent Studies ', ' Cohort Studies ', ' Ulcerated Colitis ', ' Ulcerative Colitis ', ' regional enteritis ', ' eleocolitis ', ' Granulomatous Enteritis ', "" Crohn's disorder "", "" Crohn's "", ' Crohn disease ', "" Crohn's disease "", ' Data Sources ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Epithelium Part ', ' Epithelium ', ' Future ', ' gastrointestinal disorder ', ' Gastrointestinal Diseases and Manifestations ', ' Gastrointestinal Diseases ', ' digestive canal ', ' alimentary tract ', ' Gastrointestinal Tract ', ' GI Tract ', ' Digestive Tract ', ' Alimentary Canal ', ' Gastrointestinal tract structure ', ' Gene Expression ', ' allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' Genes ', ' Genetic Counseling ', ' Population Genetics ', ' Genotype ', ' Goals ', ' Health ', ' hereditary disorder ', ' genetic disorder ', ' Molecular Disease ', ' Genetic Diseases ', ' Genetic Condition ', ' Hereditary Disease ', ' Heterogeneity ', ' Inflammatory Bowel Diseases ', ' Inflammatory Intestinal Disorder ', ' Inflammatory Intestinal Disease ', ' Inflammatory Bowel Disorder ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Leadership ', ' Linkage Disequilibrium ', ' macrophage ', ' Persons ', ' Patients ', ' Phenotype ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Research ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Societies ', ' Testing ', ' Universities ', ' Genetic Diversity ', ' Genetic Variation ', ' Work ', ' X Chromosome ', ' oriental ', ' Asians ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Enhancers ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Caring ', ' Point Mutation ', ' base ', ' improved ', ' Chronic ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Medical ', ' Evaluation ', ' insight ', ' Individual ', ' African ', ' European ', ' Fostering ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic Research ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Collaborations ', ' Coculture ', ' Cocultivation ', ' Co-culture ', ' Coculture Techniques ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Frequencies ', ' Complex ', ' Source ', ' cell type ', ' Pattern ', ' interest ', ' meetings ', ' American ', ' experience ', ' novel ', ' disorder prevention ', ' disease prevention ', ' Positioning Attribute ', ' Position ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' Sampling ', ' Human Characteristics ', ' Human Nature ', ' Quality of Care ', ' QOC ', ' case control ', ' Effectiveness ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' genome sequencing ', ' Admixture ', ' Data ', ' Funding Mechanisms ', ' Other Genetics ', ' Update ', ' sex ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' Data Coordination Center ', ' Data Coordinating Center ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Prevalence ', ' two-dimensional ', ' 2-dimensional ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' rare variant ', ' rare allele ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' ATAC-seq ', ' ATACseq ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' Preventive measure ', ' Preventative measure ', ' study population ', ' whole genome ', ' entire genome ', ' ']",NIDDK,RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,U01,2017,505613,NJ-06,-0.007792464269271461
"Genome analysis based on the integration of DNA sequence and shape DESCRIPTION (provided by applicant): Current techniques for genome analysis are mainly based on the one-dimensional DNA sequence, comprised of the letters A, C, G, and T. However, proteins recognize DNA as a three-dimensional (3D) object. Nuances in DNA shape at single nucleotide resolution play a crucial role in the binding specificity of transcription facors (TFs), including those involved in embryonic development and human cancer. This project involves the development of a battery of tools for genome analysis, through the integration of information derived from the DNA sequence and the 3D structure of DNA, or ""DNA shape"". The basis for these novel tools is a high- throughput (HT) method for the prediction of multiple features of local DNA shape at the genomic scale. Data will be made available to the community in the UCSC Genome Browser track format through a web server interface. These tools will enable users to analyze the shape of any number or length of DNA sequences, including whole genomes and the effect of DNA methylation. HT shape predictions will be validated based on X-ray crystallography, NMR spectroscopy, and hydroxyl radical cleavage data. Predictions will be combined with ORChID, an ENCODE project that infers DNA minor groove geometry from hydroxyl radical cleavage experiments. The HT method will be used to study how paralogous TFs select different target sites in vivo despite sharing core-binding motifs or having similar binding properties in vitro. To study this question, we will investigate the effect of flanking sequences on multiple structural features of TF binding sites (TFBSs). The initial focus of this study will be homeodomains and basic helix-loop-helix (bHLH) TFs. Other protein families will later be included and used to construct a comprehensive TFBS database that provides shape features for binding motifs derived from JASPAR and other motif databases. Structural effects of single nucleotide polymorphisms (SNPs) will also be analyzed. Some SNPs are associated with deleterious functions, whereas others have no apparent effect. The HT shape prediction method will be used to predict the function of SNPs in non-coding regions based on DNA shape. We will correlate quantitative effects of SNPs on DNA structure with expression quantitative trait loci (eQTLs) and genome-wide association study (GWAS) signals, to develop a predictive tool for the functional effect of SNPs. The HT shape prediction approach will be used to design DNA sequences with different AT/GC contents but similar shapes. The relative contributions of sequence and shape to binding will be tested with analytic models including multiple linear regression (MLR) and support vector regression (SVR). For systems in which the integration of sequence and shape proves advantageous, novel motif finding tools will be developed based on an extended alphabet that combines sequence with informative structural features, selected by machine learning and feature selection approaches. Sequence+shape motifs will be tested by motif scanning, compared to sequence-only motifs, and integrated into the MEME Suite. The goal of this sequence-shape integration is to increase the accuracy of finding in vivo TFBSs in the genome. PUBLIC HEALTH RELEVANCE: Protein-DNA recognition is a critical yet poorly understood component of gene regulation. This proposal will connect the fields of DNA sequence and structure analysis, which so far have been developed in parallel but largely disconnected from each other. Integration of the one-dimensional DNA sequence at a genome-wide scale with the three-dimensional DNA structure at atomic resolution will lead to the development of novel genome analysis tools and will advance our understanding of genome function, leading to fundamentally new insights into the mechanisms of gene regulation and its impact on human disease.",Genome analysis based on the integration of DNA sequence and shape,9203633,R01GM106056,"['Affect ', ' Algorithms ', ' nucleic acid sequence ', ' Nucleotide Sequence ', ' Base Sequence ', ' Reactive Site ', ' Combining Site ', ' Binding Sites ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Thymonuclease ', ' Pancreatic DNase ', ' DNase I ', ' DNA Endonuclease ', ' Deoxyribonuclease I ', ' Deoxyribonucleic Acid ', ' DNA ', ' fruit fly ', ' Drosophila ', ' Drosophila genus ', ' Embryogenesis ', ' Embryo Development ', ' Embryonic Development ', ' Family ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genome ', ' Goals ', ' Modern Man ', ' Human ', ' Hybrids ', ' In Vitro ', ' Linear Regressions ', ' Methods ', ' Methylation ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Molecular Conformation ', ' conformational state ', ' conformation ', ' Molecular Stereochemistry ', ' Molecular Configuration ', ' Nucleotides ', ' Pilot Projects ', ' pilot study ', ' Play ', ' Proteins ', ' Publishing ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Specificity ', ' Technology ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Yeasts ', ' Hydroxyl ', ' Hydroxyl Radical ', ' Measures ', ' Sequence Analyses ', ' SEQ-AN ', ' Sequence Analysis ', ' base ', ' Site ', ' Variation ', ' Variant ', ' Xray Crystallography ', ' X-Ray/Neutron Crystallography ', ' X-Ray Diffraction Crystallography ', ' X Ray Crystallographies ', ' Single Crystal Diffraction ', ' X-Ray Crystallography ', ' Training ', ' insight ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Binding Proteins ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Measurement ', ' DNA Databanks ', ' DNA Data Banks ', ' DNA Databases ', ' Biological Function ', ' Biological Process ', ' world wide web ', ' web ', ' WWW ', ' Internet ', ' Letters ', ' helix turn helix ', ' helix loop helix ', ' HTH Motifs ', ' HTH DNA Binding Domain ', ' Helix-Turn-Helix Motifs ', ' Basic Helix-Loop-Helix Transcription Factors ', ' Basic Helix-Loop-Helix Protein ', ' Basic HLH Protein ', ' BHLH Protein ', ' Shapes ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Dimensions ', ' Scanning ', ' Techniques ', ' System ', ' Width ', ' Benchmarking ', ' Best Practice Analysis ', ' Quantitative Trait Loci ', ' QTL ', ' homeodomain ', ' Homeo Domain ', ' Base Pairing ', ' Structure ', ' novel ', ' member ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Modeling ', ' Property ', ' NMR Spectroscopy ', ' nuclear magnetic resonance spectroscopy ', ' NMR Spectrometer ', ' Untranslated RNA ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' Guanine + Cytosine Composition ', ' Guanine + Cytosine Content ', ' GC Content ', ' GC Composition ', ' G+C Content ', ' G+C Compositions ', ' Gene Components ', ' DNA Integration ', ' Binding ', ' Molecular Interaction ', ' genetic evolution ', ' Protein Family ', ' Length ', ' Affinity ', ' DNA Structure ', ' Data ', ' DNase-I Footprinting ', ' Minor Groove ', ' Resolution ', ' in vivo ', ' whole-genome scan ', ' genomewide scan ', ' genome-wide scan ', ' Genome Scan ', ' Validation ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' vector ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' designing ', ' design ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' three dimensional structure ', ' 3D structure ', ' 3-dimensional structure ', ' 3-D structure ', ' Computational algorithm ', ' computer algorithm ', ' human disease ', ' public health relevance ', ' genome-wide ', ' genomewide ', ' genome scale ', ' flexibility ', ' flexible ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' ChIP-on-chip ', ' ChIP-chip ', ' genome analysis ', ' Geometry ', ' Gaussian model ', ' Gaussianity model ', ' Gaussianity ', ' Gaussian statistics ', ' whole genome ', ' entire genome ', ' predictive tools ', ' genome browser ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NIGMS,UNIVERSITY OF SOUTHERN CALIFORNIA,R01,2017,309913,CA-37,0.008765299306704591
"The Neural Mechanisms of Peer Influence on Risky Decision-Making     DESCRIPTION (provided by applicant): Risky behaviors such as smoking, drug and alcohol use, and teenaged sexual intercourse are all heavily influenced by the behaviors of one's peers. While much is known about the neural networks involved in risky decision-making, this research has largely been conducted in the absence of the rich network of social information available when making risky decisions in real-life. Given the large body of evidence suggesting the importance of information about peers' choices when making risky decisions, it is of great public-health relevance to understand how the integration of this information into the risky decision takes place at the neural level, and, particularly, what differences in processing of this information lead some people to be more susceptible to peer influence than others. The proposed research aims to answer these questions by having a sample of 50 14-19 year olds perform a novel real-stakes social gambling task in the scanner. In this task, participants will make choices about a series of risky gambles, on each trial receiving false information about the decisions of four of their friends who previously completed the task. Using the reported percentage of risk acceptance as a parametric modulator, we will identify regions in the brain where BOLD activation encodes information about others' choice behavior. Second, we will calculate a peer susceptibility score for each subject based on their choices in the task, reflecting how much their choices were swayed by the reported actions of others. We will then use a machine-learning based regression technique to generate a spatial pattern of regression weights that can predict each participant's behavioral susceptibility to peer influence. The strength of these regression weights in different areas of the brain reflects how strongly encoding of others' choices in that region predicts individuals' peer susceptibility scores. These data allow us to: 1) Identify patterns of encoding of others' choice information that are most strongly predictive of being highly susceptible to peer influence, and 2) Generate a neurologic signature that can be used in new samples of participants to predict their level of susceptibility to peer influence. We will then compare predictions of peer susceptibility derived from the brain data to patterns of real-world risk-taking of the participant and their peers. We believe that thes findings can set the stage for future work examining developmental changes in these networks, and how responses in these networks can be altered by exposure to different types of peers or by potential interventions designed to reduce susceptibility to peer influence in specific domains. These avenues of research will allow for the accelerated development of more precise and effective intervention strategies to reduce susceptibility to peer influence in the domain of publi-health relevant risk-taking. PUBLIC HEALTH RELEVANCE: The risky actions of peers strongly influence individuals' risk-taking behavior. This research will examine how information about peers' risky choices are represented in the brain, develop a set of neural markers that can predict the extent to which an individual will be influenced by the actions of their peers, based on their encoding of the peers' choices, and examine relations between these neural markers and susceptibility to peer influence in real-world risk-taking.",The Neural Mechanisms of Peer Influence on Risky Decision-Making,9247017,R21HD086375,"['etoh use ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alcohol consumption ', ' Behavior ', ' Encephalon ', ' Brain Nervous System ', ' Brain ', ' Choice Behavior ', ' Sexual Intercourse ', ' Coitus ', ' Costs and Benefits ', ' Decision Making ', ' Divorced state ', ' Divorce ', ' Economics ', ' Environment ', ' Exercise ', ' Future ', ' Gambling ', ' Health ', ' Information Networks ', ' Laboratories ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Learning ', ' Maps ', ' Neighborhoods ', ' Perception ', ' Public Health ', ' Punishment ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Rewards ', ' Risk ', ' Risk-Taking ', ' Role ', ' social role ', ' Smoking ', ' Social Environment ', ' socioenvironment ', ' social context ', ' social climate ', ' Weight ', ' Work ', ' Friends ', ' Measures ', ' at risk behavior ', ' Risky Behavior ', ' Risk Behaviors ', ' socioeconomic position ', ' socio-economic position ', ' Socio-economic status ', ' Socioeconomic Status ', ' Social Network ', ' Prefrontal Cortex ', ' base ', ' Area ', ' Biological ', ' Neurological ', ' Neurologic ', ' Series ', ' Link ', ' Susceptibility ', ' Predisposition ', ' using substances ', ' substance using ', ' substance use ', ' AOD use ', ' Alcohol or Other Drugs use ', ' Individual ', ' drug use ', ' Drug usage ', ' Exposure to ', ' Shapes ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Life ', ' Parietal ', ' Pattern ', ' Techniques ', ' interest ', ' preference ', ' Biological Neural Networks ', ' neural network ', ' relating to nervous system ', ' neural ', ' neuroimaging ', ' neuro-imaging ', ' novel ', ' Participant ', ' peer ', ' member ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Reporting ', ' social ', ' Ventral Striatum ', ' Sampling ', ' response ', ' behavior influence ', ' behavioral influence ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Behavior assessment ', ' behavioral assessment ', ' Brain region ', ' Address ', ' Base of the Brain ', ' Data ', ' teenage ', ' teen years ', ' Teen ', ' Teenagers ', ' Characteristics ', ' Process ', ' developmental ', ' Development ', ' Behavioral ', ' willingness ', ' Outcome ', ' Adolescent Risk Behavior ', ' risk behavior in youth ', ' adolescent risk taking ', ' Youth Risk Behavior ', ' neuromechanism ', ' neural mechanism ', ' 19 year old ', ' nineteen years old ', ' nineteen year old ', ' age 19 years ', ' 19 years of age ', ' parental involvement ', ' peer influence ', ' cognitive control ', ' therapy design ', ' treatment design ', ' intervention design ', ' information processing ', ' public health relevance ', ' effective intervention ', ' ']",NICHD,"UNIV OF MARYLAND, COLLEGE PARK",R21,2017,190000,MD-05,0.005911248916360429
"Data-Driven Statistical Learning with Applications to Genomics DESCRIPTION (provided by applicant): This project involves the development of statistical and computational methods for the analysis of high throughput biological data. Effective methods for analyzing this data must balance two opposing ideals. They must be (a) flexible and sufficiently data-adaptive to deal with the data's complex structure, yet (b) sufficiently simpe and transparent to interpret their results and analyze their uncertainty (so as not to mislead with conviction). This is additionally challenging because these datasets are massive, so attacking these problems requires a marriage of statistical and computational ideas. This project develops frameworks for attacking several problems involving this biological data. These frameworks balance flexibility and simplicity and are computationally tractable even on massive datasets. This application has three specific aims. Aim 1: A flexible and computationally tractable framework for building predictive models. Commonly we are interested in modelling phenotypic traits of an individual using omics data. We would like to find a small subset of genetic features which are important in phenotype expression level. In this approach, I propose a method for flexibly modelling a response variable (e.g. phenotype) with a small, adaptively chosen subset of features, in a computationally scalable fashion. Aim 2: A framework for jointly identifying and testing regions which differ across conditions. For example, in the context of methylation data measured in normal and cancer tissue samples, one might expect that some regions are more methylated in one tissue type or the other. These regions might suggest targets for therapy. However, we do not have the background biological knowledge to pre-specify regions to test. I propose an approach which adaptively selects regions and then tests them in a principled way. This approach is based on a convex formulation to the problem, using shrinkage to achieve sparse differences. Aim 3: A principled framework for developing and evaluating predictive biomarkers during clinical trials. Modern treatments target specific genetic abnormalities that are generally present in only a subset of patients with a disease. A major current goal in medicine is to develop biomarkers that identify those patients likely to benefit from treatment. I propose a framework for developing and testing biomarkers during large-scale clinical trials. This framework simultaneously builds these biomarkers and applies them to restrict enrollment into the trial to only those likely to benefit from treatment. The statistical tools that result from th proposed research will be implemented in freely available software. PUBLIC HEALTH RELEVANCE: Recent advances in high-throughput biotechnology have provided us with a wealth of new biological data, a large step towards unlocking the tantalizing promise of personalized medicine: the tailoring of treatment to the genetic makeup of each individual and disease. However, classical statistical and computational tools have proven unable to exploit the extensive information these new experimental technologies bring to bear. This project focuses on building new flexible, data-adaptive tools to translate this wealth of low level information into actionable discoveries, and actual biological understanding.",Data-Driven Statistical Learning with Applications to Genomics,9349367,DP5OD019820,"['bear ', ' Ursidae ', ' Bears ', ' Ursidae Family ', ' Biology ', ' Biotech ', ' Biotechnology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' Clinical Trials ', ' Computers ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' Disorder ', ' Disease ', ' balance function ', ' balance ', ' Equilibrium ', ' Gene Expression ', ' Goals ', ' Marriage ', ' Medicine ', ' Memory ', ' Methods ', ' Methylation ', ' Polynomial Models ', ' polynomials ', ' Modernization ', ' Patients ', ' Phenotype ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Science ', ' Computer software ', ' Software ', ' statistics ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Work ', ' Measures ', ' Telomerase ', ' doubt ', ' Uncertainty ', ' Dataset ', ' Data Set ', ' base ', ' Site ', ' Specified ', ' Specific qualifier value ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' Measurement ', ' molecular aberrations ', ' Genetic Abnormality ', ' Cytogenetic or Molecular Genetic Abnormality ', ' Chromosomal, Gene, or Protein Abnormality ', ' Molecular Abnormality ', ' Genetic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' Dependence ', ' Event ', ' Techniques ', ' System ', ' interest ', ' Somatic Mutation ', ' Performance ', ' relating to nervous system ', ' neural ', ' trait ', ' Structure ', ' novel ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Code ', ' Coding System ', ' Statistical Methods ', ' Modeling ', ' response ', ' high throughput analysis ', ' Proteomics ', ' Genomics ', ' Tissue Sample ', ' Address ', ' Data ', ' Cancer Patient ', ' Clinical Trials Design ', ' enroll ', ' Enrollment ', ' Update ', ' developmental ', ' Development ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' convict ', ' Outcome ', ' Population ', ' public health relevance ', ' patient population ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' flexibility ', ' flexible ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' Bayesian Modeling ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored medical treatment ', ' individualized treatment ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' personalized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' genetic makeup ', ' genetic make-up ', ' genetic signature ', ' gene signatures ', ' Formulation ', ' data to knowledge ', ' data into knowledge ', ' patient subsets ', ' patient subtypes ', ' high dimensionality ', ' ']",OD,UNIVERSITY OF WASHINGTON,DP5,2017,326785,WA-07,0.03241670064550863
"Predicting gene regulation across populations to understand mechanisms underlying complex traits Project Summary A better understanding of the degree of transferability of genetic association results and implicated genes across populations has implications for precision medicine and can only be accomplished by studying the genetic architecture of complex traits in diverse populations. For many complex traits, gene regulation is likely to play a crucial mechanistic role given the consistent enrichment of regulatory variants among trait-associated variants. We have developed a gene-level association method called PrediXcan that harnesses the regulatory knowledge generated by expression quantitative trait loci (eQTL) studies to directly test for genes associated with complex traits. An advantage of this gene-based approach over other aggregate variant approaches is that the results are inherently mechanistic and provide directionality, guiding follow-up experiments and future drug development. The genetic contribution to population phenotypic differentiation is driven by differences in causal allele frequencies, effect sizes, and genetic architectures. We propose to broaden the scope of PrediXcan to include diverse populations by (1) optimizing predictors of gene expression within and across diverse populations in multiple tissues and (2) performing gene-level association studies and quantifying regulability on a range of phenotypes in non-European populations. We will use machine learning to optimize predictive models of gene expression in datasets with both genome-wide genotype and gene expression data. We will integrate prior results from larger European populations when appropriate. Based on preliminary results, we expect a range of predictive power (assessed by cross-validation R2) will be observed across genes dependent on the heritability of each gene expression trait and differences in allele frequencies and effect sizes among populations. We will compare populations by 1) calculating the correlation between heritability estimates and cross-validated prediction performance and by 2) by calculating trans-population genetic effect size correlations (allele frequency independent) and trans-population genetic impact correlations (allele frequency dependent). The optimal models will also inform the underlying genetic architectures (sparse vs. polygenic) of gene expression traits and how they vary across populations. As we have done for European populations, the predictive models and heritability estimates developed here will be added to an open access database for use in PrediXcan and other studies. We hypothesize that PrediXcan will increase power to identify genes and implicate mechanisms underlying complex traits and that we can quantify the overall effect of phenotypic variation explained by transcriptome regulation within and across populations. We will compare gene-level results across populations to determine if the same and/or unique genes and pathways are implicated for a particular phenotype. We will estimate the proportion of phenotypic variance explained collectively by all gene expression levels, which we name the regulability of a trait. All results, scripts, and software will be available in publicly accessible databases and repositories. Project Narrative Differences in DNA sequence among individuals can lead to differences in gene expression levels, which in turn can lead to trait differences. We have developed a method that harnesses these DNA differences to predict gene expression levels, which are then tested for correlation with a disease or other trait of interest. Our project will lead to a better understanding of the degree of transferability of genetic association results and implicated genes across populations, which has the potential to improve the implementation of precision medicine among diverse populations and reduce health disparities.",Predicting gene regulation across populations to understand mechanisms underlying complex traits,9304684,R15HG009569,"['senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', "" Alzheimer's Disease "", ' Engineering / Architecture ', ' Architecture ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Atherosclerosis ', ' malignant breast tumor ', ' Breast Cancer ', ' malignant breast neoplasm ', ' Cholesterol ', ' Concurrent Studies ', ' Cohort Studies ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Future ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' Genes ', ' Population Genetics ', ' Genome ', ' Genotype ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Methods ', ' monocyte ', ' Marrow monocyte ', ' Blood monocyte ', ' Names ', ' Phenotype ', ' Play ', ' Role ', ' social role ', ' Computer software ', ' Software ', ' statistics ', ' T-Lymphocyte ', ' thymus derived lymphocyte ', ' Thymus-Dependent Lymphocytes ', ' T-Cells ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Triacylglycerol ', ' Triglycerides ', ' Weight ', ' Protein Coding Region ', ' ORFs ', ' Open Reading Frames ', ' falls ', ' population diversity ', ' heterogeneous population ', ' diverse populations ', ' Population Heterogeneity ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' European ', ' data repository ', ' Databanks ', ' Data Bases ', ' Data Banks ', ' Databases ', ' Genetic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' Scanning ', ' Height ', ' interest ', ' Performance ', ' Quantitative Trait Loci ', ' QTL ', ' trait ', ' novel ', ' lymphoblastoid cell line ', ' Regulation ', ' Modeling ', ' response ', ' drug development ', ' repository ', ' health disparity ', ' disparity in health ', ' genetic association ', ' Data ', ' Transcript ', ' Validation ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' pathway ', ' Pathway interactions ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' risk prediction model ', ' prognostic model ', ' computer based prediction ', ' predictive modeling ', ' Population ', ' Heritability ', ' genome-wide ', ' genomewide ', ' genome scale ', ' database of Genotypes and Phenotypes ', ' dbGaP ', ' precision medicine ', ' Genetic study ', ' transcriptome ', ' phenotypic data ', ' Genotype-Tissue Expression Project ', ' GTEx ', ' data access ', ' experimental study ', ' experimental research ', ' experiment ', ' ']",NHGRI,LOYOLA UNIVERSITY OF CHICAGO,R15,2017,429000,IL-09,-0.03440812802477225
"Signals of Epigenetic Modification in Sjogrens Syndrome     DESCRIPTION (provided by applicant): The objective of the project is to characterize the potential role of DNA methylation patterns in Sjgren's Syndrome (SS) disease etiology and mechanism. A growing body of evidence indicates that epigenetic changes, in particular, altered patterns of DNA methylation, contribute to the development of autoimmune disease and can mediate genetic risk factors. To date, aberrant DNA methylation has been associated with several human autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. My proposal focuses on the identification of unique epigenetic profiles in SS, focusing primarily on T cells, B cells, and salivary gland tissue, a primary site of the inflammatory disease. An understanding of these profiles in the context of genetic background, publicly available genomic data (RNA, ChIP-seq, WGBS) and annotation data (TF binding motifs, genomic QTLs), and cell types have the potential to significantly transform our understanding of SS etiology, particularly given the well-established heterogeneity in clinical manifestations. Further, these DNA methylation profiles could become useful clinical biomarkers for determining risk and prognosis in SS, especially if their biological relevance can be validated in future functional studies. The overall hypothesis of this project is that DNA methylation changes in key genomic regions are associated with SS status and phenotype. The project will use genome-wide SNP data, epigenome-wide methylation array data, and clinical characteristics abstracted from 100 SS cases and 20 controls to address 3 related hypotheses: First, that epigenome-wide DNA methylation patterns in T cells, B cells (both derived from peripheral blood), and salivary gland biopsy tissue are associated with primary SS status after correcting for cell-type heterogeneity. Case-control differences will be tested using supervised machine learning algorithms, new region-discovery methods, and cell-mixture inference techniques. Publicly available data (listed above) will be used to infer biological relevance. Second, that epigenome-wide DNA methylation patterns in these samples are representative of SS sub-phenotypes. Cases (and initially controls) will be clustered using principal component analysis (PCA) applied to all relevant DNA methylation probes and subsets of probes measuring CpGs implicated in specific pathways relevant to SS. The reduced representations will be tested for association with specific clinical and serological profiles. Third, that risk alleles identifie by genome-wide association studies (GWAS) are directly or indirectly associated with SS-specific DNA methylation patterns. Allelic dosage and random forest selection frequency (RFSF) analyses will be used to identify novel methylation quantitative trait loci within SS-associated genes in cases and controls (separately), and we will test whether cell-proportion or eQTLs can explain SS-specific methylation patterns.         PUBLIC HEALTH RELEVANCE: Sjgren's Syndrome is a chronic, highly heterogenous, multisystem autoimmune disease predominantly affecting women. This disease is known to be associated with epigenetic changes, including DNA methylation, an axis of epigenetic variation that has been implicated as a mediator of disease risk in other autoimmune diseases. Full characterization of DNA methylation patterns across different cell types and affected tissues will provide new insights into disease etiology, phenotype classification, and targets for future therapeutic strategies.                ",Signals of Epigenetic Modification in Sjogrens Syndrome,9240483,F31DE025176,"['Affect ', ' ages ', ' Age ', ' Algorithms ', ' Allelomorphs ', ' Alleles ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' autoimmune disorder ', ' auto-immune disorder ', ' auto-immune disease ', ' Autoimmune Diseases ', ' Autoimmune Status ', ' Autoimmunity ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-cell ', ' B-Cells ', ' B cells ', ' B cell ', ' B blood cells ', ' B-Lymphocytes ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biological Assay ', ' Biopsy ', ' Carbon ', ' Cell Body ', ' Cells ', ' Systematics ', ' Classification ', ' Cytosine ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Exhibits ', ' Fellowship ', ' Female ', ' Future ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Systemic Lupus Erythematosus ', ' systemic lupus erythematosis ', ' disseminated lupus erythematosus ', ' Systemic SLE - Lupus Erythematosus ', ' Systemic Lupus Erythmatosus ', ' SLE ', ' Lupus Erythematosus Disseminatus ', ' Mentors ', ' Methods ', ' Methylation ', ' Parents ', ' Patients ', ' Phenotype ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Recruitment Activity ', ' recruit ', ' active recruitment ', ' Resources ', ' Research Resources ', ' Risk ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' Role ', ' social role ', ' Salivary Glands ', ' Salivary Glands Head and Neck ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Supervision ', ' T-Lymphocyte ', ' thymus derived lymphocyte ', ' Thymus-Dependent Lymphocytes ', ' T-Cells ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Transactivators ', ' Trans-Acting Factors ', ' Trans-Activators ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Woman ', ' Work ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' Measures ', ' forest ', ' Mediating ', ' Lasso ', ' Dataset ', ' Data Set ', ' base ', ' dosage ', ' Site ', ' Chronic ', ' Clinical ', ' Biological ', ' Serologic ', ' Serological ', ' Logistic Regressions ', ' Link ', ' peripheral blood ', ' insight ', ' European ', ' Therapeutic ', ' Genetic ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Dimensions ', ' Frequencies ', ' Complex ', ' cell type ', ' Pattern ', ' Techniques ', ' Country ', ' Severity of illness ', ' disease severity ', ' Quantitative Trait Loci ', ' QTL ', ' novel ', ' Participant ', ' disorder risk ', ' disease risk ', ' Pathogenesis ', ' genetic risk factor ', ' inherited factor ', ' Sampling ', ' high throughput technology ', ' case control ', ' Genomics ', ' Labial Salivary Gland ', ' histone modification ', ' chromatin remodeling ', ' Transcriptional Regulation ', ' Transcriptional Control ', ' Transcription Regulation ', ' Binding ', ' Molecular Interaction ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Aberrant DNA Methylation ', ' Data ', ' Individual National Research Service Award ', ' NIH National Research Service Award for Individual ', ' International ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Salivary Gland Tissue ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' Population ', ' pre-doctoral ', ' predoctoral ', ' predoc ', ' pre-doc ', ' epigenetic variation ', ' public health relevance ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' genome-wide ', ' genomewide ', ' genome scale ', ' ChIP-seq ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' epigenome ', ' methylation pattern ', ' bead chip ', ' BeadChip ', ' epigenome-wide association studies ', ' epigenome wide association analysis ', ' EWAS ', ' clinical biomarkers ', ' clinically useful biomarkers ', ' disease heterogeneity ', ' whole genome ', ' entire genome ', ' genomic data ', ' ']",NIDCR,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2017,39597,CA-13,0.04957654797638651
"Fast and Robust Methods for Large Scale Genotype Phenotype Association Study     DESCRIPTION (provided by applicant): A fundamental challenge in life sciences is the characterization of genetic factors that underlie phenotypic differences. Thanks to the advanced sequencing technologies, an enormous amount of genetic variants have been identified and cataloged. Such data hold great potential to understand how genes affect phenotypes and contribute to the susceptibility to environmental stimulus. However, the existing computational methods for analyzing and interpreting the highthroughput genetic data are still in their infancy.    We propose to systematically investigate the computational and statistical principles in modeling and discovering genetic basis of complex phenotypes. The proposed research provides answers to the following fundamental questions in genetic association study: (1) How to effectively and efficiently assess statistical significance of the findings? (2) How to account for the relatedness between samples in genetic association study? (3) How to accurately capture possible interactions between multiple genetic factors and their joint contribution to phenotypic variation? In particular, we will develop data structures and efficient algorithms for accurate and robust significance assessment that account for local population structure and joint effect of multiple genetic factors.    The proposed computational tools will be integrated into software packages under common application framework adopted by the broad scientific community. PUBLIC HEALTH RELEVANCE: A fundamental challenge in life sciences is the characterization of genetic factors that underlie phenotypic differences. Existing methods are not able to adequately address the complexity of high throughput data. Innovative computational models and methods developed in this project will enable scientists more effectively analyze the research data, thus further understanding of human diseases and speed the development diagnostic tools, cures, and therapies.",Fast and Robust Methods for Large Scale Genotype Phenotype Association Study,9300990,R01GM115833,"['Affect ', ' Algorithms ', ' Life Sciences ', ' Bioscience ', ' Biologic Sciences ', ' Biological Sciences ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Foundations ', ' Gene Expression ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Information Networks ', ' Joints ', ' Methods ', ' Mining ', ' Mus ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Noise ', ' Phenotype ', ' Phylogeny ', ' Pilot Projects ', ' pilot study ', ' Publications ', ' Scientific Publication ', ' Research ', ' Research Institute ', ' Computer software ', ' Software ', ' Technology ', ' Testing ', ' Trees ', ' Measures ', ' base ', ' improved ', ' Area ', ' Variation ', ' Variant ', ' Susceptibility ', ' Predisposition ', ' infantile ', ' infancy ', ' Stimulus ', ' Genetic ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Computational Biology ', ' computer biology ', ' Catalogs ', ' exhaustion ', ' Scientist ', ' Adopted ', ' Complex ', ' interest ', ' experience ', ' Performance ', ' Quantitative Trait Loci ', ' QTL ', ' trait ', ' Genetic Marker Expression ', ' Speed ', ' Structure ', ' novel ', ' Modeling ', ' Sampling ', ' Property ', ' Bioinformatics ', ' Bio-Informatics ', ' data mining ', ' datamining ', ' genetic association ', ' Address ', ' Data ', ' Negative Finding ', ' developmental ', ' Development ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' computational tools ', ' computerized tools ', ' Population ', ' innovation ', ' innovative ', ' innovate ', ' human disease ', ' public health relevance ', ' ']",NIGMS,UNIVERSITY OF CALIFORNIA LOS ANGELES,R01,2017,274718,CA-33,0.011690470210707378
"Bioinformatics strategies to relate age of onset with gene-gene interaction     DESCRIPTION (provided by applicant):         Time to onset of chronic diseases such as cancer, cardiovascular disease, and diabetes is expected to be influenced by multiple gene-gene interactions that add to the complexity of the genotype-phenotype mapping relationship. Unfortunately, parametric statistical methods such as Cox regression lack sufficient power to detect high-order gene-gene interactions due to the sparseness of the data. Machine learning methods offer a more powerful alternative but rely on computationally-intensive searching methods to identify the top models. We propose here to develop a powerful and computationally efficient bioinformatics strategy that combines machine learning algorithm and Cox regression for identifying gene-gene and gene-environment interaction models that are associated with time of onset of chronic disease. Specifically, we firs propose to develop a novel Robust Survival Multifactor Dimensionality Reduction method (RS-MDR) for the detection of gene-gene interactions in rare variants that influence time of onset of human disease (AIM 1). The power of RS-MDR method will be evaluated by comparing it to other existing methods in simulation studies. We then propose to change the representation space of the gene-gene interaction models using RS-MDR's construction induction method and apply L1 penalized Cox regression to identify a set of interaction models that can predict patients' survival probability (AIM 2). We hypothesize that RS-MDR can effectively identify high order interaction models and the combined approach provides a powerful and computational efficient way to select a set of interaction models. We will use extensive simulations that are derived from GWAS studies to thoroughly evaluate this hypothesis. Next, we will apply the new combined method for detecting and characterizing gene-gene and gene-environment interactions in genome-wide association study (GWAS) data from large population-based studies of lung cancer and rheumatoid arthritis (AIM 3). Results from the real data analysis will be used to refine the method. Finally, we will distribute the proposed method as part of an open- source R software package (AIM 4). We anticipate that the proposed method will combine the strength from both parametric and non-parametric methods and enable detection of interaction models that are jointly affecting time of onset of chronic diseases. This is important because time of onset has more variation than case-control status and it may be more clinically relevant. Furthermore, studies of genetic factors predicting time of onset have not been pursued aggressively using GWAS studies, despite the relevance of this information for the discovery of high risk variants like mutations in BRCA1. Narrative This project will provide a general method for genome data analysis that can be potentially apply to any specific disease. We focus the application of this method on an investigation into the role of genetic polymorphisms in lung cancer and rheumatoid arthritis. This will increase our knowledge of the basic biology and lead for screening and targeted therapy.",Bioinformatics strategies to relate age of onset with gene-gene interaction,9306198,R01LM012012,"['Affect ', ' Algorithms ', ' Atrophic Arthritis ', ' Rheumatoid Arthritis ', ' Biology ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Malignant Neoplasms ', ' cardiovascular disorder ', ' Cardiovascular Diseases ', ' chronic disorder ', ' Chronic Illness ', ' Chronic Disease ', ' Communities ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' diabetes ', ' Diabetes Mellitus ', ' Disorder ', ' Disease ', ' Europe ', ' Genes ', ' Genome ', ' Genotype ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Methods ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' North America ', ' Patients ', ' Phenotype ', ' Genetic Polymorphism ', ' polymorphism ', ' Probability ', ' Research ', ' Risk ', ' Role ', ' social role ', ' Computer software ', ' Software ', ' Testing ', ' Texas ', ' Time ', ' United Kingdom ', ' base ', ' Variation ', ' Variant ', ' Age of Onset ', ' Link ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' BRCA1 gene ', ' brca 1 gene ', ' RNF53 ', ' Hereditary Breast Cancer 1 ', ' Early Onset Gene Breast Cancer 1 ', ' Breast Cancer Type 1 Susceptibility Gene ', ' Breast Cancer 1 Gene ', ' BRCA1 ', ' Investigation ', ' Dimensions ', ' gene environment interaction ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' gene interaction ', ' simulation ', ' novel ', ' Population Study ', ' study of the population ', ' studies of populations ', ' population-level study ', ' population-based study ', ' Predictive Factor ', ' Statistical Methods ', ' Modeling ', ' case control ', ' Gene Order ', ' Gene Position ', ' Gene Arrangement ', ' Bioinformatics ', ' Bio-Informatics ', ' Data ', ' Detection ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' clinically relevant ', ' clinical relevance ', ' open source ', ' human disease ', ' high risk ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' screening ', ' rare variant ', ' rare allele ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' Genetic study ', ' learning strategy ', ' learning method ', ' learning activity ', ' survival outcome ', ' ']",NLM,DARTMOUTH COLLEGE,R01,2017,352350,NH-02,0.005155430180847282
"Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia     DESCRIPTION (provided by applicant): Schizophrenia (SZ) represents a significant and costly public health burden. Recently, we have witnessed the emergence of the first molecular insights into the etiopathogenic mechanisms of SZ, via the first genome-wide association studies (GWAS) with sufficient case-control sample sizes to detect allelic effects. Importantly, a polygenic signature, which includes genome-wide significant common genetic variants of small effect, has been clearly demonstrated to influence SZ risk. The availability of well-defined risk factors makes it possible, for the first time, to address several critical questions about the genetic architecture of SZ and its component phenotypes and endophenotypes. The overarching goals of this K01 proposal are 1) to test polygenic risk score prediction of dimensional SZ and schizotypy phenotypes across large case, high-density SZ pedigree, and prodromal-aged GWAS samples, and 2) to develop and test, with leaders of the Psychiatric Genomics Consortium, innovative statistical methods to identify and characterize ""genetic subtypes"" of SZ.  This proposal delineates a series of training and research goals for the candidate that incorporates strengths from phenotypic assessment, statistical genetics, and molecular genetics and combines samples reflecting a broad range of genetic risk. The candidate will capitalize on previously established expertise in schizotypy and clinical risk assessment, as well as expertise in the familial transmission of dimensional traits, to establish a program of translational research wherein the application of statistical genetic/bioinformatic techniques to genetic subtyping analyses will be used to generate promising candidates for further exploration in human genomic data. Empirically-based genetic subtyping methods will be developed and tested in the largest SZ case sample to date, and subtypes will be characterized with respect to dimensional phenotypic traits. Top loci hits in subtype analyses of dimensional symptoms will be validated in secondary analyses of differential gene expression in post-mortem SZ brain. This will allow for a detailed analysis of function at both the SNP and gene levels, and will provide the candidate with substantive training in both statistical and molecular genetics methods. The institutional environment is ideal for the candidate's goal of developing a comprehensive program in SZ research, and the proposed research represents an important contribution toward advancing the understanding of SZ through a combination of clinical, statistical, molecular, and translational methods, consistent with the mission of the NIMH. PUBLIC HEALTH RELEVANCE: Mental illnesses such as schizophrenia constitute 13% of the global burden of disease and schizophrenia, although relatively rare, is highly heritable (80%) and one of the most severe mental disorders. This project aims to elucidate the influence of genetic factors and gene function on dimensional schizophrenia and schizotypy symptoms with multiple measures, across multiple samples of varying genetic risk. Insights gained from this research will inform prediction, prevention, intervention, and treatment efforts by clarifying the biological mechanisms underlying SZ symptoms.",Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia,9429123,K01MH109765,"['Accounting ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' alcohol consumed ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alleles ', ' Allelomorphs ', ' Autopsy ', ' postmortem ', ' necropsy ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' Classification ', ' Systematics ', ' Disease ', ' Disorder ', ' Environment ', ' Gene Expression ', ' Genes ', ' Goals ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Interview ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Maps ', ' Mentors ', ' Methods ', ' Mission ', ' National Institute of Mental Health ', ' NIMH ', ' genetic pedigree ', ' pedigree structure ', ' Pedigree ', ' Personality ', ' Phenotype ', ' Genetic Polymorphism ', ' polymorphism ', ' Psychotic Disorders ', ' psychotic illness ', ' Psychoses ', ' Public Health ', ' Questionnaires ', ' Research ', ' Risk ', ' Risk Factors ', ' Sampling Studies ', ' Schizophrenia ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizotypal Personality Disorder ', ' schizotypal ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Students ', ' Suicide attempt ', ' suicidal attempt ', ' nonfatal attempt ', ' non fatal attempt ', ' Testing ', ' Time ', ' Trees ', ' Wisconsin ', ' Measures ', ' Molecular Genetics ', ' Risk Assessment ', ' Prefrontal Cortex ', ' base ', ' density ', ' improved ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Series ', ' Age of Onset ', ' Training ', ' insight ', ' Individual ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Malignant neoplasm of lung ', ' Measurement ', ' Sample Size ', ' Genetic Heterogeneity ', ' Collaborations ', ' Genetic ', ' gene function ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Dimensions ', ' Complex ', ' Techniques ', ' brain tissue ', ' mind control ', ' brain control ', ' Performance ', ' trait ', ' Structure ', ' novel ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' response ', ' theories ', ' case control ', ' disorder subtype ', ' disease subtype ', ' disease subgroups ', ' Genomics ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Malignant neoplasm of ovary ', ' ovarian cancer ', ' Ovary Cancer ', ' Malignant Tumor of the Ovary ', ' Malignant Ovarian Tumor ', ' Malignant Ovarian Neoplasm ', ' Bioinformatics ', ' Bio-Informatics ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Address ', ' Symptoms ', ' Data ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Subgroup ', ' Genetic Risk ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' Transcript ', ' Validation ', ' Transmission ', ' transmission process ', ' Molecular ', ' Process ', ' sex ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' cost ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' burden of illness ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' severe mental illness ', ' Outcome ', ' aged ', ' innovative ', ' innovate ', ' innovation ', ' Heritability ', ' endophenotype ', ' public health relevance ', ' genomewide ', ' genome scale ', ' genome-wide ', ' cocaine use ', ' clinical risk ', ' RDoC ', ' Research Domain Criteria ', ' transcriptional differences ', ' differentially expressed ', ' differential expression ', ' cannabis use ', ' THC use ', ' THC co-use ', ' marijuana use ', ' Gaussianity model ', ' Gaussianity ', ' Gaussian statistics ', ' Gaussian model ', ' training opportunity ', ' dimensional analysis ', ' genomic data ', ' symptomatology ', ' substance misuse ', ' population stratification ', ' secondary analysis ', ' translation research enterprise ', ' Translational Research Enterprise ', ' translational research program ', ' nicotine consumption ', ' nicotine use ', ' genetic architecture ', ' ']",NIMH,UNIVERSITY OF UTAH,K01,2018,178674,UT-02,0.029512319638808373
"From GWAS loci to blood pressure genes, variants & mechanisms The current forward genetics of genome-wide association studies (GWAS) have successfully identified ~300 distinct loci regulating blood pressure (BP), primarily implicating sequence variation within the non-coding genome. However, for precision medicine of hypertension (HTN), a major challenge for public health, mechanistic identification of the genomic components altering the expression of BP genes is required. To solve this important bottleneck, we use a functional genomics inspired reverse genetics strategy to identify the transcription factors (TF), cis-regulatory elements (CRE), DNA variants and BP genes in four BP relevant tissues. Taking advantage of the analytical expertise and collaborations within the Family Blood Pressure Program Essential Hypertension GWAS consortium (FEHGAS3), and newly developed experimental and computational tools, we propose a novel framework for discovering the functional genetic modules, at identified BP loci and genome-wide, affecting inter-individual BP variation. Our approach enables answers to long-standing questions in BP genomics and physiology, with lessons for understanding many other complex diseases. We propose three major aims: (1) Identifying the transcription factors (TF), enhancers (CRE) and expressed genes in BP-relevant tissues; (2) Connecting enhancer (CRE) variation to gene expression and BP variation; and, (3) Identifying causal mechanisms that modulate BP to provide translational insights. No changes from original submission Contact PD/PI: Chakravarti, Aravinda The major hypothesis explaining the results of blood pressure (BP) genome-wide association studies (GWAS) is that sequence variants at specific cis-regulatory elements (CRE or enhancer) affect the binding of their cognate transcription factors (TF) to alter expression of specific BP genes. In this second renewal of the FEHGAS consortium, we propose new computational and experimental approaches to identify the TFs, CREs, and target genes, active in four blood pressure target tissues, so that the effects of causal BP affecting genetic variation can be tested, within identified BP loci and genome-wide. This tissue-based view provides an alternative, complementary approach for understanding how BP variation leads to primary hypertension and hypertensive target organ damage, a major public health challenge. Project Narrative Page 8 No change to original submission","From GWAS loci to blood pressure genes, variants & mechanisms",9671237,R01HL086694,"['Adrenal Glands ', ' suprarenal gland ', ' Adrenals ', ' Affect ', ' Algorithms ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood Pressure ', ' Blood Vessels ', ' vascular ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cells ', ' Cell Body ', ' Chromatin ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Family ', ' Gene Cluster ', ' Gene Expression ', ' Gene Frequency ', ' allelic frequency ', ' Allele Frequency ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genetic Screening ', ' Genome ', ' Genotype ', ' Goals ', ' Health ', ' Heart ', ' Hypertension ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Joints ', ' Kidney ', ' renal ', ' Kidney Urinary System ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Maps ', ' Methods ', ' Minor ', ' Physiology ', ' pressure ', ' Public Health ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' statistics ', ' Testing ', ' Tissues ', ' Body Tissues ', ' transcription factor ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Variation ', ' Genetic Diversity ', ' Essential Hypertension ', ' primary hypertension ', ' idiopathic hypertension ', ' Enhancers ', ' Data Set ', ' Dataset ', ' base ', ' Organ ', ' Variation ', ' Variant ', ' Biological ', ' insight ', ' Individual ', ' Gene Targeting ', ' Sample Size ', ' Collaborations ', ' Therapeutic ', ' Genetic ', ' Reporter ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Physiologic pulse ', ' Pulse ', ' Frequencies ', ' Complex ', ' cell type ', ' receptor ', ' Receptor Protein ', ' trait ', ' Base Pairing ', ' blood pressure regulation ', ' regulate blood pressure ', ' regulate BP ', ' blood pressure management ', ' blood pressure homeostasis ', ' blood pressure control ', ' BP regulation ', ' BP management ', ' BP homeostasis ', ' BP control ', ' novel ', ' protein protein interaction ', ' functional genomics ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' Smooth Muscle Myocytes ', ' Smooth Muscle Tissue Cell ', ' Smooth Muscle Cells ', ' Leiomyocyte ', ' Binding ', ' Molecular Interaction ', ' Data ', ' Regulatory Element ', ' NHLBI ', ' National Heart, Lung, and Blood Institute ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' epigenomics ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' computational tools ', ' computerized tools ', ' genomewide ', ' genome scale ', ' genome-wide ', ' biorepository ', ' biobank ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' forward genetics ', ' rare allele ', ' rare variant ', ' precision-based medicine ', ' precision medicine ', ' DNaseI-seq ', ' DNase-seq ', ' DNase I hypersensitive sites sequencing ', ' reverse genetics ', ' ATACseq ', ' ATAC-seq ', ' phenotypic data ', ' GTEx ', ' Genotype-Tissue Expression Project ', ' TOPMed ', ' Trans-Omics for Precision Medicine ', ' blood pressure medicine ', ' blood pressure medication ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2018,676888,NY-12,-0.003620159381133954
"Cardiac genetic effects across HLBS phenotypes Forward genetic genome-wide association studies (GWAS) have successfully mapped thousands of loci regulating disorders of the heart, lung, blood and sleep (HLBS), implicating widespread sequence variation within the non-coding genome. However, their functions, mechanisms of action and how they impact disease is still unclear. To solve this new and important GWAS bottleneck, we use a functional genomics-inspired reverse genetics strategy to identify the `transcriptional machinery' (transcription factors (TF), cis-regulatory elements (CRE), target genes) controlling HLBS-relevant tissue functions and how DNA variants in them affect HLBS diseases. Taking advantage of our long-standing expertise and successes in complex, cardiovascular disorders, and novel computational methods we have recently developed, we propose novel genomics analyses of the Trans-Omics for Precision Medicine (TOPMed) Program phenotypes and their whole genome sequences, together with publicly available epigenomics data, to identify the molecular bases of HLBS disease. We will first focus on the transcriptional machinery controlling heart physiology and its disorders before exploring other HLBS-relevant tissues and disorders in collaboration with other TOPMed investigators. Our specific aims are: (1) Identifying the transcriptional machinery in the heart and other HLBS relevant tissues; and, (2) Connecting genomic variation in the transcriptional machinery to HLBS traits. Our approach will enable identification of the core molecular components that control HLBS tissues and how they are compromised in HLBS disorders. The major hypothesis explaining the results of heart, lung, blood and sleep (HLBS) genome-wide association studies (GWAS) is that sequence variants at specific cis-regulatory elements (CRE or enhancer) affect the binding of their cognate transcription factors (TF) to alter expression of specific HLBS genes and, thereby, modulate variation in the phenotype and disorders. In this proposal, we advance new computational approaches to identify the `transcriptional machinery' (TF, CRE, target genes) controlling HLBS-relevant tissue functions so that the effects of causal genetic variation can be identified within identified trait loci genome- wide. This tissue-based view provides an alternative, complementary approach for understanding HLBS trait and disease variation, a major public health challenge.",Cardiac genetic effects across HLBS phenotypes,9521873,R01HL141980,"['Affect ', ' Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Chromatin ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Family ', ' Gene Expression ', ' Gene Frequency ', ' allelic frequency ', ' Allele Frequency ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genome ', ' Genotype ', ' Heart ', ' Heart Diseases ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Hematological Disease ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lung ', ' pulmonary ', ' Lung Respiratory System ', ' Lung diseases ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Maps ', ' Minor ', ' United States National Institutes of Health ', ' National Institutes of Health ', ' NIH ', ' Phenotype ', ' Physiology ', ' Public Health ', ' Publishing ', ' Quality Control ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Sleep ', ' Testing ', ' Tissues ', ' Body Tissues ', ' transcription factor ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Variation ', ' Genetic Diversity ', ' Weight ', ' Enhancers ', ' base ', ' improved ', ' Peripheral ', ' Variation ', ' Variant ', ' Link ', ' Individual ', ' Gene Targeting ', ' Sample Size ', ' Collaborations ', ' Genetic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Complex ', ' success ', ' trait ', ' Base Pairing ', ' novel ', ' Code ', ' Coding System ', ' Sleep Disorders ', ' sleep problem ', ' Modeling ', ' functional genomics ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' histone modification ', ' Binding ', ' Molecular Interaction ', ' Data ', ' Regulatory Element ', ' Molecular ', ' Cardiac ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' epigenomics ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' genome-wide identification ', ' genome wide studies ', ' genome wide analysis ', ' genome-wide analysis ', ' discover genes ', ' gene discovery ', ' genomewide ', ' genome scale ', ' genome-wide ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' rare allele ', ' rare variant ', ' DNaseI-seq ', ' DNase-seq ', ' DNase I hypersensitive sites sequencing ', ' genomic variation ', ' reverse genetics ', ' ATACseq ', ' ATAC-seq ', ' GTEx ', ' Genotype-Tissue Expression Project ', ' full genome ', ' entire genome ', ' whole genome ', ' genomic data ', ' TOPMed ', ' Trans-Omics for Precision Medicine ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2018,438051,NY-12,-0.005753053521484095
"IBD Gene Mapping by Clinical and Population Subset PROJECT SUMMARY Inflammatory bowel disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC) are complex genetic disorders of the gastrointestinal tract, and a major health burden to patients and society. Tremendous progress has been made in dissecting IBD genetic etiology with identification of over 200 IBD loci by genome wide association studies (GWAS) but mainly limited to persons of European ancestry. The IBD Genetics Consortium (IBDGC) was established to facilitate multicenter collaborative studies of 6 Genetics Research Centers (GRCs) organized with a Data Coordinating Center (DCC). Our GRC at Johns Hopkins (JHGRC) has contributed to all IBDGC studies, meeting recruitment objectives and taking roles in IBDGC leadership positions. Our particular focus is on African American (AA) IBD genetics. We performed the first large-scale evaluation of European loci in the AA population, replicating several genes, but also finding unique African-ancestral variants within these loci, as well as identified multiple admixture significant loci. We also published the first AA IBD genome-wide association study (GWAS), a collaborative effort that identified two African-specific gene loci, and replicated multiple additional European loci. We have also explored why some loci with proven risk variants in Europeans and other populations only cause disease in one ancestral population but not others. More research in AA IBD is needed to understand the etiology of IBD in this ancestrally distinct, major American population. In this application we will re-evaluate the AA GWAS by better imputation, evaluate whole genome sequencing data to test low frequency and rare variants, and perform an evaluation for chromosome X variants. We will recruit a large number of AA IBD patients through our own and multiple Satellite Recruitment Centers to power a second AA IBD GWAS, both UC and CD, and meta-analyze with the first to identify more novel loci, identify more African specific risk variants, and replicate known loci for this population and replicate our admixture loci. We will also incorporate diverse data sources to incorporate into our GWAS analyses including RNA-Seq currently being generated on lymophoblastoid cell lines from AA CD cases and controls, and RNA-Seq that we will generate in colonic biopsies from UC cases and controls. We will evaluate chromatin differences and expression of genes in cell types relevant to IBD from European, AA and East Asian ancestries in an effort to better understand locus heterogeneity by ancestry. We will continue to participate in all IBDGC activities to maximize the Impact of IBD genetics research by this cooperative funding mechanism. According to the Center for Disease Control and Prevention, an estimated 1.4 million Americans suffer from Inflammatory Bowel Disease (IBD), a chronic debilitating disorder with no cure that includes Crohn's disease and ulcerative colitis. IBD ranks in the top 5 in prevalence for gastrointestinal disorders and represents a significant financial burden to society requiring a lifetime of medical care. This proposed research aims to determine the genetic variations that cause IBD which will aid in developing preventive measures, improving the quality of care with better treatments and educating patients through genetic counseling.",IBD Gene Mapping by Clinical and Population Subset,9567544,U01DK062431,"['Algorithms ', ' Biopsy ', ' Cell Line ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Centers for Disease Control and Prevention (U.S.) ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Charge ', ' Chromatin ', ' Chromosome Mapping ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Cohort Studies ', ' Concurrent Studies ', ' Ulcerative Colitis ', ' Ulcerated Colitis ', "" Crohn's disease "", ' regional enteritis ', ' eleocolitis ', ' Granulomatous Enteritis ', "" Crohn's disorder "", "" Crohn's "", ' Crohn disease ', ' Data Sources ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Epithelium ', ' Epithelium Part ', ' Future ', ' Gastrointestinal Diseases ', ' gastrointestinal disorder ', ' Gastrointestinal Diseases and Manifestations ', ' Gastrointestinal tract structure ', ' digestive canal ', ' alimentary tract ', ' Gastrointestinal Tract ', ' GI Tract ', ' Digestive Tract ', ' Alimentary Canal ', ' Gene Expression ', ' Gene Frequency ', ' allelic frequency ', ' Allele Frequency ', ' Genes ', ' Genetic Counseling ', ' Population Genetics ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Inflammatory Bowel Diseases ', ' Inflammatory Intestinal Disorder ', ' Inflammatory Intestinal Disease ', ' Inflammatory Bowel Disorder ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Leadership ', ' Linkage Disequilibrium ', ' macrophage ', ' Persons ', ' Patients ', ' Phenotype ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Societies ', ' Testing ', ' Universities ', ' Genetic Variation ', ' Genetic Diversity ', ' Work ', ' X Chromosome ', ' Asians ', ' oriental ', ' African American ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' Enhancers ', ' Hispanics ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Caring ', ' Point Mutation ', ' base ', ' improved ', ' Chronic ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Medical ', ' Evaluation ', ' insight ', ' Individual ', ' African ', ' European ', ' Fostering ', ' data base ', ' Data Bases ', ' Databases ', ' Genetic Research ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Collaborations ', ' Coculture ', ' Cocultivation ', ' Co-culture ', ' Coculture Techniques ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Frequencies ', ' Complex ', ' Source ', ' cell type ', ' Pattern ', ' interest ', ' meetings ', ' American ', ' experience ', ' novel ', ' Positioning Attribute ', ' Position ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' Sampling ', ' Human Characteristics ', ' Human Nature ', ' Quality of Care ', ' QOC ', ' case control ', ' Effectiveness ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' genome sequencing ', ' Admixture ', ' Data ', ' Funding Mechanisms ', ' Other Genetics ', ' Update ', ' sex ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' Data Coordination Center ', ' Data Coordinating Center ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' novel strategies ', ' Population ', ' Prevalence ', ' 2-dimensional ', ' two-dimensional ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' rare allele ', ' rare variant ', ' race disparity ', ' disparities in race ', ' racial disparity ', ' ATACseq ', ' ATAC-seq ', ' transcriptional differences ', ' differentially expressed ', ' differential expression ', ' Preventative measure ', ' Preventive measure ', ' study population ', ' full genome ', ' entire genome ', ' whole genome ', ' recruit ', ' genetic disorder ', ' genetic condition ', ' Genetic Diseases ', ' ']",NIDDK,RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,U01,2018,477338,NJ-06,-0.007792464269271461
"Genetic Factors in Keratoconus DESCRIPTION (provided by applicant): The purpose of this grant is to develop techniques for use in the 'early' detection of keratoconus (KC) and identify genetic variants that contribute to is development. KC is a complex genetic eye disorder and a leading cause of corneal transplantation in the young, with approximately 300,000 affected individuals in the US. Undiagnosed, subclinical KC is one of the major causes for complications of LASIK (Laser-in-situ- Keratomilieusis) surgery, commonly performed for vision correction. In the past two decades we have made major improvements to the early diagnosis of KC and have also made significant contributions to the delineation of major genetic determinants of KC through genome wide linkage studies (GWLS), fine mapping, and genome wide association studies (GWAS). In this proposal, we intend to follow up on these studies using new powerful approaches to achieve the following specific aims: In Aim 1 we will combine corneal optical coherence tomography (OCT) and Pentacam HR Scheimpflug Tomography (PST), new technologies that measure both the anterior and posterior surface of the cornea, with videokeratography (VK), a method which revolutionized KC diagnosis, to characterize criteria and to improve the diagnosis of subclinical KC. In Aim 2, to identify additional KC genes, we will perform a 2.5 million SNP GWAS, with an additional 6,000 SNPs, to fine- map already identified genes. We will confirm these results in a separate cohort of KC patients. For this two- stage GWAS design we are assembling the largest group of KC patients described to date: 2000 KC patients in total, 1,000 for the GWAS discovery stage and 1,000 for the confirmation stage. The controls for GWAS discovery will come from the Cardiovascular Health Study (CHS; 3300) and for confirmation will come from 400 subjects with VK, PST, and OCT measurements under Aim 1 and 600 ""convenience controls"" from the Cholesterol and Pharmacogenetics (CAP) study. In our current state of knowledge, the most cost-effective approach to increase the number of identified KC genes is to proceed with the expanded GWAS proposed herein. In Aim 3, we will test the impact of the genes identified in Aim 2 on the 'early' subclinical phenotypes identified through the use o VK, PST and OCT measures in Aim 1. Lastly, for the second part of Aim 3, we will investigate the potential function of KC variants by testing their ability to influence gene structure, expression and function in corneal cell models, including iPS cells derived from corneal keratocytes developed by our research team. The results of these studies will help advance our understanding of the genetic susceptibility to KC and may result in novel treatment options to slow the progression of the disease. PUBLIC HEALTH RELEVANCE: Improving methods for the 'early' detection of keratoconus will help patients avoid complications of LASIK surgery, allow us to identify genetic variants that contribute to its development, and design therapies to retard its progression.",Genetic Factors in Keratoconus,9467545,R01EY009052,"['Affect ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Cells ', ' Cell Body ', ' Cornea ', ' corneal ', ' Keratoplasty ', ' corneal transplant ', ' corneal keratoplasty ', ' Corneal Transplantation ', ' Corneal Grafting ', ' Cornea Transplantation ', ' Diagnosis ', ' Discriminant Analysis ', ' Discriminant Analyses ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Eye ', ' Eyeball ', ' Eye diseases ', ' ophthalmopathy ', ' eye disorder ', ' Genes ', ' Genotype ', ' Grant ', ' Immunohistochemistry ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' indexing ', ' Keratoconus ', ' Lasers ', ' Laser Radiation ', ' Laser Electromagnetic ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Literature ', ' Maps ', ' Methods ', ' Patients ', ' Pharmacogenetics ', ' Phenotype ', ' Research ', ' Research Design ', ' study design ', ' Study Type ', ' Risk ', ' Testing ', ' Time ', ' tomography ', ' Genetic Transcription ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Variation ', ' Genetic Diversity ', ' Vision ', ' visual function ', ' Sight ', ' Measures ', ' Family member ', ' Custom ', ' base ', ' improved ', ' Anterior ', ' Surface ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Collaborations ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' In Situ ', ' Techniques ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Early Diagnosis ', ' early detection ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' cohort ', ' trait ', ' Videokeratographies ', ' Videokeratography ', ' novel ', ' new technology ', ' novel technologies ', ' Pathogenesis ', ' Laser In Situ Keratomileusis ', ' Laser-Assisted Stromal In Situ Keratomileusis ', ' Laser Intrastromal Keratomileusis ', ' Laser Intrastromal Keratomileuses ', ' LASIK ', ' Optical Coherence Tomography ', ' optical coherence Doppler tomography ', ' optical Doppler tomography ', ' OCT Tomography ', ' Doppler OCT ', ' Genetic Determinism ', ' genetic determinant ', ' Bioinformatics ', ' Bio-Informatics ', ' protein expression ', ' prevent ', ' preventing ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' genetic association ', ' Data ', ' Gene Structure/Organization ', ' Gene Organization ', ' Gene Structure ', ' Molecular ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' protein function ', ' developmental ', ' Development ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' designing ', ' design ', ' cost-effective ', ' cost effective ', ' susceptibility variant ', ' susceptibility locus ', ' susceptibility allele ', ' predisposing gene ', ' Predisposition gene ', ' Susceptibility Gene ', ' Cellular model ', ' Cell model ', ' manage cholesterol ', ' cholesterol management ', ' cholesterol control ', ' iPSCs ', ' iPSC ', ' iPS ', ' induced pluripotent stem cell ', ' treatment design ', ' intervention design ', ' therapy design ', ' genomewide linkage ', ' genome-wide linkage ', ' public health relevance ', ' cardiovascular health ', ' BeadChip ', ' bead chip ', ' ']",NEI,CEDARS-SINAI MEDICAL CENTER,R01,2018,759253,CA-28,0.03201496200991613
"Identification of epigenetic subclones in lymphomas and leukemias Abstract Epigenetic modifications, such as DNA methylation, play a significant role in human disease. DNA methylation is altered in cancer, and DNA methylation-induced silencing of promoters of tumor-suppressors is thought to play a key role in tumorigenesis. Though there is an increasing number of methylation sequencing datasets generated from cancer, they are confounded by tumor heterogeneity. Understanding the subclonal architecture underlying heterogeneity is important because individual cancer subclones impact cancer growth, treatment resistance, and metastasis. Increased epigenetic heterogeneity, or variation in DNA methylation patterns, was determined to be correlated with worse prognosis in patients with diffuse large B-cell lymphoma (DLBCL) and acute myeloid leukemia (AML). However, these studies only profiled epigenetic heterogeneity at a global scale and did not analyze methylation of individual subclones. Many computational methods have been developed for this purpose in epigenome-wide association studies (EWAS), but these methods are not applicable for methylation sequencing data. As such, there is a need to develop new computational methods to study subclonal methylation profiles in cancer. I will develop a novel computational method (DXM) that deconvolves DNA methylation of heterogeneous clinical samples into their major subpopulations, their prevalence, and their respective DNA methylation profiles (Aim 1). DXM will be developed on simulations generated from data available from both the Roadmap Epigenomics Project and the Blueprint Epigenome Project and will be validated with methylation sequencing on DLBCL samples. I will then leverage DXM to study subclonal methylation profiles in AML (Aim 2). I hypothesize that methylation can confer fitness advantages in epigenetic subclones of AML, leading to clonal expansion following therapeutic intervention and subsequent relapse. Using DXM, I will first identify epigenetic subclones from whole genome bisulfite sequencing data from AML patients with well-characterized genetic subclonal architecture and compare the epigenetic subclonal architecture to that of the genetic subclones. In a second dataset containing methylation sequencing data from paired diagnosis-relapse samples, I will apply DXM, identify subclonal methylation profiles, and characterize all genes impacted by subclonal methylation to determine if they are expected to confer fitness advantages. Finally, I will test if mutations known to impact DNA methylation in AML (DNMT3A, IDH1/2) alter epigenetic subclonal expansion. Taken together, this proposal will result in a new computational approach to interpret epigenetic data from heterogeneous clinical samples as well as identification of DNA methylation changes in epigenetic subclones of AML that contribute to disease progression and correlate with prognosis. Project Narrative Studies that characterize which variations in cancer relate to worse outcome may do analysis on the entire tumor sample, which is composed of many different types of cells, each with distinct biology. The goal of this proposal is to develop a novel computational method to analyze variations in cancer at the level of cell-types. These results can be used to improve patient prognostics and care in multiple cancers.",Identification of epigenetic subclones in lymphomas and leukemias,9611428,F30CA224687,"['Algorithms ', ' Antibodies ', ' Architecture ', ' Engineering / Architecture ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cells ', ' Cell Body ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Diagnosis ', ' Future ', ' Gene Expression ', ' Genes ', ' Genome ', ' Goals ', ' Growth ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Heterogeneity ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Acute Myelocytic Leukemia ', ' acute myeloid leukemia ', ' acute granulocytic leukemia ', ' Acute Myelogenous Leukemia ', ' Acute Myeloblastic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Mentorship ', ' Methods ', ' Methylation ', ' Mutation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Neoplasm Metastasis ', ' tumor cell metastasis ', ' cancer metastasis ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastatic Mass ', ' Metastatic Lesion ', ' Metastasize ', ' Metastasis ', ' Pathology ', ' Patients ', ' Physicians ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Relapse ', ' Role ', ' social role ', ' statistics ', ' Testing ', ' Tumor Promoters ', ' United States ', ' X Inactivation ', ' X-Chromosome Inactivation ', ' Lyonization ', ' CpG dinucleotide ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' bisulfite ', ' hydrosulfite ', ' hydrogen sulfite ', ' Fluorescence-Activated Cell Sorting ', ' Fluorescence-Activated Cell Sortings ', ' Fluorescence Activated Cell Sorting Fractionation ', ' Tumor Suppressor Genes ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' promoter ', ' promotor ', ' Data Set ', ' Dataset ', ' Caring ', ' career ', ' improved ', ' Surface ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' prognostic ', ' Training ', ' Individual ', ' Parental Imprinting ', ' Genetic Imprinting ', ' Genomic Imprinting ', ' Disease Progression ', ' Genetic ', "" large cell Diffuse non-Hodgkin's lymphoma "", ' Diffuse Large B-Cell Lymphoma ', ' DLBCL ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' Scientist ', ' Frequencies ', ' Complex ', ' cell type ', ' Tumor Suppressor Proteins ', ' tumor suppressor ', ' Retrotransposon ', ' simulation ', ' novel ', ' Therapeutic Intervention ', ' intervention therapy ', ' Sampling ', ' Bioinformatics ', ' Bio-Informatics ', ' tumorigenesis ', ' Oncogenesis ', ' genome sequencing ', ' Address ', ' fitness ', ' Data ', ' Cancer Biology ', ' Cancer Patient ', ' Clonal Expansion ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' Newly Diagnosed ', ' Modification ', ' developmental ', ' Development ', ' treatment resistance ', ' therapeutic resistance ', ' resistant to therapy ', ' resistance to therapy ', ' therapy resistant ', ' epigenomics ', ' cancer research ', ' anti-cancer research ', ' anticancer research ', ' designing ', ' design ', ' Outcome ', ' lymphoma/leukemia ', ' leukemia/lymphoma ', ' Prevalence ', ' human disease ', ' tumor ', ' clinical care ', ' epigenome ', ' methylation pattern ', ' single cell sequencing ', ' bisulfite-seq ', ' Bisulfite-based sequencing ', ' BS-seq ', ' bisulfite sequencing ', ' epigenome wide association analysis ', ' EWAS ', ' epigenome-wide association studies ', ' stratified patient ', ' patient stratification ', ' intratumor heterogeneity ', ' intra-tumoral heterogeneity ', ' heterogeneity in tumors ', ' Intratumoral heterogeneity ', ' tumor heterogeneity ', ' full genome ', ' entire genome ', ' whole genome ', ' ']",NCI,WASHINGTON UNIVERSITY,F30,2018,30434,MO-01,0.022565372541578105
"Identification of gene-gene interactions in relation to risk of esophageal adenocarcinoma and Barrett's esophagus PROJECT SUMMARY / ABSTRACT Esophageal adenocarcinoma (EA) is an often lethal cancer and a significant public health concern in the U.S. Several risk factors have been identified for EA and its precursor, Barrett's esophagus (BE), including symptomatic gastroesophageal reflux disease (GERD), central adiposity, smoking, male sex, and European ancestry, but our understanding of the molecular/genetic determinants that govern why most people with reflux never develop BE, and most with BE never progress to EA, remains limited. Inherited genetics represents another likely contributor to disease susceptibility, and recent genome-wide association studies (GWAS) within the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) have identified multiple novel germline genetic variants associated with altered risk of BE/EA. As observed for other cancers and complex diseases, however, the majority of estimated heritability for BE and EA appears unexplained. One plausible source for this missing heritability lies in the joint effects of multiple loci acting in combination. We seek to identify novel gene-gene interactions (GG) in relation to risk of BE/EA, using a novel fusion of advanced analytical approaches aimed at overcoming technical limitations often encountered in the conduct of large-scale GG (e.g. computational complexity and low statistical power). In a discovery scan (Aim 1), we initially will use two complementary knowledge-guided filtering methods to reduce the dimensionality of the GG search space: first, we select ~500 genes with known or hypothesized relationships to BE/EA etiology and pathogenesis based on findings from GWAS, TCGA, and related studies; second, we select ~50,000 gene-gene pairs with highest-likelihood annotated biological relationships based on an integrated knowledge resource of pathways, processes, and interactions (Biofiler). Using existing germline genetic data on 2515 EA patients, 3295 BE patients, and 3207 controls from BEACON, we next will adopt a recently-described `hierarchical group-lasso' machine learning framework to select, in a joint model, ~1000 candidate pairwise SNP-SNP interactions most predictive of case status. These interactions are then evaluated using an independent validation dataset of 1609 EA cases, 1037 BE cases, and 3537 controls (Aim 2), using standard logistic regression models. In exploratory work, we will perform stratified analyses by sex or smoking history. The proposed studies are anticipated to expand our basic understanding of key biological pathways and mechanisms underlying the emergence of BE/EA; generate new leads and possible candidate targets for interventional strategies; and expand the foundation for future collaborative initiatives to integrate genetic, epidemiologic, and clinical data into robust disease models and novel predictive tools for BE/EA risk assessment and precision prevention. PROJECT NARRATIVE (PUBLIC HEALTH RELEVANCE) Esophageal adenocarcinoma (EA) is an often lethal cancer that represents a significant public health burden in the U.S. In this proposal, we capitalize on the availability of large-scale existing datasets derived from expensive multi-year international collaborations, and perform new analyses to improve our understanding of how inherited gene variants interact to influence susceptibility to EA and its precursor, Barrett's esophagus (BE). Findings from this study will expand our basic understanding of key biological pathways underlying this cancer and ultimately help advance the development of better strategies for prevention and treatment.",Identification of gene-gene interactions in relation to risk of esophageal adenocarcinoma and Barrett's esophagus,9590939,R03CA223731,"['Barrett Esophagus ', ' Columnar-Lined Esophagus ', ' Columnar Epithelial-Lined Lower Esophagus ', ' Barrett Ulcer ', ' Barrett Syndrome ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Disease ', ' Disorder ', ' Disease susceptibility ', ' liability to disease ', ' Diathesis ', ' Elements ', ' Epidemiology ', ' epidemiological ', ' epidemiologic ', ' Foundations ', ' Future ', ' Gastroesophageal reflux disease ', ' Gastroesophageal Reflux ', ' Gastro-oesophageal Reflux ', ' GERD ', ' Esophageal Reflux ', ' Acid Reflux ', ' Genes ', ' Genotype ', ' Incidence ', ' Inflammation ', ' Joints ', ' Learning ', ' Life Style ', ' Lifestyle ', ' male ', ' Methods ', ' Methodology ', ' Obesity ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Patients ', ' Public Health ', ' Research ', ' Resources ', ' Research Resources ', ' Risk ', ' Risk Factors ', ' Role ', ' social role ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Smoking ', ' Supervision ', ' Testing ', ' Work ', ' Molecular Genetics ', ' Risk Assessment ', ' Lasso ', ' Data Set ', ' Dataset ', ' base ', ' improved ', ' Chronic ', ' Phase ', ' Biological ', ' Logistic Regressions ', ' Ensure ', ' Evaluation ', ' Susceptibility ', ' Predisposition ', ' Lesion ', ' Upper Gastrointestinal Tract ', ' Upper GI Tract ', ' Upper digestive tract structure ', ' Reflux ', ' insight ', ' European ', ' root ', ' Plant Roots ', ' Adenocarcinoma of the Esophagus ', ' Esophageal Adenocarcinoma ', ' Collaborations ', ' Genetic ', ' Metaplastic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Adopted ', ' Dimensions ', ' Inherited ', ' Hereditary ', ' Complex ', ' Dependence ', ' Scanning ', ' Source ', ' Techniques ', ' gene interaction ', ' Intercept ', ' knowledge base ', ' knowledgebase ', ' Informatics ', ' novel ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' disorder risk ', ' disease risk ', ' Disease model ', ' disorder model ', ' Pathogenesis ', ' Therapeutic Intervention ', ' intervention therapy ', ' Statistical Methods ', ' Modeling ', ' response ', ' protein protein interaction ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genetic Determinism ', ' genetic determinant ', ' text searching ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Address ', ' Data ', ' Information Resources ', ' knowledge resources ', ' knowledge resource ', ' information resource ', ' International ', ' Molecular Target ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Subgroup ', ' Clinical Data ', ' Smoking History ', ' Validation ', ' Molecular ', ' Process ', ' sex ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' Advanced Development ', ' Coupling ', ' Heritability ', ' multidisciplinary ', ' public health relevance ', ' genomewide ', ' genome scale ', ' genome-wide ', ' Epidemiology data ', ' Epidemiological data ', ' epidemiologic data ', ' TCGA ', ' The Cancer Genome Atlas ', ' precision prevention ', ' personalized prevention ', ' individualized prevention ', ' clinically actionable ', ' predictive tools ', ' high dimensionality ', ' genetic architecture ', ' ']",NCI,ROSWELL PARK CANCER INSTITUTE CORP,R03,2018,93591,NY-26,0.01000517079334853
"Gene-Environment Interactions in Glaucoma Primary open-angle glaucoma (POAG) is the leading cause of chronic optic neuropathy and a major source of ocular morbidity worldwide. Understanding preclinical events, early phase disease and disease heterogeneity represent key objectives in early disease detection, prevention and treatment of POAG. In this study, we propose 4 specific aims. 1) We will perform both targeted and untargeted metabolome-wide association studies (MWAS) for POAG using pre-clinical serum from a large case-control group (500 cases and 500 controls) nested within ongoing prospective studies of the Nurses' Health Study (NHS), NHS2, and Health Professionals Follow-up Study (HPFS) to advance our understanding of the biochemical events that precede POAG diagnosis (blood was collected ~ 10 years prior to disease diagnosis). Prior studies suggest that nitric oxide metabolites represent genetically informed markers and will form the basis for targeted profiling. 2) While considerable discoveries have been made of POAG genes, more work is needed to leverage genome-wide information to inform POAG etiology. Thus, we will create a genome-wide genetic correlation matrix between POAG and complex traits previously linked to POAG, using data from the NEIGHBORHOOD (National Eye Institute Glaucoma Human Genetics Collaboration Heritable Overall Operational Database; 3800 POAG cases) consortium and publicly available summary genome-wide association study data. An assessment of the shared heritability between POAG and these traits as well as the relation between the genetic risk scores for these traits and POAG will lead to new etiologic insights. 3) New-onset POAG is clinically heterogeneous with variable visual field (VF) loss patterns that may reflect different etiologies. We will apply archetype analysis, which objectively quantifies a patient's VF loss pattern to 16 existing clinically validated archetypes (ATs), 9 of which are glaucomatous in nature. Each POAG case (n=1250 from NHS, NHS2 and HPFS) and10 matched controls will be assigned 16 weighted coefficients that add up to 1, with each value representing how consistent his / her VF loss pattern is with each glaucomatous AT. We will evaluate the differential relation between established POAG risk factors and the values on the 16 ATs, to identify unique risk factors for homogeneous incident POAG subtypes. 4) A carbohydrate-restricted diet may meet the energy requirement in the non-myelinated retinal ganglion cell axon segment of the optic nerve and reduce risk of POAG. We will conduct a prospective evaluation of this exposure in relation to POAG and POAG subtypes in the 3 cohorts (n=2100 cases). By integrating MWAS, genomics with prospective environmental exposure data and AT analysis, this proposal addresses a number of important knowledge gapsin particular, it will shed light on how genetic and pre-diagnostic risk factors influence POAG and POAG heterogeneity. Linking specific exposures with POAG subtypes will provide important mechanistic understanding as well as evidence of causality, which will contribute to discovering precision medicine approaches for this condition. Primary open-angle glaucoma (POAG) is an intraocular pressure-related chronic optic nerve disease that produces characteristic visual loss patterns. In this proposal we will study a host of genes, plasma metabolites and environmental factors in relation to POAG overall as well as it's objectively determined subtypes based on visual loss pattern. Understanding how these various exposures relate to POAG and it's subtypes will highlight disease prevention strategies and precision medical treatment options for this potentially blinding disease that requires lifetime management.",Gene-Environment Interactions in Glaucoma,9519600,R01EY015473,"['Acetyl Coenzyme A ', ' S-acetate Coenzyme A ', ' Acetyl CoA ', "" Alzheimer's Disease "", ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', ' Archives ', ' Arginine ', ' L-Arginine ', ' Axon ', ' Biogenesis ', ' Origin of Life ', ' Blood ', ' Blood Reticuloendothelial System ', ' Carbohydrates ', ' Case-Control Studies ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Citrulline ', ' Control Groups ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' MODY ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Diagnosis ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Environmental Exposure ', ' Family ', ' Follow-Up Studies ', ' Followup Studies ', ' Genes ', ' Glaucoma ', ' glaucomatous ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Human Genetics ', ' Physiologic Intraocular Pressure ', ' intra-ocular pressure ', ' Ocular Tension ', ' Intraocular Pressure ', ' Life Style ', ' Lifestyle ', ' Light ', ' Photoradiation ', ' Linkage Disequilibrium ', ' Metabolism ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Mitochondria ', ' mitochondrial ', ' Morbidity - disease rate ', ' Morbidity ', ' Neighborhoods ', ' Nested Case-Control Study ', ' Nitric Oxide ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Optic Nerve ', ' Second Cranial Nerve ', ' Cranial Nerve II ', ' optic nerve disorder ', ' second cranial nerve disorder ', ' Second Cranial Nerve Diseases ', ' Optic Neuropathy ', ' Optic Nerve Diseases ', ' Neural-Optical Lesion ', ' Cranial Nerve II Disorder ', ' Cranial Nerve II Diseases ', ' Ornithine ', ' 2,5-Diaminopentanoic Acid ', ' Patients ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Prospective Studies ', ' Retinal Ganglion Cells ', ' retinal ganglion ', ' Risk ', ' Risk Factors ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Thinness ', ' Leanness ', ' Visual Fields ', ' eye field ', ' Woman ', ' Work ', ' Measures ', ' Mediating ', ' beta-Hydroxybutyrate ', ' -Hydroxybutyrate ', ' 3 Hydroxybutyrate ', ' base ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Peripheral ', ' Chronic ', ' Clinical ', ' Phase ', ' Biochemical ', ' Medical ', ' Link ', ' Evaluation ', ' Blood Serum ', ' Serum ', ' disability ', ' insight ', ' Visual ', ' data base ', ' Data Bases ', ' Databases ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Collaborations ', ' Therapeutic ', ' Genetic ', ' Primary Open Angle Glaucoma ', ' POAG ', ' Diagnostic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' dietary restriction ', ' restricted diet ', ' diet restriction ', ' Complex ', ' Event ', ' Source ', ' Pattern ', ' Blindness ', ' visual loss ', ' vision loss ', ' gene environment interaction ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' cohort ', ' trait ', ' novel ', ' Participant ', ' disorder prevention ', ' disease prevention ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' Therapeutic Intervention ', ' intervention therapy ', ' Sampling ', ' case control ', ' time interval ', ' Genomics ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' metabolomics ', ' metabonomics ', ' metabolism measurement ', ' Address ', ' Preventive ', ' Adherence ', ' Data ', ' Detection ', ' Genetic Risk ', ' Actions of Nitric Oxide in the Heart ', ' Nitric Oxide Pathway ', "" Nurses' Health Study "", ' Characteristics ', ' Modification ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' Healthcare professional ', ' Health Care Professional ', ' Health Professional ', ' preclinical ', ' pre-clinical ', ' National Eye Institute ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' prospective ', ' Heritability ', ' Impairment ', ' mitochondrial dysfunction ', ' common treatment ', ' genomewide ', ' genome scale ', ' genome-wide ', ' disease diagnosis ', ' precision-based medicine ', ' precision medicine ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' metabonome ', ' metabolome ', ' disease heterogeneity ', ' Prospective cohort ', ' secondary analysis ', ' ']",NEI,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2018,571504,NY-13,-0.0032992027782979246
"Data-Driven Statistical Learning with Applications to Genomics DESCRIPTION (provided by applicant): This project involves the development of statistical and computational methods for the analysis of high throughput biological data. Effective methods for analyzing this data must balance two opposing ideals. They must be (a) flexible and sufficiently data-adaptive to deal with the data's complex structure, yet (b) sufficiently simpe and transparent to interpret their results and analyze their uncertainty (so as not to mislead with conviction). This is additionally challenging because these datasets are massive, so attacking these problems requires a marriage of statistical and computational ideas. This project develops frameworks for attacking several problems involving this biological data. These frameworks balance flexibility and simplicity and are computationally tractable even on massive datasets. This application has three specific aims. Aim 1: A flexible and computationally tractable framework for building predictive models. Commonly we are interested in modelling phenotypic traits of an individual using omics data. We would like to find a small subset of genetic features which are important in phenotype expression level. In this approach, I propose a method for flexibly modelling a response variable (e.g. phenotype) with a small, adaptively chosen subset of features, in a computationally scalable fashion. Aim 2: A framework for jointly identifying and testing regions which differ across conditions. For example, in the context of methylation data measured in normal and cancer tissue samples, one might expect that some regions are more methylated in one tissue type or the other. These regions might suggest targets for therapy. However, we do not have the background biological knowledge to pre-specify regions to test. I propose an approach which adaptively selects regions and then tests them in a principled way. This approach is based on a convex formulation to the problem, using shrinkage to achieve sparse differences. Aim 3: A principled framework for developing and evaluating predictive biomarkers during clinical trials. Modern treatments target specific genetic abnormalities that are generally present in only a subset of patients with a disease. A major current goal in medicine is to develop biomarkers that identify those patients likely to benefit from treatment. I propose a framework for developing and testing biomarkers during large-scale clinical trials. This framework simultaneously builds these biomarkers and applies them to restrict enrollment into the trial to only those likely to benefit from treatment. The statistical tools that result from th proposed research will be implemented in freely available software. PUBLIC HEALTH RELEVANCE: Recent advances in high-throughput biotechnology have provided us with a wealth of new biological data, a large step towards unlocking the tantalizing promise of personalized medicine: the tailoring of treatment to the genetic makeup of each individual and disease. However, classical statistical and computational tools have proven unable to exploit the extensive information these new experimental technologies bring to bear. This project focuses on building new flexible, data-adaptive tools to translate this wealth of low level information into actionable discoveries, and actual biological understanding.",Data-Driven Statistical Learning with Applications to Genomics,9559432,DP5OD019820,"['Ursidae Family ', ' bear ', ' Ursidae ', ' Bears ', ' Biology ', ' Biotechnology ', ' Biotech ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Clinical Trials ', ' Computers ', ' Computing Methodologies ', ' computing method ', ' computer methods ', ' computational methods ', ' computational methodology ', ' Data Analyses ', ' data interpretation ', ' Data Analysis ', ' Disease ', ' Disorder ', ' Equilibrium ', ' balance function ', ' balance ', ' Gene Expression ', ' Goals ', ' Marriage ', ' Medicine ', ' Memory ', ' Methods ', ' Methylation ', ' Polynomial Models ', ' polynomials ', ' Modernization ', ' Patients ', ' Phenotype ', ' Research ', ' Research Personnel ', ' Researchers ', ' Investigators ', ' Science ', ' Computer software ', ' Software ', ' statistics ', ' Technology ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Work ', ' Measures ', ' Telomerase ', ' Uncertainty ', ' doubt ', ' Data Set ', ' Dataset ', ' base ', ' Site ', ' Specified ', ' Specific qualifier value ', ' Variation ', ' Variant ', ' Biological ', ' Individual ', ' Measurement ', ' molecular aberrations ', ' Genetic Abnormality ', ' Cytogenetic or Molecular Genetic Abnormality ', ' Chromosomal, Gene, or Protein Abnormality ', ' Molecular Abnormality ', ' Genetic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' Dependence ', ' Event ', ' Techniques ', ' System ', ' interest ', ' Somatic Mutation ', ' Performance ', ' relating to nervous system ', ' neural ', ' trait ', ' Structure ', ' novel ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Code ', ' Coding System ', ' Statistical Methods ', ' Modeling ', ' response ', ' high throughput analysis ', ' Proteomics ', ' Genomics ', ' Tissue Sample ', ' Address ', ' Data ', ' Cancer Patient ', ' Clinical Trials Design ', ' enroll ', ' Enrollment ', ' Update ', ' developmental ', ' Development ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' convict ', ' Outcome ', ' Population ', ' public health relevance ', ' patient population ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' flexible ', ' flexibility ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' Bayesian tracking algorithms ', ' Bayesian statistical models ', ' Bayesian spatial models ', ' Bayesian spatial image models ', ' Bayesian spatial data model ', ' Bayesian nonparametric models ', ' Bayesian network model ', ' Bayesian hierarchical model ', ' Bayesian framework ', ' Bayesian belief updating model ', ' Bayesian belief network ', ' Bayesian adaptive models ', ' Bayesian adaptive designs ', ' Bayesian Modeling ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' individualized medicine ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' predictive marker ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' targeted treatment ', ' genetic make-up ', ' genetic makeup ', ' gene signatures ', ' genetic signature ', ' Formulation ', ' data into knowledge ', ' data to knowledge ', ' patient subtypes ', ' patient subpopulations ', ' patient subgroups ', ' patient subsets ', ' high dimensionality ', ' ']",OD,UNIVERSITY OF WASHINGTON,DP5,2018,325326,WA-07,0.03241670064550863
"Toward Diagnostics and Therapies of Molecular Subcategories of CAD     DESCRIPTION (provided by applicant): Coronary artery disease (CAD) is a leading cause of death worldwide and in the US. While the genetics of this disease are intrinsically complex, thanks to huge research investments during the last 5-10 years, particularly in genome-wide association studies (GWAS), a more unbiased, data-driven and realistic view of CAD has been achieved. As part of this achievement, ~160 common risk loci for CAD/myocardial infarction (MI) have been identified. An important task is now to understand the molecular mechanisms/pathways by which these loci exert risk for CAD/MI allowing to translating the initial findings into new therapies and diagnostics. However, since the loci identified thus far explain only ~10% of variation in CAD/MI risk, it is also essential to define additional CAD pathways operating in parallel with GWA loci. In recent years, clinical studies that consider intermediate phenotypes (between DNA and disease) have greatly enhanced interpretations of risk loci identified in GWA datasets. In addition, disease networks that can be identified from intermediate molecular phenotypes provide an essential framework to identify novel CAD pathways and targets for new CAD therapies. Over the last 6 years, we have performed a clinical study considering many intermediate phenotypes in CAD patients (the STARNET study). In this proposal we intend to use newly generated DNA genotype and RNA sequence data from the STARNET study to identify atherosclerosis and metabolic networks underlying CAD. We then propose a new prospective study of CAD (the NGS-PREDICT study) with the main purpose of validating findings from the STARNET study. We hypothesize that the extent and stability of coronary lesions, thus clinical outcomes can be accurately assessed by defining the status of key atherosclerosis gene networks. In turn, metabolic networks active in liver, abdominal fat, and skeletal muscle influence the status of the atherosclerosis gene networks. In addition, molecular data isolated from easily obtainable tissues (e.g., blood, subcutaneous fat and plasma) can be used to identify biomarkers that can predict risk for clinical events caused by CAD. To test these hypotheses, we propose the following specific aims. Aim 1: To identify regulatory Bayesian gene networks causally linked to CAD and/or CAD sub-phenotypes using the STARNET datasets and the CARDIoGRAM meta-analysis GWA datasets. Aim 2: Identify biomarkers predicting clinical events of CAD (reflected in SYNTAX score) by applying machine learning on DNA genotype, RNA sequence and CAD plasma protein data from easily obtainable tissues of the STARNET cases. Aim 3: To validate the identified causal CAD eQTLs/networks and the biomarkers using the NGS-PREDICT study performed at the Mt. Sinai Hospital, the Swedish Twin study and CAD cell and animal models. We believe the proposed studies can lead to a significantly better molecular understanding of CAD and thus, serve the more long-term goal of preventive and personalized therapies of CAD patients diagnosed in well-defined molecular subcategories. PUBLIC HEALTH RELEVANCE:  Coronary artery disease (CAD) is the world's leading cause of death. We will perform systems genetic analysis of DNA and RNAseq data from 9 CAD-relevant tissues in 700 well-characterized patients (STARNET) integrated with genome-wide association data to reveal CAD-causing metabolic and atherosclerosis gene networks, and within these, new inherited risk variants, CAD-mechanisms, therapeutic targets and biomarkers will be identified and validated in a new prospective clinical study of CAD (NGS-PREDICT). Our studies promise to significantly advance understanding of CAD towards achieving preventive and personalized care.",Toward Diagnostics and Therapies of Molecular Subcategories of CAD,9497813,R01HL125863,"['Abdomen ', ' Abdominal ', ' Achievement ', ' Achievement Attainment ', ' Alleles ', ' Allelomorphs ', ' Angiography ', ' angiographic imaging ', ' Angiogram ', ' Atherosclerosis ', ' atherosclerotic vascular disease ', ' atherosclerotic disease ', ' atheromatosis ', ' Atherosclerotic Cardiovascular Disease ', ' Atheroscleroses ', ' Biology ', ' Biopsy ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Vessels ', ' vascular ', ' Cardiology ', ' Cardiovascular system ', ' circulatory system ', ' Heart Vascular ', ' Cardiovascular Organ System ', ' Cardiovascular Body System ', ' Cardiovascular ', ' Cause of Death ', ' Cell Differentiation process ', ' Cell Differentiation ', ' Clinical Research ', ' Clinical Study ', ' Coronary Arteriosclerosis ', ' coronary arterial disease ', ' atherosclerotic coronary disease ', ' Coronary Atherosclerosis ', ' Coronary Artery Disorder ', ' Coronary Artery Disease ', ' Coronary Artery Bypass ', ' coronary bypass ', ' Coronary Artery Bypass Surgery ', ' Coronary Artery Bypass Grafting ', ' Aortocoronary Bypass ', ' Diagnosis ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Pharmacotherapy ', ' drug treatment ', ' Drug Therapy ', ' Engineering ', ' Family ', ' Fatty acid glycerol esters ', ' Fats ', ' Foam Cells ', ' Foundations ', ' Future ', ' Genes ', ' Regulator Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Genotype ', ' Goals ', ' Hospitals ', ' In Vitro ', ' Institutes ', ' Investments ', ' Lead ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Liver ', ' hepatic organ system ', ' hepatic body system ', ' macrophage ', ' Maps ', ' Biological Models ', ' Model System ', ' Biologic Models ', ' Genetic Models ', ' monocyte ', ' Marrow monocyte ', ' Blood monocyte ', ' Myocardial Infarction ', ' heart infarction ', ' heart infarct ', ' heart attack ', ' coronary infarction ', ' coronary infarct ', ' coronary attack ', ' cardiac infarct ', ' Myocardial Infarct ', ' Cardiac infarction ', ' New York ', ' Patients ', ' Phenotype ', ' Plasma ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma Proteins ', ' Prospective Studies ', ' Research ', ' Research Proposals ', ' Risk ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' medical schools ', ' school of medicine ', ' medical college ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Translating ', ' Twin Multiple Birth ', ' Twins ', ' Data Set ', ' Dataset ', ' RNA Sequences ', ' DNA analysis ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Link ', ' Individual ', ' Voluntary Muscle ', ' Skeletal Muscle ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Twin Studies ', ' Metabolic ', ' Genetic ', ' Diagnostic ', ' Whole Blood ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Inherited ', ' Hereditary ', ' Complex ', ' Event ', ' subcutaneous ', ' Techniques ', ' System ', ' Benchmarking ', ' Best Practice Analysis ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Quantitative Trait Loci ', ' QTL ', ' Animal Model ', ' model organism ', ' model of animal ', ' Animal Models and Related Studies ', ' trait ', ' novel ', ' disorder risk ', ' disease risk ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' genetic analysis ', ' Genetic analyses ', ' Chest ', ' Thorax ', ' Thoracic ', ' Thorace ', ' Pathway Analysis ', ' Network Analysis ', ' Sampling ', ' Genomics ', ' Meta-Analysis ', ' Meta-Analyses ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Address ', ' Preventive ', ' Data ', ' Disease Pathway ', ' Subcategory ', ' in vivo Model ', ' Molecular ', ' followed up ', ' follow up ', ' Active Follow-up ', ' follow-up ', ' developmental ', ' Development ', ' percutaneous coronary intervention ', ' abdominal adiposity ', ' abdominal fat ', ' pathway ', ' Pathway interactions ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' Bayesian computation ', ' Bayesian Networks ', ' computer based statistical methods ', ' risk prediction model ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' predictive modeling ', ' Outcome ', ' prospective ', ' Heritability ', ' Cellular model ', ' Cell model ', ' multidisciplinary ', ' novel therapy ', ' novel drugs ', ' novel drug treatments ', ' next generation therapeutics ', ' new therapy ', ' new therapeutics ', ' new drugs ', ' new drug treatments ', ' novel therapeutics ', ' next generation diagnostics ', ' new diagnostics ', ' novel diagnostics ', ' therapeutic target ', ' public health relevance ', ' molecular phenotype ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' biological systems ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' transcriptome sequencing ', ' clinical risk ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' personalized treatment ', ' personalized therapy ', ' personalization of treatment ', ' personalized medicine ', ' precision diagnostics ', ' personalized diagnosis ', ' personalized diagnostics ', ' clinical predictors ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' predictive marker ', ' personalized patient care ', ' individualized patient care ', ' individualized care ', ' Precision care ', ' personalized care ', ' targeted biomarker ', ' protein markers ', ' protein biomarkers ', ' Preventative care ', ' Preventive care ', ' Preventative therapy ', ' Preventive therapy ', ' recruit ', ' genetic disorder ', ' genetic condition ', ' Genetic Diseases ', ' Molecular Disease ', ' coronary lesion ', ' coronary event ', ' ']",NHLBI,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2018,798847,NY-13,0.02933024705622009
"Signals of Epigenetic Modification in Sjogrens Syndrome     DESCRIPTION (provided by applicant): The objective of the project is to characterize the potential role of DNA methylation patterns in Sjgren's Syndrome (SS) disease etiology and mechanism. A growing body of evidence indicates that epigenetic changes, in particular, altered patterns of DNA methylation, contribute to the development of autoimmune disease and can mediate genetic risk factors. To date, aberrant DNA methylation has been associated with several human autoimmune diseases, including rheumatoid arthritis and systemic lupus erythematosus. My proposal focuses on the identification of unique epigenetic profiles in SS, focusing primarily on T cells, B cells, and salivary gland tissue, a primary site of the inflammatory disease. An understanding of these profiles in the context of genetic background, publicly available genomic data (RNA, ChIP-seq, WGBS) and annotation data (TF binding motifs, genomic QTLs), and cell types have the potential to significantly transform our understanding of SS etiology, particularly given the well-established heterogeneity in clinical manifestations. Further, these DNA methylation profiles could become useful clinical biomarkers for determining risk and prognosis in SS, especially if their biological relevance can be validated in future functional studies. The overall hypothesis of this project is that DNA methylation changes in key genomic regions are associated with SS status and phenotype. The project will use genome-wide SNP data, epigenome-wide methylation array data, and clinical characteristics abstracted from 100 SS cases and 20 controls to address 3 related hypotheses: First, that epigenome-wide DNA methylation patterns in T cells, B cells (both derived from peripheral blood), and salivary gland biopsy tissue are associated with primary SS status after correcting for cell-type heterogeneity. Case-control differences will be tested using supervised machine learning algorithms, new region-discovery methods, and cell-mixture inference techniques. Publicly available data (listed above) will be used to infer biological relevance. Second, that epigenome-wide DNA methylation patterns in these samples are representative of SS sub-phenotypes. Cases (and initially controls) will be clustered using principal component analysis (PCA) applied to all relevant DNA methylation probes and subsets of probes measuring CpGs implicated in specific pathways relevant to SS. The reduced representations will be tested for association with specific clinical and serological profiles. Third, that risk alleles identifie by genome-wide association studies (GWAS) are directly or indirectly associated with SS-specific DNA methylation patterns. Allelic dosage and random forest selection frequency (RFSF) analyses will be used to identify novel methylation quantitative trait loci within SS-associated genes in cases and controls (separately), and we will test whether cell-proportion or eQTLs can explain SS-specific methylation patterns. PUBLIC HEALTH RELEVANCE: Sjgren's Syndrome is a chronic, highly heterogenous, multisystem autoimmune disease predominantly affecting women. This disease is known to be associated with epigenetic changes, including DNA methylation, an axis of epigenetic variation that has been implicated as a mediator of disease risk in other autoimmune diseases. Full characterization of DNA methylation patterns across different cell types and affected tissues will provide new insights into disease etiology, phenotype classification, and targets for future therapeutic strategies.",Signals of Epigenetic Modification in Sjogrens Syndrome,9458167,F31DE025176,"['rheumatic arthritis ', ' Atrophic Arthritis ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Autoimmunity ', ' Autoimmune Status ', ' B-Lymphocytes ', ' Bursa-Equivalent Lymphocyte ', ' Bursa-Dependent Lymphocytes ', ' B-cell ', ' B-Cells ', ' B cells ', ' B cell ', ' B blood cells ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biopsy ', ' Carbon ', ' Cells ', ' Cell Body ', ' Classification ', ' Systematics ', ' Cytosine ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Exhibits ', ' Fellowship ', ' Female ', ' Future ', ' Gene Expression ', ' Genes ', ' Genetic Code ', ' Genotype ', ' Goals ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Systemic Lupus Erythematosus ', ' systemic lupus erythematosis ', ' disseminated lupus erythematosus ', ' Systemic SLE - Lupus Erythematosus ', ' Systemic Lupus Erythmatosus ', ' SLE ', ' Lupus Erythematosus Disseminatus ', ' Mentors ', ' Methods ', ' Methylation ', ' Parents ', ' Patients ', ' Phenotype ', ' Play ', ' outcome forecast ', ' Prognosis ', ' Resources ', ' Research Resources ', ' Risk ', ' RNA ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' Role ', ' social role ', ' Salivary Glands ', ' Salivary Glands Head and Neck ', ' Signal Transduction ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Supervision ', ' T-Lymphocyte ', ' thymus derived lymphocyte ', ' Thymus-Dependent Lymphocytes ', ' T-Cells ', ' Testing ', ' Tissues ', ' Body Tissues ', ' Trans-Activators ', ' Transactivators ', ' Trans-Acting Factors ', ' transcription factor ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' Woman ', ' Work ', ' CpG dinucleotide ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' Measures ', ' forest ', ' Mediating ', ' Lasso ', ' Data Set ', ' Dataset ', ' base ', ' dosage ', ' Site ', ' Chronic ', ' Clinical ', ' Biological ', ' Serologic ', ' Serological ', ' Logistic Regressions ', ' Link ', ' peripheral blood ', ' insight ', ' European ', ' Therapeutic ', ' Genetic ', ' Inflammatory ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Principal Component Analysis ', ' Principal Component Analyses ', ' Dimensions ', ' Frequencies ', ' Complex ', ' cell type ', ' Pattern ', ' Techniques ', ' Country ', ' Severity of illness ', ' disease severity ', ' Quantitative Trait Loci ', ' QTL ', ' novel ', ' Participant ', ' disorder risk ', ' disease risk ', ' Pathogenesis ', ' genetic risk factor ', ' inherited factor ', ' Sampling ', ' high throughput technology ', ' case control ', ' Genomics ', ' Labial Salivary Gland ', ' histone modification ', ' chromatin remodeling ', ' Transcriptional Regulation ', ' Transcriptional Control ', ' Transcription Regulation ', ' Binding ', ' Molecular Interaction ', ' Etiology ', ' disease causation ', ' causation ', ' Causality ', ' Mediator of activation protein ', ' Mediator of Activation ', ' Mediator ', ' Address ', ' Aberrant DNA Methylation ', ' Data ', ' Individual National Research Service Award ', ' NIH National Research Service Award for Individual ', ' International ', ' Subgroup ', ' Clinical Data ', ' Collection ', ' enroll ', ' Enrollment ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Epigenetic Process ', ' genomic region ', ' Genomic Segment ', ' Non-Hispanic ', ' Not Hispanic or Latino ', ' Salivary Gland Tissue ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' Sjgren Syndrome ', ' Sjogrens ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genome wide association study ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' genetic variant ', ' Population ', ' predoctoral ', ' predoc ', ' pre-doc ', ' pre-doctoral ', ' epigenetic variation ', ' public health relevance ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' Biological Markers ', ' genomewide ', ' genome scale ', ' genome-wide ', ' chromatin immunoprecipitation-sequencing ', ' ChIP Sequencing ', ' ChIP-seq ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' risk variant ', ' epigenome ', ' methylation pattern ', ' BeadChip ', ' bead chip ', ' epigenome wide association analysis ', ' EWAS ', ' epigenome-wide association studies ', ' clinically useful biomarkers ', ' clinical biomarkers ', ' disease heterogeneity ', ' full genome ', ' entire genome ', ' whole genome ', ' genomic data ', ' recruit ', ' Affect ', ' Age ', ' ages ', ' Algorithms ', ' Alleles ', ' Allelomorphs ', ' Rheumatoid Arthritis ', ' ']",NIDCR,UNIVERSITY OF CALIFORNIA BERKELEY,F31,2018,21727,CA-13,0.04957654797638651
"Genetic Factors in Keratoconus DESCRIPTION (provided by applicant): The purpose of this grant is to develop techniques for use in the 'early' detection of keratoconus (KC) and identify genetic variants that contribute to is development. KC is a complex genetic eye disorder and a leading cause of corneal transplantation in the young, with approximately 300,000 affected individuals in the US. Undiagnosed, subclinical KC is one of the major causes for complications of LASIK (Laser-in-situ- Keratomilieusis) surgery, commonly performed for vision correction. In the past two decades we have made major improvements to the early diagnosis of KC and have also made significant contributions to the delineation of major genetic determinants of KC through genome wide linkage studies (GWLS), fine mapping, and genome wide association studies (GWAS). In this proposal, we intend to follow up on these studies using new powerful approaches to achieve the following specific aims: In Aim 1 we will combine corneal optical coherence tomography (OCT) and Pentacam HR Scheimpflug Tomography (PST), new technologies that measure both the anterior and posterior surface of the cornea, with videokeratography (VK), a method which revolutionized KC diagnosis, to characterize criteria and to improve the diagnosis of subclinical KC. In Aim 2, to identify additional KC genes, we will perform a 2.5 million SNP GWAS, with an additional 6,000 SNPs, to fine- map already identified genes. We will confirm these results in a separate cohort of KC patients. For this two- stage GWAS design we are assembling the largest group of KC patients described to date: 2000 KC patients in total, 1,000 for the GWAS discovery stage and 1,000 for the confirmation stage. The controls for GWAS discovery will come from the Cardiovascular Health Study (CHS; 3300) and for confirmation will come from 400 subjects with VK, PST, and OCT measurements under Aim 1 and 600 ""convenience controls"" from the Cholesterol and Pharmacogenetics (CAP) study. In our current state of knowledge, the most cost-effective approach to increase the number of identified KC genes is to proceed with the expanded GWAS proposed herein. In Aim 3, we will test the impact of the genes identified in Aim 2 on the 'early' subclinical phenotypes identified through the use o VK, PST and OCT measures in Aim 1. Lastly, for the second part of Aim 3, we will investigate the potential function of KC variants by testing their ability to influence gene structure, expression and function in corneal cell models, including iPS cells derived from corneal keratocytes developed by our research team. The results of these studies will help advance our understanding of the genetic susceptibility to KC and may result in novel treatment options to slow the progression of the disease. PUBLIC HEALTH RELEVANCE: Improving methods for the 'early' detection of keratoconus will help patients avoid complications of LASIK surgery, allow us to identify genetic variants that contribute to its development, and design therapies to retard its progression.",Genetic Factors in Keratoconus,9634922,R01EY009052,"['Affect ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Cell Body ', ' Cells ', ' corneal ', ' Cornea ', ' corneal transplant ', ' corneal keratoplasty ', ' Corneal Transplantation ', ' Corneal Grafting ', ' Cornea Transplantation ', ' Keratoplasty ', ' Diagnosis ', ' Discriminant Analyses ', ' Discriminant Analysis ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Eyeball ', ' Eye ', ' ophthalmopathy ', ' eye disorder ', ' Eye diseases ', ' Genes ', ' Structural Genes ', ' Genotype ', ' Grant ', ' Immunohistochemistry Staining Method ', ' Immunohistochemistry Cell/Tissue ', ' Immunohistochemistry ', ' indexing ', ' Keratoconus ', ' Laser Radiation ', ' Laser Electromagnetic ', ' Lasers ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Literature ', ' Maps ', ' Methods ', ' Patients ', ' Pharmacogenetics ', ' Phenotype ', ' Research ', ' study design ', ' Study Type ', ' Research Design ', ' Risk ', ' Testing ', ' Time ', ' tomography ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Genetic Diversity ', ' Genetic Variation ', ' visual function ', ' Sight ', ' Vision ', ' Measures ', ' Family member ', ' Custom ', ' base ', ' improved ', ' Anterior ', ' Surface ', ' Clinical ', ' Variant ', ' Variation ', ' Biological ', ' Individual ', ' Measurement ', ' Disease Progression ', ' Collaborations ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Complex ', ' In Situ ', ' Techniques ', ' Operative Surgical Procedures ', ' surgery ', ' Surgical Procedure ', ' Surgical Interventions ', ' Surgical ', ' Operative Procedures ', ' Early Diagnosis ', ' early detection ', ' Reverse Transcriptase Polymerase Chain Reaction ', ' reverse transcriptase PCR ', ' RTPCR ', ' RT-PCR ', ' cohort ', ' trait ', ' Videokeratographies ', ' Videokeratography ', ' novel ', ' new technology ', ' novel technologies ', ' Pathogenesis ', ' Laser In Situ Keratomileusis ', ' Laser-Assisted Stromal In Situ Keratomileusis ', ' Laser Intrastromal Keratomileusis ', ' Laser Intrastromal Keratomileuses ', ' LASIK ', ' Optical Coherence Tomography ', ' optical coherence Doppler tomography ', ' optical Doppler tomography ', ' OCT Tomography ', ' Doppler OCT ', ' Genetic Determinism ', ' genetic determinant ', ' Bioinformatics ', ' Bio-Informatics ', ' protein expression ', ' preventing ', ' prevent ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' Data ', ' Gene Structure ', ' Gene Structure/Organization ', ' Gene Organization ', ' Molecular ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' protein function ', ' Development ', ' developmental ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' design ', ' designing ', ' cost effective ', ' Susceptibility Gene ', ' susceptibility variant ', ' susceptibility locus ', ' susceptibility allele ', ' predisposing gene ', ' Predisposition gene ', ' Cell model ', ' Cellular model ', ' cholesterol control ', ' manage cholesterol ', ' cholesterol management ', ' induced pluripotent stem cell ', ' iPSCs ', ' iPSC ', ' iPS ', ' therapy design ', ' treatment design ', ' intervention design ', ' genome-wide linkage ', ' genomewide linkage ', ' public health relevance ', ' cardiovascular health ', ' bead chip ', ' BeadChip ', ' ']",NEI,CEDARS-SINAI MEDICAL CENTER,R01,2019,714430,CA-28,0.03201496200991613
"Identification of gene-gene interactions in relation to risk of esophageal adenocarcinoma and Barrett's esophagus PROJECT SUMMARY / ABSTRACT Esophageal adenocarcinoma (EA) is an often lethal cancer and a significant public health concern in the U.S. Several risk factors have been identified for EA and its precursor, Barrett's esophagus (BE), including symptomatic gastroesophageal reflux disease (GERD), central adiposity, smoking, male sex, and European ancestry, but our understanding of the molecular/genetic determinants that govern why most people with reflux never develop BE, and most with BE never progress to EA, remains limited. Inherited genetics represents another likely contributor to disease susceptibility, and recent genome-wide association studies (GWAS) within the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) have identified multiple novel germline genetic variants associated with altered risk of BE/EA. As observed for other cancers and complex diseases, however, the majority of estimated heritability for BE and EA appears unexplained. One plausible source for this missing heritability lies in the joint effects of multiple loci acting in combination. We seek to identify novel gene-gene interactions (GG) in relation to risk of BE/EA, using a novel fusion of advanced analytical approaches aimed at overcoming technical limitations often encountered in the conduct of large-scale GG (e.g. computational complexity and low statistical power). In a discovery scan (Aim 1), we initially will use two complementary knowledge-guided filtering methods to reduce the dimensionality of the GG search space: first, we select ~500 genes with known or hypothesized relationships to BE/EA etiology and pathogenesis based on findings from GWAS, TCGA, and related studies; second, we select ~50,000 gene-gene pairs with highest-likelihood annotated biological relationships based on an integrated knowledge resource of pathways, processes, and interactions (Biofiler). Using existing germline genetic data on 2515 EA patients, 3295 BE patients, and 3207 controls from BEACON, we next will adopt a recently-described `hierarchical group-lasso' machine learning framework to select, in a joint model, ~1000 candidate pairwise SNP-SNP interactions most predictive of case status. These interactions are then evaluated using an independent validation dataset of 1609 EA cases, 1037 BE cases, and 3537 controls (Aim 2), using standard logistic regression models. In exploratory work, we will perform stratified analyses by sex or smoking history. The proposed studies are anticipated to expand our basic understanding of key biological pathways and mechanisms underlying the emergence of BE/EA; generate new leads and possible candidate targets for interventional strategies; and expand the foundation for future collaborative initiatives to integrate genetic, epidemiologic, and clinical data into robust disease models and novel predictive tools for BE/EA risk assessment and precision prevention. PROJECT NARRATIVE (PUBLIC HEALTH RELEVANCE) Esophageal adenocarcinoma (EA) is an often lethal cancer that represents a significant public health burden in the U.S. In this proposal, we capitalize on the availability of large-scale existing datasets derived from expensive multi-year international collaborations, and perform new analyses to improve our understanding of how inherited gene variants interact to influence susceptibility to EA and its precursor, Barrett's esophagus (BE). Findings from this study will expand our basic understanding of key biological pathways underlying this cancer and ultimately help advance the development of better strategies for prevention and treatment.",Identification of gene-gene interactions in relation to risk of esophageal adenocarcinoma and Barrett's esophagus,9746654,R03CA223731,"['Barrett Esophagus ', ' Columnar-Lined Esophagus ', ' Columnar Epithelial-Lined Lower Esophagus ', ' Barrett Ulcer ', ' Barrett Syndrome ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Disorder ', ' Disease ', ' liability to disease ', ' Diathesis ', ' Disease susceptibility ', ' Elements ', ' epidemiological ', ' epidemiologic ', ' Epidemiology ', ' Foundations ', ' Future ', ' Gastroesophageal Reflux ', ' Gastro-oesophageal Reflux ', ' GERD ', ' Esophageal Reflux ', ' Acid Reflux ', ' Gastroesophageal reflux disease ', ' Genes ', ' Genotype ', ' Incidence ', ' Inflammation ', ' Joints ', ' Lifestyle ', ' Life Style ', ' male ', ' Methods ', ' Methodology ', ' obese population ', ' obese person ', ' obese people ', ' obese ', ' corpulentia ', ' corpulency ', ' corpulence ', ' adiposity ', ' Obesity ', ' Patients ', ' Public Health ', ' Research ', ' Research Resources ', ' Resources ', ' Risk ', ' Risk Factors ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Smoking ', ' Testing ', ' Work ', ' Molecular Genetics ', ' Risk Assessment ', ' Lasso ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Chronic ', ' Phase ', ' Biological ', ' Logistic Regressions ', ' Ensure ', ' Evaluation ', ' Predisposition ', ' Susceptibility ', ' Lesion ', ' Upper digestive tract structure ', ' Upper Gastrointestinal Tract ', ' Upper GI Tract ', ' Reflux ', ' insight ', ' European ', ' Plant Roots ', ' root ', ' Esophageal Adenocarcinoma ', ' Adenocarcinoma of the Esophagus ', ' Collaborations ', ' Genetic ', ' Metaplastic ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Adopted ', ' Dimensions ', ' Inherited ', ' Hereditary ', ' Complex ', ' Dependence ', ' Scanning ', ' Source ', ' Techniques ', ' gene interaction ', ' Intercept ', ' knowledge base ', ' knowledgebase ', ' Informatics ', ' novel ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' disorder risk ', ' disease risk ', ' Disease model ', ' disorder model ', ' Pathogenesis ', ' Therapeutic Intervention ', ' intervention therapy ', ' Statistical Methods ', ' Modeling ', ' response ', ' protein protein interaction ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' Genetic Determinism ', ' genetic determinant ', ' text mining ', ' literature searching ', ' literature mining ', ' discovery mining ', ' text searching ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Address ', ' Data ', ' Information Resources ', ' knowledge resources ', ' knowledge resource ', ' information resource ', ' International ', ' Molecular Target ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Subgroup ', ' Clinical Data ', ' Smoking History ', ' Validation ', ' Molecular ', ' Process ', ' sex ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' Advanced Development ', ' Coupling ', ' Heritability ', ' multidisciplinary ', ' public health relevance ', ' genome-wide ', ' genomewide ', ' genome scale ', ' epidemiologic data ', ' Epidemiology data ', ' Epidemiological data ', ' The Cancer Genome Atlas ', ' TCGA ', ' individualized prevention ', ' precision prevention ', ' personalized prevention ', ' clinically actionable ', ' predictive tools ', ' high dimensionality ', ' genetic architecture ', ' supervised learning ', ' supervised machine learning ', ' ']",NCI,ROSWELL PARK CANCER INSTITUTE CORP,R03,2019,93591,NY-26,0.01000517079334853
"Identification of epigenetic subclones in lymphomas and leukemias Abstract Epigenetic modifications, such as DNA methylation, play a significant role in human disease. DNA methylation is altered in cancer, and DNA methylation-induced silencing of promoters of tumor-suppressors is thought to play a key role in tumorigenesis. Though there is an increasing number of methylation sequencing datasets generated from cancer, they are confounded by tumor heterogeneity. Understanding the subclonal architecture underlying heterogeneity is important because individual cancer subclones impact cancer growth, treatment resistance, and metastasis. Increased epigenetic heterogeneity, or variation in DNA methylation patterns, was determined to be correlated with worse prognosis in patients with diffuse large B-cell lymphoma (DLBCL) and acute myeloid leukemia (AML). However, these studies only profiled epigenetic heterogeneity at a global scale and did not analyze methylation of individual subclones. Many computational methods have been developed for this purpose in epigenome-wide association studies (EWAS), but these methods are not applicable for methylation sequencing data. As such, there is a need to develop new computational methods to study subclonal methylation profiles in cancer. I will develop a novel computational method (DXM) that deconvolves DNA methylation of heterogeneous clinical samples into their major subpopulations, their prevalence, and their respective DNA methylation profiles (Aim 1). DXM will be developed on simulations generated from data available from both the Roadmap Epigenomics Project and the Blueprint Epigenome Project and will be validated with methylation sequencing on DLBCL samples. I will then leverage DXM to study subclonal methylation profiles in AML (Aim 2). I hypothesize that methylation can confer fitness advantages in epigenetic subclones of AML, leading to clonal expansion following therapeutic intervention and subsequent relapse. Using DXM, I will first identify epigenetic subclones from whole genome bisulfite sequencing data from AML patients with well-characterized genetic subclonal architecture and compare the epigenetic subclonal architecture to that of the genetic subclones. In a second dataset containing methylation sequencing data from paired diagnosis-relapse samples, I will apply DXM, identify subclonal methylation profiles, and characterize all genes impacted by subclonal methylation to determine if they are expected to confer fitness advantages. Finally, I will test if mutations known to impact DNA methylation in AML (DNMT3A, IDH1/2) alter epigenetic subclonal expansion. Taken together, this proposal will result in a new computational approach to interpret epigenetic data from heterogeneous clinical samples as well as identification of DNA methylation changes in epigenetic subclones of AML that contribute to disease progression and correlate with prognosis. Project Narrative Studies that characterize which variations in cancer relate to worse outcome may do analysis on the entire tumor sample, which is composed of many different types of cells, each with distinct biology. The goal of this proposal is to develop a novel computational method to analyze variations in cancer at the level of cell-types. These results can be used to improve patient prognostics and care in multiple cancers.",Identification of epigenetic subclones in lymphomas and leukemias,9752227,F30CA224687,"['Algorithms ', ' Antibodies ', ' Architecture ', ' Engineering / Architecture ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biology ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cell Body ', ' Cells ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Diagnosis ', ' Future ', ' Gene Expression ', ' Genes ', ' Genome ', ' Goals ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Heterogeneity ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' acute myeloid leukemia ', ' acute granulocytic leukemia ', ' Acute Myelogenous Leukemia ', ' Acute Myeloblastic Leukemia ', ' AML - Acute Myeloid Leukemia ', ' Acute Myelocytic Leukemia ', ' Mentorship ', ' Methods ', ' Methylation ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' tumor cell metastasis ', ' cancer metastasis ', ' Secondary Tumor ', ' Secondary Neoplasm ', ' Metastatic Tumor ', ' Metastatic Neoplasm ', ' Metastatic Mass ', ' Metastatic Lesion ', ' Metastasize ', ' Metastasis ', ' Neoplasm Metastasis ', ' Pathology ', ' Patients ', ' Physicians ', ' Play ', ' Prognosis ', ' outcome forecast ', ' Relapse ', ' social role ', ' Role ', ' statistics ', ' Testing ', ' Tumor Promoters ', ' United States ', ' X-Chromosome Inactivation ', ' Lyonization ', ' X Inactivation ', ' cytosine-guanine dinucleotide ', "" cytidylyl-3'-5'-guanosine "", ' cytidine monophosphate guanosine ', ' CG-dinucleotide ', "" 3'-5'-CpG "", ' CpG dinucleotide ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' Fluorescence-Activated Cell Sortings ', ' Fluorescence Activated Cell Sorting Fractionation ', ' Fluorescence-Activated Cell Sorting ', ' oncosuppressor gene ', ' Tumor Suppressing Genes ', ' Recessive Oncogenes ', ' Oncogenes-Tumor Suppressors ', ' Onco-Suppressor Genes ', ' Emerogenes ', ' Cancer Suppressor Genes ', ' Antioncogenes ', ' Anti-Oncogenes ', ' Tumor Suppressor Genes ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' Caring ', ' career ', ' improved ', ' Surface ', ' Clinical ', ' Variant ', ' Variation ', ' Link ', ' prognostic ', ' Training ', ' Individual ', ' Genomic Imprinting ', ' Parental Imprinting ', ' Genetic Imprinting ', ' Disease Progression ', ' Genetic ', "" large cell Diffuse non-Hodgkin's lymphoma "", ' Diffuse Large B-Cell Lymphoma ', ' DLBCL ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' Scientist ', ' Frequencies ', ' Complex ', ' cell type ', ' Tumor Suppressor Proteins ', ' tumor suppressor ', ' Retrotransposon ', ' simulation ', ' novel ', ' Therapeutic Intervention ', ' intervention therapy ', ' Sampling ', ' Bioinformatics ', ' Bio-Informatics ', ' Oncogenesis ', ' tumorigenesis ', ' genome sequencing ', ' Address ', ' fitness ', ' Data ', ' Cancer Biology ', ' Cancer Patient ', ' Clonal Expansion ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Newly Diagnosed ', ' Modification ', ' Development ', ' developmental ', ' therapy resistant ', ' treatment resistance ', ' therapeutic resistance ', ' resistant to therapy ', ' resistance to therapy ', ' epigenomics ', ' anticancer research ', ' cancer research ', ' anti-cancer research ', ' design ', ' designing ', ' Outcome ', ' leukemia/lymphoma ', ' lymphoma/leukemia ', ' Prevalence ', ' human disease ', ' tumor ', ' clinical care ', ' epigenome ', ' methylation pattern ', ' single cell sequencing ', ' bisulfite sequencing ', ' bisulfite-seq ', ' Bisulfite-based sequencing ', ' BS-seq ', ' epigenome-wide association studies ', ' epigenome wide association analysis ', ' EWAS ', ' patient stratification ', ' stratified patient ', ' tumor heterogeneity ', ' intratumor heterogeneity ', ' intra-tumoral heterogeneity ', ' heterogeneity in tumors ', ' Intratumoral heterogeneity ', ' whole genome ', ' full genome ', ' entire genome ', ' ']",NCI,WASHINGTON UNIVERSITY,F30,2019,30926,MO-01,0.022565372541578105
"Modeling stress-induced, de novo epiallele architecture in the model Arabidopsis as a tractable entrypoint PROJECT SUMMARY/ABSTRACT Epigenetic memory is a phenomenon of trans-generational, altered trait inheritance without changes to DNA sequence. Our present ability to predict or direct epigenomic behavior is extremely limited, even though epigenetic factors participate in nearly all aspects of multicellular development, environmental stress response, and disease development. There are critical gaps in our current knowledge of DNA methylation patterning, stable epiallele formation, and the relationship of genome-wide epigenomic behavior to gene expression and phenotype in both plant and animal systems. We have developed a system that will directly address these questions. Our long-term goals are to decode the heritable epigenome, and its relationship to organismal phenotype, particularly in response to stress. What distinguishes our proposed research is the availability of robust biologicals in the model plant Arabidopsis to impose artificial stress, recurrent heritable epigenetic memory, and methylome repatterning. These resources emanate from discovery of the MSH1 gene, disruption of which leads to epigenomic reprogramming. Recent data from this system lead to the overarching hypothesis that stress-induced gene expression recruits methylation machinery to gene networks in a non-stochastic manner. To address this hypothesis, we have developed novel genome-wide methylome analysis procedures for high-resolution identification of gene-associated methylation repatterning. These analyses reveal gene networks that are strikingly consistent with phenotype changes, and display repatterning that is intragenic and often subtle, yet reproducible. We have also identified epigenetic components of the DNA methylation and RdDM pathways that are essential to reprogramming based on msh1 double mutant analysis. Building upon strong preliminary data, we propose to pursue three specific aims to characterize trans-generational epigenomic behavior: (1) To delineate stable, de novo epialleles in the Arabidopsis msh1 model system, exploiting a five-generation memory lineage, (2) to develop a mechanistic understanding of stable epiallele formation in response to stress, implementing machine learning and mutant screening, and (3) to test locus-specific mechanics of epiallele establishment, capitalizing on gene relocation to delimit germane local chromatin features. The proposed research will broadly impact the field by providing the first example of inducible epigenomic reprogramming in a non-stochastic pattern that permits machine learning-based predictive modeling and identification of cis-acting sequence features. The results will be pertinent to mammalian systems and, possibly, to diagnostic strategies for diseases with a strong GxE component. PROJECT NARRATIVE The proposed research has relevance to public health priorities as we see life style diseases, stress and environmental impacts on health, in utero and throughout development, pose greater challenges to conventional medicine. Environmental stress is a multifaceted influence on health, and epigenomic response is an important, under-investigated factor in cancer, neurodevelopmental, metabolic and toxin-related disorders with high GxE effects. Upon conclusion of the study, we will have defined the architectural features of stable, de novo epiallelic variation, assessed its influence on heritable phenotype, and refined a methodology for high resolution analysis of epigenomic data that is necessary to inform the development of early diagnostics and countermeasures.","Modeling stress-induced, de novo epiallele architecture in the model Arabidopsis as a tractable entrypoint",9801992,R01GM134056,"['Affect ', ' Animals ', ' Architecture ', ' Engineering / Architecture ', ' Behavior ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Chromatin ', ' Complement Proteins ', ' Complement ', ' Cytosine ', ' data interpretation ', ' Data Analysis ', ' Data Analyses ', ' statistical analysis ', ' Statistical Data Analysis ', ' Statistical Data Analyses ', ' Statistical Data Interpretation ', ' Cognitive Discrimination ', ' Discrimination ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' Physiological Homeostasis ', ' Autoregulation ', ' Homeostasis ', ' Information Technology Systems ', ' IT Systems ', ' Data Systems ', ' Information Systems ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Lifestyle ', ' Life Style ', ' Medicine ', ' Memory ', ' Methods ', ' Methodology ', ' Methylation ', ' Model System ', ' Biologic Models ', ' Biological Models ', ' Nucleosomes ', ' living system ', ' Organism ', ' Phenotype ', ' Plants ', ' Recurrent ', ' Recurrence ', ' Reinforcement ', ' Psychological reinforcement ', ' Reproduction ', ' Research ', ' Research Resources ', ' Resources ', ' Splicing ', ' RNA Splicing ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Stress ', ' Testing ', ' Thermodynamic ', ' Thermodynamics ', ' Toxin ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' hydrosulfite ', ' hydrogen sulfite ', ' bisulfite ', ' Generations ', ' stress', ' reaction ', ' stress response ', ' reaction', ' crisis ', ' biological adaptation to stress ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Arabidopsis ', ' base ', ' density ', ' Procedures ', ' Site ', ' Variant ', ' Variation ', ' Biological ', ' Link ', ' insight ', ' Gene Targeting ', ' Environmental Impact ', ' Ecological impact ', ' Transgenes ', ' Liquid substance ', ' liquid ', ' fluid ', ' Metabolic ', ' Genetic ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Knowledge ', ' programs ', ' Mechanics ', ' mechanical ', ' Pattern ', ' System ', ' mutant ', ' trait ', ' novel ', ' Reporting ', ' Positioning Attribute ', ' Position ', ' Modeling ', ' response ', ' behavior influence ', ' behavioral influence ', ' Genomics ', ' histone modification ', ' Small RNA ', ' Address ', ' Chromatin Modeling ', ' Chromatin Assembly ', ' Data ', ' Detection ', ' Plant Model ', ' Reproducibility ', ' Resolution ', ' Cis-Acting Sequence ', ' Cis-Acting Locus ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Pattern Recognition ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Process ', ' Development ', ' developmental ', ' Pathway interactions ', ' pathway ', ' in utero ', ' epigenomics ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' genome-wide ', ' genomewide ', ' genome scale ', ' public health priorities ', ' flexibility ', ' flexible ', ' screening ', ' methylome ', ' epigenome ', ' biophysical properties ', ' biophysical parameters ', ' biophysical measurement ', ' biophysical characterization ', ' biophysical characteristics ', ' transgenerational epigenetic inheritance ', ' transgenerational inheritance ', ' methylation pattern ', ' epigenetic memory ', ' experimental study ', ' experimental research ', ' experiment ', ' recruit ', ' ']",NIGMS,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2019,319720,PA-12,0.010817638228897123
"Gene-Environment Interactions in Glaucoma Primary open-angle glaucoma (POAG) is the leading cause of chronic optic neuropathy and a major source of ocular morbidity worldwide. Understanding preclinical events, early phase disease and disease heterogeneity represent key objectives in early disease detection, prevention and treatment of POAG. In this study, we propose 4 specific aims. 1) We will perform both targeted and untargeted metabolome-wide association studies (MWAS) for POAG using pre-clinical serum from a large case-control group (500 cases and 500 controls) nested within ongoing prospective studies of the Nurses' Health Study (NHS), NHS2, and Health Professionals Follow-up Study (HPFS) to advance our understanding of the biochemical events that precede POAG diagnosis (blood was collected ~ 10 years prior to disease diagnosis). Prior studies suggest that nitric oxide metabolites represent genetically informed markers and will form the basis for targeted profiling. 2) While considerable discoveries have been made of POAG genes, more work is needed to leverage genome-wide information to inform POAG etiology. Thus, we will create a genome-wide genetic correlation matrix between POAG and complex traits previously linked to POAG, using data from the NEIGHBORHOOD (National Eye Institute Glaucoma Human Genetics Collaboration Heritable Overall Operational Database; 3800 POAG cases) consortium and publicly available summary genome-wide association study data. An assessment of the shared heritability between POAG and these traits as well as the relation between the genetic risk scores for these traits and POAG will lead to new etiologic insights. 3) New-onset POAG is clinically heterogeneous with variable visual field (VF) loss patterns that may reflect different etiologies. We will apply archetype analysis, which objectively quantifies a patient's VF loss pattern to 16 existing clinically validated archetypes (ATs), 9 of which are glaucomatous in nature. Each POAG case (n=1250 from NHS, NHS2 and HPFS) and10 matched controls will be assigned 16 weighted coefficients that add up to 1, with each value representing how consistent his / her VF loss pattern is with each glaucomatous AT. We will evaluate the differential relation between established POAG risk factors and the values on the 16 ATs, to identify unique risk factors for homogeneous incident POAG subtypes. 4) A carbohydrate-restricted diet may meet the energy requirement in the non-myelinated retinal ganglion cell axon segment of the optic nerve and reduce risk of POAG. We will conduct a prospective evaluation of this exposure in relation to POAG and POAG subtypes in the 3 cohorts (n=2100 cases). By integrating MWAS, genomics with prospective environmental exposure data and AT analysis, this proposal addresses a number of important knowledge gapsin particular, it will shed light on how genetic and pre-diagnostic risk factors influence POAG and POAG heterogeneity. Linking specific exposures with POAG subtypes will provide important mechanistic understanding as well as evidence of causality, which will contribute to discovering precision medicine approaches for this condition. Primary open-angle glaucoma (POAG) is an intraocular pressure-related chronic optic nerve disease that produces characteristic visual loss patterns. In this proposal we will study a host of genes, plasma metabolites and environmental factors in relation to POAG overall as well as it's objectively determined subtypes based on visual loss pattern. Understanding how these various exposures relate to POAG and it's subtypes will highlight disease prevention strategies and precision medical treatment options for this potentially blinding disease that requires lifetime management.",Gene-Environment Interactions in Glaucoma,9788096,R01EY015473,"['Acetyl Coenzyme A ', ' S-acetate Coenzyme A ', ' Acetyl CoA ', "" Alzheimer's Disease "", ' senile dementia of the Alzheimer type ', ' primary degenerative dementia ', ' dementia of the Alzheimer type ', ' Primary Senile Degenerative Dementia ', ' Alzheimers disease ', ' Alzheimers Dementia ', "" Alzheimer's "", ' Alzheimer syndrome ', ' Alzheimer sclerosis ', ' Alzheimer disease ', ' Alzheimer Type Dementia ', ' Alzheimer ', ' Archives ', ' Arginine ', ' L-Arginine ', ' Axon ', ' Biogenesis ', ' Origin of Life ', ' Blood ', ' Blood Reticuloendothelial System ', ' Carbohydrates ', ' Case-Referrent Studies ', ' Case-Referent Studies ', ' Case-Compeer Studies ', ' Case-Comparison Studies ', ' Case-Base Studies ', ' Case-Control Studies ', ' Citrulline ', ' Control Groups ', ' type two diabetes ', ' type II DM ', ' type 2 DM ', ' maturity onset diabetes ', ' ketosis resistant diabetes ', ' adult onset diabetes ', ' Type II diabetes ', ' Type II Diabetes Mellitus ', ' Type 2 diabetes ', ' Type 2 Diabetes Mellitus ', ' T2DM ', ' T2D ', ' T2 DM ', ' Stable Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Noninsulin Dependent Diabetes Mellitus ', ' Noninsulin Dependent Diabetes ', ' Non-Insulin Dependent Diabetes ', ' NIDDM ', ' Maturity-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Diagnosis ', ' dietary ', ' Diet ', ' Disorder ', ' Disease ', ' Environmental Exposure ', ' Family ', ' Followup Studies ', ' Follow-Up Studies ', ' Genes ', ' glaucomatous ', ' Glaucoma ', ' Heterogeneity ', ' History ', ' Recording of previous events ', ' Human Genetics ', ' intra-ocular pressure ', ' Ocular Tension ', ' Intraocular Pressure ', ' Physiologic Intraocular Pressure ', ' Lifestyle ', ' Life Style ', ' Photoradiation ', ' Light ', ' Linkage Disequilibrium ', ' Metabolic Processes ', ' Intermediary Metabolism ', ' Metabolism ', ' mitochondrial ', ' Mitochondria ', ' Morbidity ', ' Morbidity - disease rate ', ' Neighborhoods ', ' Nested Case-Control Study ', ' endothelial cell derived relaxing factor ', ' Nitrogen Protoxide ', ' Nitrogen Monoxide ', ' Mononitrogen Monoxide ', ' Endothelium-Derived Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Nitric Oxide ', ' Second Cranial Nerve ', ' Cranial Nerve II ', ' Optic Nerve ', ' second cranial nerve disorder ', ' Second Cranial Nerve Diseases ', ' Optic Neuropathy ', ' Optic Nerve Diseases ', ' Neural-Optical Lesion ', ' Cranial Nerve II Disorder ', ' Cranial Nerve II Diseases ', ' optic nerve disorder ', ' 2,5-Diaminopentanoic Acid ', ' Ornithine ', ' Patients ', ' Reticuloendothelial System, Serum, Plasma ', ' Plasma Serum ', ' Blood Plasma ', ' Plasma ', ' Prospective Studies ', ' retinal ganglion ', ' Retinal Ganglion Cells ', ' Risk ', ' Risk Factors ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Leanness ', ' Thinness ', ' eye field ', ' Visual Fields ', ' Woman ', ' Work ', ' Measures ', ' Mediating ', ' -Hydroxybutyrate ', ' 3 Hydroxybutyrate ', ' beta-Hydroxybutyrate ', ' base ', ' Blood specimen ', ' Blood Sample ', ' improved ', ' Peripheral ', ' Chronic ', ' Clinical ', ' Phase ', ' Biochemical ', ' Medical ', ' Link ', ' Evaluation ', ' Serum ', ' Blood Serum ', ' disability ', ' insight ', ' Visual ', ' Databases ', ' data base ', ' Data Bases ', ' Biochemical Pathway ', ' Metabolic Networks ', ' Collaborations ', ' Therapeutic ', ' Genetic ', ' Primary Open Angle Glaucoma ', ' POAG ', ' Diagnostic ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' dietary restriction ', ' restricted diet ', ' diet restriction ', ' Complex ', ' Event ', ' Source ', ' Pattern ', ' Blindness ', ' visual loss ', ' vision loss ', ' gene environment interaction ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' cohort ', ' trait ', ' novel ', ' Participant ', ' disorder prevention ', ' disease prevention ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Prevention ', ' Therapeutic Intervention ', ' intervention therapy ', ' Sampling ', ' case control ', ' time interval ', ' Genomics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' Address ', ' Preventive ', ' Adherence ', ' Data ', ' Detection ', ' Genetic Risk ', ' Nitric Oxide Pathway ', ' Actions of Nitric Oxide in the Heart ', "" Nurses' Health Study "", ' Characteristics ', ' Modification ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' Health Professional ', ' Healthcare professional ', ' Health Care Professional ', ' pre-clinical ', ' preclinical ', ' National Eye Institute ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' prospective ', ' Heritability ', ' Impairment ', ' mitochondrial dysfunction ', ' common treatment ', ' genome-wide ', ' genomewide ', ' genome scale ', ' disease diagnosis ', ' precision medicine ', ' precision-based medicine ', ' targeted treatment ', ' targeted therapy ', ' targeted therapeutic agents ', ' targeted therapeutic ', ' targeted drug treatments ', ' targeted drug therapy ', ' metabolome ', ' metabonome ', ' disease heterogeneity ', ' Prospective cohort ', ' secondary analysis ', ' ']",NEI,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2019,528837,NY-13,-0.0032992027782979246
"Genetic and Genomic Dissection of Psoriatic Arthritis Psoriatic arthritis (PsA) is distinctive amongst the inflammatory/autoimmune joint diseases in that its onset is commonly preceded by cutaneous psoriasis (PsC). This provides an unparalleled opportunity for the identification of predictive biomarkers to determine which of the approximately 25% of psoriasis vulgaris (PsV) patients will develop PsA. Over the past decade, we have expanded our genetic study of PsV to focus on PsA, resulting in the collection of 1,279 PsA patients at Michigan, 743 of whom have already been subjected to GWAS. Initiated in 2007, the International Psoriatic Arthritis Research Team (IPART) has accumulated 1,919 Canadian PsA patients, of whom 1,370 have already been subjected to GWAS. In 2015, we completed a meta- GWAS of PsC and PsA involving a discovery cohort of 1,430 PsA cases and 1,417 controls, with 9,293 additional PsV replication samples (3,061 PsA, 3,110 PsC) and 13,670 controls. We detected 10 associations for PsA and 11 for PsC, as well as a new association for PsV. Utilizing an innovative core exome array to genotype additional cases and controls, we carried out the largest meta-GWAS of PsV to date (~40,000 subjects) and found 16 more susceptibility regions, highlighting the roles of interferon signaling and the NFB cascade, and demonstrating strong enrichment for psoriasis genetic signals in T-cell regulatory elements. Using machine learning to model ~200 genetic variants in our PsA vs. PsC GWAS, we achieved 82% area under receiver operator curve for distinguishing PsA vs PsC, with 98% accuracy among the top 10% of patients with the highest genetic load. We also carried out RNA-seq on mRNA and miRNA from 65 pairs of pre- and post-conversion samples from PsC patients who developed PsA. Suggestive of a shift from skin- focused to systemic autoimmunity, we found significant post-conversion enrichment for central memory CD4+ T-cell (CD4-Tcm) transcripts among the up-regulated genes. We also observed highly correlated pre- and post- conversion behaviors of 54 differentially-expressed miRNAs and their mRNA targets, as well as multiple serum miRNAs that are significantly differentially expressed in PsA vs. PsC. A metabolomic study of 50 paired converter sera revealed 293 biochemicals with significant alterations, 275 of which were increased. Finally, we identified noncoding eQTLs for IL23R that correlate strikingly with a region of selective PsA association.  Based on these results, we hypothesize that PsA and PsC have pathogenetic mechanisms that are T-cell, osteoblast and osteoclast-driven and progress from skin to systemic during transition to PsA. We propose that this paradigm can be used to develop a useful test to predict PsA in PsC patients, while increasing our basic understanding of PsA. To test this hypothesis, we propose four aims: (1) to maintain and grow our longitudinal clinical resource; (2) To identify biomarkers for the development of PsA in PsC patients; (3) To integrate the biomarkers identified in Aim 2 into a clinically-useful tool for PsA identification using machine learning ; and (4) to explore the mechanisms by which the IL23R gene contributes to PsA pathogenesis. PROJECT NARRATIVE: Psoriatic Arthritis (PsA) is a major health problem in the United States and around the world. The mechanisms that predispose patients with psoriasis to develop PsA are unknown. The proposed research will utilize the power of genome-wide association studies, transcriptome analysis, metabolomics, and the largest longitudinal resource of PsA in the world to develop a clinically-relevant tool for PsA prediction and to address a major gap in our mechanistic understanding of the causes of PsA. The results of this research are also likely to be relevant to other autoimmune diseases.",Genetic and Genomic Dissection of Psoriatic Arthritis,9819281,R01AR063611,"['Alleles ', ' Allelomorphs ', ' Arthritis ', ' arthritic ', ' Psoriatic Arthritis ', ' Psoriasis Arthropathica ', ' Arthritic Psoriasis ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Behavior ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Banks ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' co-morbidity ', ' Comorbidity ', ' Dermatology ', ' Dissection ', ' Deoxyribonucleic Acid ', ' DNA ', ' Elements ', ' Exhibits ', ' Genes ', ' genetic biomarker ', ' Genetic Markers ', ' Genotype ', ' Health ', ' HLA-C ', ' HLA-C Antigens ', ' Hospitals ', ' Immunity ', ' In Vitro ', ' IFN ', ' Interferons ', ' joint disorder ', ' arthropathy ', ' arthropathic ', ' Joint Diseases ', ' arthropathies ', ' Memory ', ' Michigan ', ' Osteoblasts ', ' Osteoclasts ', ' Patients ', ' Proteins ', ' psoriatic ', ' psoriasiform ', ' Psoriasis ', ' Research ', ' Research Resources ', ' Resources ', ' Rheumatology ', ' Risk ', ' Ribonucleic Acid ', ' RNA Gene Products ', ' Non-Polyadenylated RNA ', ' RNA ', ' mRNA ', ' Messenger RNA ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Suggestion ', ' thymus derived lymphocyte ', ' T-Cells ', ' T-Lymphocyte ', ' regulatory T-cells ', ' Treg ', ' Regulatory T-Lymphocyte ', ' Testing ', ' United States ', ' Mutagenesis Molecular Biology ', ' Genetics-Mutagenesis ', ' Mutagenesis ', ' base ', ' Blood specimen ', ' Blood Sample ', ' Site ', ' Area ', ' Clinical ', ' Variant ', ' Variation ', ' Biochemical ', ' Predisposition ', ' Susceptibility ', ' Cutaneous ', ' Serum ', ' Blood Serum ', ' insight ', ' Individual ', ' Collaborations ', ' Genetic ', ' Inflammatory ', ' tool ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Life ', ' Chronic small plaque psoriasis ', ' Psoriasis vulgaris ', ' Plaque psoriasis ', ' Nummular psoriasis ', ' Discoid psoriasis ', ' Clinic ', ' Autoimmune Process ', ' Autoimmune ', ' Genetic Load ', ' cohort ', ' TYK2 ', ' novel ', ' Pathogenesis ', ' Code ', ' Coding System ', ' Modeling ', ' Sampling ', ' case control ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-translated RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' Meta-Analysis ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Small Interfering RNA ', ' siRNA ', ' Short interfering RNA ', ' MicroRNAs ', ' miRNAs ', ' miRNA ', ' Micro RNA ', ' Skin ', ' osteoblastic differentiation ', ' osteoblast cell differentiation ', ' osteoblast differentiation ', ' metabonomics ', ' metabolism measurement ', ' metabolomics ', ' TNFSF15 gene ', ' Vascular Endothelial Growth Inhibitor ', ' VEGI ', ' Tumor Necrosis Factor Ligand Superfamily Member 15 ', ' TNFSF15 ', ' TNF15 ', ' TNF Ligand-Related Molecule 1 ', ' TL1 ', ' STAT3 gene ', ' STAT3 ', ' CD8B1 gene ', ' LYT3 ', ' CD8B1 ', ' CD8B ', ' CD8 ', ' Address ', ' Data ', ' International ', ' Regulatory Element ', ' Cellular Assay ', ' cell assay ', ' Collection ', ' Transcript ', ' follow-up ', ' followup ', ' followed up ', ' follow up ', ' active followup ', ' Active Follow-up ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' memory CD4 T lymphocyte ', ' memory CD4 T cell ', ' innovation ', ' innovative ', ' innovate ', ' clinically relevant ', ' clinical relevance ', ' tool development ', ' high risk ', ' Biological Markers ', ' biomarker ', ' biologic marker ', ' bio-markers ', ' systemic autoimmunity ', ' exome ', ' exomes ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' rare variant ', ' rare allele ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' CRISPR/Cas system ', ' CRISPR ', ' predictive marker ', ' predictive molecular biomarker ', ' predictive biomarkers ', ' Genetic study ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' biomarker development ', ' transcriptome ', ' global transcription profile ', ' global gene expression ', ' metabolome ', ' metabonome ', ' Longitudinal cohort ', ' Longterm cohort ', ' Long-term cohort ', ' recruit ', ' causal variant ', ' causative variant ', ' causative mutation ', ' causal mutation ', ' causal gene ', ' causal allele ', ' ']",NIAMS,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2019,678336,MI-12,0.028878028843721325
"Tinnitus: Audiological measures and genetic susceptibility PROJECT SUMMARY/ABSTRACT Tinnitus, the phantom perception of sound in absence of an external sound source, is a prevalent hearing disorder. To date, the exact neural and molecular mechanisms underlying tinnitus are not known. Tinnitus is associated with a number of otological diseases and clinical conditions; however, almost 50% of tinnitus cases are not attributable to any known cause (Stouffer & Tyler, 1990). There is likely a genetic component to tinnitus (Sand et al, 2007). A critical gap in the knowledge base is how to clinically identify those who are genetically predisposed to tinnitus well before they acquire this hearing health issue. The short-term goal of this R21 Early Career Research PAR 16-057 application, entitled Tinnitus: Audiological measures and genetic susceptibility, is to identify detailed phenotypic and genotypic profiles of chronic tinnitus in young adults. The application is proposed by a team of researchers: The PI is Ishan Bhatt, Ph.D. in audiology (CCC-A, FAAA), who is working with Co-PIs Jason Wilder, Ph.D. in genetics, Jin Wang, Ph.D. in statistics, and Raquel Dias, Ph.D. in Bioinformatics. This project will fill the gap in knowledge by identifying the critical variables associated with a genetic predisposition to CT. This investigation will include college-aged young participants to control for age- related confounding variables such as systemic diseases and hearing loss. According to the PIs pilot study (Bhatt, 2017a), the estimated prevalence of chronic tinnitus (CT), acute tinnitus (AT) and no tinnitus (NT) is around 8%, 13% and 79%, respectively. To accomplish our short-term goal, we will conduct a case-control- control exonic genome-wide association study (GWAS) (N = 300) in which subjects will be divided into three groups: those with (1) CT (tinnitus for > 1 year; n=100), (2) AT (tinnitus for  1 year, presumably due to acute environmental exposure; n=100); and (3) NT (no experience of tinnitus in a lifetime; n=100). The Specific Aims are: (1) to identify associations between exonic Single Nucleotide Polymorhisms (SNPs) and tinnitus phenotype. Based on the criteria laid out in the preliminary studies (Bhatt, 2017a; Bhatt et al., 2016; Phillip et al., 2015), our working hypothesis is that causal SNPs will exhibit a higher frequency of a specific genotype for subjects with CT compared to subjects with AT and NT. (2) To identify association between selected SNPs in a candidate set of genes and audiologic measures among subjects with CT, AT and NT, Based on our preliminary studies (Bhatt et al., 2016, Phillips et al., 2015), our working hypothesis is that subjects with causal alleles for CT will exhibit pathophysiological variation in the audiometric measures. Significance: Successful completion of this project will enable us to identify phenotypic and genotypic profiles of CT. This will help us to achieve our long term goal, which is to develop a genetic Risk Profile that can be used by health-care providers, and educators (e.g., health professionals, music and industrial arts teachers) to identify individuals genetically at risk for CT. Project Narrative Tinnitus, the phantom perception of sound in absence of an external sound source, is a prevalent hearing disorder. The short-term goal of this study is to identify detailed phenotypic and genotypic profiles of chronic tinnitus in college-aged young adults. The relevance of the project to public health is reflected in the long-term goal, which is to construct a genetic risk profile which can be used by health-care providers and educators to identify individuals genetically at risk for chronic tinnitus.",Tinnitus: Audiological measures and genetic susceptibility,9655203,R21DC016704,"['Age ', ' ages ', ' Aging ', ' Anxiety ', ' Audiology ', ' Auditory Perception ', ' sound perception ', ' hearing perception ', ' Epidemiologic Confounding Factor ', ' Confounding Variables ', ' Confounding Factors (Epidemiology) ', ' depression ', ' Mental Depression ', ' Disorder ', ' Disease ', ' drug/agent ', ' Pharmaceutic Preparations ', ' Medication ', ' Drugs ', ' Pharmaceutical Preparations ', ' Educational aspects ', ' Education ', ' Environmental Exposure ', ' Auditory Evoked Response ', ' Auditory Evoked Potentials ', ' Exhibits ', ' Family ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' treatment provider ', ' medical personnel ', ' healthcare personnel ', ' health workforce ', ' health provider ', ' health care worker ', ' health care personnel ', ' Healthcare worker ', ' Healthcare Providers ', ' Health Care Providers ', ' Health Personnel ', ' healthcare policy ', ' health care policy ', ' Health Policy ', ' Hearing ', ' Modern Man ', ' Human ', ' Industrial Arts ', ' Military ', ' Armed Forces Personnel ', ' Military Personnel ', ' Multivariate Analyses ', ' Multivariate Analysis ', ' Music ', ' Noise ', ' Nucleotides ', ' middle ear infection ', ' Otitis Media ', ' Phenotype ', ' pilot study ', ' Pilot Projects ', ' polymorphism ', ' Genetic Polymorphism ', ' Prostaglandin Synthetase ', ' Prostaglandin Synthase ', ' Prostaglandin H2 Synthetase ', ' Prostaglandin H Synthase ', ' Prostaglandin G-H Synthase ', ' Prostaglandin Endoperoxide Synthetase ', ' Prostaglandin Cyclooxygenase ', ' Prostaglandin Cyclo-Oxygenase ', ' PGH2 Synthetase ', ' PGH Synthase ', ' Hydroperoxide Cyclase ', ' Fatty Acid Cyclo-Oxygenase ', ' Cyclooxygenase ', ' Cyclo-Oxygenase ', ' Arachidonic Acid Cyclooxygenase ', ' Prostaglandin-Endoperoxide Synthase ', ' Public Health ', ' QOL ', ' Quality of life ', ' 5-Hydroxytryptamine Receptors ', ' 5-HT Receptors ', ' serotonin receptor ', ' noise sensitivity ', ' loudness intolerance ', ' decreased loudness tolerance ', ' Loudness Recruitment ', ' Loudness Perception Disturbances ', ' Hyperacusia ', ' Hyperacusis ', ' Research ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Risk ', ' Risk Factors ', ' Hippophaine ', ' Enteramine ', ' 5HT ', ' 5-Hydroxytryptamine ', ' 5-HT ', ' Serotonin ', ' Tridymite ', ' Silica ', ' Sand ', ' Cristobalite ', ' Silicon Dioxide ', ' Smoking ', ' Na element ', ' Sodium ', ' sound ', ' statistics ', ' Testing ', ' Ringing-Buzzing-Tinnitus ', ' Tinnitus ', ' Veterans ', ' Measures ', ' otoacoustic emission ', ' serotonin transporter ', ' sodium-dependent serotonin transporter ', ' 5HTT protein ', ' 5HT transporter ', ' base ', ' career ', ' Acute ', ' Chronic ', ' Clinical ', ' Phase ', ' Variant ', ' Variation ', ' Physiological ', ' Physiologic ', ' Adolescent ', ' juvenile human ', ' juvenile ', ' Adolescent Youth ', ' Financial compensation ', ' Compensation ', ' Predisposition ', ' Susceptibility ', ' teacher ', ' insight ', ' Individual ', ' young adult ', ' young adulthood ', ' adult youth ', ' Policy Maker ', ' Ethnic Origin ', ' Ethnicity ', ' Hearing problem ', ' hearing disease ', ' Hearing Disorders ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Exposure to ', ' Impaired cognition ', ' cognitive loss ', ' cognitive dysfunction ', ' Disturbance in cognition ', ' Cognitive function abnormal ', ' Cognitive decline ', ' Cognitive Impairment ', ' Cognitive Disturbance ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Knowledge ', ' Investigation ', ' Frequencies ', ' Complex ', ' Systemic disease ', ' Source ', ' college ', ' collegiate ', ' American ', ' experience ', ' gene environment interaction ', ' environment effect on gene ', ' GxE interaction ', ' Gene x Environment Interaction ', ' voltage gated channel ', ' knowledge base ', ' knowledgebase ', ' relating to nervous system ', ' neural ', ' trait ', ' Genetic screening method ', ' genetic testing ', ' gene-based testing ', ' gene testing ', ' novel ', ' Participant ', ' Prevention strategy ', ' Preventive strategy ', ' Preventative strategy ', ' General Population ', ' General Public ', ' Environmental Risk Factor ', ' environmental risk ', ' Environmental Factor ', ' Reporting ', ' Regulation ', ' Modeling ', ' Sampling ', ' case control ', ' Sleeplessness ', ' Insomnia Disorder ', ' Insomnia ', ' Bioinformatics ', ' Bio-Informatics ', ' genetic association ', ' Candidate Disease Gene ', ' Candidate Gene ', ' PTGS1 gene ', ' PTGS1 ', ' PTGHS ', ' PHS1 ', ' PGHS1 ', ' PGHS-1 ', ' PCOX1 ', ' COX3 ', ' COX1 ', ' PTGS2 gene ', ' hCOX-2 ', ' PTGS2 ', ' PHS-2 ', ' PGHS-2 ', ' COX2 ', ' COX-2 ', ' hearing impairment ', ' hearing dysfunction ', ' hearing disability ', ' hearing difficulty ', ' hearing deficit ', ' hearing defect ', ' dysfunctional hearing ', ' Hypoacusis ', ' Hypoacuses ', ' Hearing Loss ', ' Address ', ' Doctor of Philosophy ', ' PhD ', ' Ph.D. ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Genetic Risk ', ' Characteristics ', ' Molecular ', ' Development ', ' developmental ', ' Health Professional ', ' Healthcare professional ', ' Health Care Professional ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' age related ', ' age dependent ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' Population ', ' Prevalence ', ' aged ', ' innovation ', ' innovative ', ' innovate ', ' aging population ', ' population aging ', ' aged population ', ' treatment strategy ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' Genetic study ', ' learning strategy ', ' learning method ', ' learning activity ', ' clinical development ', ' causal variant ', ' causative variant ', ' causative mutation ', ' causal mutation ', ' causal gene ', ' causal allele ', ' ']",NIDCD,NORTHERN ARIZONA UNIVERSITY,R21,2019,151994,AZ-01,0.03807702812633902
"Cardiac genetic effects across HLBS phenotypes Forward genetic genome-wide association studies (GWAS) have successfully mapped thousands of loci regulating disorders of the heart, lung, blood and sleep (HLBS), implicating widespread sequence variation within the non-coding genome. However, their functions, mechanisms of action and how they impact disease is still unclear. To solve this new and important GWAS bottleneck, we use a functional genomics-inspired reverse genetics strategy to identify the `transcriptional machinery' (transcription factors (TF), cis-regulatory elements (CRE), target genes) controlling HLBS-relevant tissue functions and how DNA variants in them affect HLBS diseases. Taking advantage of our long-standing expertise and successes in complex, cardiovascular disorders, and novel computational methods we have recently developed, we propose novel genomics analyses of the Trans-Omics for Precision Medicine (TOPMed) Program phenotypes and their whole genome sequences, together with publicly available epigenomics data, to identify the molecular bases of HLBS disease. We will first focus on the transcriptional machinery controlling heart physiology and its disorders before exploring other HLBS-relevant tissues and disorders in collaboration with other TOPMed investigators. Our specific aims are: (1) Identifying the transcriptional machinery in the heart and other HLBS relevant tissues; and, (2) Connecting genomic variation in the transcriptional machinery to HLBS traits. Our approach will enable identification of the core molecular components that control HLBS tissues and how they are compromised in HLBS disorders. The major hypothesis explaining the results of heart, lung, blood and sleep (HLBS) genome-wide association studies (GWAS) is that sequence variants at specific cis-regulatory elements (CRE or enhancer) affect the binding of their cognate transcription factors (TF) to alter expression of specific HLBS genes and, thereby, modulate variation in the phenotype and disorders. In this proposal, we advance new computational approaches to identify the `transcriptional machinery' (TF, CRE, target genes) controlling HLBS-relevant tissue functions so that the effects of causal genetic variation can be identified within identified trait loci genome- wide. This tissue-based view provides an alternative, complementary approach for understanding HLBS trait and disease variation, a major public health challenge.",Cardiac genetic effects across HLBS phenotypes,9692018,R01HL141980,"['Affect ', ' Algorithms ', ' Blood ', ' Blood Reticuloendothelial System ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' Chromatin ', ' computing method ', ' computer methods ', ' computer based method ', ' computational methods ', ' computational methodology ', ' Computing Methodologies ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Gene Expression ', ' allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genome ', ' Genotype ', ' Heart ', ' heart disorder ', ' Cardiac Disorders ', ' Cardiac Diseases ', ' Heart Diseases ', ' blood disorder ', ' Hematological Disorder ', ' Hematologic Diseases ', ' Blood Diseases ', ' Hematological Disease ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' pulmonary ', ' Lung Respiratory System ', ' Lung ', ' lung disorder ', ' disorder of the lung ', ' disease of the lung ', ' Respiratory System Disorder ', ' Respiratory System Disease ', ' Respiratory Disease ', ' Pulmonary Disorder ', ' Pulmonary Diseases ', ' Lung diseases ', ' Maps ', ' Minor ', ' National Institutes of Health ', ' NIH ', ' United States National Institutes of Health ', ' Phenotype ', ' Physiology ', ' Public Health ', ' Publishing ', ' Quality Control ', ' Researchers ', ' Investigators ', ' Research Personnel ', ' Research Resources ', ' Resources ', ' social role ', ' Role ', ' Sleep ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Genetic Diversity ', ' Genetic Variation ', ' Weight ', ' Enhancers ', ' base ', ' improved ', ' Peripheral ', ' Variant ', ' Variation ', ' Link ', ' Individual ', ' Sample Size ', ' Collaborations ', ' Genetic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Complex ', ' success ', ' trait ', ' Base Pairing ', ' novel ', ' Code ', ' Coding System ', ' Sleep Disorders ', ' sleep problem ', ' sleep dysregulation ', ' sleep dysfunction ', ' Modeling ', ' functional genomics ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-translated RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' Data ', ' Regulatory Element ', ' Molecular ', ' Cardiac ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' epigenomics ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' genome-wide analysis ', ' genome-wide identification ', ' genome wide studies ', ' genome wide analysis ', ' gene discovery ', ' discover genes ', ' genome-wide ', ' genomewide ', ' genome scale ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' rare variant ', ' rare allele ', ' DNase I hypersensitive sites sequencing ', ' DNaseI-seq ', ' DNase-seq ', ' genomic variation ', ' reverse genetics ', ' ATAC-seq ', ' ATACseq ', ' Genotype-Tissue Expression Project ', ' GTEx ', ' whole genome ', ' full genome ', ' entire genome ', ' genomic data ', ' genomic dataset ', ' genomic data-set ', ' Trans-Omics for Precision Medicine ', ' TOPMed ', ' causal variant ', ' causative variant ', ' causative mutation ', ' causal mutation ', ' causal gene ', ' causal allele ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2019,436249,NY-12,-0.005753053521484095
"IBD Gene Mapping by Clinical and Population Subset PROJECT SUMMARY Inflammatory bowel disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC) are complex genetic disorders of the gastrointestinal tract, and a major health burden to patients and society. Tremendous progress has been made in dissecting IBD genetic etiology with identification of over 200 IBD loci by genome wide association studies (GWAS) but mainly limited to persons of European ancestry. The IBD Genetics Consortium (IBDGC) was established to facilitate multicenter collaborative studies of 6 Genetics Research Centers (GRCs) organized with a Data Coordinating Center (DCC). Our GRC at Johns Hopkins (JHGRC) has contributed to all IBDGC studies, meeting recruitment objectives and taking roles in IBDGC leadership positions. Our particular focus is on African American (AA) IBD genetics. We performed the first large-scale evaluation of European loci in the AA population, replicating several genes, but also finding unique African-ancestral variants within these loci, as well as identified multiple admixture significant loci. We also published the first AA IBD genome-wide association study (GWAS), a collaborative effort that identified two African-specific gene loci, and replicated multiple additional European loci. We have also explored why some loci with proven risk variants in Europeans and other populations only cause disease in one ancestral population but not others. More research in AA IBD is needed to understand the etiology of IBD in this ancestrally distinct, major American population. In this application we will re-evaluate the AA GWAS by better imputation, evaluate whole genome sequencing data to test low frequency and rare variants, and perform an evaluation for chromosome X variants. We will recruit a large number of AA IBD patients through our own and multiple Satellite Recruitment Centers to power a second AA IBD GWAS, both UC and CD, and meta-analyze with the first to identify more novel loci, identify more African specific risk variants, and replicate known loci for this population and replicate our admixture loci. We will also incorporate diverse data sources to incorporate into our GWAS analyses including RNA-Seq currently being generated on lymophoblastoid cell lines from AA CD cases and controls, and RNA-Seq that we will generate in colonic biopsies from UC cases and controls. We will evaluate chromatin differences and expression of genes in cell types relevant to IBD from European, AA and East Asian ancestries in an effort to better understand locus heterogeneity by ancestry. We will continue to participate in all IBDGC activities to maximize the Impact of IBD genetics research by this cooperative funding mechanism. According to the Center for Disease Control and Prevention, an estimated 1.4 million Americans suffer from Inflammatory Bowel Disease (IBD), a chronic debilitating disorder with no cure that includes Crohn's disease and ulcerative colitis. IBD ranks in the top 5 in prevalence for gastrointestinal disorders and represents a significant financial burden to society requiring a lifetime of medical care. This proposed research aims to determine the genetic variations that cause IBD which will aid in developing preventive measures, improving the quality of care with better treatments and educating patients through genetic counseling.",IBD Gene Mapping by Clinical and Population Subset,9780486,U01DK062431,"['Algorithms ', ' Biopsy ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' United States Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' Centers for Disease Control ', ' CDC ', ' Centers for Disease Control and Prevention (U.S.) ', ' Charge ', ' Chromatin ', ' genetic mapping ', ' Total Human and Non-Human Gene Mapping ', ' Linkage Mapping ', ' Gene Mapping Genetics ', ' Gene Mapping ', ' Gene Localization ', ' Chromosome Mapping ', ' Concurrent Studies ', ' Cohort Studies ', ' Ulcerated Colitis ', ' Ulcerative Colitis ', ' regional enteritis ', ' eleocolitis ', ' Granulomatous Enteritis ', "" Crohn's disorder "", "" Crohn's "", ' Crohn disease ', "" Crohn's disease "", ' Data Sources ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Epithelium Part ', ' Epithelium ', ' Future ', ' gastrointestinal disorder ', ' Gastrointestinal Diseases and Manifestations ', ' Gastrointestinal Diseases ', ' digestive canal ', ' alimentary tract ', ' Gastrointestinal Tract ', ' GI Tract ', ' Digestive Tract ', ' Alimentary Canal ', ' Gastrointestinal tract structure ', ' Gene Expression ', ' allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' Genes ', ' Genetic Counseling ', ' Population Genetics ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Inflammatory Intestinal Disorder ', ' Inflammatory Intestinal Disease ', ' Inflammatory Bowel Disorder ', ' Inflammatory Bowel Diseases ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Leadership ', ' Linkage Disequilibrium ', ' macrophage ', ' Persons ', ' Patients ', ' Phenotype ', ' Scientific Publication ', ' Publications ', ' Publishing ', ' Research ', ' Research Resources ', ' Resources ', ' social role ', ' Role ', ' Societies ', ' Testing ', ' Universities ', ' Genetic Diversity ', ' Genetic Variation ', ' Work ', ' X Chromosome ', ' oriental ', ' Asians ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Enhancers ', ' hispanic community ', ' Spanish Origin ', ' Latino Population ', ' Hispanic Populations ', ' Hispanics ', ' Caring ', ' Point Mutation ', ' base ', ' improved ', ' Chronic ', ' Clinical ', ' Phase ', ' Variant ', ' Variation ', ' Medical ', ' Evaluation ', ' insight ', ' Individual ', ' African ', ' European ', ' Fostering ', ' Databases ', ' data base ', ' Data Bases ', ' Genetic Research ', ' Funding ', ' Ethnic Origin ', ' Ethnicity ', ' Collaborations ', ' Coculture Techniques ', ' Coculture ', ' Cocultivation ', ' Co-culture ', ' Genetic ', ' Genetic Predisposition to Disease ', ' genetically predisposed ', ' genetic vulnerability ', ' genetic mechanism of disease ', ' genetic etiology ', ' Inherited Susceptibility ', ' Inherited Predisposition ', ' Genetic Susceptibility ', ' Genetic Predisposition ', ' Nature ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Investigation ', ' Frequencies ', ' Complex ', ' Source ', ' cell type ', ' Pattern ', ' interest ', ' meetings ', ' American ', ' experience ', ' novel ', ' Positioning Attribute ', ' Position ', ' Pathway Analysis ', ' Network Analysis ', ' Modeling ', ' Sampling ', ' Human Characteristics ', ' Human Nature ', ' Quality of Care ', ' QOC ', ' case control ', ' Effectiveness ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genetic association ', ' genome sequencing ', ' Admixture ', ' Data ', ' Funding Mechanisms ', ' Other Genetics ', ' Update ', ' sex ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' Data Coordinating Center ', ' Data Coordination Center ', ' novel strategies ', ' novel strategy ', ' novel approaches ', ' new approaches ', ' Population ', ' Prevalence ', ' two-dimensional ', ' 2-dimensional ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' risk variant ', ' risk locus ', ' risk loci ', ' risk genotype ', ' risk gene ', ' risk allele ', ' Risk-associated variant ', ' rare variant ', ' rare allele ', ' racial disparity ', ' race disparity ', ' disparities in race ', ' ATAC-seq ', ' ATACseq ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' Preventive measure ', ' Preventative measure ', ' study population ', ' whole genome ', ' full genome ', ' entire genome ', ' recruit ', ' Genetic Diseases ', ' genetic disorder ', ' genetic condition ', ' Financial Hardship ', ' financial stress ', ' financial strain ', ' financial distress ', ' financial burden ', ' ']",NIDDK,RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,U01,2019,467173,NJ-06,-0.007792464269271461
"A Platform for Safe, Noninvasive Prenatal Genetic Testing at Five Weeks of Pregnancy The purpose of this research is to provide a flexible prenatal genetic testing product that can be expanded to detect any inheritable trait as early as 5, and up to 20, weeks of gestation, from a safe, noninvasive Pap smear. Published studies, as well as our own experience, show that perinatal Pap collections using a cervical cytobrush pose no risk to mother or fetus, and captures trophoblast cells that migrate from the placenta into the reproductive tract. Trophoblast retrieval and isolation from the cervix (TRIC) efficiently isolates hundreds of trophoblast cells without limitations due to early gestational age, maternal obesity, or uteroplacental insufficiency disorders. In our report published in Science Translational Medicine, we isolated sufficient genomic DNA from intact fetal trophoblast cells obtained by TRIC at 5-19 weeks of gestation (n=20) to definitively distinguish maternal and fetal DNA by targeted next-generation sequencing (NGS) of short terminal repeats (STRs) and single nucleotide polymorphisms (SNPs). Compared to massively parallel sequencing of cell-free fetal DNA from maternal serum, which has a fetal fraction of only 4-10% at week 10 of gestation, the complete genome obtained by TRIC has a fetal fraction of 85-100%, and provides nucleotide-specific haplotyping. In our Phase I award, we developed this technology for prenatal genotyping of single gene disorders located on the hemoglobin B (HBB) gene, using custom multiplex PCR amplification of SNPs, STRs and loci across HBB for NGS. We successfully haplotyped the locus for the sickle cell disease (SCD) point mutation and genotyped the remainder of the HBB exome, which includes alternate SCD loci, beta thalassemias and anemias. In Phase II, we will expand the test to include HBA1 and HBA1 genes (alpha thalassemias) to provide a comprehensive hemoglobinopathy screen. Phase I studies revealed that genotyping was consistently accurate, unless cervical specimen collection was suboptimal and <40 trophoblast cells were isolated. Commercialization will require operators to obtain adequate specimens. We will accomplish six milestones towards commercialization of this test: 1. Incorporate the HBA1 and HBA2 loci into a comprehensive hemoglobinopathy test. 2. Optimize success rates through operator training and innovations in collection device designs to increase cervical cell recoveries. 3. Innovate a novel alternative method to cytobrush-based cervical collection. 4. Automate the TRIC processing pipeline for high throughput cell isolation, DNA purification and NGS. 5. Establish sample quality assessment tools powered by artificial intelligence and machine learning. 6. Perform a clinical validation trial to assess test performance. With an estimated annual market potential over $284 million for prenatal hemoglobinopathies testing, the envisioned technology will fill an existing gap in clinical diagnostics and outcompete existing invasive prenatal testing. Our initial commercial product will to enable management of high-risk pregnancies and provide valuable information to physicians and patients in the process of establishing families. Specifically, this initial product will benefit pregnancies at risk of having a child with SCA or other hemoglobinopathies such as thalassemia and anemia. This research provides major public health benefits by leveraging a safe, noninvasive method to capture fetal cells that migrate into the reproductive tract from a Pap smear for development of genetic tests to identify women carrying a fetus with an inherited disorder. We will build a DNA sequencing kit that can be commercialized to determine the genotype of fetuses at risk for sickle cell anemia and other hemoglobinopathies as early as 5 weeks of pregnancy. Advances emerging from the proposed research will generate new clinical tools for managing pregnancy complications to benefit the well-being of mothers and their babies.","A Platform for Safe, Noninvasive Prenatal Genetic Testing at Five Weeks of Pregnancy",9776011,R44HD092205,"['alpha-Thalassemia ', ' -thalassemia ', ' treatment associated acute myelogenous leukemia ', ' secondary leukemia ', ' Hemoglobin H Disease ', ' Amniocentesis ', ' Anemia ', ' Sickle Cell Anemia ', ' sicklemia ', ' sickle disease ', ' sickle cell disease ', ' Hemoglobin sickle cell disorder ', ' Hemoglobin sickle cell disease ', ' Hemoglobin S Disease ', ' HbSS disease ', ' Hb SS disease ', ' Artificial Intelligence ', ' Machine Intelligence ', ' Computer Reasoning ', ' Automation ', ' Award ', ' beta Thalassemia ', ' -thalassemia ', ' p-Thalassemia ', ' B-thalassemia ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Biopsy ', ' Cell Number ', ' Cell Count ', ' cell sorting ', ' Cell Separation Technology ', ' Cell Segregation ', ' Cell Isolation ', ' Cell Separation ', ' Cell Body ', ' Cells ', ' Uterine Cervix ', ' Cervix ', ' Cervix Uteri ', ' youngster ', "" childrens' "", ' children ', ' Children (0-21) ', ' Child Youth ', ' 0-11 years old ', ' Child ', ' Chorion ', ' Chromosomes ', ' Communities ', ' Conceptions ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Family ', ' Feasibility Studies ', ' Fetus ', ' Future ', ' Genes ', ' Genome ', ' Genotype ', ' sexual cell ', ' initial cell ', ' Sex Cell ', ' Reproductive Cells ', ' Germ-Line Cells ', ' Gametes ', ' Germ Cells ', ' Fetal Age ', ' Chronologic Fetal Maturity ', ' Gestational Age ', ' ontogeny ', ' Tissue Growth ', ' Generalized Growth ', ' Growth ', ' Haplotypes ', ' Hemoglobinopathies ', ' Hemoglobin ', ' inherited genetic disorder ', ' inherited genetic disease ', ' inherited diseases ', ' inborn error ', ' hereditary disorder ', ' Inherited disorder ', ' Inborn Genetic Diseases ', ' Hereditary Disease ', ' Modern Man ', ' Human ', ' Industry ', ' newborn children ', ' newborn child ', ' Newborns ', ' 0-4 weeks old ', ' Newborn Infant ', ' Manuals ', ' Methods ', ' Mothers ', ' genome mutation ', ' Genetic defect ', ' Genetic Change ', ' Genetic Alteration ', ' Mutation ', ' Nucleotides ', ' Patents ', ' Legal patent ', ' Patients ', ' wellbeing ', ' well-being ', ' Personal Satisfaction ', ' Physicians ', ' Placentome ', ' Placenta Embryonic Tissue ', ' Normal Placentoma ', ' Cells Placenta-Tissue ', ' Placenta ', ' Gestation ', ' Pregnancy ', ' pregnancy-related complications ', ' complications during pregnancy ', ' Pregnancy Complications ', ' First Trimester ', ' Early Placental Phase ', ' 1st trimester ', ' First Pregnancy Trimester ', ' Public Health ', ' Publishing ', ' Records ', ' Research ', ' Risk ', ' Speculums ', ' Technology ', ' Terminal Repeat ', ' Flanking Repeat Sequences ', ' Terminal Repeat Sequences ', ' Testing ', ' Thalassemia ', ' Body Tissues ', ' Tissues ', ' trophoblast ', ' Vaginal ', ' Vagina ', ' Woman ', ' hemoglobin B ', ' cervical/vaginal smear ', ' Vaginal Smears ', ' Papanicolaou Test ', ' Papanicolaou Smear ', ' Pap Test ', ' Cervical Smears ', ' Pap smear ', ' Measures ', ' black American ', ' Black Populations ', ' Afroamerican ', ' Afro American ', ' African American ', ' Device Designs ', ' Health Benefit ', ' health care ', ' Healthcare ', ' Custom ', ' Point Mutation ', ' base ', ' Perinatal ', ' Peripartum ', ' improved ', ' Procedures ', ' sample collection ', ' specimen collection ', ' Cervical ', ' Clinical ', ' Phase ', ' Medical ', ' Ensure ', ' Training ', ' Visual ', ' Recovery ', ' High-Risk Pregnancy ', ' tool ', ' Specimen ', ' Research Specimen ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' Disease Management ', ' Disorder Management ', ' Inherited ', ' Hereditary ', ' fetus at risk ', ' at-risk fetus ', ' Test Result ', ' fetal ', ' interest ', ' Services ', ' experience ', ' Gene Mutation ', ' Gene Alteration ', ' success ', ' fetal diagnosis ', ' trait ', ' prenatal ', ' unborn ', ' Genetic screening method ', ' genetic testing ', ' gene-based testing ', ' gene testing ', ' novel ', ' Mediation ', ' Negotiation ', ' Negotiating ', ' Reporting ', ' Positioning Attribute ', ' Position ', ' reproductive ', ' Single Nucleotide Polymorphism ', ' Single Base Polymorphism ', ' Sampling ', ' performance tests ', ' DNA purification ', ' Intervention ', ' interventional strategy ', ' Intervention Strategies ', ' fetus cell ', ' fetal cell ', ' Provider ', ' prenatal testing ', ' prenatal screening ', ' Data ', ' Resolution ', ' Retrieval ', ' Collection ', ' Computer Analysis ', ' computer analyses ', ' computational analysis ', ' computational analyses ', ' Conceptus ', ' Other Genetics ', ' Short Tandem Repeat ', ' Simple Sequence Repeat ', ' Small Business Innovation Research Grant ', ' Small Business Innovation Research ', ' SBIR ', ' Translational Research ', ' translation research ', ' Translational Science ', ' Validation ', ' Villous ', ' Preparation ', ' Process ', ' Development ', ' developmental ', ' innovation ', ' innovative ', ' innovate ', ' perinatal health ', ' clinically relevant ', ' clinical relevance ', ' translational medicine ', ' maternal serum ', ' commercialization ', ' industry partner ', ' industry partnership ', ' industrial partnership ', ' exome ', ' exomes ', ' flexibility ', ' flexible ', ' phase 1 study ', ' Phase I Study ', ' operation ', ' next generation sequencing ', ' nextgen sequencing ', ' next gen sequencing ', ' NGS system ', ' NGS Method ', ' screening ', ' Massive Parallel Sequencing ', ' Massively Parallel Sequencing ', ' Massively Parallel DNA Sequencing ', ' Genomic DNA ', ' gDNA ', ' Mendelian disorder ', ' single-gene disorder ', ' single-gene disease ', ' monogenic disorder ', ' monogenic disease ', ' Mendelian genetic disorder ', ' Mendelian disease ', ' cell free fetal DNA ', ' cffDNA ', ' cff DNA ', ' targeted sequencing ', ' Assessment tool ', ' Assessment instrument ', ' reproductive tract ', ' genital tract ', ' maternal obesity ', ' maternal adiposity ', ' clinical diagnostics ', ' DNA sequencing ', ' DNAseq ', ' DNA seq ', ' testing services ', ' Genetic Diseases ', ' genetic disorder ', ' genetic condition ', ' Infrastructure ', ' off-patent ', ' ']",NICHD,"CRADLE GENOMICS, INC.",R44,2019,1098375,CA-52,0.007867762074737255
"Computational modeling of DNA methylation-mediated gene regulation Abstract Large numbers of complete methylomes are being acquired through clinical sequencing projects, such as through The Cancer Genome Atlas, Blueprint Epigenome Project, and International Cancer Genome Consortium. Furthermore, third-generation nanopore sequencers, which detect DNA methylation and genetic variation in a single experiment, are nearly ready for routine clinical sequencing and will provide complete methylomes for all patients where whole-genome sequencing is indicated. Current analysis tools however only perform preliminary methylome processing and catalogue differentially methylated regions (DMRs). In order to transform methylome analysis into a clinically useful diagnostic/prognostic test, we need to develop predictive tools to interpret the functional and pathological consequences of identified methylation changes. Towards this goal, we have published a series of papers demonstrating that machine-learning based models utilizing high- resolution signatures of all methylation changes around a promoter vastly outperform conventional DMR methods. Our models accurately predict expression states at genes potentially regulated by methylation and reveal predictive methylation signatures that facilitate mechanistic interpretation. Nonetheless, several challenges remain before we can achieve our goals of translating genome-wide methylation data for routine clinical use: (1) To our knowledge, no current models integrate distal enhancers, whose activation is affected by DNA methylation. Such integrative analysis is necessary to understand consequences of methylation changes in cancers, whose genomes frequently undergo wide-spread methylation changes. In addition, such modelling will be essential to understand the role of 5-hydroxymethylcytosine (5hmC), which may play both repressive and activating roles in neurons depending on whether it is found at promoters or enhancers. (2) Our current models (and conventional approaches) represent methylation data independent of DNA sequence despite mechanistic studies demonstrating that methylation changes can have different functional effects depending on which sequences change and depending on the context of the local regulatory grammar. In this proposal, we will meet these challenges by first developing a predictive model that incorporates 5-methylcytosine and 5hmC at promoters and enhancers to determine how these marks act in concert. In particular, we will examine the hypothesized dual role of 5hmC as a repressor at promoters and as an activator at enhancers in cortical neurons. We will then use new advances in natural language processing to model DNA sequence and methylation to predict expression states. Our results will reveal which regulatory elements and transcription factors binding sites are affected by DNA methylation and how changes at different sites collaborate to affect expression changes. We will experimentally validate our in silico predictions using a combination of reporter assays and CRISPR- based epigenome-editing tools. Thus, the software tools we develop will form an important toolkit for the analysis and mechanistic interpretation of whole-genome methylation studies, both in the laboratory and clinic. Public Narrative DNA normally undergoes a variety of chemical modifications including the addition of methyl- and hydroxymethyl- groups to cytosines (DNA methylation). Though we are unsure how to interpret them, abnormal patterns of DNA methylation are often found in human diseases and will likely soon be routinely measured in the clinic. In this proposal, we will develop advanced computational approaches to predict the functional and pathological consequences of DNA methylation changes in disease. In the future, the approaches we develop will lead to software that suggests individualized therapies for patients based on clinical methylation data.",Computational modeling of DNA methylation-mediated gene regulation,9896942,R01LM013096,"['Affect ', ' Binding Sites ', ' Reactive Site ', ' Combining Site ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' Malignant Neoplasms ', ' neoplasm/cancer ', ' malignancy ', ' Malignant Tumor ', ' Cancers ', ' Cataloging ', ' Cell Body ', ' Cells ', ' Communities ', ' virtual simulation ', ' in silico ', ' computerized simulation ', ' computerized modeling ', ' computer based models ', ' computational simulation ', ' computational models ', ' computational modeling ', ' Mathematical Models and Simulations ', ' Mathematical Model Simulation ', ' Computerized Models ', ' Computer based Simulation ', ' Computer Models ', ' Computer Simulation ', ' Cytosine ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Elements ', ' Future ', ' Gene Expression ', ' Gene Regulation Process ', ' Gene Regulation ', ' Gene Action Regulation ', ' Gene Expression Regulation ', ' Genes ', ' Genome ', ' neuroglia tumor ', ' neuroglia neoplasm ', ' glial-derived tumor ', ' Neuroglial Tumor ', ' Neuroglial Neoplasm ', ' Glial Tumor ', ' Glial Neoplasm ', ' Glial Cell Tumors ', ' Glioma ', ' Goals ', ' Laboratories ', ' Maps ', ' Methods ', ' Methylation ', ' Murine ', ' Mice Mammals ', ' Mice ', ' Mus ', ' natural language understanding ', ' Natural Language Processing ', ' neuronal ', ' Neurocyte ', ' Neural Cell ', ' Nerve Unit ', ' Nerve Cells ', ' Neurons ', ' Paper ', ' Patients ', ' Play ', ' Publishing ', ' Recurrent ', ' Recurrence ', ' genetic regulatory element ', ' Regulatory Regions ', ' Nucleic Acid Regulator Regions ', ' Nucleic Acid Regulatory Sequences ', ' social role ', ' Role ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Software ', ' Computer software ', ' Computer Software Tools ', ' Software Tools ', ' Testing ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Translating ', ' Genetic Diversity ', ' Genetic Variation ', ' Generations ', ' Measures ', ' Enhancers ', ' Mediating ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' cofactor ', ' Label ', ' Distal ', ' Site ', ' Clinical ', ' Series ', ' Chemicals ', ' prognostic ', ' Training ', ' Individual ', ' Binding Proteins ', ' bound protein ', ' Protein Binding ', ' Ligand Binding Protein Gene ', ' Ligand Binding Protein ', ' Reporter ', ' tool ', ' Diagnostic ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' DNA Methylation ', ' Catalogs ', ' Clinic ', ' Pattern ', ' embryonic stem cell ', ' stem cell of embryonic origin ', ' ES cell ', ' mutant ', ' success ', ' demethylation ', ' relating to nervous system ', ' neural ', ' Regulation ', ' Modeling ', ' Sampling ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' genome sequencing ', ' Data ', ' International ', ' Regulatory Element ', ' Resolution ', ' Retrieval ', ' Epigenetic Process ', ' Epigenetic Mechanism ', ' Epigenetic Change ', ' Epigenetic ', ' Pathologic ', ' Characteristics ', ' Modification ', ' Development ', ' developmental ', ' epigenomics ', ' cancer genome ', ' tumor genome ', ' cancer cell genome ', ' predictive modeling ', ' prognostic model ', ' prediction model ', ' computer based prediction ', ' nanopore ', ' nano pore ', ' cancer type ', ' human disease ', ' genome-wide ', ' genomewide ', ' genome scale ', ' The Cancer Genome Atlas ', ' TCGA ', ' genome wide methylation ', ' global methylation ', ' genomewide methylation ', ' methylome ', ' epigenome ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' CRISPR/Cas system ', ' CRISPR ', ' network architecture ', ' individualized medicine ', ' unique treatment ', ' tailored treatment ', ' tailored therapy ', ' tailored medical treatment ', ' individualized treatment ', ' individualized therapy ', ' individualized patient treatment ', ' customized treatment ', ' customized therapy ', ' methylation pattern ', ' clinical sequencing ', ' whole genome ', ' full genome ', ' entire genome ', ' predictive tools ', ' prognostic assays ', ' prognostic test ', ' experimental study ', ' experimental research ', ' experiment ', ' DNA sequencing ', ' DNAseq ', ' DNA seq ', ' recruit ', ' epigenetic therapy ', ' long short term memory network ', ' long short term memory neural network ', ' epigenome editing ', ' ']",NLM,WASHINGTON UNIVERSITY,R01,2019,362352,MO-01,0.04537188909802945
"Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia     DESCRIPTION (provided by applicant): Schizophrenia (SZ) represents a significant and costly public health burden. Recently, we have witnessed the emergence of the first molecular insights into the etiopathogenic mechanisms of SZ, via the first genome-wide association studies (GWAS) with sufficient case-control sample sizes to detect allelic effects. Importantly, a polygenic signature, which includes genome-wide significant common genetic variants of small effect, has been clearly demonstrated to influence SZ risk. The availability of well-defined risk factors makes it possible, for the first time, to address several critical questions about the genetic architecture of SZ and its component phenotypes and endophenotypes. The overarching goals of this K01 proposal are 1) to test polygenic risk score prediction of dimensional SZ and schizotypy phenotypes across large case, high-density SZ pedigree, and prodromal-aged GWAS samples, and 2) to develop and test, with leaders of the Psychiatric Genomics Consortium, innovative statistical methods to identify and characterize ""genetic subtypes"" of SZ.  This proposal delineates a series of training and research goals for the candidate that incorporates strengths from phenotypic assessment, statistical genetics, and molecular genetics and combines samples reflecting a broad range of genetic risk. The candidate will capitalize on previously established expertise in schizotypy and clinical risk assessment, as well as expertise in the familial transmission of dimensional traits, to establish a program of translational research wherein the application of statistical genetic/bioinformatic techniques to genetic subtyping analyses will be used to generate promising candidates for further exploration in human genomic data. Empirically-based genetic subtyping methods will be developed and tested in the largest SZ case sample to date, and subtypes will be characterized with respect to dimensional phenotypic traits. Top loci hits in subtype analyses of dimensional symptoms will be validated in secondary analyses of differential gene expression in post-mortem SZ brain. This will allow for a detailed analysis of function at both the SNP and gene levels, and will provide the candidate with substantive training in both statistical and molecular genetics methods. The institutional environment is ideal for the candidate's goal of developing a comprehensive program in SZ research, and the proposed research represents an important contribution toward advancing the understanding of SZ through a combination of clinical, statistical, molecular, and translational methods, consistent with the mission of the NIMH. PUBLIC HEALTH RELEVANCE: Mental illnesses such as schizophrenia constitute 13% of the global burden of disease and schizophrenia, although relatively rare, is highly heritable (80%) and one of the most severe mental disorders. This project aims to elucidate the influence of genetic factors and gene function on dimensional schizophrenia and schizotypy symptoms with multiple measures, across multiple samples of varying genetic risk. Insights gained from this research will inform prediction, prevention, intervention, and treatment efforts by clarifying the biological mechanisms underlying SZ symptoms.",Modeling Dimensionality and Genetic Heterogeneity in Schizophrenia,9644559,K01MH109765,"['Accounting ', ' Alcohol consumption ', ' ethanol use ', ' ethanol product use ', ' ethanol intake ', ' ethanol ingestion ', ' ethanol drinking ', ' ethanol consumption ', ' alcoholic drink intake ', ' alcoholic beverage consumption ', ' alcohol use ', ' alcohol product use ', ' alcohol intake ', ' alcohol ingestion ', ' EtOH use ', ' EtOH drinking ', ' Alcohol Drinking ', ' Alleles ', ' Allelomorphs ', ' Autopsy ', ' postmortem ', ' necropsy ', ' Mental disorders ', ' psychological disorder ', ' psychiatric illness ', ' mental illness ', ' Psychiatric Disorder ', ' Psychiatric Disease ', ' Mental health disorders ', ' Brain ', ' Encephalon ', ' Brain Nervous System ', ' malignant breast neoplasm ', ' malignant breast tumor ', ' Breast Cancer ', ' Disorder ', ' Disease ', ' Environment ', ' Gene Expression ', ' Genes ', ' Goals ', ' Heterogeneity ', ' Modern Man ', ' Human ', ' Interview ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Mentors ', ' Methods ', ' Mission ', ' NIMH ', ' National Institute of Mental Health ', ' pedigree structure ', ' Pedigree ', ' genetic pedigree ', ' Personality ', ' Phenotype ', ' polymorphism ', ' Genetic Polymorphism ', ' psychotic illness ', ' Psychoses ', ' Psychotic Disorders ', ' Public Health ', ' Questionnaires ', ' Research ', ' Risk ', ' Risk Factors ', ' Sampling Studies ', ' schizophrenic ', ' dementia praecox ', ' Schizophrenic Disorders ', ' Schizophrenia ', ' schizotypal ', ' Schizotypal Personality Disorder ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' Students ', ' suicidal attempt ', ' nonfatal attempt ', ' non fatal attempt ', ' Suicide attempt ', ' Testing ', ' Time ', ' Wisconsin ', ' Measures ', ' Molecular Genetics ', ' Risk Assessment ', ' Prefrontal Cortex ', ' base ', ' density ', ' improved ', ' Clinical ', ' Variant ', ' Variation ', ' Biological ', ' Series ', ' Age of Onset ', ' Training ', ' insight ', ' Individual ', ' Malignant neoplasm of lung ', ' lung cancer ', ' Pulmonary malignant Neoplasm ', ' Pulmonary Cancer ', ' Malignant Tumor of the Lung ', ' Measurement ', ' Sample Size ', ' Genetic Heterogeneity ', ' Collaborations ', ' Genetic ', ' gene function ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Dimensions ', ' Complex ', ' Techniques ', ' brain tissue ', ' mind control ', ' brain control ', ' Performance ', ' trait ', ' Structure ', ' novel ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' response ', ' theories ', ' case control ', ' disorder subtype ', ' disease subtype ', ' disease subgroups ', ' Genomics ', ' Meta-Analysis ', ' Data Pooling ', ' Clinical Trial Overviews ', ' Malignant neoplasm of ovary ', ' ovarian cancer ', ' Ovary Cancer ', ' Malignant Tumor of the Ovary ', ' Malignant Ovarian Tumor ', ' Malignant Ovarian Neoplasm ', ' Bioinformatics ', ' Bio-Informatics ', ' disease causation ', ' causation ', ' Causality ', ' Etiology ', ' Address ', ' Symptoms ', ' Data ', ' Preventive Intervention ', ' preventional intervention strategy ', ' Prevention intervention ', ' Preventative intervention ', ' Subgroup ', ' Genetic Risk ', ' Tissue-Specific Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Differential Gene Expression ', ' Transcript ', ' Validation ', ' transmission process ', ' Transmission ', ' Molecular ', ' Process ', ' sex ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' cost ', ' burden of illness ', ' years of life lost to disease ', ' years of life lost to disability ', ' disease burden ', ' burden of disease ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' severe mental illness ', ' severe mental disorder ', ' serious mental illness ', ' serious mental disorder ', ' persistent mental illness ', ' chronic mental illness ', ' Outcome ', ' aged ', ' innovation ', ' innovative ', ' innovate ', ' Heritability ', ' endophenotype ', ' public health relevance ', ' genome-wide ', ' genomewide ', ' genome scale ', ' cocaine use ', ' clinical risk ', ' Research Domain Criteria ', ' RDoC ', ' differential expression ', ' transcriptional differences ', ' differentially expressed ', ' marijuana use ', ' cannabis use ', ' THC use ', ' THC co-use ', ' Gaussian model ', ' Gaussianity model ', ' Gaussianity ', ' Gaussian statistics ', ' training opportunity ', ' dimensional analysis ', ' genomic data ', ' genomic dataset ', ' genomic data-set ', ' symptomatology ', ' substance misuse ', ' population stratification ', ' secondary analysis ', ' translational research program ', ' translation research enterprise ', ' Translational Research Enterprise ', ' nicotine use ', ' nicotine consumption ', ' genetic architecture ', ' classification trees ', ' regression trees ', ' ']",NIMH,UNIVERSITY OF UTAH,K01,2019,176985,UT-02,0.029512319638808373
"From GWAS loci to blood pressure genes, variants & mechanisms The current forward genetics of genome-wide association studies (GWAS) have successfully identified ~300 distinct loci regulating blood pressure (BP), primarily implicating sequence variation within the non-coding genome. However, for precision medicine of hypertension (HTN), a major challenge for public health, mechanistic identification of the genomic components altering the expression of BP genes is required. To solve this important bottleneck, we use a functional genomics inspired reverse genetics strategy to identify the transcription factors (TF), cis-regulatory elements (CRE), DNA variants and BP genes in four BP relevant tissues. Taking advantage of the analytical expertise and collaborations within the Family Blood Pressure Program Essential Hypertension GWAS consortium (FEHGAS3), and newly developed experimental and computational tools, we propose a novel framework for discovering the functional genetic modules, at identified BP loci and genome-wide, affecting inter-individual BP variation. Our approach enables answers to long-standing questions in BP genomics and physiology, with lessons for understanding many other complex diseases. We propose three major aims: (1) Identifying the transcription factors (TF), enhancers (CRE) and expressed genes in BP-relevant tissues; (2) Connecting enhancer (CRE) variation to gene expression and BP variation; and, (3) Identifying causal mechanisms that modulate BP to provide translational insights. The major hypothesis explaining the results of blood pressure (BP) genome-wide association studies (GWAS) is that sequence variants at specific cis-regulatory elements (CRE or enhancer) affect the binding of their cognate transcription factors (TF) to alter expression of specific BP genes. In this second renewal of the FEHGAS consortium, we propose new computational and experimental approaches to identify the TFs, CREs, and target genes, active in four blood pressure target tissues, so that the effects of causal BP affecting genetic variation can be tested, within identified BP loci and genome-wide. This tissue-based view provides an alternative, complementary approach for understanding how BP variation leads to primary hypertension and hypertensive target organ damage, a major public health challenge.","From GWAS loci to blood pressure genes, variants & mechanisms",9645655,R01HL086694,"['Adrenal Glands ', ' suprarenal gland ', ' Adrenals ', ' Affect ', ' Algorithms ', ' Biological Assay ', ' Biologic Assays ', ' Bioassay ', ' Assay ', ' Blood Pressure ', ' cultured cell line ', ' Strains Cell Lines ', ' CellLine ', ' Cell Line ', ' Cell Body ', ' Cells ', ' Chromatin ', ' Disorder ', ' Disease ', ' Deoxyribonucleic Acid ', ' DNA ', ' Vascular Endothelium ', ' Family ', ' Gene Cluster ', ' Gene Expression ', ' allelic frequency ', ' Allele Frequency ', ' Gene Frequency ', ' Genes ', ' trans acting element ', ' regulatory gene ', ' Transcriptional Regulatory Elements ', ' Regulator Genes ', ' Genetic Screening ', ' Genome ', ' Genotype ', ' Goals ', ' Health ', ' Heart ', ' hypertensive disease ', ' hyperpiesis ', ' hyperpiesia ', ' high blood pressure ', ' Vascular Hypertensive Disorder ', ' Vascular Hypertensive Disease ', ' Hypertension ', ' Joints ', ' renal ', ' Kidney Urinary System ', ' Kidney ', ' heavy metal lead ', ' heavy metal Pb ', ' Pb element ', ' Lead ', ' Maps ', ' Methods ', ' Minor ', ' Physiology ', ' pressure ', ' Public Health ', ' biological signal transduction ', ' Signaling ', ' Signal Transduction Systems ', ' Intracellular Communication and Signaling ', ' Cell Signaling ', ' Cell Communication and Signaling ', ' Signal Transduction ', ' statistics ', ' Testing ', ' Body Tissues ', ' Tissues ', ' Transcription factor genes ', ' Transcription Factor Proto-Oncogene ', ' General Transcription Factors ', ' General Transcription Factor Gene ', ' Basal transcription factor genes ', ' Basal Transcription Factor ', ' transcription factor ', ' Transcription ', ' RNA Expression ', ' Gene Transcription ', ' Genetic Transcription ', ' Genetic Diversity ', ' Genetic Variation ', ' primary hypertension ', ' idiopathic hypertension ', ' Essential Hypertension ', ' Enhancers ', ' base ', ' Organ ', ' Variant ', ' Variation ', ' Biological ', ' insight ', ' Individual ', ' Gene Targeting ', ' Sample Size ', ' Collaborations ', ' Therapeutic ', ' Genetic ', ' Reporter ', ' Machine Learning ', ' support vector machine ', ' statistical learning ', ' kernel methods ', ' programs ', ' Physiologic pulse ', ' Pulse ', ' Frequencies ', ' Complex ', ' cell type ', ' receptor ', ' Receptor Protein ', ' trait ', ' Base Pairing ', ' Structure ', ' blood pressure regulation ', ' regulate blood pressure ', ' regulate BP ', ' blood pressure management ', ' blood pressure homeostasis ', ' blood pressure control ', ' BP regulation ', ' BP management ', ' BP homeostasis ', ' BP control ', ' novel ', ' protein protein interaction ', ' functional genomics ', ' Untranslated RNA ', ' noncoding ', ' Nontranslated RNA ', ' Noncoding RNA ', ' Non-translated RNA ', ' Non-Coding RNA ', ' Non-Coding ', ' Functional RNA ', ' Genomics ', ' Smooth Muscle Myocytes ', ' Smooth Muscle Tissue Cell ', ' Smooth Muscle Cells ', ' Leiomyocyte ', ' Molecular Interaction ', ' Binding ', ' Data ', ' Regulatory Element ', ' National Heart, Lung, and Blood Institute ', ' NHLBI ', ' genome wide association study ', ' whole genome association study ', ' whole genome association studies ', ' whole genome association analysis ', ' genomewide association study ', ' genomewide association studies ', ' genomewide association scan ', ' genome wide association studies ', ' genome wide association scan ', ' genome wide association ', ' GWAS ', ' GWA study ', ' epigenomics ', ' genetic variant ', ' genomic variant ', ' allelic variant ', ' allele variant ', ' Gene variant ', ' computerized tools ', ' computational tools ', ' genome-wide ', ' genomewide ', ' genome scale ', ' biobank ', ' biorepository ', ' transcriptome sequencing ', ' RNAseq ', ' RNA sequencing ', ' RNA Seq ', ' forward genetics ', ' rare variant ', ' rare allele ', ' precision medicine ', ' precision-based medicine ', ' DNase I hypersensitive sites sequencing ', ' DNaseI-seq ', ' DNase-seq ', ' reverse genetics ', ' ATAC-seq ', ' ATACseq ', ' phenotypic data ', ' Genotype-Tissue Expression Project ', ' GTEx ', ' genomic data ', ' genomic dataset ', ' genomic data-set ', ' Trans-Omics for Precision Medicine ', ' TOPMed ', ' blood pressure medication ', ' blood pressure medicine ', ' ']",NHLBI,NEW YORK UNIVERSITY SCHOOL OF MEDICINE,R01,2019,615264,NY-12,-0.003620159381133954
"Modeling stress-induced, de novo epiallele architecture in the model Arabidopsis as a tractable entrypoint PROJECT SUMMARY/ABSTRACT Epigenetic memory is a phenomenon of trans-generational, altered trait inheritance without changes to DNA sequence. Our present ability to predict or direct epigenomic behavior is extremely limited, even though epigenetic factors participate in nearly all aspects of multicellular development, environmental stress response, and disease development. There are critical gaps in our current knowledge of DNA methylation patterning, stable epiallele formation, and the relationship of genome-wide epigenomic behavior to gene expression and phenotype in both plant and animal systems. We have developed a system that will directly address these questions. Our long-term goals are to decode the heritable epigenome, and its relationship to organismal phenotype, particularly in response to stress. What distinguishes our proposed research is the availability of robust biologicals in the model plant Arabidopsis to impose artificial stress, recurrent heritable epigenetic memory, and methylome repatterning. These resources emanate from discovery of the MSH1 gene, disruption of which leads to epigenomic reprogramming. Recent data from this system lead to the overarching hypothesis that stress-induced gene expression recruits methylation machinery to gene networks in a non-stochastic manner. To address this hypothesis, we have developed novel genome-wide methylome analysis procedures for high-resolution identification of gene-associated methylation repatterning. These analyses reveal gene networks that are strikingly consistent with phenotype changes, and display repatterning that is intragenic and often subtle, yet reproducible. We have also identified epigenetic components of the DNA methylation and RdDM pathways that are essential to reprogramming based on msh1 double mutant analysis. Building upon strong preliminary data, we propose to pursue three specific aims to characterize trans-generational epigenomic behavior: (1) To delineate stable, de novo epialleles in the Arabidopsis msh1 model system, exploiting a five-generation memory lineage, (2) to develop a mechanistic understanding of stable epiallele formation in response to stress, implementing machine learning and mutant screening, and (3) to test locus-specific mechanics of epiallele establishment, capitalizing on gene relocation to delimit germane local chromatin features. The proposed research will broadly impact the field by providing the first example of inducible epigenomic reprogramming in a non-stochastic pattern that permits machine learning-based predictive modeling and identification of cis-acting sequence features. The results will be pertinent to mammalian systems and, possibly, to diagnostic strategies for diseases with a strong GxE component. PROJECT NARRATIVE The proposed research has relevance to public health priorities as we see life style diseases, stress and environmental impacts on health, in utero and throughout development, pose greater challenges to conventional medicine. Environmental stress is a multifaceted influence on health, and epigenomic response is an important, under-investigated factor in cancer, neurodevelopmental, metabolic and toxin-related disorders with high GxE effects. Upon conclusion of the study, we will have defined the architectural features of stable, de novo epiallelic variation, assessed its influence on heritable phenotype, and refined a methodology for high resolution analysis of epigenomic data that is necessary to inform the development of early diagnostics and countermeasures.","Modeling stress-induced, de novo epiallele architecture in the model Arabidopsis as a tractable entrypoint",9983094,R01GM134056,"['Affect ', ' Animals ', ' Architecture ', ' Engineering / Architecture ', ' Behavior ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Chromatin ', ' Complement ', ' Complement Proteins ', ' Cytosine ', ' Data Analyses ', ' Data Analysis ', ' data interpretation ', ' Statistical Data Interpretation ', ' Statistical Data Analyses ', ' Statistical Data Analysis ', ' statistical analysis ', ' Discrimination ', ' Cognitive Discrimination ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Gene Expression ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' Homeostasis ', ' Autoregulation ', ' Physiological Homeostasis ', ' Information Systems ', ' Data Systems ', ' IT Systems ', ' Information Technology Systems ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Life Style ', ' Lifestyle ', ' Medicine ', ' Memory ', ' Methods ', ' Methodology ', ' Methylation ', ' Biological Models ', ' Biologic Models ', ' Model System ', ' Nucleosomes ', ' Organism ', ' living system ', ' Phenotype ', ' Plants ', ' Recurrence ', ' Recurrent ', ' Psychological reinforcement ', ' Reinforcement ', ' Reproduction ', ' Research ', ' Resources ', ' Research Resources ', ' RNA Splicing ', ' Splicing ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Stress ', ' Testing ', ' Thermodynamics ', ' Thermodynamic ', ' Toxin ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' bisulfite ', ' hydrogen sulfite ', ' hydrosulfite ', ' Generations ', ' reaction', ' crisis ', ' stress response ', ' stress', ' reaction ', ' biological adaptation to stress ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' Arabidopsis ', ' base ', ' density ', ' Procedures ', ' Site ', ' Variation ', ' Variant ', ' Biological ', ' Link ', ' insight ', ' Gene Targeting ', ' Ecological impact ', ' Environmental Impact ', ' Transgenes ', ' fluid ', ' liquid ', ' Liquid substance ', ' Metabolic ', ' Genetic ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Knowledge ', ' programs ', ' mechanical ', ' Mechanics ', ' Pattern ', ' System ', ' mutant ', ' trait ', ' novel ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' response ', ' behavioral influence ', ' behavior influence ', ' Genomics ', ' histone modification ', ' Small RNA ', ' Address ', ' Chromatin Assembly ', ' Chromatin Modeling ', ' Data ', ' Detection ', ' Plant Model ', ' Reproducibility ', ' Resolution ', ' Cis-Acting Locus ', ' Cis-Acting Sequence ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Pattern Recognition ', ' Differential Gene Expression ', ' Tissue-Specific Differential Gene Expression ', ' Tissue-Specific Gene Expression ', ' Process ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' in utero ', ' epigenomics ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' innovate ', ' innovative ', ' innovation ', ' Heritability ', ' genome scale ', ' genomewide ', ' genome-wide ', ' public health priorities ', ' flexible ', ' flexibility ', ' screening ', ' methylome ', ' epigenome ', ' biophysical characteristics ', ' biophysical characterization ', ' biophysical measurement ', ' biophysical parameters ', ' biophysical properties ', ' transgenerational inheritance ', ' transgenerational epigenetic inheritance ', ' methylation pattern ', ' epigenetic memory ', ' experiment ', ' experimental research ', ' experimental study ', ' recruit ', ' ']",NIGMS,PENNSYLVANIA STATE UNIVERSITY-UNIV PARK,R01,2020,319720,PA-12,0.010817638228897123
"Uncovering the epitranscriptome regulatory codes using machine learning Project Summary N6-methyladenosine (m6A) is the most abundant methylation widely found in mRNAs of mammalian cells whose function is largely unknown. Recent research has accumulated increasingly strong evidence of m6A's involvement in different diseases such as leukemia, breast cancer, lung cancer, and AIDs. While m6A's close involvement in many diseases is apparent, mechanistic evidence linking m6A alterations to disease phenotypes is mostly missing. Most of the recent research is fueled by the high throughput sequencing technologies such as MeRIP-seq for transcriptome-wide profiling of m6A methylation. However, due to the innate limitations of such technologies, sophisticated machine learning based algorithms are urgently needed to address the problem of detecting m6A sites with high sensitivity and precision, accurate quantification of m6A methylation levels and the prediction of m6A sites differentially affected under disease and normal conditions and the prediction of genes whose expression levels are regulated by m6A. Without bridging these knowledge gaps, it is impossible to made inroads to the problem of finding m6A's role in regulating diseases. To address these issues, our aims in this proposal are 1) Establish a deep learning algorithm for base-resolution m6A site prediction; 2) Establish base- resolution m6A differential site prediction using a hierarchical Bayesian approach; and 3) Determine m6A- mediated genes and functions by Bayesian Negative-Binomial regression. The proposed research will employ deep learning and adversarial learned inference methods and utilize both methylation quantification and sequence information for the first time. Also, it will employ Bayesian graphical model-based methods for combining sequence and methylation level information. It is expected that the developed algorithms will have broad applications in functional study, for which we plan to closely work with our collaborators in applying these algorithms in their research of Kaposi's sarcoma-associated herpesvirus (KSHV), which will lead to the fulfillment our long term goal in the eventual validation and practical medical application of m6A research in the future. Project Narrative  This project proposes to address the problem of detecting m6A sites with high sensitivity and precision, accurate quantification of m6A methylation levels, the prediction of m6A sites differentially affected under disease and normal conditions and the prediction of genes whose expression levels are regulated by m6A. The overall goal is to elucidate m6A's role in regulating diseases.",Uncovering the epitranscriptome regulatory codes using machine learning,9937431,SC3GM136594,"['Affect ', ' Algorithms ', ' malignant breast neoplasm ', ' Breast Cancer ', ' malignant breast tumor ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Disease ', ' Disorder ', ' Future ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Genes ', ' Goals ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Learning ', ' leukemia ', ' Methods ', ' Methylation ', ' Play ', ' Problem Solving ', ' Proteins ', ' Research ', ' Messenger RNA ', ' mRNA ', ' Role ', ' social role ', ' Statistical Distributions ', ' Supervision ', ' Technology ', ' Time ', ' cell transformation ', ' transformed cells ', ' Work ', ' RNA-Binding Proteins ', ' Mediating ', ' base ', ' improved ', ' Site ', ' Area ', ' Medical ', ' Link ', ' Bayesian Methodology ', ' Bayesian Statistical Method ', ' Bayesian approaches ', ' Bayesian classification method ', ' Bayesian classification procedure ', ' Bayesian posterior distribution ', ' Bayesian Method ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Biological Function ', ' Biological Process ', ' gene function ', ' tool ', ' machine learned ', ' Machine Learning ', ' HHV-8 ', ' HHV8 ', ' KSHV ', ' Kaposi Sarcoma-Associated Herpes Virus ', ' Kaposi Sarcoma-Associated Herpesvirus ', ' Kaposi sarcoma associated virus ', ' Kaposi sarcoma herpes virus ', "" Kaposi's sarcoma (KS)-associated herpesvirus "", ' Virus-HHV8 ', "" kaposi's sarcoma-associated human herpesvirus "", ' Human Herpesvirus 8 ', ' Knowledge ', "" 5'UTR "", ' mRNA Leader Sequences ', "" 5' Untranslated Regions "", "" 3'UTR "", "" 3' Untranslated Regions "", ' novel ', ' Coding System ', ' Code ', ' Regulation ', ' Modeling ', ' Molecular Interaction ', ' Binding ', ' mRNA Stability ', ' preventing ', ' prevent ', ' Oncogenesis ', ' tumorigenesis ', ' Address ', ' Cellular Transformation ', ' metaplastic cell transformation ', ' Data ', ' Detection ', ' Hypermethylation ', ' Mammalian Cell ', ' Resolution ', ' Transcript ', ' Validation ', ' Modification ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' disease phenotype ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' effective treatment ', ' effective therapy ', ' High-Throughput Sequencing ', ' High-Throughput Nucleotide Sequencing ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' epitranscriptome ', ' deep learning ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' machine learned algorithm ', ' machine learning algorithm ', ' deep learning algorithm ', ' ']",NIGMS,UNIVERSITY OF TEXAS SAN ANTONIO,SC3,2020,97500,TX-20,-0.0003711739795976547
"A Platform for Safe, Noninvasive Prenatal Genetic Testing at Five Weeks of Pregnancy The purpose of this research is to provide a flexible prenatal genetic testing product that can be expanded to detect any inheritable trait as early as 5, and up to 20, weeks of gestation, from a safe, noninvasive Pap smear. Published studies, as well as our own experience, show that perinatal Pap collections using a cervical cytobrush pose no risk to mother or fetus, and captures trophoblast cells that migrate from the placenta into the reproductive tract. Trophoblast retrieval and isolation from the cervix (TRIC) efficiently isolates hundreds of trophoblast cells without limitations due to early gestational age, maternal obesity, or uteroplacental insufficiency disorders. In our report published in Science Translational Medicine, we isolated sufficient genomic DNA from intact fetal trophoblast cells obtained by TRIC at 5-19 weeks of gestation (n=20) to definitively distinguish maternal and fetal DNA by targeted next-generation sequencing (NGS) of short terminal repeats (STRs) and single nucleotide polymorphisms (SNPs). Compared to massively parallel sequencing of cell-free fetal DNA from maternal serum, which has a fetal fraction of only 4-10% at week 10 of gestation, the complete genome obtained by TRIC has a fetal fraction of 85-100%, and provides nucleotide-specific haplotyping. In our Phase I award, we developed this technology for prenatal genotyping of single gene disorders located on the hemoglobin B (HBB) gene, using custom multiplex PCR amplification of SNPs, STRs and loci across HBB for NGS. We successfully haplotyped the locus for the sickle cell disease (SCD) point mutation and genotyped the remainder of the HBB exome, which includes alternate SCD loci, beta thalassemias and anemias. In Phase II, we will expand the test to include HBA1 and HBA1 genes (alpha thalassemias) to provide a comprehensive hemoglobinopathy screen. Phase I studies revealed that genotyping was consistently accurate, unless cervical specimen collection was suboptimal and <40 trophoblast cells were isolated. Commercialization will require operators to obtain adequate specimens. We will accomplish six milestones towards commercialization of this test: 1. Incorporate the HBA1 and HBA2 loci into a comprehensive hemoglobinopathy test. 2. Optimize success rates through operator training and innovations in collection device designs to increase cervical cell recoveries. 3. Innovate a novel alternative method to cytobrush-based cervical collection. 4. Automate the TRIC processing pipeline for high throughput cell isolation, DNA purification and NGS. 5. Establish sample quality assessment tools powered by artificial intelligence and machine learning. 6. Perform a clinical validation trial to assess test performance. With an estimated annual market potential over $284 million for prenatal hemoglobinopathies testing, the envisioned technology will fill an existing gap in clinical diagnostics and outcompete existing invasive prenatal testing. Our initial commercial product will to enable management of high-risk pregnancies and provide valuable information to physicians and patients in the process of establishing families. Specifically, this initial product will benefit pregnancies at risk of having a child with SCA or other hemoglobinopathies such as thalassemia and anemia. This research provides major public health benefits by leveraging a safe, noninvasive method to capture fetal cells that migrate into the reproductive tract from a Pap smear for development of genetic tests to identify women carrying a fetus with an inherited disorder. We will build a DNA sequencing kit that can be commercialized to determine the genotype of fetuses at risk for sickle cell anemia and other hemoglobinopathies as early as 5 weeks of pregnancy. Advances emerging from the proposed research will generate new clinical tools for managing pregnancy complications to benefit the well-being of mothers and their babies.","A Platform for Safe, Noninvasive Prenatal Genetic Testing at Five Weeks of Pregnancy",9940863,R44HD092205,"['alpha-Thalassemia ', ' Hemoglobin H Disease ', ' secondary leukemia ', ' treatment associated acute myelogenous leukemia ', ' -thalassemia ', ' Amniocentesis ', ' Anemia ', ' Sickle Cell Anemia ', ' Hb SS disease ', ' HbSS disease ', ' Hemoglobin S Disease ', ' Hemoglobin sickle cell disease ', ' Hemoglobin sickle cell disorder ', ' sickle cell disease ', ' sickle disease ', ' sicklemia ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Automation ', ' Award ', ' beta Thalassemia ', ' B-thalassemia ', ' p-Thalassemia ', ' -thalassemia ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Biopsy ', ' Cell Count ', ' Cell Number ', ' Cell Separation ', ' Cell Isolation ', ' Cell Segregation ', ' Cell Separation Technology ', ' cell sorting ', ' Cells ', ' Cell Body ', ' Cervix Uteri ', ' Cervix ', ' Uterine Cervix ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Chorion ', ' Chromosomes ', ' Communities ', ' Conceptions ', ' Data Reporting ', ' data representation ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Family ', ' Feasibility Studies ', ' Fetus ', ' Future ', ' Genes ', ' Genome ', ' Genotype ', ' Germ Cells ', ' Gametes ', ' Germ-Line Cells ', ' Reproductive Cells ', ' Sex Cell ', ' initial cell ', ' sexual cell ', ' Gestational Age ', ' Chronologic Fetal Maturity ', ' Fetal Age ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Haplotypes ', ' Hemoglobinopathies ', ' Hemoglobin ', ' Hereditary Disease ', ' Inborn Genetic Diseases ', ' Inherited disorder ', ' hereditary disorder ', ' heritable disorder ', ' inborn error ', ' inherited diseases ', ' inherited genetic disease ', ' inherited genetic disorder ', ' Human ', ' Modern Man ', ' Industry ', ' Newborn Infant ', ' 0-4 weeks old ', ' Newborns ', ' newborn child ', ' newborn children ', ' Manuals ', ' Methods ', ' Mothers ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' Nucleotides ', ' Legal patent ', ' Patents ', ' Patients ', ' Personal Satisfaction ', ' well-being ', ' wellbeing ', ' Physicians ', ' Placenta ', ' Cells Placenta-Tissue ', ' Normal Placentoma ', ' Placenta Embryonic Tissue ', ' Placentome ', ' Pregnancy ', ' Gestation ', ' Pregnancy Complications ', ' complications during pregnancy ', ' pregnancy-related complications ', ' First Pregnancy Trimester ', ' 1st trimester ', ' Early Placental Phase ', ' First Trimester ', ' Public Health ', ' Publishing ', ' Records ', ' Research ', ' Risk ', ' Speculums ', ' Technology ', ' Terminal Repeat Sequences ', ' Flanking Repeat Sequences ', ' Terminal Repeat ', ' Testing ', ' Thalassemia ', ' Tissues ', ' Body Tissues ', ' trophoblast ', ' Vagina ', ' Vaginal ', ' Woman ', ' hemoglobin B ', ' Pap smear ', ' Pap Test ', ' Pap screening ', ' Papanicolaou Smear ', ' Papanicolaou Test ', ' Measures ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Device Designs ', ' Health Benefit ', ' health care ', ' Healthcare ', ' Custom ', ' Point Mutation ', ' base ', ' Peripartum ', ' Perinatal ', ' improved ', ' Procedures ', ' specimen collection ', ' sample collection ', ' Cervical ', ' Clinical ', ' Phase ', ' Medical ', ' Ensure ', ' Training ', ' Visual ', ' Recovery ', ' High-Risk Pregnancy ', ' tool ', ' Research Specimen ', ' Specimen ', ' machine learned ', ' Machine Learning ', ' Disorder Management ', ' Disease Management ', ' Hereditary ', ' Inherited ', ' at-risk fetus ', ' fetus at risk ', ' Test Result ', ' fetal ', ' interest ', ' Services ', ' experience ', ' Gene Alteration ', ' Gene Mutation ', ' success ', ' fetal diagnosis ', ' trait ', ' unborn ', ' prenatal ', ' novel ', ' Negotiating ', ' Negotiation ', ' Mediation ', ' Reporting ', ' Position ', ' Positioning Attribute ', ' reproductive ', ' Single Base Polymorphism ', ' single nucleotide variant ', ' Single Nucleotide Polymorphism ', ' Sampling ', ' performance tests ', ' DNA purification ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' fetal cell ', ' fetus cell ', ' Provider ', ' prenatal screening ', ' prenatal testing ', ' Resolution ', ' Retrieval ', ' Collection ', ' computational analyses ', ' computational analysis ', ' computer analyses ', ' Computer Analysis ', ' Conceptus ', ' Other Genetics ', ' Simple Sequence Repeat ', ' Short Tandem Repeat ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Translational Science ', ' translation research ', ' Translational Research ', ' Validation ', ' Villous ', ' Preparation ', ' Process ', ' developmental ', ' Development ', ' innovate ', ' innovative ', ' innovation ', ' perinatal health ', ' clinical relevance ', ' clinically relevant ', ' translational medicine ', ' maternal serum ', ' commercialization ', ' industrial partnership ', ' industry partnership ', ' industry partner ', ' exomes ', ' exome ', ' flexible ', ' flexibility ', ' Phase I Study ', ' phase 1 study ', ' operation ', ' NGS Method ', ' NGS system ', ' next gen sequencing ', ' nextgen sequencing ', ' next generation sequencing ', ' screening ', ' Massively Parallel DNA Sequencing ', ' Massively Parallel Sequencing ', ' Massive Parallel Sequencing ', ' gDNA ', ' Genomic DNA ', ' Mendelian disease ', ' Mendelian genetic disorder ', ' monogenic disease ', ' monogenic disorder ', ' single-gene disease ', ' single-gene disorder ', ' Mendelian disorder ', ' cff DNA ', ' cffDNA ', ' cell free fetal DNA ', ' targeted sequencing ', ' Assessment instrument ', ' Assessment tool ', ' genital tract ', ' reproductive tract ', ' maternal adiposity ', ' maternal obesity ', ' clinical diagnostics ', ' DNA seq ', ' DNAseq ', ' DNA sequencing ', ' testing services ', ' genetic condition ', ' genetic disorder ', ' Genetic Diseases ', ' data infrastructure ', ' gene testing ', ' gene-based testing ', ' genetic testing ', ' gene locus ', ' genetic locus ', ' genomic locus ', ' ']",NICHD,"CRADLE GENOMICS, INC.",R44,2020,901625,CA-52,0.007867762074737255
"IBD Gene Mapping by Clinical and Population Subset PROJECT SUMMARY Inflammatory bowel disease (IBD), Crohn's disease (CD) and ulcerative colitis (UC) are complex genetic disorders of the gastrointestinal tract, and a major health burden to patients and society. Tremendous progress has been made in dissecting IBD genetic etiology with identification of over 200 IBD loci by genome wide association studies (GWAS) but mainly limited to persons of European ancestry. The IBD Genetics Consortium (IBDGC) was established to facilitate multicenter collaborative studies of 6 Genetics Research Centers (GRCs) organized with a Data Coordinating Center (DCC). Our GRC at Johns Hopkins (JHGRC) has contributed to all IBDGC studies, meeting recruitment objectives and taking roles in IBDGC leadership positions. Our particular focus is on African American (AA) IBD genetics. We performed the first large-scale evaluation of European loci in the AA population, replicating several genes, but also finding unique African-ancestral variants within these loci, as well as identified multiple admixture significant loci. We also published the first AA IBD genome-wide association study (GWAS), a collaborative effort that identified two African-specific gene loci, and replicated multiple additional European loci. We have also explored why some loci with proven risk variants in Europeans and other populations only cause disease in one ancestral population but not others. More research in AA IBD is needed to understand the etiology of IBD in this ancestrally distinct, major American population. In this application we will re-evaluate the AA GWAS by better imputation, evaluate whole genome sequencing data to test low frequency and rare variants, and perform an evaluation for chromosome X variants. We will recruit a large number of AA IBD patients through our own and multiple Satellite Recruitment Centers to power a second AA IBD GWAS, both UC and CD, and meta-analyze with the first to identify more novel loci, identify more African specific risk variants, and replicate known loci for this population and replicate our admixture loci. We will also incorporate diverse data sources to incorporate into our GWAS analyses including RNA-Seq currently being generated on lymophoblastoid cell lines from AA CD cases and controls, and RNA-Seq that we will generate in colonic biopsies from UC cases and controls. We will evaluate chromatin differences and expression of genes in cell types relevant to IBD from European, AA and East Asian ancestries in an effort to better understand locus heterogeneity by ancestry. We will continue to participate in all IBDGC activities to maximize the Impact of IBD genetics research by this cooperative funding mechanism. According to the Center for Disease Control and Prevention, an estimated 1.4 million Americans suffer from Inflammatory Bowel Disease (IBD), a chronic debilitating disorder with no cure that includes Crohn's disease and ulcerative colitis. IBD ranks in the top 5 in prevalence for gastrointestinal disorders and represents a significant financial burden to society requiring a lifetime of medical care. This proposed research aims to determine the genetic variations that cause IBD which will aid in developing preventive measures, improving the quality of care with better treatments and educating patients through genetic counseling.",IBD Gene Mapping by Clinical and Population Subset,10001511,U01DK062431,"['Algorithms ', ' Biopsy ', ' Cell Line ', ' CellLine ', ' Strains Cell Lines ', ' cultured cell line ', ' Centers for Disease Control and Prevention (U.S.) ', ' CDC ', ' Centers for Disease Control ', ' Centers for Disease Control and Prevention ', ' United States Centers for Disease Control ', ' United States Centers for Disease Control and Prevention ', ' Charge ', ' Chromatin ', ' Chromosome Mapping ', ' Gene Localization ', ' Gene Mapping ', ' Gene Mapping Genetics ', ' Linkage Mapping ', ' Total Human and Non-Human Gene Mapping ', ' genetic mapping ', ' Cohort Studies ', ' Concurrent Studies ', ' Ulcerative Colitis ', ' Ulcerated Colitis ', "" Crohn's disease "", ' Crohn disease ', "" Crohn's "", "" Crohn's disorder "", ' Granulomatous Enteritis ', ' eleocolitis ', ' regional enteritis ', ' Data Sources ', ' Digestive System Disorders ', ' Digestive Diseases ', ' Digestive System Diseases ', ' GI tract disorder ', ' digestive disorder ', ' digestive tract disease ', ' gastrointestinal tract disease ', ' gastrointestinal tract disorder ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Epithelium ', ' Epithelium Part ', ' Future ', ' Gastrointestinal Diseases ', ' gastrointestinal disorder ', ' Gene Expression ', ' Gene Frequency ', ' Allele Frequency ', ' allelic frequency ', ' Genes ', ' Genetic Counseling ', ' Population Genetics ', ' Genotype ', ' Goals ', ' Health ', ' Heterogeneity ', ' Inflammatory Bowel Diseases ', ' Inflammatory Bowel Disorder ', ' Inflammatory Intestinal Disease ', ' Inflammatory Intestinal Disorder ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Leadership ', ' Linkage Disequilibrium ', ' macrophage ', ' Persons ', ' Patients ', ' Phenotype ', ' Publications ', ' Scientific Publication ', ' Publishing ', ' Research ', ' Resources ', ' Research Resources ', ' Role ', ' social role ', ' Societies ', ' Testing ', ' Universities ', ' Genetic Variation ', ' Genetic Diversity ', ' Work ', ' X Chromosome ', ' Asians ', ' oriental ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Enhancers ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' Caring ', ' Point Mutation ', ' base ', ' improved ', ' Chronic ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Medical ', ' Evaluation ', ' Epithelial ', ' insight ', ' Individual ', ' African ', ' European ', ' Fostering ', ' Data Bases ', ' data base ', ' Databases ', ' Genetic Research ', ' Funding ', ' Ethnicity ', ' Ethnic Origin ', ' Collaborations ', ' Co-culture ', ' Cocultivation ', ' Coculture ', ' Coculture Techniques ', ' Genetic ', ' Genetic Predisposition ', ' Genetic Susceptibility ', ' Inherited Predisposition ', ' Inherited Susceptibility ', ' genetic etiology ', ' genetic mechanism of disease ', ' genetic vulnerability ', ' genetically predisposed ', ' Genetic Predisposition to Disease ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Investigation ', ' Frequencies ', ' Complex ', ' Source ', ' cell type ', ' Pattern ', ' interest ', ' meetings ', ' American ', ' experience ', ' novel ', ' Position ', ' Positioning Attribute ', ' Network Analysis ', ' Pathway Analysis ', ' Modeling ', ' Sampling ', ' Human Nature ', ' Human Characteristics ', ' QOC ', ' Quality of Care ', ' case control ', ' Effectiveness ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' genetic association ', ' genome sequencing ', ' Admixture ', ' Data ', ' Funding Mechanisms ', ' Other Genetics ', ' Update ', ' sex ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' Data Coordination Center ', ' Data Coordinating Center ', ' new approaches ', ' novel approaches ', ' novel strategy ', ' novel strategies ', ' Population ', ' Prevalence ', ' 2-dimensional ', ' two-dimensional ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' Risk-associated variant ', ' risk allele ', ' risk gene ', ' risk genotype ', ' risk loci ', ' risk locus ', ' risk variant ', ' rare allele ', ' rare variant ', ' disparities in race ', ' race disparity ', ' racial disparity ', ' ATACseq ', ' ATAC-seq ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' Preventative measure ', ' Preventive measure ', ' study population ', ' entire genome ', ' full genome ', ' whole genome ', ' recruit ', ' genetic condition ', ' genetic disorder ', ' Genetic Diseases ', ' financial burden ', ' financial distress ', ' financial strain ', ' financial stress ', ' Financial Hardship ', ' data diversity ', ' diverse data ', ' gene locus ', ' genetic locus ', ' genomic locus ', ' ']",NIDDK,RBHS-ROBERT WOOD JOHNSON MEDICAL SCHOOL,U01,2020,451377,NJ-06,-0.007792464269271461
"Tinnitus: Audiological measures and genetic susceptibility PROJECT SUMMARY/ABSTRACT Tinnitus, the phantom perception of sound in absence of an external sound source, is a prevalent hearing disorder. To date, the exact neural and molecular mechanisms underlying tinnitus are not known. Tinnitus is associated with a number of otological diseases and clinical conditions; however, almost 50% of tinnitus cases are not attributable to any known cause (Stouffer & Tyler, 1990). There is likely a genetic component to tinnitus (Sand et al, 2007). A critical gap in the knowledge base is how to clinically identify those who are genetically predisposed to tinnitus well before they acquire this hearing health issue. The short-term goal of this R21 Early Career Research PAR 16-057 application, entitled Tinnitus: Audiological measures and genetic susceptibility, is to identify detailed phenotypic and genotypic profiles of chronic tinnitus in young adults. The application is proposed by a team of researchers: The PI is Ishan Bhatt, Ph.D. in audiology (CCC-A, FAAA), who is working with Co-PIs Jason Wilder, Ph.D. in genetics, Jin Wang, Ph.D. in statistics, and Raquel Dias, Ph.D. in Bioinformatics. This project will fill the gap in knowledge by identifying the critical variables associated with a genetic predisposition to CT. This investigation will include college-aged young participants to control for age- related confounding variables such as systemic diseases and hearing loss. According to the PIs pilot study (Bhatt, 2017a), the estimated prevalence of chronic tinnitus (CT), acute tinnitus (AT) and no tinnitus (NT) is around 8%, 13% and 79%, respectively. To accomplish our short-term goal, we will conduct a case-control- control exonic genome-wide association study (GWAS) (N = 300) in which subjects will be divided into three groups: those with (1) CT (tinnitus for > 1 year; n=100), (2) AT (tinnitus for  1 year, presumably due to acute environmental exposure; n=100); and (3) NT (no experience of tinnitus in a lifetime; n=100). The Specific Aims are: (1) to identify associations between exonic Single Nucleotide Polymorhisms (SNPs) and tinnitus phenotype. Based on the criteria laid out in the preliminary studies (Bhatt, 2017a; Bhatt et al., 2016; Phillip et al., 2015), our working hypothesis is that causal SNPs will exhibit a higher frequency of a specific genotype for subjects with CT compared to subjects with AT and NT. (2) To identify association between selected SNPs in a candidate set of genes and audiologic measures among subjects with CT, AT and NT, Based on our preliminary studies (Bhatt et al., 2016, Phillips et al., 2015), our working hypothesis is that subjects with causal alleles for CT will exhibit pathophysiological variation in the audiometric measures. Significance: Successful completion of this project will enable us to identify phenotypic and genotypic profiles of CT. This will help us to achieve our long term goal, which is to develop a genetic Risk Profile that can be used by health-care providers, and educators (e.g., health professionals, music and industrial arts teachers) to identify individuals genetically at risk for CT. Project Narrative Tinnitus, the phantom perception of sound in absence of an external sound source, is a prevalent hearing disorder. The short-term goal of this study is to identify detailed phenotypic and genotypic profiles of chronic tinnitus in college-aged young adults. The relevance of the project to public health is reflected in the long-term goal, which is to construct a genetic risk profile which can be used by health-care providers and educators to identify individuals genetically at risk for chronic tinnitus.",Tinnitus: Audiological measures and genetic susceptibility,9824578,R21DC016704,"['Age ', ' ages ', ' Aging ', ' Anxiety ', ' Audiology ', ' Auditory Perception ', ' hearing perception ', ' sound perception ', ' Confounding Factors (Epidemiology) ', ' Confounding Variables ', ' Epidemiologic Confounding Factor ', ' Mental Depression ', ' depression ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Education ', ' Educational aspects ', ' Environmental Exposure ', ' Auditory Evoked Potentials ', ' Auditory Evoked Response ', ' Exhibits ', ' Family ', ' Genes ', ' Genotype ', ' Goals ', ' Health ', ' Health Personnel ', ' Health Care Providers ', ' Healthcare Providers ', ' Healthcare worker ', ' health care personnel ', ' health care worker ', ' health provider ', ' health workforce ', ' healthcare personnel ', ' medical personnel ', ' treatment provider ', ' Health Policy ', ' health care policy ', ' healthcare policy ', ' Hearing ', ' Human ', ' Modern Man ', ' Industrial Arts ', ' Military Personnel ', ' Armed Forces Personnel ', ' Military ', ' Multivariate Analysis ', ' Multivariate Analyses ', ' Music ', ' Noise ', ' Nucleotides ', ' Otitis Media ', ' middle ear infection ', ' Phenotype ', ' Pilot Projects ', ' pilot study ', ' Genetic Polymorphism ', ' polymorphism ', ' Prostaglandin-Endoperoxide Synthase ', ' Arachidonic Acid Cyclooxygenase ', ' Cyclo-Oxygenase ', ' Cyclooxygenase ', ' Fatty Acid Cyclo-Oxygenase ', ' Hydroperoxide Cyclase ', ' PGH Synthase ', ' PGH2 Synthetase ', ' Prostaglandin Cyclo-Oxygenase ', ' Prostaglandin Cyclooxygenase ', ' Prostaglandin Endoperoxide Synthetase ', ' Prostaglandin G-H Synthase ', ' Prostaglandin H Synthase ', ' Prostaglandin H2 Synthetase ', ' Prostaglandin Synthase ', ' Prostaglandin Synthetase ', ' Public Health ', ' Quality of life ', ' QOL ', ' serotonin receptor ', ' 5-HT Receptors ', ' 5-Hydroxytryptamine Receptors ', ' Hyperacusis ', ' Hyperacusia ', ' Loudness Perception Disturbances ', ' Loudness Recruitment ', ' decreased loudness tolerance ', ' loudness intolerance ', ' noise sensitivity ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Risk Factors ', ' Serotonin ', ' 5-HT ', ' 5-Hydroxytryptamine ', ' 5HT ', ' Enteramine ', ' Hippophaine ', ' Silicon Dioxide ', ' Cristobalite ', ' Sand ', ' Silica ', ' Tridymite ', ' Smoking ', ' Sodium ', ' Na element ', ' sound ', ' statistics ', ' Testing ', ' Tinnitus ', ' Ringing-Buzzing-Tinnitus ', ' Veterans ', ' Measures ', ' otoacoustic emission ', ' 5HT transporter ', ' 5HTT protein ', ' sodium-dependent serotonin transporter ', ' serotonin transporter ', ' base ', ' career ', ' Acute ', ' Chronic ', ' Clinical ', ' Phase ', ' Variation ', ' Variant ', ' Physiologic ', ' Physiological ', ' Adolescent Youth ', ' juvenile ', ' juvenile human ', ' Adolescent ', ' Compensation ', ' Financial compensation ', ' Susceptibility ', ' Predisposition ', ' teacher ', ' insight ', ' Individual ', ' adult youth ', ' young adulthood ', ' young adult ', ' Policy Maker ', ' Ethnicity ', ' Ethnic Origin ', ' Hearing Disorders ', ' auditory disease ', ' auditory disorder ', ' auditory problem ', ' hearing disease ', ' Hearing problem ', ' Genetic ', ' Genetic Predisposition ', ' Genetic Susceptibility ', ' Inherited Predisposition ', ' Inherited Susceptibility ', ' genetic etiology ', ' genetic mechanism of disease ', ' genetic vulnerability ', ' genetically predisposed ', ' Genetic Predisposition to Disease ', ' Exposure to ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Investigation ', ' Frequencies ', ' Complex ', ' Systemic disease ', ' Source ', ' collegiate ', ' college ', ' American ', ' experience ', ' Gene x Environment Interaction ', ' GxE interaction ', ' environment effect on gene ', ' gene environment interaction ', ' voltage gated channel ', ' knowledgebase ', ' knowledge base ', ' neural ', ' relating to nervous system ', ' trait ', ' novel ', ' Participant ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' General Public ', ' General Population ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Reporting ', ' Regulation ', ' Modeling ', ' Sampling ', ' case control ', ' Insomnia ', ' Insomnia Disorder ', ' Sleeplessness ', ' Bio-Informatics ', ' Bioinformatics ', ' genetic association ', ' Candidate Gene ', ' Candidate Disease Gene ', ' COX1 ', ' COX3 ', ' PCOX1 ', ' PGHS-1 ', ' PGHS1 ', ' PHS1 ', ' PTGHS ', ' PTGS1 ', ' PTGS1 gene ', ' COX-2 ', ' COX2 ', ' PGHS-2 ', ' PHS-2 ', ' PTGS2 ', ' hCOX-2 ', ' PTGS2 gene ', ' Hearing Loss ', ' Hypoacuses ', ' Hypoacusis ', ' dysfunctional hearing ', ' hearing defect ', ' hearing deficit ', ' hearing difficulty ', ' hearing disability ', ' hearing dysfunction ', ' hearing impairment ', ' Address ', ' Ph.D. ', ' PhD ', ' Doctor of Philosophy ', ' Preventative intervention ', ' Prevention intervention ', ' preventional intervention strategy ', ' Preventive Intervention ', ' Genetic Risk ', ' Characteristics ', ' Molecular ', ' developmental ', ' Development ', ' Health Care Professional ', ' Healthcare professional ', ' Health Professional ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' age dependent ', ' age related ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' Population ', ' Prevalence ', ' aged ', ' innovate ', ' innovative ', ' innovation ', ' aged population ', ' population aging ', ' aging population ', ' treatment strategy ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' Genetic study ', ' learning activity ', ' learning method ', ' learning strategy ', ' clinical development ', ' causal allele ', ' causal gene ', ' causal mutation ', ' causative mutation ', ' causative variant ', ' causal variant ', ' gene testing ', ' gene-based testing ', ' genetic testing ', ' ']",NIDCD,NORTHERN ARIZONA UNIVERSITY,R21,2020,151994,AZ-01,0.03807702812633902
"Computational modeling of DNA methylation-mediated gene regulation Abstract Large numbers of complete methylomes are being acquired through clinical sequencing projects, such as through The Cancer Genome Atlas, Blueprint Epigenome Project, and International Cancer Genome Consortium. Furthermore, third-generation nanopore sequencers, which detect DNA methylation and genetic variation in a single experiment, are nearly ready for routine clinical sequencing and will provide complete methylomes for all patients where whole-genome sequencing is indicated. Current analysis tools however only perform preliminary methylome processing and catalogue differentially methylated regions (DMRs). In order to transform methylome analysis into a clinically useful diagnostic/prognostic test, we need to develop predictive tools to interpret the functional and pathological consequences of identified methylation changes. Towards this goal, we have published a series of papers demonstrating that machine-learning based models utilizing high- resolution signatures of all methylation changes around a promoter vastly outperform conventional DMR methods. Our models accurately predict expression states at genes potentially regulated by methylation and reveal predictive methylation signatures that facilitate mechanistic interpretation. Nonetheless, several challenges remain before we can achieve our goals of translating genome-wide methylation data for routine clinical use: (1) To our knowledge, no current models integrate distal enhancers, whose activation is affected by DNA methylation. Such integrative analysis is necessary to understand consequences of methylation changes in cancers, whose genomes frequently undergo wide-spread methylation changes. In addition, such modelling will be essential to understand the role of 5-hydroxymethylcytosine (5hmC), which may play both repressive and activating roles in neurons depending on whether it is found at promoters or enhancers. (2) Our current models (and conventional approaches) represent methylation data independent of DNA sequence despite mechanistic studies demonstrating that methylation changes can have different functional effects depending on which sequences change and depending on the context of the local regulatory grammar. In this proposal, we will meet these challenges by first developing a predictive model that incorporates 5-methylcytosine and 5hmC at promoters and enhancers to determine how these marks act in concert. In particular, we will examine the hypothesized dual role of 5hmC as a repressor at promoters and as an activator at enhancers in cortical neurons. We will then use new advances in natural language processing to model DNA sequence and methylation to predict expression states. Our results will reveal which regulatory elements and transcription factors binding sites are affected by DNA methylation and how changes at different sites collaborate to affect expression changes. We will experimentally validate our in silico predictions using a combination of reporter assays and CRISPR- based epigenome-editing tools. Thus, the software tools we develop will form an important toolkit for the analysis and mechanistic interpretation of whole-genome methylation studies, both in the laboratory and clinic. Public Narrative DNA normally undergoes a variety of chemical modifications including the addition of methyl- and hydroxymethyl- groups to cytosines (DNA methylation). Though we are unsure how to interpret them, abnormal patterns of DNA methylation are often found in human diseases and will likely soon be routinely measured in the clinic. In this proposal, we will develop advanced computational approaches to predict the functional and pathological consequences of DNA methylation changes in disease. In the future, the approaches we develop will lead to software that suggests individualized therapies for patients based on clinical methylation data.",Computational modeling of DNA methylation-mediated gene regulation,10018936,R01LM013096,"['Affect ', ' Binding Sites ', ' Combining Site ', ' Reactive Site ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Cataloging ', ' Cells ', ' Cell Body ', ' Communities ', ' Cytosine ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Elements ', ' Future ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Genes ', ' Genome ', ' Glioma ', ' Glial Cell Tumors ', ' Glial Neoplasm ', ' Glial Tumor ', ' Neuroglial Neoplasm ', ' Neuroglial Tumor ', ' glial-derived tumor ', ' neuroglia neoplasm ', ' neuroglia tumor ', ' Goals ', ' Laboratories ', ' Maps ', ' Methods ', ' Methylation ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Natural Language Processing ', ' natural language understanding ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Paper ', ' Patients ', ' Play ', ' Publishing ', ' Recurrence ', ' Recurrent ', ' Nucleic Acid Regulatory Sequences ', ' Nucleic Acid Regulator Regions ', ' Regulatory Regions ', ' genetic regulatory element ', ' Role ', ' social role ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Testing ', ' transcription factor ', ' Basal Transcription Factor ', ' Basal transcription factor genes ', ' General Transcription Factor Gene ', ' General Transcription Factors ', ' Transcription Factor Proto-Oncogene ', ' Transcription factor genes ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Translating ', ' Genetic Variation ', ' Genetic Diversity ', ' Generations ', ' Measures ', ' Enhancers ', ' Mediating ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' DNA Sequence ', ' base ', ' cofactor ', ' Label ', ' Distal ', ' Site ', ' Clinical ', ' Series ', ' Chemicals ', ' prognostic ', ' Training ', ' Individual ', ' Ligand Binding Protein ', ' Ligand Binding Protein Gene ', ' Protein Binding ', ' bound protein ', ' Binding Proteins ', ' Reporter ', ' tool ', ' Diagnostic ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Catalogs ', ' Clinic ', ' Pattern ', ' ES cell ', ' stem cell of embryonic origin ', ' embryonic stem cell ', ' mutant ', ' success ', ' demethylation ', ' neural ', ' relating to nervous system ', ' Regulation ', ' Modeling ', ' Sampling ', ' histone modification ', ' Molecular Interaction ', ' Binding ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' genome sequencing ', ' Data ', ' International ', ' Regulatory Element ', ' Resolution ', ' Retrieval ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Pathologic ', ' Characteristics ', ' Modification ', ' developmental ', ' Development ', ' epigenomics ', ' cancer cell genome ', ' tumor genome ', ' cancer genome ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' nano pore ', ' nanopore ', ' cancer type ', ' human disease ', ' genome scale ', ' genomewide ', ' genome-wide ', ' TCGA ', ' The Cancer Genome Atlas ', ' genomewide methylation ', ' global methylation ', ' genome wide methylation ', ' methylome ', ' epigenome ', ' CRISPR ', ' CRISPR/Cas system ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' network architecture ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' methylation pattern ', ' clinical sequencing ', ' entire genome ', ' full genome ', ' whole genome ', ' predictive tools ', ' prognostic test ', ' prognostic assays ', ' experiment ', ' experimental research ', ' experimental study ', ' DNA seq ', ' DNAseq ', ' DNA sequencing ', ' recruit ', ' epigenetic therapy ', ' long short term memory neural network ', ' long short term memory network ', ' epigenome editing ', ' Computerized Models ', ' computational modeling ', ' computational models ', ' computer based models ', ' computerized modeling ', ' Computer Models ', ' in silico ', ' ']",NLM,WASHINGTON UNIVERSITY,R01,2020,350896,MO-01,0.04537188909802945
"DNA 3.0: Developing novel enzymes for DNA synthesis with deep learning and combinatorial genetics Project Summary/Abstract  DNA synthesis has played a key role in the biotechnology revolution. The ready availability of synthetic DNA oligonucleotides and of genes assembled from them, has been invaluable for elucidating and unlocking biological function and enabling the new field of synthetic biology which can create novel cells, enzymes, therapeutics, diagnostics and other reagents of commercial value. Despite this impact, DNA synthesis uses chemical strategies developed over 30 years ago which are costly and limited to molecules of 200 nucleotides or less in length.  Next-generation enzymatic DNA synthesis technologies are being explored that use template- independent DNA polymerases (TIDPs) for controlled addition of nucleotides to a growing DNA strand. Although advances have been reported recently, enzymatic DNA synthesis is still limited by the low efficiency of available TIDPs, and specifically by the relative inability of these polymerases to incorporate 3'-blocked nucleotides.  In this Phase I Small Business Innovation Research (SBIR) project, Primordial Genetics Inc, a synthetic biology company with differentiated combinatorial genetic technology, and Denovium Inc., an artificial intelligence company pioneering novel Al methods for genetic discovery, are joining forces to develop novel and highly efficient TIDPs for enzymatic DNA synthesis in vitro.  Denovium will use their computational capabilities based on machine learning algorithms to discover novel TIDPs with the desired activities from proprietary and public databases. Denovium will also perform proprietary artificial intelligence (AI) scans to determine the functional impact of all possible mutations on the selected TIDPs. Primordial Genetics will synthesize and express the resulting collection of sequences, and test them in vitro to identify the most active enzymes. The best 2 enzymes will be diversified using Primordial Genetics' proprietary Function Generator technology and other randomized diversification methods. Populations of genes encoding enzyme variants will be screened with ultra-high-throughput screens to identify the most active enzymes. The dataset resulting from this work will be used to train Denovium's sequence prediction algorithm to accelerate further enzyme improvements in Phase II.  The proposed work is a feasibility study for isolating and developing novel enzymes suitable for enzymatic DNA synthesis, and also for creating a pipeline of enzyme optimization tools. The enzymes discovered and in this work will be directly useful for enzymatic DNA synthesis applications, and can be licensed or sold to leading DNA and gene manufaturers. Project Narrative The principal aim of this project is to develop novel and improved DNA polymerases for the industrial synthesis of DNA, which is currently performed by synthetic chemical methods and represents one of the cornerstone technologies of the biotechnology industry. To overcome limitations of the current chemical technology in cost, efficiency and the length of DNA molecules that can be synthesized, there have been widespread attempts to develop specific DNA polymerases as efficient molecular machines for synthesizing DNA. This project will develop novel and more efficient polymerases than are currently available, which will impact the diagnosis, prevention and treatment of human diseases such as cancer, heart disease, HIV and genetic diseases such as cystic fibrosis.",DNA 3.0: Developing novel enzymes for DNA synthesis with deep learning and combinatorial genetics,10010243,R43HG010995,"['Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Biotechnology ', ' Biotech ', ' Malignant Neoplasms ', ' Cancers ', ' Malignant Tumor ', ' malignancy ', ' neoplasm/cancer ', ' Capital ', ' Cells ', ' Cell Body ', ' Chemistry ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Cystic Fibrosis ', ' Mucoviscidosis ', ' Diagnosis ', ' DNA ', ' Deoxyribonucleic Acid ', ' DNA Nucleotidylexotransferase ', ' Deoxynucleotidyl Transferase ', ' Deoxynucleotidyltransferase ', ' Desoxynucleotidyl Transferase ', ' Desoxynucleotidyltransferase ', ' Terminal Addition Enzyme ', ' Terminal Deoxynucleotidyl Transferase ', ' Terminal Deoxynucleotidyltransferase ', ' Terminal Deoxyribonucleotidyl Transferase ', ' Terminal Deoxyribonucleotidyltransferase ', ' DNA-Directed DNA Polymerase ', ' DNA Polymerases ', ' DNA-Dependent DNA Polymerases ', ' Single-Stranded DNA ', ' Enzymes ', ' Enzyme Gene ', ' Equipment ', ' Evolution ', ' Feasibility Studies ', ' Genes ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' HIV ', ' AIDS Virus ', ' Acquired Immune Deficiency Syndrome Virus ', ' Acquired Immunodeficiency Syndrome Virus ', ' Human Immunodeficiency Viruses ', ' LAV-HTLV-III ', ' Lymphadenopathy-Associated Virus ', ' Virus-HIV ', ' In Vitro ', ' Industrialization ', ' Industry ', ' Libraries ', ' Methods ', ' Modernization ', ' Molecular Biology ', ' DNA Molecular Biology ', ' Mutation ', ' Genetic Alteration ', ' Genetic Change ', ' Genetic defect ', ' genome mutation ', ' Nucleotides ', ' Oligonucleotides ', ' Oligo ', ' oligos ', ' Play ', ' Proteins ', ' Reagent ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Technology ', ' Testing ', ' Work ', ' Generations ', ' Molecular Genetics ', ' TimeLine ', ' Dataset ', ' Data Set ', ' base ', ' improved ', ' Phase ', ' Variation ', ' Variant ', ' Biological ', ' Chemicals ', ' Training ', ' Data Bases ', ' data base ', ' Databases ', ' Licensing ', ' data retrieval ', ' data storage ', ' Data Storage and Retrieval ', ' R-Series Research Projects ', ' R01 Mechanism ', ' R01 Program ', ' Research Grants ', ' Research Projects ', ' Research Project Grants ', ' Biological Function ', ' Biological Process ', ' Therapeutic ', ' Genetic ', ' tool ', ' Diagnostic ', ' Scanning ', ' Performance ', ' synthetic DNA ', ' synthetic construct ', ' DNA Replication ', ' DNA Synthesis ', ' DNA biosynthesis ', ' novel ', ' Prevention ', ' Reporting ', ' genetic technology ', ' Modeling ', ' High Throughput Assay ', ' high throughput screening ', ' model development ', ' phosphoramidite ', ' Bio-Informatics ', ' Bioinformatics ', ' Polymerase ', ' Length ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Collection ', ' SBIR ', ' Small Business Innovation Research ', ' Small Business Innovation Research Grant ', ' Molecular ', ' Process ', ' developmental ', ' Development ', ' cost ', ' next generation ', ' Population ', ' Microbe ', ' Molecular Machines ', ' synthetic biology ', ' combinatorial ', ' human disease ', ' in vitro testing ', ' predictive algorithm ', ' predictor algorithm ', ' prediction algorithm ', ' Cost efficiency ', ' genetic condition ', ' genetic disorder ', ' Genetic Diseases ', ' predictive assay ', ' predictive test ', ' deep learning ', ' machine learned algorithm ', ' machine learning algorithm ', ' ']",NHGRI,"PRIMORDIAL GENETICS, INC",R43,2020,374524,CA-49,0.020899596393968867
"Scalable detection and interpretation of structural variation in human genomes PROJECT SUMMARY Structural variation (SV), is a diverse class of genome variation that includes copy number variants (CNVs) such as deletions and duplications, as well as balanced rearrangements, such as inversions and reciprocal translocations. A typical human genome harbors >4,000 SVs larger than 300bp and their large size increases the potential to delete or duplicate genes, disrupt chromatin structure, and alter expression. Despite their prevalence and potential for phenotypic consequence, SVs remain notoriously difficult to detect and genotype with high accuracy. Much of this difficulty is driven by the fact DNA sequence alignment signals indicating SVs are far more complex than for single-nucleotide and insertion deletion variants. Unlike SNP alignments that vary only in allele state, alignments supporting SVs vary in state (supports an alternate structure or not) alignment location, and type. Consequently, the accuracy of SV discovery is much lower than that of SNPs and INDELs. Furthermore, SV pipelines scale poorly and are difficult to run. These challenges are a barrier for single genome analysis and studies of families must invest substantial effort into eliminating a sea of false positives. These problems become exponentially more acute for large-scale sequencing efforts such as TOPmed, the Centers for Common Disease Genetics, and the All of Us program. Software efficiency is key to scalability for such projects. However, of equal importance is comprehensive, accurate discovery.  Building upon more than a decade of software development experience and analyzing SV in diverse disease contexts, we have invested significant effort into understanding the causes of the insufficient accuracy for SV discovery. These efforts, together with our research and development experience in this area, give us unique insight into improving the accuracy and scalability of SV discovery. Our goal is to narrow the accuracy gap between SNP/INDEL variation and structural variation discovery. These developments will empower studies of human genomes in diverse contexts and will therefore have broad impact. Our goals are to: 1. Develop a deep learning model to correct systematic variation in sequence depth. This new machine  learning model will correct systematic biases in DNA sequence depth and dramatically improve the  discovery of deletions and duplications. 2. Improve the speed, scalability, and accuracy of SV detection and genotyping. Using new algorithms,  we will bring the accuracy of SV detection much closer to that of SNP and INDEL discovery and allow  accurate SV discovery to be deployed at scale. 3. Create a map of genomic constraint for SV from population-scale genome analysis. We will deploy  our new methods to detect and genotype structural variation among tens of thousands of human genomes.  The resulting SV map will empower the creation of a model of genomic constraint for SV and enable new  software to predict deleterious SVs, especially in the noncoding genome. PROJECT NARRATIVE Single-nucleotide DNA changes paint an incomplete picture of a humans genome. A more complete picture must include a genome's structural variation (SV), an important class of genome variation that includes copy number variants (CNVs) such as deletions and duplications. However, existing methods have poor accuracy. As the genetics community transitions to large-scale genome sequencing studies, there is an acute need for improved SV discovery methods. This proposal introduces a series of algorithmic and software innovations that will empower SV discovery, genotyping, and interpretation in large-scale human disease studies.",Scalable detection and interpretation of structural variation in human genomes,9973582,R01HG010757,"['Affect ', ' Algorithms ', ' Alleles ', ' Allelomorphs ', ' Automobile Driving ', ' driving ', ' Systematic Bias ', ' Biological Assay ', ' Assay ', ' Bioassay ', ' Biologic Assays ', ' Communities ', ' Data Reporting ', ' data representation ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Environment ', ' Exhibits ', ' Future ', ' Gene Duplication ', ' Gene Expression ', ' Gene Fusion ', ' Genome ', ' Human Genome ', ' human whole genome ', ' Genotype ', ' Goals ', ' Human ', ' Modern Man ', ' Laboratories ', ' Maps ', ' Methods ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Noise ', ' Nucleotides ', ' Paint ', ' Phenotype ', ' Research ', ' research and development ', ' Development and Research ', ' R & D ', ' R&D ', ' Running ', ' Sea ', ' Sensitivity and Specificity ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Technology ', ' Genetic Variation ', ' Genetic Diversity ', ' Sequence Alignment ', ' sequencing alignment ', ' DNA Sequence ', ' Clip ', ' base ', ' dosage ', ' method development ', ' improved ', ' Family Study ', ' Area ', ' Acute ', ' Variation ', ' Variant ', ' Series ', ' Training ', ' insight ', ' Individual ', ' Error Sources ', ' Funding ', ' Genetic ', ' Reciprocal Translocation ', ' tool ', ' machine learned ', ' Machine Learning ', ' Complex ', ' Source ', ' Techniques ', ' Location ', ' experience ', ' Performance ', ' success ', ' Speed ', ' Structure ', ' novel ', ' Chromosomal Organization ', ' Chromosomal Structure ', ' Chromosome Organization ', ' Chromosome Structures ', ' Position ', ' Positioning Attribute ', ' Coding System ', ' Code ', ' Modeling ', ' Sampling ', ' develop software ', ' developing computer software ', ' software development ', ' Functional RNA ', ' Non-Coding ', ' Non-Coding RNA ', ' Non-translated RNA ', ' Noncoding RNA ', ' Nontranslated RNA ', ' noncoding ', ' Untranslated RNA ', ' Genomics ', ' developmental disorder ', ' developmental disease ', ' Pathogenicity ', ' preventing ', ' prevent ', ' genome sequencing ', ' copy number variant ', ' copy number variation ', ' Copy Number Polymorphism ', ' Data ', ' Detection ', ' Chromatin Structure ', ' Gene Organization ', ' Gene Structure/Organization ', ' genes structure ', ' Gene Structure ', ' Large-Scale Sequencing ', ' Process ', ' developmental ', ' Development ', ' indel ', ' insertion-deletion ', ' insertion-deletion mutation ', ' insertion/deletion ', ' insertion/deletion mutation ', ' nano pore ', ' nanopore ', ' Population ', ' Prevalence ', ' innovate ', ' innovative ', ' innovation ', ' human disease ', ' genome scale ', ' genomewide ', ' genome-wide ', ' exomes ', ' exome ', ' genome analysis ', ' Cloud Infrastructure ', ' cloud computer ', ' Cloud Computing ', ' Algorithmic Tools ', ' Software Algorithm ', ' Algorithmic Software ', ' entire genome ', ' full genome ', ' whole genome ', ' TOPMed ', ' Trans-Omics for Precision Medicine ', ' genetic condition ', ' genetic disorder ', ' Genetic Diseases ', ' All of Us Program ', ' All of Us Research Project ', ' AoURP ', ' All of Us Research Program ', ' deep learning ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' algorithm development ', ' large data sets ', ' large datasets ', ' variant detection ', ' ']",NHGRI,UNIVERSITY OF UTAH,R01,2020,692048,UT-02,-0.03141592875025244
"Gene-Environment Interactions in Glaucoma Primary open-angle glaucoma (POAG) is the leading cause of chronic optic neuropathy and a major source of ocular morbidity worldwide. Understanding preclinical events, early phase disease and disease heterogeneity represent key objectives in early disease detection, prevention and treatment of POAG. In this study, we propose 4 specific aims. 1) We will perform both targeted and untargeted metabolome-wide association studies (MWAS) for POAG using pre-clinical serum from a large case-control group (500 cases and 500 controls) nested within ongoing prospective studies of the Nurses' Health Study (NHS), NHS2, and Health Professionals Follow-up Study (HPFS) to advance our understanding of the biochemical events that precede POAG diagnosis (blood was collected ~ 10 years prior to disease diagnosis). Prior studies suggest that nitric oxide metabolites represent genetically informed markers and will form the basis for targeted profiling. 2) While considerable discoveries have been made of POAG genes, more work is needed to leverage genome-wide information to inform POAG etiology. Thus, we will create a genome-wide genetic correlation matrix between POAG and complex traits previously linked to POAG, using data from the NEIGHBORHOOD (National Eye Institute Glaucoma Human Genetics Collaboration Heritable Overall Operational Database; 3800 POAG cases) consortium and publicly available summary genome-wide association study data. An assessment of the shared heritability between POAG and these traits as well as the relation between the genetic risk scores for these traits and POAG will lead to new etiologic insights. 3) New-onset POAG is clinically heterogeneous with variable visual field (VF) loss patterns that may reflect different etiologies. We will apply archetype analysis, which objectively quantifies a patient's VF loss pattern to 16 existing clinically validated archetypes (ATs), 9 of which are glaucomatous in nature. Each POAG case (n=1250 from NHS, NHS2 and HPFS) and10 matched controls will be assigned 16 weighted coefficients that add up to 1, with each value representing how consistent his / her VF loss pattern is with each glaucomatous AT. We will evaluate the differential relation between established POAG risk factors and the values on the 16 ATs, to identify unique risk factors for homogeneous incident POAG subtypes. 4) A carbohydrate-restricted diet may meet the energy requirement in the non-myelinated retinal ganglion cell axon segment of the optic nerve and reduce risk of POAG. We will conduct a prospective evaluation of this exposure in relation to POAG and POAG subtypes in the 3 cohorts (n=2100 cases). By integrating MWAS, genomics with prospective environmental exposure data and AT analysis, this proposal addresses a number of important knowledge gapsin particular, it will shed light on how genetic and pre-diagnostic risk factors influence POAG and POAG heterogeneity. Linking specific exposures with POAG subtypes will provide important mechanistic understanding as well as evidence of causality, which will contribute to discovering precision medicine approaches for this condition. Primary open-angle glaucoma (POAG) is an intraocular pressure-related chronic optic nerve disease that produces characteristic visual loss patterns. In this proposal we will study a host of genes, plasma metabolites and environmental factors in relation to POAG overall as well as it's objectively determined subtypes based on visual loss pattern. Understanding how these various exposures relate to POAG and it's subtypes will highlight disease prevention strategies and precision medical treatment options for this potentially blinding disease that requires lifetime management.",Gene-Environment Interactions in Glaucoma,9933925,R01EY015473,"['Acetyl Coenzyme A ', ' Acetyl CoA ', ' S-acetate Coenzyme A ', "" Alzheimer's Disease "", ' AD dementia ', ' Alzheimer ', ' Alzheimer Type Dementia ', ' Alzheimer disease ', ' Alzheimer sclerosis ', ' Alzheimer syndrome ', "" Alzheimer's "", "" Alzheimer's disease dementia "", ' Alzheimers Dementia ', ' Alzheimers disease ', ' Primary Senile Degenerative Dementia ', ' dementia of the Alzheimer type ', ' primary degenerative dementia ', ' senile dementia of the Alzheimer type ', ' Archives ', ' Arginine ', ' L-Arginine ', ' Axon ', ' Biogenesis ', ' Origin of Life ', ' Blood ', ' Blood Reticuloendothelial System ', ' Carbohydrates ', ' Case-Control Studies ', ' Case-Base Studies ', ' Case-Comparison Studies ', ' Case-Compeer Studies ', ' Case-Referent Studies ', ' Case-Referrent Studies ', ' Citrulline ', ' Control Groups ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Diagnosis ', ' Diet ', ' dietary ', ' Disease ', ' Disorder ', ' Environmental Exposure ', ' Family ', ' Follow-Up Studies ', ' Followup Studies ', ' Genes ', ' Glaucoma ', ' glaucomatous ', ' Heterogeneity ', ' Recording of previous events ', ' History ', ' Human Genetics ', ' Physiologic Intraocular Pressure ', ' Intraocular Pressure ', ' Ocular Tension ', ' intra-ocular pressure ', ' Life Style ', ' Lifestyle ', ' Light ', ' Photoradiation ', ' Linkage Disequilibrium ', ' Metabolism ', ' Intermediary Metabolism ', ' Metabolic Processes ', ' Mitochondria ', ' mitochondrial ', ' Morbidity - disease rate ', ' Morbidity ', ' Neighborhoods ', ' Nested Case-Control Study ', ' Nitric Oxide ', ' Endogenous Nitrate Vasodilator ', ' Endothelium-Derived Nitric Oxide ', ' Mononitrogen Monoxide ', ' Nitrogen Monoxide ', ' Nitrogen Protoxide ', ' endothelial cell derived relaxing factor ', ' Optic Nerve ', ' Cranial Nerve II ', ' Second Cranial Nerve ', ' optic nerve disorder ', ' Cranial Nerve II Diseases ', ' Cranial Nerve II Disorder ', ' Neural-Optical Lesion ', ' Optic Nerve Diseases ', ' Optic Neuropathy ', ' Second Cranial Nerve Diseases ', ' second cranial nerve disorder ', ' Ornithine ', ' 2,5-Diaminopentanoic Acid ', ' Patients ', ' Plasma ', ' Blood Plasma ', ' Plasma Serum ', ' Reticuloendothelial System, Serum, Plasma ', ' Prospective Studies ', ' Retinal Ganglion Cells ', ' retinal ganglion ', ' Risk ', ' Risk Factors ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Thinness ', ' Leanness ', ' Visual Fields ', ' eye field ', ' Woman ', ' Work ', ' Measures ', ' Mediating ', ' 3 Hydroxybutyrate ', ' -Hydroxybutyrate ', ' beta-Hydroxybutyrate ', ' base ', ' Blood Sample ', ' Blood specimen ', ' improved ', ' Peripheral ', ' Chronic ', ' Clinical ', ' Phase ', ' Biochemical ', ' Medical ', ' Link ', ' Evaluation ', ' Blood Serum ', ' Serum ', ' disability ', ' insight ', ' Visual ', ' Data Bases ', ' data base ', ' Databases ', ' Metabolic Networks ', ' Biochemical Pathway ', ' Collaborations ', ' Therapeutic ', ' Genetic ', ' POAG ', ' Primary Open Angle Glaucoma ', ' Diagnostic ', ' Nature ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' diet restriction ', ' restricted diet ', ' dietary restriction ', ' Complex ', ' Event ', ' Source ', ' Pattern ', ' vision loss ', ' visual loss ', ' Blindness ', ' Gene x Environment Interaction ', ' GxE interaction ', ' environment effect on gene ', ' gene environment interaction ', ' cohort ', ' trait ', ' novel ', ' Participant ', ' disease prevention ', ' disorder prevention ', ' Preventative strategy ', ' Preventive strategy ', ' Prevention strategy ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Prevention ', ' intervention therapy ', ' Therapeutic Intervention ', ' Sampling ', ' case control ', ' time interval ', ' Genomics ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' Address ', ' Preventive ', ' Adherence ', ' Data ', ' Detection ', ' Genetic Risk ', ' Actions of Nitric Oxide in the Heart ', ' Nitric Oxide Pathway ', "" Nurses' Health Study "", ' Characteristics ', ' Modification ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' Health Care Professional ', ' Healthcare professional ', ' Health Professional ', ' preclinical ', ' pre-clinical ', ' National Eye Institute ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' prospective ', ' Heritability ', ' Impairment ', ' mitochondrial dysfunction ', ' common treatment ', ' genome scale ', ' genomewide ', ' genome-wide ', ' disease diagnosis ', ' precision-based medicine ', ' precision medicine ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' metabonome ', ' metabolome ', ' disease heterogeneity ', ' Prospective cohort ', ' secondary analysis ', ' ']",NEI,ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI,R01,2020,546195,NY-13,-0.0032992027782979246
"Computational Methods for Next-Generation GWAS Project Summary/Abstract  Predicting phenotypes from DNA sequence variation is a major goal for genetics with potential applications in evolutionary biology, crop breeding, and public health. A central challenge in this task is separating genetic and environmental effects on phenotypes. In natural populations breeding structure is often correlated with the environment across space such that different subpopulations experience different environments. For genome-wide association studies (GWAS) this creates a problem: genetic and environmental effects can be confounded by population structure, leading to inflated test statistics and low predictive power across populations (Bulik-Sullivan et al. 2015, Mathieson and Mcvean, 2012). Understanding when association studies are biased by population stratification and creating better methods to correct for it are thus important challenges for population genetics over the next decade.  To identify conditions under which existing methods of population stratification correction are subject to bias and develop robust new alternatives suitable for use with the continental-scale genomic datasets that are now routinely available for humans, we propose to use simulations and machine learning to separate the signals of fine-scale ancestry from polygenic phenotype association. In our first aim we will develop simulations of polygenic phenotype evolution in continuous space and use the output to evaluate existing methods of stratification control including linear mixed models, PC correction, and LD score regression. In this aim we will seek to identify the regions of parameter space  i.e. the strength of isolation by distance and the spatial distribution of environmental variation  in which existing methods can be expected to produce reliable effect size estimates, and establish guidelines for applications of GWAS to structured populations.  We will then train machine learning algorithms on real genotype data from humans and mosquitoes to describe continuous structure in large spatial samples using a variational autoencoder, a dimensionality reduction technique based on deep neural networks that can take advantage of both allele frequency and haplotype-based measures of differentiation in a single analysis and thus offer improved control of stratification inflation in GWAS relative to the now standard PCA regression approach. Last we will apply deep learning techniques to the problem of linking phenotypes and genotypes in structured samples by training neural networks on simulated phenotypes and empirical genetic data. By training our networks on empirical genetic data and incorporating contextual information about surrounding haplotype structure into the model, our networks should learn to discriminate causal associations from false positives created by population structure in the sample cohort, which will improve performance when attempting to identify associations with the real phenotype. These methods will be applied to existing genomic datasets of height in humans, tested against the current state-of-the-art approaches, and packaged as scalable software for the broader scientific community. Project Narrative Separating the signals of polygenic trait association and population structure has emerged as a major challenge for the interpretation of genome-wide association studies (GWAS). We propose to develop new simulations of populations evolving in continuous space that will allow us to rigorously benchmark existing methods of stratification control in GWAS while fully controlling the underlying demographic and selective process. We will then apply deep learning techniques to develop (1) a new method of dimensionality reduction to test as a covariate for ancestry in GWAS, and (2) a neural network that identifies genotype-phenotype connections while controlling for population structure in the sample cohort.",Computational Methods for Next-Generation GWAS,9910009,F32GM136123,"['Agriculture ', ' agricultural ', ' Biology ', ' Breeding ', ' Communities ', ' Computing Methodologies ', ' computational methodology ', ' computational methods ', ' computer based method ', ' computer methods ', ' computing method ', ' Non-Insulin-Dependent Diabetes Mellitus ', ' Adult-Onset Diabetes Mellitus ', ' Ketosis-Resistant Diabetes Mellitus ', ' Maturity-Onset Diabetes Mellitus ', ' NIDDM ', ' Non-Insulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes ', ' Noninsulin Dependent Diabetes Mellitus ', ' Slow-Onset Diabetes Mellitus ', ' Stable Diabetes Mellitus ', ' T2 DM ', ' T2D ', ' T2DM ', ' Type 2 Diabetes Mellitus ', ' Type 2 diabetes ', ' Type II Diabetes Mellitus ', ' Type II diabetes ', ' adult onset diabetes ', ' ketosis resistant diabetes ', ' maturity onset diabetes ', ' type 2 DM ', ' type II DM ', ' type two diabetes ', ' Environment ', ' Evolution ', ' Gene Frequency ', ' Allele Frequency ', ' allelic frequency ', ' Population Genetics ', ' Genotype ', ' Geographic Locations ', ' Geographic Area ', ' Geographic Region ', ' Geographical Location ', ' geographic site ', ' Goals ', ' Haplotypes ', ' Health ', ' Heart Diseases ', ' Cardiac Diseases ', ' Cardiac Disorders ', ' heart disorder ', ' Human ', ' Modern Man ', ' image reconstruction ', ' image construction ', ' image generation ', ' Learning ', ' Linear Models ', ' Linear Regressions ', ' Methods ', ' Methodology ', ' Culicidae ', ' Mosquitoes ', ' Phenotype ', ' Public Health ', ' Running ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Computer software ', ' Software ', ' Spatial Distribution ', ' statistics ', ' Testing ', ' Measures ', ' diverse populations ', ' heterogeneous population ', ' population diversity ', ' Population Heterogeneity ', ' DNA Sequence ', ' Guidelines ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Link ', ' Training ', ' Genetic ', ' tool ', ' machine learned ', ' Machine Learning ', ' Dimensions ', ' Techniques ', ' Height ', ' Best Practice Analysis ', ' Benchmarking ', ' experience ', ' human data ', ' Performance ', ' cohort ', ' trait ', ' Structure ', ' simulation ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' Sampling ', ' Oligogenic Inheritances ', ' Oligogenic Traits ', ' Polygenic Characters ', ' Polygenic Inheritances ', ' Polygenic Traits ', ' Data ', ' Stratification ', ' Sum ', ' Process ', ' imaging ', ' Image ', ' Output ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' next generation ', ' Population ', ' Coupled ', ' large scale simulation ', ' genome scale ', ' genomewide ', ' genome-wide ', ' biorepository ', ' biobank ', ' learning activity ', ' learning method ', ' learning strategy ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' TOPMed ', ' Trans-Omics for Precision Medicine ', ' population stratification ', ' deep learning based neural network ', ' deep learning neural network ', ' deep neural net ', ' deep neural network ', ' deep learning ', ' neural network ', ' autoencoding neural network ', ' autoencoder ', ' machine learned algorithm ', ' machine learning algorithm ', ' supervised machine learning ', ' supervised learning ', ' data diversity ', ' diverse data ', ' polygenic risk score ', ' ']",NIGMS,UNIVERSITY OF OREGON,F32,2020,19290,OR-04,0.05559937949334992
"Mathematical Models of Vulnerability and Cell-Type Specific Analysis of DNA Modifications in Aging Project Summary Understanding the biochemical processes underlying aging that give rise to age-related pathologies is the central concept of geroscience research. A focus in geroscience is to identify interventions that slow/prevent aging. These could both alter the trajectory of aging and have beneficial effects across a number of diseases, delaying onset or slowing progression. However, evaluating anti-aging interventions requires years-long studies in mammalian model organisms and is almost impossible in clinical trials that would require of multi-year studies to evaluate lifespan and healthspan extensions. The solution to this problem lies in developing endpoints that indicate biological age and the health-related changes that go with it with sufficient sensitivity. The recent development of epigenetic clocks, chronological age-predictive machine learning models that use DNA cytosine methylation data, are leading the field in age estimation accuracy and precision. The difference between a persons chronological age and the estimated methylation age has been proposed as a measure of aging acceleration or deceleration  a biological age. Age acceleration predicted by methylation has shown robust correlations to all-cause mortality risk, but weak correlations in age-related diseases. Age-related biological outcomes such as cognitive decline have found little to no association with methylation age acceleration. Put simply, epigenetic clocks have been developed to predict chronological age but have so far demonstrated marginal utility to predict disease states. However, our preliminary results indicate that as many as 20% of genomic cytosines have age-related methylation changes which may be leveraged to understand biological aging and its outcomes simultaneously. Using the largest collection of methylation data with disease, age, tissue, and sex labels from our previous work in natural language processing, we will create the first model of epigenetic aging to identify healthy aging loci and disease-predictive loci. These loci will give us insight into the molecular pathways disturbed by age-related methylation changes, providing targets for therapeutic intervention and a predictor for patient disease risk. However, it is still unknown how epigenetic clocks tick, especially considering their performance across tissues. We will test how epigenetic changes with age are distributed throughout specific cell types in the central nervous system and cell types common across all tissues  such as vascular endothelium and immune cells. Using single-cell bisulfite sequencing and cell-type specific promoter-driven labelling, we can detect if the epigenetic clock changes are truly occurring in all cells or if they are restricted to some cell types common across tissues. This information is critical for predicting the downstream effects of changes identified by epigenetic clocks and interpreting the effects of reversing epigenetic aging. These experiments will further our understanding of the role epigenetics play in the aging process and in neurological diseases of age such as Alzheimers and Parkinsons Disease. Project Narrative Epigenetic clocks, models of DNA methylation changes with age, have been shown as robust biomarkers for aging and all-cause mortality risk, but weakly predict disease risk and thus biological aging. This proposed research plan will generate a new epigenetic model by identifying loci predictive of both age and disease to create an Epigenetic Vulnerability Estimator (EVE), granting insights into disease-associated pathways affected by DNA methylation aging. We will also determine how epigenetic clocks tick in the brain using cell-type specific single-cell bisulfite sequencing to understand what cellular populations are reflecting both age-related epigenetic dysregulation and potentially responding to anti-aging interventions.",Mathematical Models of Vulnerability and Cell-Type Specific Analysis of DNA Modifications in Aging,10067953,F31AG063493,"['Acceleration ', ' Affect ', ' Age ', ' ages ', ' Aging ', ' Alleles ', ' Allelomorphs ', "" Alzheimer's Disease "", ' AD dementia ', ' Alzheimer ', ' Alzheimer Type Dementia ', ' Alzheimer disease ', ' Alzheimer sclerosis ', ' Alzheimer syndrome ', "" Alzheimer's "", "" Alzheimer's disease dementia "", ' Alzheimers Dementia ', ' Alzheimers disease ', ' Primary Senile Degenerative Dementia ', ' dementia of the Alzheimer type ', ' primary degenerative dementia ', ' senile dementia of the Alzheimer type ', ' Animals ', ' Astrocytes ', ' Astrocytus ', ' Astroglia ', ' astrocytic glia ', ' Blood ', ' Blood Reticuloendothelial System ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cell Nucleus ', ' Nucleus ', ' Cells ', ' Cell Body ', ' Chronology ', ' Clinical Trials ', ' Cytosine ', ' Deceleration ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Vascular Endothelium ', ' Genes ', ' Genome ', ' Grant ', ' Health ', ' Heterogeneity ', ' Human ', ' Modern Man ', ' Joints ', ' Longevity ', ' Length of Life ', ' life span ', ' lifespan ', ' Methylation ', ' Genetic Models ', ' Mus ', ' Mice ', ' Mice Mammals ', ' Murine ', ' Persons ', ' Natural Language Processing ', ' natural language understanding ', ' nervous system disorder ', ' Nervous System Diseases ', ' Neurologic Disorders ', ' Neurological Disorders ', ' neurological disease ', ' Neurons ', ' Nerve Cells ', ' Nerve Unit ', ' Neural Cell ', ' Neurocyte ', ' neuronal ', ' Parkinson Disease ', ' Paralysis Agitans ', ' Parkinson ', "" Parkinson's disease "", ' Parkinsons disease ', ' Primary Parkinsonism ', ' Pathology ', ' Patients ', ' Phagocytes ', ' Phagocytic Cell ', ' amebocyte ', ' Play ', ' Research ', ' Ribosomes ', ' Risk Factors ', ' Role ', ' social role ', ' Computer software ', ' Software ', ' Testing ', ' Ticks ', ' Ixodida ', ' Tissues ', ' Body Tissues ', ' Work ', ' Euchromatin ', ' Measures ', ' Biological Aging ', ' Enhancers ', ' promotor ', ' promoter ', ' Dataset ', ' Data Set ', ' base ', ' Organ ', ' Label ', ' DNA analysis ', ' Site ', ' Biological ', ' Hortega cell ', ' gitter cell ', ' mesoglia ', ' microglial cell ', ' microgliocyte ', ' perivascular glial cell ', ' Microglia ', ' Link ', ' insight ', ' Individual ', ' Cognitive Disturbance ', ' Cognitive Impairment ', ' Cognitive decline ', ' Cognitive function abnormal ', ' Disturbance in cognition ', ' cognitive dysfunction ', ' cognitive loss ', ' Impaired cognition ', ' Age-associated cognitive decline ', ' Age-related cognitive decline ', ' Benign senescent forgetfulness ', ' age associated memory decline ', ' age related cognitive deficit ', ' age related cognitive impairment ', ' age related memory dysfunction ', ' Age-associated memory impairment ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Entropy ', ' Immunes ', ' Immune ', ' Source ', ' cell type ', ' Nuclear ', ' Degenerative Neurologic Diseases ', ' Degenerative Neurologic Disorders ', ' Nervous System Degenerative Diseases ', ' Neural Degenerative Diseases ', ' Neural degenerative Disorders ', ' Neurodegenerative Diseases ', ' Neurologic Degenerative Conditions ', ' degenerative diseases of motor and sensory neurons ', ' degenerative neurological diseases ', ' neurodegenerative illness ', ' Neurodegenerative Disorders ', ' Performance ', ' animal data ', ' Animal Models and Related Studies ', ' model of animal ', ' model organism ', ' Animal Model ', ' Disease Outcome ', ' novel ', ' disease risk ', ' disorder risk ', ' intervention therapy ', ' Therapeutic Intervention ', ' Modeling ', ' Sampling ', ' Math Models ', ' mathematic model ', ' mathematical modeling ', ' mathematical model ', ' Intervention Strategies ', ' interventional strategy ', ' Intervention ', ' Genomics ', ' CNS Nervous System ', ' Central Nervous System ', ' Neuraxis ', ' Neural Stem Cell ', ' neural precursor ', ' neural precursor cell ', ' neural progenitor ', ' neural progenitor cells ', ' neuron progenitors ', ' neuronal progenitor ', ' neuronal progenitor cells ', ' neuronal stem cells ', ' neuroprogenitor ', ' nerve stem cell ', ' DNA Modification ', ' DNA Modification Process ', ' Vascular Endothelial Cell ', ' preventing ', ' prevent ', ' Biochemical Process ', ' Data ', ' Research Training ', ' Collection ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Molecular ', ' Process ', ' sex ', ' developmental ', ' Development ', ' pathway ', ' Pathway interactions ', ' meta data ', ' Metadata ', ' age dependent ', ' age related ', ' aging effect ', ' age effect ', ' anti aging drug ', ' anti aging medicine ', ' antiaging ', ' antiaging drug ', ' antiaging medicine ', ' anti aging ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Outcome ', ' Population ', ' aged brain ', ' aging brain ', ' normal aging ', ' develop therapy ', ' intervention development ', ' treatment development ', ' therapy development ', ' healthy aging ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' Geroscience ', ' Cre-Lox ', ' Cre/LoxP ', ' Cre-LoxP ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' single cell sequencing ', ' BS-seq ', ' Bisulfite-based sequencing ', ' bisulfite-seq ', ' bisulfite sequencing ', ' lab assignment ', ' lab experiment ', ' laboratory activity ', ' laboratory assignment ', ' laboratory exercise ', ' laboratory experiment ', ' experiment ', ' experimental research ', ' experimental study ', ' health-span ', ' healthspan ', ' death risk ', ' mortality risk ', ' ']",NIA,UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR,F31,2020,34001,OK-05,-0.005332520841156353
"Integrating Multiple Omics to Illuminate Gene Networks Underlying Cigarette Smoking and Opioids. PROJECT SUMMARY/ABSTRACT The goal of the proposed research is to discover neurobiologically interpretable gene networks for addiction, specifically for cigarettes and opioids. To achieve this goal, we will apply a new multi-omics, multi-method frameworkGene Network Identification and Integration (GNetII)to identify gene networks associated uniquely with cigarette or opioid outcomes and networks shared across these addictions. GNetII includes genome-wide epistasis, Explainable Artificial Intelligence, gene network construction, and Lines-of-Evidence methods. These cornerstone methods will enable integration of large-scale genome-wide association study (GWAS) data in living subjects, postmortem human brain data (RNA-sequencing, DNA methylation, chromatin immunoprecipitation sequencing, and variant genotypes) from addiction case and control decedents (deceased individuals), and public omics data. Cigarette smoking and opioid outcomes are genetically correlated, and we have parallel GWAS and multi-omics brain data available in two highly relevant tissues, dorsolateral prefrontal cortex and nucleus accumbens, for both of these addictions. Cigarettes and opioids are leading causes of preventable morbidity and mortality in the United States. These addictions affect millions of U.S. adults and youths and are highly heritable (e.g., 54% and 71% for opioid addiction and nicotine dependence, respectively). GWAS analyses have identified 300+ loci at genome-wide significance for smoking. GWAS for opioids are farther behind in sample size, but genome-wide significant loci are emerging. Neurobiological effects of known loci are largely unknown, and more loci and connections among the loci are still to be discovered. We hypothesize that applying new big data science methods to large-scale GWAS and gene regulation data in brain tissue will reveal previously undetected relationships (such as epistatic interactions between genes) and add knowledge of the neurobiology underlying addiction. We propose the following specific aims:  Aim 1: Integrate multi-omics data to discover cigarette-associated gene networks.  Aim 2: Integrate multi-omics data to discover opioid-associated gene networks.  Aim 3: Integrate multi-omics data to find general addiction-associated gene networks. For cigarettes, Aims 1 and 3 will leverage GWAS (N=528,259) and multi-omics data in postmortem human brain from active smoker and nonsmoker decedents (N=262). For opioids, Aims 2 and 3 will use GWAS (N=49,178) and multi-omics brain data from opioid overdose case and control decedents (N=147). Analyses will be performed on Summit, the world's fastest supercomputer, which will greatly improve the likelihood of neurobiologically meaningful discoveries. Our study will capture complex networks across the genome to find previously unknown genes, as well as help explain the neurobiological underpinnings for the growing number of genetic loci associated with cigarette or opioid outcomes. PROJECT NARRATIVE Addictions to cigarettes and opioids are public health epidemics. The goal of this study is to identify gene networks that predispose individuals to these addictions. We will leverage cutting-edge methods (such as Explainable Artificial Intelligence), large-scale genome-wide association data in living subjects, and multiple omics data in postmortem human brain to further our understanding of the neurobiology underlying addiction.",Integrating Multiple Omics to Illuminate Gene Networks Underlying Cigarette Smoking and Opioids.,10056112,R01DA051913,"['Affect ', ' Algorithms ', ' Artificial Intelligence ', ' AI system ', ' Computer Reasoning ', ' Machine Intelligence ', ' Autopsy ', ' necropsy ', ' postmortem ', ' Brain ', ' Brain Nervous System ', ' Encephalon ', ' Cotinine ', ' Scotine ', ' Cessation of life ', ' Death ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemic ', ' Genetic Epistasis ', ' Epistasis ', ' Epistatic Deviation ', ' Interaction Deviation ', ' epistatic relationship ', ' gene x gene interaction ', ' genetic epistases ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Genes ', ' Genome ', ' Genotype ', ' Goals ', ' Human ', ' Modern Man ', ' Intelligence ', ' Laboratories ', ' Maps ', ' Methods ', ' Methylation ', ' Morbidity - disease rate ', ' Morbidity ', ' mortality ', ' Neurobiology ', ' neurobiological ', ' Nicotine Dependence ', ' nicotine addiction ', ' nicotine dependent ', ' Nucleus Accumbens ', ' Public Health ', ' Research ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Smoking ', ' Testing ', ' Time ', ' Tissues ', ' Body Tissues ', ' Toxicology ', ' United States ', ' Weight ', ' conference ', ' convention ', ' summit ', ' symposia ', ' symposium ', ' Prefrontal Cortex ', ' base ', ' improved ', ' Variation ', ' Variant ', ' insight ', ' Individual ', ' adult youth ', ' young adulthood ', ' young adult ', ' cigarette use ', ' cigarette smoking ', ' Opiates ', ' Opioid ', ' Sample Size ', ' Genetic ', ' Attenuated ', ' Smoker ', ' nonsmoker ', ' non-smoker ', ' DNA Methylation ', ' Knowledge ', ' Frequencies ', ' Complex ', ' brain tissue ', ' Opiate Dependence ', ' opioid addiction ', ' opioid dependence ', ' opioid dependent ', ' Opiate Addiction ', ' supercomputer ', ' Cigarette ', ' novel ', ' Reporting ', ' case control ', ' Oranges ', ' Address ', ' Systems Biology ', ' Data ', ' International ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' Outcome ', ' Heritability ', ' addictive disorder ', ' addiction ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' genome scale ', ' genomewide ', ' genome-wide ', ' ChIP Sequencing ', ' chromatin immunoprecipitation-sequencing ', ' ChIP-seq ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' multiomics ', ' multiple omics ', ' GTEx ', ' Genotype-Tissue Expression Project ', ' opiate consumption ', ' opiate drug use ', ' opiate intake ', ' opiate use ', ' opioid consumption ', ' opioid drug use ', ' opioid intake ', ' opioid use ', ' smoke addiction ', ' smoking dependence ', ' smoking dependent ', ' smoking addiction ', ' opiate overdose ', ' opiate related overdose ', ' opioid drug overdose ', ' opioid induced overdose ', ' opioid intoxication ', ' opioid medication overdose ', ' opioid poisoning ', ' opioid related overdose ', ' opioid toxicity ', ' opioid overdose ', ' addiction to cigarettes ', ' cigarette addiction ', ' random forest ', ' multiple omic data ', ' Multiomic Data ', ' big-data science ', ' gene locus ', ' genetic locus ', ' genomic locus ', ' ']",NIDA,RESEARCH TRIANGLE INSTITUTE,R01,2020,597080,NC-04,-0.009245428581949275
"Identifying Genetic and Epigenetic Risk Factors Regulating Gene Expression for Childhood Asthma Candidate: Dr. Soyeon Kim obtained her Ph.D. degree in Statistics at Rice University. For her doctoral research, she developed statistical machine learning methods to identify biomarkers for precision medicine approaches to treating lung cancer. She is currently a post-doctoral fellow at UPMC Childrens Hospital of Pittsburgh (CHP) and supported by a T32 grant awarded to one of her mentors, Dr. Juan C. Celedn. The goal of her research is to understand the pathogenesis of diseases by developing statistical methods for integrative analysis of multi-omics data. She is an author and co-author of eight manuscripts, including ones in high-profile journals such as Nature Genetics. Environment: CHP, affiliated with the University of Pittsburgh, School of Medicine, is a leading pediatric center for clinical care, research, and educational excellence. Dr. Kim works in the Rangos Research Center, comprised of nine floors of state-of-the-art laboratories, offices, and conference facilities. In addition to superb mentoring by Drs. Wei Chen, Juan C. Celedn and George Tseng, she will use the Pittsburgh supercomputing center (PSC), an excellent source of computing powers for intensive bioinformatics work. Research: Although both single-nucleotide polymorphisms (SNPs) and DNA methylation play important roles in regulating gene expression, the associations between SNPs/DNA methylation and expression of disease genes in childhood asthma are mostly unknown. Due to the multiple-testing problem, most studies focus on identifying the regulation of gene expression by cis- (nearby) DNA features, rather than a combination of cis- and trans (far from genes) regulation. To overcome the major multiple-testing problem, we will develop a novel statistical machine learning method that can handle a large number of variables of omics data without multiple- testing correction issues. In Aim 1, I will identify cis and trans genetic (SNPs) and epigenetic (methylation) factors that regulate gene expression in the nasal epithelium of asthmatic and healthy subjects. Through this analysis, I will uncover novel SNPs and methylation CpGs that may have not been found in genome-wide association studies (GWAS) or epigenome-wide association studies (EWAS). In Aim 2, I will estimate the genetic and epigenetic contributions to the expressions of genes that are associated with atopic asthma. This study also will classify genes that are affected the most by genetic factors and genes that are affected mostly by epigenetic factors, which include environmental factors. In Aim 3, I will develop statistical methods to identify SNPs that indirectly regulate gene expression through methylation in nasal epithelium of asthmatic and healthy subjects. The outcome of this work will be a better understanding of the abnormal molecular and cellular mechanisms through which asthma develops, and the application of this knowledge to help to produce new therapies for asthma. Project Narrative 6 million children in the US suffer from asthma, and the likelihood that any child will develop asthma depends heavily on their genetic and epigenetic regulations. My statistical machine learning models will identify new genetic and epigenetic risk factors that are associated with childhood asthma by regulating the expression of disease-causing or disease-preventing genes. This knowledge will help to advance precision medicine approaches to treating childhood asthma.",Identifying Genetic and Epigenetic Risk Factors Regulating Gene Expression for Childhood Asthma,10038897,K01HL153792,"['statistics ', ' Testing ', ' Genetic Transcription ', ' Gene Transcription ', ' RNA Expression ', ' Transcription ', ' Universities ', ' Work ', ' Measures ', ' Health Care Costs ', ' Health Costs ', ' Healthcare Costs ', ' conference ', ' convention ', ' summit ', ' symposia ', ' symposium ', ' Allergic asthma ', ' atopic asthma ', ' extrinsic allergic asthma ', ' Extrinsic asthma ', ' Magazine ', ' Journals ', ' base ', ' Biological ', ' pediatric ', ' Childhood ', ' Malignant Tumor of the Lung ', ' Pulmonary Cancer ', ' Pulmonary malignant Neoplasm ', ' lung cancer ', ' Malignant neoplasm of lung ', ' Chromosomal, Gene, or Protein Abnormality ', ' Cytogenetic or Molecular Genetic Abnormality ', ' Genetic Abnormality ', ' molecular aberrations ', ' Molecular Abnormality ', ' Asthma in Children ', ' Pediatric asthma ', ' Childhood Asthma ', ' Genetic ', ' Nature ', ' DNA Methylation ', ' Knowledge ', ' Distant ', ' Source ', ' Postdoc ', ' Research Associate ', ' post-doc ', ' post-doctoral ', ' Postdoctoral Fellow ', ' Nasal Epithelium ', ' Manuscripts ', ' novel ', ' Negotiating ', ' Negotiation ', ' Mediation ', ' Environmental Factor ', ' environmental risk ', ' Environmental Risk Factor ', ' Pathogenesis ', ' Single Base Polymorphism ', ' single nucleotide variant ', ' Single Nucleotide Polymorphism ', ' Statistical Methods ', ' Regulation ', ' Modeling ', ' Bio-Informatics ', ' Bioinformatics ', ' preventing ', ' prevent ', ' CIS Gene ', ' CIS protein ', ' CIS-1 Gene ', ' CIS-1 Protein ', ' CISH Protein ', ' Cytokine Inducible SH2-Containing Protein ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B ', ' Cytokine-Inducible Inhibitor of Signaling Type 1B Gene ', ' Cytokine-Inducible SH2-Containing Protein Gene ', ' G18 ', ' G18 Gene ', ' SOCS Gene ', ' Suppressor of Cytokine Signaling ', ' Suppressor of Cytokine Signaling Gene ', ' CISH gene ', ' Data ', ' Ph.D. ', ' PhD ', ' Doctor of Philosophy ', ' super computing ', ' Supercomputing ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Transcript ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' Outcome ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' clinical care ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' precision-based medicine ', ' precision medicine ', ' targeted drug therapy ', ' targeted drug treatments ', ' targeted therapeutic ', ' targeted therapeutic agents ', ' targeted therapy ', ' targeted treatment ', ' asthmatic ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' epigenetic regulation ', ' learning activity ', ' learning method ', ' learning strategy ', ' EWAS ', ' epigenome wide association analysis ', ' epigenome-wide association studies ', ' multiple omic data ', ' Multiomic Data ', ' statistical learning ', ' statistical and machine learning ', ' machine learning method ', ' clinical center ', ' Affect ', ' Asthma ', ' Bronchial Asthma ', ' Award ', ' Child ', ' 0-11 years old ', ' Child Youth ', ' Children (0-21) ', ' children ', "" childrens' "", ' youngster ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Environment ', ' Floor ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Genes ', ' Goals ', ' Grant ', ' Pediatric Hospitals ', "" Children's Hospital "", ' Laboratories ', ' Mentors ', ' Methylation ', ' Morbidity - disease rate ', ' Morbidity ', ' Play ', ' Puerto Rican ', ' Quality of life ', ' QOL ', ' Research ', ' Rice ', ' Risk Factors ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Role ', ' social role ', ' medical schools ', ' medical college ', ' school of medicine ', ' ']",NHLBI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,K01,2020,141178,PA-18,-0.0038170887325693352
"Predicting gene regulation across populations to understand mechanisms underlying complex traits Project Summary Deeper understanding of the degree of transferability of genetic association results and implicated biological mechanisms across populations is essential for equitable precision medicine implementation and can only be accomplished by studying the genetic architecture of complex traits in diverse populations. In our initial project period, we have shown that genetic correlation of gene expression depends on shared ancestry proportions in African American, Hispanic, and European populations. We identified a subset of genes that are well-predicted in one population, but poorly predicted in another and showed these differences are due to allele frequency differences between populations. Our results demonstrate that when comparing predicted expression levels to the observed, a balance of the training population with ancestry similar to the test population and total sample size leads to optimal predicted gene expression. Our studies of lipid traits in Yoruba, Filipino and Hispanic populations uncovered key genes likely regulated by variants that are monomorphic or rare in European populations, demonstrating why studies in diverse populations are crucial. We have optimized genetic prediction models of gene expression levels in diverse populations and thus have broadened the scope of PrediXcan. In this proposal, we seek to (1) optimize global and local ancestry-aware omics trait prediction models within and across diverse populations and (2) predict the intermediate omics traits and perform poly- omic PrediXcan analyses of complex traits in GWAS cohorts from diverse populations. We have gathered data of multiple omics traits from diverse populations for this project (genome-wide genotype, RNA-Seq, methylomics, metabolomics, and microbiome). We will use machine learning to optimize genotypic prediction models of gene expression levels, splicing ratios, methylation, metabolite levels, and microbial diversity. We expect a range of predictive power will be observed across omics traits dependent on the heritability of each trait and differences in allele frequencies and effect sizes among populations. We will integrate regulatory data and previous results from larger European populations when appropriate to prioritize functional variants in our prediction models. For each omics trait, we will survey its genetic architecture to inform the best prediction models. Our models will account for global and local ancestry and we will quantify the ancestry specific components of each omics trait. We will test the predicted omics traits for association with phenotypes of interest using either raw genotypes or summary statistics. We will use colocalization methods to determine if the SNPs driving each omics trait prediction model are also those most associated with the phenotype and thus most likely to be causal. We will combine predicted omics traits in poly-omic models to determine which genes and biological pathways are implicated for a particular phenotype. Our team is well positioned to perform novel PrediXcan-based analyses of omics traits in diverse populations and promises to maximize impact by making our scripts, models, and results publicly available. Project Narrative Differences in DNA sequence among individuals can lead to differences in omics traits like gene expression, splicing, methylation, metabolite levels, and microbial diversity, which in turn can lead to trait differences. We have developed a method that harnesses DNA differences to predict omics traits, which are then tested for association with a disease or other trait of interest. Our project will lead to a better understanding of the degree of transferability of genetic association results across populations, which has the potential to improve the implementation of precision medicine among diverse populations and reduce health disparities.",Predicting gene regulation across populations to understand mechanisms underlying complex traits,9880471,R15HG009569,"['Authorship ', ' Automobile Driving ', ' driving ', ' Awareness ', ' Bipolar Disorder ', ' Bipolar Affective Psychosis ', ' Manic-Depressive Psychosis ', ' bipolar affective disorder ', ' bipolar disease ', ' bipolar illness ', ' manic depressive disorder ', ' manic depressive illness ', ' Cohort Studies ', ' Concurrent Studies ', ' Communities ', ' Disease ', ' Disorder ', ' DNA ', ' Deoxyribonucleic Acid ', ' Gene Expression ', ' Gene Expression Regulation ', ' Gene Action Regulation ', ' Gene Regulation ', ' Gene Regulation Process ', ' Gene Frequency ', ' Allele Frequency ', ' allelic frequency ', ' Genes ', ' Genotype ', ' Lead ', ' Pb element ', ' heavy metal Pb ', ' heavy metal lead ', ' Lipids ', ' Methods ', ' Methylation ', ' Mission ', ' Phenotype ', ' Publishing ', ' RNA Splicing ', ' Splicing ', ' Schizophrenia ', ' Schizophrenic Disorders ', ' dementia praecox ', ' schizophrenic ', ' statistics ', ' Surveys ', ' Survey Instrument ', ' Testing ', ' Afro American ', ' Afroamerican ', ' Black Populations ', ' black American ', ' African American ', ' Hispanic Populations ', ' Latino Population ', ' Spanish Origin ', ' hispanic community ', ' Hispanics ', ' diverse populations ', ' heterogeneous population ', ' population diversity ', ' Population Heterogeneity ', ' DNA Sequence ', ' base ', ' improved ', ' Variation ', ' Variant ', ' Biological ', ' Training ', ' Individual ', ' European ', ' Filipino ', ' Sample Size ', ' Genetic ', ' machine learned ', ' Machine Learning ', ' Malignant Tumor of the Prostate ', ' Malignant prostatic tumor ', ' Prostate CA ', ' Prostate Cancer ', ' Prostatic Cancer ', ' Malignant neoplasm of prostate ', ' Knowledge ', ' Catalogs ', ' Adopted ', ' Complex ', ' interest ', ' Performance ', ' cohort ', ' microbial ', ' trait ', ' Manuscripts ', ' novel ', ' Position ', ' Positioning Attribute ', ' Modeling ', ' disparity in health ', ' health disparity ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' genetic association ', ' Data ', ' pathway ', ' Pathway interactions ', ' microbiome ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' epigenomics ', ' Complex Genetic Trait ', ' epidemiological model ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' Balance training ', ' Population ', ' Heritability ', ' genome scale ', ' genomewide ', ' genome-wide ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' undergraduate ', ' undergraduate student ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' precision-based medicine ', ' precision medicine ', ' genetic predictors ', ' Genetic study ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' microbial consortia ', ' microbial flora ', ' microflora ', ' multispecies consortia ', ' microbiota ', ' TOPMed ', ' Trans-Omics for Precision Medicine ', ' methylomics ', ' predictive assay ', ' predictive test ', ' genetic architecture ', ' multiple omic data ', ' Multiomic Data ', ' ']",NHGRI,LOYOLA UNIVERSITY OF CHICAGO,R15,2020,436000,IL-09,-0.0190114258285672
"Epigenetic and transcriptomic determinants of Sjogren's Syndrome subtypes utilizing data from the Sjogren's International Collaborative Clinical Alliance (SICCA) cohort ABSTRACT  Sjgren's Syndrome (SS) is a systemic autoimmune disease affecting the exocrine system, with hallmark symptoms of dry mouth and/or dry eyes caused by the dysfunction of salivary and/or lacrimal glands, respectively. While Genome-Wide Association Studies (GWAS) and other studies have increased our knowledge of genetic risk factors for SS, the disease etiology remains not well understood, and such risk factors have not been translatable to any immunological treatment options for SS. The NIH-NIDCR-funded Sjgren's International Collaborative Clinical Alliance (SICCA) was established to improve the understanding, diagnosis and treatment of patients with SS by developing/validating standardized classification criteria for SS; and developing a rich biospecimen repository with clinical data to be used for future epidemiologic, pathogenesis, and genetic studies of SS.[1, 2] For this project, we will focus on genomic data and measures of the 2016 ACR-EULAR classification criteria, involving ocular, oral, and autoantibody manifestations. As shown in our previous work, the genetics of SS varies with ancestry; thus, we will cluster patients by both the criteria subphenotypes and genetic ancestry. We believe that accounting for disease heterogeneity in this way will enable us to more precisely identify disease pathways and mechanisms. Using previously secured funding, we are completing DNA methylation typing on LSGs in 373 SICCA patients and single-cell RNA sequencing (scRNAseq) on PBMCs of 86 SICCA patients who also have DNA methylation profiling. This data provides a unique opportunity for multi-omics analysis to determine correlates between LSG tissue epigenetics, peripheral blood cell-type distributions and cell-specific gene expression by SS subsets. First, using GWAS data and DNA methylation data from LSG biopsies, we will identify genetic and epigenetic modifications associated with subtypes of SS in SICCA patients. We will then examine the relationships between them by testing for genotype-specific methylation and expression, and utilizing mendelian randomization and causal inference testing to investigate causality between these measures. Second, we will analyze scRNAseq data to identify how cell types, states and cell- specific gene expression correlate with SS subtypes. Finally, we will integrate genetics, epigenetics, and transcriptomics to determine multi-omics profiles associated with SS subtypes. We will jointly model associated features from the genomic data to investigate causal pathways via correlation networks, conditional analysis, and machine learning. We anticipate that SS subtypes will exhibit specific relationships within the multi- omics data and that this will advance our understanding of SS disease processes, leading to better treatment targets. PROJECT NARRATIVE Our proposal leverages unique NIDCR-funded resources by utilizing existing infrastructure and data with high level expertise to better understand the pathogenesis of Sjgren's syndrome and identify new therapeutic pathways. We propose to analyze genetic, epigenetic, and transcriptomic data recently generated on patients of the Sjgren's International Collaborative Clinical Alliance (SICCA) biorepository/registry. We will identify genomic determinants of subtypes of SS derived from subphenotypes and genetic ancestry, which we believe will be more indicative of underlying biologic pathways and will lead to more appropriate genomic candidates for SS treatments.",Epigenetic and transcriptomic determinants of Sjogren's Syndrome subtypes utilizing data from the Sjogren's International Collaborative Clinical Alliance (SICCA) cohort,10041649,R03DE029800,"['Accounting ', ' Affect ', ' Arthralgia ', ' Joint Pain ', ' Autoantibodies ', ' autoimmune antibody ', ' self reactive antibody ', ' Biopsy ', ' Blood Cells ', ' Peripheral Blood Cell ', ' Cells ', ' Cell Body ', ' Classification ', ' Systematics ', ' Clinical Trials ', ' Cohort Studies ', ' Concurrent Studies ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Pharmaceutical Preparations ', ' Drugs ', ' Medication ', ' Pharmaceutic Preparations ', ' drug/agent ', ' Epidemiology ', ' epidemiologic ', ' epidemiological ', ' Exanthema ', ' Exanthem ', ' Rash ', ' Skin Rash ', ' Exhibits ', ' Fatigue ', ' Lack of Energy ', ' Future ', ' Gene Expression ', ' Genes ', ' Genome ', ' Genotype ', ' Hereditary Disease ', ' Inborn Genetic Diseases ', ' Inherited disorder ', ' hereditary disorder ', ' heritable disorder ', ' inborn error ', ' inherited diseases ', ' inherited genetic disease ', ' inherited genetic disorder ', ' Laboratories ', ' Lacrimal gland structure ', ' Lacrimal Glands ', ' Systemic Lupus Erythematosus ', ' Lupus Erythematosus Disseminatus ', ' SLE ', ' Systemic Lupus Erythematous ', ' Systemic Lupus Erythmatosus ', ' disseminated lupus erythematosus ', ' systemic lupus erythematosis ', ' Lymphoma ', ' Germinoblastic Sarcoma ', ' Germinoblastoma ', ' Malignant Lymphoma ', ' Reticulolymphosarcoma ', ' Methylation ', ' monocyte ', ' Blood monocyte ', ' Marrow monocyte ', ' United States National Institutes of Health ', ' NIH ', ' National Institutes of Health ', ' Patients ', ' Phenotype ', ' Registries ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Resources ', ' Research Resources ', ' Rheumatism ', ' Musculoskeletal Pain Disorder ', ' Rheumatic Diseases ', ' Rheumatologic Disorder ', ' Rheumatology ', ' Risk ', ' Risk Factors ', ' Salivary Glands ', ' Salivary Glands Head and Neck ', ' Standardization ', ' Testing ', ' Work ', ' Xerostomia ', ' Asialia ', ' Hyposalivation ', ' Mouth Dryness ', ' aptyalism ', ' dry mouth ', ' Measures ', ' Mediating ', ' Caring ', ' improved ', ' Site ', ' Clinical ', ' Variation ', ' Variant ', ' Biological ', ' Biological Substance Banks ', ' biological specimen repository ', ' biosample repository ', ' biospecimen repository ', ' specimen bank ', ' specimen repository ', ' Biological Specimen Banks ', ' European ', ' Genetic Heterogeneity ', ' Funding ', ' Dysfunction ', ' Physiopathology ', ' pathophysiology ', ' Functional disorder ', ' Collaborations ', ' Genetic ', ' dry eye ', ' eye dryness ', ' machine learned ', ' Machine Learning ', ' DNA Methylation ', ' Knowledge ', ' Oral ', ' cell type ', ' collegiate ', ' college ', ' American ', ' QTL ', ' Quantitative Trait Loci ', ' success ', ' cohort ', ' PBMC ', ' Peripheral Blood Mononuclear Cell ', ' Participant ', ' Pathogenesis ', ' Position ', ' Positioning Attribute ', ' inherited factor ', ' genetic risk factor ', ' Modeling ', ' genetic epidemiologic study ', ' genetic epidemiology ', ' depository ', ' repository ', ' Genomics ', ' Labial Salivary Gland ', ' Causality ', ' causation ', ' disease causation ', ' Etiology ', ' genetic association ', ' Symptoms ', ' Data ', ' Disease Pathway ', ' International ', ' NIDCR ', ' NIDR ', ' National Institute of Dental Research ', ' National Institute of Dental and Craniofacial Research ', ' randomisation ', ' randomization ', ' randomly assigned ', ' Randomized ', ' Clinical Data ', ' Epigenetic ', ' Epigenetic Change ', ' Epigenetic Mechanism ', ' Epigenetic Process ', ' Exocrine System ', ' Salivary Gland Tissue ', ' Validation ', ' Immunochemical Immunologic ', ' Immunologic ', ' Immunological ', ' Immunologically ', ' Immunologics ', ' Molecular ', ' Process ', ' Modification ', ' developmental ', ' Development ', ' Sjogrens ', ' Sjgren Syndrome ', "" Sjogren's Syndrome "", ' pathway ', ' Pathway interactions ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' transcriptomics ', ' new drug treatments ', ' new drugs ', ' new therapeutics ', ' new therapy ', ' next generation therapeutics ', ' novel drug treatments ', ' novel drugs ', ' novel therapy ', ' novel therapeutics ', ' systemic autoimmune disorder ', ' systemic autoimmune disease ', ' biorepository ', ' biobank ', ' Secure ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' epigenome ', ' Genetic study ', ' methylation testing ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' multiomics ', ' multiple omics ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' disease heterogeneity ', ' entire genome ', ' full genome ', ' whole genome ', ' genomic data-set ', ' genomic dataset ', ' genomic data ', ' scRNA-seq ', ' single cell RNA-seq ', ' single cell RNAseq ', ' single-cell RNA sequencing ', ' Infrastructure ', ' multiple omic data ', ' Multiomic Data ', ' ']",NIDCR,"UNIVERSITY OF CALIFORNIA, SAN FRANCISCO",R03,2020,161500,CA-12,0.02505444608079635
"Genetic and Genomic Dissection of Psoriatic Arthritis Psoriatic arthritis (PsA) is distinctive amongst the inflammatory/autoimmune joint diseases in that its onset is commonly preceded by cutaneous psoriasis (PsC). This provides an unparalleled opportunity for the identification of predictive biomarkers to determine which of the approximately 25% of psoriasis vulgaris (PsV) patients will develop PsA. Over the past decade, we have expanded our genetic study of PsV to focus on PsA, resulting in the collection of 1,279 PsA patients at Michigan, 743 of whom have already been subjected to GWAS. Initiated in 2007, the International Psoriatic Arthritis Research Team (IPART) has accumulated 1,919 Canadian PsA patients, of whom 1,370 have already been subjected to GWAS. In 2015, we completed a meta- GWAS of PsC and PsA involving a discovery cohort of 1,430 PsA cases and 1,417 controls, with 9,293 additional PsV replication samples (3,061 PsA, 3,110 PsC) and 13,670 controls. We detected 10 associations for PsA and 11 for PsC, as well as a new association for PsV. Utilizing an innovative core exome array to genotype additional cases and controls, we carried out the largest meta-GWAS of PsV to date (~40,000 subjects) and found 16 more susceptibility regions, highlighting the roles of interferon signaling and the NFB cascade, and demonstrating strong enrichment for psoriasis genetic signals in T-cell regulatory elements. Using machine learning to model ~200 genetic variants in our PsA vs. PsC GWAS, we achieved 82% area under receiver operator curve for distinguishing PsA vs PsC, with 98% accuracy among the top 10% of patients with the highest genetic load. We also carried out RNA-seq on mRNA and miRNA from 65 pairs of pre- and post-conversion samples from PsC patients who developed PsA. Suggestive of a shift from skin- focused to systemic autoimmunity, we found significant post-conversion enrichment for central memory CD4+ T-cell (CD4-Tcm) transcripts among the up-regulated genes. We also observed highly correlated pre- and post- conversion behaviors of 54 differentially-expressed miRNAs and their mRNA targets, as well as multiple serum miRNAs that are significantly differentially expressed in PsA vs. PsC. A metabolomic study of 50 paired converter sera revealed 293 biochemicals with significant alterations, 275 of which were increased. Finally, we identified noncoding eQTLs for IL23R that correlate strikingly with a region of selective PsA association.  Based on these results, we hypothesize that PsA and PsC have pathogenetic mechanisms that are T-cell, osteoblast and osteoclast-driven and progress from skin to systemic during transition to PsA. We propose that this paradigm can be used to develop a useful test to predict PsA in PsC patients, while increasing our basic understanding of PsA. To test this hypothesis, we propose four aims: (1) to maintain and grow our longitudinal clinical resource; (2) To identify biomarkers for the development of PsA in PsC patients; (3) To integrate the biomarkers identified in Aim 2 into a clinically-useful tool for PsA identification using machine learning ; and (4) to explore the mechanisms by which the IL23R gene contributes to PsA pathogenesis. PROJECT NARRATIVE: Psoriatic Arthritis (PsA) is a major health problem in the United States and around the world. The mechanisms that predispose patients with psoriasis to develop PsA are unknown. The proposed research will utilize the power of genome-wide association studies, transcriptome analysis, metabolomics, and the largest longitudinal resource of PsA in the world to develop a clinically-relevant tool for PsA prediction and to address a major gap in our mechanistic understanding of the causes of PsA. The results of this research are also likely to be relevant to other autoimmune diseases.",Genetic and Genomic Dissection of Psoriatic Arthritis,10017154,R01AR063611,"['Alleles ', ' Allelomorphs ', ' Psoriatic Arthritis ', ' Arthritic Psoriasis ', ' Psoriasis Arthropathica ', ' Autoimmune Diseases ', ' autoimmune disorder ', ' Behavior ', ' Blood ', ' Blood Reticuloendothelial System ', ' Blood Banks ', ' Cardiovascular Diseases ', ' cardiovascular disorder ', ' comorbidity ', ' co-morbid ', ' co-morbidity ', ' Dermatology ', ' Dissection ', ' DNA ', ' Deoxyribonucleic Acid ', ' Elements ', ' Exhibits ', ' Genes ', ' Genetic Markers ', ' genetic biomarker ', ' Genotype ', ' Health ', ' HLA-C Antigens ', ' HLA-C ', ' Hospitals ', ' Immunity ', ' In Vitro ', ' Interferons ', ' IFN ', ' arthropathies ', ' Joint Diseases ', ' arthropathic ', ' arthropathy ', ' joint disorder ', ' Memory ', ' Michigan ', ' Osteoblasts ', ' Osteoclasts ', ' Patients ', ' Proteins ', ' Psoriasis ', ' psoriasiform ', ' psoriatic ', ' Research ', ' Resources ', ' Research Resources ', ' Rheumatology ', ' Risk ', ' RNA ', ' Non-Polyadenylated RNA ', ' RNA Gene Products ', ' Ribonucleic Acid ', ' Messenger RNA ', ' mRNA ', ' Role ', ' social role ', ' Signal Transduction ', ' Cell Communication and Signaling ', ' Cell Signaling ', ' Intracellular Communication and Signaling ', ' Signal Transduction Systems ', ' Signaling ', ' biological signal transduction ', ' Suggestion ', ' T-Lymphocyte ', ' T-Cells ', ' thymus derived lymphocyte ', ' Regulatory T-Lymphocyte ', ' Treg ', ' regulatory T-cells ', ' Testing ', ' United States ', ' Mutagenesis ', ' Genetics-Mutagenesis ', ' Mutagenesis Molecular Biology ', ' base ', ' Blood Sample ', ' Blood specimen ', ' Site ', ' Area ', ' Clinical ', ' Variation ', ' Variant ', ' Biochemical ', ' Susceptibility ', ' Predisposition ', ' Cutaneous ', ' Blood Serum ', ' Serum ', ' insight ', ' Individual ', ' Collaborations ', ' Genetic ', ' Inflammatory ', ' tool ', ' machine learned ', ' Machine Learning ', ' Life ', ' Discoid psoriasis ', ' Nummular psoriasis ', ' Plaque psoriasis ', ' Psoriasis vulgaris ', ' Chronic small plaque psoriasis ', ' Clinic ', ' Autoimmune ', ' Autoimmune Process ', ' Genetic Load ', ' cohort ', ' TYK2 ', ' novel ', ' Pathogenesis ', ' Coding System ', ' Code ', ' Modeling ', ' Sampling ', ' case control ', ' Functional RNA ', ' Non-Coding ', ' Non-Coding RNA ', ' Non-translated RNA ', ' Noncoding RNA ', ' Nontranslated RNA ', ' noncoding ', ' Untranslated RNA ', ' Genomics ', ' Meta-Analysis ', ' Short interfering RNA ', ' siRNA ', ' Small Interfering RNA ', ' Micro RNA ', ' miRNA ', ' miRNAs ', ' MicroRNAs ', ' Skin ', ' osteoblast cell differentiation ', ' osteoblastic differentiation ', ' osteoblast differentiation ', ' metabolism measurement ', ' metabonomics ', ' metabolomics ', ' TL1 ', ' TNF Ligand-Related Molecule 1 ', ' TNF15 ', ' TNFSF15 ', ' Tumor Necrosis Factor Ligand Superfamily Member 15 ', ' VEGI ', ' Vascular Endothelial Growth Inhibitor ', ' TNFSF15 gene ', ' STAT3 ', ' STAT3 gene ', ' CD8 ', ' CD8B ', ' CD8B1 ', ' LYT3 ', ' CD8B1 gene ', ' Address ', ' Data ', ' International ', ' Regulatory Element ', ' cell assay ', ' Cellular Assay ', ' Collection ', ' Transcript ', ' Active Follow-up ', ' active followup ', ' follow up ', ' followed up ', ' followup ', ' follow-up ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' Gene variant ', ' allele variant ', ' allelic variant ', ' genomic variant ', ' genetic variant ', ' memory CD4 T cell ', ' memory CD4 T lymphocyte ', ' innovate ', ' innovative ', ' innovation ', ' clinical relevance ', ' clinically relevant ', ' tool development ', ' high risk ', ' bio-markers ', ' biologic marker ', ' biomarker ', ' Biological Markers ', ' systemic autoimmunity ', ' exomes ', ' exome ', ' RNA Seq ', ' RNA sequencing ', ' RNAseq ', ' transcriptome sequencing ', ' rare allele ', ' rare variant ', ' CRISPR ', ' CRISPR/Cas system ', ' Clustered Regularly Interspaced Short Palindromic Repeats ', ' predictive biomarkers ', ' predictive molecular biomarker ', ' predictive marker ', ' Genetic study ', ' differentially expressed ', ' transcriptional differences ', ' differential expression ', ' biomarker development ', ' global gene expression ', ' global transcription profile ', ' transcriptome ', ' metabonome ', ' metabolome ', ' Long-term cohort ', ' Longterm cohort ', ' Longitudinal cohort ', ' recruit ', ' causal allele ', ' causal gene ', ' causal mutation ', ' causative mutation ', ' causative variant ', ' causal variant ', ' ']",NIAMS,UNIVERSITY OF MICHIGAN AT ANN ARBOR,R01,2020,638643,MI-12,0.028878028843721325
"Deep-learning-based prediction of AMD and its progression with GWAS and fundus image data Age-related macular degeneration (AMD) is a leading cause of irreversible blindness worldwide. Successful genome-wide association studies (GWAS) of AMD have identified many disease-susceptibility genes. Through great efforts from international GWAS consortium and large-scale collaborative projects, massive datasets including high-quality GWAS data and well-characterized clinical phenotypes are now available in public repositories such as dbGaP and UK Biobank. Clinically, color fundus images have been extensively used by ophthalmologists to diagnose AMD and its severity level. The combination of wealthy GWAS data and fundus image data provides an unprecedented opportunity for researchers to test new hypotheses that are beyond the objectives of original projects. Among them, predictive models for AMD development and its progression based on both GWAS and fundus image data have not been explored. Most existing prediction models only focus on classic statistical approaches, often regression models with a limited number of predictors (e.g., SNPs). Moreover, most predictions only give static risks rather than dynamic risk trajectories over time, of which the latter is more informative for a progressive disease like AMD. Recent advances of machine learning techniques, particularly deep learning, have been proven to significantly improve prediction accuracy by incorporating multiple layers of hidden non-linear effects when large-scale training datasets with well-defined phenotypes are available. Despite its success in many areas, deep learning has not been fully explored in AMD and other eye diseases. Motivated by multiple large-scale studies of AMD development or progression, where GWAS and/or longitudinal fundus image data have been collected, we propose novel deep learning methods for predicting AMD status and its progression, and to identify subgroups with significant different risk profiles. Specially, in Aim 1, we will construct a novel local convolutional neural network to predict disease occurrence (AMD or not) and severity (e.g., mild AMD, intermediate AMD, late AMD) based on (1a): a large cohort of 35,000+ individuals with GWAS data and (1b): a smaller cohort of 4,000+ individuals with both GWAS and fundus image data. In Aim 2, we will develop a novel deep neural network survival model for predicting individual disease progression trajectory (e.g., time to late-AMD). In both aims, we will use the local linear approximation technique to identify important predictors that contribute to individual risk profile prediction and to identify subgroups with different risk profiles. In Aim 3, we will validate and calibrate our methods using independent cohorts and implement proposed methods into user-friendly software and easy-to-access web interface. With the very recent FDA approval for Beovu, a novel injection treatment for wet AMD (one type of late AMD) by inhibiting VEGF and thus suppressing the growth of abnormal blood vessels, it makes our study more significant, as it will provide most cutting-edge and comprehensive prediction models for AMD which have great potential to facilitate early diagnosis and tailored treatment and clinical management of the disease. PROJECT NARRATIVE The objective of this proposal is to develop new analytic methods and software tools to facilitate novel prediction of AMD development and its progression. The successful completion of the project will generate the first comprehensive set of deep-learning-based prediction models and web-based interfaces, which jointly analyzes large-scale GWAS and fundus image data and has the great potential to enhance the early diagnosis and current clinical management of AMD. The analytic approach can be applied to other eye diseases where large-scale genetics and/or image data are collected.",Deep-learning-based prediction of AMD and its progression with GWAS and fundus image data,10056062,R21EY030488,"['Achievement ', ' Achievement Attainment ', ' Elderly ', ' advanced age ', ' elders ', ' geriatric ', ' late life ', ' later life ', ' older adult ', ' older person ', ' senior citizen ', ' Blood Vessels ', ' vascular ', ' Cohort Studies ', ' Concurrent Studies ', ' Color ', ' Communities ', ' Diagnosis ', ' Disease ', ' Disorder ', ' Disease susceptibility ', ' Diathesis ', ' liability to disease ', ' Eye diseases ', ' eye disorder ', ' ophthalmopathy ', ' Genes ', ' Genotype ', ' Growth ', ' Generalized Growth ', ' Tissue Growth ', ' ontogeny ', ' Methods ', ' Online Systems ', ' On-Line Systems ', ' online computer ', ' web based ', ' Phenotype ', ' Research ', ' Research Personnel ', ' Investigators ', ' Researchers ', ' Risk ', ' Computer software ', ' Software ', ' Software Tools ', ' Computer Software Tools ', ' Testing ', ' Time ', ' Universities ', ' Work ', ' Dataset ', ' Data Set ', ' analytical method ', ' base ', ' improved ', ' Area ', ' Clinical ', ' Biological ', ' Training ', ' Individual ', ' Age-Related Maculopathy ', ' age related macular dystrophy ', ' senile macular disease ', ' Age related macular degeneration ', ' Disease Progression ', ' Ophthalmologist ', ' Genetic ', ' Exposure to ', ' machine learned ', ' Machine Learning ', ' Knowledge ', ' Disorder Management ', ' Disease Management ', ' Severities ', ' Techniques ', ' vision loss ', ' visual loss ', ' Blindness ', ' interest ', ' early detection ', ' Early Diagnosis ', ' success ', ' user friendly computer software ', ' user friendly software ', ' synergism ', ' cohort ', ' novel ', ' Categories ', ' Position ', ' Positioning Attribute ', ' Statistical Methods ', ' Modeling ', ' Sampling ', ' VEGF ', ' VEGFs ', ' Vascular Endothelial Growth Factors ', ' Progressive Disease ', ' Data ', ' Grant Proposals ', ' Applications Grants ', ' International ', ' Subgroup ', ' Clinical Management ', ' Collection ', ' Monitor ', ' Characteristics ', ' developmental ', ' Development ', ' imaging ', ' Image ', ' National Eye Institute ', ' clinical phenotype ', ' GWA study ', ' GWAS ', ' genome wide association ', ' genome wide association scan ', ' genome wide association studies ', ' genomewide association scan ', ' genomewide association studies ', ' genomewide association study ', ' whole genome association analysis ', ' whole genome association studies ', ' whole genome association study ', ' genome wide association study ', ' computer based prediction ', ' prediction model ', ' prognostic model ', ' predictive modeling ', ' computational tools ', ' computerized tools ', ' innovate ', ' innovative ', ' innovation ', ' Predisposition gene ', ' predisposing gene ', ' susceptibility allele ', ' susceptibility locus ', ' susceptibility variant ', ' Susceptibility Gene ', ' user-friendly ', ' web interface ', ' Network-based ', ' Graphical interface ', ' graphic user interface ', ' software user interface ', ' graphical user interface ', ' web based interface ', ' genome wide analysis ', ' genome wide studies ', ' genome-wide identification ', ' genome-wide analysis ', ' genome scale ', ' genomewide ', ' genome-wide ', ' dbGaP ', ' database of Genotypes and Phenotypes ', ' biorepository ', ' biobank ', ' customized therapy ', ' customized treatment ', ' individualized patient treatment ', ' individualized therapy ', ' individualized treatment ', ' patient specific therapies ', ' patient specific treatment ', ' tailored medical treatment ', ' tailored therapy ', ' tailored treatment ', ' unique treatment ', ' individualized medicine ', ' learning activity ', ' learning method ', ' learning strategy ', ' secondary analysis ', ' Injections ', ' Individualized risk prediction ', ' personalized risk prediction ', ' Individualized Predictors ', ' individualized predictions ', ' personalized predictors ', ' personalized predictions ', ' Data Banks ', ' Databanks ', ' data depository ', ' data repository ', ' data warehouse ', ' fundus imaging ', ' deep learning based neural network ', ' deep learning neural network ', ' deep neural net ', ' deep neural network ', ' deep learning ', ' neural network ', ' ConvNet ', ' convolutional network ', ' convolutional neural nets ', ' convolutional neural network ', ' public repository ', ' ']",NEI,UNIVERSITY OF PITTSBURGH AT PITTSBURGH,R21,2020,188198,PA-18,0.06041352233868105
